target_id,target_gene,organism,pdb_uniprot,allosteric_pdb,modulator_serial,modulator_alias,modulator_chain,modulator_class,modulator_feature,modulator_name,modulator_resi,function,position,pubmed_id,ref_title,site_overlap,allosteric_site_residue
ASD00020000_1,aroG,Escherichia coli,P0AB91,1KFL,ASD02170001,PHE,A,Lig,Inhibitor,(2S)-2-amino-3-phenyl-propanoic acid,1354,Inner Protein Regulator,Protein-Protein Interaction,12126632,Allosteric inhibition of 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase alters the coordination of both substrates.,No,"Chain A:PRO150,GLN151,ALA154,GLY178,LEU179,SER180,PHE209,SER211,LYS214,VAL221; Chain B:ASP6,ASP7,ILE10"
ASD00020000_2,aroF,Escherichia coli,P00888,6AGM,,TYR,A,Lig,Inhibitor,TYROSINE,601,Inner Protein Regulator,Inner Protein,,,No,
ASD00020000_4,aroF,Thermotoga maritima,Q9WYH8,3PG9,ASD00690002,TYR,A,Lig,Inhibitor,(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid,339,Inner Protein Regulator,Protein-Protein Interaction,21282100,Tyrosine latching of a regulatory gate affords allosteric control of aromatic amino acid biosynthesis,No,"Chain A:SER31,GLY33,GLN34,GLU35,ARG36,VAL38; Chain F:MET1,ILE2,GLY40,ILE41,ILE42,GLY43,ASP45,VAL65,LEU66"
ASD00020000_5,ARO4,Saccharomyces cerevisiae,P32449,1OF6,ASD00020003,DTY,A,Lig,Inhibitor,(2R)-2-amino-3-(4-hydroxyphenyl)propanoic acid,1370,Inner Protein Regulator,Protein-Protein Interaction,,Crystal Structure of the Double Complex of the Tyrosine Sensitive Dahp Synthase from Yeast,No,"Chain A:THR162,GLN166,ALA169,GLY193,LEU194,SER195,PHE224,GLY226,VAL227; Chain B:GLU21,ASP22,ILE25,TYR28"
ASD00020000_5,ARO4,Saccharomyces cerevisiae,P32449,1OFR,ASD02170001,PHE,H,Lig,Inhibitor,(2S)-2-amino-3-phenyl-propanoic acid,1002,Inner Protein Regulator,Protein-Protein Interaction,15019786,Substrate and Metal Complexes of 3-Deoxy-D-Arabino-Heptulosonate-7-Phosphate Synthase from Saccharomyces Cerevisiae Provide New Insights Into the Catalytic Mechanism.,No,"Chain G:THR162,PRO165,GLN166,ALA169,LEU190,GLY193,LEU194,SER195; Chain H:GLU21,ASP22,ILE25"
ASD00020000_5,ARO4,Saccharomyces cerevisiae,P32449,1OG0,ASD02170001,PHE,A,Lig,Inhibitor,(2S)-2-amino-3-phenyl-propanoic acid,1012,Inner Protein Regulator,Protein-Protein Interaction,,Crystal Structure of the Mutant G226S of the Tyrosine-Regulated 3-Deoxy-D-Arabino-Heptulosonate -7-Phosphate Synthase from Saccharomyces Cerevisiae Complexed with Phenylalanine and Manganese,No,"Chain A:THR162,GLN166,ALA169,LEU190,GLY193,LEU194,SER195,SER226,LYS229; Chain B:GLU21,ASP22,ILE25,TYR28"
ASD00020000_6,aroG,Neisseria meningitidis serogroup B,Q9K169,4UC5,ASD10090002,PHE,A,Lig,Inhibitor,PHENYLALANINE,1354,Allosteric Function,Allosteric Position,26794122,Calculated Pka Variations Expose Dynamic Allosteric Communication Networks.,No,"Chain B:THR7,ILE12,ILE10,ASP8,VAL15,ASP9"
ASD00060000_1,PDPK1,Homo sapiens,O15530,3HRF,ASD00060001,P47,A,Lig,Activator,(Z)-5-(4-chlorophenyl)-3-phenyl-pent-2-enoic acid,1374,Inner Protein Regulator,Inner Protein,19718043,Structure and allosteric effects of low-molecular-weight activators on the protein kinase PDK1.,No,3HRF
ASD00060000_1,PDPK1,Homo sapiens,O15530,3NAX,ASD00060027,MP7,A,Lig,Inhibitor,"1-[(3,4-difluorophenyl)methyl]-2-oxo-N-[(1R)-2-[(2-oxo-1,3-dihydrobenzimidazol-5-yl)oxy]-1-phenyl-ethyl]pyridine-3-carboxamide",363,Inner Protein Regulator,Inner Protein,21118801,Genetic and pharmacological inhibition of PDK1 in cancer cells: characterization of a selective allosteric kinase inhibitor.,Yes,3NAX
ASD00060000_1,PDPK1,Homo sapiens,O15530,3ORX,ASD00060035,1F8,A,Lig,Inhibitor,2-methyl-N-(2-sulfanylethyl)-1-benzofuran-3-carboxamide,1,Inner Protein Regulator,Inner Protein,21430264,Turning a protein kinase on or off from a single allosteric site via disulfide trapping.,No,3ORX
ASD00060000_1,PDPK1,Homo sapiens,O15530,3ORZ,ASD00068003,2A2,A,Lig,Activator,1-[4-(3-chlorophenyl)piperazin-1-yl]-4-sulfanyl-butan-1-one,1,Inner Protein Regulator,Inner Protein,21430264,Turning a protein kinase on or off from a single allosteric site via disulfide trapping.,No,3ORZ
ASD00060000_1,PDPK1,Homo sapiens,O15530,3OTU,ASD00068007,J30,A,Lig,Activator,1-[4-(naphthalen-1-ylmethyl)piperazin-1-yl]-4-sulfanyl-butan-1-one,1,Inner Protein Regulator,Inner Protein,21430264,Turning a protein kinase on or off from a single allosteric site via disulfide trapping.,No,3OTU
ASD00060000_1,PDPK1,Homo sapiens,O15530,4A06,ASD00060038,A06,A,Lig,Activator,(3S)-4-(5-chloro-1H-benzimidazol-2-yl)-3-(4-chlorophenyl)butanoic acid,600,Inner Protein Regulator,Inner Protein,22118680,Allosteric Regulation of Protein Kinase Pkczeta by the N-Terminal C1 Domain and Small Compounds to the Pif-Pocket.,No,4A06
ASD00060000_1,PDPK1,Homo sapiens,O15530,4A07,ASD00060039,AZ7,A,Lig,Activator,"(3S)-4-[5,7-bis(chloranyl)-1H-benzimidazol-2-yl]-3-(4-chlorophenyl)butanoic acid",600,Inner Protein Regulator,Inner Protein,22118680,Allosteric Regulation of Protein Kinase Pkczeta by the N-Terminal C1 Domain and Small Compounds to the Pif-Pocket.,No,4A07
ASD00060000_1,PDPK1,Homo sapiens,O15530,4AW0,ASD00068008,MJF,A,Lig,Activator,2-[(1R)-3-(4-chlorophenyl)-3-oxidanylidene-1-phenyl-propyl]propanedioic acid,600,Inner Protein Regulator,Inner Protein,22999883,Substrate-Selective Inhibition of Protein Kinase Pdk1 by Small Compounds that Bind to the Pif-Pocket Allosteric Docking Site.,No,4AW0
ASD00060000_1,PDPK1,Homo sapiens,O15530,4AW1,ASD00068002,21O,A,Lig,Activator,2-[(1R)-3-oxidanylidene-1-phenyl-3-[4-(trifluoromethyl)phenyl]propyl]propanedioic acid,1361,Inner Protein Regulator,Inner Protein,22999883,Substrate-Selective Inhibition of Protein Kinase Pdk1 by Small Compounds that Bind to the Pif-Pocket Allosteric Docking Site.,No,4AW1
ASD00060000_1,PDPK1,Homo sapiens,O15530,4CT1,ASD00060029,31S,A,Lig,Inhibitor,(Z)-5-(4-chlorophenyl)-3-(4-phenylphenyl)pent-2-enoic acid,600,Inner Protein Regulator,Inner Protein,24836908,Molecular Mechanism of Regulation of the Atypical Protein Kinase C by N-Terminal Domains and an Allosteric Small Compound.,No,4CT1
ASD00060000_1,PDPK1,Homo sapiens,O15530,4RQK,ASD00060028,R1S,A,Lig,Inhibitor,"N-(6-chloro-1,3-benzothiazol-2-yl)-1-benzothiophene-3-sulfonamide",404,Allosteric function,Allosteric position,25518860,A small-molecule mimic of a peptide docking motif inhibits the protein kinase PDK1.,No,4RQK
ASD00060000_1,PDPK1,Homo sapiens,O15530,4RQV,ASD00060031,R2S,A,Lig,Inhibitor,"N-(6-chloro-1,3-benzothiazol-2-yl)-1-benzothiophene-2-sulfonamide",406,Allosteric function,Allosteric position,25518860,A small-molecule mimic of a peptide docking motif inhibits the protein kinase PDK1.,No,4RQV
ASD00060000_1,PDPK1,Homo sapiens,O15530,4XX9,ASD00060037,RF4,A,Lig,Regulator,"(2-{[2-(2,6-dimethylphenoxy)ethyl]sulfanyl}- 1H-benzimidazol-1-yl)acetic acid",402,Allosteric Function,Allosteric Position,26443011,Small-Molecule Allosteric Modulators of the Protein Kinase PDK1 from Structure-Based Docking.,No,4XX9
ASD00060000_1,PDPK1,Homo sapiens,O15530,5ACK,ASD00060062,SVQ,A,Lig,Regulator,1-(4-CHLOROPHENETHYL)-2-(2-CHLOROPHENYL)- 6-OXOPIPERIDINE-3-CARBOXYLIC ACID,600,Allosteric Function,Allosteric Position,26385475,Discovery of a Potent Allosteric Kinase Modulator by Combining Computational and Synthetic Methods.,No,5ACK
ASD00060000_1,PDPK1,Homo sapiens,O15530,5LVL,ASD05213050,537,A,Lig,Inhibitor,"2,6-DIHYDROANTHRA/1,9-CD/PYRAZOL-6-ONE",401,Allosteric Fuction,Allosteric Position,27693059,Bidirectional Allosteric Communication between the ATP-Binding Site and the Regulatory PIF Pocket in PDK1 Protein Kinase.,Yes,5LVL
ASD00060000_1,PDPK1,Homo sapiens,O15530,5LVN,ASD08628001,ADN,A,Lig,Activator,ADENOSINE,402,Allosteric Fuction,Allosteric Position,27693059,Bidirectional Allosteric Communication between the ATP-Binding Site and the Regulatory PIF Pocket in PDK1 Protein Kinase.,Yes,5LVN
ASD00060000_1,PDPK1,Homo sapiens,O15530,5LVO,ASD00060056,78W,A,Lig,Activator,2-oxidanylidenepropyl ~{N}-(2-chloranyl-6-fluoranyl-phenyl)carbonyl-~{N}'-(4-chlorophenyl)carbamimidothioate,402,Allosteric Fuction,Allosteric Position,27693059,Bidirectional Allosteric Communication between the ATP-Binding Site and the Regulatory PIF Pocket in PDK1 Protein Kinase.,Yes,5LVO
ASD00060000_1,PDPK1,Homo sapiens,O15530,5LVP,,HM-peptide,E,Pep,Activator,hydrophobic-motif peptide of PKB/Akt,1-15,Allosteric Fuction,Allosteric Position,27693059,Bidirectional Allosteric Communication between the ATP-Binding Site and the Regulatory PIF Pocket in PDK1 Protein Kinase.,Yes,5LVP
ASD00060000_1,PDPK1,Homo sapiens,O15530,5MRD,ASD00060061,S26,A,Lig,Inhibitor,"ethyl (2~{S})-1-(6-chloranyl-1,3-benzothiazol-2-yl)-4-oxidanyl-5-oxidanylidene-2-thiophen-2-yl-2~{H}-pyrrole-3-carboxylate",401,Allosteric Fuction,Allosteric Position,28045490,An Allosteric Inhibitor Scaffold Targeting the PIF-Pocket of Atypical Protein Kinase C Isoforms.,Yes,5MRD
ASD00170000_1,ADORA1,Homo sapiens,P30542,7LD3,,XTD,R,Lig,Regulator,"{2-amino-4-[3,5-bis(trifluoromethyl)phenyl]thiophen-3-yl}(4-chlorophenyl)methanone",402,,,,,,7LD3
ASD00180000_1,ADORA2A,Homo sapiens,P29274,3VG9,ASD00180006;ASD00180006,Chain_B;Chain_C,B;C,Pep,Inhibitor,,Chain_B;Chain_C,Inner Protein Regulator,Protein-Protein Interaction,22286059,G-protein-coupled receptor inactivation by an allosteric inverse-agonist antibody,No,3VG9
ASD00180000_1,ADORA2A,Homo sapiens,P29274,3VGA,ASD00180006;ASD00180006,Chain_B;Chain_C,B;C,Pep,Inhibitor,,Chain_B;Chain_C,Inner Protein Regulator,Protein-Protein Interaction,22286059,G-protein-coupled receptor inactivation by an allosteric inverse-agonist antibody,No,3VGA
ASD00230000_2,Ache,Mus musculus,P21836,1J07,ASD00230007,DCU,A,Lig,Inhibitor,"10-(3,8-diamino-6-phenyl-phenanthridin-5-ium-5-yl)decyl-trimethyl-azanium",951,Inner Protein Regulator,Inner Protein,12505979,Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site,Yes,"Chain A:TYR72,TRP286,HIS287,LEU289,GLN291,GLU292,SER293"
ASD00230000_2,Ache,Mus musculus,P21836,1N5M,ASD00230008,GMN,A,Lig,Inhibitor,"2-[2,6-bis(2-triethylazaniumylethoxy)phenoxy]ethyl-triethyl-azanium",951,Inner Protein Regulator,Inner Protein,12505979,Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site,Yes,"Chain A:TYR72,ASP74,TYR124,TRP286,TYR341"
ASD00230000_2,Ache,Mus musculus,P21836,1N5R,ASD00230009,PRM,A,Lig,Inhibitor,"3-(3,8-diamino-6-phenyl-phenanthridin-5-ium-5-yl)propyl-diethyl-methyl-azanium",951,Inner Protein Regulator,Inner Protein,12505979,Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site,Yes,"Chain A:TYR72,TRP286,HIS287,LEU289,SER293,TYR341"
ASD00230000_2,Ache,Mus musculus,P21836,2HA0,ASD00230014,CHH,A,Lig,Regulator,trimethyl-(4-oxopentyl)azanium,1602,Inner Protein Regulator,Inner Protein,16837465,Substrate and product trafficking through the active center gorge of acetylcholinesterase analyzed by crystallography and equilibrium binding,Yes,"Chain A:TYR72,ASP74,TYR124,TRP286,TYR341"
ASD00230000_2,Ache,Mus musculus,P21836,2HA2,ASD00230017,SCK,A,Lig,Regulator,trimethyl-[2-[4-oxo-4-(2-trimethylazaniumylethoxy)butanoyl]oxyethyl]azanium,901,Inner Protein Regulator,Inner Protein,16837465,Substrate and product trafficking through the active center gorge of acetylcholinesterase analyzed by crystallography and equilibrium binding,Yes,"Chain A:TYR72,ASP74,TRP86,TYR124,TRP286,PHE297,TYR337,PHE338,TYR341,HIS447"
ASD00230000_2,Ache,Mus musculus,P21836,2HA3,ASD00230015,CHT,A,Lig,Regulator,2-hydroxyethyl-trimethyl-azanium,952,Inner Protein Regulator,Inner Protein,16837465,Substrate and product trafficking through the active center gorge of acetylcholinesterase analyzed by crystallography and equilibrium binding,Yes,"Chain A:TYR72,ASP74,TYR124,TRP286,TYR341"
ASD00230000_2,Ache,Mus musculus,P21836,2HA4,ASD00230019,ACH,A,Lig,Regulator,2-acetyloxyethyl-trimethyl-azanium,545,Inner Protein Regulator,Inner Protein,16837465,Substrate and product trafficking through the active center gorge of acetylcholinesterase analyzed by crystallography and equilibrium binding,Yes,"Chain A:TYR72,TYR124,TRP286,PHE297,PHE338,TYR341"
ASD00230000_2,Ache,Mus musculus,P21836,2HA5,ASD00230012,ETM,A,Lig,Regulator,trimethyl-(2-sulfanylethyl)azanium,1905,Inner Protein Regulator,Inner Protein,16837465,Substrate and product trafficking through the active center gorge of acetylcholinesterase analyzed by crystallography and equilibrium binding,Yes,"Chain A:TYR72,TYR124,TRP286,TYR341"
ASD00230000_2,Ache,Mus musculus,P21836,2HA6,ASD00230017,SCK,A,Lig,Regulator,trimethyl-[2-[4-oxo-4-(2-trimethylazaniumylethoxy)butanoyl]oxyethyl]azanium,901,Inner Protein Regulator,Inner Protein,16837465,Substrate and product trafficking through the active center gorge of acetylcholinesterase analyzed by crystallography and equilibrium binding,Yes,"Chain A:TYR72,ASP74,TRP86,GLY121,TYR124,GLU202,ALA203,TRP286,PHE297,TYR337,PHE338,TYR341"
ASD00230000_2,Ache,Mus musculus,P21836,2HA7,ASD00230016,BCH,A,Lig,Regulator,2-butanoylsulfanylethyl-trimethyl-azanium,910,Inner Protein Regulator,Inner Protein,16837465,Substrate and product trafficking through the active center gorge of acetylcholinesterase analyzed by crystallography and equilibrium binding,Yes,"Chain A:TYR72,TYR124,TRP286,TYR337,TYR341"
ASD00230000_3,ache,Torpedo californica,P04058,2C4H,ASD00230010,AT3,A,Lig,Regulator,2-ethanoylsulfanylethyl-trimethyl-azanium,1541,Inner Protein Regulator,Inner Protein,16763558,Structural Insights Into Substrate Traffic and Inhibition in Acetylcholinesterase.,Yes,"Chain A:TYR70,TYR121,TRP279,PHE330,TYR334"
ASD00230000_3,ache,Torpedo californica,P04058,2C58,ASD00230010,AT3,A,Lig,Regulator,2-ethanoylsulfanylethyl-trimethyl-azanium,1537,Inner Protein Regulator,Inner Protein,16763558,Structural Insights Into Substrate Traffic and Inhibition in Acetylcholinesterase.,Yes,"Chain A:TYR70,TYR121,TRP279,PHE330,PHE331"
ASD00230000_3,ache,Torpedo californica,P04058,2C5F,ASD00230014,CHH,A,Lig,Regulator,trimethyl-(4-oxopentyl)azanium,1542,Inner Protein Regulator,Inner Protein,16763558,Structural Insights Into Substrate Traffic and Inhibition in Acetylcholinesterase.,Yes,"Chain A:TYR70,TYR121,TRP279,PHE331,TYR334"
ASD00230000_3,ache,Torpedo californica,P04058,2C5G,ASD00230012,ETM,A,Lig,Regulator,trimethyl-(2-sulfanylethyl)azanium,1538,Inner Protein Regulator,Inner Protein,16763558,Structural Insights Into Substrate Traffic and Inhibition in Acetylcholinesterase.,Yes,"Chain A:TYR70,TYR121,TRP279"
ASD00230000_3,ache,Torpedo californica,P04058,2J3Q,ASD00230021,TFL,A,Lig,Activator,"2-(4-dimethylaminophenyl)-3-methyl-1,3-benzothiazol-3-ium-6-ol",1538,Inner Protein Regulator,Inner Protein,18512913,Crystal Structure of Thioflavin T Bound to the Peripheral Site of Torpedo Californica Acetylcholinesterase Reveals How Thioflavin T Acts as a Sensitive Fluorescent Reporter of Ligand Binding to the Acylation Site.,Yes,"Chain A:TYR70,TYR121,TRP279,PHE330,PHE331,TYR334"
ASD00240000_1,AMD1,Homo sapiens,P17707,1I72,ASD00240001,PUT,A,Lig,Activator,"butane-1,4-diamine",350,Inner Protein Regulator,Inner Protein,11583147,The structural basis for substrate specificity and inhibition of human S-adenosylmethionine decarboxylase.,No,1I72
ASD00240000_1,AMD1,Homo sapiens,P17707,1I79,ASD00240001,PUT,A,Lig,Activator,"butane-1,4-diamine",350,Inner Protein Regulator,Inner Protein,11583147,The structural basis for substrate specificity and inhibition of human S-adenosylmethionine decarboxylase.,No,1I79
ASD00240000_1,AMD1,Homo sapiens,P17707,1I7B,ASD00240001,PUT,A,Lig,Activator,"butane-1,4-diamine",350,Inner Protein Regulator,Inner Protein,11583147,The structural basis for substrate specificity and inhibition of human S-adenosylmethionine decarboxylase.,No,1I7B
ASD00240000_1,AMD1,Homo sapiens,P17707,1I7C,ASD00240001,PUT,A,Lig,Activator,"butane-1,4-diamine",350,Inner Protein Regulator,Inner Protein,11583147,The structural basis for substrate specificity and inhibition of human S-adenosylmethionine decarboxylase.,No,1I7C
ASD00240000_1,AMD1,Homo sapiens,P17707,1I7M,ASD00240001,PUT,B,Lig,Activator,"butane-1,4-diamine",350,Inner Protein Regulator,Inner Protein,11583147,The structural basis for substrate specificity and inhibition of human S-adenosylmethionine decarboxylase.,No,1I7M
ASD00240000_1,AMD1,Homo sapiens,P17707,1MSV,ASD00240001,PUT,A,Lig,Inhibitor,"butane-1,4-diamine",355,Inner Protein Regulator,Inner Protein,12600205,Mechanism of human S-adenosylmethionine decarboxylase proenzyme processing as revealed by the structure of the S68A mutant.,No,1MSV
ASD00240000_1,AMD1,Homo sapiens,P17707,3DZ3,ASD00240001,PUT,B,Lig,Activator,"butane-1,4-diamine",350,Inner Protein Regulator,Inner Protein,19209891,New Insights into the Design of Inhibitors of Human S-Adenosylmethionine Decarboxylase: Studies of Adenine C(8) Substitution in Structural Analogues of S-Adenosylmethionine (dagger).,No,3DZ3
ASD00240000_1,AMD1,Homo sapiens,P17707,3EP5,ASD00240018,URE,A,Lig,Activator,urea,350,Inner Protein Regulator,Inner Protein,19053272,Structural basis for putrescine activation of human S-adenosylmethionine decarboxylase.,No,3EP5
ASD00240000_1,AMD1,Homo sapiens,P17707,3EPA,ASD00240001,PUT,A,Lig,Activator,"butane-1,4-diamine",350,Inner Protein Regulator,Inner Protein,19053272,Structural basis for putrescine activation of human S-adenosylmethionine decarboxylase.,No,3EPA
ASD00240000_1,AMD1,Homo sapiens,P17707,3EPB,ASD00240001,PUT,B,Lig,Activator,"butane-1,4-diamine",350,Inner Protein Regulator,Inner Protein,19053272,Structural basis for putrescine activation of human S-adenosylmethionine decarboxylase.,No,3EPB
ASD00240000_1,AMD1,Homo sapiens,P17707,3H0V,ASD00240001,PUT,B,Lig,Activator,"butane-1,4-diamine",350,Inner Protein Regulator,Inner Protein,19527050,Role of the sulfonium center in determining the ligand specificity of human s-adenosylmethionine decarboxylase.,No,3H0V
ASD00240000_1,AMD1,Homo sapiens,P17707,3H0W,ASD00240001,PUT,B,Lig,Activator,"butane-1,4-diamine",350,Inner Protein Regulator,Inner Protein,19527050,Role of the sulfonium center in determining the ligand specificity of human s-adenosylmethionine decarboxylase.,No,3H0W
ASD00250000_6,,Solanum tuberosum,P23509,1YP2,ASD02880002;ASD02880002,SO4;SO4,A;A,Ion,Activator,sulfate;sulfate,2000;2008,Inner Protein Regulator,Protein-Protein Interaction,15692569,Crystal structure of potato tuber ADP-glucose pyrophosphorylase.,No,"Chain A:ARG41,PRO47,ARG53,HIS84,GLN314,ARG316,ASP370,LYS404,LYS441"
ASD00250000_6,,Solanum tuberosum,P23509,1YP2,ASD02880002,SO4,A,Ion,Activator,sulfate,2007,Inner Protein Regulator,Inner Protein,15692569,Crystal structure of potato tuber ADP-glucose pyrophosphorylase.,No,"Chain A:LYS69,GLU133,HIS134,THR135; Chain D:ARG83"
ASD00250000_6,,Solanum tuberosum,P23509,1YP3,ASD02880002;ASD02880002,SO4;SO4,A;A,Ion,Activator,sulfate;sulfate,1000;1008,Inner Protein Regulator,Protein-Protein Interaction,15692569,Crystal structure of potato tuber ADP-glucose pyrophosphorylase.,No,"Chain A:ARG41,PRO47,ARG53,SER80,HIS84,GLN314,ARG316,ASP370,LYS404,LYS441"
ASD00250000_6,,Solanum tuberosum,P23509,1YP3,ASD02880002,SO4,A,Ion,Activator,sulfate,1007,Inner Protein Regulator,Inner Protein,15692569,Crystal structure of potato tuber ADP-glucose pyrophosphorylase.,No,"Chain A:LYS69,GLU133,HIS134,THR135; Chain D:ARG83"
ASD00250000_6,,Solanum tuberosum,P23509,1YP4,ASD02880002;ASD02880002,SO4;SO4,A;A,Ion,Activator,sulfate;sulfate,1000;1008,Inner Protein Regulator,Protein-Protein Interaction,15692569,Crystal structure of potato tuber ADP-glucose pyrophosphorylase.,No,"Chain A:ARG41,PRO47,ARG53,SER80,ARG83,HIS84,GLN314,ARG316,ASP370,LYS404,LYS441"
ASD00250000_6,,Solanum tuberosum,P23509,1YP4,ASD02880002,SO4,A,Ion,Activator,sulfate,1007,Inner Protein Regulator,Inner Protein,15692569,Crystal structure of potato tuber ADP-glucose pyrophosphorylase.,No,"Chain A:LYS69,GLU133,HIS134,THR135"
ASD00250000_7,glgC,Rhizobium radiobacter,P39669,3BRK,ASD02880002,SO4,X,Ion,Activator,sulfate,601,Inner Protein Regulator,Inner Protein,18355040,Structural analysis of ADP-glucose pyrophosphorylase from the bacterium Agrobacterium tumefaciens.,No,"Chain X:ARG33,TYR39,ARG45,SER72,HIS379"
ASD00250000_7,glgC,Rhizobium radiobacter,P39669,5W5R,ASD00340002,PYR,A,Lig,Activator,PYRUVIC ACID,503,Allosteric function,Allosteric position,30401744,Structural analysis reveals a pyruvate-binding activator site in theAgrobacterium tumefaciensADP-glucose pyrophosphorylase.,No,"Chain P:THR307,GLY330,VAL328,SER329,ALA310,PRO309,LYS44,ASP331,PRO308"
ASD00250000_7,glgC,Rhizobium radiobacter,P39669,5W5T,,9X7,F,Lig,Activator,ethyl 2-oxopropanoate,503,Allosteric function,Allosteric position,30401744,Structural analysis reveals a pyruvate-binding activator site in theAgrobacterium tumefaciensADP-glucose pyrophosphorylase.,No,
ASD00280000_1,purF,Bacillus subtilis,P00497,1AO0,ASD01720027,ADP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate",468,Inner Protein Regulator,Protein-Protein Interaction,9271502,Mechanism of the synergistic end-product regulation of Bacillus subtilis glutamine phosphoribosylpyrophosphate amidotransferase by nucleotides.,Yes,"Chain A:HIS25,TYR242,SER244,ARG245,PRO246,ARG259,PRO281,ASP282,SER283,LYS305,LYS328; Chain B:ILE304,LYS305,ASN306,ARG307"
ASD00280000_1,purF,Bacillus subtilis,P00497,1GPH,ASD00030001,AMP,1,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",468,Inner Protein Regulator,Protein-Protein Interaction,8197456,Structure of the allosteric regulatory enzyme of purine biosynthesis.,Yes,"Chain 1:HIS25,TYR242,SER244,ARG245,PRO246,ARG259,PRO281,ASP282,SER283,LYS305; Chain 2:ILE304,LYS305,ARG307"
ASD00280000_2,purF,Escherichia coli,P0AG16,1ECB,ASD00860008,5GP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl dihydrogen phosphate",506,Inner Protein Regulator,Protein-Protein Interaction,9333323,Coupled formation of an amidotransferase interdomain ammonia channel and a phosphoribosyltransferase active site.,Yes,"Chain A:HIS25,TYR258,ALA260,ARG261,PRO262,ARG275,PRO302,GLU303,THR304,LYS326,ASP367; Chain B:VAL325,LYS326,ASN327,ARG328"
ASD00310000_1,Prkag1,Rattus norvegicus,P80385,2V8Q,ASD00030001,AMP,E,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",1329,Protein-Protein Interaction Regulator,Inner Protein,17851531,Structural Basis for AMP Binding to Mammalian AMP-Activated Protein Kinase,No,"Chain E:HIS150,THR199,ASN202,ILE203,ALA204,VAL224,SER225,ALA226,PRO228,HIS297,ILE311,SER313,SER315,ASP316"
ASD00310000_1,Prkag1,Rattus norvegicus,P80385,2V92,ASD00030001,AMP,E,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",1329,Protein-Protein Interaction Regulator,Inner Protein,17851531,Structural Basis for AMP Binding to Mammalian AMP-Activated Protein Kinase,No,"Chain E:HIS150,THR199,ASN202,ILE203,ALA204,VAL224,SER225,ALA226,PRO228,HIS297,ILE311,SER313,SER315,ASP316"
ASD00310000_1,Prkag1,Rattus norvegicus,P80385,2V9J,ASD00030001,AMP,E,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",1329,Protein-Protein Interaction Regulator,Inner Protein,17851531,Structural Basis for AMP Binding to Mammalian AMP-Activated Protein Kinase,No,"Chain E:HIS150,THR199,ASN202,ILE203,ALA204,VAL224,SER225,ALA226,PRO228,HIS297,ILE311,SER313,SER315,ASP316"
ASD00310000_1,Prkag1,Rattus norvegicus,P80385,2Y8L,ASD00030001,AMP,E,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",1329,Protein-Protein Interaction Regulator,Inner Protein,21399626,Structure of Mammalian Ampk and its Regulation by Adp,No,"Chain E:HIS150,THR199,ASN202,ILE203,ALA204,VAL224,SER225,ALA226,PRO228,HIS297,ILE311,SER313,SER315,ASP316"
ASD00310000_1,Prkag1,Rattus norvegicus,P80385,2Y8Q,ASD00030001,AMP,E,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",1328,Protein-Protein Interaction Regulator,Inner Protein,21399626,Structure of Mammalian Ampk and its Regulation by Adp,No,"Chain E:HIS150,THR199,ASN202,ILE203,ALA204,VAL224,SER225,ALA226,PRO228,ILE311,SER313,SER315,ASP316"
ASD00310000_1,Prkag1,Rattus norvegicus,P80385,2YA3,ASD00030001,AMP,E,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",1327,Protein-Protein Interaction Regulator,Inner Protein,21399626,Structure of Mammalian Ampk and its Regulation by Adp,No,"Chain E:HIS150,THR199,ASN202,ILE203,ALA204,VAL224,SER225,ALA226,PRO228,HIS297,ILE311,SER313,SER315,ASP316"
ASD00310000_1,Prkag1,Rattus norvegicus,P80385,4CFH,ASD00030001,AMP,E,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",1326,Protein-Protein Interaction Regulator,Inner Protein,21399626,Structure of Mammalian Ampk and its Regulation by Adp,No,"Chain E:HIS150,THR199,ASN202,ILE203,ALA204,VAL224,SER225,ALA226,LEU227,PRO228,HIS297,ILE311,SER313,SER315,ASP316"
ASD00310000_1,Prkag1,Rattus norvegicus,P80385,4EAG,ASD00150001,ATP,C,Lig,Activator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",402,Protein-Protein Interaction Regulator,Inner Protein,22659875,AMP-activated protein kinase undergoes nucleotide-dependent conformational changes,No,"Chain C:HIS150,HIS168,THR199,ASN202,ILE203,ALA204,VAL224,SER225,ALA226,LEU227,PRO228,HIS297,ARG298,ILE311,SER313,LEU314,SER315,ASP316"
ASD00310000_1,Prkag1,Rattus norvegicus,P80385,4EAJ,ASD00030001,AMP,C,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",403,Protein-Protein Interaction Regulator,Inner Protein,,AMP-activated protein kinase undergoes nucleotide-dependent conformational changes,No,"Chain C:HIS150,THR199,ASN202,ILE203,ALA204,VAL224,SER225,ALA226,PRO228,HIS297,ILE311,SER313,SER315,ASP316"
ASD00310000_1,Prkag1,Rattus norvegicus,P80385,4EAK,ASD00150001,ATP,C,Lig,Activator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",402,Protein-Protein Interaction Regulator,Inner Protein,22659875,AMP-activated protein kinase undergoes nucleotide-dependent conformational changes,No,"Chain C:HIS150,HIS168,THR199,ASN202,ILE203,ALA204,VAL224,SER225,ALA226,PRO228,HIS297,ARG298,ILE311,SER313,LEU314,SER315,ASP316"
ASD00310000_1,Prkag1,Rattus norvegicus,P80385,4EAL,ASD00030001,AMP,C,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",402,Protein-Protein Interaction Regulator,Inner Protein,22659875,AMP-activated protein kinase undergoes nucleotide-dependent conformational changes,No,"Chain C:HIS150,THR199,ILE203,ALA204,VAL224,SER225,ALA226,PRO228,ILE311,SER313,SER315,ASP316"
ASD00310000_1,Prkag1,Rattus norvegicus,P80385,4QFG,ASD00030001,AMP,C,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",401,Protein-Protein Interaction Regulator,Inner Protein,25066137,Structural Basis for AMPK Activation: Natural and Synthetic Ligands Regulate Kinase Activity from Opposite Poles by Different Molecular Mechanisms.,No,"Chain C:HIS150,THR199,ASN202,ILE203,ALA204,VAL224,SER225,ALA226,ARG298,ILE311,SER313,SER315,ASP316"
ASD00310000_1,Prkag1,Rattus norvegicus,P80385,4QFR,ASD00030001,AMP,C,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",401,Protein-Protein Interaction Regulator,Inner Protein,25066137,Structural Basis for AMPK Activation: Natural and Synthetic Ligands Regulate Kinase Activity from Opposite Poles by Different Molecular Mechanisms.,No,"Chain C:HIS150,THR199,ILE203,ALA204,VAL224,SER225,ALA226,PRO228,HIS297,ARG298,ILE311,SER313,SER315,ASP316"
ASD00310000_1,Prkag1,Rattus norvegicus,P80385,4QFS,ASD00030001,AMP,C,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",401,Protein-Protein Interaction Regulator,Inner Protein,25066137,Structural Basis for AMPK Activation: Natural and Synthetic Ligands Regulate Kinase Activity from Opposite Poles by Different Molecular Mechanisms.,No,"Chain C:HIS150,ILE203,ALA204,VAL224,SER225,ALA226,PRO228,HIS297,ARG298,SER313,SER315,ASP316"
ASD00310000_3,Prkaa1,Rattus norvegicus,P54645,5KQ5,ASD00310206,6VT,A,Lig,Activator,6-chloranyl-5-[4-(1-oxidanylcyclobutyl)phenyl]-1~{H}-indole-3-carboxylic acid,602,Inner Protein Regulator,Allosteric Position,27490827,"Discovery and Preclinical Characterization of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577), a Direct Activator of Adenosine Monophosphate-activated Protein Kinase (AMPK), for the Potential Treatment of Diabetic Nephropathy.",No,"Chain B:ALA114,ASP108,VAL113,ILE115,ARG83,ASN111,THR106,ARG107,VAL81"
ASD00310000_3,Prkaa1,Rattus norvegicus,P54645,5T5T,ASD00310185,75O,B,Lig,Activator,6-chloro-5-[6-(dimethylamino)-2-methoxypyridin-3-yl]-1H-indole-3-carboxylic acid,4000,Inner Protein Regulator,Allosteric Position,28289077,Selective Activation of AMPK beta 1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy.,No,Chain B:VAL113
ASD00310000_5,PRKAG1,Homo sapiens,P54619,4CFE,ASD00030001,AMP,E,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",1328,Protein-Protein Interaction Regulator,Inner Protein,24352254,Structural Basis of Ampk Regulation by Small Molecule Activators.,No,4CFE
ASD00310000_5,PRKAB1,Homo sapiens,Q9Y478,4CFF,ASD00310001,C1V,B,Lig,Activator,"3-[4-(2-hydroxyphenyl)phenyl]-4-oxidanyl-6-oxidanylidene-7H-thieno[2,3-b]pyridine-5-carbonitrile",1271,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24352254,Structural Basis of Ampk Regulation by Small Molecule Activators.,No,4CFF
ASD00310000_5,PRKAG1,Homo sapiens,P54619,4CFF,ASD00030001,AMP,E,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",1327,Protein-Protein Interaction Regulator,Inner Protein,24352254,Structural Basis of Ampk Regulation by Small Molecule Activators.,No,4CFF
ASD00310000_5,PRKAB2,Homo sapiens,O43741,4RER,ASD00310360,BCD,,Lig,Regulator,BETA-CYCLODEXTRIN,301,Protein-Protein Interaction,Protein-Protein Interaction,25412657,Structural basis of AMPK regulation by adenine nucleotides and glycogen.,No,4RER
ASD00310000_6,MJ1225,Methanocaldococcus jannaschii,Q58622,3KH5,ASD00030001,AMP,A,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",282,Inner Protein Regulator,Inner Protein,20382158,The crystal structure of protein MJ1225 from Methanocaldococcus jannaschii shows strong conservation of key structural features seen in the eukaryal gamma-AMPK.,No,"Chain A:ARG180,ARG181,ILE193,THR195,THR197,ASP198,LYS201,LYS230,ASP232,VAL233,ILE234,ILE254,ALA256"
ASD00310000_7,PRKAA2,Homo sapiens,P54646,4CFE,ASD00310005,992,A,Lig,Activator,5-[[6-chloranyl-5-(1-methylindol-5-yl)-1H-benzimidazol-2-yl]oxy]-2-methyl-benzoic acid,1553,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24352254,Structural Basis of Ampk Regulation by Small Molecule Activators.,No,4CFE
ASD00310000_7,PRKAA2,Homo sapiens,P54646,4ZHX,ASD00310181,C2Z,"E,F",Lig,Activator,5-(5-hydroxyl-isoxazol-3-yl)-furan-2-phosphonic acid,"401,402",Allosteric Function,Allosteric Position,26952388,Structural basis of allosteric and synergistic activation of AMPK by furan-2-phosphonic derivative C2 binding.,No,4ZHX
ASD00310000_7,PRKAA2,Homo sapiens,P54646,5EZV,ASD00310181,C2Z,E,Lig,Acttivator,5-(5-hydroxyl-isoxazol-3-yl)-furan-2-phosphonic acid,401,Protein-Protein Interaction,Protein-Protein Interaction,26952388,Structural basis of allosteric and synergistic activation of AMPK by furan-2-phosphonic derivative C2 binding.,No,5EZV
ASD00320000_1,trpE,Salmonella typhimurium,P00898,1I1Q,ASD00320001,TRP,A,Lig,Inhibitor,(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid,1001,Inner Protein Regulator,Inner Protein,11224570,Structure of the cooperative allosteric anthranilate synthase from Salmonella typhimurium.,No,"Chain A:LEU38,GLU39,SER40,ASP48,LEU49,LYS50,PRO291,TYR292,MET293,VAL453,GLY454,TYR455,ASP463,CYS465"
ASD00320000_3,trpE,Serratia marcescens,P00897,1I7S,ASD00320001,TRP,A,Lig,Inhibitor,(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid,601,Inner Protein Regulator,Inner Protein,11371633,"The structures of anthranilate synthase of Serratia marcescens crystallized in the presence of (i) its substrates, chorismate and glutamine, and a product, glutamate, and (ii) its end-product inhibitor, L-tryptophan.",No,"Chain A:LEU38,GLU39,SER40,LEU49,GLN50,PRO291,TYR292,MET293,VAL453,GLY454,TYR455,ASP463,CYS465"
ASD00330000_2,pyrI,Escherichia coli,E8Y329,4KGV,ASD00150001,ATP,B,Lig,Activator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",202,Inner Protein Regulator,Inner Protein,24138583,New Paradigm for Allosteric Regulation of Escherichia coli Aspartate Transcarbamoylase.,No,"Chain B:ALA11,ILE12,VAL17,ASP19,HIS20,LYS60,ASN84,ILE86,TYR89,VAL91,LYS94"
ASD00330000_2,pyrI,Escherichia coli,E8Y329,4KGX,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",202,Inner Protein Regulator,Inner Protein,24138583,New Paradigm for Allosteric Regulation of Escherichia coli Aspartate Transcarbamoylase.,No,"Chain B:GLU10,ALA11,ILE12,VAL17,ASP19,HIS20,LYS60,THR82,ASN84,ILE86,TYR89,VAL91,LYS94"
ASD00330000_2,pyrI,Escherichia coli,E8Y329,4KH0,ASD00330030;ASD01140145;ASD00330030,ATP;MG;ATP,B;B;B,Lig,Activator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate;magnesium(+2) cation;[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",202;203;204,Inner Protein Regulator,Inner Protein,24138583,New Paradigm for Allosteric Regulation of Escherichia coli Aspartate Transcarbamoylase.,No,"Chain B:ALA11,ILE12,VAL17,ASP19,HIS20,THR43,GLY45,LEU48,PRO49,SER50,GLY51,GLU52,LYS56,LYS60,ASN84,ILE86,TYR89,VAL91,LYS94; Chain D:LYS6,LEU7,GLN8,VAL9,THR43"
ASD00330000_2,pyrI,Escherichia coli,E8Y329,4KH1,ASD00150003;ASD00150002;ASD00330030,CTP;MG;UTP,B;B;B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate;magnesium(+2) cation;[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",202;203;204,Inner Protein Regulator,Inner Protein,24138583,New Paradigm for Allosteric Regulation of Escherichia coli Aspartate Transcarbamoylase.,No,"Chain B:LEU7,GLN8,VAL9,ALA11,ILE12,VAL17,ASP19,HIS20,LEU48,PRO49,SER50,GLY51,GLU52,LYS56,LEU58,LYS60,ASN84,ILE86,TYR89,VAL91,LYS94"
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,1RAA,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",999,Inner Protein Regulator,Inner Protein,8441751,Crystal structure of CTP-ligated T state aspartate transcarbamoylase at 2.5 A resolution: implications for ATCase mutants and the mechanism of negative cooperativity.,No,"Chain B:VAL9,ALA11,ILE12,VAL17,ASP19,LYS60,THR82,ASN84,ILE86,TYR89,VAL91,LYS94"
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,1RAB,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",999,Inner Protein Regulator,Inner Protein,8441751,Crystal structure of CTP-ligated T state aspartate transcarbamoylase at 2.5 A resolution: implications for ATCase mutants and the mechanism of negative cooperativity.,No,"Chain B:VAL9,ALA11,ILE12,VAL17,ASP19,LYS60,THR82,ASN84,ILE86,TYR89,VAL91,LYS94"
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,1RAC,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",999,Inner Protein Regulator,Inner Protein,8441751,Crystal structure of CTP-ligated T state aspartate transcarbamoylase at 2.5 A resolution: implications for ATCase mutants and the mechanism of negative cooperativity.,No,"Chain B:VAL9,ALA11,ILE12,VAL17,ASP19,LYS60,THR82,ASN84,ILE86,TYR89,VAL91,LYS94"
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,1RAD,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",999,Inner Protein Regulator,Inner Protein,8441751,Crystal structure of CTP-ligated T state aspartate transcarbamoylase at 2.5 A resolution: implications for ATCase mutants and the mechanism of negative cooperativity.,No,"Chain B:VAL9,ALA11,ILE12,VAL17,ASP19,LYS60,THR82,ASN84,ILE86,TYR89,VAL91,LYS94"
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,1RAE,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",999,Inner Protein Regulator,Inner Protein,8441751,Crystal structure of CTP-ligated T state aspartate transcarbamoylase at 2.5 A resolution: implications for ATCase mutants and the mechanism of negative cooperativity.,No,"Chain B:VAL9,ALA11,ILE12,VAL17,ASP19,LYS60,THR82,ASN84,ILE86,TYR89,VAL91,LYS94"
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,1RAF,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",999,Inner Protein Regulator,Inner Protein,8441751,Crystal structure of CTP-ligated T state aspartate transcarbamoylase at 2.5 A resolution: implications for ATCase mutants and the mechanism of negative cooperativity.,No,"Chain B:VAL9,ALA11,ILE12,VAL17,ASP19,HIS20,LYS60,THR82,ASN84,ILE86,TYR89,VAL91,LYS94"
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,1RAG,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",999,Inner Protein Regulator,Inner Protein,8441751,Crystal structure of CTP-ligated T state aspartate transcarbamoylase at 2.5 A resolution: implications for ATCase mutants and the mechanism of negative cooperativity.,No,"Chain B:VAL9,ALA11,ILE12,VAL17,ASP19,HIS20,LYS60,THR82,ASN84,ILE86,TYR89,VAL91,LYS94"
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,1RAH,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",999,Inner Protein Regulator,Inner Protein,8441751,Crystal structure of CTP-ligated T state aspartate transcarbamoylase at 2.5 A resolution: implications for ATCase mutants and the mechanism of negative cooperativity.,No,"Chain B:VAL9,ALA11,ILE12,VAL17,ASP19,HIS20,LYS60,THR82,ASN84,ILE86,TYR89,VAL91,LYS94"
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,1RAI,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",999,Inner Protein Regulator,Inner Protein,8441751,Crystal structure of CTP-ligated T state aspartate transcarbamoylase at 2.5 A resolution: implications for ATCase mutants and the mechanism of negative cooperativity.,No,"Chain B:VAL9,ALA11,ILE12,VAL17,ASP19,HIS20,LYS60,THR82,ASN84,ILE86,TYR89,VAL91,LYS94"
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,1TUG,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",1156,Inner Protein Regulator,Inner Protein,15288791,Monitoring the Transition from the T to the R State in E.coli Aspartate Transcarbamoylase by X-ray Crystallography: Crystal Structures of the E50A Mutant Enzyme in Four Distinct Allosteric States.,No,"Chain B:MET1,THR2,ALA11,ILE12,VAL17,ASP19,HIS20,LYS60,ASN84,ILE86,TYR89,GLU90,VAL91,LYS94"
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,1ZA1,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",901,Inner Protein Regulator,Inner Protein,15951418,Structural basis for ordered substrate binding and cooperativity in aspartate transcarbamoylase,No,"Chain B:THR2,ALA11,ILE12,VAL17,ASP19,HIS20,LEU58,LYS60,ILE86,TYR89,VAL91,LYS94"
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,1ZA2,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",155,Inner Protein Regulator,Inner Protein,15951418,Structural basis for ordered substrate binding and cooperativity in aspartate transcarbamoylase,No,"Chain B:ALA11,ILE12,VAL17,ASP19,HIS20,LEU58,LYS60,ASN84,ILE86,TYR89,VAL91,LYS94"
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,2FZC,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",901,Inner Protein Regulator,Inner Protein,16906764,T-state Inhibitors of E. coli Aspartate Transcarbamoylase that Prevent the Allosteric Transition.,No,"Chain B:THR2,HIS3,GLU10,ALA11,ILE12,VAL17,ASP19,HIS20,LYS60,ASN84,ILE86,TYR89,VAL91,LYS94"
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,2FZG,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",901,Inner Protein Regulator,Inner Protein,16906764,T-state Inhibitors of E. coli Aspartate Transcarbamoylase that Prevent the Allosteric Transition.,No,"Chain B:THR2,ASP4,ALA11,ILE12,VAL17,ASP19,HIS20,LEU58,LYS60,ASN84,ILE86,TYR89,VAL91,LYS94"
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,2FZK,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",901,Inner Protein Regulator,Inner Protein,16906764,T-state Inhibitors of E. coli Aspartate Transcarbamoylase that Prevent the Allosteric Transition.,No,"Chain B:THR2,ASP4,ALA11,ILE12,VAL17,HIS20,LYS60,ASN84,ILE86,TYR89,VAL91,LYS94"
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,4AT1,ASD00150001,ATP,B,Lig,Activator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",155,Inner Protein Regulator,Inner Protein,2271528,Structural consequences of effector binding to the T state of aspartate carbamoyltransferase: crystal structures of the unligated and ATP- and CTP-complexed enzymes at 2.6-A resolution.,No,"Chain B:VAL9,GLU10,ALA11,ILE12,VAL17,ASP19,LEU58,LYS60,ASN84,TYR89,VAL91,LYS94"
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,4FYV,ASD00900001,DCP,B,Lig,Inhibitor,"[(2R,3S,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3-hydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",202,Inner Protein Regulator,Inner Protein,22906065,Metal Ion Involvement in the Allosteric Mechanism of Escherichia coli Aspartate Transcarbamoylase.,No,"Chain B:ALA11,ILE12,VAL17,LYS60,ILE86,TYR89,GLU90"
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,4FYW,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",202,Inner Protein Regulator,Inner Protein,22906065,Metal Ion Involvement in the Allosteric Mechanism of Escherichia coli Aspartate Transcarbamoylase.,No,"Chain B:ALA11,ILE12,VAL17,ASP19,HIS20,LEU58,LYS60,ASN84,ILE86,TYR89,VAL91,LYS94"
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,4FYX,ASD00150002;ASD00900001;ASD00330030,UTP;MG;DCP,B;B;B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate;magnesium(+2) cation;[(2R,3S,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3-hydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",202;203;204,Inner Protein Regulator,Inner Protein,22906065,Metal Ion Involvement in the Allosteric Mechanism of Escherichia coli Aspartate Transcarbamoylase.,No,"Chain B:LYS6,LEU7,GLN8,VAL9,ALA11,ILE12,VAL17,ASP19,HIS20,LEU48,PRO49,SER50,GLY51,GLU52,LYS56,LEU58,LYS60,THR82,ASN84,ILE86,TYR89,VAL91,LYS94"
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,4FYY,ASD00150002;ASD00150003;ASD00330030,UTP;MG;CTP,B;B;B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate;magnesium(+2) cation;[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",202;203;204,Inner Protein Regulator,Inner Protein,22906065,Metal Ion Involvement in the Allosteric Mechanism of Escherichia coli Aspartate Transcarbamoylase.,No,"Chain B:LEU7,GLN8,VAL9,ALA11,ILE12,VAL17,ASP19,HIS20,LEU48,PRO49,SER50,GLY51,GLU52,LYS56,LEU58,LYS60,THR82,ASN84,ILE86,TYR89,VAL91,LYS94"
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,5AT1,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",155,Inner Protein Regulator,Inner Protein,2271528,Structural consequences of effector binding to the T state of aspartate carbamoyltransferase: crystal structures of the unligated and ATP- and CTP-complexed enzymes at 2.6-A resolution.,No,"Chain B:GLU10,ALA11,ILE12,VAL17,ASP19,SER50,GLY51,LEU58,LYS60,ASN84,ILE86,TYR89,VAL91,LYS94"
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,7AT1,ASD00150001,ATP,B,Lig,Activator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",155,Inner Protein Regulator,Inner Protein,2271529,"Crystal structures of aspartate carbamoyltransferase ligated with phosphonoacetamide, malonate, and CTP or ATP at 2.8-A resolution and neutral pH.",No,"Chain B:GLU10,ALA11,ILE12,VAL17,ASP19,HIS20,GLU52,LEU58,LYS60,ASN84,ILE86,TYR89,VAL91,LYS94"
ASD00330000_3,pyrI,Escherichia coli,P0A7F3,8AT1,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",155,Inner Protein Regulator,Inner Protein,2271529,"Crystal structures of aspartate carbamoyltransferase ligated with phosphonoacetamide, malonate, and CTP or ATP at 2.8-A resolution and neutral pH.",No,"Chain B:GLU10,ILE12,ASP19,HIS20,LYS60,ASN84,ILE86,TYR89,VAL91,LYS94"
ASD00330000_4,pyrI,Sulfolobus acidocaldarius,P74766,2BE9,ASD00150003,CTP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",401,Inner Protein Regulator,Inner Protein,18477471,Crystal structure of Sulfolobus acidocaldarius aspartate carbamoyltransferase in complex with its allosteric activator CTP.,No,"Chain B:LYS14,ILE15,VAL20,ASP22,HIS23,LYS64,ASN88,VAL90,TYR93,VAL95,LYS98"
ASD00350000_1,MJ0571,Methanocaldococcus jannaschii,Q57991,3C1N,ASD00350001,THR,A,Lig,Inhibitor,"(2S,3R)-2-amino-3-hydroxy-butanoic acid",471,Inner Protein Regulator,Protein-Protein Interaction,18334478,The structural basis for allosteric inhibition of a threonine-sensitive aspartokinase.,No,"Chain A:MET414,GLY416,ALA417,GLY419,ILE420,ALA421,GLN440,GLU444; Chain B:ASN434,ILE435"
ASD00350000_2,AK1,Arabidopsis thaliana,Q9LYU8,2CDQ,ASD00350007,SAM,A,Lig,Inhibitor,"(2S)-2-amino-4-[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl-methyl-sulfonio]butanoate",1500,Inner Protein Regulator,Protein-Protein Interaction,16731588,A Novel Organization of Act Domains in Allosteric Enzymes Revealed by the Crystal Structure of Arabidopsis Aspartate Kinase,No,Chain B:VAL355
ASD00350000_3,lysC,Synechocystis sp.,P74569,3L76,ASD00910001,LYS,A,Lig,Inhibitor,[(5S)-5-amino-6-hydroxy-6-oxo-hexyl]azanium,603,Inner Protein Regulator,Inner Protein,20398676,A new mode of dimerization of allosteric enzymes with ACT domains revealed by the crystal structure of the aspartate kinase from Cyanobacteria,No,"Chain A:ASP298,ILE299,ASP300,MET537,HIS540,PRO541,GLY542,VAL543,ALA544,THR563,SER564,GLU565,ILE568"
ASD00350000_3,lysC,Synechocystis sp.,P74569,3L76,ASD00910001,LYS,A,Lig,Inhibitor,[(5S)-5-amino-6-hydroxy-6-oxo-hexyl]azanium,604,Inner Protein Regulator,Inner Protein,20398676,A new mode of dimerization of allosteric enzymes with ACT domains revealed by the crystal structure of the aspartate kinase from Cyanobacteria,No,"Chain A:MET365,ARG368,PRO369,GLY370,ILE371,ALA372,SER392,GLU393,SER472,VAL473,ASP474"
ASD00350000_3,lysC,Synechocystis sp.,P74569,3L76,ASD00350001,THR,A,Lig,Inhibitor,"(2S,3R)-2-amino-3-hydroxy-butanoic acid",601,Inner Protein Regulator,Inner Protein,20398676,A new mode of dimerization of allosteric enzymes with ACT domains revealed by the crystal structure of the aspartate kinase from Cyanobacteria,No,"Chain A:ASP280,ARG281,PRO282,GLY283,VAL284,ALA285,GLN304,ASN557,ILE558"
ASD00350000_3,lysC,Synechocystis sp.,P74569,3L76,ASD00350001,THR,A,Lig,Inhibitor,"(2S,3R)-2-amino-3-hydroxy-butanoic acid",602,Inner Protein Regulator,Inner Protein,20398676,A new mode of dimerization of allosteric enzymes with ACT domains revealed by the crystal structure of the aspartate kinase from Cyanobacteria,No,"Chain A:ASN385,ILE386,VAL452,ASP454,ARG455,PRO456,GLY457,MET458,ALA459,GLN478"
ASD00360000_1,ACLY,Homo sapiens,P53396,6O0H,,LBG,A,lig,Inhibitor,"methyl 3-chloro-5-[(4,6-difluoro[1,1'-biphenyl]-3-yl)sulfamoyl]-4-hydroxybenzoate",2001,Allosteric function,Inner Protein,,,Yes,6O0H
ASD00370000_1,met3,Penicillium chrysogenum,Q12650,1I2D,ASD01720025,ADX,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl sulfo hydrogen phosphate",575,Inner Protein Regulator,Inner Protein,11389593,Crystal structure of ATP sulfurylase from Penicillium chrysogenum: insights into the allosteric regulation of sulfate assimilation.,No,"Chain A:MET405,ASP434,ARG437,PHE446,ARG451,ASN454,PRO476,ILE477,ALA478,PRO479,ILE517,LYS527,GLY528,PHE529,THR530"
ASD00370000_1,met3,Penicillium chrysogenum,Q12650,1M8P,ASD00370003,PPS,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxy-oxolan-2-yl]methyl sulfo hydrogen phosphate",574,Inner Protein Regulator,Inner Protein,12426581,Allosteric inhibition via R-state destabilization in ATP sulfurylase from Penicillium chrysogenum.,No,"Chain A:MET405,ASP434,ARG437,PHE446,ARG451,ASN454,ILE455,PRO476,ILE477,ALA478,PRO479,ARG515,ILE517,ILE526,LYS527,GLY528,PHE529,THR530"
ASD00430000_1,ACC1,Saccharomyces cerevisiae,Q00955,1W96,ASD00431046,S1A,A,Lig,Inhibitor,"(1R,2S,5S,10S,11R,12E,14S,15S,16S,17S,18R)-1,17-dihydroxy-10,11,18-trimethoxy-2,14,16-trimethyl-5-phenyl-4,19-dioxabicyclo[13.3.1]nonadec-12-en-3-one",1567,Inner Protein Regulator,Inner Protein,15610732,"A mechanism for the potent inhibition of eukaryotic acetyl-coenzyme A carboxylase by soraphen A, a macrocyclic polyketide natural product.",No,"Chain A:ILE69,LYS73,ARG76,SER77,PRO389,GLU392,MET393,GLY396,VAL397,ASN398,CYS454,ASN485,TRP487,PHE510,PHE512"
ASD00440000_1,,Escherichia coli,P06709,2EWN,ASD00440002,BTX,A,Lig,Activator,"((2R,3S,4R,5R)-5-(6-AMINO-9H-PURIN-9-YL)- 3,4-DIHYDROXY-TETRAHYDROFURAN-2-YL)METHYL 5- ((3AS,4S,6AR)-2-OXO-HEXAHYDRO-1H-THIENO[3,4- D]IMIDAZOL-4-YL)PENTYL HYDROGEN PHOSPHATE",501,Protein-Protein Interaction Regulator,Inner Protein,16438984,Co-repressor induced order and biotin repressor dimerization: a case for divergent followed by convergent evolution.,No,"Chain A:ALA185,LYS172,GLY206,ILE187,GLY117,ASN220,GLN92,GLY186,ASP176,VAL219,PRO126,ILE224,LEU188,ALA205,TRP223,LYS122,SER125,LEU131,SER89,ARG116,SER134,LEU133,GLN221,GLY222,PHE124,VAL214,MET211,TYR132,GLU313,ARG118,ILE207,ALA114,LEU184,ARG121,ASN130,ASN208,GLN112,LYS183,TRP123,GLU190,VAL218,ARG119,ILE203,ASP88,GLY204,GLY115,THR90,ASN91"
ASD00440000_1,,Escherichia coli,P06709,4WF2,ASD00440002,BTX,A,Lig,Activator,"((2R,3S,4R,5R)-5-(6-AMINO-9H-PURIN-9-YL)- 3,4-DIHYDROXY-TETRAHYDROFURAN-2-YL)METHYL 5- ((3AS,4S,6AR)-2-OXO-HEXAHYDRO-1H-THIENO[3,4- D]IMIDAZOL-4-YL)PENTYL HYDROGEN PHOSPHATE",501,Protein-Protein Interaction Regulator,Inner Protein,25746672,Allosteric Coupling via Distant Disorder-to-Order Transitions.,No,"Chain A:ALA185,LYS172,GLY206,ILE187,GLY117,GLN92,GLY186,ASP176,PRO126,ILE224,LEU188,ALA205,TRP223,LYS122,SER125,LEU131,SER89,ARG116,SER134,LEU133,PHE124,MET211,TYR132,ARG118,ILE207,ASN175,ALA114,LEU184,ARG121,ASN130,ASN208,GLN112,LYS183,TRP123,ARG119,ILE203,ASP88,GLY204,GLY115,THR90,ASN91"
ASD00440000_2,,Pyrococcus horikoshii,O57883,1WQW,ASD00440001,BT5,A,Lig,Activator,BIOTINYL-5-AMP,1301,Protein-Protein Interaction Regulator,Inner Protein,16169557,Crystal Structures of Biotin Protein Ligase from Pyrococcus horikoshii OT3 and its Complexes: Structural Basis of Biotin Activation,No,"Chain A:ASN134,GLY139,GLN42,THR141,LEU60,GLY47,VAL115,LEU62,VAL136,THR20,GLY127,GLY114,ARG51,TRP53,PRO137,ALA140,SER55,GLY129,ARG48,GLY45,HIS46,TRP61,ILE112,MET44,LEU130,LYS111,ASP104,ASN103,PRO56,ALA113,LEU49,SER63,GLU54,ILE128,GLU24,LYS52,THR22,SER21,ASN131,ASN23,LYS135,LEU116"
ASD00440000_2,,Pyrococcus horikoshii,O57883,2DEQ,ASD00440001,BT5,B,Lig,Activator,BIOTINYL-5-AMP,1301,Protein-Protein Interaction Regulator,Inner Protein,,Ligand Structures Of Biotin Protein Ligase From Pyrococcus Horikoshii OT3,No,"Chain A:ASN134,GLN42,THR141,LEU60,GLY47,VAL115,GLY111,LEU62,VAL136,THR20,GLY127,GLY114,ARG51,TRP53,PRO137,ALA140,SER55,GLY129,ARG48,GLY45,HIS46,TRP61,ILE112,MET44,LEU130,ASP104,ASN103,PRO56,ALA113,LEU49,SER63,GLU54,ILE128,GLU24,LYS52,THR22,SER21,ASN131,ASN23,LYS135,LEU116"
ASD00440000_2,,Pyrococcus horikoshii,O57883,2DJZ,ASD00440001,BT5,A,Lig,Activator,BIOTINYL-5-AMP,1301,Protein-Protein Interaction Regulator,Inner Protein,,Ligand Structures Of Biotin Protein Ligase From Pyrococcus Horikoshii OT3,No,"Chain A:ASN134,ALA111,GLN42,THR141,LEU60,GLY47,VAL115,LEU62,VAL136,THR20,GLY127,GLY114,ARG51,TRP53,PRO137,ALA140,SER55,GLY129,ARG48,GLY45,HIS46,TRP61,ILE112,MET44,LEU130,ASP104,ASN103,PRO56,ALA113,LEU49,LYS135,SER63,GLU54,ILE128,SER231,GLU24,LYS52,THR22,SER21,ASN131,ASN23,GLU118,LEU116"
ASD00440000_2,,Pyrococcus horikoshii,O57883,2DKG,ASD00440001,BT5,B,Lig,Activator,BIOTINYL-5-AMP,1301,Protein-Protein Interaction Regulator,Inner Protein,,Ligand Structures Of Biotin Protein Ligase From Pyrococcus Horikoshii Ot3,No,"Chain A:ASN134,GLN42,THR141,LEU60,GLY47,VAL115,LEU62,VAL136,THR20,GLY127,GLY114,ARG51,TRP53,PRO137,ALA140,SER55,GLY129,ARG48,GLY45,HIS46,TRP61,ILE112,MET44,LEU130,LYS111,ASP104,ASN103,PRO56,ALA113,LEU49,SER63,GLU54,ILE128,GLU24,LYS52,THR22,SER21,ASN131,ASN23,LYS135,LEU116"
ASD00440000_2,,Pyrococcus horikoshii,O57883,2DTI,ASD00440001,BT5,B,Lig,Activator,BIOTINYL-5-AMP,1301,Protein-Protein Interaction Regulator,Inner Protein,,Ligand Structures Of Biotin Protein Ligase From Pyrococcus Horikoshii OT3,No,"Chain A:ASN134,GLN42,LEU60,GLY47,VAL115,LEU62,VAL136,THR20,GLY127,GLY114,ARG51,TRP53,PRO137,ALA140,SER55,GLY129,ARG48,GLY45,HIS46,TRP61,ILE112,MET44,THR141,LYS111,ASP104,ASN103,PRO56,ALA113,LEU49,SER63,GLU54,ILE128,GLU24,LYS52,THR22,SER21,ASN131,ASN23,LYS135,LEU116"
ASD00440000_2,,Pyrococcus horikoshii,O57883,2DVE,ASD00440001,BT5,B,Lig,Activator,BIOTINYL-5-AMP,1301,Protein-Protein Interaction Regulator,Inner Protein,,Ligand Structures of Biotin Protein Ligase From Pyrococcus Horikoshii OT3,No,"Chain A:ASN134,GLY139,GLN42,THR141,LEU60,GLY47,VAL115,LEU62,VAL136,THR20,GLY127,GLY114,TRP53,PRO137,ALA140,SER55,GLY129,ARG48,GLY45,ALA51,HIS46,TRP61,ILE112,MET44,LEU130,LYS111,ASP104,ASN103,PRO56,ALA113,LEU49,TYR227,SER63,GLU54,ILE128,GLU24,LYS52,THR22,SER21,ASN131,ASN23,LYS135,LEU116"
ASD00440000_2,,Pyrococcus horikoshii,O57883,2DXU,ASD00440001,BT5,B,Lig,Activator,BIOTINYL-5-AMP,2301,Protein-Protein Interaction Regulator,Inner Protein,18372281,Protein biotinylation visualized by a complex structure of biotin protein ligase with a substrate,No,"Chain A:ASN134,GLY139,GLN42,THR141,LEU60,GLY47,VAL115,LEU62,VAL136,THR20,GLY127,GLY114,ARG51,TRP53,PRO137,ALA140,SER55,GLY129,GLY45,HIS46,TRP61,ILE112,MET44,LEU130,LYS111,ASP104,ASN103,PRO56,ALA113,LEU49,SER63,GLU54,ILE128,GLU24,ALA48,LYS52,THR22,ASN138,SER21,ASN131,ASN23,LYS135,LEU116"
ASD00440000_2,,Pyrococcus horikoshii,O57883,2DZ9,ASD00440001,BT5,B,Lig,Activator,BIOTINYL-5-AMP,1001,Protein-Protein Interaction Regulator,Inner Protein,,Ligand Structures Of Biotin Protein Ligase From Pyrococcus Horikoshii Ot3,No,"Chain A:ASN134,GLY139,GLN42,ALA104,THR141,LEU60,GLY47,VAL115,LEU62,VAL136,THR20,GLY127,GLY114,ARG51,TRP53,PRO137,ALA140,SER55,GLY129,ARG48,GLY45,HIS46,TRP61,ILE112,MET44,LEU130,LYS111,LEU116,ASN103,PRO56,ALA113,LEU49,SER63,GLU54,ILE128,GLU24,LYS52,THR22,ASN138,SER21,ASN131,ASN23,LYS135"
ASD00440000_3,,Mycobacterium tuberculosis,I6YFP0,4OP0,ASD00440001,BT5,A,Lig,Activator,BIOTINYL-5-AMP,301,Protein-Protein Interaction Regulator,Inner Protein,24723382,Active site conformational changes upon reaction intermediate biotinyl-5'-AMP binding in biotin protein ligase from Mycobacterium tuberculosis.,No,"Chain A:ARG69,GLN161,ALA170,TRP74,LEU139,VAL155,LEU153,SER38,LYS138,ALA41,THR171,ARG67,THR39,ALA76,ASP167,ALA140,ASN158,LEU84,GLN81,ALA75,ALA65,GLY66,ILE83,GLY156,ASN40,ASP169,GLY154,GLY73,LEU157,SER85,ASN130,ILE142,LEU143,ASP131,GLY37,GLY68,VAL166,ILE82,GLN63,ARG72,GLY141,HIS70"
ASD00450000_1,BRAF,Homo sapiens,P15056,1UWH,ASD00450013,BAX,A,Lig,Inhibitor,4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide,1723,Inner Protein Regulator,Inner Protein,15035987,Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.,Yes,1UWH
ASD00450000_1,BRAF,Homo sapiens,P15056,1UWJ,ASD00450013,BAX,A,Lig,Inhibitor,4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide,1723,Inner Protein Regulator,Inner Protein,15035987,Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.,Yes,1UWJ
ASD00450000_1,BRAF,Homo sapiens,P15056,3IDP,ASD00450021,L1E,A,Lig,Inhibitor,"N1-(4-chlorophenyl)-6-methyl-N5-[3-(7H-purin-6-yl)pyridin-2-yl]isoquinoline-1,5-diamine",2,Inner Protein Regulator,Inner Protein,19764794,Selective inhibitors of the mutant B-Raf pathway: discovery of a potent and orally bioavailable aminoisoquinoline.,Yes,3IDP
ASD00450000_1,BRAF,Homo sapiens,P15056,3Q96,ASD00450016,0NF,A,Lig,Inhibitor,"(2S)-N-[3-(2-azanylpropan-2-yl)-5-(trifluoromethyl)phenyl]-7-[(7-oxo-6,8-dihydro-5H-1,8-naphthyridin-4-yl)oxy]-1,2,3,4-tetrahydronaphthalene-2-carboxamide",1,Inner Protein Regulator,Inner Protein,21341678,Design and optimization of potent and orally bioavailable tetrahydronaphthalene raf inhibitors.,Yes,3Q96
ASD00450000_1,BRAF,Homo sapiens,P15056,4DBN,ASD00450017,0JA,A,Lig,Inhibitor,"2-chloranyl-3-(1-cyanocyclopropyl)-N-[5-[[2-(cyclopropylcarbonylamino)-[1,3]thiazolo[5,4-b]pyridin-5-yl]oxy]-2-fluoranyl-phenyl]benzamide",901,Inner Protein Regulator,Inner Protein,22376051,"Design and synthesis of novel DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitors. 1. Exploration of [5,6]-fused bicyclic scaffolds.",Yes,4DBN
ASD00450000_1,BRAF,Homo sapiens,P15056,4FC0,ASD00450019,0T2,A,Lig,Inhibitor,"2-chloranyl-3-(2-cyanopropan-2-yloxy)-N-[5-[[2-(cyclopropylcarbonylamino)-[1,3]thiazolo[5,4-b]pyridin-5-yl]-methyl-amino]-2-fluoranyl-phenyl]benzamide",901,Inner Protein Regulator,Inner Protein,22883026,"Design and synthesis of novel DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitors: 3. Evaluation of 5-amino-linked thiazolo[5,4-d]pyrimidine and thiazolo[5,4-b]pyridine derivatives.",Yes,4FC0
ASD00450000_1,BRAF,Homo sapiens,P15056,4G9C,ASD00450022,0WP,A,Lig,Inhibitor,"3-[[3-(2-cyanopropan-2-yl)phenyl]carbonylamino]-2,6-bis(fluoranyl)-N-(3-methoxy-2H-pyrazolo[3,4-b]pyridin-5-yl)benzamide",801,Inner Protein Regulator,Inner Protein,22954737,Pyrazolopyridine inhibitors of B-Raf(V600E). Part 4: Rational design and kinase selectivity profile of cell potent type II inhibitors.,Yes,4G9C
ASD00450000_1,BRAF,Homo sapiens,P15056,4G9R,ASD00450020,B1E,A,Lig,Inhibitor,3-(2-cyanopropan-2-yl)-N-[4-methyl-3-[(3-methyl-4-oxidanylidene-quinazolin-6-yl)amino]phenyl]benzamide,801,Inner Protein Regulator,Inner Protein,22954737,Pyrazolopyridine inhibitors of B-Raf(V600E). Part 4: Rational design and kinase selectivity profile of cell potent type II inhibitors.,Yes,4G9R
ASD00450000_1,BRAF,Homo sapiens,P15056,4JVG,ASD00740009,B96,A,Lig,Inhibitor,3-[5-tert-butyl-2-(4-methylphenyl)pyrazol-3-yl]-1-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]urea,801,Inner Protein Regulator,Inner Protein,23685672,Inhibitors that stabilize a closed RAF kinase domain conformation induce dimerization.,Yes,4JVG
ASD00450000_1,BRAF,Homo sapiens,P15056,4WO5,ASD00450023,324,A,Lig,Inhibitor,"N-{3-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl}propane-1-sulfonamide",801,Inner Protein Regulator,Inner Protein,25437913,Crystal structure of a BRAF kinase domain monomer explains basis for allosteric regulation.,Yes,4WO5
ASD00450000_1,BRAF,Homo sapiens,P15056,6P7G,,E7M,A,Lig,Inhibitor,"3-[(imidazo[1,2-b]pyridazin-3-yl)ethynyl]-4-methyl-N-[4-({[2-(morpholin-4-yl)ethyl]amino}methyl)-3-(trifluoromethyl)phenyl]benzamide",801,,,,,,6P7G
ASD00460000_1,CASR,Homo sapiens,P41180,7DTT,,CA,A,Ion,Activator,CALCIUM ION,1101,,,,,,7DTT
ASD00460000_1,CASR,Homo sapiens,P41180,7DTT,,CA,A,Ion,Activator,CALCIUM ION,1102,,,,,,7DTT
ASD00460000_1,CASR,Homo sapiens,P41180,7DTU,,TRP,A,Lig,Activator,TRYPTOPHAN,1101,,,,,,7DTU
ASD00460000_1,CASR,Homo sapiens,P41180,7DTV,,CA,A,Ion,Activator,CALCIUM ION,1108,,,,,,7DTV
ASD00460000_1,CASR,Homo sapiens,P41180,7DTV,,CA,A,Ion,Activator,CALCIUM ION,1102,,,,,,7DTV
ASD00460000_1,CASR,Homo sapiens,P41180,7DTV,,TRP,A,Lig,Activator,TRYPTOPHAN,1101,,,,,,7DTV
ASD00460000_1,CASR,Homo sapiens,P41180,7E6T,,CA,A,Ion,Activator,CALCIUM ION,902,,,,,,7E6T
ASD00460000_1,CASR,Homo sapiens,P41180,7E6T,,CA,A,Ion,Activator,CALCIUM ION,903,,,,,,7E6T
ASD00460000_1,CASR,Homo sapiens,P41180,7E6T,,TCR,A,Lig,Activator,CYCLOMETHYLTRYPTOPHAN,907,,,,,,7E6T
ASD00460000_1,CASR,Homo sapiens,P41180,7E6T,,CA,A,Ion,Activator,CALCIUM ION,904,,,,,,7E6T
ASD00470000_3,CALM1,Homo sapiens,P62158,1CKK,ASD11630001;ASD11630001;ASD11630001;ASD11630001,CA;CA;CA;CA,A;A;A;A,Ion,Regulator,CALCIUM ION,151;152;153;154,Inner Protein Regulator,Inner Protein,10467092,A novel target recognition revealed by calmodulin in complex with Ca2+-calmodulin-dependent kinase kinase.,No,1CKK
ASD00470000_3,CALM1,Homo sapiens,P62158,1IQ5,ASD11630001;ASD11630001;ASD11630001;ASD11630001,CA;CA;CA;CA,A;A;A;A,Ion,Regulator,CALCIUM ION,361;362;363;364,Inner Protein Regulator,Inner Protein,11545585,Target-induced conformational adaptation of calmodulin revealed by the crystal structure of a complex with nematode Ca(2+)/calmodulin-dependent kinase kinase peptide,No,1IQ5
ASD00470000_3,CALM1,Homo sapiens,P62158,1NWD,ASD11630001;ASD11630001;ASD11630001;ASD11630001,CA;CA;CA;CA,A;A;A;A,Ion,Regulator,CALCIUM ION,149;150;151;152,Inner Protein Regulator,Inner Protein,12684008,Structural Basis for Simultaneous Binding of Two Carboxy-terminal Peptides of Plant Glutamate Decarboxylase to Calmodulin,No,1NWD
ASD00470000_3,CALM1,Homo sapiens,P62158,3J41,ASD11630001;ASD11630001;ASD11630001;ASD11630001,CA;CA;CA;CA,E;E;E;E,Ion,Regulator,CALCIUM ION,201;202;203;204,Inner Protein Regulator,Inner Protein,23893133,Allosteric mechanism of water-channel gating by Ca(2+)-calmodulin.,No,3J41
ASD00480000_1,crp,Escherichia coli,P0ACJ8,1CGP,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",206,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,1653449,Crystal structure of a CAP-DNA complex: the DNA is bent by 90 degrees.,No,"Chain A:VAL49,LEU61,SER62,LEU64,ILE70,GLY71,GLU72,LEU73,GLY74,ARG82,SER83,ALA84,VAL86,TYR99,ARG123,THR127; Chain B:LEU124,SER128"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,1G6N,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",621,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,11124031,Modeling the cAMP-induced allosteric transition using the crystal structure of CAP-cAMP at 2.1 A resolution.,No,"Chain A:VAL49,LEU61,SER62,LEU64,ILE70,GLY71,GLU72,LEU73,GLY74,ARG82,SER83,ALA84,VAL86,ARG123,THR127; Chain B:LEU424,SER428"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,1HW5,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",210,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,11124966,The structure of the T127L/S128A mutant of cAMP receptor protein facilitates promoter site binding.,No,"Chain A:VAL49,LEU61,SER62,LEU64,ILE70,GLY71,GLU72,LEU73,GLY74,ARG82,SER83,ALA84,VAL86,TYR99,ARG123,LEU127; Chain B:LEU124"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,1I5Z,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,,The effect of the D53H point mutation on the macroscopic motions of E. coli Cyclic AMP Receptor Protein,No,"Chain A:ILE30,VAL49,LEU61,SER62,ILE70,GLY71,GLU72,LEU73,ARG82,SER83,ALA84,VAL86,ARG123,THR127; Chain B:LEU124,SER128"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,1I6X,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,,The effect of the D53H point mutation on the macroscopic motions of E. coli Cyclic AMP Receptor Protein,No,"Chain A:ILE30,VAL49,LEU61,SER62,LEU64,ILE70,GLY71,GLU72,LEU73,ARG82,SER83,ALA84,VAL86,TYR99,ARG123,THR127; Chain B:LEU124,SER128"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,1J59,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",762,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,8757802,Structure of the CAP-DNA complex at 2.5 angstroms resolution: a complete picture of the protein-DNA interface.,No,"Chain A:ILE30,ALA36,VAL49,LEU61,SER62,GLY71,GLU72,LEU73,ARG82,SER83,VAL86,ARG123,THR127; Chain B:LEU124,SER128"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,1LB2,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",679,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,12202833,Structural basis of transcription activation: the CAP-alpha CTD-DNA complex.,No,"Chain A:ILE30,VAL49,LEU61,SER62,ILE70,GLY71,GLU72,LEU73,GLY74,ARG82,SER83,ALA84,VAL86,TYR99,ARG123,THR127"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,1O3Q,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",1,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,11724532,Indirect readout of DNA sequence at the primary-kink site in the CAP-DNA complex: DNA binding specificity based on energetics of DNA kinking.,No,"Chain A:VAL49,LEU61,SER62,ILE70,GLY71,GLU72,LEU73,GLY74,ARG82,SER83,ALA84,VAL86,ARG123,THR127"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,1O3R,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",1,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,11724532,Indirect readout of DNA sequence at the primary-kink site in the CAP-DNA complex: DNA binding specificity based on energetics of DNA kinking.,No,"Chain A:ILE30,VAL49,LEU61,SER62,ILE70,GLY71,GLU72,LEU73,GLY74,ARG82,SER83,ALA84,VAL86,TYR99,ARG123,THR127"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,1O3S,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",1,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,11724532,Indirect readout of DNA sequence at the primary-kink site in the CAP-DNA complex: alteration of DNA binding specificity through alteration of DNA kinking.,No,"Chain A:ILE30,VAL49,LEU61,SER62,ILE70,GLY71,GLU72,LEU73,ARG82,SER83,ALA84,VAL86,ARG123,THR127"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,1O3T,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",762,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,11724532,Indirect readout of DNA sequence at the primary-kink site in the CAP-DNA complex: alteration of DNA binding specificity through alteration of DNA kinking.,No,"Chain A:VAL49,LEU61,ILE70,GLY71,GLU72,LEU73,ARG82,SER83,ALA84,VAL86,THR127; Chain B:LEU124,SER128"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,1RUN,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",679,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,8836098,Aromatic hydrogen bond in sequence-specific protein DNA recognition.,No,"Chain A:VAL49,SER62,ILE70,GLY71,GLU72,LEU73,GLY74,ARG82,SER83,ALA84,THR127; Chain B:LEU124,SER128"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,1RUO,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",210,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,8836098,Aromatic hydrogen bond in sequence-specific protein DNA recognition.,No,"Chain A:VAL49,LEU61,SER62,PHE69,ILE70,GLY71,GLU72,LEU73,ARG82,SER83,ALA84,VAL86,ARG123,THR127; Chain B:LEU124,SER128"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,1ZRC,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",210,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,16427082,Indirect readout of DNA sequence at the primary-kink site in the CAP-DNA complex: recognition of pyrimidine-purine and purine-purine steps.,No,"Chain A:VAL49,LEU61,ILE70,GLY71,GLU72,LEU73,GLY74,ARG82,SER83,ALA84,VAL86,ARG123,THR127; Chain B:LEU124,SER128"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,1ZRD,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",210,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,16427082,Indirect readout of DNA sequence at the primary-kink site in the CAP-DNA complex: recognition of pyrimidine-purine and purine-purine steps.,No,"Chain A:VAL49,LEU61,SER62,ILE70,GLY71,GLU72,LEU73,GLY74,GLU81,ARG82,SER83,ALA84,VAL86,ARG123,THR127; Chain B:LEU124,SER128"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,1ZRE,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",210,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,16427082,Indirect readout of DNA sequence at the primary-kink site in the CAP-DNA complex: recognition of pyrimidine-purine and purine-purine steps.,No,"Chain A:ILE30,VAL49,LEU61,SER62,ILE70,GLY71,GLU72,LEU73,GLY74,ARG82,SER83,ALA84,VAL86,TYR99,ARG123,THR127; Chain B:LEU124,SER128"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,1ZRF,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",622,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,16427082,Indirect readout of DNA sequence at the primary-kink site in the CAP-DNA complex: recognition of pyrimidine-purine and purine-purine steps.,No,"Chain A:ILE30,VAL49,LEU61,SER62,ILE70,GLY71,GLU72,LEU73,ARG82,SER83,ALA84,VAL86,TYR99,ARG123,THR127; Chain B:LEU124,SER128"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,2CGP,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",621,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,9096308,The structure of a CAP-DNA complex having two cAMP molecules bound to each monomer.,No,"Chain A:ILE30,VAL49,LEU61,SER62,ILE70,GLY71,GLU72,LEU73,ARG82,SER83,ALA84,VAL86,ARG123,THR127"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,2GZW,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",1301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,,Crystal structure of activated CRP protein from E coli,No,"Chain A:ILE30,VAL49,LEU61,SER62,ILE70,GLY71,GLU72,LEU73,ARG82,SER83,ALA84,VAL86,TYR99,ARG123,THR127; Chain B:LEU124,SER128"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,3IYD,ASD00480003,CMP,G,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",679,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,19903881,Three-dimensional EM structure of an intact activator-dependent transcription initiation complex,No,"Chain G:ILE30,VAL49,LEU61,LEU64,GLY71,GLU72,LEU73,GLY74,GLU81,ARG82,SER83,ALA84,VAL86,ARG123,THR127; Chain H:GLN125,SER128"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,3KCC,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,,The Structure of a D138L Mutant of Catabolite Gene Activator Protein Reveals two cAMP Binding Sites in each monomer,No,"Chain A:ILE30,VAL49,LEU61,SER62,ILE70,GLY71,GLU72,LEU73,GLY74,ARG82,SER83,ALA84,VAL86,ARG123,THR127; Chain B:LEU124,SER128"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,3N4M,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",210,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,,Combined structural model for a transcription activation assembly,No,"Chain A:ILE30,VAL49,LEU61,SER62,ILE70,GLY71,GLU72,LEU73,GLY74,ARG82,SER83,ALA84,VAL86,TYR99,ARG123,THR127"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,3QOP,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,,Domain-Domain Flexibility Leads to Allostery within the Camp Receptor Protein (Crp),No,"Chain A:ILE30,VAL49,LEU61,PHE62,ILE70,GLY71,GLU72,LEU73,GLY74,ARG82,SER83,ALA84,VAL86,ARG123,THR127; Chain B:LEU124,SER128"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,3RDI,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,,Domain-Domain Flexibility Leads to Allostery within the Cam Receptor Protein (Crp),No,"Chain A:ILE30,VAL49,LEU61,PHE62,ILE70,GLY71,GLU72,LEU73,ARG82,SER83,ALA84,VAL86,ARG123,THR127; Chain B:LEU124,SER128"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,3ROU,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,,Domain-Domain Flexibility Leads to Allostery within the Cam Receptor Protein (Crp),No,"Chain A:ILE30,VAL49,LEU61,PHE62,ILE70,GLY71,GLU72,LEU73,GLY74,ARG82,SER83,ALA84,VAL86,TYR99,ARG123,THR127; Chain B:LEU124,SER128"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,3RPQ,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,,Domain-Domain Flexibility Leads to Allostery within the Cam Receptor Protein (Crp),No,"Chain A:ILE30,VAL49,LEU61,PHE62,ILE70,GLY71,GLU72,LEU73,ARG82,SER83,ALA84,VAL86,ARG123,THR127; Chain B:LEU124,SER128"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,3RYP,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,,Domain-Domain Flexibility Leads to Allostery within the Cam Receptor Protein (Crp),No,"Chain A:ILE30,VAL49,LEU61,SER62,LEU64,ILE70,GLY71,GLU72,LEU73,GLY74,ARG82,SER83,ALA84,VAL86,TYR99,ARG123,THR127; Chain B:LEU124,SER128"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,3RYR,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,,Domain-Domain Flexibility Leads to Allostery within the Cam Receptor Protein (Crp),No,"Chain A:ILE30,VAL49,LEU61,SER62,ILE70,GLY71,GLU72,LEU73,ARG82,SER83,ALA84,VAL86,ARG123,THR127; Chain B:LEU124,SER128"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,4FT8,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,24817710,Structure of catabolite activator protein with cobalt(II) and sulfate.,No,"Chain A:ILE30,VAL49,LEU61,SER62,ILE70,GLY71,GLU72,LEU73,GLY74,ARG82,SER83,ALA84,VAL86,TYR99,ARG123,THR127; Chain B:LEU124,SER128"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,4HZF,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,24058293,Modulation of global low-frequency motions underlies allosteric regulation: demonstration in CRP/FNR family transcription factors.,No,"Chain A:ILE31,VAL50,LEU62,SER63,LEU65,ILE71,GLY72,GLU73,LEU74,GLY75,ARG83,SER84,ALA85,VAL87,ARG124,THR128; Chain B:LEU125,SER129"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,4I01,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,24058293,Modulation of global low-frequency motions underlies allosteric regulation: demonstration in CRP/FNR family transcription factors.,No,"Chain A:ILE31,VAL50,LEU62,SER63,ILE71,GLY72,GLU73,LEU74,ARG83,SER84,ALA85,VAL87,ARG124,THR128; Chain B:LEU125,SER129"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,4I02,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,24058293,Modulation of global low-frequency motions underlies allosteric regulation: demonstration in CRP/FNR family transcription factors.,No,"Chain A:ILE31,VAL50,LEU62,SER63,ILE71,GLY72,GLU73,LEU74,GLY75,ARG83,SER84,ALA85,VAL87,TYR100,ARG124,THR128; Chain E:LEU125,SER129"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,4I09,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,24058293,Modulation of global low-frequency motions underlies allosteric regulation: demonstration in CRP/FNR family transcription factors.,No,"Chain A:ILE31,VAL50,LEU62,SER63,LEU65,ILE71,GLY72,GLU73,LEU74,GLY75,ARG83,SER84,ALA85,VAL87,TYR100,ARG124,THR128; Chain B:LEU125,SER129"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,4I0A,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,24058293,Modulation of global low-frequency motions underlies allosteric regulation: demonstration in CRP/FNR family transcription factors.,No,"Chain A:ILE31,VAL50,LEU62,SER63,LEU65,ILE71,GLY72,GLU73,LEU74,GLY75,ARG83,SER84,ALA85,VAL87,TYR100,ARG124,THR128; Chain B:LEU125,SER129"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,4I0B,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,24058293,Modulation of global low-frequency motions underlies allosteric regulation: demonstration in CRP/FNR family transcription factors.,No,"Chain A:ILE31,VAL50,LEU62,SER63,ILE71,GLY72,GLU73,LEU74,GLY75,ARG83,SER84,ALA85,VAL87,TYR100,ARG124,THR128; Chain B:LEU125,SER129"
ASD00480000_1,crp,Escherichia coli,P0ACJ8,4R8H,ASD00480004,SP1,"A, B",Lig,Inhibitor,"6-(6-AMINO-PURIN-9-YL)-2-THIOXO-TETRAHYDRO-2-FURO[3,2-D][1,3,2]DIOXAPHOSPHININE-2,7-DIOL",301,Protein-Protein Interaction,Protein-Protein Interaction,26187469,The Role of Protein-Ligand Contacts in Allosteric Regulation of the Escherichia coli Catabolite Activator Protein.,No,"Chain B:LEU125,SER129,GLN126"
ASD00480000_2,crp,Mycobacterium tuberculosis,P9WMH3,3I54,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,19740754,Structural Insights into the Mechanism of the Allosteric Transitions of Mycobacterium tuberculosis cAMP Receptor Protein.,No,"Chain A:PHE38,ILE57,LEU69,THR70,MET72,PHE78,GLY79,GLU80,LEU81,SER82,ARG89,THR90,SER91,ARG130,THR134; Chain B:ASN135"
ASD00480000_2,crp,Mycobacterium tuberculosis,P9WMH3,3I59,ASD00480042,N6R,A,Lig,Inhibitor,"(1S,4R,6R,7R,8R)-4-hydroxy-4-oxo-8-[6-[[(2R)-1-phenylpropan-2-yl]amino]purin-9-yl]-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,19740754,Structural Insights into the Mechanism of the Allosteric Transitions of Mycobacterium tuberculosis cAMP Receptor Protein.,No,"Chain A:PHE38,ILE57,LEU69,PHE78,GLY79,GLU80,LEU81,SER82,ARG89,THR90,SER91,ARG130,THR134,ASN137,LEU141; Chain B:ASN135"
ASD00480000_2,crp,Mycobacterium tuberculosis,P9WMH2,3MZH,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",623,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,,Crystal Structure of Camp Receptor Protein from Mycobacterium Tuberculosis in Complex with DNA and cAMP,No,"Chain A:PHE38,ILE57,LEU69,PHE78,GLY79,GLU80,LEU81,SER82,ARG89,THR90,SER91,ARG130,THR134; Chain B:LEU131,ARG132,ASN135"
ASD00480000_2,P425_03821,Mycobacterium tuberculosis,I6Y496,4A2U,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",280,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,,A New Crystal Form of Crp from M. Tuberculosis and Conformational Effects of Crystal Packing,No,"Chain A:PHE38,ILE57,LEU69,THR70,MET72,PHE78,GLY79,GLU80,LEU81,SER82,ARG89,THR90,SER91,ARG130,THR134; Chain B:LEU131,ASN135"
ASD00480000_3,vfr,Pseudomonas aeruginosa,P55222,2OZ6,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,21665969,Crystal Structure of the Pseudomonas aeruginosa Virulence Factor Regulator.,No,"Chain A:ILE32,CYS38,ILE51,ILE63,PHE72,GLY73,GLU74,LEU75,GLY76,ARG87,SER88,ALA89,VAL91,TYR104,ARG128,THR132"
ASD00490000_1,carB,Escherichia coli,P00968,1A9X,ASD00490004,ORN,A,Lig,Activator,"(2S)-2,5-bis(azanyl)pentanoic acid",1920,Inner Protein Regulator,Inner Protein,10029528,Carbamoyl phosphate synthetase: caught in the act of glutamine hydrolysis.,No,"Chain A:GLU783,ASP791,ALA793,GLU892,VAL893,LEU907,TYR1040,ASP1041,THR1042"
ASD00490000_1,carB,Escherichia coli,P00968,1BXR,ASD00490004,ORN,A,Lig,Activator,"(2S)-2,5-bis(azanyl)pentanoic acid",1085,Inner Protein Regulator,Inner Protein,10029528,Carbamoyl phosphate synthetase: closure of the B-domain as a result of nucleotide binding.,No,"Chain A:GLU783,ASP791,SER792,ALA793,GLU892,VAL893,LEU907,TYR1040,ASP1041,THR1042"
ASD00490000_1,carB,Escherichia coli,P00968,1C30,ASD00490004,ORN,A,Lig,Activator,"(2S)-2,5-bis(azanyl)pentanoic acid",4010,Inner Protein Regulator,Inner Protein,10587438,The small subunit of carbamoyl phosphate synthetase: snapshots along the reaction pathway.,No,"Chain A:GLU783,ASP791,SER792,ALA793,GLU892,VAL893,LEU895,LEU907,TYR1040,ASP1041,THR1042"
ASD00490000_1,carB,Escherichia coli,P00968,1C3O,ASD00490004,ORN,A,Lig,Activator,"(2S)-2,5-bis(azanyl)pentanoic acid",4011,Inner Protein Regulator,Inner Protein,10587438,The small subunit of carbamoyl phosphate synthetase: snapshots along the reaction pathway.,No,"Chain A:GLU783,ASP791,ALA793,GLU892,VAL893,LEU895,LEU907,HIS1039,TYR1040,ASP1041,THR1042"
ASD00490000_1,carB,Escherichia coli,P00968,1CE8,ASD00490004,ORN,A,Lig,Activator,"(2S)-2,5-bis(azanyl)pentanoic acid",5011,Inner Protein Regulator,Inner Protein,10428826,The binding of inosine monophosphate to Escherichia coli carbamoyl phosphate synthetase.,No,"Chain A:GLU783,ASP791,ALA793,GLU892,VAL893,LEU895,LEU907,HIS1039,TYR1040,ASP1041,THR1042"
ASD00490000_1,carB,Escherichia coli,P00968,1CE8,ASD01320076,IMP,A,Lig,Regulator,"[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate",5012,Inner Protein Regulator,Inner Protein,10428826,The binding of inosine monophosphate to Escherichia coli carbamoyl phosphate synthetase.,No,"Chain A:SER948,VAL949,LYS954,THR974,HIS975,GLY976,THR977,LYS993,VAL994,HIS995,ILE1001,ASN1015,THR1016,THR1017,ASP1025,SER1026,VAL1028,ILE1029,ARG1030"
ASD00490000_1,carB,Escherichia coli,P00968,1CS0,ASD00490004,ORN,A,Lig,Activator,"(2S)-2,5-bis(azanyl)pentanoic acid",5010,Inner Protein Regulator,Inner Protein,10587438,The small subunit of carbamoyl phosphate synthetase: snapshots along the reaction pathway.,No,"Chain A:GLU783,ASP791,SER792,ALA793,GLU892,VAL893,LEU895,LEU907,HIS1039,TYR1040,ASP1041,THR1042"
ASD00490000_1,carB,Escherichia coli,P00968,1JDB,ASD00490004,ORN,B,Lig,Activator,"(2S)-2,5-bis(azanyl)pentanoic acid",1095,Inner Protein Regulator,Inner Protein,10089390,The structure of carbamoyl phosphate synthetase determined to 2.1 A resolution.,No,"Chain B:GLU782,ASP790,ALA792,GLU891,VAL892,LEU894,LEU906,TYR1039,ASP1040,THR1041"
ASD00490000_1,carB,Escherichia coli,P00968,1KEE,ASD00490004,ORN,A,Lig,Activator,"(2S)-2,5-bis(azanyl)pentanoic acid",5011,Inner Protein Regulator,Inner Protein,11729189,Inactivation of the amidotransferase activity of carbamoyl phosphate synthetase by the antibiotic acivicin.,No,"Chain A:GLU783,ASP791,ALA793,GLU892,VAL893,LEU895,LEU907,TYR1040,ASP1041,THR1042"
ASD00490000_1,carB,Escherichia coli,P00968,1M6V,ASD00490004,ORN,A,Lig,Activator,"(2S)-2,5-bis(azanyl)pentanoic acid",4011,Inner Protein Regulator,Inner Protein,12130656,Carbamoyl-phosphate synthetase. Creation of an escape route for ammonia.,No,"Chain A:GLU783,ASP791,ALA793,GLU892,VAL893,LEU907,TYR1040,ASP1041,THR1042"
ASD00490000_1,carB,Escherichia coli,P00968,1T36,ASD00490004,ORN,A,Lig,Activator,"(2S)-2,5-bis(azanyl)pentanoic acid",1089,Inner Protein Regulator,Inner Protein,15322282,Long-range allosteric transitions in carbamoyl phosphate synthetase.,No,"Chain A:GLU783,ASP791,SER792,ALA793,GLU892,VAL893,LEU907,TYR1040,ASP1041,THR1042"
ASD00490000_1,carB,Escherichia coli,P00968,1T36,ASD00490001,U,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl dihydrogen phosphate",1091,Inner Protein Regulator,Inner Protein,15322282,Long-range allosteric transitions in carbamoyl phosphate synthetase.,No,"Chain A:SER948,VAL949,ARG950,LYS954,THR974,HIS975,GLY976,THR977,LYS993,HIS995,ASN1015,THR1016,THR1017,ALA1022,ASP1025,SER1026,ILE1029"
ASD00510000_1,CSNK2A1,Homo sapiens,P68400,3H30,ASD00510001,RFZ,A,Lig,Inhibitor,"(2R,3R,4S,5R)-2-(5,6-dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol",337,Inner Protein Regulator,Inner Protein,18291315,The CK2 alpha/CK2 beta interface of human protein kinase CK2 harbors a binding pocket for small molecules.,No,3H30
ASD00520000_1,CASP1,Homo sapiens,P29466,2FQQ,ASD00520001,F1G,B,Lig,Inhibitor,"1-methyl-N-(2-sulfanylethyl)-3-(trifluoromethyl)thieno[4,5-d]pyrazole-5-carboxamide",1,Inner Protein Regulator,Protein-Protein Interaction,16682620,A common allosteric site and mechanism in caspases.,No,2FQQ
ASD00530000_1,CASP3,Homo sapiens,P42574,3KJF,ASD00530003,B92,B,Lig,Inhibitor,"(3S)-3-({[(5S,10aS)-2-{(2S)-4-carboxy-2-[(phenylacetyl)amino]butyl}- 1,3-dioxo-2,3,5,7,8,9,10,10a-octahydro-1H- [1,2,4]triazolo[1,2-a]cinnolin-5-yl]carbonyl}amino)- 4-oxopentanoic acid",285,Inner Protein Regulator,Protein-Protein Interaction,20580860,Kinetic and structural characterization of caspase-3 and caspase-8 inhibition by a novel class of irreversible inhibitors.,No,3KJF
ASD00540000_1,CASP7,Homo sapiens,P55210,1SHJ,ASD00530002,NXN,A,Lig,Inhibitor,"2-(2,4-dichlorophenoxy)-N-(2-sulfanylethyl)ethanamide",401,Inner Protein Regulator,Protein-Protein Interaction,15314233,Discovery of an allosteric site in the caspases.,No,1SHJ
ASD00540000_1,CASP7,Homo sapiens,P55210,1SHL,ASD00530001,FXN,A,Lig,Inhibitor,5-fluoro-N-(2-sulfanylethyl)-1H-indole-2-carboxamide,401,Inner Protein Regulator,Protein-Protein Interaction,15314233,Discovery of an allosteric site in the caspases.,No,1SHL
ASD00540000_1,CASP7,Homo sapiens,P55210,2QLJ,ASD00360007,CIT,A,Lig,Inhibitor,"2-hydroxypropane-1,2,3-tricarboxylic acid",850,Inner Protein Regulator,Protein-Protein Interaction,17697120,Plasticity of S2-S4 specificity pockets of executioner caspase-7 revealed by structural and kinetic analysis.,No,2QLJ
ASD00540000_1,CASP7,Homo sapiens,P55210,4FEA,ASD00540004,0TE,A,Lig,Inhibitor,"chloro{methyl hydrogenato(3-)-kappa~2~N,S [pyridin-2-yl(pyridin-2(1H)-ylidene-kappaN)methyl]carbonodithiohydrazonate}copper",701,Inner Protein Regulator,Protein-Protein Interaction,22795132,A class of allosteric caspase inhibitors identified by high-throughput screening.,No,4FEA
ASD00540000_1,CASP7,Homo sapiens,P55210,5V6U,ASD00540002,8YM,B,Lig,Inhibitor,2-[(2-acetylphenyl)sulfanyl]benzoic acid,401,Allosteric function,Allosteric position,28940929,Allosteric Tuning of Caspase-7: A Fragment-Based Drug Discovery Approach.,No,5V6U
ASD00540000_1,CASP7,Homo sapiens,P55210,5V6Z,,8YJ,B,Lig,Inhibitor,2-{[2-(4-chlorophenyl)-2-oxoethyl]sulfanyl}benzoic acid,401,Allosteric function,Allosteric position,,Crystal structure of human caspase-7 soaked with allosteric inhibitor,No,5V6Z
ASD00570000_1,CHEK1,Homo sapiens,O14757,3F9N,ASD00570016,38M,A,Lig,Inhibitor,"3-(3-chlorophenyl)-2-[(2S)-1-[(6S)-4,8-diazaspiro[5.5]undecan-4-yl]-1-oxo-hexan-2-yl]sulfanyl-quinazolin-4-one",324,Inner Protein Regulator,Inner Protein,19155174,"Development of thioquinazolinones, allosteric Chk1 kinase inhibitors.",No,3F9N
ASD00570000_1,CHEK1,Homo sapiens,O14757,3JVR,ASD00570017,AGX,A,Lig,Inhibitor,"[(1S)-1-(1H-benzimidazol-2-yl)ethyl] N-(3,4-dichlorophenyl)carbamate",901,Inner Protein Regulator,Inner Protein,19743875,Characterization of the CHK1 allosteric inhibitor binding site.,No,3JVR
ASD00570000_1,CHEK1,Homo sapiens,O14757,3JVS,ASD00570018,AGY,A,Lig,Inhibitor,1-[(4-tert-butyl-3-nitro-phenyl)carbonylamino]-3-naphthalen-1-yl-urea,900,Inner Protein Regulator,Inner Protein,19743875,Characterization of the CHK1 allosteric inhibitor binding site.,No,3JVS
ASD00600000_2,CCR5,Clostridium pasteurianum,P00268,4MBS,ASD00600010,MRV,A,Lig,Inhibitor,"4,4-bis(fluoranyl)-N-[(1S)-3-[(1R,5S)-3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenyl-propyl]cyclohexane-1-carboxamide",1101,Inner Protein Regulator,Inner Protein,24030490,Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex.,No,"Chain A:TYR37,TRP86,TYR89,TYR108,PHE109,PHE112,PHE182,LYS191,GLN194,THR195,ILE198,TRP248,TYR251,LEU255,THR259,MET279,GLU283,THR284,MET287"
ASD00600000_2,,Clostridium pasteurianum,P00268,4XNV,,BUR,A,Lig,Inhibitor,1-[2-(2-tert-butylphenoxy)pyridin-3-yl]-3- [4-(trifluoromethoxy)phenyl]urea,1101,Inner Protein Regulator,Allosteric Position,25822790,Two disparate ligand-binding sites in the human P2Y1 receptor,No,
ASD00680000_1,ESR2,Homo sapiens,Q92731,2FSZ,ASD00680003,OHT,B,Lig,Inhibitor,4-[(Z)-1-[4-(2-dimethylaminoethoxy)phenyl]-2-phenyl-but-1-enyl]phenol,104,Protein-Protein Interaction Regulator,Protein-Protein Interaction,16782818,A second binding site for hydroxytamoxifen within the coactivator-binding groove of estrogen receptor beta.,Yes,2FSZ
ASD00690000_1,ARO7,Saccharomyces cerevisiae,P32178,1CSM,ASD00320001,TRP,B,Lig,Activator,(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid,501,Inner Protein Regulator,Protein-Protein Interaction,7971967,The crystal structure of allosteric chorismate mutase at 2.2-A resolution.,No,"Chain A:HIS71,ILE74,ARG75,ARG76,SER79,GLU82,TYR100; Chain B:ASN138,ASN139,PHE140,GLY141,SER142,THR145"
ASD00690000_1,ARO7,Saccharomyces cerevisiae,P32178,2CSM,ASD00690002,TYR,A,Lig,Inhibitor,(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid,300,Inner Protein Regulator,Protein-Protein Interaction,9384560,Crystal structure of the T state of allosteric yeast chorismate mutase and comparison with the R state.,No,"Chain A:ILE74,ARG75,ARG76"
ASD00690000_1,ARO7,Saccharomyces cerevisiae,P32178,3CSM,ASD00320001,TRP,A,Lig,Activator,(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid,300,Inner Protein Regulator,Protein-Protein Interaction,9384560,Mechanisms of catalysis and allosteric regulation of yeast chorismate mutase from crystal structures.,No,"Chain A:HIS71,ILE74,ARG75,ARG76,SER79,GLU82,ILE98,TYR100"
ASD00690000_1,ARO7,Saccharomyces cerevisiae,P32178,4CSM,ASD00690002,TYR,A,Lig,Inhibitor,(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid,300,Inner Protein Regulator,Protein-Protein Interaction,9384560,Mechanisms of catalysis and allosteric regulation of yeast chorismate mutase from crystal structures.,No,"Chain A:HIS71,ILE74,ARG75,ARG76,SER79,GLU82,ILE98,TYR100"
ASD00690000_1,ARO7,Saccharomyces cerevisiae,P32178,5CSM,ASD00320001,TRP,A,Lig,Activator,(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid,300,Inner Protein Regulator,Protein-Protein Interaction,9384560,Mechanisms of catalysis and allosteric regulation of yeast chorismate mutase from crystal structures.,No,"Chain A:HIS71,ILE74,ARG76,GLU82"
ASD00710000_1,gltA,Escherichia coli,P0ABH7,1NXG,ASD06128001,NAI,A,Lig,Inhibitor,"[[(2R,3S,4R,5R)-5-(3-aminocarbonyl-4H-pyridin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl hydrogen phosphate",3000,Inner Protein Regulator,Inner Protein,12741811,Insights into the evolution of allosteric properties. The NADH binding site of hexameric type II citrate synthases.,No,"Chain A:THR106,THR108,ARG109,HIS110,THR111,MET112,ILE113,HIS114,TYR145,ILE159,PHE162,ARG163,LYS167,ASN189"
ASD00710000_1,gltA,Escherichia coli,P0ABH7,1OWB,ASD01720006,NAD,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(3-aminocarbonylpyridin-1-ium-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphate",3000,Inner Protein Regulator,Inner Protein,12824188,Probing the roles of key residues in the unique regulatory NADH binding site of type II citrate synthase of Escherichia coli.,No,"Chain A:THR106,THR108,LEU109,HIS110,THR111,MET112,ILE113,HIS114,TYR145,ASP147,ILE159,PHE162,ARG163,LYS167,ASN189"
ASD00710000_1,gltA,Escherichia coli,P0ABH7,4JAF,ASD06128001,NAI,A,Lig,Inhibitor,"[[(2R,3S,4R,5R)-5-(3-aminocarbonyl-4H-pyridin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl hydrogen phosphate",503,Inner Protein Regulator,Inner Protein,23954305,Enzyme-substrate complexes of allosteric citrate synthase: Evidence for a novel intermediate in substrate binding.,No,"Chain A:THR106,THR108,ARG109,HIS110,THR111,MET112,ILE113,HIS114,TYR145,ARG155,GLU158,ILE159,PHE162,ARG163,LYS167,ASN189"
ASD00730000_1,CRHR1,Homo sapiens,P34998,4K5Y,ASD00730004,1Q5,A,Lig,Inhibitor,"3,6-dimethyl-N-(pentan-3-yl)-2-(2,4,6-trimethylphenoxy)pyridin-4-amine",401,Allosteric function,Allosteric position,23863939,Structure of class B GPCR corticotropin-releasing factor receptor 1.,No,4K5Y
ASD00740000_1,SRC,Gallus gallus,P00523,2OIQ,ASD00740007,STI,A,Lig,Inhibitor,4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide,1001,Inner Protein Regulator,Inner Protein,17355866,c-Src binds to the cancer drug imatinib with an inactive Abl/c-Kit conformation and a distributed thermodynamic penalty.,Yes,"Chain A:LEU273,VAL281,ALA293,ILE294,LYS295,GLU310,VAL313,MET314,LEU317,ILE336,THR338,TYR340,MET341,GLY344,VAL383,HIS384,ARG385,LEU393,ALA403,ASP404,PHE405"
ASD00740000_1,SRC,Gallus gallus,P00523,3EL8,ASD09800002,PD5,A,Lig,Inhibitor,"1-[4-(4-amino-1-propan-2-yl-pyrazolo[5,4-d]pyrimidin-3-yl)phenyl]-3-[3-(trifluoromethyl)phenyl]urea",601,Inner Protein Regulator,Inner Protein,,Small Molecule Recognition of c-Src via the Imatinib-Binding Conformation,Yes,"Chain A:LEU273,VAL281,ALA293,LYS295,GLU310,VAL313,MET314,LEU317,LEU322,VAL323,THR338,GLU339,TYR340,MET341,LEU393,VAL402,ALA403,ASP404,GLY406"
ASD00740000_1,SRC,Gallus gallus,P00523,3F3T,ASD00740003,1AU,A,Lig,Inhibitor,3-[2-(3-aminophenyl)-5-tert-butyl-pyrazol-3-yl]-1-naphthalen-1-yl-urea,1,Inner Protein Regulator,Inner Protein,19396179,A new screening assay for allosteric inhibitors of cSrc.,Yes,"Chain A:ALA293,LYS295,GLU310,VAL313,MET314,LEU317,LEU322,ILE336,THR338,TYR382,VAL402,ALA403,ASP404,PHE405,GLY406"
ASD00740000_1,SRC,Gallus gallus,P00523,3F3U,ASD00740002,1AW,A,Lig,Inhibitor,3-[2-(3-aminophenyl)-5-tert-butyl-pyrazol-3-yl]-1-phenyl-urea,1,Inner Protein Regulator,Inner Protein,19396179,A new screening assay for allosteric inhibitors of cSrc.,Yes,"Chain A:GLU310,MET314,LEU317,LEU322,VAL323,THR338,TYR382,HIS384,VAL402,ALA403,ASP404,PHE405,GLY406"
ASD00740000_1,SRC,Gallus gallus,P00523,3F3V,ASD00740016,1BU,A,Lig,Inhibitor,3-[4-[(6-aminoquinazolin-4-yl)amino]phenyl]-1-[5-tert-butyl-2-(3-methylphenyl)pyrazol-3-yl]urea,1,Inner Protein Regulator,Inner Protein,19462975,Hybrid compound design to overcome the gatekeeper T338M mutation in cSrc.,Yes,"Chain A:LEU273,ALA293,GLU310,MET314,LEU322,GLU339,TYR340,MET341,GLY344,TYR382,LEU393,VAL402,ALA403,ASP404,PHE405,GLY406"
ASD00740000_1,SRC,Gallus gallus,P00523,3F3W,ASD00740016,1BU,A,Lig,Inhibitor,3-[4-[(6-aminoquinazolin-4-yl)amino]phenyl]-1-[5-tert-butyl-2-(3-methylphenyl)pyrazol-3-yl]urea,1,Inner Protein Regulator,Inner Protein,19462975,Hybrid compound design to overcome the gatekeeper T338M mutation in cSrc.,Yes,"Chain A:VAL281,ALA293,GLU310,MET314,LEU322,MET338,GLU339,MET341,GLY344,TYR382,HIS384,LEU393,VAL402,ALA403,ASP404,PHE405,GLY406"
ASD00740000_1,SRC,Gallus gallus,P00523,3G6G,ASD00740024,G6G,A,Lig,Inhibitor,"N-[3-[[3-[4-[(4-methoxyphenyl)amino]-1,3,5-triazin-2-yl]pyridin-2-yl]amino]-4-methyl-phenyl]-4-[(4-methylpiperazin-1-yl)methyl]benzamide",1,Inner Protein Regulator,Inner Protein,19276351,Equally potent inhibition of c-Src and Abl by compounds that recognize inactive kinase conformations.,Yes,"Chain A:VAL281,ALA293,LYS295,GLU310,MET314,LEU317,LEU322,VAL323,ILE336,THR338,GLU339,TYR340,MET341,GLY344,VAL383,HIS384,ARG385,LEU393,ALA403,ASP404,PHE405"
ASD00740000_1,SRC,Gallus gallus,P00523,3TZ7,ASD00740027,AQB,A,Lig,Inhibitor,N-[4-[[4-[[2-(3-aminophenyl)-5-tert-butyl-pyrazol-3-yl]carbamoylamino]phenyl]amino]quinazolin-6-yl]-4-(dimethylamino)butanamide,601,Inner Protein Regulator,Inner Protein,,Overcoming Gatekeeper Mutations in cSrc and Abl by Hybrid Compound Design,Yes,"Chain A:ALA293,THR338,ALA311,LEU317,VAL402,MET341,LEU322,VAL313,ASP348,PHE405,GLY406,HIS384,VAL281,GLU339,LYS343,GLY274,LEU393,VAL377,VAL323,MET314,GLU310,CYS345,TYR382,LYS295,SER342,TYR340,ASP404,GLY344,LEU273,ALA403,GLN309"
ASD00740000_1,SRC,Gallus gallus,P00523,3TZ8,ASD00740029,AQM,A,Lig,Inhibitor,N-[4-[[4-[[2-(3-aminophenyl)-5-tert-butyl-pyrazol-3-yl]carbamoylamino]phenyl]amino]quinazolin-6-yl]-3-(4-methylpiperazin-1-yl)propanamide,1,Inner Protein Regulator,Inner Protein,,Overcoming Gatekeeper Mutations in cSrc and Abl by Hybrid Compound Design,Yes,"Chain A:ALA293,THR338,ALA311,LEU317,VAL402,MET341,LEU322,VAL313,ASP348,PHE405,GLY406,HIS384,VAL281,VAL383,GLU339,LYS343,GLY274,LEU393,VAL377,VAL323,MET314,GLU310,CYS345,TYR382,LYS295,SER342,TYR340,ASP404,GLY344,LEU273,ALA403,GLN309"
ASD00740000_1,SRC,Gallus gallus,P00523,3TZ9,ASD00740028,AQU,A,Lig,Inhibitor,1-[2-(3-aminophenyl)-5-tert-butyl-pyrazol-3-yl]-3-[4-(quinazolin-4-ylamino)phenyl]urea,1,Inner Protein Regulator,Inner Protein,,Overcoming Gatekeeper Mutations in cSrc and Abl by Hybrid Compound Design,Yes,"Chain A:ALA293,THR338,ALA311,LEU317,VAL402,MET341,LEU322,VAL313,PHE405,GLY406,HIS384,VAL281,LEU407,GLU339,LYS343,LEU393,VAL377,VAL323,MET314,GLU310,CYS345,TYR382,LYS295,SER342,TYR340,ASP404,GLY344,LEU273,ALA403,GLN309"
ASD00740000_1,SRC,Gallus gallus,P00523,4AGW,ASD00740025,NG7,A,Lig,Inhibitor,"3-[2-(cyclopropylcarbonylamino)-[1,3]thiazolo[5,4-b]pyridin-5-yl]-N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide",1534,Inner Protein Regulator,Inner Protein,20299508,"Discovery of a Small-Molecule Type II Inhibitor of Wild-Type and Gatekeeper Mutants of Bcr-Abl, Pdgfralpha, Kit, and Src Kinases: Novel Type II Inhibitor of Gatekeeper Mutants.",Yes,"Chain A:LEU273,ALA293,LYS295,GLU310,VAL313,MET314,LEU317,LEU322,VAL323,THR338,GLU339,TYR340,MET341,SER342,LYS343,GLY344,TYR382,VAL383,HIS384,ARG385,LEU393,VAL402,ALA403,ASP404,PHE405"
ASD00740000_1,SRC,Gallus gallus,P00523,5J5S,ASD09800026,6G3,A,Lig,Inhibitor,"N-{4-[8-amino-3-(propan-2-yl)imidazo[1,5-a]pyrazin-1-yl]naphthalen-1-yl}-N'-[3-(trifluoromethyl)phenyl]urea",601,Allosteric Fuction,Allosteric Position,,Structural and Functional Analysis of the Allosteric Modulation of IRE1a with ATP-Competitive Kinase Inhibitors,No,"Chain A:ALA293,PHE278,THR338,ALA311,SER345,MET341,GLU310,LEU297,ASP348,GLY276,GLY279,PHE307,GLN312,VAL281,SER342,CYS277,ILE294,GLU339,GLY274,LEU393,MET302,TRP282,MET314,ILE334,GLN275,VAL337,LYS295,ILE336,VAL323,TYR340,ASP404,GLY344,LEU273,ALA403"
ASD00750000_1,pyrG,Escherichia coli,P0A7E5,5TKV,ASD00150003,CTP,A,Lig,Inhibitor,CYTIDINE-5'-TRIPHOSPHATE,601,Allosteric function,Allosteric position,28459447,Human CTP synthase filament structure reveals the active enzyme conformation.,Yes,"Chain A:GLY352,GLN513,MET439,GLN383,GLU403,ILE378,GLU472,HIS469,TYR471,ARG468,GLY351,CYS379,PRO350,PHE353,VAL413,GLY381,LEU380,HIS515,ARG470,GLY354,PHE404"
ASD00750000_1,pyrG,Escherichia coli,P0A7E5,5U3C,ASD00150003,CTP,A,Lig,Inhibitor,CYTIDINE-5'-TRIPHOSPHATE,601,Allosteric function,Allosteric position,28459447,Human CTP synthase filament structure reveals the active enzyme conformation.,Yes,"Chain B:GLN114,THR112,VAL115,ILE116,PRO117,GLU155"
ASD00750000_1,pyrG,Escherichia coli,P0A7E5,5U6R,ASD00150003,CTP,A,Lig,Inhibitor,CYTIDINE-5'-TRIPHOSPHATE,601,Allosteric function,Allosteric position,28459447,Human CTP synthase filament structure reveals the active enzyme conformation.,Yes,"Chain B:GLN114,THR112,VAL115,ILE116,PRO117,GLU155"
ASD00770000_1,CBS,Homo sapiens,P35520,4PCU,ASD00350007,SAM,A,Lig,Activator,S-ADENOSYLMETHIONINE,603,Inner Protein Regulator,Inner Protein,25197074,Structural insight into the molecular mechanism of allosteric activation of human cystathionine beta-synthase by S-adenosylmethionine.,No,4PCU
ASD00770000_1,CBS,Homo sapiens,P35520,4UUU,ASD00350007,SAM,A,Lig,Activator,S-ADENOSYLMETHIONINE,1546,Inner Protein Regulator,Inner Protein,25336647,Inter-Domain Communication of Human Cystathionine Beta Synthase: Structural Basis of S-Adenosyl-L-Methionine Activation.,No,4UUU
ASD00840000_1,CYP3A4,Homo sapiens,P08684,1W0F,ASD09650003,STR,A,Lig,Regulator,"(8S,9S,10R,13S,14S,17S)-17-ethanoyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one",1499,Inner Protein Regulator,Inner Protein,15256616,Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone.,No,1W0F
ASD00850000_1,eryF,Saccharopolyspora erythraea,Q00441,1EGY,ASD00850001,9AP,A,Lig,Activator,phenanthren-9-amine,801,Inner Protein Regulator,Inner Protein,10716705,Crystal structures of ligand complexes of P450eryF exhibiting homotropic cooperativity.,Yes,"Chain A:ALA74,PHE78,PHE86,ARG185,VAL237,ALA241,LEU391"
ASD00850000_1,eryF,Saccharopolyspora erythraea,Q00441,1EUP,ASD09650004,ASD,A,Lig,Activator,"(8R,9S,10R,13S,14S)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione",452,Inner Protein Regulator,Inner Protein,10716705,Crystal structures of ligand complexes of P450eryF exhibiting homotropic cooperativity.,Yes,"Chain A:ALA74,TYR75,PHE86,SER171,ILE174,LEU175,LEU240,GLU244,LEU391"
ASD00870000_1,NT5C2,Homo sapiens,P49902,2JC9,ASD01240004,ADN,A,Lig,Activator,"(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol",1497,Inner Protein Regulator,Protein-Protein Interaction,17405878,Crystal structure of human cytosolic 5'-nucleotidase II: insights into allosteric regulation and substrate recognition.,No,2JC9
ASD00870000_1,NT5C2,Homo sapiens,P49902,2JC9,ASD01240004,ADN,A,Lig,Activator,"(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol",1498,Inner Protein Regulator,Inner Protein,17405878,Crystal structure of human cytosolic 5'-nucleotidase II: insights into allosteric regulation and substrate recognition.,No,2JC9
ASD00870000_1,NT5C2,Homo sapiens,P49902,2XCV,ASD03910075,DG2,A,Lig,Activator,"2,3-diphosphonooxypropanoic acid",1489,Inner Protein Regulator,Protein-Protein Interaction,21396942,Structural Basis for the Allosteric Regulation and Substrate Recognition of Human Cytosolic 5'-Nucleotidase II,No,2XCV
ASD00870000_1,NT5C2,Homo sapiens,P49902,2XCW,ASD00150001,ATP,A,Lig,Activator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1489,Inner Protein Regulator,Protein-Protein Interaction,21396942,Structural Basis for the Allosteric Regulation and Substrate Recognition of Human Cytosolic 5'-Nucleotidase II,No,2XCW
ASD00870000_1,NT5C2,Homo sapiens,P49902,2XJC,ASD00870007,B4P,A,Lig,Activator,"[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl] [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl hydrogen phosphate",1490,Inner Protein Regulator,Protein-Protein Interaction,21396942,Structural Basis for the Allosteric Regulation and Substrate Recognition of Human Cytosolic 5'-Nucleotidase II,No,2XJC
ASD00870000_1,NT5C2,Homo sapiens,P49902,2XJD,ASD00150001,ATP,A,Lig,Activator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1489,Inner Protein Regulator,Protein-Protein Interaction,21396942,Structural Basis for the Allosteric Regulation and Substrate Recognition of Human Cytosolic 5'-Nucleotidase II.,No,2XJD
ASD00870000_1,NT5C2,Homo sapiens,P49902,2XJE,ASD00150001,ATP,A,Lig,Activator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1490,Inner Protein Regulator,Protein-Protein Interaction,21396942,Structural Basis for the Allosteric Regulation and Substrate Recognition of Human Cytosolic 5'-Nucleotidase II,No,2XJE
ASD00870000_1,NT5C2,Homo sapiens,P49902,2XJF,ASD03910075,DG2,A,Lig,Activator,"2,3-diphosphonooxypropanoic acid",1489,Inner Protein Regulator,Protein-Protein Interaction,21396942,Structural Basis for the Allosteric Regulation and Substrate Recognition of Human Cytosolic 5'-Nucleotidase II,No,2XJF
ASD00870000_1,NT5C2,Homo sapiens,P49902,4H4B,ASD00870013,11H,A,Lig,Activator,"9,10-bis(oxidanylidene)anthracene-2,6-disulfonic acid",601,Inner Protein Regulator,Protein-Protein Interaction,23220537,Identification and characterization of inhibitors of cytoplasmic 5'-nucleotidase cN-II issued from virtual screening.,No,4H4B
ASD00870000_1,NT5C2,Homo sapiens,P49902,5OPK,ASD00330030,MG,A,Ion,Activator,MAGNESIUM ION,512,Allosteric function,Allosteric position,29535428,Relapsed acute lymphoblastic leukemia-specific mutations in NT5C2 cluster into hotspots driving intersubunit stimulation.,No,5OPK
ASD00870000_1,NT5C2,Homo sapiens,P49902,5OPK,ASD00870004,DTP,A,Lig,Activator,2'-DEOXYADENOSINE 5'-TRIPHOSPHATE,514,Allosteric function,Allosteric position,29535428,Relapsed acute lymphoblastic leukemia-specific mutations in NT5C2 cluster into hotspots driving intersubunit stimulation.,No,5OPK
ASD00870000_1,NT5C2,Homo sapiens,P49902,5OPM,ASD00330030,MG,A,Ion,Activator,MAGNESIUM ION,610,Allosteric function,Allosteric position,29535428,Relapsed acute lymphoblastic leukemia-specific mutations in NT5C2 cluster into hotspots driving intersubunit stimulation.,No,5OPM
ASD00870000_1,NT5C2,Homo sapiens,P49902,5OPM,ASD00870004,DTP,A,Lig,Activator,2'-DEOXYADENOSINE 5'-TRIPHOSPHATE,504,Allosteric function,Allosteric position,29535428,Relapsed acute lymphoblastic leukemia-specific mutations in NT5C2 cluster into hotspots driving intersubunit stimulation.,No,5OPM
ASD00880000_1,ddl,Staphylococcus aureus,Q5HEB7,2I80,ASD00880002,G1L,A,Lig,Inhibitor,"3-chloro-2,2-dimethyl-N-[4-(trifluoromethyl)phenyl]propanamide",400,Inner Protein Regulator,Inner Protein,17015835,Allosteric inhibition of Staphylococcus aureus D-alanine:D-alanine ligase revealed by crystallographic studies.,Yes,"Chain A:VAL19,SER20,THR23,PHE92,PRO93,LEU94,LEU95,HIS96,VAL117,GLY118,LEU289,MET310,PRO311,GLY312,PHE313,LEU337"
ASD00890000_2,,Hepatitis C virus,O92972,3GNV,ASD00898002,XNZ,A,Lig,Inhibitor,"(6R)-6-(2-chloro-4-phenylmethoxy-phenyl)-5-ethanoyl-1-hydroxy-9,9-dimethyl-6,8,10,11-tetrahydrobenzo[b][1,4]benzodiazepin-7-one",579,Inner Protein Regulator,Inner Protein,19507864,Structure-based design of a benzodiazepine scaffold yields a potent allosteric inhibitor of hepatitis C NS5B RNA polymerase.,Yes,"Chain A:PHE193,PRO197,ARG200,CYS366,SER367,SER368,LEU384,ARG386,SER407,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449"
ASD00890000_2,,Hepatitis C virus,O92972,3GNW,ASD00898001,XNC,A,Lig,Inhibitor,"[(5S)-5-(2-fluoro-4-phenylmethoxy-phenyl)-10-hydroxy-2,2-dimethyl-4,4-dioxo-1,3,5,11-tetrahydrothiopyrano[2,3-c][1,5]benzodiazepin-6-yl]-(6-methylpyridin-2-yl)methanone",579,Inner Protein Regulator,Inner Protein,19507864,Structure-based design of a benzodiazepine scaffold yields a potent allosteric inhibitor of hepatitis C NS5B RNA polymerase.,Yes,"Chain A:ARG158,PHE193,PRO197,ARG200,SER365,CYS366,SER367,SER368,LEU384,ARG386,SER407,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449,SER556"
ASD00890000_2,,Hepatitis C virus,O92972,3MWW,ASD00890012,BIW,B,Lig,Inhibitor,1-[2-(4-carboxypiperidin-1-yl)-2-oxo-ethyl]-3-cyclohexyl-2-furan-3-yl-indole-6-carboxylic acid,577,Inner Protein Regulator,Inner Protein,20942454,Importance of ligand bioactive conformation in the discovery of potent indole-diamide inhibitors of the hepatitis C virus NS5B.,No,"Chain B:MET36,VAL37,ALA395,ALA396,HIS428,LEU492,GLY493,VAL494,PRO495,TRP500,ARG503"
ASD00890000_2,,Hepatitis C virus,Q9HXM5,4DQW,ASD01140145;ASD00890024;ASD01140145;ASD00890024,ATP;MN;ATP;MN,A;A;A;A,Lig,Regulator,ADENOSINE-5'-TRIPHOSPHATE;MANGANESE (II) ION;ADENOSINE-5'-TRIPHOSPHATE;MANGANESE (II) ION;,501;502;503;504,Inner Protein Regulator,Inner Protein,23643948,MgATP Regulates Allostery and Fiber Formation in IMPDHs.,No,"Chain B:GLU180,ARG136,ARG178"
ASD00890000_2,,Hepatitis C virus,O92972,4JJS,ASD00890010,1M9,A,Lig,Inhibitor,2-[(4-methylcyclohexyl)carbonyl-propan-2-yl-amino]-5-[2-(trifluoromethyl)phenoxy]benzoic acid,601,Inner Protein Regulator,Inner Protein,23768906,Structure-based design of novel HCV NS5B thumb pocket 2 allosteric inhibitors with submicromolar gt1 replicon potency: Discovery of a quinazolinone chemotype.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,VAL485,ALA486,LEU489,LEU497,TRP528"
ASD00890000_2,,Hepatitis C virus,O92972,4JJU,ASD00890014,1MB,A,Lig,Inhibitor,"1-[[2,4-bis(fluoranyl)phenyl]methyl]-6-[3-(trifluoromethyl)pyridin-2-yl]oxy-quinazolin-4-one",3002,Inner Protein Regulator,Inner Protein,23768906,Structure-based design of novel HCV NS5B thumb pocket 2 allosteric inhibitors with submicromolar gt1 replicon potency: Discovery of a quinazolinone chemotype.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,VAL485,ALA486,LEU489,LEU497,TRP528"
ASD00890000_2,,Hepatitis C virus,O92972,4JTW,ASD01410426,1NU,A,Lig,Inhibitor,"6-[2-(trifluoromethyl)phenoxy]-1-[[2,4,6-tris(fluoranyl)phenyl]methyl]quinazolin-4-one",3002,Inner Protein Regulator,Inner Protein,23773186,Molecular Dynamics Simulations and Structure-Based Rational Design Lead to Allosteric HCV NS5B Polymerase Thumb Pocket 2 Inhibitor with Picomolar Cellular Replicon Potency.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,VAL485,ALA486,LEU489,LEU497,TRP528"
ASD00890000_2,,Hepatitis C virus,O92972,4JTY,ASD01410428,1NV,A,Lig,Inhibitor,"3-[4-oxidanylidene-1-[[2,4,6-tris(fluoranyl)phenyl]methyl]quinazolin-6-yl]oxy-2-(trifluoromethyl)benzamide",3002,Inner Protein Regulator,Inner Protein,23773186,Molecular Dynamics Simulations and Structure-Based Rational Design Lead to Allosteric HCV NS5B Polymerase Thumb Pocket 2 Inhibitor with Picomolar Cellular Replicon Potency.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,VAL485,ALA486,LEU489,PRO496,LEU497,TRP528"
ASD00890000_2,,Hepatitis C virus,O92972,4JTZ,ASD01410430,1NW,A,Lig,Inhibitor,"3-[4-oxidanylidene-1-[[2,4,6-tris(fluoranyl)phenyl]methyl]quinazolin-6-yl]oxy-N-pyridin-3-yl-2-(trifluoromethyl)benzamide",3002,Inner Protein Regulator,Inner Protein,23773186,Molecular Dynamics Simulations and Structure-Based Rational Design Lead to Allosteric HCV NS5B Polymerase Thumb Pocket 2 Inhibitor with Picomolar Cellular Replicon Potency.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,VAL485,ALA486,ARG490,PRO496,LEU497,TRP528"
ASD00890000_2,,Hepatitis C virus,O92972,4JU1,ASD01410432,1NZ,A,Lig,Inhibitor,"6-[3-([1,3]oxazolo[4,5-b]pyridin-2-yl)-2-(trifluoromethyl)phenoxy]-1-[[2,4,6-tris(fluoranyl)phenyl]methyl]quinazolin-4-one",3002,Inner Protein Regulator,Inner Protein,23773186,Molecular Dynamics Simulations and Structure-Based Rational Design Lead to Allosteric HCV NS5B Polymerase Thumb Pocket 2 Inhibitor with Picomolar Cellular Replicon Potency.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,VAL485,ALA486,LEU489,ARG490,VAL494,PRO495,PRO496,LEU497,TRP528"
ASD00890000_2,,Hepatitis C virus,O92972,4JU2,ASD01410440,1O0,A,Lig,Inhibitor,"6-[3-pyridin-2-yl-2-(trifluoromethyl)phenoxy]-1-[[2,4,6-tris(fluoranyl)phenyl]methyl]quinazolin-4-one",3002,Inner Protein Regulator,Inner Protein,23773186,Molecular Dynamics Simulations and Structure-Based Rational Design Lead to Allosteric HCV NS5B Polymerase Thumb Pocket 2 Inhibitor with Picomolar Cellular Replicon Potency.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,VAL485,ALA486,LEU489,VAL494,PRO495,PRO496,LEU497,TRP528"
ASD00890000_2,,Hepatitis C virus,O92972,4JVQ,ASD01410464,1ML,A,Lig,Inhibitor,5-[4-[(4-methoxyphenyl)carbonylamino]phenoxy]-2-[(4-methylcyclohexyl)carbonyl-propan-2-yl-amino]benzoic acid,3002,Inner Protein Regulator,Inner Protein,24024973,Enantiomeric Atropisomers Inhibit HCV Polymerase and/or HIV Matrix: Characterizing Hindered Bond Rotations and Target Selectivity.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,LEU489,ARG490,VAL494,PRO496,LEU497,TRP528"
ASD00890000_2,,Hepatitis C virus,O92972,5CZB,ASD00890015,55W,"A,B",Lig,Inhibitor,"1-[4-(7-amino-5-methylpyrazolo[1,5-a]pyrimidin- 2-yl)phenyl]-3-{[(R)-(2,4-dimethylphenyl)(methoxy)phosphoryl]amino}- 1H-pyrazole-4-carboxylic acid",601,Inner Protein Regulator,Allosteric Position,27520942,Synthesis of potent and broad genotypically active NS5B HCV non-nucleoside inhibitors binding to the thumb domain allosteric site 2 of the viral polymerase.,No,Chain A:MET423
ASD00900000_3,comEB,Streptococcus mutans serotype c,Q8DSE5,2HVW,ASD00900001,DCP,A,Lig,Activator,"[(2R,3S,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3-hydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",1201,Inner Protein Regulator,Inner Protein,18255096,Crystal structures of Streptococcus mutans 2'-deoxycytidylate deaminase and its complex with substrate analog and allosteric regulator dCTP x Mg2+.,No,"Chain A:ARG21,THR23,GLY43,TYR44,GLY46,GLY47,ALA49,ASP50,ASN53,ASN75; Chain B:GLN108"
ASD00900000_3,,Streptococcus mutans serotype c,Q8DSE5,4P9D,ASD02040015,TTP,A,Lig,Inhibitor,THYMIDINE-5'-TRIPHOSPHATE,203,Inner Protein Regulator,Protein-Protein Interaction,25404739,The First Crystal Structure of a dTTP-bound Deoxycytidylate Deaminase Validates and Details the Allosteric-Inhibitor Binding Site.,No,Chain D:GLN104
ASD00900000_3,comEB,Streptococcus mutans serotype c,Q8DSE5,5C2O,ASD02040015,TTP,"A,B",Lig,modulator,THYMIDINE-5'-TRIPHOSPHATE,704,Allosteric Function,Allosteric Position,,Mechanism of the allosteric regulation of Streptococcus mutans 2'-deoxycytidylate deaminase,No,"Chain B:ASN45,ALA72,GLY43,GLN79,ASN75,GLY46,TYR44,ALA76,ALA41,ASN53,THR42,THR51,ASP50,GLY47,VAL70,THR23,ILE18,ARG21,GLN108,VAL48,ALA49"
ASD00910000_1,,Escherichia coli,P0A6L2,1YXD,ASD00910001,LYS,B,Lig,Inhibitor,LYSINE,2300,Inner Protein Regulator,Inner Protein,16041077,The crystal structures of native and (S)-lysine-bound dihydrodipicolinate synthase from Escherichia coli with improved resolution show new features of biological significance.,No,Chain B:ALA83
ASD00910000_1,,Escherichia coli,P0A6L2,2ATS,ASD00910002,DLY,A,Lig,Inhibitor,LYSINE,3001,Inner Protein Regulator,Inner Protein,,The co-crystallisation of (S)-lysine-bound dihydrodipicolinate synthase from E. coli indicates that domain movements are not responsible for (S)-lysine inhibition,No,Chain B:ALA83
ASD00910000_3,,Pseudomonas aeruginosa,Q9I4W3,3PUO,ASD00910001,LYS,A,Lig,Inhibitor,LYSINE,293,Inner Protein Regulator,Inner Protein,21396954,Biochemical studies and crystal structure determination of dihydrodipicolinate synthase from Pseudomonas aeruginosa,No,"Chain B:GLU84,SER81,ASN80,TYR106"
ASD00910000_3,,Pseudomonas aeruginosa,Q9I4W3,3TCE,ASD00910005,LYZ,A,Lig,Inhibitor,LYSINE,4990,Inner Protein Regulator,Inner Protein,,Crystal structure of the complex of Dihydrodipicolinate synthase from Acinetobacter baumannii with 5-Hydroxylysine at 2.6 A resolution,No,"Chain B:GLU84,TYR107,ASN80,TYR106"
ASD00910000_3,,Pseudomonas aeruginosa,Q9I4W3,4DPQ,ASD00910001,LYS,A,Lig,Inhibitor,LYSINE,404,Inner Protein Regulator,Inner Protein,22792278,Characterisation of the first enzymes committed to lysine biosynthesis in Arabidopsis thaliana,No,"Chain B:SER144,GLU147,SER142,TYR169,ASN143,TYR170"
ASD00910000_3,,Pseudomonas aeruginosa,Q9I4W3,4FHA,ASD00910001,LYS,A,Lig,Inhibitor,LYSINE,401,Inner Protein Regulator,Inner Protein,,"Structure, Function, Stability and Knockout Phenotype of Dihydrodipicolinate Synthase from Streptococcus pneumoniae",No,"Chain B:TYR114,THR85,ASP87,TYR113,ASN86"
ASD00910000_3,,Pseudomonas aeruginosa,Q9I4W3,4HNN,ASD00910001,LYS,A,Lig,Inhibitor,LYSINE,401,Inner Protein Regulator,Inner Protein,23354837,"Structural, kinetic and computational investigation of Vitis vinifera DHDPS reveals new insight into the mechanism of lysine-mediated allosteric inhibition.",No,"Chain B:TYR131,SER106,GLU109,SER104,ASN105,TYR132"
ASD00910000_3,,Pseudomonas aeruginosa,Q9I4W3,4I7W,ASD00910001,LYS,A,Lig,Inhibitor,LYSINE,301,Inner Protein Regulator,Inner Protein,,"Structure, function and allostery of the bona fide DHDPS from the plant pathogen Agrobacterium tumefaciens",No,"Chain B:ASN81,TYR107,SER79,GLU84,ASN80,TYR106"
ASD00910000_3,,Pseudomonas aeruginosa,Q9I4W3,4M19,ASD00910001,LYS,A,Lig,Inhibitor,LYSINE,301,Inner Protein Regulator,Inner Protein,25369463,Tyrosine 110 Plays a Critical Role in Regulating the Allosteric Inhibition of Campylobacter jejuni Dihydrodipicolinate Synthase by Lysine.,No,"Chain B:ASN84,ALA85,SER83,GLU88,TYR111,TYR110"
ASD00910000_3,,Pseudomonas aeruginosa,Q9I4W3,4MLR,ASD00910001,LYS,A,Lig,Inhibitor,LYSINE,301,Inner Protein Regulator,Inner Protein,25369463,Tyrosine 110 Plays a Critical Role in Regulating the Allosteric Inhibition of Campylobacter jejuni Dihydrodipicolinate Synthase by Lysine.,No,"Chain D:SER83,TYR111,PHE110,GLU88,ASN84,ALA85"
ASD00910000_4,dapA,Campylobacter jejuni subsp. jejuni serotype O:2,Q9PPB4,5F1U,ASD00910006,3VN,"A,D",Lig,Inhibitor,"(2R,5R)-2,5-diamino-2,5-bis(4-aminobutyl)hexanedioic acid",301,Inner Protein Regulator,Allosteric Position,26836694,Biomimetic Design Results in a Potent Allosteric Inhibitor of Dihydrodipicolinate Synthase from Campylobacter jejuni.,No,"Chain D:HIS59,SER83,GLU50,THR53,GLU88,THR55,ASN84,LEU92,GLY82,PHE110,TYR111,SER51,VAL45,ALA52,LEU54,HIS56,ALA85"
ASD00910000_4,dapA,Campylobacter jejuni subsp. jejuni serotype O:2,Q9PPB4,5F1V,ASD00910006,3VN,A,Lig,Regulator,"(2R,5R)-2,5-diamino-2,5-bis(4-aminobutyl)hexanedioic acidbis-Lysine (Synonym)",304,Allosteric Function,Allosteric Position,26836694,Biomimetic Design Results in a Potent Allosteric Inhibitor of Dihydrodipicolinate Synthase from Campylobacter jejuni.,No,"Chain C:LEU54,VAL45,SER83,GLY82,TYR111,TYR110,ALA52,HIS59,THR53,HIS56,THR55,LEU92,ALA85,ASN84,SER51,GLU88"
ASD01000000_1,KIF11,Homo sapiens,P52732,1Q0B,ASD01000005,NAT,A,Lig,Inhibitor,"ethyl (4S)-4-(3-hydroxyphenyl)-6-methyl-2-sulfanylidene-3,4-dihydro-1H-pyrimidine-5-carboxylate",604,Inner Protein Regulator,Inner Protein,14672662,"Inhibition of a mitotic motor protein: where, how, and conformational consequences",No,1Q0B
ASD01000000_1,KIF11,Homo sapiens,P52732,1X88,ASD01000005,NAT,A,Lig,Inhibitor,"ethyl (4S)-4-(3-hydroxyphenyl)-6-methyl-2-sulfanylidene-3,4-dihydro-1H-pyrimidine-5-carboxylate",801,Inner Protein Regulator,Inner Protein,,Structural Basis of Eg5 Inhibition by Monastrol,No,1X88
ASD01000000_1,KIF11,Homo sapiens,P52732,1YRS,ASD01000016,L47,A,Lig,Inhibitor,"1-[(5S)-3-(2-chlorophenyl)-5-(3-hydroxyphenyl)-4,5-dihydropyrazol-1-yl]ethanone",604,Inner Protein Regulator,Inner Protein,15808464,"Kinesin spindle protein (KSP) inhibitors. Part 1: The discovery of 3,5-diaryl-4,5-dihydropyrazoles as potent and selective inhibitors of the mitotic kinesin KSP",No,1YRS
ASD01000000_1,KIF11,Homo sapiens,P52732,2FKY,ASD01000137,N2T,A,Lig,Inhibitor,"(2S)-4-(2,5-difluorophenyl)-N-methyl-2-phenyl-N-piperidin-4-yl-2,5-dihydropyrrole-1-carboxamide",604,Inner Protein Regulator,Inner Protein,16439123,"Kinesin spindle protein (KSP) inhibitors. Part 2: the design, synthesis, and characterization of 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP.",No,2FKY
ASD01000000_1,KIF11,Homo sapiens,P52732,2FL2,ASD01000139,N4T,A,Lig,Inhibitor,"(2S)-2-amino-2-cyclopropyl-1-[(2S)-4-(2,5-difluorophenyl)-2-phenyl-2,5-dihydropyrrol-1-yl]ethanone",604,Inner Protein Regulator,Inner Protein,16439123,"Kinesin spindle protein (KSP) inhibitors. Part 2: the design, synthesis, and characterization of 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP.",No,2FL2
ASD01000000_1,KIF11,Homo sapiens,P52732,2FL6,ASD01000138,N5T,A,Lig,Inhibitor,"(2S)-4-(2,5-difluorophenyl)-N,N-dimethyl-2-phenyl-2,5-dihydropyrrole-1-carboxamide",604,Inner Protein Regulator,Inner Protein,16439123,"Kinesin spindle protein (KSP) inhibitors. Part 2: the design, synthesis, and characterization of 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP.",No,2FL6
ASD01000000_1,KIF11,Homo sapiens,P52732,2G1Q,ASD01000027,N9H,A,Lig,Inhibitor,"(5S)-5-(3-aminopropyl)-3-(2,5-difluorophenyl)-N-ethyl-5-phenyl-4H-pyrazole-1-carboxamide",604,Inner Protein Regulator,Inner Protein,16603356,"Kinesin spindle protein (KSP) inhibitors. Part 4: Structure-based design of 5-alkylamino-3,5-diaryl-4,5-dihydropyrazoles as potent, water-soluble inhibitors of the mitotic kinesin KSP.",No,2G1Q
ASD01000000_1,KIF11,Homo sapiens,P52732,2GM1,ASD01008001,2AZ,A,Lig,Inhibitor,"N-(3-aminopropyl)-N-[(R)-[5-chloro-4-oxo-3-(phenylmethyl)pyrrolo[2,1-f][1,2,4]triazin-2-yl]-cyclopropyl-methyl]-4-methyl-benzamide",371,Inner Protein Regulator,Inner Protein,16730979,Synthesis and SAR of pyrrolotriazine-4-one based Eg5 inhibitors.,No,2GM1
ASD01000000_1,KIF11,Homo sapiens,P52732,2IEH,ASD01000134,MOY,A,Lig,Inhibitor,"[(4R)-4-(3-hydroxyphenyl)-1,6-dimethyl-2-sulfanylidene-3,4-dihydropyrimidin-5-yl]-phenyl-methanone",602,Inner Protein Regulator,Inner Protein,17251189,Structure of human Eg5 in complex with a new monastrol-based inhibitor bound in the R configuration.,No,2IEH
ASD01000000_1,KIF11,Homo sapiens,P52732,2PG2,ASD01001111,K01,A,Lig,Inhibitor,"N,N-diethyl-2-(thiophen-2-ylcarbonylamino)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide",604,Inner Protein Regulator,Inner Protein,17498954,Synthesis and SAR of thiophene containing kinesin spindle protein (KSP) inhibitors,No,2PG2
ASD01000000_1,KIF11,Homo sapiens,P52732,2Q2Y,ASD01000097,MKR,A,Lig,Inhibitor,"1-[(3R,3aR)-3-[3-(4-ethanoylpiperazin-1-yl)propyl]-8-fluoro-3-phenyl-3a,4-dihydropyrazolo[5,1-c][1,4]benzoxazin-2-yl]ethanone",604,Inner Protein Regulator,Inner Protein,17766111,"Kinesin spindle protein (KSP) inhibitors. Part 8: Design and synthesis of 1,4-diaryl-4,5-dihydropyrazoles as potent inhibitors of the mitotic kinesin KSP.",No,2Q2Y
ASD01000000_1,KIF11,Homo sapiens,P52732,2Q2Z,ASD01000133,MKK,A,Lig,Inhibitor,1-[(4R)-4-[3-(4-ethanoylpiperazin-1-yl)propyl]-1-(2-fluoro-5-methyl-phenyl)-4-phenyl-5H-pyrazol-3-yl]ethanone,604,Inner Protein Regulator,Inner Protein,17766111,"Kinesin spindle protein (KSP) inhibitors. Part 8: Design and synthesis of 1,4-diaryl-4,5-dihydropyrazoles as potent inhibitors of the mitotic kinesin KSP.",No,2Q2Z
ASD01000000_1,KIF11,Homo sapiens,P52732,2UYI,ASD01008008,K02,A,Lig,Inhibitor,"(5R)-N,N-diethyl-5-methyl-2-(thiophen-2-ylcarbonylamino)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide",604,Inner Protein Regulator,Inner Protein,17498954,Synthesis and Sar of Thiophene Containing Kinesin Spindle Protein (Ksp) Inhibitors.,No,2UYI
ASD01000000_1,KIF11,Homo sapiens,P52732,2UYM,ASD01001133,K03,A,Lig,Inhibitor,"N,N-diethyl-5,5-dimethyl-2-(thiophen-2-ylcarbonylamino)-6,7-dihydro-4H-1-benzothiophene-3-carboxamide",604,Inner Protein Regulator,Inner Protein,17498954,Synthesis and Sar of Thiophene Containing Kinesin Spindle Protein (Ksp) Inhibitors.,No,2UYM
ASD01000000_1,KIF11,Homo sapiens,P52732,2WOG,ASD01000061,ZZD,A,Lig,Inhibitor,(2R)-2-amino-3-tritylsulfanyl-propanoic acid,1365,Inner Protein Regulator,Inner Protein,19793049,An Allosteric Transition Trapped in an Intermediate State of a New Kinesin-Inhibitor Complex.,No,2WOG
ASD01000000_1,KIF11,Homo sapiens,P52732,2X2R,ASD01000067,X2O,A,Lig,Inhibitor,"(2R)-2-amino-3-[(2R)-2-methyl-1,1-diphenyl-butyl]sulfanyl-propanoic acid",1367,Inner Protein Regulator,Inner Protein,21344920,Structure-Activity Relationship and Multidrug Resistance Study of New S-Trityl-L-Cysteine Derivatives as Inhibitors of Eg5.,No,2X2R
ASD01000000_1,KIF11,Homo sapiens,P52732,2X7C,ASD01000068,KZ9,A,Lig,Inhibitor,"(4S)-4-(3-hydroxyphenyl)-2-sulfanylidene-1,3,4,6,7,8-hexahydroquinazolin-5-one",1365,Inner Protein Regulator,Inner Protein,20597485,"Structural Basis for Inhibition of Eg5 by Dihydropyrimidines: Stereoselectivity of Antimitotic Inhibitors Enastron, Dimethylenastron and Fluorastrol.",No,2X7C
ASD01000000_1,KIF11,Homo sapiens,P52732,2X7D,ASD01000069,EGB,A,Lig,Inhibitor,"(4S)-4-(3-hydroxyphenyl)-7,7-dimethyl-2-sulfanylidene-3,4,6,8-tetrahydro-1H-quinazolin-5-one",1369,Inner Protein Regulator,Inner Protein,20597485,"Structural Basis for Inhibition of Eg5 by Dihydropyrimidines: Stereoselectivity of Antimitotic Inhibitors Enastron, Dimethylenastron and Fluorastrol.",No,2X7D
ASD01000000_1,KIF11,Homo sapiens,P52732,2X7E,ASD01000070,X7E,A,Lig,Inhibitor,"(4R)-5-[(S)-(3,4-difluorophenyl)-hydroxy-methyl]-4-(3-hydroxyphenyl)-1,6-dimethyl-3,4-dihydropyrimidine-2-thione",1365,Inner Protein Regulator,Inner Protein,20597485,"Structural Basis for Inhibition of Eg5 by Dihydropyrimidines: Stereoselectivity of Antimitotic Inhibitors Enastron, Dimethylenastron and Fluorastrol.",No,2X7E
ASD01000000_1,KIF11,Homo sapiens,P52732,2XAE,ASD01000071,2XA,A,Lig,Inhibitor,(2R)-2-amino-3-[(4-chlorophenyl)-diphenyl-methyl]sulfanyl-propanoic acid,1365,Inner Protein Regulator,Inner Protein,21344920,Structure-Activity Relationship and Multidrug Resistance Study of New S-Trityl-L-Cysteine Derivatives as Inhibitors of Eg5.,No,2XAE
ASD01000000_1,KIF11,Homo sapiens,P52732,3CJO,ASD01000130,K30,A,Lig,Inhibitor,"(2S)-4-(2,5-difluorophenyl)-N-[(1S,3R,4S)-3-fluoro-1-methyl-piperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-5H-pyrrole-1-carboxamide",1,Inner Protein Regulator,Inner Protein,18578472,"Kinesin spindle protein (KSP) inhibitors. 9. Discovery of (2S)-4-(2,5-difluorophenyl)-n-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide (MK-0731) for the treatment of taxane-refractory cancer.",No,3CJO
ASD01000000_1,KIF11,Homo sapiens,P52732,3K3B,ASD01001293,L31,A,Lig,Inhibitor,"1-[(1R)-1-(3-hydroxyphenyl)-6-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl]ethanone",371,Inner Protein Regulator,Inner Protein,19945875,The discovery of tetrahydro-beta-carbolines as inhibitors of the kinesin Eg5.,No,3K3B
ASD01000000_1,KIF11,Homo sapiens,P52732,3K5E,ASD01000126,K5E,A,Lig,Inhibitor,"(4S)-5-hydroxy-4-(3-hydroxyphenyl)-3,4,5,6,7,8-hexahydro-1H-quinazoline-2-thione",369,Inner Protein Regulator,Inner Protein,,The structure of human kinesin-like motor protein Kif11/KSP/Eg5 in complex with ADP and enastrol.,No,3K5E
ASD01000000_1,KIF11,Homo sapiens,P52732,3KEN,ASD01000061,ZZD,A,Lig,Inhibitor,(2R)-2-amino-3-tritylsulfanyl-propanoic acid,370,Inner Protein Regulator,Inner Protein,20299460,Allosteric drug discrimination is coupled to mechanochemical changes in the kinesin-5 motor core.,No,3KEN
ASD01000000_1,KIF11,Homo sapiens,P52732,3L9H,ASD01008007,EMQ,A,Lig,Inhibitor,"1-[[(2R,4aS,5R,10bS)-5-phenyl-9-(trifluoromethyl)-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinolin-2-yl]methyl]-3-(2-dimethylaminoethyl)urea",601,Inner Protein Regulator,Inner Protein,20149654,"The discovery and optimization of hexahydro-2H-pyrano[3,2-c]quinolines (HHPQs) as potent and selective inhibitors of the mitotic kinesin-5.",No,3L9H
ASD01000000_1,KIF11,Homo sapiens,P52732,3WPN,ASD01001277,B4S,A,Lig,Inhibitor,3'-fluoro-4'-(trifluoromethyl)biphenyl-4- sulfonamide,401,Inner Protein Regulator,Allosteric Position,25622007,Structural basis of new allosteric inhibition in Kinesin spindle protein eg5,No,3WPN
ASD01000000_1,KIF11,Homo sapiens,P52732,3ZCW,ASD01000082,4A2,A,Lig,Inhibitor,(2E)-2-(3-fluoranyl-4-methoxy-phenyl)imino-1-[[2-(trifluoromethyl)phenyl]methyl]-3H-benzimidazole-5-carboxylic acid,1366,Inner Protein Regulator,Inner Protein,23305346,Structural Insights Into a Unique Inhibitor Binding Pocket in Kinesin Spindle Protein.,No,3ZCW
ASD01000000_1,KIF11,Homo sapiens,P52732,3ZCW,ASD01000082,4A2,A,Lig,Inhibitor,(2E)-2-(3-fluoranyl-4-methoxy-phenyl)imino-1-[[2-(trifluoromethyl)phenyl]methyl]-3H-benzimidazole-5-carboxylic acid,1367,Inner Protein Regulator,Inner Protein,23305346,Structural Insights Into a Unique Inhibitor Binding Pocket in Kinesin Spindle Protein.,No,3ZCW
ASD01000000_1,KIF11,Homo sapiens,P52732,4A50,ASD01000089,DQ6,A,Lig,Inhibitor,"(2S)-2-azanyl-5-(3-methylphenyl)-5,5-diphenyl-pentanoic acid",1367,Inner Protein Regulator,Inner Protein,22248262,Triphenylbutanamines: Kinesin Spindle Protein Inhibitors with in Vivo Antitumor Activity.,No,4A50
ASD01000000_1,KIF11,Homo sapiens,P52732,4A51,ASD01000101,DQ8,A,Lig,Inhibitor,1-[3-[2-azanylethylsulfanyl(diphenyl)methyl]phenyl]ethanone,801,Inner Protein Regulator,Inner Protein,22248262,Triphenylbutanamines: Kinesin Spindle Protein Inhibitors with in Vivo Antitumor Activity.,No,4A51
ASD01000000_1,KIF11,Homo sapiens,P52732,4AP0,ASD01000105,G7X,A,Lig,Inhibitor,N-(3-azanylpropyl)-N-[(1R)-1-[7-chloranyl-4-oxidanylidene-3-(phenylmethyl)quinazolin-2-yl]-2-methyl-propyl]-4-methyl-benzamide,2001,Inner Protein Regulator,Inner Protein,22993085,The Structure of the Ternary Eg5-Adp-Ispinesib Complex,No,4AP0
ASD01000000_1,KIF11,Homo sapiens,P52732,4AS7,ASD01001224,6LX,A,Lig,Inhibitor,N-(3-azanylpropyl)-N-[(1R)-1-[7-chloranyl-4-oxidanylidene-3-(phenylmethyl)chromen-2-yl]-2-methyl-propyl]-4-methyl-benzamide,1375,Inner Protein Regulator,Inner Protein,23875972,The Mitotic Kinesin Eg5 Overcomes Inhibition to the Phase I/II Clinical Candidate Sb743921 by an Allosteric Resistance Mechanism.,No,4AS7
ASD01000000_1,KIF11,Homo sapiens,P52732,4BBG,ASD01000140,V02,A,Lig,Inhibitor,3-[(R)-2-azanylethylsulfanyl-(3-ethylphenyl)-phenyl-methyl]phenol,1370,Inner Protein Regulator,Inner Protein,23394180,Optimized S-Trityl-L-Cysteine-Based Inhibitors of Kinesin Spindle Protein with Potent in Vivo Antitumor Activity in Lung Cancer Xenograft Models.,No,4BBG
ASD01000000_1,KIF11,Homo sapiens,P52732,4BXN,ASD01000141,MJQ,A,Lig,Inhibitor,N-(3-azanylpropyl)-N-[(1R)-1-[7-chloranyl-4-oxidanylidene-3-(phenylmethyl)chromen-2-yl]-2-methyl-propyl]-4-methyl-benzamide,1375,Inner Protein Regulator,Inner Protein,23875972,The Mitotic Kinesin Eg5 Overcomes Inhibition to the Phase I/II Clinical Candidate Sb743921 by an Allosteric Resistance Mechanism.,No,4BXN
ASD01000000_1,KIF11,Homo sapiens,P52732,6HKX,,GCE,A,Lig,Inhibitor,"(2~{S})-2-(3-azanylpropyl)-5-[2,5-bis(fluoranyl)phenyl]-~{N}-methoxy-~{N}-methyl-2-phenyl-1,3,4-thiadiazole-3-carboxamide",602,Allosteric function,Allosteric position,,,No,6HKX
ASD01000000_1,KIF11,Homo sapiens,P52732,6HKY,,GCE,A,Lig,Inhibitor,"(2~{S})-2-(3-azanylpropyl)-5-[2,5-bis(fluoranyl)phenyl]-~{N}-methoxy-~{N}-methyl-2-phenyl-1,3,4-thiadiazole-3-carboxamide",403,Allosteric function,Allosteric position,,,No,6HKY
ASD01000000_1,KIF11,Homo sapiens,P52732,6TA3,,MZK,K,Lig,Inhibitor,"6-[4-(trifluoromethyl)phenyl]-3,4-dihydro-1~{H}-quinolin-2-one",501,,Protein-protein interaction,,,,6TA3
ASD01000000_1,KIF11,Homo sapiens,P52732,6TIW,,MZK,K,Lig,Inhibitor,"6-[4-(trifluoromethyl)phenyl]-3,4-dihydro-1~{H}-quinolin-2-one",501,,Protein-protein interaction,,,,6TIW
ASD01020000_1,EGFR,Homo sapiens,P00533,5D41,ASD01020013,57N,A,Lig,Inhibitor,"(2R)-2-(1-oxo-1,3-dihydro-2H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide",1103,Allosteric Function,Allosteric Position,27251290,Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors.,No,5D41
ASD01020000_1,EGFR,Homo sapiens,P00533,6DUK,,JBJ,A,Lig,Inhibitor,"(2R)-2-(5-fluoro-2-hydroxyphenyl)-2-{1-oxo-6-[4-(piperazin-1-yl)phenyl]-1,3-dihydro-2H-isoindol-2-yl}-N-(1,3-thiazol-2-yl)acetamide",1103,Allosteric function,Allosteric position,,,No,6DUK
ASD01020000_1,EGFR,Homo sapiens,P00533,6P1D,,NQ1,A,Lig,Inhibitor,"10-benzyl-8-fluoro-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-one",1302,,,,,,6P1D
ASD01020000_1,EGFR,Homo sapiens,P00533,6P1L,,9LL,A,Lig,Inhibitor,"(2R)-2-(5-fluoro-2-hydroxyphenyl)-2-(1-oxo-1,3-dihydro-2H-isoindol-2-yl)-N-(1,3-thiazol-2-yl)acetamide",1102,,,,,,6P1L
ASD01020000_1,EGFR,Homo sapiens,P00533,6P1Q,,NQ1,B,Lig,Inhibitor,"10-benzyl-8-fluoro-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-one",1102,Allosteric function,Allosteric position,,,No,6P1D
ASD01020000_1,EGFR,Homo sapiens,P00533,6P8Q,,O57,A,Lig,Inhibitor,"10-benzyl-2-fluoro-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-one",2001,,,,,,6P8Q
ASD01020000_1,EGFR,Homo sapiens,P00533,6Z4B,,9LL,A,Lig,Inhibitor,"(2R)-2-(5-fluoro-2-hydroxyphenyl)-2-(1-oxo-1,3-dihydro-2H-isoindol-2-yl)-N-(1,3-thiazol-2-yl)acetamide",1102,,,,,,6Z4B
ASD01020000_1,EGFR,Homo sapiens,P00533,7A2A,,57N,A,Lig,Inhibitor,"(2R)-2-(1-oxo-1,3-dihydro-2H-isoindol-2-yl)-2-phenyl-N-(1,3-thiazol-2-yl)acetamide",1101,,,,,,7A2A
ASD01020000_1,EGFR,Homo sapiens,P00533,7JXQ,ASD01020081,VNS,"G,I,M,O",compound,,"2-(5-fluoro-2-hydroxyphenyl)-2-[5-[4-(1-methylpiperidin-4-yl)phenyl]-3-oxo-1H-isoindol-2-yl]-N-(1,3-thiazol-2-yl)acetamide",,,,35422503,,,7JXQ
ASD01020000_1,EGFR,Homo sapiens,P00533,7VRA,ASD01020069,I0A,B,compound,,"25-chloro-11-(ethylsulfonyl)-44-morpholino-11H-5,12-dioxa-3-aza-1(3,6)-indola-2(4,2)-pyrimidina-4(1,3)-benzenacyclododecaphane",,,,35446588,,,7VRA
ASD01020000_1,EGFR,Homo sapiens,P00533,7VRE,ASD01020058,7VH,B,compound,,5-Chloro-N-{5-chloro-2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}-4-[1-(ethylsulfonyl)-1H-Indol-3-yl]pyrimidin-2-amine,,,,35446588,,,7VRE
ASD01030000_1,EPHX2,Homo sapiens,P34913,6I5G,,PTG,A,Lig,Inhibitor,"(5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid",607,,,,,,6I5G
ASD01040000_1,ESR1,Homo sapiens,P03372,5DI7,ASD01040015,5CQ,A,Lig,Regulator,"(1S,3aR,5S,7aS)-5-(4-hydroxy-2-methylphenyl)-7a-methyloctahydro-1H-inden-1-ol",601,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DI7
ASD01040000_1,ESR1,Homo sapiens,P03372,5DID,ASD01040014,5CK,A,Lig,Regulator,"(1S,3aR,5S,7aS)-5-(2,3-difluoro-4-hydroxyphenyl)-7a-methyloctahydro-1H-inden-1-ol",601,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DID
ASD01040000_1,ESR1,Homo sapiens,P03372,5DIE,ASD01040013,5CJ,A,Lig,Regulator,"(1S,3aR,5S,7aS)-7a-methyl-5-(2,3,5-trifluoro-4-hydroxyphenyl)octahydro-1H-inden-1-ol",601,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DIE
ASD01040000_1,ESR1,Homo sapiens,P03372,5DIG,ASD01040012,5CE,,Lig,Regulator,"(1S,3aR,5S,7aS)-5-[4-hydroxy-2-(trifluoromethyl)phenyl]-7a-methyloctahydro-1H-inden-1-ol",601,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DIG
ASD01040000_1,ESR1,Homo sapiens,P03372,5DK9,ASD01040011,5CC,A,Lig,Regulator,"4,4'-{2-[3-(phenylamino)phenyl]but-1-ene-1,1-diyl}diphenol",601,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DK9
ASD01040000_1,ESR1,Homo sapiens,P03372,5DKB,ASD01040010,5C9,A,Lig,Regulator,"4,4'-(2-{3-[(3-methylphenyl)amino]phenyl}but-1-ene-1,1-diyl)diphenol",601,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DKB
ASD01040000_1,ESR1,Homo sapiens,P03372,5DKE,ASD01040009,5C8,A,Lig,Regulator,"4,4'-[2-(naphthalen-2-yl)prop-1-ene-1,1-diyl]diphenol",601,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DKE
ASD01040000_1,ESR1,Homo sapiens,P03372,5DKG,ASD01040008,5C7,A,Lig,Regulator,"4,4'-[2-(4-tert-butylphenyl)prop-1-ene-1,1-diyl]diphenol",601,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DKG
ASD01040000_1,ESR1,Homo sapiens,P03372,5DKS,ASD01040003,5C6,A,Lig,Regulator,"4,4'-{2-[3-(naphthalen-1-ylamino)phenyl]but-1-ene-1,1-diyl}diphenol",601,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DKS
ASD01040000_1,ESR1,Homo sapiens,P03372,5DL4,ASD01040001,5C4,A,Lig,Regulator,"4,4'-{2-[3-(phenylamino)phenyl]prop-1-ene-1,1-diyl}diphenol",601,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DL4
ASD01040000_1,ESR1,Homo sapiens,P03372,5DLR,ASD01040018,5DJ,A,Lig,Regulator,"4,4'-(2-phenylethene-1,1-diyl)diphenol",601,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DLR
ASD01040000_1,ESR1,Homo sapiens,P03372,5DMC,ASD01040017,5DH,A,Lig,Regulator,"3,3-bis(4-hydroxyphenyl)-2-phenylprop-2-enenitrile",601,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DMC
ASD01040000_1,ESR1,Homo sapiens,P03372,5DMF,ASD01040016,5DG,A,Lig,Regulator,"4,4'-(2-{3-[(4-fluorophenyl)amino]phenyl}prop-1-ene-1,1-diyl)diphenol",601,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DMF
ASD01040000_1,ESR1,Homo sapiens,P03372,5DP0,ASD01040019,5ES,A,Lig,Regulator,"4,4'-(2-{3-[(4-fluorophenyl)amino]phenyl}ethene-1,1-diyl)diphenol",601,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DP0
ASD01040000_1,ESR1,Homo sapiens,P03372,5DRJ,ASD01040021,5EU,A,Lig,Regulator,"4,4'-(3-methylthiene-2,5-diyl)bis(3-chlorophenol)",601,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DRJ
ASD01040000_1,ESR1,Homo sapiens,P03372,5DRM,ASD01040020,5ET,A,Lig,Regulator,"4,4'-thiene-2,5-diylbis(3-chlorophenol)",601,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DRM
ASD01040000_1,ESR1,Homo sapiens,P03372,5DTV,ASD01040022,5FS,A,Lig,Regulator,"3,4-bis(4-hydroxy-2-methylphenyl)-1H-1lambda~6~-thiophene-1,1-dione",601,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DTV
ASD01040000_1,ESR1,Homo sapiens,P03372,5DU5,ASD01040026,5G2,A,Lig,Regulator,"3,4-bis(2-chloro-4-hydroxyphenyl)-1H-1lambda~6~-thiophene-1,1-dione",601,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DU5
ASD01040000_1,ESR1,Homo sapiens,P03372,5DUE,ASD01040025,5FY,A,Lig,Regulator,"4-hydroxyphenyl (1S,2S,4S,7S)-5,6-bis(4-hydroxy-2-methylphenyl)-7-thiabicyclo[2.2.1]hept-5-ene-2-sulfonate 7-oxide",900,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DUE
ASD01040000_1,ESR1,Homo sapiens,P03372,5DUG,ASD01040024,5FV,A,Lig,Regulator,"phenyl (1S,2S,4S,7S)-5,6-bis(4-hydroxy-2-methylphenyl)-7-thiabicyclo[2.2.1]hept-5-ene-2-sulfonate 7-oxide",900,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DUG
ASD01040000_1,ESR1,Homo sapiens,P03372,5DUH,ASD01040023,5FT,A,Lig,Regulator,"phenyl (1S,2S,4S,7S)-5,6-bis(4-hydroxy-3-methylphenyl)-7-thiabicyclo[2.2.1]hept-5-ene-2-sulfonate 7-oxide",900,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DUH
ASD01040000_1,ESR1,Homo sapiens,P03372,5DVS,ASD01040031,5G7,A,Lig,Regulator,"4,4'-[(2-methylphenyl)carbonimidoyl]diphenol",900,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DVS
ASD01040000_1,ESR1,Homo sapiens,P03372,5DVV,ASD01040030,5G6,A,Lig,Regulator,"4,4'-(phenylcarbonimidoyl)diphenol",900,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DVV
ASD01040000_1,ESR1,Homo sapiens,P03372,5DWE,ASD01040029,5G5,A,Lig,Regulator,"4,4'-[(2-chlorophenyl)carbonimidoyl]diphenol",900,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DWE
ASD01040000_1,ESR1,Homo sapiens,P03372,5DWG,ASD01040028,5G4,A,Lig,Regulator,"4-{(E)-(4-hydroxyphenyl)[(2-methylphenyl)imino]methyl}benzene-1,3-diol",900,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DWG
ASD01040000_1,ESR1,Homo sapiens,P03372,5DWI,ASD01040027,5G3,A,Lig,Regulator,"4-[(E)-[(2-chlorophenyl)imino](4-hydroxyphenyl)methyl]benzene-1,3-diol",900,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DWI
ASD01040000_1,ESR1,Homo sapiens,P03372,5DWJ,ASD01040037,5J2,A,Lig,Regulator,"4-[(E)-[(4-fluorophenyl)imino](4-hydroxyphenyl)methyl]benzene-1,3-diol",901,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DWJ
ASD01040000_1,ESR1,Homo sapiens,P03372,5DXK,ASD01040036,5J1,A,Lig,Regulator,"4,4'-[(9s)-bicyclo[3.3.1]non-9-ylmethanediyl]diphenol",900,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DXK
ASD01040000_1,ESR1,Homo sapiens,P03372,5DXM,ASD01040035,5J0,A,Lig,Regulator,"3-[(E)-(1s,5s)-bicyclo[3.3.1]non-9-ylidene(4-hydroxyphenyl)methyl]phenol",900,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DXM
ASD01040000_1,ESR1,Homo sapiens,P03372,5DXP,ASD01040033,5HX,A,Lig,Regulator,"4-[(E)-(1s,5s)-bicyclo[3.3.1]non-9-ylidene(phenyl)methyl]phenol",900,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DXP
ASD01040000_1,ESR1,Homo sapiens,P03372,5DXQ,ASD01040034,5HZ,A,Lig,Regulator,"4,4'-[(1s,5s)-bicyclo[3.3.1]non-9-ylidenemethanediyl]diphenol",900,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DXQ
ASD01040000_1,ESR1,Homo sapiens,P03372,5DXR,ASD01040032,5HW,A,Lig,Regulator,"4,4'-{[(3R)-3-methylcyclohexylidene]methanediyl}diphenol",900,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DXR
ASD01040000_1,ESR1,Homo sapiens,P03372,5DY8,ASD01040043,5K4,A,Lig,Regulator,"4,4'-{[(3S)-3-ethylcyclohexylidene]methanediyl}diphenol",900,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DY8
ASD01040000_1,ESR1,Homo sapiens,P03372,5DYB,ASD01040042,5K2,A,Lig,Regulator,"4,4'-(3,4-dihydronaphthalen-2(1H)-ylidenemethanediyl)diphenol",900,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DYB
ASD01040000_1,ESR1,Homo sapiens,P03372,5DYD,ASD01040041,5K1,A,Lig,Regulator,"4,4'-{[(3S)-3-(methylsulfanyl)cyclohexylidene]methanediyl}diphenol",900,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DYD
ASD01040000_1,ESR1,Homo sapiens,P03372,5DZ0,ASD01040040,5K0,A,Lig,Regulator,"4,4'-[(4-methylcyclohexylidene)methanediyl]diphenol",900,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DZ0
ASD01040000_1,ESR1,Homo sapiens,P03372,5DZ1,ASD01040039,5JY,A,Lig,Regulator,"4,4'-[(4-ethylcyclohexylidene)methanediyl]diphenol",900,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DZ1
ASD01040000_1,ESR1,Homo sapiens,P03372,5DZ3,ASD01040038,5JX,A,Lig,Regulator,"4,4'-{[4-(fluoromethyl)cyclohexylidene]methanediyl}diphenol",900,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DZ3
ASD01040000_1,ESR1,Homo sapiens,P03372,5DZH,ASD01040052,5KG,A,Lig,Regulator,"4,4'-{[4-(2-hydroxyethyl)cyclohexylidene]methanediyl}diphenol",900,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DZH
ASD01040000_1,ESR1,Homo sapiens,P03372,5DZI,ASD01040051,5KF,A,Lig,Regulator,"4,4'-{[(3S)-3-(2-hydroxyethyl)cyclohexylidene]methanediyl}diphenol",901,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5DZI
ASD01040000_1,ESR1,Homo sapiens,P03372,5E0W,ASD01040050,5KE,A,Lig,Regulator,"4,4'-{[(3S)-3-(4-hydroxyphenyl)cyclohexylidene]methanediyl}diphenol",900,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5E0W
ASD01040000_1,ESR1,Homo sapiens,P03372,5E0X,ASD01040049,5KD,A,Lig,Regulator,"4,4'-{[(3S)-3-(4-methoxyphenyl)cyclohexylidene]methanediyl}diphenol",900,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5E0X
ASD01040000_1,ESR1,Homo sapiens,P03372,5.00E+14,ASD01040048,5KB,A,Lig,Regulator,"4,4'-{[(3R)-3-phenylcyclohexylidene]methanediyl}diphenol",900,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5.00E+14
ASD01040000_1,ESR1,Homo sapiens,P03372,5.00E+15,ASD01040047,5KA,A,Lig,Regulator,"4,4'-({4-[2-(4-fluorobutoxy)ethyl]cyclohexylidene}methanediyl)diphenol",900,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5.00E+15
ASD01040000_1,ESR1,Homo sapiens,P03372,5.00E+19,ASD01040045,5K7,A,Lig,Regulator,methyl {4-[bis(4-hydroxyphenyl)methylidene]cyclohexyl}acetate,901,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5.00E+19
ASD01040000_1,ESR1,Homo sapiens,P03372,5E1C,ASD01040046,5K8,A,Lig,Regulator,dimethyl-{(1S)-3-[bis(4-hydroxyphenyl)methylidene]cyclohexyl}propanedioate,900,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5E1C
ASD01040000_1,ESR1,Homo sapiens,P03372,5EHJ,ASD01040044,5K5,,Lig,,"4,4'-[(4aR,8aR)-octahydronaphthalen-2(1H)-ylidenemethanediyl]diphenol",900,Allosteric function,Allosteric position,27107013,Predictive features of ligand-specific signaling through the estrogen receptor.,No,5EHJ
ASD01070000_1,fecA,Escherichia coli,P13036,1KMP,ASD01070001,FDC,A,Lig,Regulator,iron(+3) cation;iron(+3) cation,742,Inner Protein Regulator,Inner Protein,11872840,Structural basis of gating by the outer membrane transporter FecA.,No,"Chain A:THR138,GLN176,GLN178,SER180,ARG365,LEU369,GLN371,ARG380,ARG438,SER521,GLN570,ASP573,ASN721"
ASD01070000_1,fecA,Escherichia coli,P13036,1PO0,ASD00360007;ASD00360007,FLC;FLC,A;A,Ion,Regulator,"2-hydroxypropane-1,2,3-tricarboxylate;2-hydroxypropane-1,2,3-tricarboxylate",742;743,Inner Protein Regulator,Inner Protein,12948487,Structural evidence for iron-free citrate and ferric citrate binding to the TonB-dependent outer membrane transporter FecA.,No,"Chain A:THR138,ARG155,LEU156,GLN176,GLN178,ARG365,ARG380,ARG438,SER521,ASP720"
ASD01070000_1,fecA,Escherichia coli,P13036,1PO3,ASD00360007;ASD00360007;ASD01070006;ASD01070006,FLC;FLC;FE;FE,A;A;A;A,Ion,Regulator,"2-hydroxypropane-1,2,3-tricarboxylate;2-hydroxypropane-1,2,3-tricarboxylate",742;743;744;745,Inner Protein Regulator,Inner Protein,12948487,Structural evidence for iron-free citrate and ferric citrate binding to the TonB-dependent outer membrane transporter FecA.,No,"Chain A:THR138,GLN176,GLN178,SER180,ARG365,GLN371,ARG380,ARG419,ARG438,SER521,SER568,GLN570,ASP573,ASN721"
ASD01120000_1,FBP1,Homo sapiens,P09467,1FTA,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",338,Inner Protein Regulator,Inner Protein,7961695,"The allosteric site of human liver fructose-1,6-bisphosphatase. Analysis of six AMP site mutants based on the crystal structure.",No,1FTA
ASD01120000_1,,Homo sapiens,P09467,2FHY,ASD01120002,A37,A,Lig,Inhibitor,"2,5-dichloro-N-(5-chloro-1,3-benzoxazol-2-yl)benzenesulfonamide",502,Inner Protein Regulator,Inner Protein,16442285,"Benzoxazole benzenesulfonamides are novel allosteric inhibitors of fructose-1,6-bisphosphatase with a distinct binding mode.",No,2FHY
ASD01120000_1,,Homo sapiens,P09467,2FIE,ASD01120216,A74,A,Lig,Inhibitor,"2,5-dichloro-N-[5-methoxy-7-(6-methoxypyridin-3-yl)-1,3-benzoxazol-2-yl]benzenesulfonamide",701,Inner Protein Regulator,Inner Protein,16446092,"Benzoxazole benzenesulfonamides as allosteric inhibitors of fructose-1,6-bisphosphatase.",No,2FIE
ASD01120000_1,,Homo sapiens,P09467,2FIX,ASD01120221,870,A,Lig,Inhibitor,"N-[7-(3-aminophenyl)-5-methoxy-1,3-benzoxazol-2-yl]-2,5-dichloro-benzenesulfonamide",701,Inner Protein Regulator,Inner Protein,16446092,"Benzoxazole benzenesulfonamides as allosteric inhibitors of fructose-1,6-bisphosphatase.",No,2FIX
ASD01120000_1,FBP1,Homo sapiens,P09467,2JJK,ASD01120385,R15,A,Lig,Inhibitor,1-(3-chlorophenyl)sulfonyl-3-[7-[(3-chlorophenyl)sulfonylcarbamoylamino]heptyl]urea,1336,Inner Protein Regulator,Inner Protein,18650089,Allosteric Fbpase Inhibitors Gain 10(5) Times in Potency When Simultaneously Binding Two Neighboring AMP Sites.,No,2JJK
ASD01120000_1,FBP1,Homo sapiens,P09467,2VT5,ASD01120223,ROK,A,Lig,Inhibitor,1-(4-aminophenyl)sulfonyl-3-(2-sulfanylethyl)urea,1337,Inner Protein Regulator,Inner Protein,18650089,Allosteric Fbpase Inhibitors Gain 10(5) Times in Potency When Simultaneously Binding Two Neighboring AMP Sites.,No,2VT5
ASD01120000_1,FBP1,Homo sapiens,P09467,2WBB,ASD01120381,RO3,A,Lig,Inhibitor,"1-(5-bromo-3H-1,3-thiazol-2-ylidene)-3-(4-methylphenyl)sulfonyl-urea",1336,Inner Protein Regulator,Inner Protein,19969452,"Sulfonylureido Thiazoles as Fructose-1,6-Bisphosphatase Inhibitors for the Treatment of Type-2 Diabetes.",No,2WBB
ASD01120000_1,FBP1,Homo sapiens,P09467,2WBD,ASD01120382,RO5,A,Lig,Inhibitor,"1-(5-bromo-1,3-thiazol-2-yl)-3-(3-ethylphenyl)sulfonyl-urea",1337,Inner Protein Regulator,Inner Protein,19969452,"Sulfonylureido Thiazoles as Fructose-1,6-Bisphosphatase Inhibitors for the Treatment of Type-2 Diabetes.",No,2WBD
ASD01120000_1,FBP1,Homo sapiens,P09467,2Y5K,ASD01121010,YCU,A,Lig,Inhibitor,1-[5-(2-methoxyethyl)-4-methyl-thiophen-2-yl]sulfonyl-3-[4-methoxy-6-(methylcarbamoylamino)pyridin-2-yl]urea,1336,Inner Protein Regulator,Inner Protein,21550236,"Orally Active Aminopyridines as Inhibitors of Tetrameric Fructose-1,6-Bisphosphatase.",No,2Y5K
ASD01120000_1,FBP1,Homo sapiens,P09467,2Y5L,ASD01121001,RO8,A,Lig,Inhibitor,"(1Z)-1-(5-bromo-3H-1,3-thiazol-2-ylidene)-3-(3-chlorophenyl)sulfonyl-urea",1000,Inner Protein Regulator,Inner Protein,21550236,"Orally Active Aminopyridines as Inhibitors of Tetrameric Fructose-1,6-Bisphosphatase.",No,2Y5L
ASD01120000_1,FBP1,Homo sapiens,P09467,3A29,ASD01120383,2T0,A,Lig,Inhibitor,"(2-amino-4,5-dihydrobenzo[e][1,3]benzothiazol-8-yl) dihydrogen phosphate",401,Inner Protein Regulator,Inner Protein,19762234,"Synthesis, SAR, and X-ray structure of tricyclic compounds as potent FBPase inhibitors",No,3A29
ASD01120000_1,FBP2,Homo sapiens,O00757,3IFA,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",339,Inner Protein Regulator,Inner Protein,22120740,"Structure of E69Q mutant of human muscle fructose-1,6-bisphosphatase",No,3IFA
ASD01120000_1,FBP2,Homo sapiens,O00757,3IFC,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",339,Inner Protein Regulator,Inner Protein,22120740,"Structure of E69Q mutant of human muscle fructose-1,6-bisphosphatase",No,3IFC
ASD01120000_1,FBP1,Homo sapiens,P09467,3KBZ,ASD01120378,2T4,A,Lig,Inhibitor,"(2-azanyl-4H-indeno[1,2-d][1,3]thiazol-8-yl)oxymethylphosphonic acid",401,Inner Protein Regulator,Inner Protein,20045638,"Structure-based drug design of tricyclic 8H-indeno[1,2-d][1,3]thiazoles as potent FBPase inhibitors.",No,3KBZ
ASD01120000_1,FBP1,Homo sapiens,P09467,3KC0,ASD01120379,2T5,A,Lig,Inhibitor,"4H-indeno[1,2-d][1,3]thiazol-8-yloxymethylphosphonic acid",401,Inner Protein Regulator,Inner Protein,20045638,"Structure-based drug design of tricyclic 8H-indeno[1,2-d][1,3]thiazoles as potent FBPase inhibitors.",No,3KC0
ASD01120000_1,FBP1,Homo sapiens,P09467,3KC1,ASD01120380,2T6,A,Lig,Inhibitor,"(5-aminocarbonyl-4H-indeno[1,2-d][1,3]thiazol-8-yl)oxymethylphosphonic acid",401,Inner Protein Regulator,Inner Protein,20045638,"Structure-based drug design of tricyclic 8H-indeno[1,2-d][1,3]thiazoles as potent FBPase inhibitors.",No,3KC1
ASD01120000_1,FBP1,Homo sapiens,P09467,4MJO,ASD01121008,2C1,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",401,Inner Protein Regulator,Inner Protein,24128068,Determination of protein-ligand binding constants of a cooperatively regulated tetrameric enzyme using electrospray mass spectrometry.,No,4MJO
ASD01120000_1,FBP1,Homo sapiens,P09467,5PZR,,93S,A,Lig,Inhibitor,"N,N'-{oxybis[(propane-3,1-diyl)carbamoyl]}bis(3-chlorobenzene-1-sulfonamide)",401,,,,,,5PZR
ASD01120000_1,FBP1,Homo sapiens,P09467,5PZS,,93Y,A,Lig,Inhibitor,"N,N'-(hexane-1,6-diyldicarbamoyl)bis(3-chlorobenzene-1-sulfonamide)",401,,,,,,5PZS
ASD01120000_1,FBP1,Homo sapiens,P09467,5PZT,,947,A,Lig,Inhibitor,"N-[(5-bromo-1,3-thiazol-2-yl)carbamoyl]-2-ethyl[1,1'-biphenyl]-4-sulfonamide",401,,,,,,5PZT
ASD01120000_1,FBP1,Homo sapiens,P09467,5PZU,,94D,A,Lig,Inhibitor,"{5-[2-amino-5-(2-methylpropyl)-1,3-thiazol-4-yl]furan-2-yl}phosphonic acid",401,,,,,,5PZU
ASD01120000_1,FBP1,Homo sapiens,P09467,5PZV,,94G,A,Lig,Inhibitor,N-[(4-bromopyridin-2-yl)carbamoyl]-4-chlorobenzene-1-sulfonamide,401,,,,,,5PZV
ASD01120000_1,FBP1,Homo sapiens,P09467,5PZW,,94J,A,Lig,Inhibitor,"N,N'-(pentane-1,5-diyldicarbamoyl)bis(3-chlorobenzene-1-sulfonamide)",401,,,,,,5PZW
ASD01120000_1,FBP1,Homo sapiens,P09467,5PZX,,94S,A,Lig,Inhibitor,"N-[(5-bromo-1,3-thiazol-2-yl)carbamoyl]-4-methoxy-3-(2-methylpropyl)benzene-1-sulfonamide",401,,,,,,5PZX
ASD01120000_1,FBP1,Homo sapiens,P09467,5PZY,,94V,A,Lig,Inhibitor,"N-[(5-bromo-1,3-thiazol-2-yl)carbamoyl]-2-chlorobenzene-1-sulfonamide",401,,,,,,5PZY
ASD01120000_1,FBP1,Homo sapiens,P09467,5PZZ,,94Y,A,Lig,Inhibitor,"N-[(5-bromo-1,3-thiazol-2-yl)carbamoyl]-3,4-dichlorobenzene-1-sulfonamide",401,,,,,,5PZZ
ASD01120000_1,FBP1,Homo sapiens,P09467,5Q00,,95D,A,Lig,Inhibitor,"2-[(3-{[(5-bromo-1,3-thiazol-2-yl)carbamoyl]sulfamoyl}-1-methyl-1H-indol-7-yl)oxy]acetamide",401,,,,,,5Q00
ASD01120000_1,FBP1,Homo sapiens,P09467,5Q01,,95G,A,Lig,Inhibitor,"N-[(5-bromo-1,3-thiazol-2-yl)carbamoyl]-4-[(3,4-dichloro-1-methyl-1H-pyrazol-5-yl)oxy]benzene-1-sulfonamide",401,,,,,,5Q01
ASD01120000_1,FBP1,Homo sapiens,P09467,5Q02,,95J,A,Lig,Inhibitor,"N-[(5-bromo-1,3-thiazol-2-yl)carbamoyl]-5-(1,2-oxazol-3-yl)thiophene-2-sulfonamide",401,,,,,,5Q02
ASD01120000_1,FBP1,Homo sapiens,P09467,5Q03,,95M,A,Lig,Inhibitor,"N-[(5-bromo-1,3-thiazol-2-yl)carbamoyl]-5-(2-methylpropyl)thiophene-2-sulfonamide",401,,,,,,5Q03
ASD01120000_1,FBP1,Homo sapiens,P09467,5Q04,,95P,A,Lig,Inhibitor,"4-bromo-N-[(5-bromo-1,3-thiazol-2-yl)carbamoyl]-5-chlorothiophene-2-sulfonamide",401,,,,,,5Q04
ASD01120000_1,FBP1,Homo sapiens,P09467,5Q05,,95S,A,Lig,Inhibitor,"N-[(5-bromo-1,3-thiazol-2-yl)carbamoyl]-5-(2-methoxyethyl)-4-methylthiophene-2-sulfonamide",401,,,,,,5Q05
ASD01120000_1,FBP1,Homo sapiens,P09467,5Q06,,95V,A,Lig,Inhibitor,"N-[(5-bromo-1,3-thiazol-2-yl)carbamoyl]-4-(2-methyl-1,3-thiazol-4-yl)benzene-1-sulfonamide",401,,,,,,5Q06
ASD01120000_1,FBP1,Homo sapiens,P09467,5Q07,,95Y,A,Lig,Inhibitor,N-{[4-bromo-6-(morpholin-4-yl)pyridin-2-yl]carbamoyl}-5-(2-methoxyethyl)-4-methylthiophene-2-sulfonamide,401,,,,,,5Q07
ASD01120000_1,FBP1,Homo sapiens,P09467,5Q08,,967,A,Lig,Inhibitor,"N-[(5-bromo-1,3-thiazol-2-yl)carbamoyl]-1-benzothiophene-3-sulfonamide",401,,,,,,5Q08
ASD01120000_1,FBP1,Homo sapiens,P09467,5Q09,,96A,A,Lig,Inhibitor,N-{[4-bromo-6-(carbamoylamino)pyridin-2-yl]carbamoyl}-5-(2-methoxyethyl)-4-methylthiophene-2-sulfonamide,401,,,,,,5Q09
ASD01120000_1,FBP1,Homo sapiens,P09467,5Q0A,,96D,A,Lig,Inhibitor,N-[(5-cyanopyrazin-2-yl)carbamoyl]-3-(difluoromethoxy)benzene-1-sulfonamide,401,,,,,,5Q0A
ASD01120000_1,FBP1,Homo sapiens,P09467,5Q0B,,96J,A,Lig,Inhibitor,"N-[(4-bromo-3-methyl-1,2-thiazol-5-yl)carbamoyl]-3-methylbenzene-1-sulfonamide",401,,,,,,5Q0B
ASD01120000_1,FBP1,Homo sapiens,P09467,6LS5,,EUF,A,Lig,Inhibitor,"2-(ethyldisulfanyl)-1,3-benzothiazole",401,Allosteric function,Allosteric position,,,Yes,6LS5
ASD01120000_3,FBP1,Sus scrofa,P00636,1EYJ,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",341,Inner Protein Regulator,Inner Protein,10913263,"Crystal structures of fructose 1,6-bisphosphatase: mechanism of catalysis and allosteric inhibition revealed in product complexes.",No,"Chain A:VAL17,GLU20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177"
ASD01120000_3,FBP1,Sus scrofa,P00636,1EYK,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",341,Inner Protein Regulator,Inner Protein,10913263,"Crystal structures of fructose 1,6-bisphosphatase: mechanism of catalysis and allosteric inhibition revealed in product complexes.",No,"Chain A:VAL17,GLU20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177"
ASD01120000_3,FBP1,Sus scrofa,P00636,1FBP,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",337,Inner Protein Regulator,Inner Protein,2164670,"Crystal structure of fructose-1,6-bisphosphatase complexed with fructose 6-phosphate, AMP, and magnesium.",No,"Chain A:VAL17,GLN20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,MET177"
ASD01120000_3,FBP1,Sus scrofa,P00636,1FJ9,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",401,Inner Protein Regulator,Inner Protein,10998248,"Tryptophan fluorescence reveals the conformational state of a dynamic loop in recombinant porcine fructose-1,6-bisphosphatase.",No,"Chain A:VAL17,GLU20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177"
ASD01120000_3,FBP1,Sus scrofa,P00636,1FPD,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",339,Inner Protein Regulator,Inner Protein,7703244,"Structural aspects of the allosteric inhibition of fructose-1,6-bisphosphatase by AMP: the binding of both the substrate analogue 2,5-anhydro-D-glucitol 1,6-bisphosphate and catalytic metal ions monitored by X-ray crystallography.",No,"Chain A:VAL17,GLN20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177"
ASD01120000_3,FBP1,Sus scrofa,P00636,1FPE,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",339,Inner Protein Regulator,Inner Protein,7703244,"Structural aspects of the allosteric inhibition of fructose-1,6-bisphosphatase by AMP: the binding of both the substrate analogue 2,5-anhydro-D-glucitol 1,6-bisphosphate and catalytic metal ions monitored by X-ray crystallography.",No,"Chain A:VAL17,GLN20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LEU34,LYS112,TYR113,ARG140,VAL160,MET177"
ASD01120000_3,FBP1,Sus scrofa,P00636,1FPF,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",339,Inner Protein Regulator,Inner Protein,7703244,"Structural aspects of the allosteric inhibition of fructose-1,6-bisphosphatase by AMP: the binding of both the substrate analogue 2,5-anhydro-D-glucitol 1,6-bisphosphate and catalytic metal ions monitored by X-ray crystallography.",No,"Chain A:VAL17,GLN20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177"
ASD01120000_3,FBP1,Sus scrofa,P00636,1FPG,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",339,Inner Protein Regulator,Inner Protein,7703244,"Structural aspects of the allosteric inhibition of fructose-1,6-bisphosphatase by AMP: the binding of both the substrate analogue 2,5-anhydro-D-glucitol 1,6-bisphosphate and catalytic metal ions monitored by X-ray crystallography.",No,"Chain A:VAL17,GLN20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177"
ASD01120000_3,FBP1,Sus scrofa,P00636,1FPI,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",339,Inner Protein Regulator,Inner Protein,7568043,"Crystallographic evidence for the action of potassium, thallium, and lithium ions on fructose-1,6-bisphosphatase.",No,"Chain A:VAL17,GLN20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177"
ASD01120000_3,FBP1,Sus scrofa,P00636,1FPJ,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",338,Inner Protein Regulator,Inner Protein,7568043,"Crystallographic evidence for the action of potassium, thallium, and lithium ions on fructose-1,6-bisphosphatase.",No,"Chain A:VAL17,GLN20,GLY21,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177"
ASD01120000_3,FBP1,Sus scrofa,P00636,1FPL,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",339,Inner Protein Regulator,Inner Protein,7568043,"Crystallographic evidence for the action of potassium, thallium, and lithium ions on fructose-1,6-bisphosphatase.",No,"Chain A:VAL17,GLN20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177"
ASD01120000_3,FBP1,Sus scrofa,P00636,1FRP,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",338,Inner Protein Regulator,Inner Protein,7809062,"Crystal structure of fructose-1,6-bisphosphatase complexed with fructose 2,6-bisphosphate, AMP, and Zn2+ at 2.0-A resolution: aspects of synergism between inhibitors.",No,"Chain A:VAL17,GLN20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177"
ASD01120000_3,FBP1,Sus scrofa,P00636,1FSA,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",340,Inner Protein Regulator,Inner Protein,8931152,"Evidence for an active T-state pig kidney fructose 1,6-bisphosphatase: interface residue Lys-42 is important for allosteric inhibition and AMP cooperativity.",No,"Chain A:VAL17,GLN20,GLY21,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160"
ASD01120000_3,FBP1,Sus scrofa,P00636,1KZ8,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",737,Inner Protein Regulator,Inner Protein,12190310,"ANILINOQUINAZOLINE INHIBITORS OF FRUCTOSE 1,6-BISPHOSPHATASE BIND AT A NOVEL ALLOSTERIC SITE: SYNTHESIS, IN VITRO CHARACTERIZATION, AND X-RAY CRYSTALLOGRAPHY",No,"Chain A:VAL17,GLN20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177"
ASD01120000_3,FBP1,Sus scrofa,P00636,1KZ8,ASD01120014,PFE,A,Lig,Inhibitor,"[4-[3-[(6,7-diethoxyquinazolin-4-yl)amino]phenyl]-1,3-thiazol-2-yl]methanol",738,Inner Protein Regulator,Protein-Protein Interaction,12190310,"ANILINOQUINAZOLINE INHIBITORS OF FRUCTOSE 1,6-BISPHOSPHATASE BIND AT A NOVEL ALLOSTERIC SITE: SYNTHESIS, IN VITRO CHARACTERIZATION, AND X-RAY CRYSTALLOGRAPHY",No,"Chain A:ALA47,LYS50,ALA51,GLY52,ILE53,HIS55,LEU56,VAL70,LYS71,LYS72,LEU73,LEU76"
ASD01120000_3,FBP1,Sus scrofa,P00636,1LEV,ASD01120167,CLI,A,Lig,Inhibitor,"3-(2-carboxyethyl)-4,6-dichloro-1H-indole-2-carboxylic acid",342,Inner Protein Regulator,Inner Protein,12781194,"3-(2-carboxyethyl)-4,6-dichloro-1H-indole-2-carboxylic acid: an allosteric inhibitor of fructose-1,6-bisphosphatase at the AMP site.",No,"Chain A:PHE16,VAL17,GLU20,GLY21,GLY26,THR27,GLY28,GLU29,MET30,THR31,LEU34,TYR113,LEU175,MET177"
ASD01120000_3,FBP1,Sus scrofa,P00636,1NV7,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",3337,Inner Protein Regulator,Inner Protein,12595529,"Interaction of Tl+ with product complexes of fructose-1,6-bisphosphatase",No,"Chain A:VAL1017,GLU1020,GLY1021,ALA1024,GLY1026,THR1027,GLY1028,GLU1029,MET1030,THR1031,LYS1112,TYR1113,ARG1140,VAL1160,MET1177"
ASD01120000_3,FBP1,Sus scrofa,P00636,1Q9D,ASD01120405,OI1,B,Lig,Inhibitor,"(3S,11aS)-2-[(2S)-1-[2-(4-hydroxyphenyl)ethylamino]-1-oxo-pentan-2-yl]-3-[(4-hydroxyphenyl)methyl]-4-oxo-3,6,11,11a-tetrahydropyrazino[4,3-b]isoquinolin-2-ium-1-olate",406,Inner Protein Regulator,Protein-Protein Interaction,14530289,"Inhibition of fructose-1,6-bisphosphatase by a new class of allosteric effectors",No,"Chain A:GLY52,ALA54,HIS55,ILE59; Chain B:ASP187,ALA189,ILE190"
ASD01120000_3,FBP1,Sus scrofa,P00636,1RDY,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",339,Inner Protein Regulator,Inner Protein,8844845,"Crystal structures of the active site mutant (Arg-243-->Ala) in the T and R allosteric states of pig kidney fructose-1,6-bisphosphatase expressed in Escherichia coli.",No,"Chain A:VAL17,GLN20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160"
ASD01120000_3,FBP1,Sus scrofa,P00636,1RDZ,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",339,Inner Protein Regulator,Inner Protein,8844845,"Crystal structures of the active site mutant (Arg-243-->Ala) in the T and R allosteric states of pig kidney fructose-1,6-bisphosphatase expressed in Escherichia coli.",No,"Chain A:VAL17,GLN20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160"
ASD01120000_3,FBP1,Sus scrofa,P00636,1YYZ,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",435,Inner Protein Regulator,Inner Protein,15767255,"R-state AMP complex reveals initial steps of the quaternary transition of fructose-1,6-bisphosphatase.",No,"Chain A:VAL17,GLU20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,MET177"
ASD01120000_3,FBP1,Sus scrofa,P00636,1YZ0,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",1844,Inner Protein Regulator,Inner Protein,15767255,"R-state AMP complex reveals initial steps of the quaternary transition of fructose-1,6-bisphosphatase.",No,"Chain A:VAL17,GLU20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177"
ASD01120000_3,FBP1,Sus scrofa,P00636,2F3D,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",435,Inner Protein Regulator,Inner Protein,Not in PubMed,"Mechanism of displacement of a catalytically essential loop from the active site of fructose-1,6-bisphosphatase",No,"Chain A:VAL17,GLU20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,MET177"
ASD01120000_3,FBP1,Sus scrofa,P00636,4FBP,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",338,Inner Protein Regulator,Inner Protein,1850623,"Conformational transition of fructose-1,6-bisphosphatase: structure comparison between the AMP complex (T form) and the fructose 6-phosphate complex (R form).",No,"Chain A:VAL17,GLN20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177"
ASD01120000_3,FBP1,Sus scrofa,P00636,4GBV,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",405,Inner Protein Regulator,Inner Protein,,"Water Structure of the Central Hydrophobic Cavity of Mammalian Fructose-1,6-bisphosphatase: a Potential Thermodynamic Determinant of Allowed Quaternary States",No,"Chain A:VAL17,GLU20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,MET177"
ASD01120000_3,FBP1,Sus scrofa,P00636,4GBW,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",406,Inner Protein Regulator,Inner Protein,,"Water Structure of the Central Hydrophobic Cavity of Mammalian Fructose-1,6-bisphosphatase: a Potential Thermodynamic Determinant of Allowed Quaternary States",No,"Chain A:VAL17,MET18,GLU20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177"
ASD01120000_3,FBP1,Sus scrofa,P00636,4GWS,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",403,Inner Protein Regulator,Inner Protein,,"Hydrophobic Central Cavity in Fructose-1,6-bisphosphatase is Essential for the Synergism in AMP/Fructose 2,6-bisphosphate Inhibition",No,"Chain A:VAL17,GLU20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177"
ASD01120000_3,FBP1,Sus scrofa,P00636,4GWY,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",406,Inner Protein Regulator,Inner Protein,,"Functional Importance of Subunit Pair Rotation in Regulation of Tetrameric Mammalian Fructose-1,6-bisphosphatase",No,"Chain A:VAL17,GLU20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,MET177"
ASD01120000_3,FBP1,Sus scrofa,P00636,4GWZ,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",404,Inner Protein Regulator,Inner Protein,,"Functional Importance of Subunit Pair Rotation in Regulation of Tetrameric Mammalian Fructose-1,6-bisphosphatase",No,"Chain A:VAL17,GLU20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177"
ASD01120000_3,FBP1,Sus scrofa,P00636,4GX4,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",404,Inner Protein Regulator,Inner Protein,,"Dimer-dimer Interface in Porcine Liver Fructose-1,6-bisphosphatase is Essential in Cooperative Binding of AMP",No,"Chain A:VAL17,GLU20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177"
ASD01120000_3,FBP1,Sus scrofa,P00636,4GX6,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",404,Inner Protein Regulator,Inner Protein,,"Dimer-dimer Interface in Porcine Liver Fructose-1,6-bisphosphatase is Essential in Cooperative Binding of AMP",No,"Chain A:VAL17,GLU20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177"
ASD01120000_3,FBP1,Sus scrofa,P00636,4H46,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",404,Inner Protein Regulator,Inner Protein,,"Fluorescent 2',3'-O-(2,4,6-trinitrophenyl) (TNP)-AMP Is an Active Site Inhibitor for Porcine Liver Fructose-1,6-bisphosphatase Rather Than Allosteric Inhibitor",No,"Chain A:VAL17,GLU20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LEU34,LYS112,TYR113,ARG140,VAL160,MET177"
ASD01120000_3,FBP1,Sus scrofa,P00636,4KXP,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",405,Inner Protein Regulator,Inner Protein,23844654,"Mechanism of Displacement of a Catalytically Essential Loop from the Active Site of Mammalian Fructose-1,6-bisphosphatase.",No,"Chain A:VAL17,GLU20,GLY21,ALA24,GLY26,THR27,GLY28,GLU29,MET30,THR31,LYS112,TYR113,ARG140,VAL160,MET177"
ASD01120000_7,fbp,Escherichia coli,P0A993,2GQ1,ASD02880002,SO4,A,Ion,Activator,sulfate,344,Inner Protein Regulator,Protein-Protein Interaction,16670087,"Novel Allosteric Activation Site in Escherichia coli Fructose-1,6-bisphosphatase.",No,"Chain A:THR3,LEU4,GLY5,LYS30"
ASD01120000_7,fbp,Escherichia coli,P0A993,2Q8M,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",341,Inner Protein Regulator,Inner Protein,17567577,"Structure of Inhibited Fructose-1,6-bisphosphatase from Escherichia coli: DISTINCT ALLOSTERIC INHIBITION SITES FOR AMP AND GLUCOSE 6-PHOSPHATE AND THE CHARACTERIZATION OF A GLUCONEOGENIC SWITCH.",No,"Chain A:ILE8,LYS11,GLN12,PHE15,ALA18,THR19,GLY20,GLU21,LEU22,THR23,LYS104,TYR105,ARG132,THR171"
ASD01120000_7,fbp,Escherichia coli,P0A993,2Q8M,ASD01120373,BG6,A,Lig,Inhibitor,"[(2R,3S,4S,5R,6R)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl dihydrogen phosphate",340,Inner Protein Regulator,Protein-Protein Interaction,17567577,"Structure of Inhibited Fructose-1,6-bisphosphatase from Escherichia coli: DISTINCT ALLOSTERIC INHIBITION SITES FOR AMP AND GLUCOSE 6-PHOSPHATE AND THE CHARACTERIZATION OF A GLUCONEOGENIC SWITCH.",No,"Chain A:GLU207,TYR210,ILE221,LYS222,GLN225"
ASD01140000_3,GABRA1,Homo sapiens,P14867,6I53,,,,Pep,Regulator,Megabody38,,,,30602789,Cryo-EM structure of the human alpha 1 beta 3 gamma 2 GABAAreceptor in a lipid bilayer.,,6I53
ASD01140000_3,GABRA1,Homo sapiens,P14867,8DD2,ASD01140041,R5R,E,Compound,,"N,N-dimethyl-2-(6-methyl-2-p-tolylimidazo[1,2-a]pyridin-3-yl)acetamide",,,,35933426,,,8DD2
ASD01140000_3,GABRA1,Homo sapiens,P14867,8DD3,ASD01142004,R63,"Q,T,U",Compound,,"methyl 4-ethyl-6,7-dimethoxy-9H-pyrido[3,4-b]indole-3-carboxylate",,,,35933426,,,8DD3
ASD01140000_9,Gabra1,Mus musculus,P62812,5OSB,ASD01140475,A8Z,A,Lig,Regulator,Tetrahydrodeoxycorticosterone,501,Allosteric function,Allosteric position,28967882,Crystal structures of a GABAA-receptor chimera reveal new endogenous neurosteroid-binding sites.,No,"Chain E:ILE238,PHE399,PRO400,GLN241,TRP245,ARG396,VAL242,PHE244"
ASD01140000_9,Gabra1,Mus musculus,P62812,5OSC,ASD02030036,A8W,A,Lig,Regulator,Pregnenolone sulfate,503,Allosteric function,Allosteric position,28967882,Crystal structures of a GABAA-receptor chimera reveal new endogenous neurosteroid-binding sites.,No,"Chain A:ALA398,PHE399,ILE391,SER395,THR305,LEU394,LYS390,GLU302,LEU402,PHE295,ARG316,SER298"
ASD01150000_1,GABBR1,Homo sapiens,Q9UBS5,6UO8,,QDA,A,Lig,Activator,"N~4~,N~6~-dicyclopentyl-2-(methylsulfanyl)-5-nitropyrimidine-4,6-diamine",1009,,,,,,6UO8
ASD01150000_1,GABBR1,Homo sapiens,Q9UBS5,7C7Q,,2C0,A,Lig,Regulator,baclofen,1007,,,,,,7C7Q
ASD01150000_1,GABBR1,Homo sapiens,Q9UBS5,7CUM,,2BV,A,Lig,Inhibitor,"(R)-(cyclohexylmethyl)[(2S)-3-{[(1S)-1-(3,4-dichlorophenyl)ethyl]amino}-2-hydroxypropyl]phosphinic acid",1001,,,,,,7CUM
ASD01150000_2,GABBR2,Homo sapiens,O75899,7CA3,,FN0,B,Lig,Regulator,"(3S)-5,7-ditert-butyl-3-oxidanyl-3-(trifluoromethyl)-1-benzofuran-2-one",902,,,,,,7CA3
ASD01170000_1,glmU,Haemophilus influenzae,P43889,2VD4,ASD01170010,P21,A,Lig,Inhibitor,"4-chloro-N-(3-methoxypropyl)-N-[(1S,3S)-1-phenethylpiperidin-3-yl]benzamide",1454,Inner Protein Regulator,Inner Protein,18218712,Structure of a Small-Molecule Inhibitor Complexed with Glmu from Haemophilus Influenzae Reveals an Allosteric Binding Site.,Yes,"Chain A:TYR139,ASN169,THR170,VAL220,MET221,VAL223,GLU224,GLY225,GLN231,ALA234,LEU235"
ASD01170000_2,Tb11.02.0120,Trypanosoma brucei brucei,Q386Q8,4BQH,ASD01170009,9VU,A,Lig,Inhibitor,"(3S)-3-[2-(1,3-benzodioxol-5-yl)-2-oxidanylidene-ethyl]-4-bromanyl-5-methyl-3-oxidanyl-1H-indol-2-one",1539,Inner Protein Regulator,Inner Protein,23834437,A Novel Allosteric Inhibitor of the Uridine Diphosphate N-Acetylglucosamine Pyrophosphorylase from Trypanosoma Brucei.,No,"Chain A:GLY44,VAL45,ASP46,HIS49,PHE50,SER207,VAL209,GLY232,GLY233,GLY235,ALA236,PHE238,ALA239,ALA242,ALA367,MET370,LYS371,TYR376,ALA397"
ASD01180000_1,GLP1R,Homo sapiens,P43220,5VEW,ASD01180088,97Y,A,Lig,Inhibitor,"N-{4-[(R)-(3,3-dimethylcyclobutyl)({6-[4-(trifluoromethyl)-1H-imidazol-1-yl]pyridin-3-yl}amino)methyl]benzene-1-carbonyl}-beta-alanine",1201,Allosteric Function,Allosteric Position,28514449,Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators.,No,5VEW
ASD01180000_1,GLP1R,Homo sapiens,P43220,5VEX,ASD01180104,97V,A,Lig,Inhibitor,4-{[(4-cyclohexylphenyl){[3-(methylsulfonyl)phenyl]carbamoyl}amino]methyl}-N-(1H-tetrazol-5-yl)benzamide,1201,Allosteric Function,Allosteric Position,28514449,Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators.,No,5VEX
ASD01180000_1,GLP1R,Homo sapiens,P43220,6VCB,,QW7,R,Lig,Activator,"1-[(1R)-1-(2,6-dichloro-3-methoxyphenyl)ethyl]-6-{2-[(2R)-piperidin-2-yl]phenyl}-1H-benzimidazole",501,,,,,,6VCB
ASD01180000_1,GLP1R,Homo sapiens,P43220,7DUQ,,HNO,A,Lig,Activator,"N-tert-butyl-6,7-bis(chloranyl)quinoxalin-2-amine",701,,,,,,7DUQ
ASD01200000_1,GCK,Homo sapiens,P35557,1V4S,ASD01200012,MRK,A,Lig,Activator,"2-amino-4-fluoro-5-(1-methylimidazol-2-yl)sulfanyl-N-(1,3-thiazol-2-yl)benzamide",501,Inner Protein Regulator,Inner Protein,15016359,Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase,No,1V4S
ASD01200000_1,GCK,Homo sapiens,P35557,3A0I,ASD01200023,AJI,X,Lig,Activator,"3-(4-fluorophenyl)sulfanyl-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide",501,Inner Protein Regulator,Inner Protein,19362831,"Discovery of novel 3,6-disubstituted 2-pyridinecarboxamide derivatives as GK activators",No,3A0I
ASD01200000_1,GCK,Homo sapiens,P35557,3F9M,ASD01200012,MRK,A,Lig,Activator,"2-amino-4-fluoro-5-(1-methylimidazol-2-yl)sulfanyl-N-(1,3-thiazol-2-yl)benzamide",501,Inner Protein Regulator,Inner Protein,,Pancreatic Glucokinase,No,3F9M
ASD01200000_1,GCK,Homo sapiens,P35557,3FR0,ASD01200052,AJB,A,Lig,Activator,"2-amino-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]benzamide",501,Inner Protein Regulator,Inner Protein,19188063,Identification of novel and potent 2-amino benzamide derivatives as allosteric glucokinase activators,No,3FR0
ASD01200000_1,GCK,Homo sapiens,P35557,3GOI,ASD01200066,LOI,A,Lig,Activator,"2-methylamino-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]benzamide",1,Inner Protein Regulator,Inner Protein,19362831,"Discovery of novel 3,6-disubstituted 2-pyridinecarboxamide derivatives as GK activators",No,3GOI
ASD01200000_1,GCK,Homo sapiens,P35557,3H1V,ASD01200321,TK1,X,Lig,Activator,"1-[[6-(4-methylsulfonylphenoxy)-2-pyridin-2-yl-3H-benzimidazol-5-yl]methyl]pyrrolidine-2,5-dione",501,Inner Protein Regulator,Inner Protein,19736020,The design and optimization of a series of 2-(pyridin-2-yl)-1H-benzimidazole compounds as allosteric glucokinase activators.,No,3H1V
ASD01200000_1,GCK,Homo sapiens,P35557,3ID8,ASD01200012,MRK,A,Lig,Activator,"2-amino-4-fluoro-5-(1-methylimidazol-2-yl)sulfanyl-N-(1,3-thiazol-2-yl)benzamide",501,Inner Protein Regulator,Inner Protein,22101819,The active conformation of human glucokinase is not altered by allosteric activators,No,3ID8
ASD01200000_1,GCK,Homo sapiens,P35557,3IMX,ASD01200263,B84,A,Lig,Activator,"(2R)-3-cyclopentyl-N-(5-methoxy-[1,3]thiazolo[5,4-b]pyridin-2-yl)-2-[4-(4-methylpiperazin-1-yl)sulfonylphenyl]propanamide",466,Inner Protein Regulator,Inner Protein,19746978,Investigation of functionally liver selective glucokinase activators for the treatment of type 2 diabetes.,No,3IMX
ASD01200000_1,GCK,Homo sapiens,P35557,3S41,ASD01200334,S41,A,Lig,Activator,"N,N-dimethyl-5-[[2-methyl-6-[(5-methylpyrazin-2-yl)carbamoyl]-1-benzofuran-4-yl]oxy]pyrimidine-2-carboxamide",4000,Inner Protein Regulator,Inner Protein,,"Designing glucokinase activators with reduced hypoglycemia risk: discovery of N,N-dimethyl-5-(2-methyl-6-((5-methylpyrazin-2-yl)-carbamoyl)benzofuran-4-yloxy)pyrimidine-2-carboxamide as a clinical candidate for the treatment of type 2 diabetes mellitus",No,3S41
ASD01200000_1,GCK,Homo sapiens,P35557,3VEV,ASD01200332,0H4,A,Lig,Activator,(2S)-3-cyclopentyl-N-(5-methylpyridin-2-yl)-2-[2-oxidanylidene-4-(trifluoromethyl)pyridin-1-yl]propanamide,502,Inner Protein Regulator,Inner Protein,22298776,Insights into Mechanism of Glucokinase Activation: OBSERVATION OF MULTIPLE DISTINCT PROTEIN CONFORMATIONS.,No,3VEV
ASD01200000_1,GCK,Homo sapiens,P35557,3VEY,ASD01200325,0H5,A,Lig,Activator,6-methoxy-N-(1-methylpyrazol-3-yl)quinazolin-4-amine,504,Inner Protein Regulator,Inner Protein,22298776,Insights into Mechanism of Glucokinase Activation: OBSERVATION OF MULTIPLE DISTINCT PROTEIN CONFORMATIONS.,No,3VEY
ASD01200000_1,GCK,Homo sapiens,P35557,3VF6,ASD01200270,0H6,A,Lig,Activator,6-[[(2S)-3-cyclopentyl-2-[4-(trifluoromethyl)imidazol-1-yl]propanoyl]amino]pyridine-3-carboxylic acid,502,Inner Protein Regulator,Inner Protein,22298776,Insights into Mechanism of Glucokinase Activation: OBSERVATION OF MULTIPLE DISTINCT PROTEIN CONFORMATIONS.,No,3VF6
ASD01200000_1,GCK,Homo sapiens,P35557,4DCH,ASD01200001,4DC,A,Lig,Activator,"(2R)-3-cyclopentyl-2-(4-methylsulfonylphenyl)-N-(1,3-thiazol-2-yl)propanamide",502,Inner Protein Regulator,Inner Protein,22298776,Insights into Mechanism of Glucokinase Activation: OBSERVATION OF MULTIPLE DISTINCT PROTEIN CONFORMATIONS.,No,4DCH
ASD01200000_1,GCK,Homo sapiens,P35557,4DHY,ASD01200334,S41,A,Lig,Activator,"N,N-dimethyl-5-[[2-methyl-6-[(5-methylpyrazin-2-yl)carbamoyl]-1-benzofuran-4-yl]oxy]pyrimidine-2-carboxamide",502,Inner Protein Regulator,Inner Protein,22298776,Insights into Mechanism of Glucokinase Activation: OBSERVATION OF MULTIPLE DISTINCT PROTEIN CONFORMATIONS.,No,4DHY
ASD01200000_1,GCK,Homo sapiens,P35557,4ISE,ASD01200341,1FW,A,Lig,Activator,"(2S)-3-cyclohexyl-2-(6-fluoranyl-4-oxidanylidene-quinazolin-3-yl)-N-(1,3-thiazol-2-yl)propanamide",501,Inner Protein Regulator,Inner Protein,23434031,"Design, synthesis and SAR of novel glucokinase activators.",No,4ISE
ASD01200000_1,GCK,Homo sapiens,P35557,4ISF,ASD01200340,1FX,A,Lig,Activator,"(2S)-3-cyclohexyl-2-[6-fluoranyl-2,4-bis(oxidanylidene)-1H-quinazolin-3-yl]-N-(1,3-thiazol-2-yl)propanamide",501,Inner Protein Regulator,Inner Protein,23434031,"Design, synthesis and SAR of novel glucokinase activators.",No,4ISF
ASD01200000_1,GCK,Homo sapiens,P35557,4ISG,ASD01200342,1FY,A,Lig,Activator,"(2S)-3-cyclohexyl-2-(4-methylsulfonyl-2-oxidanylidene-piperazin-1-yl)-N-(1,3-thiazol-2-yl)propanamide",501,Inner Protein Regulator,Inner Protein,23434031,"Design, synthesis and SAR of novel glucokinase activators.",No,4ISG
ASD01200000_1,GCK,Homo sapiens,P35557,4IWV,ASD01200338,1J9,A,Lig,Activator,"(2S)-N-(5-chloranylpyridin-2-yl)-2-[1-(2-chlorophenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxy-3-(2-hydroxyethyloxy)propanamide",503,Inner Protein Regulator,Inner Protein,,Optimising pharmacokinetics of glucokinase activators with matched triplicate design sets the discovery of AZD3651 and AZD9485,No,4IWV
ASD01200000_1,GCK,Homo sapiens,P35557,4IXC,ASD01200336,1JD,A,Lig,Activator,"(2S)-2-[1-(3-chloranylpyridin-2-yl)pyrazolo[3,4-d]pyrimidin-4-yl]oxy-N-(5-methylpyridin-2-yl)-3-propan-2-yloxy-propanamide",503,Inner Protein Regulator,Inner Protein,,Matched triplicate design sets in the optimisation of glucokinase activators    maximising medicinal chemistry information content,No,4IXC
ASD01200000_1,GCK,Homo sapiens,P35557,4L3Q,ASD01200326,926,A,Lig,Activator,6-[3-(1-methylimidazol-2-yl)sulfanylphenyl]-1H-pyridin-2-one,501,Inner Protein Regulator,Inner Protein,23831135,Pyrimidone-based series of glucokinase activators with alternative donor-acceptor motif.,No,4L3Q
ASD01200000_1,GCK,Homo sapiens,P35557,4MLE,ASD01200322,VO1,A,Lig,Activator,"4-methyl-N-(3-phenylmethoxypyridin-2-yl)-1,3-thiazol-2-amine",502,Inner Protein Regulator,Inner Protein,24015910,Identification of a New Class of Glucokinase Activators through Structure-Based Design.,No,4MLE
ASD01200000_1,GCK,Homo sapiens,P35557,4MLH,ASD01200323,VO2,A,Lig,Activator,"4-methyl-N-(5-methyl-3-phenylmethoxy-pyridin-2-yl)-1,3-thiazol-2-amine",502,Inner Protein Regulator,Inner Protein,24015910,Identification of a New Class of Glucokinase Activators through Structure-Based Design.,No,4MLH
ASD01200000_1,GCK,Homo sapiens,P35557,4NO7,ASD01200261,2N8,A,Lig,Activator,(2R)-2-[3-chloro-4-(methylsulfonyl)phenyl]-3-[(1R)-3-oxocyclopentyl]-N-(pyrazin-2-yl)propanamide,502,Inner Protein Regulator,Inner Protein,,The active conformation of human glucokinase is not altered by allosteric activators.,No,4NO7
ASD01200000_1,GCK,Homo sapiens,P35557,5V4W,ASD01209001,8WM,A,Lig,Activator,"(2S)-2-[4-(cyclopropylsulfonyl)-1H-indazol- 1-yl]-N-(5-fluoro-1,3-thiazol-2-yl)-3-(oxan- 4-yl)propanamide",501,Inner Protein Regulator,Inner Protein,28512030,"Discovery of potent and orally active 1,4-disubstituted indazoles as novel allosteric glucokinase activators.",No,5V4W
ASD01200000_1,GCK,Homo sapiens,P35557,5V4X,ASD01200361,8WJ,A,Lig,Activator,"(2S)-3-cyclohexyl-2-[4-(cyclopentylsulfonyl)- 2-oxopyridin-1(2H)-yl]-N-(1,3-thiazol-2-yl)propanamide",501,Inner Protein Regulator,Inner Protein,28512030,"Discovery of potent and orally active 1,4-disubstituted indazoles as novel allosteric glucokinase activators.",No,5V4X
ASD01210000_1,nagB,Escherichia coli,P0A759,1FRZ,ASD01218001,16G,A,Lig,Activator,"[(2R,3S,4R,5R,6S)-5-acetamido-3,4,6-trihydroxy-oxan-2-yl]methyl dihydrogen phosphate",1267,Inner Protein Regulator,Protein-Protein Interaction,11752775,"Structural flexibility, an essential component of the allosteric activation in Escherichia coli glucosamine-6-phosphate deaminase.",No,"Chain A:MET1,ARG2"
ASD01210000_1,nagB,Escherichia coli,P0A759,1FS5,ASD01218001,16G,A,Lig,Activator,"[(2R,3S,4R,5R,6S)-5-acetamido-3,4,6-trihydroxy-oxan-2-yl]methyl dihydrogen phosphate",1267,Inner Protein Regulator,Protein-Protein Interaction,11752775,"Structural flexibility, an essential component of the allosteric activation in Escherichia coli glucosamine-6-phosphate deaminase.",No,"Chain A:MET1,ARG2,LEU258"
ASD01210000_1,nagB,Escherichia coli,P0A759,1HOT,ASD01218001,16G,A,Lig,Activator,"[(2R,3S,4R,5R,6S)-5-acetamido-3,4,6-trihydroxy-oxan-2-yl]methyl dihydrogen phosphate",269,Inner Protein Regulator,Protein-Protein Interaction,8747459,Structure and catalytic mechanism of glucosamine 6-phosphate deaminase from Escherichia coli at 2.1 A resolution.,No,"Chain A:MET1,ARG2"
ASD01210000_1,nagB,Escherichia coli,P0A759,2WU1,ASD01218001,16G,A,Lig,Activator,"[(2R,3S,4R,5R,6S)-5-acetamido-3,4,6-trihydroxy-oxan-2-yl]methyl dihydrogen phosphate",1267,Inner Protein Regulator,Protein-Protein Interaction,Not in PubMed,Glucosamine-6-Phosphate Deaminase Mechanism: The Substrate Piranosic Ring Opening,No,"Chain A:MET1,ARG2"
ASD01210000_3,GNPDA1,Homo sapiens,P46926,1NE7,ASD01218001,16G,B,Lig,Activator,"[(2R,3S,4R,5R,6S)-5-acetamido-3,4,6-trihydroxy-oxan-2-yl]methyl dihydrogen phosphate",2299,Inner Protein Regulator,Protein-Protein Interaction,12965206,Two mammalian glucosamine-6-phosphate deaminases: a structural and genetic study.,No,1NE7
ASD01230000_1,GRIA2,Homo sapiens,P42262,2XHD,ASD01230265,7T9,B,Lig,Activator,"N-[(2S)-5-(6-fluoropyridin-3-yl)-2,3-dihydro-1H-inden-2-yl]propane-2-sulfonamide",1266,Inner Protein Regulator,Protein-Protein Interaction,20614889,"Discovery of N-[(2S)-5-(6-Fluoro-3-Pyridinyl)-2,3-Dihydro-1H-Inden-2-Yl]-2-Propanesulfonamide, a Novel Clinical Ampa Receptor Positive Modulator.",No,2XHD
ASD01230000_1,GRIA2,Homo sapiens,P42262,3RN8,ASD01238022,RN8,A,Lig,Activator,3-[4-(2-carboxy-4-cyano-5-ethyl-thiophen-3-yl)phenyl]-4-cyano-5-ethyl-thiophene-2-carboxylic acid,281,Inner Protein Regulator,Protein-Protein Interaction,21543522,Structural and functional analysis of two new positive allosteric modulators of GluA2 desensitization and deactivation.,No,3RN8
ASD01230000_1,GRIA2,Homo sapiens,P42262,3RNN,ASD01238015,RNN,A,Lig,Activator,N-[2-[4-[2-(propan-2-ylsulfonylamino)ethyl]phenyl]ethyl]propane-2-sulfonamide,280,Inner Protein Regulator,Protein-Protein Interaction,21543522,Structural and functional analysis of two new positive allosteric modulators of GluA2 desensitization and deactivation.,No,3RNN
ASD01230000_1,GRIA2,Homo sapiens,P42262,5YBF,ASD01230243,8SR,A,Lig,Activator,"2-[2-[5-methyl-3-(trifluoromethyl)pyrazol-1-yl]ethanoylamino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide",902,Allosteric function,Allosteric position,29298820,"HBT1, a Novel AMPA Receptor Potentiator with Lower Agonistic Effect, Avoided Bell-Shaped Response in In Vitro BDNF Production.",No,5YBF
ASD01230000_1,GRIA2,Homo sapiens,P42262,5YBG,,8SO,A,Lig,Activator,N-[(2R)-2-[4-[4-[2-(methylsulfonylamino)ethyl]phenyl]phenyl]propyl]propane-2-sulfonamide,902,Allosteric function,Allosteric position,29298820,"HBT1, a Novel AMPA Receptor Potentiator with Lower Agonistic Effect, Avoided Bell-Shaped Response in In Vitro BDNF Production.",No,5YBG
ASD01230000_2,Gria2,Rattus norvegicus,P19491,1LBC,ASD01238024,CYZ,A,Lig,Activator,"(3S)-3-[(1S,4S,6S)-6-bicyclo[2.2.1]hept-2-enyl]-6-chloro-1,1-dioxo-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide",330,Inner Protein Regulator,Protein-Protein Interaction,12015593,Mechanism of glutamate receptor desensitization.,No,"Chain A:LYS104,PRO105,PHE106,MET107,SER108,LEU239,SER242,LEU247,ASP248,LYS251; Chain C:ILE92,SER217,LYS218,GLY219"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,2AL4,ASD01230247,CX6,C,Lig,Activator,"2,3,6A,7,8,9-HEXAHYDRO-11H-[1,4]DIOXINO[2,3- G]PYRROLO[2,1-B][1,3]BENZOXAZIN-11-ONE",801,Inner Protein Regulator,Protein-Protein Interaction,16192394,Mechanism of positive allosteric modulators acting on AMPA receptors.,No,"Chain A:PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,ASN242; Chain C:PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,ASN242"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,2AL5,ASD01230001,4MP,A,Lig,Activator,1-(4-methoxyphenyl)carbonylpyrrolidin-2-one,801,Inner Protein Regulator,Protein-Protein Interaction,16192394,Mechanism of positive allosteric modulators acting on AMPA receptors.,No,"Chain A:PRO105,MET107,SER108,SER217,LYS218,GLY219,ASN242; Chain B:PRO105,SER108,SER217,LYS218,GLY219,ASN242"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,2XX7,ASD01230281,1ND,A,Lig,Activator,"pyrrolidin-1-yl-[4-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]phenyl]methanone",310,Inner Protein Regulator,Protein-Protein Interaction,21128618,Integration of Lead Optimization with Crystallography for a Membrane-Bound Ion Channel Target: Discovery of a New Class of Ampa Receptor Positive Allosteric Modulators.,No,"Chain A:ILE92,LYS104,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242,LEU247; Chain C:ILE92,LYS104,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242,LEU247"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,2XX8,ASD01230283,1NE,A,Lig,Activator,"N,N-dimethyl-4-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]benzamide",310,Inner Protein Regulator,Protein-Protein Interaction,21128618,Integration of Lead Optimization with Crystallography for a Membrane-Bound Ion Channel Target: Discovery of a New Class of Ampa Receptor Positive Allosteric Modulators.,No,"Chain A:ILE92,LYS104,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242; Chain C:ILE92,LYS104,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,2XX9,ASD01230284,1NF,A,Lig,Activator,"1-[[2-fluoro-4-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]phenyl]methyl]pyrrolidin-2-one",310,Inner Protein Regulator,Protein-Protein Interaction,21128618,Integration of Lead Optimization with Crystallography for a Membrane-Bound Ion Channel Target: Discovery of a New Class of Ampa Receptor Positive Allosteric Modulators.,No,"Chain A:ILE92,LYS104,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242,LEU247; Chain C:ILE92,LYS104,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242,LEU247"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,2XXH,ASD01230285,1NG,A,Lig,Activator,"1-pyrrolidin-1-yl-2-[4-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]phenyl]ethanone",310,Inner Protein Regulator,Protein-Protein Interaction,21128618,Integration of Lead Optimization with Crystallography for a Membrane-Bound Ion Channel Target: Discovery of a New Class of Ampa Receptor Positive Allosteric Modulators.,No,"Chain A:ILE92,LYS104,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242,LEU247; Chain C:ILE92,LYS104,PRO105,PHE106,SER108,SER217,LYS218,GLY219,LEU239,SER242,LEU247"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,2XXI,ASD01230286,JAC,A,Lig,Activator,"1-[[4-[3-(trifluoromethyl)-6,7-dihydro-4H-pyrano[3,4-d]pyrazol-1-yl]phenyl]methyl]pyrrolidin-2-one",1302,Inner Protein Regulator,Protein-Protein Interaction,21128618,Integration of Lead Optimization with Crystallography for a Membrane-Bound Ion Channel Target: Discovery of a New Class of Ampa Receptor Positive Allosteric Modulators.,No,"Chain A:ILE92,LYS104,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242,LEU247; Chain C:ILE92,LYS104,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242,LEU247"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3BBR,ASD01230134,BHY,A,Lig,Activator,N-[(2R)-2-[4-[4-[(2R)-1-(methylsulfonylamino)propan-2-yl]phenyl]phenyl]propyl]methanesulfonamide,268,Inner Protein Regulator,Protein-Protein Interaction,18022568,Structural proof of a dimeric positive modulator bridging two identical AMPA receptor-binding sites,No,"Chain A:LYS104,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239; Chain B:ILE92,LYS104,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3H6T,ASD01238024,CYZ,A,Lig,Activator,"(3S)-3-[(1S,4S,6S)-6-bicyclo[2.2.1]hept-2-enyl]-6-chloro-1,1-dioxo-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide",265,Inner Protein Regulator,Protein-Protein Interaction,19591837,Distinct structural features of cyclothiazide are responsible for effects on peak current amplitude and desensitization kinetics at iGluR2.,No,"Chain A:LYS104,PRO105,PHE106,MET107,SER108,LEU239,SER242,LEU247,ASP248,LYS251; Chain C:ILE92,SER217,LYS218,GLY219"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3H6U,ASD01238019,NS3,A,Lig,Activator,"(3S)-3-cyclopentyl-6-methyl-7-(4-methylpiperazin-1-yl)sulfonyl-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide",265,Inner Protein Regulator,Protein-Protein Interaction,19591837,Distinct structural features of cyclothiazide are responsible for effects on peak current amplitude and desensitization kinetics at iGluR2.,No,"Chain A:LYS104,PRO105,MET107,SER108,LEU239,SER242,LEU247,ASP248,LYS251"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3H6V,ASD01238020,NS6,A,Lig,Activator,"(3R)-3-cyclopentyl-7-(4-methylpiperazin-1-yl)sulfonyl-3,4-dihydro-2H-benzo[e][1,2]thiazine 1,1-dioxide",265,Inner Protein Regulator,Protein-Protein Interaction,19591837,Distinct structural features of cyclothiazide are responsible for effects on peak current amplitude and desensitization kinetics at iGluR2.,No,"Chain A:PRO105,PHE106,MET107,SER108,LEU239,SER242,LEU247,ASP248,LYS251; Chain B:ILE92,SER217,LYS218"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3H6W,ASD01238021,NS7,A,Lig,Activator,"(3R)-3-cyclopentyl-6-methyl-7-(4-methylpiperazin-1-yl)sulfonyl-3,4-dihydro-2H-benzo[e][1,2]thiazine 1,1-dioxide",265,Inner Protein Regulator,Protein-Protein Interaction,19591837,Distinct structural features of cyclothiazide are responsible for effects on peak current amplitude and desensitization kinetics at iGluR2.,No,"Chain A:LYS104,PRO105,PHE106,MET107,SER108,LEU239,SER242,LEU247,ASP248,LYS251"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3IJO,ASD01230003;ASD01230003,B4D;B4D,B;B,Lig;Lig,Activator,"(3S)-6-chloro-1,1-dioxo-3-(prop-2-enylsulfanylmethyl)-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide",401;800,Inner Protein Regulator,Protein-Protein Interaction,19673491,Probing the allosteric modulator binding site of GluR2 with thiazide derivatives,No,"Chain B:ILE92,THR93,LYS104,PRO105,PHE106,MET107,SER108,SER217,LEU239,SER242,LEU247,ASP248,LYS251; Chain E:ILE92,PRO105,PHE106,MET107,SER108,SER217,LEU239,SER242,LEU247,ASP248,LYS251"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3IJX,ASD01230004,HCZ,B,Lig,Activator,"6-chloro-1,1-dioxo-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide",800,Inner Protein Regulator,Protein-Protein Interaction,19673491,Probing the allosteric modulator binding site of GluR2 with thiazide derivatives,No,"Chain B:LYS104,PRO105,SER108,LEU239,SER242; Chain D:ILE92,PRO105,SER108,SER217,LYS218,GLY219"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3IK6,ASD01230004;ASD01230004,HCZ;HCZ,B;B,Lig;Lig,Activator,"6-chloro-1,1-dioxo-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide",262;800,Inner Protein Regulator,Protein-Protein Interaction,19673491,Probing the allosteric modulator binding site of GluR2 with thiazide derivatives,No,"Chain B:ILE92,LYS104,PRO105,SER108,SER217,LYS218,GLY219,LEU239,SER242; Chain E:ILE92,LYS104,PRO105,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3IL1,ASD01230202;ASD01230202,B5D;B5D,B;B,Lig;Lig,Activator,"(3S)-7-chloro-3-methyl-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide",262;801,Inner Protein Regulator,Protein-Protein Interaction,19673491,Probing the allosteric modulator binding site of GluR2 with thiazide derivatives,No,"Chain B:ILE92,LYS104,PRO105,SER108,SER217,LYS218,GLY219,VAL238,SER242; Chain E:ILE92,LYS104,PRO105,SER108,SER217,LYS218,GLY219,VAL238,LEU239,SER242"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3ILT,ASD01230209,TRU,B,Lig,Activator,"(3R)-6-chloro-3-(dichloromethyl)-1,1-dioxo-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide",800,Inner Protein Regulator,Protein-Protein Interaction,19673491,Probing the allosteric modulator binding site of GluR2 with thiazide derivatives,No,"Chain B:LYS104,PRO105,PHE106,MET107,SER108,LEU239,SER242,LEU247,ASP248,LYS251; Chain E:ILE92,SER217,LYS218"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3ILU,ASD01230008,HFZ,B,Lig,Activator,"1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide",800,Inner Protein Regulator,Protein-Protein Interaction,19673491,Probing the allosteric modulator binding site of GluR2 with thiazide derivatives,No,"Chain B:LYS104,PRO105,PHE106,MET107,SER108,LEU239,SER242; Chain E:ILE92,PRO105,SER108,SER217,LYS218,GLY219"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3KGC,ASD01230318,LY7,A,Lig,Activator,N-[(2S)-2-[4-(4-cyanophenyl)phenyl]propyl]propane-2-sulfonamide,264,Inner Protein Regulator,Protein-Protein Interaction,19946266,"X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor",No,"Chain A:ILE92,PRO105,SER108,SER217,LYS218,GLY219,SER242,LEU247; Chain B:LYS104,PRO105,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3LSF,ASD04920002,PZI,E,Lig,Activator,2-(2-oxopyrrolidin-1-yl)ethanamide,800,Inner Protein Regulator,Protein-Protein Interaction,20163115,Piracetam Defines a New Binding Site for Allosteric Modulators of alpha-Amino-3-hydroxy-5-methyl-4-isoxazole-propionic Acid (AMPA) Receptors.,No,"Chain B:PRO105,SER108,SER217,LYS218,GLY219; Chain E:PRO105,PHE106,MET107,SER108,SER242,LEU247,ASP248,LYS251"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3LSF,ASD04920002,PZI,E,Lig,Activator,2-(2-oxopyrrolidin-1-yl)ethanamide,802,Inner Protein Regulator,Protein-Protein Interaction,20163115,Piracetam Defines a New Binding Site for Allosteric Modulators of alpha-Amino-3-hydroxy-5-methyl-4-isoxazole-propionic Acid (AMPA) Receptors.,No,"Chain B:ASP248,ASN252; Chain E:ASP216,SER217"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3LSL,ASD04920002,PZI,A,Lig,Activator,2-(2-oxopyrrolidin-1-yl)ethanamide,801,Inner Protein Regulator,Protein-Protein Interaction,20163115,Piracetam Defines a New Binding Site for Allosteric Modulators of alpha-Amino-3-hydroxy-5-methyl-4-isoxazole-propionic Acid (AMPA) Receptors.,No,"Chain A:ILE92,PRO105,MET107,SER108,SER217,LYS218,GLY219; Chain D:PRO105,PHE106,MET107,SER108,ASN242"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3LSL,ASD04920002,PZI,A,Lig,Activator,2-(2-oxopyrrolidin-1-yl)ethanamide,802,Inner Protein Regulator,Protein-Protein Interaction,20163115,Piracetam Defines a New Binding Site for Allosteric Modulators of alpha-Amino-3-hydroxy-5-methyl-4-isoxazole-propionic Acid (AMPA) Receptors.,No,"Chain A:ASP248,ASN252; Chain D:ASP216,SER217"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3M3L,ASD04920003,P99,A,Lig,Activator,"2-[2,6-difluoro-4-[2-(phenylsulfonylamino)ethylsulfanyl]phenoxy]ethanamide",800,Inner Protein Regulator,Protein-Protein Interaction,20199107,Molecular mechanism of flop selectivity and subsite recognition for an AMPA receptor allosteric modulator: structures of GluA2 and GluA3 in complexes with PEPA.,No,"Chain A:ILE92,LYS104,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,VAL238,LEU239,ASN242; Chain D:ILE92,LYS104,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,VAL238,LEU239,ASN242"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3O28,ASD01238011,O28,A,Lig,Activator,"2-[2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]ethanoylamino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide",264,Inner Protein Regulator,Protein-Protein Interaction,20805031,A novel series of positive modulators of the AMPA receptor: discovery and structure based hit-to-lead studies.,No,"Chain A:ILE92,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3O29,ASD01238012,O29,A,Lig,Activator,"N-(2-dimethylaminoethyl)-2-[2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]ethanoylamino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide",271,Inner Protein Regulator,Protein-Protein Interaction,20805031,A novel series of positive modulators of the AMPA receptor: discovery and structure based hit-to-lead studies.,No,"Chain A:ILE92,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242,LEU247,ASP248"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3O2A,ASD01230270,O30,A,Lig,Activator,"N-(3-azanylpropyl)-2-[2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]ethanoylamino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide",264,Inner Protein Regulator,Protein-Protein Interaction,20805031,A novel series of positive modulators of the AMPA receptor: discovery and structure based hit-to-lead studies.,No,"Chain A:ILE92,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242,LEU247,ASP248"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3O6G,ASD01230251,O27,A,Lig,Activator,"N-[(3R)-pyrrolidin-3-yl]-2-[2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]ethanoylamino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide",268,Inner Protein Regulator,Protein-Protein Interaction,20817521,A novel series of positive modulators of the AMPA receptor: structure-based lead optimization.,No,"Chain A:ILE92,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242,LEU247,ASP248"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3O6H,ASD01238009,O25,A,Lig,Activator,"2-[2-[4-(ethylaminomethyl)-3-(trifluoromethyl)pyrazol-1-yl]ethanoylamino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide",268,Inner Protein Regulator,Protein-Protein Interaction,20817521,A novel series of positive modulators of the AMPA receptor: structure-based lead optimization.,No,"Chain A:ILE92,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3O6I,ASD01238010,O26,A,Lig,Activator,"2-[2-[3-tert-butyl-4-(methylaminomethyl)pyrazol-1-yl]ethanoylamino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide",265,Inner Protein Regulator,Protein-Protein Interaction,20817521,A novel series of positive modulators of the AMPA receptor: structure-based lead optimization.,No,"Chain A:ILE92,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3PMV,ASD01238005,557,A,Lig,Activator,N-[(2S)-2-[4-[4-(hydroxymethyl)-3-(trifluoromethyl)pyrazol-1-yl]phenyl]propyl]propane-2-sulfonamide,270,Inner Protein Regulator,Protein-Protein Interaction,21190850,Structure based evolution of a novel series of positive modulators of the AMPA receptor.,No,"Chain A:ILE92,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,SER242,LEU247"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3PMW,ASD01238007,G69,A,Lig,Activator,"N-[(2S)-5-[[4-(hydroxymethyl)-3-(trifluoromethyl)pyrazol-1-yl]methyl]-2,3-dihydro-1H-inden-2-yl]propane-2-sulfonamide",274,Inner Protein Regulator,Protein-Protein Interaction,21190850,Structure based evolution of a novel series of positive modulators of the AMPA receptor.,No,"Chain A:ILE92,LYS104,PRO105,MET107,SER108,SER217,LYS218,GLY219,VAL238,LEU239,SER242"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3PMX,ASD01238006,808,A,Lig,Activator,"N-[(2S)-5-[[5-(trifluoromethyl)furan-2-yl]methyl]-2,3-dihydro-1H-inden-2-yl]propane-2-sulfonamide",277,Inner Protein Regulator,Protein-Protein Interaction,21190850,Structure based evolution of a novel series of positive modulators of the AMPA receptor.,No,"Chain A:ILE92,LYS104,PRO105,SER217,LYS218,GLY219,LEU239"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3TDJ,ASD01238023,3TJ,B,Lig,Activator,"4-ethyl-7-fluoranyl-2,3-dihydro-1$l^{6},2,4-benzothiadiazine 1,1-dioxide",265,Inner Protein Regulator,Protein-Protein Interaction,21895609,Thermodynamics and structural analysis of positive allosteric modulation of the ionotropic glutamate receptor GluA2.,No,"Chain A:ILE92,PRO105,MET107,SER108,SER217,LYS218,GLY219; Chain B:LYS104,PRO105,PHE106,MET107,SER108,LEU239,SER242"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,3TKD,ASD01238024,CYZ,A,Lig,Activator,"(3S)-3-[(1S,4S,6S)-6-bicyclo[2.2.1]hept-2-enyl]-6-chloro-1,1-dioxo-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide",266,Inner Protein Regulator,Protein-Protein Interaction,21895609,Thermodynamics and structural analysis of positive allosteric modulation of the ionotropic glutamate receptor GluA2.,No,"Chain A:LYS104,PRO105,PHE106,MET107,SER108,VAL238,LEU239,SER242,LEU247,ASP248,LYS251; Chain B:ILE92,THR93,PRO105,SER217,LYS218,GLY219"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,4FAT,ASD01230298,496,A,Lig,Activator,"2-[2-[4-(hydroxymethyl)-3-(trifluoromethyl)pyrazol-1-yl]ethanoylamino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide",302,Inner Protein Regulator,Protein-Protein Interaction,22735771,Functional analysis of a novel positive allosteric modulator of AMPA receptors derived from a structure-based drug design strategy.,No,"Chain A:ILE92,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,SER242"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,4IY5,ASD01230300,CX5,B,Lig,Activator,piperidin-1-yl(quinoxalin-6-yl)methanone,301,Inner Protein Regulator,Protein-Protein Interaction,23999288,Structural analysis of the positive AMPA receptor modulators CX516 and Me-CX516 in complex with the GluA2 ligand-binding domain,No,"Chain A:PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219; Chain B:PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,4IY6,ASD01230301,MQR,A,Lig,Activator,[(3R)-3-methylpiperidin-1-yl]-quinoxalin-6-yl-methanone,301,Inner Protein Regulator,Protein-Protein Interaction,23999288,Structural analysis of the positive AMPA receptor modulators CX516 and Me-CX516 in complex with the GluA2 ligand-binding domain,No,"Chain A:PRO105,PHE106,MET107,SER108,SER217,LYS218,SER242,LEU247"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,4LZ5,ASD01238016,1YV,B,Lig,Activator,N-[(2R)-2-[4-(4-cyanophenyl)phenyl]propyl]propane-2-sulfonamide,805,Inner Protein Regulator,Protein-Protein Interaction,24215237,Discovery and Characterization of a Novel Dihydroisoxazole Class of alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) Receptor Potentiators.,No,"Chain B:ILE481,PRO494,PHE495,MET496,SER497,SER729,LYS730,GLY731,ASN754,LEU759"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,4LZ7,ASD01230322,1YW,C,Lig,Activator,"N-[[(5S)-3-(3-fluoranyl-4-pyrrolidin-1-yl-phenyl)-4,5-dihydro-1,2-oxazol-5-yl]methyl]ethanamide",804,Inner Protein Regulator,Protein-Protein Interaction,24215237,Discovery and Characterization of a Novel Dihydroisoxazole Class of alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) Receptor Potentiators.,No,"Chain A:LYS493,PRO494,PHE495,MET496,SER497,SER729,LYS730,GLY731,ASN754; Chain C:LYS493,PRO494,PHE495,MET496,SER497,SER729,LYS730,GLY731,ASN754"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,4LZ8,ASD01230325,1YX,A,Lig,Activator,"N-[(3S)-1-[2-fluoranyl-4-[(5S)-5-[(propan-2-ylsulfonylamino)methyl]-4,5-dihydro-1,2-oxazol-3-yl]phenyl]pyrrolidin-3-yl]ethanamide",802,Inner Protein Regulator,Protein-Protein Interaction,24215237,Discovery and Characterization of a Novel Dihydroisoxazole Class of alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) Receptor Potentiators.,No,"Chain A:ILE481,LYS493,PRO494,PHE495,MET496,SER497,SER729,LYS730,GLY731,VAL750,LEU751,ASN754; Chain C:LYS493,PRO494,PHE495,MET496,SER497,SER729,LYS730,GLY731,VAL750,LEU751,ASN754"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,4N07,ASD01200253,2J9,A,Lig,Activator,"4-cyclopropyl-7-fluoranyl-2,3-dihydro-1$l^{6},2,4-benzothiadiazine 1,1-dioxide",301,Inner Protein Regulator,Protein-Protein Interaction,24131202,"Synthesis, pharmacological and structural characterization, and thermodynamic aspects of GluA2-positive allosteric modulators with a 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide scaffold.",No,"Chain A:LYS104,PRO105,PHE106,MET107,SER108,LEU239,SER242,LEU247"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,4U4S,ASD01230047,3C1,"A,B",Lig,Activator,"4-ethyl-3,4-dihydro-2H-pyrido[4,3-e][1,2,4]thiadiazine 1,1-dioxide",774,Allosteric Function,Allosteric Position,25375781,"Positive Allosteric Modulators of 2-Amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic Acid Receptors Belonging to 4-Cyclopropyl-3,4-dihydro-2H-1,2,4-pyridothiadiazine Dioxides and Diversely Chloro-Substituted 4-Cyclopropyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-Dioxides.",No,"Chain B:CYS773,CYS718,GLY774,GLY771,SER775,GLN714,GLU772,TYR768"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,4U4X,ASD01230046,3C2,"A,B",Lig,Activator,"4-ethyl-3,4-dihydro-2H-pyrido[3,2-e][1,2,4]thiadiazine 1,1-dioxide",801,Allosteric Function,Allosteric Position,25375781,"Positive Allosteric Modulators of 2-Amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic Acid Receptors Belonging to 4-Cyclopropyl-3,4-dihydro-2H-1,2,4-pyridothiadiazine Dioxides and Diversely Chloro-Substituted 4-Cyclopropyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-Dioxides.",No,"Chain B:PRO494,LEU498,SER729,LYS493,THR482,ILE481,SER754,TYR732,PHE495,VAL750,SER497,LEU751,LYS730,LEU759,GLY731,MET496"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,4U5B,ASD01230309,FWF,D,Lig,Activator,N-[(2R)-2-[4-[4-[(2R)-1-(propan-2-ylsulfonylamino)propan-2-yl]phenyl]phenyl]propyl]propane-2-sulfonamide,903,Inner Protein Regulator,Protein-Protein Interaction,25103405,X-ray structures of AMPA receptor-cone snail toxin complexes illuminate activation mechanism.,No,"Chain A:ILE481,PRO494,PHE495,MET496,SER497,SER729,LYS730,GLY731,LEU751,SER754; Chain D:ILE481,LYS493,PRO494,MET496,SER497,SER729,LYS730,GLY731,LEU751,SER754"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,4U5C,ASD01230309,FWF,D,Lig,Activator,N-[(2R)-2-[4-[4-[(2R)-1-(propan-2-ylsulfonylamino)propan-2-yl]phenyl]phenyl]propyl]propane-2-sulfonamide,903,Inner Protein Regulator,Protein-Protein Interaction,25103405,X-ray structures of AMPA receptor-cone snail toxin complexes illuminate activation mechanism.,No,"Chain A:ILE481,LYS493,PRO494,PHE495,MET496,SER497,SER729,LYS730,GLY731,SER754; Chain D:ILE481,PRO494,PHE495,MET496,SER497,SER729,LYS730,GLY731,SER754"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,4U5D,ASD01230309,FWF,A,Lig,Activator,N-[(2R)-2-[4-[4-[(2R)-1-(propan-2-ylsulfonylamino)propan-2-yl]phenyl]phenyl]propyl]propane-2-sulfonamide,903,Inner Protein Regulator,Protein-Protein Interaction,25103405,X-ray structures of AMPA receptor-cone snail toxin complexes illuminate activation mechanism.,No,"Chain A:LYS493,PRO494,MET496,SER497,SER729,LYS730,GLY731,VAL750,LEU751,SER754; Chain D:PRO494,PHE495,MET496,SER497,SER729,LYS730,GLY731,LEU751,SER754"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,4U5E,ASD01230309,FWF,A,Lig,Activator,N-[(2R)-2-[4-[4-[(2R)-1-(propan-2-ylsulfonylamino)propan-2-yl]phenyl]phenyl]propyl]propane-2-sulfonamide,903,Inner Protein Regulator,Protein-Protein Interaction,25103405,X-ray structures of AMPA receptor-cone snail toxin complexes illuminate activation mechanism.,No,"Chain A:ILE481,LYS493,PRO494,PHE495,MET496,SER497,SER729,LYS730,GLY731,VAL750,LEU751,SER754; Chain D:ILE481,LYS493,PRO494,MET496,SER497,SER729,LYS730,GLY731,LEU751,SER754"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,4U5F,ASD01230309,FWF,D,Lig,Activator,N-[(2R)-2-[4-[4-[(2R)-1-(propan-2-ylsulfonylamino)propan-2-yl]phenyl]phenyl]propyl]propane-2-sulfonamide,901,Inner Protein Regulator,Protein-Protein Interaction,25103405,X-ray structures of AMPA receptor-cone snail toxin complexes illuminate activation mechanism.,No,"Chain A:ILE481,LYS493,PRO494,PHE495,MET496,SER497,SER729,LYS730,GLY731,LEU751,SER754; Chain D:ILE481,PRO494,MET496,SER497,SER729,LYS730,GLY731,SER754"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,4X48,ASD01230383,XPF,B,Lig,Activator,"N-{(3S,4S)-4-[4-(5-cyanothiophen-2-yl)phenoxy]tetrahydrofuran- 3-yl}propane-2-sulfonamide",804,Allosteric Function,Inner Protein,25905800,"The Discovery and Characterization of the alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Potentiator N-{(3S,4S)-4-[4-(5-Cyano-2-thienyl)phenoxy]tetrahydrofuran-3-yl}propane-2-sulfonamide (PF-04958242).",No,"Chain B:LEU751,LYS730,TYR732,LEU759,PRO494,LYS493,GLU755,GLY731,SER729,PHE495,MET496,ASP760,VAL750,ASN754,LEU498,SER497"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,5BUU,ASD01230178,4V6,A,Lig,Activator,"(3R)-7-chloro-2,3,4-trimethyl-3,4-dihydro- 2H-1,2,4-benzothiadiazine 1,1-dioxide",801,Allosteric Function,Allosteric Position,26771108,"Synthesis and Pharmacology of Mono-, Di-, and Trialkyl-Substituted 7-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-Dioxides Combined with X-ray Structure Analysis to Understand the Unexpected Structure-Activity Relationship at AMPA Receptors.",No,"Chain B:LEU751,PRO494,LYS493,GLU755,PHE495,VAL750,SER754,LEU759,MET496,SER497"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,5ELV,ASD01230232,5PX,"A,B",Lig,Activator,"4-Cyclopropyl-3,4-dihydro-7-hydroxy-2H-1,2,4- benzothiadiazine 1,1-dioxide",312,Inner Protein Regulator,Allosteric Position,27276258,Enthalpy-Entropy Compensation in the Binding of Modulators at Ionotropic Glutamate Receptor GluA2.,No,"Chain B:ILE92,LEU109,SER217,SER108,LYS104,LEU239,SER242,LYS218,GLY219,LEU247,MET107,PRO105,PHE106,VAL238,THR93,TYR220"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,5O9A,ASD01230049,7M6,A,Lig,Activator,"7-chloro-4-(2-fluoroethyl)-2,3-dihydro-1,2,4-benzothiadiazine 1,1-dioxide",305,Inner Protein regulator,Inner Protein,29256599,"7-Phenoxy-Substituted 3,4-Dihydro-2H-1,2,4-benzothiadiazine 1,1-Dioxides as Positive Allosteric Modulators of alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors with Nanomolar Potency.",No,"Chain B:LEU109,SER217,SER108,PHE106,THR93,MET107,GLY219,LYS218,ILE92,PRO105,TYR220"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,5OEW,ASD01230259,9TE,B,Lig,Activator,"4-cyclopropyl-7-(3-methoxyphenoxy)-2,3-dihydro-1$l^{6},2,4-benzothiadiazine 1,1-dioxide",901,Allosteric function,Allosteric position,29256599,"7-Phenoxy-Substituted 3,4-Dihydro-2H-1,2,4-benzothiadiazine 1,1-Dioxides as Positive Allosteric Modulators of alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors with Nanomolar Potency.",No,"Chain B:ILE92,LEU109,SER217,SER108,LYS104,LEU239,LYS218,GLY219,LEU247,ASN242,MET107,PRO105,PHE106,VAL238,THR93,TYR220"
ASD01230000_2,Gria2,Rattus norvegicus,P19491,6FAZ,,D45,B,Lig,modulator,"6,6'-(Ethane-1,2-diyl)bis(4-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide)",301,,,29775064,Enhancing Action of Positive Allosteric Modulators through the Design of Dimeric Compounds.,,
ASD01230000_2,Gria2,Rattus norvegicus,P19491,6HC9,,FXW,B,Lig,Activator,"6,6'-(ETHANE-1,2-DIYL)BIS(4-CYCLOPROPYL-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE 1,1-DIOXIDE)",313,Allosteric function,Allosteric position,,,No,
ASD01230000_2,Gria2,Rattus norvegicus,P19491,6HCA,,FXW,B,Lig,Activator,"6,6'-(ETHANE-1,2-DIYL)BIS(4-CYCLOPROPYL-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE 1,1-DIOXIDE)",301,Allosteric function,Allosteric position,,,No,
ASD01230000_2,Gria2,Rattus norvegicus,P19491,6HCB,,D45,B,Lig,Activator,"6,6'-(Ethane-1,2-diyl)bis(4-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide)",304,Allosteric function,Allosteric position,,,No,
ASD01230000_2,Gria2,Rattus norvegicus,P19491,6HCC,,FXW,A,Lig,Activator,"6,6'-(ETHANE-1,2-DIYL)BIS(4-CYCLOPROPYL-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE 1,1-DIOXIDE)",301,Allosteric function,Allosteric position,,,No,
ASD01230000_2,Gria2,Rattus norvegicus,P19491,6HCH,,D45,A,Lig,Activator,"6,6'-(Ethane-1,2-diyl)bis(4-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide)",311,Allosteric function,Allosteric position,,,No,
ASD01230000_2,Gria2,Rattus norvegicus,P19491,6RUQ,,GYK,A,Lig,Regulator,"(8R)-5-(4-aminophenyl)-N,8-dimethyl-8,9-dihydro-2H,7H-[1,3]dioxolo[4,5-h][2,3]benzodiazepine-7-carboxamide",901,,,,,,
ASD01230000_2,Gria2,Rattus norvegicus,P19491,6ZYU,ASD01230694_2_ZCH@@ASD01230695_2_ZCH,QSZ@@QSW,"A,B,C@@ABC",,,,,,,34242002,,,
ASD01240000_1,GLUD1,Bos taurus,P00366,1HWY,ASD01720006,NAD,A,Lig,Activator,"[(2R,3S,4R,5R)-5-(3-aminocarbonylpyridin-1-ium-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphate",507,Inner Protein Regulator,Protein-Protein Interaction,11254391,Structures of bovine glutamate dehydrogenase complexes elucidate the mechanism of purine regulation.,No,"Chain A:HIS195,GLN205,GLY206,LYS387,ASN388,ASN390,HIS391,VAL392,SER393,ARG396,GLU445; Chain B:GLN85,ARG86,THR87,CYS115,ALA116,ASP119,VAL120,PRO121,PHE122,TYR382,ARG459,LYS488,VAL489,VAL492"
ASD01240000_1,GLUD1,Bos taurus,P00366,1HWZ,ASD00290006,GTP,A,Lig,Inhibitor,"[[(2R,3S,4R,5R)-5-(2-azanyl-6-oxidanylidene-1H-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate",553,Inner Protein Regulator,Inner Protein,11254391,Structures of bovine glutamate dehydrogenase complexes elucidate the mechanism of purine regulation.,No,"Chain A:HIS209,GLY210,SER213,ARG217,HIS258,ARG261,TYR262,ARG265,LYS289,GLU292,HIS450"
ASD01240000_1,GLUD1,Bos taurus,P00366,1NQT,ASD01720027,ADP,F,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate",502,Inner Protein Regulator,Protein-Protein Interaction,12653548,Structural studies on ADP activation of mammalian glutamate dehydrogenase and the evolution of regulation,No,"Chain A:ILE203,HIS209,LYS387,SER393,ARG396; Chain F:GLN85,ARG86,ALA116,ASP119,VAL120,ARG459,LYS488,VAL489,VAL492"
ASD01240000_1,GLUD1,Bos taurus,P00366,3ETD,ASD01240023;ASD01240023,B1T;B1T,A;E,Lig,Inhibitor,"2,4-dichloro-6-(3,5-dichloro-2-hydroxy-phenyl)sulfanyl-phenol",552;552,Inner Protein Regulator,Protein-Protein Interaction,19531491,Novel Inhibitors Complexed with Glutamate Dehydrogenase: ALLOSTERIC REGULATION BY CONTROL OF PROTEIN DYNAMICS,No,"Chain A:GLU142,ARG146,ASP181,SER185; Chain E:ARG146,ARG147"
ASD01240000_1,GLUD1,Bos taurus,P00366,3ETD,ASD00290006,GTP,A,Lig,Inhibitor,"[[(2R,3S,4R,5R)-5-(2-azanyl-6-oxidanylidene-1H-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate",553,Inner Protein Regulator,Inner Protein,19531491,Novel Inhibitors Complexed with Glutamate Dehydrogenase: ALLOSTERIC REGULATION BY CONTROL OF PROTEIN DYNAMICS,No,"Chain A:HIS209,GLY210,ILE212,ARG217,ARG261,TYR262,ARG265,GLU292,HIS450"
ASD01240000_1,GLUD1,Bos taurus,P00366,3ETE,ASD01240021;ASD01240021;ASD01240021;ASD01240021;ASD01240021;ASD01240021,H3P;H3P;H3P;H3P;H3P;H3P,A;B;C;C;D;F,Lig,Inhibitor,"3,4,6-trichloro-2-[(2,3,5-trichloro-6-hydroxy-phenyl)methyl]phenol",552;552;552;554;552;552,Inner Protein Regulator,Protein-Protein Interaction,19531491,Novel Inhibitors Complexed with Glutamate Dehydrogenase: ALLOSTERIC REGULATION BY CONTROL OF PROTEIN DYNAMICS,No,"Chain A:THR186,ILE187,TYR190; Chain E:MET150,LYS154,THR186,ILE187,HIS189,TYR190"
ASD01240000_1,GLUD1,Bos taurus,P00366,3ETE,ASD00290006,GTP,A,Lig,Inhibitor,"[[(2R,3S,4R,5R)-5-(2-azanyl-6-oxidanylidene-1H-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate",553,Inner Protein Regulator,Inner Protein,19531491,Novel Inhibitors Complexed with Glutamate Dehydrogenase: ALLOSTERIC REGULATION BY CONTROL OF PROTEIN DYNAMICS,No,"Chain A:ILE212,SER213,ARG217,LEU257,HIS258,ARG261,TYR262,ARG265,GLU292,LYS446,HIS450"
ASD01240000_1,GLUD1,Bos taurus,P00366,3ETG,ASD01240022;ASD01240022,GWD;GWD,A;E,Lig,Inhibitor,"(3E)-3-[(3,5-dibromo-4-hydroxy-phenyl)methylidene]-5-iodo-1H-indol-2-one",552;552,Inner Protein Regulator,Protein-Protein Interaction,19531491,Novel Inhibitors Complexed with Glutamate Dehydrogenase: ALLOSTERIC REGULATION BY CONTROL OF PROTEIN DYNAMICS,No,"Chain A:GLU142,ARG146,ARG147,MET150,ASP181,SER185"
ASD01240000_1,GLUD1,Bos taurus,P00366,3ETG,ASD00290006,GTP,A,Lig,Inhibitor,"[[(2R,3S,4R,5R)-5-(2-azanyl-6-oxidanylidene-1H-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate",553,Inner Protein Regulator,Inner Protein,19531491,Novel Inhibitors Complexed with Glutamate Dehydrogenase: ALLOSTERIC REGULATION BY CONTROL OF PROTEIN DYNAMICS,No,"Chain A:HIS209,GLY210,SER213,ARG217,LEU257,HIS258,ARG261,TYR262,ARG265,LYS289,GLU292,HIS450"
ASD01240000_1,GLUD1,Bos taurus,P00366,3MVQ,ASD00290006,GTP,A,Lig,Inhibitor,"[[(2R,3S,4R,5R)-5-(2-azanyl-6-oxidanylidene-1H-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate",503,Inner Protein Regulator,Inner Protein,21749647,A novel mechanism of V-type zinc inhibition of glutamate dehydrogenase results from disruption of subunit interactions necessary for efficient catalysis.,No,"Chain A:HIS209,GLY210,SER213,ARG217,LEU257,HIS258,ARG261,TYR262,ARG265,LYS289,GLU292,LYS446,HIS450"
ASD01240000_1,GLUD1,Bos taurus,P00366,3MW9,ASD00290006,GTP,A,Lig,Inhibitor,"[[(2R,3S,4R,5R)-5-(2-azanyl-6-oxidanylidene-1H-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate",602,Inner Protein Regulator,Inner Protein,10425679,The structure of bovine glutamate dehydrogenase provides insights into the mechanism of allostery.,No,"Chain A:HIS209,GLY210,SER213,ARG217,HIS258,ARG261,TYR262,ARG265,LYS289,GLU292,LYS446,HIS450"
ASD01240000_1,GLUD1,Bos taurus,P00366,3MW9,ASD06128001,NAI,A,Lig,Inhibitor,"[[(2R,3S,4R,5R)-5-(3-aminocarbonyl-4H-pyridin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl hydrogen phosphate",604,Inner Protein Regulator,Protein-Protein Interaction,10425679,The structure of bovine glutamate dehydrogenase provides insights into the mechanism of allostery.,No,"Chain A:HIS195,GLN205,GLY206,ASN387,ASN388,HIS391,VAL392,SER393; Chain B:HIS85,ARG86,CYS115,ALA116,ASP119,VAL120,PRO121,LYS488,ARG491"
ASD01240000_1,GLUD1,Bos taurus,P00366,3QMU,ASD01240001,XEG,B,Lig,Inhibitor,"[(2R,3S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate",601,Inner Protein Regulator,Protein-Protein Interaction,21813650,Green Tea Polyphenols Control Dysregulated Glutamate Dehydrogenase in Transgenic Mice by Hijacking the ADP Activation Site.,No,"Chain A:ILE203,SER204,HIS209,SER393,ARG396; Chain B:HIS85,ARG86,ALA116,ASP119,VAL120,PRO121,ARG459,GLN463,LYS488,VAL489,ARG491"
ASD01260000_4,gapN,Thermoproteus tenax,O57693,1UXN,ASD00030001,AMP,A,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",1502,Inner Protein Regulator,Inner Protein,15288789,Structural Basis of Allosteric Regulation and Substrate Specificity of the Non-Phosphorylating Glyceraldehyde 3-Phosphate Dehydrogenase from Thermoproteus Tenax,No,"Chain A:ARG72,ARG79,ILE133,GLY134,ARG154,ARG155,GLU156,TYR184,VAL479"
ASD01260000_4,gapN,Thermoproteus tenax,O57693,1UXP,ASD00030001,AMP,A,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",1502,Inner Protein Regulator,Inner Protein,15288789,Structural Basis of Allosteric Regulation and Substrate Specificity of the Non-Phosphorylating Glyceraldehyde 3-Phosphate Dehydrogenase from Thermoproteus Tenax,No,"Chain A:ARG72,ARG79,LYS132,ILE133,GLY134,GLY135,ARG154,ARG155,GLU156,PRO157,TYR184"
ASD01260000_4,gapN,Thermoproteus tenax,O57693,1UXQ,ASD00360004,G1P,A,Lig,Activator,"[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] dihydrogen phosphate",1503,Inner Protein Regulator,Inner Protein,15288789,Structural Basis of Allosteric Regulation and Substrate Specificity of the Non-Phosphorylating Glyceraldehyde 3-Phosphate Dehydrogenase from Thermoproteus Tenax,No,"Chain A:ARG72,ARG79,ILE133,ARG154,ARG155,GLU156,PRO157,TYR184"
ASD01260000_4,gapN,Thermoproteus tenax,O57693,1UXR,ASD01260013,F6P,A,Lig,Activator,"[(2R,3S,4S,5R)-3,4,5-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]methyl dihydrogen phosphate",1503,Inner Protein Regulator,Inner Protein,15288789,Structural Basis of Allosteric Regulation and Substrate Specificity of the Non-Phosphorylating Glyceraldehyde 3-Phosphate Dehydrogenase from Thermoproteus Tenax,No,"Chain A:ARG72,ARG79,ILE133,ARG154,ARG155,GLU156,TYR184"
ASD01260000_4,gapN,Thermoproteus tenax,O57693,1UXT,ASD00360004,G1P,A,Lig,Activator,"[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] dihydrogen phosphate",1502,Inner Protein Regulator,Inner Protein,15288789,Structural Basis of Allosteric Regulation and Substrate Specificity of the Non-Phosphorylating Glyceraldehyde 3-Phosphate Dehydrogenase from Thermoproteus Tenax,No,"Chain A:ARG72,ARG79,ILE133,ARG154,ARG155,GLU156,PRO157,TYR184"
ASD01260000_4,gapN,Thermoproteus tenax,O57693,1UXU,ASD00030001,AMP,A,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",503,Inner Protein Regulator,Inner Protein,15288789,Structural Basis of Allosteric Regulation and Substrate Specificity of the Non-Phosphorylating Glyceraldehyde 3-Phosphate Dehydrogenase from Thermoproteus Tenax,No,"Chain A:ARG72,ARG79,ILE133,GLY134,GLY135,ARG154,ARG155,GLU156,TYR184"
ASD01260000_4,gapN,Thermoproteus tenax,O57693,1UXV,ASD00030001,AMP,A,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",1503,Inner Protein Regulator,Inner Protein,15288789,Structural Basis of Allosteric Regulation and Substrate Specificity of the Non-Phosphorylating Glyceraldehyde 3-Phosphate Dehydrogenase from Thermoproteus Tenax,No,"Chain A:ARG72,ARG79,LYS132,ILE133,GLY134,GLY135,ARG154,ARG155,GLU156,PRO157,TYR184,VAL479"
ASD01290000_1,glpK,Escherichia coli,P0A6F3,1BO5,ASD00200001,FBP,O,Lig,Inhibitor,"[(2R,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate",502,Inner Protein Regulator,Protein-Protein Interaction,9843423,"Crystal structure of a complex of Escherichia coli glycerol kinase and an allosteric effector fructose 1,6-bisphosphate.",No,"Chain O:ASN228,GLY233,GLY234,THR235,ARG236"
ASD01320000_1,PYGM,Homo sapiens,P11217,1Z8D,ASD01320045,ADE,A,Lig,Inhibitor,9H-purin-6-amine,902,Inner Protein Regulator,Inner Protein,16523484,The crystal structure of human muscle glycogen phosphorylase a with bound glucose and AMP: An intermediate conformation with T-state and R-state features.,No,1Z8D
ASD01320000_1,PYGM,Homo sapiens,P11217,1Z8D,ASD00030001,AMP,A,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",900,Inner Protein Regulator,Inner Protein,16523484,The crystal structure of human muscle glycogen phosphorylase a with bound glucose and AMP: An intermediate conformation with T-state and R-state features.,No,1Z8D
ASD01320000_2,PYGL,Homo sapiens,P06737,1EM6,ASD01328019,CP4,A,Lig,Inhibitor,5-chloro-N-[2-[2-[2-[(5-chloro-1H-indol-2-yl)carbonylamino]ethoxy]ethoxy]ethyl]-1H-indole-2-carboxamide,862,Inner Protein Regulator,Inner Protein,10980448,Human liver glycogen phosphorylase inhibitors bind at a new allosteric site.,No,1EM6
ASD01320000_2,PYGL,Homo sapiens,P06737,1EXV,ASD01320120,700,A,Lig,Inhibitor,1-[(2S)-2-[(5-chloro-1H-indol-2-yl)carbonylamino]-3-phenyl-propanoyl]azetidine-3-carboxylic acid,862,Inner Protein Regulator,Inner Protein,10980448,Human liver glycogen phosphorylase inhibitors bind at a new allosteric site.,No,1EXV
ASD01320000_2,PYGL,Homo sapiens,P06737,1EXV,ASD01320124,MPD,A,Lig,Inhibitor,"(4S)-2-methylpentane-2,4-diol",1901,Inner Protein Regulator,Inner Protein,10980448,Human liver glycogen phosphorylase inhibitors bind at a new allosteric site.,No,1EXV
ASD01320000_2,PYGL,Homo sapiens,P06737,1L5Q,ASD01320120,700,A,Lig,Inhibitor,1-[(2S)-2-[(5-chloro-1H-indol-2-yl)carbonylamino]-3-phenyl-propanoyl]azetidine-3-carboxylic acid,862,Inner Protein Regulator,Inner Protein,12204691,Structure-activity analysis of the purine binding  site of human liver glycogen phosphorylase.,No,1L5Q
ASD01320000_2,PYGL,Homo sapiens,P06737,1L5Q,ASD01320044,CFF,A,Lig,Inhibitor,"1,3,7-trimethylpurine-2,6-dione",863,Inner Protein Regulator,Inner Protein,12204691,Structure-activity analysis of the purine binding  site of human liver glycogen phosphorylase.,No,1L5Q
ASD01320000_2,PYGL,Homo sapiens,P06737,1L5R,ASD01320120,700,A,Lig,Inhibitor,1-[(2S)-2-[(5-chloro-1H-indol-2-yl)carbonylamino]-3-phenyl-propanoyl]azetidine-3-carboxylic acid,862,Inner Protein Regulator,Inner Protein,12204691,Structure-activity analysis of the purine binding  site of human liver glycogen phosphorylase.,No,1L5R
ASD01320000_2,PYGL,Homo sapiens,P06737,1L5R,ASD01320121,RBF,A,Lig,Inhibitor,"7,8-dimethyl-10-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]benzo[g]pteridine-2,4-dione",859,Inner Protein Regulator,Inner Protein,12204691,Structure-activity analysis of the purine binding  site of human liver glycogen phosphorylase.,No,1L5R
ASD01320000_2,PYGL,Homo sapiens,P06737,1L5S,ASD01320120,700,A,Lig,Inhibitor,1-[(2S)-2-[(5-chloro-1H-indol-2-yl)carbonylamino]-3-phenyl-propanoyl]azetidine-3-carboxylic acid,862,Inner Protein Regulator,Inner Protein,12204691,Structure-activity analysis of the purine binding  site of human liver glycogen phosphorylase.,No,1L5S
ASD01320000_2,PYGL,Homo sapiens,P06737,1L5S,ASD01320128,URC,A,Lig,Inhibitor,"7,9-dihydro-3H-purine-2,6,8-trione",863,Inner Protein Regulator,Inner Protein,12204691,Structure-activity analysis of the purine binding  site of human liver glycogen phosphorylase.,No,1L5S
ASD01320000_2,PYGL,Homo sapiens,P06737,1L7X,ASD01320120,700,A,Lig,Inhibitor,1-[(2S)-2-[(5-chloro-1H-indol-2-yl)carbonylamino]-3-phenyl-propanoyl]azetidine-3-carboxylic acid,862,Inner Protein Regulator,Inner Protein,12204691,Structure-activity analysis of the purine binding  site of human liver glycogen phosphorylase.,No,1L7X
ASD01320000_2,PYGL,Homo sapiens,P06737,1L7X,ASD01320044,CFF,A,Lig,Inhibitor,"1,3,7-trimethylpurine-2,6-dione",863,Inner Protein Regulator,Inner Protein,12204691,Structure-activity analysis of the purine binding  site of human liver glycogen phosphorylase.,No,1L7X
ASD01320000_2,PYGL,Homo sapiens,P06737,1XOI,ASD01328015,288,A,Lig,Inhibitor,5-chloro-N-[2-(cyclopentyl-(2-hydroxyethyl)amino)-2-hydroxy-ethyl]-1H-indole-2-carboxamide,862,Inner Protein Regulator,Inner Protein,15603973,"5-Chloroindoloyl glycine amide inhibitors of glycogen phosphorylase: synthesis, in vitro, in vivo, and X-ray crystallographic characterization.",No,1XOI
ASD01320000_2,PYGL,Homo sapiens,P06737,2ATI,ASD01328020,IHU,A,Lig,Inhibitor,2-chloro-4-fluoro-N-[(5-hydroxy-2-methoxy-phenyl)carbamoyl]benzamide,848,Inner Protein Regulator,Inner Protein,16190745,Acyl ureas as human liver glycogen phosphorylase inhibitors for the treatment of type 2 diabetes.,No,2ATI
ASD01320000_2,PYGL,Homo sapiens,P06737,2ZB2,ASD01320154,A46,A,Lig,Inhibitor,"5-chloro-N-[4-[(1R)-1,2-dihydroxyethyl]phenyl]-1H-indole-2-carboxamide",850,Inner Protein Regulator,Inner Protein,18434170,Synthesis of 5-chloro-N-aryl-1H-indole-2-carboxamide derivatives as inhibitors of human liver glycogen phosphorylase a.,No,2ZB2
ASD01320000_2,PYGL,Homo sapiens,P06737,2ZB2,ASD01320155,MES,A,Lig,Inhibitor,2-morpholin-4-ium-4-ylethanesulfonate,848,Inner Protein Regulator,Inner Protein,18434170,Synthesis of 5-chloro-N-aryl-1H-indole-2-carboxamide derivatives as inhibitors of human liver glycogen phosphorylase a.,No,2ZB2
ASD01320000_2,PYGL,Homo sapiens,P06737,3CEH,ASD01320037,AVE,A,Lig,Inhibitor,"4-[(2-chloro-4,5-difluoro-phenyl)carbonylcarbamoylamino]-3-(trifluoromethoxy)benzoic acid",833,Inner Protein Regulator,Inner Protein,18373353,Thermodynamic characterization of allosteric glycogen phosphorylase inhibitors.,No,3CEH
ASD01320000_2,PYGL,Homo sapiens,P06737,3CEJ,ASD01320134,AVF,A,Lig,Inhibitor,"1-[2-[(2-chloro-4,5-difluoro-phenyl)carbonylcarbamoylamino]-4-fluoro-phenyl]piperidine-4-carboxylic acid",833,Inner Protein Regulator,Inner Protein,18373353,Thermodynamic characterization of allosteric glycogen phosphorylase inhibitors.,No,3CEJ
ASD01320000_2,PYGL,Homo sapiens,P06737,3CEM,ASD01320039,AVD,A,Lig,Inhibitor,"1-(2-carboxyphenyl)-7-chloro-6-[(2-chloro-4,6-difluoro-phenyl)amino]-4-oxo-quinoline-3-carboxylic acid",833,Inner Protein Regulator,Inner Protein,18373353,Thermodynamic characterization of allosteric glycogen phosphorylase inhibitors.,No,3CEM
ASD01320000_2,PYGL,Homo sapiens,P06737,3DD1,ASD01320136,25D,A,Lig,Inhibitor,"(2S)-2-cyclohexyl-2-[[3-[(2,4,6-trimethylphenyl)carbamoylamino]naphthalen-2-yl]carbonylamino]propanoic acid",905,Inner Protein Regulator,Inner Protein,19138846,"Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy.",No,3DD1
ASD01320000_2,PYGL,Homo sapiens,P06737,3DD1,ASD01320044,CFF,A,Lig,Inhibitor,"1,3,7-trimethylpurine-2,6-dione",903,Inner Protein Regulator,Inner Protein,19138846,"Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy.",No,3DD1
ASD01320000_2,PYGL,Homo sapiens,P06737,3DDS,ASD01320118,26B,A,Lig,Inhibitor,"(2S,3R)-3-[(2-methylpropan-2-yl)oxy]-2-[[3-[(2,4,6-trimethylphenyl)carbamoylamino]naphthalen-2-yl]carbonylamino]butanoic acid",905,Inner Protein Regulator,Inner Protein,19138846,"Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy.",No,3DDS
ASD01320000_2,PYGL,Homo sapiens,P06737,3DDS,ASD01320044,CFF,A,Lig,Inhibitor,"1,3,7-trimethylpurine-2,6-dione",904,Inner Protein Regulator,Inner Protein,19138846,"Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy.",No,3DDS
ASD01320000_2,PYGL,Homo sapiens,P06737,3DDW,ASD01320138,55,A,Lig,Inhibitor,(2S)-2-[[3-[(2-chloro-6-methyl-phenyl)carbamoylamino]naphthalen-2-yl]carbonylamino]-2-phenyl-ethanoic acid,905,Inner Protein Regulator,Inner Protein,19138846,"Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy.",No,3DDW
ASD01320000_2,PYGL,Homo sapiens,P06737,3DDW,ASD01320044,CFF,A,Lig,Inhibitor,"1,3,7-trimethylpurine-2,6-dione",903,Inner Protein Regulator,Inner Protein,19138846,"Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy.",No,3DDW
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1ABB,ASD01320076,IMP,A,Lig,Activator,"[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate",920,Inner Protein Regulator,Inner Protein,1304390,Control of phosphorylase b conformation by a modified cofactor: crystallographic studies on R-state glycogen phosphorylase reconstituted with pyridoxal 5'-diphosphate.,No,"Chain A:TRP67,GLN71,GLN72,TYR75,GLU76,ARG242,ARG309,ARG310,LYS315; Chain B:ASP42,ASN44,VAL45"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1B4D,ASD01320076,IMP,A,Lig,Activator,"[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate",930,Inner Protein Regulator,Inner Protein,10211820,Effects of commonly used cryoprotectants on glycogen phosphorylase activity and structure.,No,"Chain A:GLN72,TYR75,ARG309,ARG310"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1C50,ASD01320079,CHI,A,Lig,Inhibitor,5-chloro-N-[(2S)-3-(4-fluorophenyl)-1-(4-hydroxypiperidin-1-yl)-1-oxo-propan-2-yl]-1H-indole-2-carboxamide,920,Inner Protein Regulator,Inner Protein,10873856,A new allosteric site in glycogen phosphorylase b as a target for drug interactions.,No,"Chain A:ARG60,VAL64,TRP67,PRO188,TRP189,GLU190,LYS191,ALA192,PRO229"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1C8K,ASD01320080,CPB,A,Lig,Inhibitor,"2-(2-chlorophenyl)-5,7-dihydroxy-8-[(1S,3S,4R)-3-hydroxy-1-methyl-piperidin-4-yl]chromen-4-one",940,Inner Protein Regulator,Inner Protein,10924512,Flavopiridol inhibits glycogen phosphorylase by binding at the inhibitor site.,No,"Chain A:ASN282,ASN284,PHE285,ILE380,GLU382,HIS571,GLU572,ALA610,GLY612,TYR613,ARG770"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1C8L,ASD01320023,BIN,A,Lig,Inhibitor,"4-(2-chlorophenyl)-1-ethyl-6-methyl-5-propan-2-yloxycarbonyl-pyridin-1-ium-2,3-dicarboxylic acid",930,Inner Protein Regulator,Inner Protein,11368311,Structural basis of the synergistic inhibition of glycogen phosphorylase a by caffeine and a potential antidiabetic drug.,No,"Chain A:TRP67,ILE68,GLN71,GLN72,TYR75,ARG193,GLU195,PHE196,ASP227,ARG242,ARG309,ARG310"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1C8L,ASD01320044,CFF,A,Lig,Inhibitor,"1,3,7-trimethylpurine-2,6-dione",940,Inner Protein Regulator,Inner Protein,11368311,Structural basis of the synergistic inhibition of glycogen phosphorylase a by caffeine and a potential antidiabetic drug.,No,"Chain A:ASN282,ASP283,ASN284,PHE285,HIS571,ALA610,GLY612,TYR613"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1E1Y,ASD01320080,CPB,A,Lig,Inhibitor,"2-(2-chlorophenyl)-5,7-dihydroxy-8-[(1S,3S,4R)-3-hydroxy-1-methyl-piperidin-4-yl]chromen-4-one",940,Inner Protein Regulator,Inner Protein,10924512,Flavopiridol Inhibits Glycogen Phosphorylase by Binding at the Inhibitor Site,No,"Chain A:ASN284,PHE285,LEU380,GLU382,GLU572,ALA610,GLY612,TYR613,ARG770,PHE771"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1FTQ,ASD01320076,IMP,A,Lig,Activator,"[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate",930,Inner Protein Regulator,Inner Protein,16222658,Kinetic and crystallographic studies of glucopyranose spirohydantoin and glucopyranosylamine analogs inhibitors of glycogen phosphorylase.,No,"Chain A:GLN71,GLN72,TYR75,ARG309,ARG310"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1GFZ,ASD01320076,IMP,A,Lig,Activator,"[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate",930,Inner Protein Regulator,Inner Protein,10924512,Flavopiridol inhibits glycogen phosphorylase by binding at the inhibitor site.,No,"Chain A:GLN71,GLN72,TYR75,ARG309,ARG310"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1GFZ,ASD01320044,CFF,A,Lig,Inhibitor,"1,3,7-trimethylpurine-2,6-dione",940,Inner Protein Regulator,Inner Protein,10924512,Flavopiridol inhibits glycogen phosphorylase by binding at the inhibitor site.,No,"Chain A:ASN282,PHE285,HIS571,ALA610,GLY612,TYR613"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1GG8,ASD01320076,IMP,A,Lig,Activator,"[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate",930,Inner Protein Regulator,Inner Protein,8180201,Design of inhibitors of glycogen phosphorylase: a study of alpha- and beta-C-glucosides and 1-thio-beta-D-glucose compounds.,No,"Chain A:GLN71,GLN72,TYR75,ARG309,ARG310"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1GPY,ASD00360002,G6P,A,Lig,Inhibitor,"[(2R,3S,4S,5R,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl dihydrogen phosphate",998,Inner Protein Regulator,Inner Protein,8331662,Crystallographic binding studies on the allosteric inhibitor glucose-6-phosphate to T state glycogen phosphorylase b.,No,"Chain A:TRP67,ILE68,GLN71,ARG193,PHE196,ASP227,THR240,ARG242,ARG309,ARG310"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1H5U,ASD01320079,CHI,A,Lig,Inhibitor,5-chloro-N-[(2S)-3-(4-fluorophenyl)-1-(4-hydroxypiperidin-1-yl)-1-oxo-propan-2-yl]-1H-indole-2-carboxamide,920,Inner Protein Regulator,Inner Protein,11886794,"The 1.76 A Resolution Crystal Structure of Glycogen Phosphorylase B Complexed with Glucose, and Cp320626, a Potential Antidiabetic Drug",No,"Chain A:ARG60,LEU63,VAL64,TRP67,PRO188,TRP189,GLU190,LYS191,ALA192,PRO229"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1K06,ASD01328029,BZD,A,Lig,Inhibitor,"N-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]carbamoyl]benzamide",920,Inner Protein Regulator,Inner Protein,11895439,Binding of N-acetyl-N '-beta-D-glucopyranosyl urea and N-benzoyl-N '-beta-D-glucopyranosyl urea to glycogen phosphorylase b: kinetic and crystallographic studies.,No,"Chain A:ARG60,VAL64,TRP67,PRO188,TRP189,GLU190,LYS191,PRO229"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1K08,ASD01328029,BZD,A,Lig,Inhibitor,"N-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]carbamoyl]benzamide",920,Inner Protein Regulator,Inner Protein,11895439,Binding of N-acetyl-N '-beta-D-glucopyranosyl urea and N-benzoyl-N '-beta-D-glucopyranosyl urea to glycogen phosphorylase b: kinetic and crystallographic studies.,No,"Chain A:ARG60,VAL64,TRP67,PRO188,TRP189,GLU190,LYS191,PRO229"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1LWO,ASD01320079,CHI,A,Lig,Inhibitor,5-chloro-N-[(2S)-3-(4-fluorophenyl)-1-(4-hydroxypiperidin-1-yl)-1-oxo-propan-2-yl]-1H-indole-2-carboxamide,920,Inner Protein Regulator,Inner Protein,12686153,Crystal structure of rabbit muscle glycogen phosphorylase a in complex with a potential hypoglycaemic drug at 2.0 A resolution,No,"Chain A:ARG60,LEU63,VAL64,TRP67,PRO188,TRP189,GLU190,LYS191,ALA192,PRO229"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1PYG,ASD00030001,AMP,A,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",843,Inner Protein Regulator,Inner Protein,1962195,Structural basis for the activation of glycogen phosphorylase b by adenosine monophosphate.,No,"Chain A:TRP67,GLN71,GLN72,TYR75,ARG309,ARG310,LYS315,PHE316,GLY317,CYS318; Chain B:ASP42,ASN44,VAL45"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1UZU,ASD01320152,INR,A,Lig,Inhibitor,(3Z)-2-oxo-3-(3-oxo-1H-indol-2-ylidene)-1H-indole-5-sulfonic acid,1000,Inner Protein Regulator,Inner Protein,15153119,Binding of the Potential Antitumour Agent Indirubin-5-Sulphonate at the Inhibitor Site of Rabbit Muscle Glycogen Phosphorylase B. Comparison with Ligand Binding to Pcdk2-Cyclin a Complex.,No,"Chain A:ASN282,PHE285,GLU287,GLU382,GLU572,ALA610,GLY612,TYR613"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1WUT,ASD01328025,BN2,A,Lig,Inhibitor,"7-[2,6-dichloro-4-[(2-chlorophenyl)carbonylcarbamoylamino]phenoxy]heptanoic acid",930,Inner Protein Regulator,Inner Protein,15987904,"Crystallographic studies on acyl ureas, a new class of glycogen phosphorylase inhibitors, as potential antidiabetic drugs",No,"Chain A:TRP67,ILE68,GLN71,GLN72,TYR75,LYS191,ARG193"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1WUY,ASD01328026,BN3,A,Lig,Inhibitor,"4-[3-chloro-4-[(2,4-dichlorophenyl)carbonylcarbamoylamino]phenoxy]butanoic acid",930,Inner Protein Regulator,Inner Protein,15987904,"Crystallographic studies on acyl ureas, a new class of glycogen phosphorylase inhibitors, as potential antidiabetic drugs",No,"Chain A:TRP67,ILE68,GLN71,GLN72,TYR75,LYS191,ARG193"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1WV0,ASD01328027,BN4,A,Lig,Inhibitor,"4-[4-[(2,4-dichlorophenyl)carbonylcarbamoylamino]-2,3-dimethyl-phenoxy]butanoic acid",930,Inner Protein Regulator,Inner Protein,15987904,"Crystallographic studies on acyl ureas, a new class of glycogen phosphorylase inhibitors, as potential antidiabetic drugs",No,"Chain A:TRP67,ILE68,GLN71,GLN72,TYR75,LYS191,ARG193"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1WV1,ASD01320090,BN5,A,Lig,Inhibitor,"5-[3-[(2,4-dichlorophenyl)carbonylcarbamoylamino]-2-methyl-phenoxy]pentanoic acid",930,Inner Protein Regulator,Inner Protein,15987904,"Crystallographic studies on acyl ureas, a new class of glycogen phosphorylase inhibitors, as potential antidiabetic drugs",No,"Chain A:TRP67,ILE68,GLN71,GLN72,TYR75,LYS191,ARG193"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1XKX,ASD01320112,IMK,A,Lig,Inhibitor,"(2R,3S,4R,5R,6S)-2-(hydroxymethyl)-6-(5-methyl-1H-benzimidazol-2-yl)oxane-3,4,5-triol",920,Inner Protein Regulator,Inner Protein,15741340,"Kinetic and crystallographic studies on 2-(beta-D-glucopyranosyl)-5-methyl-1, 3, 4-oxadiazole, -benzothiazole, and -benzimidazole, inhibitors of muscle glycogen phosphorylase b. Evidence for a new binding site",No,"Chain A:ARG60,VAL64,TRP67,PRO188,TRP189,GLU190,LYS191"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1Z62,ASD01320116;ASD01320116,IAA;IAA,A;A,Lig;Lig,Inhibitor,2-[[(2Z)-2-(2-oxo-7H-indol-3-ylidene)-7H-indol-3-ylidene]amino]oxyethanoic acid,990;991,Inner Protein Regulator,Inner Protein,,Indirubin-3'-Aminooxy-Acetate Inhibits Glycogen Phosphorylase by Binding at the Inhibitor and the Allosteric Site. Broad Specificities of the Two Sites,No,"Chain A:TRP67,ILE68,GLN71,GLN72,TYR75,ARG193,PHE196,ARG242,ASP306,ARG309,ARG310"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1Z62,ASD01320116,IAA,A,Lig,Inhibitor,2-[[(2Z)-2-(2-oxo-7H-indol-3-ylidene)-7H-indol-3-ylidene]amino]oxyethanoic acid,992,Inner Protein Regulator,Inner Protein,,Indirubin-3'-Aminooxy-Acetate Inhibits Glycogen Phosphorylase by Binding at the Inhibitor and the Allosteric Site. Broad Specificities of the Two Sites,No,"Chain A:ASN282,PHE285,GLU382,GLU572,ALA610,GLY612,TYR613,ARG770"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1Z6P,ASD01320091,194,A,Lig,Inhibitor,4-[2-[(3-nitrophenyl)carbonylamino]phenoxy]phthalic acid,843,Inner Protein Regulator,Inner Protein,15214781,"Identification, synthesis and chracterization of new glycogen phosphorylase inhibitors binding to the allosteric AMP site",No,"Chain A:TRP67,ILE68,GLN71,GLN72,TYR75,ARG81,TYR155,LYS191,ARG193,ARG309,ARG310"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,1Z6Q,ASD01320092,195,A,Lig,Inhibitor,"4-[2,4-bis[(3-nitrophenyl)carbonylamino]phenoxy]phthalic acid",843,Inner Protein Regulator,Inner Protein,15214781,"Identification, synthesis and chracterization of new glycogen phosphorylase inhibitors binding to the allosteric AMP site",No,"Chain A:TRP67,ILE68,GLN71,GLN72,TYR75,GLU76,ARG81,TYR155,LYS191,ARG193,ARG309,ARG310"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,2AMV,ASD01320023,BIN,A,Lig,Inhibitor,"4-(2-chlorophenyl)-1-ethyl-6-methyl-5-propan-2-yloxycarbonyl-pyridin-1-ium-2,3-dicarboxylic acid",930,Inner Protein Regulator,Inner Protein,9384557,"The structure of glycogen phosphorylase b with an alkyldihydropyridine-dicarboxylic acid compound, a novel and potent inhibitor.",No,"Chain A:TRP67,ILE68,GLN71,GLN72,TYR75,ARG193,GLU195,PHE196,ASP227,ARG242,ARG309,ARG310"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,2GJ4,ASD01320151,2TH,A,Lig,Inhibitor,"2-chloro-N-[(1R,2R)-1-hydroxy-2,3-dihydro-1H-inden-2-yl]-6H-thieno[3,2-d]pyrrole-5-carboxamide",949,Inner Protein Regulator,Inner Protein,16945526,"Novel thienopyrrole glycogen phosphorylase inhibitors: synthesis, in vitro SAR and crystallographic studies.",No,"Chain A:ARG60,TRP67,PRO188,GLU190,LYS191"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,2GM9,ASD01320148,3TH,A,Lig,Inhibitor,"2-chloro-N-[(3R)-2-oxo-3,4-dihydro-1H-quinolin-3-yl]-6H-thieno[3,2-d]pyrrole-5-carboxamide",1,Inner Protein Regulator,Inner Protein,16945526,"Novel thienopyrrole glycogen phosphorylase inhibitors: synthesis, in vitro SAR and crystallographic studies.",No,"Chain A:ARG60,VAL64,TRP67,TRP189,GLU190,LYS191,PRO229"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,2IEG,ASD01320161,FRY,A,Lig,Inhibitor,"N-[(3S)-1-(2-amino-2-oxo-ethyl)-2-oxo-3,4-dihydroquinolin-3-yl]-2-chloro-2H-thieno[3,2-d]pyrrole-5-carboxamide",901,Inner Protein Regulator,Inner Protein,17095214,"Development of potent, orally active 1-substituted-3,4-dihydro-2-quinolone glycogen phosphorylase inhibitors.",No,"Chain A:ARG60,LEU63,TRP67,PRO188,GLU190,LYS191,ALA192,PRO194,PRO229; Chain B:PHE37,THR38,LEU39,VAL40,PHE53,HIS57,TYR185,GLY186,PRO188"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,2IEI,ASD01320160,FRX,A,Lig,Inhibitor,"2-chloro-N-[(3S)-1-[2-(2-hydroxyethylamino)-2-oxo-ethyl]-2-oxo-3,4-dihydroquinolin-3-yl]-6H-thieno[3,2-d]pyrrole-5-carboxamide",904,Inner Protein Regulator,Inner Protein,17095214,"Development of potent, orally active 1-substituted-3,4-dihydro-2-quinolone glycogen phosphorylase inhibitors.",No,"Chain A:ARG60,LEU63,TRP67,PRO188,GLU190,LYS191,ALA192,MET224; Chain B:THR38,LEU39,VAL40,PHE53,HIS57,ARG184,TYR185,GLY186"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,2OFF,ASD01320095,OFF,A,Lig,Inhibitor,"(2R,3S)-2,3-bis[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy]pentanedioic acid",930,Inner Protein Regulator,Inner Protein,17600143,"FR258900, a potential anti-hyperglycemic drug, binds at the allosteric site of glycogen phosphorylase",No,"Chain A:GLN71,GLN72,TYR75,TYR155,ARG193,PHE196,THR240,ARG242,ARG309,ARG310"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,2PRI,ASD01320103,D6G,A,Lig,Inhibitor,"[(2R,3S,4R,6S)-3,4,6-tris(oxidanyl)oxan-2-yl]methyl dihydrogen phosphate",930,Inner Protein Regulator,Inner Protein,7500360,The binding of 2-deoxy-D-glucose 6-phosphate to glycogen phosphorylase b: kinetic and crystallographic studies.,No,"Chain A:TRP67,ILE68,GLN71,TYR75,ARG193,ASP227,ARG242,ARG309,ARG310"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,2PRJ,ASD01320076,IMP,A,Lig,Activator,"[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate",930,Inner Protein Regulator,Inner Protein,8580837,N-acetyl-beta-D-glucopyranosylamine: a potent T-state inhibitor of glycogen phosphorylase. A comparison with alpha-D-glucose.,No,"Chain A:GLN71,GLN72,TYR75,ARG309,ARG310"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,2QN1,ASD01320096,0AS,A,Lig,Inhibitor,"(1S,2R,4aS,6aR,6aS,6bR,8aR,9R,10R,11R,12aR,14bS)-10,11-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid",930,Inner Protein Regulator,Inner Protein,18517260,"Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: synthesis, structure-activity relationships, and X-ray crystallographic studies",No,"Chain A:ILE68,GLN71,GLN72,TYR75,PHE196,ARG309,ARG310"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,2QN2,ASD01320097,0MA,A,Lig,Inhibitor,"(4aR,6aS,6aR,6bR,8aR,10R,11R,12aR,14bS)-10,11-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,5,6,6a,7,8,8a,10,11,12,13,14b-dodecahydropicene-4a-carboxylic acid",930,Inner Protein Regulator,Inner Protein,18517260,"Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: synthesis, structure-activity relationships, and X-ray crystallographic studies",No,"Chain A:ILE68,GLN71,GLN72,PHE196,ARG242,ARG309,ARG310"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,2QN7,ASD01320076,IMP,A,Lig,Activator,"[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate",930,Inner Protein Regulator,Inner Protein,,"N-(4-substituted-benzoyl)-N'-(beta-D-glucopyranosyl)ureas, inhibitors of glycogen phosphorylase: synthesis, kinetic and crystallographic evaluation",No,"Chain A:GLN71,GLN72,TYR75,ARG309,ARG310"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,2QN8,ASD01320158,NBY,A,Lig,Inhibitor,"4-nitro-N-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]carbamoyl]benzamide",920,Inner Protein Regulator,Inner Protein,,"N-(4-substituted-benzoyl)-N'-(beta-D-glucopyranosyl)ureas, inhibitors of glycogen phosphorylase: synthesis, kinetic and crystallographic evaluation",No,"Chain A:ARG60,LEU63,VAL64,TRP67,PRO188,TRP189,GLU190,LYS191,PRO229"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,2QN9,ASD01320076,IMP,A,Lig,Activator,"[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate",930,Inner Protein Regulator,Inner Protein,,"N-(4-substituted-benzoyl)-N'-(beta-D-glucopyranosyl)ureas, inhibitors of glycogen phosphorylase: synthesis, kinetic and crystallographic evaluation",No,"Chain A:GLN71,GLN72,TYR75,ARG309,ARG310"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,2QNB,ASD01328029,BZD,A,Lig,Inhibitor,"N-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]carbamoyl]benzamide",920,Inner Protein Regulator,Inner Protein,,"N-(4-substituted-benzoyl)-N'-(beta-D-glucopyranosyl)ureas, inhibitors of glycogen phosphorylase: synthesis, kinetic and crystallographic evaluation",No,"Chain A:ARG60,VAL64,TRP67,PRO188,TRP189,GLU190,LYS191,PRO229"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,2SKC,ASD01320076,IMP,A,Lig,Activator,"[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate",930,Inner Protein Regulator,Inner Protein,8976550,"Activator anion binding site in pyridoxal phosphorylase b: the binding of phosphite, phosphate, and fluorophosphate in the crystal.",No,"Chain A:GLN71,GLN72,TYR75,ARG309,ARG310"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,2SKD,ASD01320076,IMP,A,Lig,Activator,"[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate",930,Inner Protein Regulator,Inner Protein,8976550,"Activator anion binding site in pyridoxal phosphorylase b: the binding of phosphite, phosphate, and fluorophosphate in the crystal.",No,"Chain A:GLN71,GLN72,TYR75,ARG309,ARG310"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,2SKE,ASD01320076,IMP,A,Lig,Activator,"[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate",930,Inner Protein Regulator,Inner Protein,8976550,"Activator anion binding site in pyridoxal phosphorylase b: the binding of phosphite, phosphate, and fluorophosphate in the crystal.",No,"Chain A:GLN71,GLN72,TYR75,ARG309,ARG310"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3AMV,ASD01320023,BIN,A,Lig,Inhibitor,"4-(2-chlorophenyl)-1-ethyl-6-methyl-5-propan-2-yloxycarbonyl-pyridin-1-ium-2,3-dicarboxylic acid",930,Inner Protein Regulator,Inner Protein,10548038,"Allosteric inhibition of glycogen phosphorylase a by the potential antidiabetic drug 3-isopropyl 4-(2-chlorophenyl)-1,4-dihydro-1-ethyl-2-methyl-pyridine-3,5,6-tricarbo xylate.",No,"Chain A:TRP67,ILE68,GLN71,GLN72,TYR75,ARG81,ARG193,GLU195,PHE196,ASP227,ARG242,ARG309,ARG310"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3BCR,ASD01320145,AZZ,A,Lig,Inhibitor,"1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione",940,Inner Protein Regulator,Inner Protein,,D-Glucopyranosyl pyrimidine nucleoside binding to muscle glycogen phosphorylase b,No,"Chain A:ASN282,PHE285,ALA610,GLY612,TYR613"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3BCU,ASD01320159,THM,A,Lig,Inhibitor,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione",940,Inner Protein Regulator,Inner Protein,,D-Glucopyranosyl pyrimidine nucleoside binding to muscle glycogen phosphorylase b,No,"Chain A:ASN282,PHE285,ALA610,GLY612,TYR613"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3BD6,ASD01320149,RDD,A,Lig,Inhibitor,"1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazinane-2,4,6-trione",930,Inner Protein Regulator,Inner Protein,,D-Glucopyranosyl pyrimidine nucleoside binding to muscle glycogen phosphorylase b,No,"Chain A:TYR75,ARG242,ARG309,ARG310"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3BD7,ASD01320146,CKB,A,Lig,Inhibitor,"5-methyl-1-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]pyrimidine-2,4-dione",940,Inner Protein Regulator,Inner Protein,,D-Glucopyranosyl pyrimidine nucleoside binding to muscle glycogen phosphorylase b,No,"Chain A:ASN282,PHE285,ALA610,GLY612,TYR613,HIS614"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3BDA,ASD01320147,C4B,A,Lig,Inhibitor,"1-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-1,3,5-triazinane-2,4,6-trione",940,Inner Protein Regulator,Inner Protein,,D-Glucopyranosyl pyrimidine nucleoside binding to muscle glycogen phosphorylase b,No,"Chain A:PHE285,ALA610,GLY612,TYR613,HIS614"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3CUW,ASD01320162,445,A,Lig,Inhibitor,"N-phenyl-N'-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]ethanediamide",920,Inner Protein Regulator,Inner Protein,,"Tracking structure activity relationships of glycogen phosphorylase inhibitors: synthesis, kinetic and crystallographic evaluation of analogues of N-(-D-glucopyranosyl)-N'-oxamides",No,"Chain A:ARG60,VAL64,TRP67,PRO188,TRP189,GLU190,LYS191,PRO229"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3E3N,ASD00030001,AMP,A,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",843,Inner Protein Regulator,Inner Protein,,The crystal structure of the octameric muscle glycogen phosphorylase-AMP complex: insights into enzyme activation,No,"Chain A:TRP67,GLN71,TYR75,ARG309,ARG310,LYS315,PHE316,GLY317,CYS318; Chain B:ASP42,ASN44,VAL45"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3E3O,ASD01320076,IMP,A,Lig,Activator,"[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate",920,Inner Protein Regulator,Inner Protein,,The crystal structure of the octameric muscle glycogen phosphorylase-AMP complex: insights into enzyme activation,No,"Chain A:TRP67,GLN71,GLN72,TYR75,GLU76,ARG242,ARG309,ARG310; Chain B:ASP42,ASN44,VAL45"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3EBO,ASD01328023,57D,A,Lig,Inhibitor,"5,7-dihydroxy-2-phenyl-chromen-4-one",940,Inner Protein Regulator,Inner Protein,,Crystallographic binding studies of flavonoids to glycogen phosphorylase,No,"Chain A:ASN282,ASN284,PHE285,GLU382,HIS571,ALA610,GLY612,TYR613,ARG770"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3EBP,ASD01320080,CPB,A,Lig,Inhibitor,"2-(2-chlorophenyl)-5,7-dihydroxy-8-[(1S,3S,4R)-3-hydroxy-1-methyl-piperidin-4-yl]chromen-4-one",940,Inner Protein Regulator,Inner Protein,,Crystallographic binding studies of flavonoids to glycogen phosphorylase,No,"Chain A:ASN284,PHE285,LEU380,GLU382,HIS571,GLU572,ALA610,GLY612,TYR613,ARG770"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3G2H,ASD01320076,IMP,A,Lig,Activator,"[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate",930,Inner Protein Regulator,Inner Protein,,"Amide-1,2,3-triazole bioisosterism: the glycogen phosphorylase case",No,"Chain A:GLN71,GLN72,TYR75,ARG309,ARG310"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3MQF,ASD01328008,20X,A,Lig,Inhibitor,"1-[(E)-(4-fluorophenyl)methylideneamino]-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]thiourea",920,Inner Protein Regulator,Inner Protein,20947361,The binding of beta-D-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: a new class of inhibitors,No,"Chain A:ARG60,LEU63,VAL64,TRP67,ASN187,PRO188,TRP189,GLU190,LYS191,ALA192,TYR226,PRO229"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3MRT,ASD01328001,12E,A,Lig,Inhibitor,"1-[(E)-pyridin-4-ylmethylideneamino]-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]thiourea",920,Inner Protein Regulator,Inner Protein,20947361,The binding of beta-D-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: a new class of inhibitors,No,"Chain A:ARG60,VAL64,TRP67,ASN187,PRO188,TRP189,GLU190,LYS191,ALA192,TYR226,PRO229"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3MRV,ASD01320114,16F,A,Lig,Inhibitor,"1-[(Z)-(3-hydroxyphenyl)methylideneamino]-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]thiourea",920,Inner Protein Regulator,Inner Protein,20947361,The binding of beta-D-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: a new class of inhibitors,No,"Chain A:ARG60,VAL64,TRP67,ASN187,PRO188,TRP189,GLU190,LYS191,ALA192,TYR226,PRO229"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3MRX,ASD01328004,17S,A,Lig,Inhibitor,"1-[(E)-(4-methoxyphenyl)methylideneamino]-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]thiourea",920,Inner Protein Regulator,Inner Protein,20947361,The binding of beta-D-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: a new class of inhibitors,No,"Chain A:ARG60,LEU63,VAL64,TRP67,ASN187,PRO188,GLU190,LYS191,ALA192,TYR226,PRO229"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3MS2,ASD01320068,18S,A,Lig,Inhibitor,"1-[(E)-(4-methylphenyl)methylideneamino]-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]thiourea",920,Inner Protein Regulator,Inner Protein,20947361,The binding of beta-D-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: a new class of inhibitors,No,"Chain A:ARG60,LEU63,VAL64,TRP67,ASN187,PRO188,TRP189,GLU190,LYS191,ALA192,TYR226,PRO229"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3MS4,ASD01328009,21N,A,Lig,Inhibitor,"1-[(E)-[4-(trifluoromethyl)phenyl]methylideneamino]-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]thiourea",920,Inner Protein Regulator,Inner Protein,20947361,The binding of beta-D-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: a new class of inhibitors,No,"Chain A:ARG60,LEU63,VAL64,TRP67,GLY186,ASN187,PRO188,TRP189,GLU190,LYS191,ALA192,TYR226,PRO229"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3MS7,ASD01328010,22S,A,Lig,Inhibitor,"1-[(E)-(2-chlorophenyl)methylideneamino]-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]thiourea",920,Inner Protein Regulator,Inner Protein,20947361,The binding of beta-D-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: a new class of inhibitors,No,"Chain A:ARG60,VAL64,TRP67,ASN187,PRO188,TRP189,GLU190,LYS191,ALA192,TYR226,PRO229"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3MSC,ASD01320030,24S,A,Lig,Inhibitor,"1-[(Z)-(2-nitrophenyl)methylideneamino]-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]thiourea",844,Inner Protein Regulator,Inner Protein,20947361,The binding of beta-d-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: A new class of inhibitors.,No,"Chain A:ARG60,VAL64,TRP67,PRO188,TRP189,GLU190,LYS191,ALA192,ASP227,PRO229"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3MT7,ASD01328003,16O,A,Lig,Inhibitor,"1-[(E)-(4-bromophenyl)methylideneamino]-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]thiourea",920,Inner Protein Regulator,Inner Protein,20947361,The binding of beta-D-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: a new class of inhibitors,No,"Chain A:ARG60,LEU63,VAL64,TRP67,GLY186,ASN187,PRO188,GLU190,LYS191,ALA192,TYR226,PRO229"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3MT8,ASD01328005,17T,A,Lig,Inhibitor,"1-[(E)-(4-chlorophenyl)methylideneamino]-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]thiourea",920,Inner Protein Regulator,Inner Protein,20947361,The binding of beta-D-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: a new class of inhibitors,No,"Chain A:ARG60,LEU63,VAL64,TRP67,ASN187,PRO188,GLU190,LYS191,ALA192,TYR226,PRO229"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3MT9,ASD01320043,18O,A,Lig,Inhibitor,"1-[(E)-(4-nitrophenyl)methylideneamino]-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]thiourea",920,Inner Protein Regulator,Inner Protein,20947361,The binding of beta-D-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: a new class of inhibitors,No,"Chain A:ARG60,LEU63,VAL64,PRO188,TRP189,GLU190,LYS191,ALA192,TYR226,PRO229"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3MTA,ASD01320048,22O,A,Lig,Inhibitor,"1-[(E)-(3-bromophenyl)methylideneamino]-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]thiourea",920,Inner Protein Regulator,Inner Protein,20947361,The binding of beta-D-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: a new class of inhibitors,No,"Chain A:ARG60,LEU63,VAL64,TRP67,GLY186,ASN187,PRO188,TRP189,GLU190,LYS191,ALA192,TYR226,PRO229"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3MTB,ASD01328011,23V,A,Lig,Inhibitor,"1-[(E)-(3-chlorophenyl)methylideneamino]-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]thiourea",920,Inner Protein Regulator,Inner Protein,20947361,The binding of beta-D-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: a new class of inhibitors,No,"Chain A:ARG60,VAL64,TRP67,ASN187,PRO188,TRP189,GLU190,LYS191,ALA192,TYR226,PRO229"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3MTD,ASD01320075,25E,A,Lig,Inhibitor,"1-[(Z)-(4-hydroxyphenyl)methylideneamino]-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]thiourea",844,Inner Protein Regulator,Inner Protein,20947361,The binding of beta-D-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: a new class of inhibitors,No,"Chain A:HIS57,ARG60,LEU63,VAL64,ASN187,PRO188,TRP189,GLU190,LYS191,ALA192,TYR226,PRO229"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,3NC4,ASD01328014,26O,A,Lig,Inhibitor,"1-[(E)-(2-hydroxyphenyl)methylideneamino]-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]thiourea",920,Inner Protein Regulator,Inner Protein,20947361,The binding of beta-D-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: a new class of inhibitors,No,"Chain A:ARG60,VAL64,TRP67,ASN187,PRO188,TRP189,GLU190,LYS191,ALA192,TYR226,PRO229"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,4MRA,ASD02820003,QUE,A,Lig,Inhibitor,"2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-chromen-4-one",901,Inner Protein Regulator,Inner Protein,24556570,Biochemical and biological assessment of the inhibitory potency of extracts from vinification byproducts of Vitis vinifera extracts against glycogen phosphorylase.,No,"Chain A:GLU121,GLU124,CYS495,LYS544,PHE545,TYR548,ARG551,GLU552,LYS655"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,8GPB,ASD00030001,AMP,A,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",930,Inner Protein Regulator,Inner Protein,1900534,Structural mechanism for glycogen phosphorylase control by phosphorylation and AMP.,No,"Chain A:GLN71,GLN72,TYR75,ARG309,ARG310"
ASD01320000_3,PYGM,Oryctolagus cuniculus,P00489,8GPB,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",940,Inner Protein Regulator,Inner Protein,1900534,Structural mechanism for glycogen phosphorylase control by phosphorylation and AMP.,No,"Chain A:ASN282,ASP283,PHE285,GLU287,PRO611,GLY612,TYR613"
ASD01330000_1,GYS1,Homo sapiens,P13807,7Q12,ASD01330021,G6P,"I,J,K,L",Compound,,"((2R,3S,4S,5R)-3,4,5,6-tetrahydroxytetrahydro-2H-pyran-2-yl)methyl dihydrogen phosphate",,,,35835870,,,7Q12
ASD01360000_1,groL,Escherichia coli,P0A6F5,1PCQ,ASD01720027;ASD01360010,ADP;AF3,A;A,Lig;Ion,Regulator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate;trifluoroalumane",600;602,Inner Protein Regulator,Inner Protein,14517228,"Role of the gamma-phosphate of ATP in triggering protein folding by GroEL-GroES: function, structure and energetics.",No,"Chain A:THR30,LEU31,GLY32,PRO33,LYS51,ASP52,GLY53,ASP87,GLY88,THR89,THR90,THR91,ILE150,ASP398,GLY414,GLY415,ILE454,TYR478,ASN479,ALA480,ALA481,ILE493,ASP495"
ASD01360000_1,groL,Escherichia coli,P0A6F5,1SVT,ASD01720027;ASD01360010,ADP;AF3,A;A,Lig;Ion,Regulator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate;trifluoroalumane",600;602,Inner Protein Regulator,Inner Protein,15313620,Exploring the structural dynamics of the E.coli chaperonin GroEL using translation-libration-screw crystallographic refinement of intermediate states.,No,"Chain A:THR30,LEU31,GLY32,PRO33,LYS51,ASP52,GLY53,ASP87,GLY88,THR89,THR90,THR91,ILE150,GLY414,GLY415,GLY416,ILE454,TYR478,ASN479,ALA480,ALA481,MET488,ILE493,ASP495"
ASD01360000_1,groL,Escherichia coli,P0A6F5,2C7E,ASD00150001,ATP,A,Lig,Regulator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",551,Inner Protein Regulator,Inner Protein,11779463,ATP-Bound States of Groel Captured by Cryo-Electron Microscopy,No,"Chain A:THR30,LEU31,GLY32,PRO33,GLY53,ASP87,GLY88,THR89,THR90,THR91,GLY414,GLY415,GLY416,ILE454,TYR478,ASN479,ALA480,ALA481,ILE493,ASP495"
ASD01360000_1,groL,Escherichia coli,P0A6F5,4AAQ,ASD00150001,ATP,A,Lig,Regulator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1525,Inner Protein Regulator,Inner Protein,22445172,ATP-Triggered Conformational Changes Delineate Substrate-Binding and -Folding Mechanics of the Groel Chaperonin.,No,"Chain A:LEU31,GLY32,PRO33,ASP52,GLY53,VAL54,ASP87,GLY88,THR89,THR90,THR91,ILE150,GLY414,GLY415,GLY416,ILE454,TYR478,ASN479,ALA480,ALA481,ILE493,ASP495"
ASD01360000_1,groL,Escherichia coli,P0A6F5,4AAR,ASD00150001,ATP,A,Lig,Regulator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1525,Inner Protein Regulator,Inner Protein,22445172,ATP-Triggered Conformational Changes Delineate Substrate-Binding and -Folding Mechanics of the Groel Chaperonin.,No,"Chain A:LEU31,GLY32,PRO33,ASP52,GLY53,VAL54,ASP87,GLY88,THR89,THR90,THR91,ILE150,GLY414,GLY415,GLY416,ILE454,TYR478,ASN479,ALA480,ALA481,ILE493,ASP495"
ASD01360000_1,groL,Escherichia coli,P0A6F5,4AAS,ASD00150001,ATP,A,Lig,Regulator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1527,Inner Protein Regulator,Inner Protein,22445172,ATP-Triggered Conformational Changes Delineate Substrate-Binding and -Folding Mechanics of the Groel Chaperonin.,No,"Chain A:LEU31,ASP52,GLY53,VAL54,ASP87,GLY88,THR89,THR90,THR91,ILE150,SER151,ASN153,GLY414,GLY415,ILE454,TYR478,ASN479,ALA480,ALA481,ILE493,ASP495"
ASD01360000_1,groL,Escherichia coli,P0A6F5,4AAU,ASD00150001,ATP,A,Lig,Regulator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1528,Inner Protein Regulator,Inner Protein,22445172,ATP-Triggered Conformational Changes Delineate Substrate-Binding and -Folding Mechanics of the Groel Chaperonin.,No,"Chain A:LEU31,GLY32,PRO33,GLY53,VAL54,ASP87,GLY88,THR89,THR90,THR91,ILE150,ASN153,GLY414,GLY415,GLY416,ILE454,TYR478,ASN479,ALA480,ALA481,ILE493,ASP495"
ASD01360000_1,groL,Escherichia coli,P0A6F5,4AB2,ASD00150001,ATP,A,Lig,Regulator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1525,Inner Protein Regulator,Inner Protein,22445172,ATP-Triggered Conformational Changes Delineate Substrate-Binding and -Folding Mechanics of the Groel Chaperonin.,No,"Chain A:LEU31,GLY32,PRO33,GLY53,VAL54,ASP87,GLY88,THR89,THR90,THR91,ILE150,SER151,ASN153,SER154,GLY414,GLY415,GLY416,ILE454,ASN479,ALA480,ALA481,ILE493,ASP495"
ASD01360000_1,groL,Escherichia coli,P0A6F5,4AB3,ASD00150001,ATP,A,Lig,Regulator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1527,Inner Protein Regulator,Inner Protein,22445172,ATP-Triggered Conformational Changes Delineate Substrate-Binding and -Folding Mechanics of the Groel Chaperonin.,No,"Chain A:LEU31,ASP52,GLY53,VAL54,ASP87,GLY88,THR89,THR90,THR91,ILE150,SER151,ASN153,GLY414,GLY415,ILE454,ALA480,ASP495"
ASD01360000_1,groEL,Escherichia coli,Q548M1,4PKN,ASD01720027;ASD01360014,ADP;BEF,A;A,Lig;Ion,Regulator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate;trifluoroberyllium",601;602,Inner Protein Regulator,Inner Protein,25136110,"Formation and structures of GroEL:GroES2 chaperonin footballs, the protein-folding functional form.",No,"Chain A:THR30,LEU31,GLY32,PRO33,LYS51,ASP52,GLY53,ASP87,GLY88,THR89,THR90,THR91,ASP398,GLY414,GLY415,ILE454,TYR478,ASN479,ALA480,ALA481,ILE493,ASP495"
ASD01360000_1,groEL,Escherichia coli,Q548M1,4PKO,ASD01720027;ASD01360014,ADP;BEF,A;A,Lig;Ion,Regulator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate;trifluoroberyllium",601;602,Inner Protein Regulator,Inner Protein,25136110,"Formation and structures of GroEL:GroES2 chaperonin footballs, the protein-folding functional form.",No,"Chain A:THR30,LEU31,GLY32,PRO33,LYS51,ASP52,GLY53,GLY86,ASP87,GLY88,THR89,THR90,THR91,ILE150,ASP398,GLY414,GLY415,GLY416,ILE454,TYR478,ASN479,ALA480,ALA481,ILE493,ASP495"
ASD01400000_1,can,Haemophilus influenzae,P45148,3E2A,ASD01400003,BCT,F,Ion,Inhibitor,hydrogen carbonate,232,Inner Protein Regulator,Inner Protein,19459702,Allosteric site variants of Haemophilus influenzae beta-carbonic anhydrase.,No,"Chain F:ARG64,ALA49,LEU60,GLU50,VAL47,VAL62,TRP39,PRO48"
ASD01400000_1,can,Haemophilus influenzae,P45148,3E2W,ASD01400003,BCT,F,Ion,Inhibitor,hydrogen carbonate,231,Inner Protein Regulator,Inner Protein,Not in PubMed,Allosteric site mutants of H. influenzae beta-carbonic anhydrase,No,"Chain D:ARG64; Chain F:PRO48,ALA49,GLU50,ARG64"
ASD01400000_1,can,Haemophilus influenzae,P45148,3E3F,ASD01400003,BCT,B,Ion,Inhibitor,hydrogen carbonate,231,Inner Protein Regulator,Inner Protein,20359198,Evidence for a bicarbonate,No,"Chain B:TRP39,SER45,ARG46,ALA47,ALA49,ARG64"
ASD01400000_1,can,Haemophilus influenzae,P45148,3E3I,ASD01400003,BCT,B,Ion,Inhibitor,hydrogen carbonate,233,Inner Protein Regulator,Inner Protein,20359198,Evidence for a bicarbonate,No,"Chain B:TRP39,ALA41,VAL47,PRO48,ALA49,LEU52,ARG64,TYR181"
ASD01410000_1,,Hepatitis C virus,D0PY27,3PHE,ASD01418010,C9A,A,Lig,Inhibitor,(4-chlorophenyl)methyl 6-fluoro-7-(4-methylpiperazin-1-yl)-1-[(4-methylsulfonylphenyl)methyl]-4-oxo-quinoline-3-carboxylate,999,Inner Protein Regulator,Inner Protein,21145235,Quinolones as HCV NS5B polymerase inhibitors.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,SER478,PRO479,ILE482,ASN483,VAL485,ALA486,LEU489,PRO496,LEU497,TRP528"
ASD01450000_1,HK1,Homo sapiens,P19367,1CZA,ASD00360002,G6P,N,Lig,Activator,"[(2R,3S,4S,5R,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl dihydrogen phosphate",919,Inner Protein Regulator,Inner Protein,10686099,Crystal structures of mutant monomeric hexokinase I reveal multiple ADP binding sites and conformational changes relevant to allosteric regulation.,No,1CZA
ASD01450000_1,HK1,Homo sapiens,P19367,1HKB,ASD00360002,G6P,A,Lig,Activator,"[(2R,3S,4S,5R,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl dihydrogen phosphate",919,Inner Protein Regulator,Inner Protein,9493266,The mechanism of regulation of hexokinase: new insights from the crystal structure of recombinant human brain hexokinase complexed with glucose and glucose-6-phosphate.,No,1HKB
ASD01450000_1,HK1,Homo sapiens,P19367,1QHA,ASD00360002,G6P,A,Lig,Activator,"[(2R,3S,4S,5R,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl dihydrogen phosphate",919,Inner Protein Regulator,Inner Protein,10574795,Binding of non-catalytic ATP to human hexokinase I highlights the structural components for enzyme-membrane association control.,No,1QHA
ASD01470000_1,MET,Human immunodeficiency virus type 1,P08581,4O3T,ASD01470017,Chain P,P;P;P;P;P;P;P;P;P,Pep,Activator,IVGGYPWWM,495;496;497;498;499;500;501;502;503,Inner Protein Regulator,Inner Protein,24859116,An allosteric switch for pro-HGF/Met signaling using zymogen activator peptides.,No,"Chain P:VAL496,TRP501,GLY497,PRO500,TRP502,ILE495,GLY498,MET503,TYR499"
ASD01470000_1,MET,Human immunodeficiency virus type 1,P08581,4O3U,ASD01470059,Chain P,P;P;P;P;P;P;P;P;P;P;P;P;P;P,Pep,Activator,IIGGCPYWMDREEC,495;496;497;498;499;500;501;502;503;504;505;506;507;508,Inner Protein Regulator,Inner Protein,24859116,An allosteric switch for pro-HGF/Met signaling using zymogen activator peptides.,No,Chain B:THR222
ASD01510000_2,dnaK,Escherichia coli,P0A6Y8,4B9Q,ASD00150001,ATP,A,Lig,Inhibitor,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",700,Protein-Protein Interaction Regulator,Inner Protein,23123194,Structure and Dynamics of the ATP-Bound Open Conformation of Hsp70 Chaperones,No,"Chain A:GLY10,THR11,THR12,ASN13,LYS70,GLU171,GLY196,GLY197,GLY198,ALA199,GLY229,GLU267,LYS270,ILE271,SER274,GLY341,GLY342,GLN343,ARG345"
ASD01510000_2,dnaK,Escherichia coli,P0A6Y8,4JN4,ASD00150001,ATP,A,Lig,Inhibitor,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1002,Protein-Protein Interaction Regulator,Inner Protein,23708608,Allosteric opening of the polypeptide-binding site when an Hsp70 binds ATP.,No,"Chain A:GLY10,THR11,THR12,ASN13,LYS70,GLU171,GLY196,GLY197,GLY198,ALA199,GLY229,GLU267,LYS270,ILE271,SER274,GLY341,GLY342,GLN343,ARG345"
ASD01510000_2,dnaK,Escherichia coli,P0A6Y8,4JNE,ASD00150001,ATP,A,Lig,Inhibitor,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1002,Protein-Protein Interaction Regulator,Inner Protein,23708608,Allosteric opening of the polypeptide-binding site when an Hsp70 binds ATP.,No,"Chain A:GLY10,THR11,THR12,ASN13,LYS70,GLU171,GLY196,GLY197,GLY198,ALA199,GLY229,GLU267,LYS270,ILE271,SER274,GLY341,GLY342,GLN343,ARG345"
ASD01510000_2,dnaK,Escherichia coli,P0A6Y8,4R5G,ASD01510131,3JE,,Lig,Inhibitor,triphenyl(phenylethynyl)phosphonium,701,Allosteric function,Allosteric position,25148104,Structural Basis for the Inhibition of HSP70 and DnaK Chaperones by Small-Molecule Targeting of a C-Terminal Allosteric Pocket.,No,"Chain B:ALA503,VAL394,LEU392,ASP393,LEU484,LEU399,ASP481,ILE418,GLN442,SER504,ILE478,PRO396,LEU397,ALA480,THR395,ASP479,GLY482"
ASD01510000_3,HSPA1A,Homo sapiens,P08107,4IO8,ASD01510007,3FD,A,Lig,Inhibitor,"4-[[(2R,3S,4R,5R)-5-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-3,4-dihydroxy-oxolan-2-yl]methoxymethyl]benzonitrile",401,Protein-Protein Interaction Regulator,Inner Protein,24265689,Functional analysis of hsp70 inhibitors.,No,4IO8
ASD01530000_1,SLC6A4,Homo sapiens,P31645,5I73,ASD01530001,68P,A,Lig,Inhibitor,"(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile",701,Allosteric Function,Allosteric Position,27049939,X-ray structures and mechanism of the human serotonin transporter.,No,5I73
ASD01530000_1,SLC6A4,Homo sapiens,P31645,5I75,ASD01530075,69D,A,Lig,Inhibitor,"(1S)-1-(4-bromophenyl)-1-[3-(dimethylamino)propyl]-1,3-dihydro-2-benzofuran-5-carbonitrile",705,Allosteric Function,Allosteric Position,27049939,X-ray structures and mechanism of the human serotonin transporter.,No,5I75
ASD01530000_1,SLC6A4,Homo sapiens,P31645,7LWD,,YG7,A,Lig,Inhibitor,5-{4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl}-1-benzofuran-2-carboxamide,802,,,,,,7LWD
ASD01580000_1,hutP,Bacillus subtilis,P10943,1VEA,ASD01580005,HBN,B,Lig,Activator,N-(2-NAPHTHYL)HISTIDINAMIDE,1001,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,15242603,Crystal structure of activated HutP; an RNA binding protein that regulates transcription of the hut operon in Bacillus subtilis.,No,"Chain B:VAL86,ALA82,HIS84,VAL143,GLY85,GLY142,GLY144,GLU81,ILE145,PHE141,MET80,LEU83"
ASD01580000_1,hutP,Bacillus subtilis,P10943,1WMQ,ASD01580014,HIS,A,Lig,Activator,HISTIDINE,2001,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,15758992,Structural basis of HutP-mediated anti-termination and roles of the Mg2+ ion and L-histidine ligand.,No,"Chain B:GLU81,ILE145"
ASD01580000_1,hutP,Bacillus subtilis,P10943,1WPU,ASD01580014,HIS,A,Lig,Activator,HISTIDINE,2001,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,Not in PubMed,Structural basis for the HutP antitermination Complex:Role of divalent metal ions in allosteric activation,No,"Chain B:GLU81,ILE145"
ASD01580000_1,hutP,Bacillus subtilis,P10943,1WPV,ASD01580014,HIS,A,Lig,Activator,HISTIDINE,1001,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,15758992,Structural basis of HutP-mediated anti-termination and roles of the Mg2+ ion and L-histidine ligand.,No,"Chain C:TYR76,HIS77,SER72,HIS73,TYR69"
ASD01590000_1,IGF1R,Homo sapiens,P08069,3LW0,ASD01590003,CCX,A,Lig,Inhibitor,3-cyano-N-[1-[4-(5-cyano-1H-indol-3-yl)butyl]piperidin-4-yl]-1H-indole-7-carboxamide,1,Inner Protein Regulator,Inner Protein,,Allosteric IGF-1R Inhibitors,No,3LW0
ASD01630000_1,IMPDH2,Homo sapiens,P12268,6I0M,,GDP,A,Lig,Inhibitor,GUANOSINE-5'-DIPHOSPHATE,603,,,30664871,A Nucleotide-Dependent Conformational Switch Controls the Polymerization of Human IMP Dehydrogenases to Modulate their Catalytic Activity.,,6I0M
ASD01630000_1,IMPDH2,Homo sapiens,P12268,6I0M,,GDP,A,Lig,Inhibitor,GUANOSINE-5'-DIPHOSPHATE,604,,,30664871,A Nucleotide-Dependent Conformational Switch Controls the Polymerization of Human IMP Dehydrogenases to Modulate their Catalytic Activity.,,6I0M
ASD01630000_1,IMPDH2,Homo sapiens,P12268,6I0M,,GDP,A,Lig,Inhibitor,GUANOSINE-5'-DIPHOSPHATE,602,,,30664871,A Nucleotide-Dependent Conformational Switch Controls the Polymerization of Human IMP Dehydrogenases to Modulate their Catalytic Activity.,,6I0M
ASD01630000_1,IMPDH2,Homo sapiens,P12268,6I0O,,GTP,A,Lig,Inhibitor,GUANOSINE-5'-TRIPHOSPHATE,601,,,30664871,A Nucleotide-Dependent Conformational Switch Controls the Polymerization of Human IMP Dehydrogenases to Modulate their Catalytic Activity.,,6I0O
ASD01630000_1,IMPDH2,Homo sapiens,P12268,6I0O,,GTP,A,Lig,Inhibitor,GUANOSINE-5'-TRIPHOSPHATE,602,,,30664871,A Nucleotide-Dependent Conformational Switch Controls the Polymerization of Human IMP Dehydrogenases to Modulate their Catalytic Activity.,,6I0O
ASD01630000_1,IMPDH2,Homo sapiens,P12268,6I0O,,GTP,A,Lig,Inhibitor,GUANOSINE-5'-TRIPHOSPHATE,603,,,30664871,A Nucleotide-Dependent Conformational Switch Controls the Polymerization of Human IMP Dehydrogenases to Modulate their Catalytic Activity.,,6I0O
ASD01630000_3,Npr1,Rattus norvegicus,P18910,1DP4,ASD01630003,CL,A,Ion,Activator,CHLORIDE ION,610,Inner Protein Regulator,Inner Protein,10894551,Structure of the dimerized hormone-binding domain of a guanylyl-cyclase-coupled receptor.,No,"Chain A:SER89,LEU9,CYS60,PRO10,GLY85,PRO84,VAL8,SER53,TRP18,CYS86"
ASD01630000_3,Npr1,Rattus norvegicus,P18910,1T34,ASD01630003,CL,A,Ion,Activator,CHLORIDE ION,600,Inner Protein Regulator,Inner Protein,15117952,Crystal structure of hormone-bound atrial natriuretic peptide receptor extracellular domain: rotation mechanism for transmembrane signal transduction,No,"Chain A:SER89,LEU9,CYS60,PRO10,GLY85,PRO84,VAL8,SER53,TRP18,ALA90,CYS86"
ASD01630000_3,Npr1,Rattus norvegicus,P18910,3A3K,ASD01330002,BR,B,Ion,Activator,BROMIDE ION,601,Inner Protein Regulator,Inner Protein,20066666,Reversibly bound chloride in the atrial natriuretic peptide receptor hormone-binding domain: Possible allosteric regulation and a conserved structural motif for the chloride-binding site.,No,"Chain B:LEU9,PRO84,VAL8,TRP18,GLY85,CYS86,SER53,SER89,PRO10,CYS60"
ASD01660000_1,Ide,Rattus norvegicus,P35559,3TUV,ASD00150001,ATP,A,Lig,Activator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1020,Inner Protein Regulator,Inner Protein,22049080,Anion Activation Site of Insulin-degrading Enzyme.,Yes,"Chain A:ARG429,ASP895,LYS896,PRO897,LYS898,LYS899,SER901,ALA902,ALA905"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,1HYV,ASD01670077,TTA,A,Lig,Inhibitor,tetraphenylarsanium,304,Protein-Protein Interaction Regulator,Protein-Protein Interaction,11264582,Identification of a small-molecule binding site at the dimer interface of the HIV integrase catalytic domain.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,THR174"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,3ZCM,ASD01670068,PX3,A,Lig,Inhibitor,"5-[[[2-[(4-methoxyphenyl)methylcarbamoyl]phenyl]methyl-prop-2-enyl-amino]methyl]-1,3-benzodioxole-4-carboxylic acid",1214,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22808106,Small Molecule Inhibitors of the Ledgf Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,ALA98,TYR99,LEU102,THR125,ALA128,ALA129"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,3ZSO,ASD01670069,O2N,A,Lig,Inhibitor,"5-[[[2-[bis(4-methoxyphenyl)methylcarbamoyl]phenyl]methyl-prop-2-enyl-amino]methyl]-1,3-benzodioxole-4-carboxylic acid",1219,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22808106,Small Molecule Inhibitors of the Ledgf Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174; Chain B:GLN95,ALA98,TYR99,LEU102,THR125,ALA128,ALA129,TRP131,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,3ZSQ,ASD01670070,O4N,A,Lig,Inhibitor,"5-[[[2-[[(1S)-1-(4-methoxyphenyl)butyl]carbamoyl]phenyl]methyl-prop-2-enyl-amino]methyl]-1,3-benzodioxole-4-carboxylic acid",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22808106,Small Molecule Inhibitors of the Ledgf Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,ALA98,TYR99,LEU102,THR125,ALA128,ALA129,TRP131"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,3ZSR,ASD01670049,O3N,A,Lig,Inhibitor,"(2S)-2-(2-carboxyethyl)-6-[[[2-(cyclohexylmethylcarbamoyl)phenyl]methyl-prop-2-enyl-amino]methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22808106,Small Molecule Inhibitors of the Ledgf Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,GLU96,TYR99,THR125,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,3ZSV,ASD01670058,ZSV,B,Lig,Inhibitor,"(R)-[(2S)-5-carboxy-2-(2-carboxyethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]methyl-[[2-[(4-methoxyphenyl)methylcarbamoyl]phenyl]methyl]-prop-2-enyl-azanium",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22808106,Small Molecule Inhibitors of the Ledgf Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,GLU96,ALA98,TYR99,LEU102,THR125,ALA128,ALA129"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,3ZSW,ASD01670059,ZSW,A,Lig,Inhibitor,"(R)-[2-[[(2R)-butan-2-yl]carbamoyl]phenyl]methyl-[[(2S)-5-carboxy-2-(2-carboxyethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]methyl]-prop-2-enyl-azanium",1217,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22808106,Small Molecule Inhibitors of the Ledgf Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,GLU96,TYR99,THR125"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,3ZSX,ASD01670074,N44,A,Lig,Inhibitor,"5-[[[2-[(phenylmethyl)carbamoyl]phenyl]methyl-prop-2-enyl-amino]methyl]-1,3-benzodioxole-4-carboxylate",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22808106,Small Molecule Inhibitors of the Ledgf Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,TYR99,THR125,ALA128,ALA129"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,3ZSY,ASD01670075,OM3,A,Lig,Inhibitor,"(R)-(4-carboxy-1,3-benzodioxol-5-yl)methyl-[[2-(cyclohexylmethylcarbamoyl)phenyl]methyl]-methyl-azanium",1214,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22808106,Small Molecule Inhibitors of the Ledgf Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,TYR99,THR125,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,3ZSZ,ASD01670076,OM2,A,Lig,Inhibitor,"(R)-[2-[[(2S)-butan-2-yl]carbamoyl]phenyl]methyl-[(4-carboxy-1,3-benzodioxol-5-yl)methyl]-methyl-azanium",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22808106,Small Molecule Inhibitors of the Ledgf Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,TYR99,THR125,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,3ZT0,ASD01670067,ZT0,A,Lig,Inhibitor,"(4-carboxy-1,3-benzodioxol-5-yl)methyl-[[2-[(4-methoxyphenyl)methylcarbamoyl]phenyl]methyl]-methyl-azanium",1213,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22808106,Small Molecule Inhibitors of the Ledgf Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174; Chain B:GLN95,ALA98,TYR99,THR125,ALA128,ALA129"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,3ZT1,ASD01670007,OM1,A,Lig,Inhibitor,"(4-carboxy-1,3-benzodioxol-5-yl)methyl-[[2-[(4-methoxyphenyl)methylcarbamoyl]phenyl]methyl]azanium",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22808106,Small Molecule Inhibitors of the Ledgf Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,ALA98,TYR99,LEU102,THR125,ALA128,ALA129"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,3ZT2,ASD01670061,ZT2,A,Lig,Inhibitor,"5-[(E)-(2-oxidanylidene-3H-inden-1-ylidene)methyl]-1,3-benzodioxole-4-carboxylic acid",1216,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22808106,Small Molecule Inhibitors of the Ledgf Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design.,No,"Chain A:GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,TYR99,LEU102,THR125,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,3ZT2,ASD01670061,ZT2,A,Lig,Inhibitor,"5-[(E)-(2-oxidanylidene-3H-inden-1-ylidene)methyl]-1,3-benzodioxole-4-carboxylic acid",1217,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22808106,Small Molecule Inhibitors of the Ledgf Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design.,No,"Chain A:TYR83,ASN184,HIS185,ARG187,SER195,GLY197,GLU198,VAL201; Chain B:GLY106,ARG107,TRP108,PRO109,ILE204,ILE208"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,3ZT3,ASD01670063,ZT4,A,Lig,Inhibitor,"5-[(E)-(2-oxidanyl-2,3-dihydroinden-1-ylidene)methyl]-1,3-benzodioxole-4-carboxylic acid",1216,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22808106,Small Molecule Inhibitors of the Ledgf Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design.,No,"Chain A:GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,TYR99,LEU102,THR125,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,3ZT4,ASD01670061,ZT2,A,Lig,Inhibitor,"5-[(E)-(2-oxidanylidene-3H-inden-1-ylidene)methyl]-1,3-benzodioxole-4-carboxylic acid",1216,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22808106,Small Molecule Inhibitors of the Ledgf Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design,No,"Chain A:GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,TYR99,LEU102,THR125,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,3ZT4,ASD01670061,ZT2,A,Lig,Inhibitor,"5-[(E)-(2-oxidanylidene-3H-inden-1-ylidene)methyl]-1,3-benzodioxole-4-carboxylic acid",1217,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22808106,Small Molecule Inhibitors of the Ledgf Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design,No,"Chain A:TYR83,ASN184,HIS185,ARG187,SER195,GLY197,GLU198,VAL201; Chain B:GLY106,ARG107,TRP108,PRO109,LYS111,ILE204,ILE208"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CE9,ASD01670049,O3N,A,Lig,Inhibitor,"(2S)-2-(2-carboxyethyl)-6-[[[2-(cyclohexylmethylcarbamoyl)phenyl]methyl-prop-2-enyl-amino]methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1214,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,GLU96,TYR99,THR125,ALA128,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CEA,ASD01670059,ZSW,A,Lig,Inhibitor,"(R)-[2-[[(2R)-butan-2-yl]carbamoyl]phenyl]methyl-[[(2S)-5-carboxy-2-(2-carboxyethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]methyl]-prop-2-enyl-azanium",1217,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,GLU96,TYR99,THR125"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CEB,ASD01670058,ZSV,B,Lig,Inhibitor,"(R)-[(2S)-5-carboxy-2-(2-carboxyethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]methyl-[[2-[(4-methoxyphenyl)methylcarbamoyl]phenyl]methyl]-prop-2-enyl-azanium",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,GLU96,ALA98,TYR99,LEU102,THR125,ALA128,ALA129"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CEC,ASD01670057,2SS,A,Lig,Inhibitor,"(2S)-6-[[[2-(cyclobutylmethylcarbamoyl)phenyl]methyl-prop-2-enyl-amino]methyl]-2-(3-hydroxy-3-oxopropyl)-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1216,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,GLU96,TYR99,THR125,ALA128,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CED,ASD01670056,9NS,B,Lig,Inhibitor,"(2S)-6-[[[2-(furan-2-ylmethylcarbamoyl)phenyl]methyl-prop-2-enyl-amino]methyl]-2-(3-hydroxy-3-oxopropyl)-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,GLU96,TYR99,LEU102,THR125,ALA128,ALA129"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CEE,ASD01670055,B0T,A,Lig,Inhibitor,"(2S)-6-[[[2-[[(2S)-butan-2-yl]carbamoyl]phenyl]methyl-methyl-amino]methyl]-2-(3-hydroxy-3-oxopropyl)-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,GLU96,TYR99,LEU102,ALA128"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CEF,ASD01670054,D0T,A,Lig,Inhibitor,"(2S)-2-(3-hydroxy-3-oxopropyl)-6-[[methyl-[[2-[(phenylmethyl)carbamoyl]phenyl]methyl]amino]methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,GLU96,TYR99,THR125,ALA128,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CEO,ASD01670053,G0T,A,Lig,Inhibitor,"(2S)-2-(3-hydroxy-3-oxopropyl)-6-[[[2-[(4-methoxyphenyl)methylcarbamoyl]phenyl]methyl-methyl-amino]methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,GLU96,ALA98,TYR99,LEU102,THR125,ALA128,ALA129"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CEQ,ASD01670052,QCH,A,Lig,Inhibitor,"(2S)-6-[[[2-(cyclohexylmethylcarbamoyl)phenyl]methyl-methyl-amino]methyl]-2-(3-hydroxy-3-oxopropyl)-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,GLU96,TYR99,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CER,ASD01670051,VL4,A,Lig,Inhibitor,"(2S)-6-[[[2-(cyclobutylmethylcarbamoyl)phenyl]methyl-methyl-amino]methyl]-2-(3-hydroxy-3-oxopropyl)-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,GLU96,TYR99,LEU102,ALA128,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CES,ASD01670050,NFW,A,Lig,Inhibitor,"(2S)-6-[[[2-(furan-2-ylmethylcarbamoyl)phenyl]methyl-methyl-amino]methyl]-2-(3-hydroxy-3-oxopropyl)-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,GLU96,TYR99,LEU102,THR125,ALA128,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CEZ,ASD01670049,O3N,A,Lig,Inhibitor,"(2S)-2-(2-carboxyethyl)-6-[[[2-(cyclohexylmethylcarbamoyl)phenyl]methyl-prop-2-enyl-amino]methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,GLU96,TYR99,THR125,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CF0,ASD01670048,O5U,A,Lig,Inhibitor,"(2R)-6-[[(1R,2S)-2-(6-azanylhexanoylamino)-2,3-dihydro-1H-inden-1-yl]methyl]-2-(3-hydroxy-3-oxopropyl)-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1213,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,GLU96,TYR99,LEU102,THR125,ALA128,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CF1,ASD01670047,IY7,A,Lig,Inhibitor,"(2S)-6-[[(1R,2S)-2-(5-azanylpentanoylamino)-2,3-dihydro-1H-inden-1-yl]methyl]-2-(3-hydroxy-3-oxopropyl)-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,GLU96,TYR99,LEU102,THR125,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CF2,ASD01670046,3GM,A,Lig,Inhibitor,"(2S)-6-[[(1R,2S)-2-(4-azanylbutanoylamino)-2,3-dihydro-1H-inden-1-yl]methyl]-2-(3-hydroxy-3-oxopropyl)-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1213,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,GLU96,TYR99,LEU102,THR125,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CF8,ASD01670045,V7H,A,Lig,Inhibitor,"(2S)-2-(3-hydroxy-3-oxopropyl)-6-[[[2-[(phenylmethyl)carbamoyl]phenyl]methylamino]methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1217,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,GLU96,TYR99,THR125,ALA128,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CF9,ASD01670044,5EY,A,Lig,Inhibitor,"(3R)-3-(3-hydroxy-3-oxopropyl)-6-[(E)-[(2R)-2-oxidanyl-2,3-dihydroinden-1-ylidene]methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1214,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,TYR99,LEU102,THR125,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CFA,ASD01670043,WOP,A,Lig,Inhibitor,"5-[[methyl-[[(1S)-2-oxidanylidene-1-phenyl-2-[(phenylmethyl)amino]ethyl]carbamoyl]amino]methyl]-1,3-benzodioxole-4-carboxylic acid",1214,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ARG166,ASP167,GLN168,ALA169,GLU170,HIS171,THR174; Chain B:GLN95,ALA98,THR125,ALA128,ALA129"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CFB,ASD01670075,OM3,A,Lig,Inhibitor,"(R)-(4-carboxy-1,3-benzodioxol-5-yl)methyl-[[2-(cyclohexylmethylcarbamoyl)phenyl]methyl]-methyl-azanium",1217,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,TYR99,THR125,ALA128,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CFC,ASD01670041,7NV,A,Lig,Inhibitor,"5-[[[(1S)-2-(butylamino)-2-oxidanylidene-1-phenyl-ethyl]carbamoyl-methyl-amino]methyl]-1,3-benzodioxole-4-carboxylic acid",1216,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174; Chain B:GLN95,ALA98,TYR99,THR125,ALA128,ALA129"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CFD,ASD01670040,S8Y,A,Lig,Inhibitor,"5-[[[(1R)-2-(tert-butylamino)-2-oxidanylidene-1-phenyl-ethyl]carbamoyl-methyl-amino]methyl]-1,3-benzodioxole-4-carboxylic acid",1217,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174; Chain B:GLN95,ALA98,TYR99,THR125,ALA128,ALA129"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CGD,ASD01670039,8P3,A,Lig,Inhibitor,2-[(2-oxidanylidene-3H-indol-1-yl)methyl]benzoic acid,1216,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ALA169,GLU170,HIS171,THR174; Chain B:GLN95,LEU102,THR125,ALA128,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CGF,ASD01670038,UJ6,A,Lig,Inhibitor,"5-[[(3S)-2-oxidanylidene-1,3-dihydroindol-3-yl]methyl]-1,3-benzodioxole-4-carboxylic acid",1216,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,TYR99,LEU102,THR125,ALA128,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CGG,ASD01670037,K5Q,B,Lig,Inhibitor,"(2S)-6-[(E)-[(2E)-2-hydroxyimino-3H-inden-1-ylidene]methyl]-2-(3-hydroxy-3-oxopropyl)-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1218,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:GLN168,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,GLU96,TYR99,LEU102,THR125,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CGH,ASD01670036,LOZ,A,Lig,Inhibitor,"5-[[(1S,2R)-2-(4-azanylbutanoylamino)-2,3-dihydro-1H-inden-1-yl]methyl]-1,3-benzodioxole-4-carboxylic acid",1216,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,TYR99,LEU102,THR125,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CGI,ASD01670034,NZL,A,Lig,Inhibitor,"5-[[(1S,2S)-2-(6-azanylhexanoylamino)-2,3-dihydro-1H-inden-1-yl]methyl]-1,3-benzodioxole-4-carboxylic acid",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,TYR99,LEU102,THR125,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CGJ,ASD01670034,NZL,A,Lig,Inhibitor,"5-[[(1S,2S)-2-(6-azanylhexanoylamino)-2,3-dihydro-1H-inden-1-yl]methyl]-1,3-benzodioxole-4-carboxylic acid",1216,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,TYR99,LEU102,THR125,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CHN,ASD01670033,ONZ,A,Lig,Inhibitor,"2-(1,3-benzodioxol-4-ylcarbonylamino)ethanoic acid",1217,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:TYR83,ASN184,HIS185,ARG187,SER195,GLY197,GLU198,VAL201; Chain B:GLY106,ARG107,TRP108,PRO109,ILE208"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CHO,ASD01670032,U2Z,B,Lig,Inhibitor,[1-[2-(aminomethyl)phenyl]-5-methyl-pyrazol-3-yl]methanol,1218,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:GLN168,THR174,MET178; Chain B:GLN95,ALA98,TYR99,LEU102,ALA128,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CHP,ASD01670030,IMV,A,Lig,Inhibitor,"5-[(2-oxo-3H-indol-1-yl)methyl]-1,3-benzodioxole-4-carboxylic acid",1216,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,TYR99,LEU102,THR125,ALA128,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CHP,ASD01670030,IMV,A,Lig,Inhibitor,"5-[(2-oxo-3H-indol-1-yl)methyl]-1,3-benzodioxole-4-carboxylic acid",1217,Inner Protein Regulator,Inner Protein,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,Yes,"Chain A:VAL77,VAL79,GLY82,ILE84,VAL150,MET154,GLU157,LEU158,HIS183"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CHQ,ASD01670029,CWU,A,Lig,Inhibitor,"5-[[(1S,2R)-2-oxidanyl-2,3-dihydro-1H-inden-1-yl]methyl]-1,3-benzodioxole-4-carboxylic acid",1217,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,TYR99,LEU102,THR125,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CHY,ASD01670028,C5Q,B,Lig,Inhibitor,"5-(1H-indol-3-ylmethyl)-1,3-benzodioxole-4-carboxylic acid",1214,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:GLN168,THR174,MET178; Chain B:GLN95,ALA98,TYR99,LEU102,THR125,ALA128,ALA129,TRP131,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CHZ,ASD01670027,H75,A,Lig,Inhibitor,"2-(4-bromophenyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-3-one",1220,Inner Protein Regulator,Inner Protein,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,Yes,"Chain A:VAL77,VAL79,GLY82,ILE84,VAL150,MET154,GLU157,LEU158,HIS183"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CIE,ASD01670026,Y7N,A,Lig,Inhibitor,"5-[(E)-[(2S)-2-(6-azanylhexanoylamino)-2,3-dihydroinden-1-ylidene]methyl]-1,3-benzodioxole-4-carboxylic acid",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,TYR99,LEU102,THR125,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CIF,ASD01670025,JDX,A,Lig,Inhibitor,2-methoxy-6-[[[2-[(4-methoxyphenyl)methylcarbamoyl]phenyl]methyl-methyl-amino]methyl]benzoic acid,1216,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,ALA98,LEU102,THR125,ALA128,ALA129"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CIG,ASD01670024,X0P,A,Lig,Inhibitor,2-methoxy-6-[[[3-[(4-methoxyphenyl)methylcarbamoyl]naphthalen-2-yl]methyl-methyl-amino]methyl]benzoic acid,1217,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,ALA98,LEU102,THR125,ALA128,ALA129"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CJ3,ASD01670023,E4F,A,Lig,Inhibitor,"5-[[(1R,2S)-2-(5-azanylpentanoylamino)-2,3-dihydro-1H-inden-1-yl]methyl]-1,3-benzodioxole-4-carboxylic acid",1214,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,TYR99,LEU102,THR125,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CJ4,ASD01670022,S3G,A,Lig,Inhibitor,"5-[(2S)-4-methyl-2-[(pyridin-4-ylcarbonylamino)methyl]pentyl]-1,3-benzodioxole-4-carboxylic acid",1217,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,TYR99,THR125,ALA128,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CJ5,ASD01670021,4VW,A,Lig,Inhibitor,"5-[(2S)-2-[[(4-aminophenyl)carbonylamino]methyl]-4-methyl-pentyl]-1,3-benzodioxole-4-carboxylic acid",1216,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,TYR99,THR125,ALA128,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CJE,ASD01670020,Q31,A,Lig,Inhibitor,"5-[(2S)-2-[[2-(1H-imidazol-4-yl)ethanoylamino]methyl]-4-methyl-pentyl]-1,3-benzodioxole-4-carboxylic acid",1213,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,TYR99,THR125,ALA128,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CJF,ASD01670019,RVN,A,Lig,Inhibitor,"5-[(E)-(2-oxidanylidene-1H-indol-3-ylidene)methyl]-1,3-benzodioxole-4-carboxylic acid",1217,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,TYR99,LEU102,THR125,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CJK,ASD01670018,H39,A,Lig,Inhibitor,"5-[(2S)-4-methyl-2-[[2-(1H-pyrrol-3-yl)ethanoylamino]methyl]pentyl]-1,3-benzodioxole-4-carboxylic acid",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,TYR99,THR125,ALA128,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CJL,ASD01670017,9PA,A,Lig,Inhibitor,"5-[(2S)-2-[(5-azanylpentanoylamino)methyl]-4-methyl-pentyl]-1,3-benzodioxole-4-carboxylic acid",1216,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CJP,ASD01670016,4D2,A,Lig,Inhibitor,"5-[(2S)-4-methyl-2-[(pyridin-3-ylcarbonylamino)methyl]pentyl]-1,3-benzodioxole-4-carboxylic acid",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,TYR99,THR125,ALA128,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CJQ,ASD01670015,VXO,A,Lig,Inhibitor,"5-[(2S)-2-[[2-(1H-indol-3-yl)ethanoylamino]methyl]-4-methyl-pentyl]-1,3-benzodioxole-4-carboxylic acid",1214,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,TYR99,ALA128,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CJR,ASD01670014,FYM,A,Lig,Inhibitor,"2-methoxy-6-[[[6-[(4-methoxyphenyl)methylcarbamoyl]-1,3-benzodioxol-5-yl]methyl-methyl-amino]methyl]benzoic acid",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174; Chain B:GLN95,ALA98,THR125,ALA128,ALA129"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CJS,ASD01670013,L0Y,A,Lig,Inhibitor,"6-[[[2-(cyclohexylmethylcarbamoyl)phenyl]methyl-methyl-amino]methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1217,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,TYR99,THR125,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CJT,ASD01670012,HLR,A,Lig,Inhibitor,"1,2-benzoxazol-3-amine",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:TYR83,TRP108,ASN184,HIS185,GLY197,GLU198,VAL201; Chain B:GLY106,ARG107,TRP108,PRO109,ILE204,ILE208"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CJU,ASD01670011,JNS,A,Lig,Inhibitor,"5-[(Z)-2-phenylethenyl]-1,3-benzodioxole-4-carboxylic acid",1217,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,TYR99,LEU102,THR125,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CJV,ASD01670010,IV2,A,Lig,Inhibitor,"5-chloranyl-4-methyl-1,3-benzothiazol-2-amine",1212,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:TYR83,ASN184,HIS185,GLY197,GLU198,VAL201; Chain B:GLY106,ARG107,TRP108,PRO109,ILE204,ILE208"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CJW,ASD01670008,CBJ,B,Lig,Inhibitor,"6-[(5-bromo-2,3-dioxo-indol-1-yl)methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1217,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:GLN95,LEU102,THR125,ALA129,TRP132; Chain B:GLN168,ALA169,GLU170,HIS171,THR174,MET178"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CJW,ASD01670008,CBJ,A,Lig,Inhibitor,"6-[(5-bromo-2,3-dioxo-indol-1-yl)methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",1216,Inner Protein Regulator,Inner Protein,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,Yes,"Chain A:VAL79,ALA80,SER81,GLY82,ILE84,VAL150,MET154,GLU157,LEU158,HIS183"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CK1,ASD01670007,OM1,A,Lig,Inhibitor,"(4-carboxy-1,3-benzodioxol-5-yl)methyl-[[2-[(4-methoxyphenyl)methylcarbamoyl]phenyl]methyl]azanium",1216,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,LYS173,THR174,MET178; Chain B:GLN95,ALA98,TYR99,LEU102,THR125,ALA128,ALA129"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CK2,ASD01670005,NVU,A,Lig,Inhibitor,"2-(1,2-benzoxazol-3-yl)ethanoic acid",1216,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:TYR99,LEU102,ALA129"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CK2,ASD01670005,NVU,A,Lig,Inhibitor,"2-(1,2-benzoxazol-3-yl)ethanoic acid",1215,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:TYR83,ASN184,HIS185,ARG187,SER195,GLY197,GLU198; Chain B:ARG107,TRP108,PRO109,ILE208"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4CK3,ASD01670004,K1T,A,Lig,Inhibitor,"5-[(2S)-2-[(4-azanylbutanoylamino)methyl]-4-methyl-pentyl]-1,3-benzodioxole-4-carboxylic acid",1213,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV Integrase for Compounds that Bind- a Sampl Challenge.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,TYR99,THR125,ALA128,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4LH5,ASD01670001,LF0,A,Lig,Inhibitor,"(2S)-2-[4-(3,4-dihydro-2H-chromen-6-yl)-2-methyl-quinolin-3-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid",301,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24261564,Dual inhibition of HIV-1 replication by integrase-LEDGF allosteric inhibitors is predominant at the post-integration stage.,No,"Chain A:ALA169,GLU170,HIS171,THR174,MET178"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,4OVL,ASD01670003,1TD,A,Lig,Inhibitor,3-[(E)-(2-oxidanylidene-1H-indol-3-ylidene)methyl]benzoic acid,308,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24532034,Interrogating HIV integrase for compounds that bind--a SAMPL challenge.,No,"Chain A:ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,LEU102,THR125,ALA128,ALA129,TRP132"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,5KGW,ASD01670031,7SK,A,Lig,Inhibitor,"(2S)-tert-butoxy[3-(3,4-dihydro-2H-1-benzopyran-6-yl)-1-methyl-1H-indol-2-yl]acetic acid",304,Allosteric Fuction,Allosteric Position,27568085,Indole-based allosteric inhibitors of HIV-1 integrase.,No,"Chain A:LEU172,MET178,ALA169,ALA175,GLN168,LYS173,GLU170,HIS171,THR174"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,5KGX,ASD01670031,7SK,A,Lig,Inhibitor,"(2S)-tert-butoxy[3-(3,4-dihydro-2H-1-benzopyran-6-yl)-1-methyl-1H-indol-2-yl]acetic acid",301,Allosteric Fuction,Allosteric Position,27568085,Indole-based allosteric inhibitors of HIV-1 integrase.,No,"Chain A:GLU170,HIS171"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,5KRS,ASD05060085,6XI,A,Lig,Inhibitor,3-(1H-pyrrol-1-yl)-2-thiophenecarboxylic acid,302,Allosteric Fuction,Allosteric Position,27645997,A New Class of Allosteric HIV-1 Integrase Inhibitors Identified by Crystallographic Fragment Screening of the Catalytic Core Domain.,No,"Chain A:GLU92,SER123,GLY94,THR97,VAL126,THR122,ASN120,THR124,SER119,PHE121,CAF65,GLN95,THR93"
ASD01670000_2,,Human immunodeficiency virus 1,Q76353,5KRT,ASD05060099,6W6,A,Lig,Inhibitor,"3-[2,5-bis(chloranyl)pyrrol-1-yl]thiophene-2-carboxylic acid",301,Allosteric Fuction,Allosteric Position,27645997,A New Class of Allosteric HIV-1 Integrase Inhibitors Identified by Crystallographic Fragment Screening of the Catalytic Core Domain.,No,"Chain A:ILE161,ILE182,GLU157,HIS183,VAL165,GLN164,LYS186,ILE162,LYS160"
ASD01690000_2,ITGAV,Homo sapiens,P06756,1L5G,ASD01690001,RGDF-MVA,C;C;C;C;C;,Pep,Activator,RGDF-MVA,5001;5002;5003;5004;5005,Protein-Protein Interaction Regulator,Protein-Protein Interaction,11884718,Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand,No,1L5G
ASD01700000_1,ITGAL,Homo sapiens,P20701,1CQP,ASD01700012,803,A,Lig,Inhibitor,"[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-oxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate",311,Inner Protein Regulator,Inner Protein,10493852,Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain,No,1CQP
ASD01700000_1,ITGAL,Homo sapiens,P20701,1RD4,ASD01700011,L08,A,Lig,Inhibitor,1-[4-[4-[4-(2-ethoxyphenyl)sulfanyl-3-nitro-phenyl]pyridin-2-yl]piperazin-1-yl]ethanone,328,Inner Protein Regulator,Inner Protein,14992576,"Structure of an allosteric inhibitor of LFA-1 bound to the I-domain studied by crystallography, NMR, and calorimetry",No,1RD4
ASD01700000_1,ITGAL,Homo sapiens,P20701,1XDD,ASD01700013,AAY,A,Lig,Inhibitor,"[(1S,3R,7S,8S,8aR)-8-[2-[(2S,4R)-4-hydroxy-1-[[5-(hydroxymethyl)-6-methoxy-naphthalen-2-yl]methyl]-6-oxo-piperidin-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate",401,Inner Protein Regulator,Inner Protein,15304496,Improved lymphocyte function-associated antigen-1 (LFA-1) inhibition by statin derivatives: molecular basis determined by x-ray analysis and monitoring of LFA-1 conformational changes in vitro and ex vivo,No,1XDD
ASD01700000_1,ITGAL,Homo sapiens,P20701,1XDG,ASD01708002,AB8,A,Lig,Inhibitor,"[(1S,3R,7S,8S,8aR)-8-[2-[(4R,6R)-3-[(4-hydroxy-3-methoxy-phenyl)methyl]-4-(2-methylamino-2-oxo-ethyl)-2-oxo-1,3-oxazinan-6-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate",401,Inner Protein Regulator,Inner Protein,15304496,Improved lymphocyte function-associated antigen-1 (LFA-1) inhibition by statin derivatives: molecular basis determined by x-ray analysis and monitoring of LFA-2 conformational changes in vitro and ex vivo,No,1XDG
ASD01700000_1,ITGAL,Homo sapiens,P20701,1XUO,ASD01700015,LA1,A,Lig,Inhibitor,"(2S)-N-methyl-2-[(3S)-3-(2-methylpropyl)-2,5-dioxo-4-(quinolin-3-ylmethyl)-1,4-diazepan-1-yl]-3-naphthalen-2-yl-propanamide",401,Inner Protein Regulator,Inner Protein,15686945,"1,4-Diazepane-2,5-diones as novel inhibitors of LFA-1",No,1XUO
ASD01700000_1,ITGAL,Homo sapiens,P20701,2ICA,ASD01700016,2IC,A,Lig,Inhibitor,"5-[[(1R,3S,5S)-1-(4-cyanophenyl)-7-(3,5-dichlorophenyl)-9-methyl-6,8-dioxo-3,7,9-triazaspiro[4.4]nonan-3-yl]methyl]thiophene-3-carboxylic acid",1,Inner Protein Regulator,Inner Protein,17125246,"Discovery and development of 5-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non-7-yl-methyl]-3-thiophenecarboxylic acid (BMS-587101)--a small molecule antagonist of leukocyte function associated antigen-1",No,2ICA
ASD01700000_1,ITGAL,Homo sapiens,P20701,2O7N,ASD01700017,2O7,A,Lig,Inhibitor,"(8S)-8-[(4-cyanophenyl)methyl]-2-(3,5-dichlorophenyl)-3-oxo-6,7-dihydro-5H-pyrrolizine-1-carbonitrile",1,Inner Protein Regulator,Inner Protein,17291752,"Design of LFA-1 antagonists based on a 2,3-dihydro-1H-pyrrolizin-5(7aH)-one scaffold",No,2O7N
ASD01700000_1,ITGAL,Homo sapiens,P20701,3BQM,ASD01700018,BQM,B,Lig,Inhibitor,"(E)-3-[4-(3-aminophenyl)sulfanyl-2,3-bis(trifluoromethyl)phenyl]-1-morpholin-4-yl-prop-2-en-1-one",1,Inner Protein Regulator,Inner Protein,18778938,Design and synthesis of a series of meta aniline-based LFA-1 ICAM inhibitors,No,3BQM
ASD01700000_1,ITGAL,Homo sapiens,P20701,3BQN,ASD01700019,BQN,B,Lig,Inhibitor,"(E)-1-morpholin-4-yl-3-[4-[2-(pyridin-3-ylmethoxy)phenyl]sulfanyl-2,3-bis(trifluoromethyl)phenyl]prop-2-en-1-one",1,Inner Protein Regulator,Inner Protein,18783948,Structure-activity relationship of ortho- and meta-phenol based LFA-1 ICAM inhibitors,No,3BQN
ASD01700000_1,ITGAL,Homo sapiens,P20701,3E2M,ASD01700020,E2M,A,Lig,Inhibitor,"4-[[2-[4-[(E)-3-morpholin-4-yl-3-oxo-prop-1-enyl]-2,3-bis(trifluoromethyl)phenyl]sulfanylphenoxy]methyl]cyclohexane-1-carboxylic acid",1,Inner Protein Regulator,Inner Protein,18783948,Structure-activity relationship of ortho- and meta-phenol based LFA-1 ICAM inhibitors,No,3E2M
ASD01700000_1,ITGAL,Homo sapiens,P20701,3F78,ASD01700021,ICF,A,Lig,Inhibitor,"(2S)-2-chloro-2-(difluoromethoxy)-1,1,1-trifluoro-ethane",1,Inner Protein Regulator,Inner Protein,19332643,Crystal structure of isoflurane bound to integrin LFA-1 supports a unified mechanism of volatile anesthetic action in the immune and central nervous systems,No,3F78
ASD01700000_1,ITGAL,Homo sapiens,P20701,3M6F,ASD01700022,BJZ,A,Lig,Inhibitor,"6-[(5S,6R)-6-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,8-triazaspiro[4.4]nonan-8-yl]pyridine-3-carboxylic acid",1,Inner Protein Regulator,Inner Protein,20405922,"Small molecule antagonist of leukocyte function associated antigen-1 (LFA-1): structure-activity relationships leading to the identification of 6-((5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)nicotinic acid (BMS-688521).",No,3M6F
ASD01700000_1,ITGAL,Homo sapiens,P20701,4IXD,ASD01700023,1HV,A,Lig,Activator,N-(3-azanylpropyl)-4-[1-[4-(methylcarbamoyl)phenyl]indazol-3-yl]benzamide,402,Inner Protein Regulator,Inner Protein,,Identification and x-ray structure based investigation of an ICAM-1 binding enhancing small molecule activator of LFA-1,No,4IXD
ASD01720000_3,IDH1,Saccharomyces cerevisiae,P28834,3BLW,ASD00030001,AMP,A,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",2001,Inner Protein Regulator,Inner Protein,18256028,Allosteric motions in structures of yeast NAD+-specific isocitrate dehydrogenase,No,"Chain A:HIS275,GLY277,ASP279,ALA286,ASN287,ASP328; Chain B:ASN223"
ASD01760000_2,ldh,Bacillus stearothermophilus,P00344,1LDN,ASD00200001,FBP,A,Lig,Activator,"[(2R,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate",353,Inner Protein Regulator,Inner Protein,1731077,Structure of a ternary complex of an allosteric lactate dehydrogenase from Bacillus stearothermophilus at 2.5 A resolution,No,"Chain A:ARG171,GLN183,ASN184,HIS186; Chain C:ARG171,GLN183,ASN184,HIS186"
ASD01760000_2,ldh,Bacillus stearothermophilus,P00344,2LDB,ASD00200001,FBP,C,Lig,Activator,"[(2R,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate",6,Inner Protein Regulator,Inner Protein,2330370,Structure determination and refinement of Bacillus stearothermophilus lactate dehydrogenase,No,"Chain B:ARG171,GLN183,ASN184,HIS186,GLY207,ILE269; Chain C:ARG171,GLN183,ASN184,HIS186,ILE269"
ASD01770000_1,lacI,Escherichia coli,P03023,1EFA,ASD01770002,NPF,A,Lig,Activator,"(2R,3R,4S,5R,6S)-2-methyl-6-(2-nitrophenoxy)oxane-3,4,5-triol",901,Protein-DNA/RNA Interaction Regulator,Inner Protein,10700279,A closer view of the conformation of the Lac repressor bound to operator.,No,"Chain A:LEU73,ALA75,PRO76,ILE79,ASN125,LEU148,ASP149,PHE161,SER193,ARG197,TRP220,ASN246,ASP274,GLN291,PHE293"
ASD01770000_1,lacI,Escherichia coli,P03023,1JWL,ASD01770002,NPF,A,Lig,Activator,"(2R,3R,4S,5R,6S)-2-methyl-6-(2-nitrophenoxy)oxane-3,4,5-triol",334,Protein-DNA/RNA Interaction Regulator,Inner Protein,11580238,Crystallographic analysis of Lac repressor bound to natural operator O1.,No,"Chain A:ALA75,ILE79,ASN125,LEU148,ASP149,PHE161,SER193,ARG197,TRP220,ASN246,ASP274,GLN291,PHE293"
ASD01770000_1,lacI,Escherichia coli,P03023,1LBH,ASD01770001,IPT,A,Lig,Inhibitor,"(2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-propan-2-ylsulfanyl-oxane-3,4,5-triol",400,Protein-DNA/RNA Interaction Regulator,Inner Protein,8638105,Crystal structure of the lactose operon repressor and its complexes with DNA and inducer.,No,"Chain A:SER69,ALA75,ILE79,ASP149,SER191,ARG197,TRP220,ASN246,ASP274,GLN291"
ASD01770000_1,lacI,Escherichia coli,P03023,1TLF,ASD01770001,IPT,A,Lig,Inhibitor,"(2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-propan-2-ylsulfanyl-oxane-3,4,5-triol",998,Protein-DNA/RNA Interaction Regulator,Inner Protein,7792597,Crystal structure of lac repressor core tetramer and its implications for DNA looping.,No,"Chain A:SER69,LEU73,ALA75,PRO76,ILE79,ASN125,PRO127,LEU148,ASP149,SER193,ARG197,TRP220,ALA245,ASN246,ASP274,GLN291"
ASD01770000_1,lacI,Escherichia coli,P03023,2P9H,ASD01770001,IPT,A,Lig,Inhibitor,"(2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-propan-2-ylsulfanyl-oxane-3,4,5-triol",998,Protein-DNA/RNA Interaction Regulator,Inner Protein,17543986,Structural analysis of lac repressor bound to allosteric effectors.,No,"Chain A:SER69,LEU73,ALA75,PRO76,ILE79,ASN125,LEU148,ASP149,SER193,ARG197,TRP220,ASN246,ASP274,GLN291"
ASD01770000_1,lacI,Escherichia coli,P03023,2PAF,ASD01770002,NPF,A,Lig,Activator,"(2R,3R,4S,5R,6S)-2-methyl-6-(2-nitrophenoxy)oxane-3,4,5-triol",902,Protein-DNA/RNA Interaction Regulator,Inner Protein,17543986,Structural analysis of lac repressor bound to allosteric effectors.,No,"Chain A:LEU73,ALA75,PRO76,ILE79,ASN125,LEU148,ASP149,ILE160,PHE161,SER193,ARG197,TRP220,ASN246,ASP274,GLN291"
ASD01770000_1,lacI,Escherichia coli,P03023,2PE5,ASD01770010,145,A,Lig,Activator,"(2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-(2-nitrophenoxy)oxane-3,4,5-triol",901,Protein-DNA/RNA Interaction Regulator,Inner Protein,17543986,Structural analysis of lac repressor bound to allosteric effectors,No,"Chain A:LEU73,HIS74,ALA75,PRO76,ASN125,LEU148,ASP149,PHE161,SER193,ARG197,TRP220,ASN246,ASP274,GLN291,PHE293,LEU296"
ASD01770000_1,lacI,Escherichia coli,P03023,3EDC,ASD01770014,HEZ,A,Lig,Regulator,"hexane-1,6-diol",400,Protein-DNA/RNA Interaction Regulator,Inner Protein,19004002,Crystal structure of a 1.6-hexanediol bound tetrameric form of Escherichia coli lac-repressor refined to 2.1 A resolution,No,"Chain A:SER69,LEU71,LEU73,PRO76,PRO127,ASP149,ARG197,TRP220"
ASD01770000_1,lacI,Escherichia coli,P03023,4RZT,ASD01770008,40J,A,Lig,Activator,"1,6-dichloro-1,6-dideoxy-beta-D-fructofuranosyl 4-chloro-4-deoxy-alpha-D-galactopyranoside",501,Allosteric Function,Allosteric Position,26689263,Engineering an allosteric transcription factor to respond to new ligands.,Yes,"Chain A:ARG197,THR68,ILE124,ASP193,LEU128,ALA75,ILE160,ASP247,TRP220,SER191,THR149,LEU73,ALA150,PHE161,PRO127,LEU296,HIS74,LEU148,ASN125,SER69,ASP274,TYR273,GLN291,PHE293,ILE79,TYR126,PRO76,ALA245,GLN248,ASN246"
ASD01780000_1,ansA,Escherichia coli,P0A962,2HIM,ASD01780001,ASN,A,Lig,Activator,"(2S)-2,4-bis(azanyl)-4-oxidanylidene-butanoic acid",8001,Inner Protein Regulator,Protein-Protein Interaction,17451745,Crystal Structure and Allosteric Regulation of the Cytoplasmic Escherichia coli L-Asparaginase I.,No,"Chain A:ALA162,ARG240,THR271,GLN272,CYS273,THR301,VAL302,GLU303; Chain C:ARG240"
ASD01780000_1,ansA,Escherichia coli,P0A962,2P2N,ASD01780001,ASN,A,Lig,Activator,"(2S)-2,4-bis(azanyl)-4-oxidanylidene-butanoic acid",8001,Inner Protein Regulator,Protein-Protein Interaction,17451745,Crystal Structure and Allosteric Regulation of the Cytoplasmic Escherichia colil-Asparaginase I,No,"Chain A:THR162,ARG240,THR271,GLN272,CYS273,THR301,VAL302,GLU303; Chain C:ARG240"
ASD01810000_1,CHRM1,Homo sapiens,P11229,5CXV,ASD01812121,PGE,A,Lig,Modolator,TRIETHYLENE GLYCOL,504,Allosteric Function,Allosteric Position,26958838,Crystal structures of the M1 and M4 muscarinic acetylcholine receptors.,No,5CXV
ASD01820000_1,CHRM2,Homo sapiens,P08172,4MQT,ASD01840068,2CU,A,Lig,Activator,"3-azanyl-5-chloranyl-N-cyclopropyl-4-methyl-6-[2-(4-methylpiperazin-1-yl)-2-oxidanylidene-ethoxy]thieno[2,3-b]pyridine-2-carboxamide",502,Inner Protein Regulator,Inner Protein,24256733,Activation and allosteric modulation of a muscarinic acetylcholine receptor.,No,4MQT
ASD01840000_1,CHRM4,Homo sapiens,P08173,5DSG,ASD01840213,P6G,A,Lig,Regulator,HEXAETHYLENE GLYCOL,1205,Allosteric function,Allosteric position,26958838,Crystal structures of the M1 and M4 muscarinic acetylcholine receptors.,No,5DSG
ASD01840000_1,CHRM4,Homo sapiens,P08173,7V6A,ASD01840561,5XI,R,compound,,"methyl 4-(3-methyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)-[1,4'-bipiperidine]-1'-carboxylate",,,,35606397,,,7V6A
ASD01850000_1,CHRM5,Homo sapiens,P08912,6OL9,,0HK,A,Lig,Inhibitor,"(1R,2R,4S,5S,7S)-7-{[hydroxy(dithiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane",1203,,,,,,6OL9
ASD01860000_1,ME2,Homo sapiens,P23368,1GZ3,ASD01330013,FUM,A,Lig,Activator,(E)-but-2-enedioic acid,605,Inner Protein Regulator,Protein-Protein Interaction,12121650,Molecular Mechanism for the Regulation of Human Mitochondrial Nad(P)+-Dependent Malic Enzyme by ATP and Fumarate,No,1GZ3
ASD01860000_1,ME2,Homo sapiens,P23368,1GZ4,ASD01330013,FUM,A,Lig,Activator,(E)-but-2-enedioic acid,605,Inner Protein Regulator,Protein-Protein Interaction,12121650,Molecular Mechanism for the Regulation of Human Mitochondrial Nad(P)(+)-Dependent Malic Enzyme by ATP and Fumarate,No,1GZ4
ASD01860000_1,ME2,Homo sapiens,P23368,1PJ2,ASD01330013,FUM,A,Lig,Activator,(E)-but-2-enedioic acid,700,Inner Protein Regulator,Protein-Protein Interaction,12962632,Crystal structures of substrate complexes of malic enzyme and insights into the catalytic mechanism.,No,1PJ2
ASD01860000_1,ME2,Homo sapiens,P23368,1PJ3,ASD01330013,FUM,A,Lig,Activator,(E)-but-2-enedioic acid,700,Inner Protein Regulator,Protein-Protein Interaction,12962632,Crystal structures of substrate complexes of malic enzyme and insights into the catalytic mechanism.,No,1PJ3
ASD01860000_1,ME2,Homo sapiens,P23368,1PJ4,ASD01330013,FUM,A,Lig,Activator,(E)-but-2-enedioic acid,700,Inner Protein Regulator,Protein-Protein Interaction,12962632,Crystal structures of substrate complexes of malic enzyme and insights into the catalytic mechanism.,No,1PJ4
ASD01860000_3,,Ascaris lumbricoides,P27443,1O0S,ASD01860001,TTN,A,Lig,Inhibitor,2-hydroxypropanedioate,810,Inner Protein Regulator,Protein-Protein Interaction,12853453,Crystallographic studies on Ascaris suum NAD-malic enzyme bound to reduced cofactor and identification of an effector site.,No,"Chain A:MET73,GLN78,ARG81,VAL82,ARG105,LEU109; Chain B:TYR141"
ASD01910000_1,GRM5,Homo sapiens,P41594,5CGC,ASD01918085,51D,A,Lig,Regulator,3-chloro-4-fluoro-5-[6-(1H-pyrazol-1-yl)pyrimidin- 4-yl]benzonitrile,4006,Allosteric Function,Allosteric Position,26225459,Fragment and Structure-Based Drug Discovery for a Class C GPCR: Discovery of the mGlu5 Negative Allosteric Modulator HTL14242 (3-Chloro-5-[6-(5-fluoropyridin-2-yl)pyrimidin-4-yl]benzonitrile).,No,5CGC
ASD01910000_1,GRM5,Homo sapiens,P41594,5CGD,ASD01918084,51E,A,Lig,Regulator,3-chloro-5-[6-(5-fluoropyridin-2-yl)pyrimidin- 4-yl]benzonitrile,4005,Allosteric Function,Allosteric Position,26225459,Fragment and Structure-Based Drug Discovery for a Class C GPCR: Discovery of the mGlu5 Negative Allosteric Modulator HTL14242 (3-Chloro-5-[6-(5-fluoropyridin-2-yl)pyrimidin-4-yl]benzonitrile).,No,5CGD
ASD01910000_1,GRM5,Homo sapiens,P41594,6FFH,ASD01917956,D8B,A,Lig,Inhibitor,2-[2-(3-methoxyphenyl)ethynyl]-6-methyl-pyridine,4009,Allosteric function,Allosteric position,29455526,Structure-Based Optimization Strategies for G Protein-Coupled Receptor (GPCR) Allosteric Modulators: A Case Study from Analyses of New Metabotropic Glutamate Receptor 5 (mGlu5) X-ray Structures.,No,6FFH
ASD01910000_1,GRM5,Homo sapiens,P41594,6FFI,ASD01916182,D7W,A,Lig,Inhibitor,1-(3-chlorophenyl)-3-(3-methyl-5-oxidanylidene-4~{H}-imidazol-2-yl)urea,4006,Allosteric function,Allosteric position,29455526,Structure-Based Optimization Strategies for G Protein-Coupled Receptor (GPCR) Allosteric Modulators: A Case Study from Analyses of New Metabotropic Glutamate Receptor 5 (mGlu5) X-ray Structures.,No,6FFI
ASD01910000_1,GRM5,Homo sapiens,P41594,7FD8,,QUS,A,Lig,Regulator,"(S)-2-AMINO-3-(3,5-DIOXO-[1,2,4]OXADIAZOLIDIN-2-YL)-PROPIONIC ACID",902,,,,,,7FD8
ASD01910000_1,GRM5,Homo sapiens,P41594,7P2L,,4YI,A,Lig,Regulator,2-chloranyl-~{N}-[2-methoxy-4-[(~{E})-pyridin-2-yldiazenyl]phenyl]benzamide,1201,,,,,,7P2L
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,1S9J,ASD01940058,BBM,A,Lig,Inhibitor,"5-bromo-N-[(2S)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodo-phenyl)amino]benzamide",1001,Inner Protein Regulator,Inner Protein,15543157,Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition.,Yes,1S9J
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,2P55,ASD01940363,MRA,A,Lig,Inhibitor,"2-[(4-ethynyl-2-fluoro-phenyl)amino]-3,4-difluoro-N-(2-hydroxyethoxy)benzamide",9000,Inner Protein Regulator,Inner Protein,17880056,4-anilino-5-carboxamido-2-pyridone derivatives as noncompetitive inhibitors of mitogen-activated protein kinase kinase.,Yes,2P55
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,3DV3,ASD01941007,MEK,A,Lig,Inhibitor,"3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]- N-(2-hydroxyethoxy)-5-[(2-hydroxyethoxy)methyl]benzamide",9001,Inner Protein Regulator,Inner Protein,19019675,Beyond the MEK-pocket: can current MEK kinase inhibitors be utilized to synthesize novel type III NCKIs? Does the MEK-pocket exist in kinases other than MEK?,Yes,3DV3
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,3DY7,ASD01940370,1CX,A,Lig,Inhibitor,5-ethanoyl-2-[(2-fluoro-4-iodo-phenyl)amino]-N-(2-hydroxyethoxy)-1-methyl-pyrrole-3-carboxamide,9002,Inner Protein Regulator,Inner Protein,19019675,Beyond the MEK-pocket: can current MEK kinase inhibitors be utilized to synthesize novel type III NCKIs? Does the MEK-pocket exist in kinases other than MEK?,Yes,3DY7
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,3E8N,ASD01948005,VRA,A,Lig,Inhibitor,"N-[3,4-difluoro-2-[(2-fluoro-4-iodo-phenyl)amino]-6-methoxy-phenyl]-1-[(2S)-2,3-dihydroxypropyl]cyclopropane-1-sulfonamide",1001,Inner Protein Regulator,Inner Protein,19706763,"RDEA119/BAY 869766: a potent, selective, allosteric inhibitor of MEK1/2 for the treatment of cancer.",Yes,3E8N
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,3EQB,ASD01940368,LUG,A,Lig,Inhibitor,"N-[5-[3,4-difluoro-2-[(2-fluoro-4-iodo-phenyl)amino]phenyl]-1,3,4-oxadiazol-2-yl]ethane-1,2-diamine",1,Inner Protein Regulator,Inner Protein,18951019,"2-Alkylamino- and alkoxy-substituted 2-amino-1,3,4-oxadiazoles-O-Alkyl benzohydroxamate esters replacements retain the desired inhibition and selectivity against MEK (MAP ERK kinase).",Yes,3EQB
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,3EQC,ASD01940066,3BM,A,Lig,Inhibitor,"2-[(2-chloro-4-iodo-phenyl)amino]-N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-benzamide",1,Inner Protein Regulator,Inner Protein,19161339,Crystal Structures of MEK1 Binary and Ternary Complexes with Nucleotides and Inhibitors.,Yes,3EQC
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,3EQG,ASD01940099,4BM,A,Lig,Inhibitor,"N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodo-phenyl)amino]benzamide",1,Inner Protein Regulator,Inner Protein,19161339,Crystal Structures of MEK1 Binary and Ternary Complexes with Nucleotides and Inhibitors.,Yes,3EQG
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,3EQH,ASD01940268,5BM,A,Lig,Inhibitor,"(2Z)-2,3-bis[amino-(2-aminophenyl)sulfanyl-methylidene]butanedinitrile",1,Inner Protein Regulator,Inner Protein,19161339,Crystal Structures of MEK1 Binary and Ternary Complexes with Nucleotides and Inhibitors.,Yes,3EQH
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,3ORN,ASD01820239,3OR,A,Lig,Inhibitor,"3,4-difluoro-2-[(2-fluoro-4-iodo-phenyl)amino]-N-(2-hydroxyethoxy)-5-[(3-oxo-1,2-oxazinan-2-yl)methyl]benzamide",400,Inner Protein Regulator,Inner Protein,21316218,Design and synthesis of novel allosteric MEK inhibitor CH4987655 as an orally available anticancer agent.,Yes,3ORN
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,3OS3,ASD01940301,3OS,A,Lig,Inhibitor,"2-[(4-ethynyl-2-fluoro-phenyl)amino]-3,4-difluoro-N-(2-hydroxyethoxy)-5-(2-hydroxyethoxyiminomethyl)benzamide",400,Inner Protein Regulator,Inner Protein,21316218,Design and synthesis of novel allosteric MEK inhibitor CH4987655 as an orally available anticancer agent.,Yes,3OS3
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,3PP1,ASD01941047,IZG,A,Lig,Inhibitor,"3-[(2R)-2,3-dihydroxypropyl]-6-fluoro-5-[(2-fluoro-4-iodo-phenyl)amino]-8-methyl-pyrido[2,3-d]pyrimidine-4,7-dione",500,Inner Protein Regulator,Inner Protein,21310613,"Discovery of TAK-733, a potent and selective MEK allosteric site inhibitor for the treatment of cancer.",Yes,3PP1
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,3SLS,ASD01941071,77D,A,Lig,Inhibitor,"2-[(2-fluoranyl-4-iodanyl-phenyl)amino]-5,5-dimethyl-8-oxidanylidene-N-[(3R)-piperidin-3-yl]-6,7-dihydro-4H-thieno[2,3-c]azepine-3-carboxamide",500,Inner Protein Regulator,Inner Protein,22245778,Engineering human MEK-1 for structural studies: A case study of combinatorial domain hunting.,Yes,3SLS
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,3V01,ASD01948001,3V0,A,Lig,Inhibitor,"N-[(2R)-2,3-bis(oxidanyl)propoxy]-3-[(2-fluoranyl-4-iodanyl-phenyl)amino]furo[3,2-c]pyridine-2-carboxamide",501,Inner Protein Regulator,Inner Protein,22506516,"Discovery of Novel Allosteric Mitogen-Activated Protein Kinase Kinase (MEK) 1,2 Inhibitors Possessing Bidentate Ser212 Interactions.",Yes,3V01
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,3V04,ASD01948004,V04,A,Lig,Inhibitor,4-[(2-fluoranyl-4-iodanyl-phenyl)amino]-N-(2-hydroxyethyloxy)-1H-indazole-5-carboxamide,501,Inner Protein Regulator,Inner Protein,22506516,"Discovery of Novel Allosteric Mitogen-Activated Protein Kinase Kinase (MEK) 1,2 Inhibitors Possessing Bidentate Ser212 Interactions.",Yes,3V04
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,3VVH,ASD01940099,4BM,A,Lig,Inhibitor,"N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodo-phenyl)amino]benzamide",703,Inner Protein Regulator,Inner Protein,,X-ray structure of the human mitogen-activated protein kinase kinase 1 (MEK1) in complex with an inhibitor and MgATP,Yes,3VVH
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,3WIG,ASD01940388,CHU,A,Lig,Inhibitor,3-[[3-fluoranyl-2-(methylsulfamoylamino)pyridin-4-yl]methyl]-4-methyl-7-pyrimidin-2-yloxy-chromen-2-one,403,Inner Protein Regulator,Inner Protein,24746704,Disruption of CRAF-Mediated MEK Activation Is Required for Effective MEK Inhibition in KRAS Mutant Tumors,Yes,3WIG
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,4AN2,ASD01940329,EUI,A,Lig,Inhibitor,"[3,4-bis(fluoranyl)-2-[(2-fluoranyl-4-iodanyl-phenyl)amino]phenyl]-[3-oxidanyl-3-[(2S)-piperidin-2-yl]azetidin-1-yl]methanone",1382,Inner Protein Regulator,Inner Protein,24900486,Novel Carboxamide-Based Allosteric Mek Inhibitors: Discovery and Optimization Efforts Toward Xl518 (Gdc-0973),Yes,4AN2
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,4AN3,ASD01940335,5Y0,A,Lig,Inhibitor,"N-[(2S)-2,3-bis(oxidanyl)propoxy]-3,4-bis(fluoranyl)-2-[(2-fluoranyl-4-iodanyl-phenyl)amino]benzamide",1384,Inner Protein Regulator,Inner Protein,24900486,Novel Carboxamide-Based Allosteric Mek Inhibitors: Discovery and Optimization Efforts Toward Xl518 (Gdc-0973),Yes,4AN3
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,4AN9,ASD01940346,2P7,A,Lig,Inhibitor,"[3,4-bis(fluoranyl)-2-[(2-fluoranyl-4-iodanyl-phenyl)amino]phenyl]-(3-oxidanylazetidin-1-yl)methanone",1384,Inner Protein Regulator,Inner Protein,24900486,Novel Carboxamide-Based Allosteric Mek Inhibitors: Discovery and Optimization Efforts Toward Xl518 (Gdc-0973),Yes,4AN9
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,4ANB,ASD01940348,YQY,A,Lig,Inhibitor,"[3-(aminomethyl)-3-oxidanyl-azetidin-1-yl]-[3,4-bis(fluoranyl)-2-[(2-fluoranyl-4-iodanyl-phenyl)amino]phenyl]methanone",1382,Inner Protein Regulator,Inner Protein,24900486,Novel Carboxamide-Based Allosteric Mek Inhibitors: Discovery and Optimization Efforts Toward Xl518 (Gdc-0973),Yes,4ANB
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,4ARK,ASD01948006,M3K,A,Lig,Inhibitor,"2-[(3R)-3,4-bis(oxidanyl)butoxy]-4-fluoranyl-6-[(2-fluoranyl-4-iodanyl-phenyl)amino]benzamide",1385,Inner Protein Regulator,Inner Protein,23474388,Optimization of Allosteric Mek Inhibitors - Part 1: Venturing Into Unexplored Sar Territories,Yes,4ARK
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,4LMN,ASD01940329,EUI,A,Lig,Inhibitor,"[3,4-bis(fluoranyl)-2-[(2-fluoranyl-4-iodanyl-phenyl)amino]phenyl]-[3-oxidanyl-3-[(2S)-piperidin-2-yl]azetidin-1-yl]methanone",503,Inner Protein Regulator,Inner Protein,23934108,Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers.,Yes,4LMN
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,4MNE,ASD01940369,573,A,Lig,Inhibitor,"7-fluoranyl-3-[(2-fluoranyl-4-iodanyl-phenyl)amino]-N-[(2S)-2-oxidanylpropoxy]furo[3,2-c]pyridine-2-carboxamide",903,Inner Protein Regulator,Inner Protein,25155755,Structure of the BRAF-MEK Complex Reveals a Kinase Activity Independent Role for BRAF in MAPK Signaling.,Yes,4MNE
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,7B3M,,SU5,A,Lig,Inhibitor,1~{H}-indol-2-yl(pyridin-3-yl)methanone,403,,,,,,7B3M
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,7B7R,,T1K,A,Lig,Inhibitor,"2-[5-[ethyl(methyl)amino]imidazo[1,2-a]pyrimidin-7-yl]phenol",403,,,,,,7B7R
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,7B94,,T3W,A,Lig,Inhibitor,"2-(4-iodophenyl)-8~{H}-imidazo[1,2-c]pyrimidin-5-one",403,,,,,,7B94
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,7B9L,,T4N,A,Lig,Inhibitor,~{N}-(4-methoxyphenyl)-2-[(2~{S})-3-oxidanylidenethiomorpholin-2-yl]ethanamide,402,,,,,,7B9L
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,7M0T,ASD01941033,3EW,B,Compound,,"N-(3-(3-cyclopropyl-5-(2-fluoro-4-iodophenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl)phenyl)acetamide",,,,34470822,,,7M0T
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,7M0U,ASD01941075,QO7,B,Compound,,"(S)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)phenyl)(3-hydroxy-3-(piperidin-2-yl)azetidin-1-yl)methanone",,,,34470822,,,7M0U
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,7M0V,ASD01940067,EUI,B,Compound,,6-[(4-bromo-2-chloro-phenyl)amino]-7-fluoro-N-(2-hydroxyethoxy)-3-methyl-benzoimidazole-5-carboxamide,,,,34470822,,,7M0V
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,7M0W,ASD00100010,QOA,B,Compound,,,,,,34470822,,,7M0W
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,7M0X,ASD01940265,4BM,B,Compound,,6-[(4-bromo-2-fluoro-phenyl)amino]-7-fluoro-N-(2-hydroxyethoxy)-3-methyl-benzoimidazole-5-carboxamide,,,,34470822,,,7M0X
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,7M0Y,ASD01940577,QOM,B,Compound,,"N-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodo-phenyl)amino]pyridine-4-carboxamide",,,,34470822,,,7M0Y
ASD01940000_1,MAP2K1,Homo sapiens,Q02750,7M0Z,ASD01940099,CHU,B,Compound,,"(R)-N-(2,3-dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide",,,,34470822,,,7M0Z
ASD01940000_3,MAP2K1,Oryctolagus cuniculus,P29678,7JUR,,QOM,C,Lig,Inhibitor,Trametinib,402,,Protein-Protein interaction,,,,
ASD01940000_3,MAP2K1,Oryctolagus cuniculus,P29678,7JUS,,VKD,C,Lig,Inhibitor,Cobimetinib,501,,Protein-Protein interaction,,,,
ASD01940000_3,MAP2K1,Oryctolagus cuniculus,P29678,7JUT,,3EW,C,Lig,Inhibitor,3EW 5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide,402,,Protein-Protein interaction,,,,
ASD01940000_3,MAP2K1,Oryctolagus cuniculus,P29678,7JUU,,4BM,C,Lig,Inhibitor,"N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide",402,,Protein-Protein interaction,,,,
ASD01940000_3,MAP2K1,Oryctolagus cuniculus,P29678,7JUV,,VKG,C,Lig,Inhibitor,"N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)-N'-methylsulfuric diamide",402,,Protein-Protein interaction,,,,
ASD01940000_3,MAP2K1,Oryctolagus cuniculus,P29678,7JUX,,QOM,C,Lig,Inhibitor,Trametinib,402,,Protein-Protein interaction,,,,
ASD01940000_3,MAP2K1,Oryctolagus cuniculus,P29678,7JUY,,EUI,C,Lig,Inhibitor,"[3,4-BIS(FLUORANYL)-2-[(2-FLUORANYL-4-IODANYL-PHENYL)AMINO]PHENYL]-[3-OXIDANYL-3-[(2S)-PIPERIDIN-2-YL]AZETIDIN-1-YL]METHANONE",402,,Protein-Protein interaction,,,,
ASD01940000_3,MAP2K1,Oryctolagus cuniculus,P29678,7JUZ,,3EW,C,Lig,Inhibitor,5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide,402,,Protein-Protein interaction,,,,
ASD01940000_3,MAP2K1,Oryctolagus cuniculus,P29678,7JV0,,4BM,C,Lig,Inhibitor,"N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide",402,,Protein-Protein interaction,,,,
ASD01940000_3,MAP2K1,Oryctolagus cuniculus,P29678,7JV1,,VKG,C,Lig,Inhibitor,"N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)-N'-methylsulfuric diamide",402,,Protein-Protein interaction,,,,
ASD01950000_1,MAP2K2,Homo sapiens,P36507,1S9I,ASD01950002,5EA,A,Lig,Inhibitor,"5-[3,4-difluoro-2-[(2-fluoro-4-iodo-phenyl)amino]phenyl]-N-(2-morpholin-4-ylethyl)-1,3,4-oxadiazol-2-amine",1001,Inner Protein Regulator,Inner Protein,15543157,Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition,Yes,1S9I
ASD02000000_1,argA,Neisseria gonorrhoeae,Q5FAK7,3D2P,ASD02000001,ARG,A,Lig,Inhibitor,[amino-[[(4S)-4-amino-5-hydroxy-5-oxo-pentyl]amino]methylidene]azanium,438,Inner Protein Regulator,Inner Protein,19095660,Mechanism of allosteric inhibition of N-acetyl-L-glutamate synthase by L-arginine.,No,"Chain A:TYR17,LYS201,GLU220,THR221,GLN257,GLU270,LEU271,PHE272,THR273,ARG274,ASN275,GLY276,ILE277,GLY278,THR279,SER280,ASP334"
ASD02000000_3,Mmar10_0365,Maricaulis maris,Q0ASS9,4KZT,ASD02000001,ARG,A,Lig,Inhibitor,[amino-[[(4S)-4-amino-5-hydroxy-5-oxo-pentyl]amino]methylidene]azanium,501,Inner Protein Regulator,Inner Protein,23850694,Structure of N-acetyl-L-glutamate synthase/kinase from Maricaulis maris with the allosteric inhibitor L-arginine bound.,No,"Chain A:TYR28,LYS206,SER225,SER265,GLU277,LEU278,THR280,HIS281,ALA282,GLY283,GLY285,THR286,LEU287,GLY365"
ASD02030000_1,Grin1,Rattus norvegicus,P35439,5I56,ASD02032012,67P,B,Lig,Activator,N-({4-[2-(benzenecarbonyl)hydrazinecarbonyl]phenyl}methyl)-3-chloro-4-fluorobenzene-1-sulfonamide,802,Inner Protein regulator,Inner Protein,27618671,Structural Basis for Negative Allosteric Modulation of GluN2A-Containing NMDA Receptors.,No,"Chain B:PHE131,ALA217,GLU276,PRO130,MET272,THR243,PHE19,VAL132,VAL267,GLU133,VAL129,TYR245,LEU263,PHE62,LEU264,THR134,GLY244,LEU280"
ASD02030000_1,Grin1,Rattus norvegicus,P35439,5I58,ASD02030551,67R,B,Lig,Activator,"5-({[(3-chloro-4-fluorophenyl)sulfonyl]amino}methyl)-N-[(2-methyl-1,3-thiazol-5-yl)methyl]pyrazine-2-carboxamide",302,Inner Protein regulator,Inner Protein,27618671,Structural Basis for Negative Allosteric Modulation of GluN2A-Containing NMDA Receptors.,No,"Chain B:ALA217,GLU276,GLU273,PRO130,PHE131,MET272,THR243,PHE19,VAL132,VAL267,GLU133,VAL129,LEU264,LEU263,PHE62,THR134,GLY244,LEU280"
ASD02030000_1,Grin1,Rattus norvegicus,P35439,5I59,ASD02030766,67Q,B,Lig,Activator,"5-({[(3,4-difluorophenyl)sulfonyl]amino}methyl)-6-methyl-N-[(2-methyl-4H-1lambda~4~,3-thiazol-5-yl)methyl]pyrazine-2-carboxamide",302,Inner Protein regulator,Inner Protein,27618671,Structural Basis for Negative Allosteric Modulation of GluN2A-Containing NMDA Receptors.,No,"Chain B:ALA217,GLU276,GLU273,PRO130,PHE131,MET272,PHE19,VAL132,GLU133,VAL129,LEU264,LEU263,PHE62,VAL267,GLY244,LEU280"
ASD02030000_1,Grin1,Rattus norvegicus,P35439,5JTY,ASD02030552,6ND,B,Lig,Activator,"5-({[(3,4-difluorophenyl)sulfonyl]amino}methyl)-6-methyl-N-[(2-methyl-1,3-thiazol-5-yl)methyl]pyrazine-2-carboxamide",601,Inner Protein regulator,Inner Protein,27618671,Structural Basis for Negative Allosteric Modulation of GluN2A-Containing NMDA Receptors.,No,"Chain B:ALA217,GLU276,GLU273,PRO130,PHE131,MET272,THR243,PHE19,VAL132,VAL267,GLU133,VAL129,LEU264,LEU263,PHE62,THR134,GLY244,LEU280"
ASD02030000_4,GRIN2A,Homo sapiens,Q12879,5H8H,ASD02030180,5YC,B,Lig,Activator,"7-[[ethyl(phenyl)amino]methyl]-2-methyl-[1,3,4]thiadiazolo[3,2-a]pyrimidin-5-one",303,Inner Protein regulator,Inner Protein,26875626,Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function.,No,5H8H
ASD02030000_4,GRIN2A,Homo sapiens,Q12879,5H8Q,ASD02030181,5YE,B,Lig,Activator,"6-[[ethyl-(4-fluorophenyl)amino]methyl]-2,3-dihydro-1~{H}-cyclopenta[3,4][1,3]thiazolo[1,4-~{a}]pyrimidin-8-one",302,Inner Protein regulator,Inner Protein,26875626,Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function.,No,5H8Q
ASD02030000_4,GRIN2A,Homo sapiens,Q12879,5I2K,ASD02030763,67H,B,Lig,Activator,"7-{[ethyl(4-fluorophenyl)amino]methyl}-N,2- dimethyl-5-oxo-5H-[1,3]thiazolo[3,2-a]pyrimidine- 3-carboxamide",302,Inner Protein Regulator,Allosteric Position,26919761,Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design.,No,5I2K
ASD02030000_4,GRIN2A,Homo sapiens,Q12879,5I2N,ASD02030764,67J,A,Lig,Activator,"N-ethyl-7-{[2-fluoro-3-(trifluoromethyl)phenyl]methyl}- 2-methyl-5-oxo-5H-[1,3]thiazolo[3,2-a]pyrimidine- 3-carboxamide",303,Inner Protein Regulator,Allosteric Position,26919761,Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design.,No,5I2N
ASD02030000_4,GRIN2A,Homo sapiens,Q12879,5KCJ,ASD02030769,6RM,B,Lig,Activator,"7-[(4-fluoranylphenoxy)methyl]-3-[(1~{R},2~{R})-2-(hydroxymethyl)cyclopropyl]-2-methyl-[1,3]thiazolo[3,2-a]pyrimidin-5-one",302,Inner Protein regulator,Inner Protein,26875626,Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function.,No,5KCJ
ASD02030000_4,GRIN2A,Homo sapiens,Q12879,5KDT,ASD02030373,6RV,A,Lig,Activator,"(1~{R},2~{R})-2-[7-[[5-chloranyl-3-(trifluoromethyl)pyrazol- 1-yl]methyl]-5-oxidanylidene-2-(trifluoromethyl)- [1,3]thiazolo[3,2-a]pyrimidin-3-yl]cyclopropane- 1-carbonitrile",303,Inner Protein Regulator,Allosteric Position,26919761,Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design.,No,5KDT
ASD02030000_4,GRIN2A,Homo sapiens,Q12879,5TP9,ASD02030654,7H0,A,Lig,Regulator,"7-{[5-chloro-3-(trifluoromethyl)-1H-pyrazol- 1-yl]methyl}-N-ethyl-2-methyl-5-oxo-5H-[1,3]thiazolo[3,2- a]pyrimidine-3-carboxamide",303,Inner Protein Regulator,Inner Protein,28105280,GluN2A-Selective Pyridopyrimidinone Series of NMDAR Positive Allosteric Modulators with an Improved in Vivo Profile.,No,5TP9
ASD02030000_4,GRIN2A,Homo sapiens,Q12879,5TPA,ASD02030772,7H2,A,Lig,Regulator,"(1R,2R)-2-(2-{[5-chloro-3-(trifluoromethyl)- 1H-pyrazol-1-yl]methyl}-7-methyl-4-oxo-4H- pyrido[1,2-a]pyrimidin-6-yl)cyclopropane- 1-carbonitrile",302,Inner Protein Regulator,Inner Protein,28105280,GluN2A-Selective Pyridopyrimidinone Series of NMDAR Positive Allosteric Modulators with an Improved in Vivo Profile.,No,5TPA
ASD02080000_1,cysK,Salmonella typhimurium,P0A1E3,1FCJ,ASD01630003,CL,A,Ion,Inhibitor,chloride,2006,Inner Protein Regulator,Protein-Protein Interaction,11023792,Identification of an allosteric anion-binding site on O-acetylserine sulfhydrylase: structure of the enzyme with chloride bound.,No,"Chain A:ARG34,ILE267,LEU268; Chain C:ASN7"
ASD02090000_1,opd,Brevundimonas diminuta,P0A434,1QW7,ASD01030021,EBP,A,Lig,Inhibitor,1-(diethoxyphosphorylmethyl)-4-methyl-benzene,702,Inner Protein Regulator,Inner Protein,16188223,Structural and mutational studies of organophosphorus hydrolase reveal a cryptic and functional allosteric-binding site.,No,"Chain A:PHE51,THR350"
ASD02130000_2,PANK1,Homo sapiens,Q8TE04,2I7N,ASD05550001,ACO,A,Lig,Inhibitor,"S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxy-2-hydroxy-3,3-dimethyl-butanoyl]amino]propanoylamino]ethyl] ethanethioate",796,Inner Protein Regulator,Protein-Protein Interaction,17631502,Crystal structures of human pantothenate kinases. Insights into allosteric regulation and mutations linked to a neurodegeneration disorder.,No,2I7N
ASD02160000_2,,Cyanidioschyzon merolae strain 10D,M1VAN7,3WMG,ASD02160003;ASD02160003;ASD02160003;ASD02160003;ASD02160003;ASD02160003;ASD02160003;ASD02160003;ASD02160003;ASD02160003;ASD02160003;ASD02160003;ASD02160003;ASD02160003;ASD02160003;ASD02160003;ASD02160003;ASD02160003,ACE;DTR;LEU;ASP;GLN;ILE;VAL;TRP;PHE;ASN;ALA;PRO;GLY;ASP;LEU;HIS;LEU;CYS,B;B;B;B;B;B;B;B;B;B;B;B;B;B;B;B;B,Pep,Inhibitor,"ethanal;(2R)-2-amino-3-(1H-indol-3-yl)propanoic acid;(2S)-2-amino-4-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid;(2S)-2,5-diamino-5-oxo-pentanoic acid;(2S,3S)-2-amino-3-methyl-pentanoic acid;(2S)-2-amino-3-methyl-butanoic acid;(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid;(2S)-2-amino-3-phenyl-propanoic acid;(2S)-2,4-bis(azanyl)-4-oxidanylidene-butanoic acid;(2S)-2-aminopropanoic acid;(2S)-pyrrolidine-2-carboxylic acid;2-aminoethanoic acid;(2S)-2-azanylbutanedioic acid;(2S)-2-amino-4-methyl-pentanoic acid;(2S)-2-amino-3-(1H-imidazol-3-ium-4-yl)propanoic acid;(2S)-2-amino-4-methyl-pentanoic acid;(2R)-2-amino-3-sulfanyl-propanoic acid",0;1;2;3;4;5;6;7;8;9;10;11;12;13;14;15;16,Inner Protein Regulator,Inner Protein,24591620,Structural basis for gating mechanisms of a eukaryotic P-glycoprotein homolog.,No,"Chain A:ARG144,LYS162,TYR163,GLY166,ILE257,PHE258,ASN375,ASN378; Chain B:CYS17"
ASD02170000_2,PAH,Homo sapiens,P00439,5FII,ASD10090002,PHE,"A,B,C,D",Lig,Activator,PHENYLALANINE,901,Inner Protein Regulator,Allosteric Position,27049649,Structural Basis for Ligand-Dependent Dimerization of Phenylalanine Hydroxylase Regulatory Domain.,No,5FII
ASD02180000_1,ipdC,Azospirillum brasilense,P51852,2Q5O,ASD02180002,PPY,A,Lig,Activator,2-oxo-3-phenyl-propanoic acid,5003,Inner Protein Regulator,Inner Protein,17905741,Molecular mechanism of allosteric substrate activation in a thiamine diphosphate-dependent decarboxylase.,No,"Chain A:ARG60,ARG214,ARG215,MET238,ARG240,GLY241,LEU242,LEU375,GLY394,LEU395,MET396,ALA397"
ASD02180000_1,ipdC,Azospirillum brasilense,P51852,2Q5Q,ASD02180003,KPV,A,Lig,Activator,2-oxo-5-phenyl-pentanoic acid,5004,Inner Protein Regulator,Inner Protein,17905741,Molecular mechanism of allosteric substrate activation in a thiamine diphosphate-dependent decarboxylase.,No,"Chain A:ARG60,TYR61,ARG214,ARG215,MET238,ARG240,GLY241,LEU242,LEU375,GLY394,LEU395,MET396,ALA397"
ASD02190000_1,PDE4D,Homo sapiens,Q08499,3IAD,ASD02190017,15X,A,Lig,Inhibitor,1-[4-[[2-fluoro-4-methoxy-3-(3-nitrophenyl)phenyl]methyl]phenyl]urea,901,Inner Protein Regulator,Inner Protein,20037581,Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety.,Yes,3IAD
ASD02190000_1,PDE4D,Homo sapiens,Q08499,5TKB,ASD02190025,7DJ,A,Lig,Inhibitor,"N-[(2R)-2,3-dihydroxy-2-methylpropyl]-8-(methylamino)-6-[(2,3,5,6-tetrafluorophenyl)amino]imidazo[1,2-b]pyridazine-3-carboxamide",807,Allosteric function,Allosteric position,30108788,"Identification of imidazo[1,2-b]pyridazine TYK2 pseudokinase ligands as potent and selective allosteric inhibitors of TYK2 signalling.",No,5TKB
ASD02190000_1,PDE4D,Homo sapiens,Q08499,6BOJ,ASD02190026,E31,A,Lig,Inhibitor,2-(4-{[2-(3-chlorophenyl)-6-ethylpyrimidin-4-yl]methyl}phenyl)acetamide,703,Allosteric function,Allosteric position,30131563,"Memory enhancing effects of BPN14770, an allosteric inhibitor of phosphodiesterase-4D, in wild-type and humanized mice.",No,6BOJ
ASD02190000_1,PDE4D,Homo sapiens,Q08499,6NJH,,KRD,A,lig,Inhibitor,"2-(4-{[4-(3-chlorophenyl)-6-ethyl-1,3,5-triazin-2-yl]amino}phenyl)acetamide",609,Allosteric function,Allosteric position,,,Yes,6NJH
ASD02190000_1,PDE4D,Homo sapiens,Q08499,6NJI,,KR4,A,lig,Inhibitor,"2-(4-{[4-(3-chlorophenyl)-6-ethyl-1,3,5-triazin-2-yl]amino}phenyl)ethan-1-ol",702,Allosteric function,Allosteric position,,,Yes,6NJI
ASD02190000_1,PDE4D,Homo sapiens,Q08499,6NJJ,,KR7,A,lig,Inhibitor,(4-{[2-(3-chlorophenyl)-6-(trifluoromethyl)pyridin-4-yl]methyl}phenyl)acetic acid,609,Allosteric function,Allosteric position,,,Yes,6NJJ
ASD02200000_1,PDE5A,Homo sapiens,O76074,1TBF,ASD02200004,VIA,A,Lig,Inhibitor,"5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonyl-phenyl]-1-methyl-3-propyl-6H-pyrazolo[5,4-e]pyrimidin-7-one",501,Inner Protein Regulator,Inner Protein,15260978,A glutamine switch mechanism for nucleotide selectivity by phosphodiesterases.,Yes,1TBF
ASD02200000_1,PDE5A,Homo sapiens,O76074,6VBI,,FZA,A,Lig,Inhibitor,"(13bS)-4,9-dimethoxy-14-methyl-8,13,13b,14-tetrahydroindolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(7H)-one",901,,,,,,6VBI
ASD02200000_3,Pde5a,Mus musculus,Q8CG03,2K31,ASD09090001,35G,A,Lig,Activator,"GUANOSINE-3',5'-MONOPHOSPHATE",1,Inner Protein Regulator,Inner Protein,18534985,"Solution Structure of the cGMP Binding GAF Domain from Phosphodiesterase 5: Insights into Nucleotide Selectivity, Dimerization, and cGMP-Dependent Conformational Change.",No,"Chain A:ARG174,TYR175,SER176,PHE178,PHE195,ASP196,ILE211,LEU213,GLY218,ILE219,VAL220,ALA235,TYR236,ARG240,PHE241,ASN242,GLU244,VAL245,THR249,TYR251,THR253,ILE256,GLN273,ILE275"
ASD02210000_1,ppc,Escherichia coli,P00864,1FIY,ASD01260006,ASP,A,Lig,Inhibitor,(2S)-2-azanylbutanedioic acid,884,Inner Protein Regulator,Inner Protein,9927652,Three-dimensional structure of phosphoenolpyruvate carboxylase: a proposed mechanism for allosteric inhibition.,No,"Chain A:ARG587,MET769,LYS773,MET819,ILE825,ARG832,ARG880,ASN881"
ASD02210000_1,ppc,Escherichia coli,P00864,1JQN,ASD01260006,ASP,A,Lig,Inhibitor,(2S)-2-azanylbutanedioic acid,884,Inner Protein Regulator,Inner Protein,12467579,Crystal structures of C4 form maize and quaternary complex of E. coli phosphoenolpyruvate carboxylases.,No,"Chain A:ARG587,PRO591,MET769,LYS773,ILE825,ARG832,MET879,ARG880,ASN881"
ASD02210000_1,,Escherichia coli,P00864,1QB4,ASD01260006,ASP,A,Lig,Inhibitor,ASPARTIC ACID,884,Inner Protein Regulator,Inner Protein,10481043,Plausible phosphoenolpyruvate binding site revealed by 2.6 A structure of Mn2+-bound phosphoenolpyruvate carboxylase from Escherichia coli.,No,"Chain A:GLY586,MET769,GLU86,MET819,MET766,ILE829,GLY588,ARG587,ILE825,ASN881,MET616,PRO591,ARG880,LYS773,LEU822,SER828,ARG832,MET879,GLY878"
ASD02210000_2,PEP1,Zea mays,P04711,5VYJ,ASD10090003,GLY,A,Lig,Activator,GLYCINE,1001,Inner Protein regulator,Inner Protein,29743237,Identification of the allosteric site for neutral amino acids in the maize C4isozyme of phosphoenolpyruvate carboxylase: The critical role of Ser-100.,No,"Chain B:ASP228,LEU97,GLU229,LEU957,HIS53,PHE225,ARG226,HIS104,ALA224,LEU941,THR227,ILE96,SER100,LEU938"
ASD02210000_2,PEP1,Zea mays,P04711,6MGI,,G6P,A,Lig,Activator,6-O-phosphono-alpha-D-glucopyranose,1002,Allosteric function,Allosteric position,,,No,
ASD02220000_1,pfkB,Escherichia coli,P06999,3CQD,ASD00150001,ATP,B,Lig,Inhibitor,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",312,Inner Protein Regulator,Protein-Protein Interaction,18762190,Crystallographic structure of phosphofructokinase-2 from Escherichia coli in complex with two ATP molecules. Implications for substrate inhibition.,Yes,"Chain A:ASN187,LYS189,GLY226,PRO227,THR251; Chain B:TYR23,PRO24,GLY26,LYS27"
ASD02220000_1,pfkB,Escherichia coli,P06999,3UMO,ASD00150001,ATP,B,Lig,Inhibitor,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",312,Inner Protein Regulator,Protein-Protein Interaction,23823238,A Ribokinase Family Conserved Monovalent Cation Binding Site Enhances the MgATP-induced Inhibition in E. coli Phosphofructokinase-2,Yes,"Chain A:ASN187,LYS189,GLY226,PRO227,THR251; Chain B:TYR23,PRO24,GLY26,LYS27"
ASD02220000_1,pfkB,Escherichia coli,P06999,3UQD,,ATP,A,Lig,Inhibitor,ADENOSINE-5'-TRIPHOSPHATE,404,,,,Studying the phosphoryl transfer mechanism of the E. coli phosphofructokinase-2: from X-ray structure to quantum mechanics/molecular mechanics simulations,,
ASD02230000_1,serA,Mycobacterium tuberculosis,P9WNX3,3DC2,ASD01260004,SER,A,Lig,Inhibitor,(2S)-2-amino-3-hydroxy-propanoic acid,600,Inner Protein Regulator,Inner Protein,18627175,Structural analysis of substrate and effector binding in Mycobacterium tuberculosis D-3-phosphoglycerate dehydrogenase.,No,"Chain A:TYR461,ASP463,ARG464,PRO465,GLY466,ALA467,LEU468,LEU487"
ASD02230000_2,serA,Escherichia coli,P0A9T0,1PSD,ASD01260004,SER,A,Lig,Inhibitor,(2S)-2-amino-3-hydroxy-propanoic acid,451,Inner Protein Regulator,Inner Protein,7719856,The allosteric ligand site in the Vmax-type cooperative enzyme phosphoglycerate dehydrogenase.,No,"Chain A:HIS344,GLU345,ASN346,ARG347,PRO348,GLY349,VAL350,LEU351,LEU370"
ASD02230000_2,serA,Escherichia coli,P0A9T0,2P9C,ASD01260004,SER,A,Lig,Inhibitor,(2S)-2-amino-3-hydroxy-propanoic acid,451,Inner Protein Regulator,Inner Protein,17459882,The effect of hinge mutations on effector binding and domain rotation in Escherichia coli D-3-phosphoglycerate dehydrogenase.,No,"Chain A:HIS344,GLU345,ASN346,ARG347,PRO348,GLY349,LEU351,LEU370,THR372"
ASD02230000_2,serA,Escherichia coli,P0A9T0,2P9G,ASD01260004,SER,A,Lig,Inhibitor,(2S)-2-amino-3-hydroxy-propanoic acid,451,Inner Protein Regulator,Inner Protein,17459882,The effect of hinge mutations on effector binding and domain rotation in Escherichia coli D-3-phosphoglycerate dehydrogenase.,No,"Chain A:HIS344,ASN346,ARG347,PRO348,GLY349,VAL350,LEU351,LEU370,THR372; Chain B:ASN364,ILE365"
ASD02230000_2,serA,Escherichia coli,P0A9T0,2PA3,ASD01260004,SER,A,Lig,Inhibitor,(2S)-2-amino-3-hydroxy-propanoic acid,451,Inner Protein Regulator,Inner Protein,17459882,The effect of hinge mutations on effector binding and domain rotation in Escherichia coli D-3-phosphoglycerate dehydrogenase.,No,"Chain A:HIS344,ASN346,ARG347,PRO348,GLY349,VAL350,LEU351,LEU370"
ASD02280000_1,prs,Bacillus subtilis,P14193,1DKR,ASD02880002,SO4,A,Ion,Activator,sulfate,1004,Inner Protein Regulator,Protein-Protein Interaction,10742175,Structural basis for the function of Bacillus subtilis phosphoribosyl-pyrophosphate synthetase.,No,"Chain A:GLN309,SER310,VAL311,SER312; Chain B:ARG109"
ASD02280000_1,prs,Bacillus subtilis,P14193,1DKU,ASD02280001,AP2,A,Lig,Inhibitor,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]methylphosphonic acid",1002,Inner Protein Regulator,Protein-Protein Interaction,10742175,Structural basis for the function of Bacillus subtilis phosphoribosyl-pyrophosphate synthetase.,No,"Chain A:GLN140,ASP148,HIS149,SER310,VAL311,SER312,PHE315; Chain B:LYS105,ALA106,ARG107,SER108,ARG109"
ASD02280000_1,prs,Bacillus subtilis,P14193,1IBS,ASD02880002,SO4,A,Ion,Activator,sulfate,1004,Inner Protein Regulator,Protein-Protein Interaction,11790837,Binding of cations in Bacillus subtilis phosphoribosyldiphosphate synthetase and their role in catalysis.,No,"Chain A:SER310,VAL311,SER312; Chain B:ARG109"
ASD02280000_2,PRPS1,Homo sapiens,P60891,2H06,ASD02880002,SO4,A,Ion,Activator,sulfate,1006,Inner Protein Regulator,Protein-Protein Interaction,16939420,Crystal structure of human phosphoribosylpyrophosphate synthetase 1 reveals a novel allosteric site.,No,2H06
ASD02280000_2,PRPS1,Homo sapiens,P60891,2H07,ASD02880002,SO4,A,Ion,Activator,sulfate,1006,Inner Protein Regulator,Protein-Protein Interaction,16939420,Crystal structure of human phosphoribosylpyrophosphate synthetase 1 reveals a novel allosteric site.,No,2H07
ASD02280000_2,PRPS1,Homo sapiens,P60891,2H08,ASD02880002,SO4,A,Ion,Activator,sulfate,1006,Inner Protein Regulator,Protein-Protein Interaction,16939420,Crystal structure of human phosphoribosylpyrophosphate synthetase 1 reveals a novel allosteric site.,No,2H08
ASD02280000_2,PRPS1,Homo sapiens,P60891,2HCR,ASD02880002,SO4,A,Ion,Activator,sulfate,1006,Inner Protein Regulator,Protein-Protein Interaction,16939420,Crystal structure of human phosphoribosylpyrophosphate synthetase 1 reveals a novel allosteric site.,No,2HCR
ASD02280000_2,PRPS1,Homo sapiens,P60891,3S5J,ASD02880002,SO4,A,Ion,Activator,sulfate,1006,Inner Protein Regulator,Protein-Protein Interaction,25781187,Crystal and EM Structures of Human Phosphoribosyl Pyrophosphate Synthase I (PRS1) Provide Novel Insights into the Disease-Associated Mutations,No,3S5J
ASD02360000_1,NR1I2,Homo sapiens,O75469,6XP9,,QCG,"A, B",Lig,Inhibitor,"(2S)-tert-butoxy[7-(8-fluoro-5-methyl-3,4-dihydro-2H-1-benzopyran-6-yl)-5-methyl-2-phenylpyrazolo[1,5-a]pyrimidin-6-yl]acetic acid",501,,,,,,6XP9
ASD02370000_3,pheA,Chlorobium tepidum,Q8KBW6,2QMX,ASD02170001,PHE,A,Lig,Inhibitor,(2S)-2-amino-3-phenyl-propanoic acid,303,Inner Protein Regulator,Protein-Protein Interaction,18171624,Structures of open (R) and close (T) states of prephenate dehydratase (PDT) - implication of allosteric regulation by L-phenylalanine.,No,"Chain A:ASP224,LEU225,THR226,LYS227,ILE228; Chain B:ASN206,GLU207,GLY209,SER210,LEU211,SER230,TYR240,PHE242"
ASD02370000_4,pheA,Arthrobacter aurescens,A1R118,3MWB,ASD02170001,PHE,B,Lig,Inhibitor,(2S)-2-amino-3-phenyl-propanoic acid,311,Inner Protein Regulator,Protein-Protein Interaction,,The Crystal Structure of Prephenate dehydratase in complex with L-Phe from Arthrobacter aurescens to 2.0A,No,"Chain A:ASN226,LEU227,SER228,ARG229,ILE230; Chain B:LEU205,ASP208,HIS209,PRO210,GLY211,ALA212,LEU213,SER232,TYR242,PHE244"
ASD02400000_1,BCY1,Homo sapiens,P07278,3OF1,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",501,Protein-Protein Interaction Regulator,Inner Protein,21070946,Structure of Yeast Regulatory Subunit: A Glimpse into the Evolution of PKA Signaling.,No,3OF1
ASD02400000_9,Prkaca,Mus musculus,P05132,4DFX,ASD02400001,MYR,E,Lig,Activator,tetradecanoic acid,401,Inner Protein Regulator,Inner Protein,22617327,Role of N-terminal myristylation in the structure and regulation of cAMP-dependent protein kinase.,No,"Chain E:GLY1,ASN2,ALA3,ALA4,GLU11,SER14,PHE18,LEU19,PHE100,LEU152,GLU155,TYR156,ILE303,TYR306"
ASD02400000_9,Prkaca,Mus musculus,P05132,4DFZ,ASD02400001,MYR,E,Lig,Activator,tetradecanoic acid,401,Inner Protein Regulator,Inner Protein,22617327,Role of N-terminal myristylation in the structure and regulation of cAMP-dependent protein kinase.,No,"Chain E:GLY1,ASN2,ALA3,ALA4,GLU11,SER14,PHE18,LEU19,PHE100,LEU152,GLU155,TYR156,ILE303,TYR306"
ASD02440000_1,PTPN1,Homo sapiens,P18031,1T48,ASD02440028,BB3,A,Lig,Inhibitor,"3-(3,5-dibromo-4-hydroxy-phenyl)carbonyl-2-ethyl-N,N-dimethyl-1-benzofuran-6-sulfonamide",299,Inner Protein Regulator,Inner Protein,15258570,Allosteric inhibition of protein tyrosine phosphatase 1B.,No,1T48
ASD02440000_1,PTPN1,Homo sapiens,P18031,1T49,ASD02440002,892,A,Lig,Inhibitor,"3-(3,5-dibromo-4-hydroxy-phenyl)carbonyl-2-ethyl-N-(4-sulfamoylphenyl)-1-benzofuran-6-sulfonamide",301,Inner Protein Regulator,Inner Protein,15258570,Allosteric inhibition of protein tyrosine phosphatase 1B.,No,1T49
ASD02440000_1,PTPN1,Homo sapiens,P18031,1T4J,ASD02440027,FRJ,A,Lig,Inhibitor,"3-(3,5-dibromo-4-hydroxy-phenyl)carbonyl-2-ethyl-N-[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]-1-benzofuran-6-sulfonamide",299,Inner Protein Regulator,Inner Protein,15258570,Allosteric inhibition of protein tyrosine phosphatase 1B.,No,1T4J
ASD02440000_1,PTPN1,Homo sapiens,P18031,5QDF,,AWG,A,Lig,Inhibitor,"~{N}2-(1~{H}-benzimidazol-2-yl)benzene-1,2-diamine",,,,29877794,"An expanded allosteric network in PTP1B by multitemperature crystallography, fragment screening, and covalent tethering.",,5QDF
ASD02440000_1,PTPN1,Homo sapiens,P18031,5QGF,,F8D,A,Lig,Inhibitor,"1-[(3S,3aS,8bS)-7-chloro-3-(hydroxymethyl)-2,3,3a,8b-tetrahydro-1H-[1]benzofuro[3,2-b]pyrrol-1-yl]ethan-1-one",,,,29877794,"An expanded allosteric network in PTP1B by multitemperature crystallography, fragment screening, and covalent tethering.",,5QGF
ASD02440000_1,PTPN1,Homo sapiens,P18031,5T19,ASD02440057,73U,A,Lig,Inhibitor,"5-[4-methyl-4'-(methylamino)[1,1'-biphenyl]-3-yl]-1lambda~6~,2,5-thiadiazolidine-1,1,3-trione",402,Allosteric function,Allosteric position,28345882,Covalent Allosteric Inactivation of Protein Tyrosine Phosphatase 1B (PTP1B) by an Inhibitor-Electrophile Conjugate.,No,5T19
ASD02440000_1,PTPN1,Homo sapiens,P18031,6B95,ASD02440058,D0P,A,Lig,Inhibitor,"N-(2',4'-difluoro-4-hydroxy[1,1'-biphenyl]-3-yl)-2-sulfanylacetamide",402,Allosteric function,Allosteric position,29877794,"An expanded allosteric network in PTP1B by multitemperature crystallography, fragment screening, and covalent tethering.",No,6B95
ASD02440000_1,PTPN1,Homo sapiens,P18031,6W30,,SJA,A,Lig,Inhibitor,Amorphadiene,502,,,,,,6W30
ASD02470000_1,,Saccharomyces cerevisiae,P06169,2VK1,ASD00340002,PYR,A,Lig,Activator,PYRUVIC ACID,603,Inner Protein Regulator,Inner Protein,19246454,Covalently bound substrate at the regulatory site of yeast pyruvate decarboxylases triggers allosteric enzyme activation.,No,"Chain A:CYS222,ASP312,HIS313,PHE309,ALA287,SER311,HIS92,HIS310,CYS221,HIS225,VAL285,LEU288,ALA220,GLY286,MET326"
ASD02470000_1,,Saccharomyces cerevisiae,P06169,2VK8,ASD02470003,2OP,A,Lig,Activator,(2S)-2-HYDROXYPROPANOIC ACID,1566,Inner Protein Regulator,Inner Protein,19246454,Covalently bound substrate at the regulatory site of yeast pyruvate decarboxylases triggers allosteric enzyme activation.,No,"Chain A:ASP312,PHE309,ALA287,SER311,HIS92,HIS310,CYS221,HIS225,VAL285,LEU288,ARG161,ALA220,GLY286,MET326"
ASD02470000_3,,Kluyveromyces lactis,Q12629,2VJY,ASD02470009,ALK,A,Lig,Activator,(1R)-1-[DIHYDROXY(METHOXY)-LAMBDA^5^-PHOSPHANYL]ETHANOL,603,Inner Protein Regulator,Inner Protein,19246454,Covalently Bound Substrate at the Regulatory Site of Yeast Pyruvate Decarboxylases Triggers Allosteric Enzyme Activation.,No,"Chain A:CYS222,ASP312,TYR313,PHE309,ALA287,SER311,HIS92,HIS310,CYS221,HIS225,VAL285,LEU288,ARG161,ALA220,GLY286,MET326"
ASD02490000_1,PDK2,Homo sapiens,Q15119,2BU2,ASD02490001,TF1,A,Lig,Inhibitor,"4-[(2R,5S)-2,5-dimethyl-4-[(2R)-3,3,3-trifluoro-2-hydroxy-2-methyl-propanoyl]piperazin-1-yl]carbonylbenzonitrile",1387,Inner Protein Regulator,Inner Protein,16401071,Regulatory roles of the N-terminal domain based on crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands.,No,2BU2
ASD02490000_1,PDK2,Homo sapiens,Q15119,2BU5,ASD02490001,TF1,A,Lig,Inhibitor,"4-[(2R,5S)-2,5-dimethyl-4-[(2R)-3,3,3-trifluoro-2-hydroxy-2-methyl-propanoyl]piperazin-1-yl]carbonylbenzonitrile",1386,Inner Protein Regulator,Inner Protein,16401071,Regulatory roles of the N-terminal domain based on crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands.,No,2BU5
ASD02490000_1,PDK2,Homo sapiens,Q15119,2BU6,ASD02490006,TF2,A,Lig,Inhibitor,"(2R)-N-[4-(ethyl-phenyl-sulfamoyl)-2-methyl-phenyl]-3,3,3-trifluoro-2-hydroxy-2-methyl-propanamide",1386,Inner Protein Regulator,Inner Protein,16401071,Regulatory roles of the N-terminal domain based on crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands.,No,2BU6
ASD02490000_1,PDK2,Homo sapiens,Q15119,2BU7,ASD02498001,TF3,A,Lig,Inhibitor,N-(2-aminoethyl)-2-[3-chloro-4-[(4-propan-2-ylphenyl)methoxy]phenyl]ethanamide,1386,Inner Protein Regulator,Inner Protein,16401071,Regulatory roles of the N-terminal domain based on crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands.,No,2BU7
ASD02490000_1,PDK2,Homo sapiens,Q15119,2BU8,ASD02490002,TF4,A,Lig,Inhibitor,"2,2-dichloroethanoic acid",1379,Inner Protein Regulator,Inner Protein,16401071,Regulatory roles of the N-terminal domain based on crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands.,No,2BU8
ASD02500000_1,CDC19,Saccharomyces cerevisiae,P00549,1A3W,ASD00200001,FBP,A,Lig,Activator,"[(2R,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate",1007,Inner Protein Regulator,Inner Protein,9519410,"The allosteric regulation of pyruvate kinase by fructose-1,6-bisphosphate.",No,"Chain A:LEU401,SER402,THR403,SER404,GLY405,THR406,THR407,PRO408,TRP452,ARG459,GLN483,GLY484,GLY490,HIS491,SER492"
ASD02500000_2,PKM,Homo sapiens,P14618,1T5A,ASD00200001,FBP,A,Lig,Activator,"[(2R,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate",532,Inner Protein Regulator,Inner Protein,15996096,Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis.,No,1T5A
ASD02500000_2,PKM,Homo sapiens,P14618,3BJF,ASD00200001,FBP,A,Lig,Activator,"[(2R,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate",532,Inner Protein Regulator,Inner Protein,18337815,Pyruvate kinase M2 is a phosphotyrosine-binding protein.,No,3BJF
ASD02500000_2,PKM,Homo sapiens,P14618,3GQY,ASD00200001,FBP,A,Lig,Activator,"[(2R,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate",541,Inner Protein Regulator,Inner Protein,Not in PubMed,Activator-Bound Structures of Human Pyruvate Kinase M2,No,3GQY
ASD02500000_2,PKM,Homo sapiens,P14618,3GR4,ASD00200001,FBP,A,Lig,Activator,"[(2R,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate",541,Inner Protein Regulator,Inner Protein,Not in PubMed,Activator-Bound Structures of Human Pyruvate Kinase M2,No,3GR4
ASD02500000_2,PKM,Homo sapiens,P14618,3H6O,ASD00200001,FBP,A,Lig,Activator,"[(2R,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate",541,Inner Protein Regulator,Inner Protein,Not in PubMed,Activator-Bound Structures of Human Pyruvate Kinase M2,No,3H6O
ASD02500000_2,PKM,Homo sapiens,P14618,4B2D,ASD01260004,SER,A,Lig,Activator,(2S)-2-amino-3-hydroxy-propanoic acid,1532,Inner Protein Regulator,Inner Protein,23064226,Serine is a Natural Ligand and Allosteric Activator of Pyruvate Kinase M2,No,4B2D
ASD02500000_2,PKM,Homo sapiens,P14618,4B2D,ASD00200001,FBP,A,Lig,Activator,"[(2R,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate",600,Inner Protein Regulator,Inner Protein,23064226,Serine is a Natural Ligand and Allosteric Activator of Pyruvate Kinase M2,No,4B2D
ASD02500000_2,PKM,Homo sapiens,P14618,4FXF,ASD00200001,FBP,A,Lig,Activator,"[(2R,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate",604,Inner Protein Regulator,Inner Protein,23530218,M2 pyruvate kinase provides a mechanism for nutrient sensing and regulation of cell proliferation.,No,4FXF
ASD02500000_2,PKM,Homo sapiens,P14618,4G1N,ASD02500037,NZT,A,Lig,Activator,N-[4-(4-pyrazin-2-ylpiperazin-1-yl)carbonylphenyl]quinoline-8-sulfonamide,603,Inner Protein Regulator,Protein-Protein Interaction,22999886,Small Molecule Activation of PKM2 in Cancer Cells Induces Serine Auxotrophy.,No,4G1N
ASD02500000_2,PKM,Homo sapiens,P14618,5X0I,,FBP,A,Lig,Activator,"1,6-di-O-phosphono-beta-D-fructofuranose",601,,,,Mutations in the PKM2 exon-10 region are associated with reduced allostery and increased nuclear translocation,,5X0I
ASD02500000_2,PKM,Homo sapiens,P14618,6GG3,,ALA,A,lig,Inhibitor,ALANINE,533,Allosteric function,Inner Protein,,,No,6GG3
ASD02500000_2,PKM,Homo sapiens,P14618,6GG4,ASD10090002,PHE,A,Lig,Inhibitor,PHENYLALANINE,603,Allosteric function,Allosteric position,29748232,An allostatic mechanism for M2 pyruvate kinase as an amino-acid sensor.,No,6GG4
ASD02500000_2,PKM,Homo sapiens,P14618,6GG5,ASD05860010,TRP,A,Lig,Inhibitor,TRYPTOPHAN,603,Allosteric function,Allosteric position,29748232,An allostatic mechanism for M2 pyruvate kinase as an amino-acid sensor.,No,6GG5
ASD02500000_2,PKM,Homo sapiens,P14618,6GG6,ASD03470003,SER,A,Lig,Activator,SERINE,603,Allosteric function,Allosteric position,29748232,An allostatic mechanism for M2 pyruvate kinase as an amino-acid sensor.,No,6GG6
ASD02500000_2,PKM,Homo sapiens,P14618,6NU1,,CYS,A,Lig,Inhibitor,CYSTEINE,601,Allosteric function,Allosteric position,,,No,6NU1
ASD02500000_2,PKM,Homo sapiens,P14618,6NU5,,CYS,A,Lig,Inhibitor,CYSTEINE,601,Allosteric function,Allosteric position,,,No,6NU5
ASD02500000_2,PKM,Homo sapiens,P14618,6NUB,,SER,A,Lig,Activator,SERINE,601,Allosteric function,Allosteric position,,,No,6NUB
ASD02500000_2,PKM,Homo sapiens,P14618,6V74,,ASN,C,Lig,Activator,ASPARAGINE,604,,,,,,6V74
ASD02500000_2,PKM,Homo sapiens,P14618,6V75,,ASP,B,Lig,Activator,ASPARTIC ACID,610,,,,,,6V75
ASD02500000_2,PKM,Homo sapiens,P14618,6V76,,VAL,C,Lig,Inhibitor,VALINE,611,,,,,,6V76
ASD02500000_3,PKLR,Homo sapiens,P30613,2VGB,ASD00200001,FBP,A,Lig,Activator,"[(2R,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate",580,Inner Protein Regulator,Inner Protein,11960989,Structure and Function of Human Erythrocyte Pyruvate Kinase. Molecular Basis of Nonspherocytic Hemolytic Anemia.,No,2VGB
ASD02500000_3,PKLR,Homo sapiens,P30613,2VGF,ASD00200001,FBP,A,Lig,Activator,"[(2R,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate",580,Inner Protein Regulator,Inner Protein,11960989,Structure and Function of Human Erythrocyte Pyruvate Kinase. Molecular Basis of Nonspherocytic Hemolytic Anemia,No,2VGF
ASD02500000_3,PKLR,Homo sapiens,P30613,2VGG,ASD00200001,FBP,A,Lig,Activator,"[(2R,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate",580,Inner Protein Regulator,Inner Protein,11960989,Structure and Function of Human Erythrocyte Pyruvate Kinase. Molecular Basis of Nonspherocytic Hemolytic Anemia,No,2VGG
ASD02500000_3,PKLR,Homo sapiens,P30613,2VGI,ASD00200001,FBP,A,Lig,Activator,"[(2R,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate",1574,Inner Protein Regulator,Inner Protein,11960989,Structure and Function of Human Erythrocyte Pyruvate Kinase. Molecular Basis of Nonspherocytic Hemolytic Anemia.,No,2VGI
ASD02500000_3,PKLR,Homo sapiens,P30613,4IP7,ASD00200001,FBP,A,Lig,Activator,"[(2R,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate",603,Inner Protein Regulator,Inner Protein,23270483,Energetic Coupling between an Oxidizable Cysteine and the Phosphorylatable N-Terminus of Human Liver Pyruvate Kinase.,No,4IP7
ASD02500000_3,PKLR,Homo sapiens,P30613,6NN4,,FBP,A,Lig,Activator,"BETA-FRUCTOSE-1,6-DIPHOSPHATE",601,Allosteric function,Protein-Protein Interaction,,,No,6NN4
ASD02500000_4,PKM,Oryctolagus cuniculus,P11974,2G50,ASD02500002,ALA,A,Lig,Regulator,L-alanine,6101,Inner Protein Regulator,Inner Protein,16634623,Differentiating a Ligand's Chemical Requirements for Allosteric Interactions from Those for Protein Binding. Phenylalanine Inhibition of Pyruvate Kinase.,No,"Chain A:GLY67,ILE46,ARG105,ARG42,PHE469,PRO470,HIS463,ASN69,THR44,TYR465,LEU464,ALA462,GLY45,ASN43,ILE468,GLY467"
ASD02500000_4,PKM,Oryctolagus cuniculus,P11974,3N25,ASD03150001,PRO,A,Lig,Regulator,(2S)-pyrrolidine-2-carboxylic acid,1200,Inner Protein Regulator,Inner Protein,20629175,"The pyruvate kinase model system, a cautionary tale for the use of osmolyte perturbations to support conformational equilibria in allostery.",No,"Chain A:ARG42,ASN43,ASN69,ARG105,HIS463,TYR465,GLY467,ILE468,PHE469,PRO470"
ASD02500000_8,PYK,Leishmania mexicana,Q27686,3HQP,ASD01120132,FDP,A,Lig,Activator,"[(2S,3S,4S,5R)-3,4-dihydroxy-2-(hydroxymethyl)-5-(phosphonooxymethyl)oxolan-2-yl] dihydrogen phosphate",700,Inner Protein Regulator,Inner Protein,20123988,The allosteric mechanism of pryuvate kinase from Leishmania mexicana: a rock and lock model,No,"Chain A:LEU399,SER400,ASN401,THR402,ARG404,SER405,LYS453,ARG456,HIS480,ALA481,VAL485,LYS486,GLY487,TYR488,ALA489"
ASD02500000_8,PYK,Leishmania mexicana,Q27686,3HQQ,ASD01120132,FDP,A,Lig,Activator,"[(2S,3S,4S,5R)-3,4-dihydroxy-2-(hydroxymethyl)-5-(phosphonooxymethyl)oxolan-2-yl] dihydrogen phosphate",700,Inner Protein Regulator,Inner Protein,20123988,The allosteric mechanism of pryuvate kinase from Leishmania mexicana: a rock and lock model,No,"Chain A:LEU399,SER400,ASN401,THR402,ARG404,SER405,LYS453,ARG456,ILE479,HIS480,ALA481,LYS486,GLY487,TYR488,ALA489"
ASD02500000_9,PYK1,Trypanosoma brucei brucei,P30615,4HYV,ASD01120132,FDP,A,Lig,Activator,"[(2S,3S,4S,5R)-3,4-dihydroxy-2-(hydroxymethyl)-5-(phosphonooxymethyl)oxolan-2-yl] dihydrogen phosphate",1004,Inner Protein Regulator,Inner Protein,23999300,`In crystallo' substrate binding triggers major domain movements and reveals magnesium as a co-activator of Trypanosoma brucei pyruvate kinase.,No,"Chain A:LEU400,SER401,ASN402,THR403,ARG405,SER406,LYS454,ARG457,HIS481,ALA482,VAL486,LYS487,GLY488,TYR489,PRO490"
ASD02500000_9,PYK1,Trypanosoma brucei brucei,P30615,4HYW,ASD01120132,FDP,A,Lig,Activator,"[(2S,3S,4S,5R)-3,4-dihydroxy-2-(hydroxymethyl)-5-(phosphonooxymethyl)oxolan-2-yl] dihydrogen phosphate",503,Inner Protein Regulator,Inner Protein,23999300,`In crystallo' substrate binding triggers major domain movements and reveals magnesium as a co-activator of Trypanosoma brucei pyruvate kinase.,No,"Chain A:LEU400,SER401,ASN402,THR403,ARG405,SER406,LYS454,ARG457,HIS481,ALA482,VAL486,LYS487,GLY488,TYR489,PRO490"
ASD02510000_1,recA,Escherichia coli,P0A7G6,1XMS,ASD00498001,ANP,A,Lig,Regulator,"[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]amino]phosphonic acid",400,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,15610008,Crystal structures of Escherichia coli RecA in complex with MgADP and MnAMP-PNP.,No,"Chain A:PRO67,GLU68,SER69,SER70,GLY71,LYS72,THR73,THR74,ASP100,TYR103,GLN194,SER240,ILE262,TYR264,GLY265"
ASD02510000_1,recA,Escherichia coli,P0A7G6,1XMV,ASD01720027,ADP,A,Lig,Regulator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate",400,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,15610008,Crystal structures of Escherichia coli RecA in complex with MgADP and MnAMP-PNP.,No,"Chain A:PRO67,GLU68,SER69,SER70,GLY71,LYS72,THR73,THR74,ASP100,TYR103,GLN194,SER240,ILE262,TYR264,GLY265"
ASD02510000_1,recA,Escherichia coli,P0A7G6,3CMU,ASD01720027,ADP,A,Lig,Regulator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate",502,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,18497818,Mechanism of homologous recombination from the RecA-ssDNA/dsDNA structures.,No,"Chain A:PRO67,GLU68,SER69,SER70,GLY71,LYS72,THR73,THR74,ASP100,TYR103,SER240,TYR264,LYS1248,ASN1249,LYS1250,ILE1251,ALA1252,ALA1253,PRO1254"
ASD02510000_1,recA,Escherichia coli,P0A7G6,3CMV,ASD00498001,ANP,A,Lig,Regulator,"[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]amino]phosphonic acid",400,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,18497818,Mechanism of homologous recombination from the RecA-ssDNA/dsDNA structures.,No,"Chain A:GLU68,SER69,SER70,GLY71,LYS72,THR73,THR74,ASP100,TYR103,SER240,TYR264"
ASD02510000_1,recA,Escherichia coli,P0A7G6,3CMW,ASD01720027,ADP,A,Lig,Regulator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate",502,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,18497818,Mechanism of homologous recombination from the RecA-ssDNA/dsDNA structures.,No,"Chain A:SER69,SER70,GLY71,LYS72,THR73,THR74,ASP100,TYR103,SER240,TYR264,ASN1249,LYS1250,ILE1251,ALA1252,ALA1253,PRO1254"
ASD02510000_1,recA,Escherichia coli,P0A7G6,3CMX,ASD01720027,ADP,A,Lig,Regulator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate",502,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,18497818,Mechanism of homologous recombination from the RecA-ssDNA/dsDNA structures.,No,"Chain A:PRO67,GLU68,SER69,SER70,GLY71,LYS72,THR73,THR74,ASP100,TYR103,SER240,TYR264,ASN1249,LYS1250,ILE1251,ALA1252,ALA1253,PRO1254"
ASD02510000_2,recA,Mycobacterium smegmatis,Q7X416,2G88,ASD00870004,DTP,A,Lig,Activator,"[[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",833,Protein-DNA/RNA Interaction Regulator,Inner Protein,16648362,Crystallographic identification of an ordered C-terminal domain and a second nucleotide-binding site in RecA: new insights into allostery.,No,"Chain A:SER48,VAL51,LYS258,GLN259,GLU261,MET279,GLU282,HIS283,PRO346,ASP348"
ASD02520000_1,RCVRN,Bos taurus,P21457,4YI8,ASD11630001,CA,A,Ion,Activator,CALCIUM ION,301,Allosteric function,Allosteric position,26584024,Crystal Structure of Recoverin with Calcium Ions Bound to Both Functional EF Hands.,No,"Chain A:LEU81,ASP82,ALA75,GLU85,ASP74,PHE73,ASP78,ARG43,GLY79,ASN76,THR80,SER77"
ASD02520000_1,RCVRN,Bos taurus,P21457,4YI8,ASD11630001,CA,A,Ion,Activator,CALCIUM ION,302,Allosteric function,Allosteric position,26584024,Crystal Structure of Recoverin with Calcium Ions Bound to Both Functional EF Hands.,No,"Chain A:GLU121,TYR109,ILE117,SER118,ASP112,VAL111,GLY113,ASN114,ASP110,THR116,GLY115"
ASD02560000_1,gag-pol,Human immunodeficiency virus type 1,P04585,3AO2,ASD05062029,AVX,A,Lig,Inhibitor,"5-(7-bromo-1,3-benzodioxol-5-yl)-2-methyl-pyrazol-3-amine",1,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21275048,Fragment-based design of ligands targeting a novel site on the integrase enzyme of human immunodeficiency virus 1,No,"Chain A:TYR83,TRP108,ASN184,HIS185,ARG187,SER195,GLY197,GLU198,VAL201; Chain B:GLY106,ARG107,TRP108,PRO109"
ASD02560000_1,gag-pol,Human immunodeficiency virus type 1,P04585,3I0R,ASD02560079,RT3,A,Lig,Inhibitor,"S-[2-[(2-chloro-4-sulfamoyl-phenyl)amino]-2-oxo-ethyl] 6-methyl-3,4-dihydro-2H-quinoline-1-carbothioate",601,Inner Protein Regulator,Inner Protein,19631528,Substituted tetrahydroquinolines as potent allosteric inhibitors of reverse transcriptase and its key mutants.,No,"Chain A:LEU100,LYS101,LYS102,LYS103,LYS104,SER105,VAL106,VAL179,TYR181,TYR188,PRO225,TRP229,LEU234,HIS235,PRO236,TYR318"
ASD02560000_1,gag-pol,Human immunodeficiency virus type 1,P04585,3I0S,ASD02560083,RT7,A,Lig,Inhibitor,"S-[2-[(2-chloro-4-sulfamoyl-phenyl)amino]-2-oxo-ethyl] 6,8-dichloro-3,4-dihydro-2H-quinoline-1-carbothioate",601,Inner Protein Regulator,Inner Protein,19631528,Substituted tetrahydroquinolines as potent allosteric inhibitors of reverse transcriptase and its key mutants.,No,"Chain A:LEU100,LYS101,LYS102,LYS103,LYS104,SER105,VAL106,VAL179,TYR181,TYR188,PRO225,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318"
ASD02580000_1,nrdA,Escherichia coli,P00452,2R1R,ASD02040015,TTP,A,Lig,Regulator,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",762,Inner Protein Regulator,Protein-Protein Interaction,9309223,Binding of allosteric effectors to ribonucleotide reductase protein R1: reduction of active-site cysteines promotes substrate binding.,No,"Chain A:ASP232,SER233,LEU234,ARG262,ILE268,ARG269,HIS275,THR276; Chain B:SER249"
ASD02580000_1,nrdA,Escherichia coli,P00452,3R1R,ASD00150001,ATP,A,Lig,Activator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",762,Inner Protein Regulator,Inner Protein,9309223,Binding of allosteric effectors to ribonucleotide reductase protein R1: reduction of active-site cysteines promotes substrate binding.,No,"Chain A:LYS9,GLU15,ARG16,ILE17,ASN18,LYS21,ILE22,VAL25,THR55,HIS59,LYS91"
ASD02580000_1,nrdA,Escherichia coli,P00452,3UUS,ASD00870004,DTP,A,Lig,Regulator,"[[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",900,Inner Protein Regulator,Protein-Protein Interaction,22160671,Structural interconversions modulate activity of Escherichia coli ribonucleotide reductase.,No,"Chain A:ASP232,SER233,LEU234,ILE237,ILE261,ARG262,ILE268,HIS275,THR276,PHE281; Chain B:SER249,CYS292"
ASD02580000_1,nrdA,Escherichia coli,P00452,3UUS,ASD00870004,DTP,A,Lig,Inhibitor,"[[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",800,Inner Protein Regulator,Inner Protein,22160671,Structural interconversions modulate activity of Escherichia coli ribonucleotide reductase.,No,"Chain A:VAL7,LYS9,GLU15,ARG16,ILE17,ASN18,ILE22,THR55,ILE58,HIS59,PHE87,LYS91"
ASD02580000_1,nrdA,Escherichia coli,P00452,4R1R,ASD02040015,TTP,A,Lig,Regulator,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",762,Inner Protein Regulator,Protein-Protein Interaction,9309223,Binding of allosteric effectors to ribonucleotide reductase protein R1: reduction of active-site cysteines promotes substrate binding.,No,"Chain A:ASP232,SER233,LEU234,ILE237,ARG262,ILE268,ARG269,HIS275,THR276,PHE281; Chain B:SER249,ALA292"
ASD02580000_1,nrdA,Escherichia coli,P00452,5CNS,ASD00870004,DTP,A,Lig,Regulator,2'-DEOXYADENOSINE 5'-TRIPHOSPHATE,804,Allosteric function,Allosteric position,26754917,Molecular basis for allosteric specificity regulation in class Ia ribonucleotide reductase from Escherichia coli.,Yes,"Chain B:GLN250,GLY295,LYS246,GLN294,SER291,GLY296,CYS292,VAL248,SER249,SER293"
ASD02580000_1,nrdA,Escherichia coli,P00452,5CNS,ASD00870004,DTP,A,Lig,Inhibitor,2'-DEOXYADENOSINE 5'-TRIPHOSPHATE,804,Allosteric Function,Allosteric Position,26754917,Molecular basis for allosteric specificity regulation in class Ia ribonucleotide reductase from Escherichia coli.,No,"Chain B:GLN250,GLY295,LYS246,GLN294,SER291,GLY296,CYS292,VAL248,SER249,SER293"
ASD02580000_1,nrdA,Escherichia coli,P00452,5CNT,ASD00870004,DTP,A,Lig,Regulator,2'-DEOXYADENOSINE 5'-TRIPHOSPHATE,802,Allosteric function,Allosteric position,26754917,Molecular basis for allosteric specificity regulation in class Ia ribonucleotide reductase from Escherichia coli.,Yes,"Chain A:GLY95,VAL7,ASP11,THR8,GLN96,ARG10,PHE87,GLU15,LYS9,ILE17,HIS59,ARG16,ASN18,SER56,VAL25,LEU19,ILE58,LYS91,PHE49,THR55,LEU84,LYS21,ILE62,ILE22"
ASD02580000_1,nrdA,Escherichia coli,P00452,5CNU,ASD09690001,DGT,A,Lig,Regulator,2'-DEOXYGUANOSINE-5'-TRIPHOSPHATE,801,Allosteric function,Allosteric position,26754917,Molecular basis for allosteric specificity regulation in class Ia ribonucleotide reductase from Escherichia coli.,Yes,"Chain B:GLN250,GLY295,LYS246,GLN294,SER291,GLY296,CYS292,VAL248,SER249,SER293"
ASD02580000_1,nrdA,Escherichia coli,P00452,5CNV,ASD02040015,TTP,A,Lig,Regulator,THYMIDINE-5'-TRIPHOSPHATE,804,Allosteric function,Allosteric position,26754917,Molecular basis for allosteric specificity regulation in class Ia ribonucleotide reductase from Escherichia coli.,Yes,"Chain A:LYS91,PHE87,PHE97,GLU15,LYS9,LYS21,ARG24,GLU98,TRP28,VAL25"
ASD02580000_2,nrdJ,Thermotoga maritima,O33839,1XJE,ASD02040015,TTP,A,Lig,Regulator,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",1005,Inner Protein Regulator,Protein-Protein Interaction,15475969,Structural mechanism of allosteric substrate specificity regulation in a ribonucleotide reductase.,No,"Chain A:ASP141,SER142,ILE143,ILE146,ARG171,VAL177,ALA178,GLY179,ALA184,SER185,PHE190; Chain B:LYS158,VAL200,VAL201,LYS202"
ASD02580000_2,nrdJ,Thermotoga maritima,O33839,1XJF,ASD00870004,DTP,A,Lig,Regulator,"[[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1002,Inner Protein Regulator,Protein-Protein Interaction,15475969,Structural mechanism of allosteric substrate specificity regulation in a ribonucleotide reductase.,No,"Chain A:ASP141,SER142,ILE143,ILE146,ARG171,VAL177,ALA178,GLY179,THR180,LYS183,ALA184,SER185,PHE190; Chain B:LYS158,VAL200,VAL201,LYS202"
ASD02580000_2,nrdJ,Thermotoga maritima,O33839,1XJG,ASD00870004,DTP,A,Lig,Regulator,"[[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1004,Inner Protein Regulator,Protein-Protein Interaction,15475969,Structural Mechanism of Allosteric Substrate Specificity Regulation in a Ribonucleotide Reductase,No,"Chain A:ASP141,SER142,ILE143,ILE146,ARG171,VAL177,ALA178,GLY179,THR180,LYS183,ALA184,SER185,PHE190; Chain B:LYS158,VAL200,VAL201,LYS202"
ASD02580000_2,nrdJ,Thermotoga maritima,O33839,1XJJ,ASD09690001,DGT,A,Lig,Regulator,"[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1001,Inner Protein Regulator,Protein-Protein Interaction,15475969,Structural Mechanism of Allosteric Substrate Specificity Regulation in a Ribonucleotide Reductase,No,"Chain A:ASP141,SER142,ILE143,ILE146,ARG171,VAL177,ALA178,ALA184,SER185,PHE190; Chain B:HIS127,LYS158,VAL200,VAL201"
ASD02580000_2,nrdJ,Thermotoga maritima,O33839,1XJK,ASD09690001,DGT,A,Lig,Regulator,"[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1003,Inner Protein Regulator,Protein-Protein Interaction,15475969,Structural mechanism of allosteric substrate specificity regulation in a ribonucleotide reductase.,No,"Chain A:ASP141,SER142,ILE143,ILE146,ARG171,VAL177,ALA178,ALA184,SER185,PHE190; Chain B:LYS158,VAL200,VAL201,GLN203"
ASD02580000_2,nrdJ,Thermotoga maritima,O33839,1XJM,ASD02040015,TTP,A,Lig,Regulator,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",1001,Inner Protein Regulator,Protein-Protein Interaction,15475969,Structural mechanism of allosteric substrate specificity regulation in a ribonucleotide reductase.,No,"Chain A:ASP141,SER142,ILE143,ILE146,ARG171,VAL177,ALA178,GLY179,THR180,ALA184,SER185,PHE190; Chain B:LYS158,VAL200,VAL201"
ASD02580000_2,nrdJ,Thermotoga maritima,O33839,1XJN,ASD00870004,DTP,A,Lig,Regulator,"[[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1005,Inner Protein Regulator,Protein-Protein Interaction,15475969,Structural Mechanism of Allosteric Substrate Specificity Regulation in a Ribonucleotide Reductase,No,"Chain A:ASP141,SER142,ILE143,ILE146,ARG171,VAL177,ALA178,ALA184,SER185,PHE190; Chain B:LYS158,VAL200,VAL201,LYS202"
ASD02580000_2,nrdJ,Thermotoga maritima,O33839,3O0N,ASD02040015,TTP,A,Lig,Regulator,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",1001,Inner Protein Regulator,Protein-Protein Interaction,20672854,Structural Basis for Adenosylcobalamin Activation in AdoCbl-Dependent Ribonucleotide Reductases.,No,"Chain A:ASP141,SER142,ILE143,ILE146,ARG171,VAL177,ALA178,GLY179,ALA184,SER185,PHE190; Chain B:LYS158,VAL200,VAL201,LYS202"
ASD02580000_2,nrdJ,Thermotoga maritima,O33839,3O0O,ASD02040015,TTP,A,Lig,Regulator,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",1001,Inner Protein Regulator,Protein-Protein Interaction,20672854,Structural Basis for Adenosylcobalamin Activation in AdoCbl-Dependent Ribonucleotide Reductases.,No,"Chain A:ASP141,SER142,ILE143,ILE146,LEU170,ARG171,PHE176,VAL177,ALA178,GLY179,ALA184,SER185,PHE190; Chain B:LYS158,VAL200,VAL201,LYS202"
ASD02580000_2,nrdJ,Thermotoga maritima,O33839,3O0Q,ASD02040015,TTP,A,Lig,Regulator,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",1001,Inner Protein Regulator,Protein-Protein Interaction,20672854,Structural Basis for Adenosylcobalamin Activation in AdoCbl-Dependent Ribonucleotide Reductases.,No,"Chain A:ASP141,SER142,ILE143,ILE146,ARG171,VAL177,ALA178,GLY179,ALA184,SER185,PHE190; Chain B:LYS158,VAL200,VAL201,LYS202"
ASD02580000_3,nrdE,Salmonella typhimurium,Q08698,1PEO,ASD00900001,DCP,A,Lig,Regulator,"[(2R,3S,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3-hydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",716,Inner Protein Regulator,Protein-Protein Interaction,12818204,Structure of the large subunit of class Ib ribonucleotide reductase from Salmonella typhimurium and its complexes with allosteric effectors.,No,"Chain A:ASP185,ASN186,MET187,ILE190,ARG215,ILE221,LYS222"
ASD02580000_3,nrdE,Salmonella typhimurium,Q08698,1PEQ,ASD02040015,TTP,A,Lig,Regulator,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",716,Inner Protein Regulator,Protein-Protein Interaction,12818204,Structure of the large subunit of class Ib ribonucleotide reductase from Salmonella typhimurium and its complexes with allosteric effectors.,No,"Chain A:ASP185,ASN186,MET187,ILE190,LEU214,ARG215,ILE221,LYS222,SER228,SER229"
ASD02580000_3,nrdE,Salmonella typhimurium,Q08698,1PEU,ASD00870004,DTP,A,Lig,Regulator,"[[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",716,Inner Protein Regulator,Protein-Protein Interaction,12818204,Structure of the large subunit of class Ib ribonucleotide reductase from Salmonella typhimurium and its complexes with allosteric effectors.,No,"Chain A:ASP185,ASN186,MET187,ARG215,ILE221,LYS222"
ASD02580000_3,nrdE,Salmonella typhimurium,Q08698,2BQ1,ASD09690001,DGT,E,Lig,Regulator,"[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1700,Inner Protein Regulator,Protein-Protein Interaction,16631785,The First Holocomplex Structure of Ribonucleotide Reductase Gives New Insight Into its Mechanism of Action,No,"Chain E:ASP185,ASN186,MET187,ILE190,LEU214,ARG215,ILE221,LYS222; Chain F:LYS202,TYR244,ALA245,ASN246"
ASD02580000_6,RRM1,Homo sapiens,P23921,2WGH,ASD00870004,DTP,A,Lig,Regulator,"[[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1745,Inner Protein Regulator,Protein-Protein Interaction,21336276,Structural Basis for Allosteric Regulation of Human Ribonucleotide Reductase by Nucleotide-Induced Oligomerization.,No,2WGH
ASD02580000_6,RRM1,Homo sapiens,P23921,3HNC,ASD02040015,TTP,A,Lig,Regulator,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",802,Inner Protein Regulator,Protein-Protein Interaction,21336276,Structural basis for allosteric regulation of human ribonucleotide reductase by nucleotide-induced oligomerization.,No,3HNC
ASD02580000_6,RRM1,Homo sapiens,P23921,3HND,ASD02040015,TTP,A,Lig,Regulator,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",802,Inner Protein Regulator,Protein-Protein Interaction,21336276,Structural basis for allosteric regulation of human ribonucleotide reductase by nucleotide-induced oligomerization.,No,3HND
ASD02580000_6,RRM1,Homo sapiens,P23921,3HNE,ASD02040015,TTP,B,Lig,Regulator,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",805,Inner Protein Regulator,Protein-Protein Interaction,21336276,Structural basis for allosteric regulation of human ribonucleotide reductase by nucleotide-induced oligomerization.,No,3HNE
ASD02580000_6,RRM1,Homo sapiens,P23921,3HNE,ASD00150001,ATP,B,Lig,Activator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",807,Inner Protein Regulator,Inner Protein,21336276,Structural basis for allosteric regulation of human ribonucleotide reductase by nucleotide-induced oligomerization.,No,3HNE
ASD02580000_6,RRM1,Homo sapiens,P23921,3HNF,ASD02040015,TTP,B,Lig,Regulator,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",803,Inner Protein Regulator,Protein-Protein Interaction,21336276,Structural basis for allosteric regulation of human ribonucleotide reductase by nucleotide-induced oligomerization.,No,3HNF
ASD02580000_6,RRM1,Homo sapiens,P23921,3HNF,ASD00870004,DTP,B,Lig,Inhibitor,"[[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",805,Inner Protein Regulator,Inner Protein,21336276,Structural basis for allosteric regulation of human ribonucleotide reductase by nucleotide-induced oligomerization.,No,3HNF
ASD02580000_6,RRM1,Homo sapiens,P23921,6AUI,,DTP,A,Lig,Inhibitor,2'-DEOXYADENOSINE 5'-TRIPHOSPHATE,801,Allosteric function,Allosteric position,29460780,3.3- angstrom resolution cryo-EM structure of human ribonucleotide reductase with substrate and allosteric regulators bound.,No,6AUI
ASD02580000_7,NRDD,Enterobacteria phage T4,P07071,1H78,ASD00900001,DCP,A,Lig,Regulator,"[(2R,3S,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3-hydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",1589,Inner Protein Regulator,Protein-Protein Interaction,11587648,Structural Basis for Allosteric Substrate Specificty Regulation in Anaerobic Ribonucleotide Reductase,No,"Chain A:GLN98,ILE99,GLU100,PRO102,LYS103,SER104,VAL107,ALA110,ILE111,GLN114,LYS146"
ASD02580000_7,NRDD,Enterobacteria phage T4,P07071,1H79,ASD02040015,TTP,A,Lig,Regulator,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",1586,Inner Protein Regulator,Protein-Protein Interaction,11587648,Structural Basis for Allosteric Substrate Specificty Regulation in Anaerobic Ribonucleotide Reductase,No,"Chain A:ILE99,GLU100,THR101,LYS103,VAL107,ALA110,ILE111,GLN114,LYS146"
ASD02580000_7,NRDD,Enterobacteria phage T4,P07071,1H7A,ASD00870004,DTP,A,Lig,Regulator,"[[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1590,Inner Protein Regulator,Protein-Protein Interaction,11587648,Structural Basis for Allosteric Substrate Specificty Regulation in Anaerobic Ribonucleotide Reductase,No,"Chain A:ILE99,GLU100,LYS103,SER104,VAL107,ILE111,GLN114,LYS146"
ASD02580000_7,NRDD,Enterobacteria phage T4,P07071,1HK8,ASD09690001,DGT,A,Lig,Regulator,"[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1587,Inner Protein Regulator,Protein-Protein Interaction,12655046,A Metal-Binding Site in the Catalytic Subunit of Anaerobic Ribonucleotide Reductase.,No,"Chain A:ILE99,GLU100,THR101,PRO102,LYS103,VAL107,ALA110,ILE111,GLN114,LYS146"
ASD02580000_8,RNR1,Saccharomyces cerevisiae,P21524,3RSR,ASD02580032,N5P,A,Lig,Regulator,[[5-(5-nitroindol-1-yl)-3-oxidanyl-oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate,841,Inner Protein Regulator,Protein-Protein Interaction,22933704,Evaluating the therapeutic potential of a non-natural nucleotide that inhibits human ribonucleotide reductase.,No,"Chain A:ASP226,SER227,ILE228,ILE231,ILE255,ARG256,ILE262,ALA263,GLY264,THR265,SER269"
ASD02580000_8,RNR1,Saccharomyces cerevisiae,P21524,3S87,ASD09690001,DGT,A,Lig,Regulator,"[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1001,Inner Protein Regulator,Protein-Protein Interaction,,Structural and biochemical basis of lethal mutant R293A of yeast ribonucleotide reductase,No,"Chain A:ASP226,SER227,ILE228,ILE231,ILE255,ARG256,ILE262,ALA263,GLY264,ASN270"
ASD02580000_8,RNR1,Saccharomyces cerevisiae,P21524,3S8A,ASD09690001,DGT,A,Lig,Regulator,"[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1001,Inner Protein Regulator,Protein-Protein Interaction,,Structural and biochemical basis of lethal mutant R293A of yeast ribonucleotide reductase,No,"Chain A:ASP226,SER227,ILE228,ILE231,ARG256,ILE262,ALA263,GLY264,ASN270"
ASD02580000_8,RNR1,Saccharomyces cerevisiae,P21524,3S8B,ASD00498001,ANP,A,Lig,Regulator,"[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]amino]phosphonic acid",890,Inner Protein Regulator,Protein-Protein Interaction,,Structural and biochemical basis of lethal mutant R293A of yeast ribonucleotide reductase,No,"Chain A:ASP226,SER227,ILE228,ILE231,ARG256,ILE262,ALA263,SER269"
ASD02580000_8,RNR1,Saccharomyces cerevisiae,P21524,3S8C,ASD00498001,ANP,A,Lig,Regulator,"[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]amino]phosphonic acid",889,Inner Protein Regulator,Protein-Protein Interaction,,Structural and biochemical basis of lethal mutant R293A of yeast ribonucleotide reductase,No,"Chain A:ASP226,SER227,ILE228,ILE231,ARG256,ILE262,ALA263,ASN270"
ASD02580000_8,RNR1,Saccharomyces cerevisiae,P21524,3TB9,ASD00498001,ANP,A,Lig,Regulator,"[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]amino]phosphonic acid",890,Inner Protein Regulator,Protein-Protein Interaction,22465672,Role of Arginine 293 and Glutamine 288 in Communication between Catalytic and Allosteric Sites in Yeast Ribonucleotide Reductase.,No,"Chain A:ASP226,SER227,ILE228,ILE231,ARG256,ILE262,ALA263"
ASD02580000_8,RNR1,Saccharomyces cerevisiae,P21524,3TBA,ASD09690001,DGT,A,Lig,Regulator,"[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",890,Inner Protein Regulator,Protein-Protein Interaction,22465672,Role of Arginine 293 and Glutamine 288 in Communication between Catalytic and Allosteric Sites in Yeast Ribonucleotide Reductase.,No,"Chain A:ASP226,SER227,ILE228,ILE231,ARG256,ILE262,ALA263,GLY264"
ASD02670000_1,ALB,Homo sapiens,P02768,1E7B,ASD02670007;ASD02670007,HLT;HLT,A;A,Lig,Inhibitor,"(2R)-2-bromo-2-chloro-1,1,1-trifluoro-ethane",4001;4002,Inner Protein Regulator,Inner Protein,10940305,Binding of the general anesthetics propofol and halothane to human serum albumin. High resolution crystal structures,No,1E7B
ASD02670000_1,ALB,Homo sapiens,P02768,1E7C,ASD02670007,HLT,A,Lig,Inhibitor,"(2R)-2-bromo-2-chloro-1,1,1-trifluoro-ethane",4005,Inner Protein Regulator,Inner Protein,10940306,Binding of the general anesthetics propofol and halothane to human serum albumin. High resolution crystal structures,No,1E7C
ASD02670000_1,ALB,Homo sapiens,P02768,1E7C,ASD02670007;ASD02670007,HLT;HLT,A;A,Lig,Inhibitor,"(2R)-2-bromo-2-chloro-1,1,1-trifluoro-ethane",4001;4002,Inner Protein Regulator,Inner Protein,10940306,Binding of the general anesthetics propofol and halothane to human serum albumin. High resolution crystal structures,No,1E7C
ASD02670000_1,ALB,Homo sapiens,P02768,2BX8,ASD02670012,AZQ,A,Lig,Inhibitor,"5-dimethylamino-9-methyl-2-prop-2-enyl-pyrazolo[1,2-a][1,2,4]benzotriazine-1,3-dione",2001,Inner Protein Regulator,Inner Protein,16169013,Structural basis of the drug-binding specificity of human serum albumin,No,2BX8
ASD02670000_1,ALB,Homo sapiens,P02768,2BXA,ASD02670013,C1F,A,Lig,Inhibitor,2-(2-carboxyethyl)-4-methyl-5-propyl-furan-3-carboxylic acid,2001,Inner Protein Regulator,Inner Protein,16169014,Structural basis of the drug-binding specificity of human serum albumin,No,2BXA
ASD02670000_1,ALB,Homo sapiens,P02768,2BXB,ASD02670014,OPB,A,Lig,Inhibitor,"(4S)-4-butyl-1-(4-hydroxyphenyl)-2-phenyl-pyrazolidine-3,5-dione",2001,Inner Protein Regulator,Inner Protein,16169015,Structural basis of the drug-binding specificity of human serum albumin,No,2BXB
ASD02670000_1,ALB,Homo sapiens,P02768,2BXC,ASD02670015,P1Z,A,Lig,Inhibitor,"4-butyl-1,2-diphenyl-pyrazolidine-3,5-dione",2001,Inner Protein Regulator,Inner Protein,16169016,Structural basis of the drug-binding specificity of human serum albumin,No,2BXC
ASD02670000_1,ALB,Homo sapiens,P02768,2BXD,ASD02670002,RWF,A,Lig,Inhibitor,4-hydroxy-3-[(1R)-3-oxo-1-phenyl-butyl]chromen-2-one,2001,Inner Protein Regulator,Inner Protein,16169017,Structural basis of the drug-binding specificity of human serum albumin,No,2BXD
ASD02670000_1,ALB,Homo sapiens,P02768,2BXE,ASD01140129,1FL,A,Lig,Inhibitor,"5-(2,4-difluorophenyl)-2-hydroxy-benzoic acid",2002,Inner Protein Regulator,Inner Protein,16169018,Structural basis of the drug-binding specificity of human serum albumin,No,2BXE
ASD02670000_1,ALB,Homo sapiens,P02768,2BXE,ASD01140129,1FL,A,Lig,Inhibitor,"5-(2,4-difluorophenyl)-2-hydroxy-benzoic acid",2003,Inner Protein Regulator,Inner Protein,16169018,Structural basis of the drug-binding specificity of human serum albumin,No,2BXE
ASD02670000_1,ALB,Homo sapiens,P02768,2BXG,ASD02670006,IBP,A,Lig,Inhibitor,(2S)-2-[4-(2-methylpropyl)phenyl]propanoic acid,2002,Inner Protein Regulator,Inner Protein,16169020,Structural basis of the drug-binding specificity of human serum albumin,No,2BXG
ASD02670000_1,ALB,Homo sapiens,P02768,2BXH,ASD02670018,IOS,A,Lig,Inhibitor,1H-indol-3-yl hydrogen sulfate,1002,Inner Protein Regulator,Inner Protein,16169021,Structural basis of the drug-binding specificity of human serum albumin,No,2BXH
ASD02670000_1,ALB,Homo sapiens,P02768,3LU6,ASD02670019,IMX,A,Lig,Inhibitor,"2-[(1R,2R)-2-[(5-fluoro-1H-indol-2-yl)carbonylamino]-2,3-dihydro-1H-inden-1-yl]ethanoic acid",586,Inner Protein Regulator,Inner Protein,20869876,A combined spectroscopic and crystallographic approach to probing drug-human serum albumin interactions,No,3LU6
ASD02670000_1,ALB,Homo sapiens,P02768,3LU6,ASD02670019,IMX,A,Lig,Inhibitor,"2-[(1R,2R)-2-[(5-fluoro-1H-indol-2-yl)carbonylamino]-2,3-dihydro-1H-inden-1-yl]ethanoic acid",587,Inner Protein Regulator,Inner Protein,20869876,A combined spectroscopic and crystallographic approach to probing drug-human serum albumin interactions,No,3LU6
ASD02670000_1,ALB,Homo sapiens,P02768,3LU7,ASD02670021,IPX,A,Lig,Inhibitor,"4-[(1R,2R)-2-[(5-fluoro-1H-indol-2-yl)carbonylamino]-2,3-dihydro-1H-inden-1-yl]butanoic acid",586,Inner Protein Regulator,Inner Protein,20869876,A combined spectroscopic and crystallographic approach to probing drug-human serum albumin interactions,No,3LU7
ASD02790000_1,,Arabidopsis thaliana,Q9S7B5,2C2B,ASD00350007;ASD00350007,SAM;SAM,A;A,Lig,Activator,S-ADENOSYLMETHIONINE;S-ADENOSYLMETHIONINE,500;501,Inner Protein Regulator,Inner Protein,16319072,Allosteric threonine synthase. Reorganization of the pyridoxal phosphate site upon asymmetric activation through S-adenosylmethionine binding to a novel site,No,"Chain B:ASP148,GLU137,LYS152,ARG426,PHE134,ASN132,SER131,GLN281,ASN147,TRP135,LEU133,PHE282,TRP150,LYS141,ASN130,ASP283"
ASD02810000_1,TYMS,Homo sapiens,P04818,2ONB,ASD02810004,7PA,A,Lig,Inhibitor,3-phosphonopropylphosphonic acid,319,Inner Protein Regulator,Inner Protein,17297914,Cooperative inhibition of human thymidylate synthase by mixtures of active site binding and allosteric inhibitors,Yes,2ONB
ASD02810000_1,,Homo sapiens,P04818,4FGT,ASD02810013;ASD02810013;ASD02810013;ASD02810013,CYS;GLN;LEU;TYR,D;D;D;D,Pep,Inhibitor,"(2R)-2-amino-3-sulfanyl-propanoic acid;(2S)-2,5-diamino-5-oxo-pentanoic acid;(2S)-2-amino-4-methyl-pentanoic acid;(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid",66;67;68;69,Inner Protein Regulator,Inner Protein,25427005,Alanine mutants of the interface residues of human thymidylate synthase decode key features of the binding mode of allosteric anticancer peptides.,No,4FGT
ASD02810000_1,TYMS,Homo sapiens,P04818,5X69,ASD02810014,7ZC,A,Lig,Inhibitor,"1-(5-methoxy-1H-indol-3-yl)-N,N-dimethyl- methanamine",401,Inner Protein Regulator,Inner Protein,28634233,Structural analyses of human thymidylate synthase reveal a site that may control conformational switching between active and inactive states,No,5X69
ASD02820000_1,TSHR,Homo sapiens,P16473,7XW5,ASD02820002,HOI,L,Compound,,"N-[4-[[5-(3-benzyl-5-hydroxy-4-oxo-1,2-dihydroquinazolin-2-yl)-2-methoxy-phenyl]methoxy]phenyl]acetamide",,,,35940204,,,7XW5
ASD02890000_3,kynA,Xanthomonas campestris pv. campestris,Q8PDA8,2NW8,ASD00320001,TRP,A,Lig,Activator,(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid,308,Inner Protein Regulator,Protein-Protein Interaction,17197414,"Molecular insights into substrate recognition and catalysis by tryptophan 2,3-dioxygenase.",No,"Chain A:ARG85,LYS92,TYR220,SER221,GLU224,ASP225,ASP228"
ASD02900000_1,trpA,Salmonella typhimurium,P00929,1BEU,ASD02900004,IPL,A,Lig,Regulator,3-(1H-indol-3-yl)propyl dihydrogen phosphate,273,Inner Protein Regulator,Inner Protein,9692955,Cryocrystallography and microspectrophotometry of a mutant (alpha D60N) tryptophan synthase alpha 2 beta 2 complex reveals allosteric roles of alpha Asp60.,Yes,"Chain A:PHE22,ALA59,ASN60,ILE64,LEU100,TYR102,ALA129,TYR175,GLY211,GLY213,ILE232,GLY234,SER235"
ASD02900000_1,trpA,Salmonella typhimurium,P00929,1FUY,ASD02900013,FIP,A,Lig,Regulator,3-(5-fluoro-1H-indol-3-yl)propyl dihydrogen phosphate,269,Inner Protein Regulator,Inner Protein,11034989,Structural basis for the impaired channeling and allosteric inter-subunit communication in the beta A169L/beta C170W mutant of tryptophan synthase.,Yes,"Chain A:PHE22,ALA59,ASP60,ILE64,LEU100,TYR102,ALA129,ILE153,TYR175,THR183,GLY184,PHE212,GLY213,SER233,GLY234,SER235"
ASD02900000_1,trpA,Salmonella typhimurium,P00929,1K3U,ASD02908006,IAD,A,Lig,Regulator,(2S)-2-[2-(1H-indol-3-yl)ethanoylamino]butanedioic acid,801,Inner Protein Regulator,Inner Protein,11756456,Crystal structures of a new class of allosteric effectors complexed to tryptophan synthase.,Yes,"Chain A:PHE22,ASP60,ILE64,LEU100,ILE153,TYR175,THR183,GLY184,GLY211,PHE212,GLY213,ILE214,ILE232,SER233,GLY234,SER235"
ASD02900000_1,trpA,Salmonella typhimurium,P00929,1K7E,ASD02900001,IAG,A,Lig,Regulator,2-[2-(1H-indol-3-yl)ethanoylamino]ethanoic acid,401,Inner Protein Regulator,Inner Protein,11756456,Crystal structures of a new class of allosteric effectors complexed to tryptophan synthase.,Yes,"Chain A:PHE22,GLU49,ASP60,ILE64,LEU100,ILE153,TYR175,THR183,PHE212,GLY213,ILE232,GLY234,SER235"
ASD02900000_1,trpA,Salmonella typhimurium,P00929,1K7F,ASD02908007,IAV,A,Lig,Regulator,(2S)-2-[2-(1H-indol-3-yl)ethanoylamino]-3-methyl-butanoic acid,401,Inner Protein Regulator,Inner Protein,11756456,Crystal structures of a new class of allosteric effectors complexed to tryptophan synthase.,Yes,"Chain A:PHE22,ALA59,ASP60,LEU100,TYR102,LEU127,ALA129,ILE153,TYR175,GLY211,PHE212,GLY213,GLY234,SER235"
ASD02900000_1,trpA,Salmonella typhimurium,P00929,1K8Y,ASD02900028,13P,A,Lig,Regulator,(3-hydroxy-2-oxo-propyl) dihydrogen phosphate,701,Inner Protein Regulator,Inner Protein,11756454,Crystal structure of the beta Ser178--> Pro mutant of tryptophan synthase.,Yes,"Chain A:PHE22,GLU49,ILE64,LEU100,TYR175,PHE212,GLY213,SER233,GLY234,SER235"
ASD02900000_1,trpA,Salmonella typhimurium,P00929,1K8Z,ASD02900001,IAG,A,Lig,Regulator,2-[2-(1H-indol-3-yl)ethanoylamino]ethanoic acid,501,Inner Protein Regulator,Inner Protein,11756454,Crystal structure of the beta Ser178--> Pro mutant of tryptophan synthase. A,Yes,"Chain A:PHE22,GLU49,ALA59,ASP60,ILE64,LEU100,ILE153,TYR175,PHE212,ILE232,GLY234,SER235"
ASD02900000_1,trpA,Salmonella typhimurium,P00929,1KFB,ASD02900006,IGP,A,Lig,Regulator,"[(2R,3S)-2,3-dihydroxy-3-(1H-indol-3-yl)propyl] dihydrogen phosphate",550,Inner Protein Regulator,Inner Protein,12460570,On the Role of alphaTHR183 in the Allosteric Regulation and Catalytic Mechanism of Tryptophan Synthase,Yes,"Chain A:PHE22,GLU49,ALA59,ASP60,LEU100,TYR102,ALA129,ILE153,TYR175,PHE212,GLY213,SER233,GLY234,SER235"
ASD02900000_1,trpA,Salmonella typhimurium,P00929,1KFC,ASD02900004,IPL,A,Lig,Regulator,3-(1H-indol-3-yl)propyl dihydrogen phosphate,674,Inner Protein Regulator,Inner Protein,12460570,On the Role of AlphaTHR183 in the Allosteric Regulation and Catalytic Mechanism of Tryptophan Synthase,Yes,"Chain A:PHE22,ALA59,ASP60,LEU100,ALA129,ILE153,TYR175,PHE212,GLY213,ILE232,SER233,GLY234,SER235"
ASD02900000_1,trpA,Salmonella typhimurium,P00929,1TJP,ASD02900027,HPF,A,Lig,Regulator,"[(2R,3R)-2,3-dihydroxy-3-[(2-hydroxyphenyl)amino]propyl] dihydrogen phosphate",1001,Inner Protein Regulator,Inner Protein,16120446,"On the structural basis of the catalytic mechanism and the regulation of the alpha subunit of tryptophan synthase from Salmonella typhimurium and BX1 from maize, two evolutionarily related enzymes.",Yes,"Chain A:PHE22,GLU49,ALA59,ASP60,ILE64,LEU100,TYR175,THR183,GLY184,PHE212,GLY213,ILE232,SER233,GLY234,SER235"
ASD02900000_1,trpA,Salmonella typhimurium,P00929,2CLE,ASD02908001,F6F,A,Lig,Regulator,2-[[4-(trifluoromethoxy)phenyl]carbonylamino]ethyl dihydrogen phosphate,1268,Inner Protein Regulator,Inner Protein,17559195,Synthesis and Characterization of Allosteric Probes of Substrate Channeling in the Tryptophan Synthase Bienzyme Complex.,Yes,"Chain A:GLU49,ALA59,ASP60,LEU100,ALA129,ILE153,TYR175,PHE212,GLY213,ILE232,GLY234,SER235; Chain B:PRO18"
ASD02900000_1,trpA,Salmonella typhimurium,P00929,2CLF,ASD02908001,F6F,A,Lig,Regulator,2-[[4-(trifluoromethoxy)phenyl]carbonylamino]ethyl dihydrogen phosphate,1269,Inner Protein Regulator,Inner Protein,17559195,Synthesis and Characterization of Allosteric Probes of Substrate Channeling in the Tryptophan Synthase Bienzyme Complex.,Yes,"Chain A:GLU49,ALA59,ASP60,LEU100,LEU127,ALA129,ILE153,TYR175,PHE212,GLY213,ILE232,GLY234,SER235; Chain B:PRO18"
ASD02900000_1,trpA,Salmonella typhimurium,P00929,2CLH,ASD02900010,F19,A,Lig,Regulator,2-(naphthalen-2-ylsulfonylamino)ethyl dihydrogen phosphate,1268,Inner Protein Regulator,Inner Protein,17559195,Synthesis and Characterization of Allosteric Probes of Substrate Channeling in the Tryptophan Synthase Bienzyme Complex.,Yes,"Chain A:PHE22,GLU49,ALA59,ASP60,LEU100,LEU127,ALA129,ILE153,TYR175,THR183,GLY184,PHE212,GLY213,ILE232,SER233,GLY234,SER235"
ASD02900000_1,trpA,Salmonella typhimurium,P00929,2CLI,ASD02900008,F9F,A,Lig,Regulator,2-[[4-(trifluoromethoxy)phenyl]sulfonylamino]ethyl dihydrogen phosphate,1269,Inner Protein Regulator,Inner Protein,17559195,Synthesis and Characterization of Allosteric Probes of Substrate Channeling in the Tryptophan Synthase Bienzyme Complex.,Yes,"Chain A:PHE22,GLU49,ALA59,LEU100,LEU127,ALA129,ILE153,TYR175,THR183,GLY184,PHE212,GLY213,ILE232,SER233,GLY234,SER235; Chain B:PRO18"
ASD02900000_1,trpA,Salmonella typhimurium,P00929,2CLK,ASD02900029,G3H,A,Lig,Regulator,[(2R)-2-hydroxy-3-oxo-propyl] dihydrogen phosphate,1268,Inner Protein Regulator,Inner Protein,17559195,Synthesis and Characterization of Allosteric Probes of Substrate Channeling in the Tryptophan Synthase Bienzyme Complex.,Yes,"Chain A:PHE22,ILE64,LEU100,TYR175,THR183,GLY184,PHE212,GLY213,ILE232,SER233,GLY234,SER235"
ASD02900000_1,trpA,Salmonella typhimurium,P00929,2CLL,ASD02900008,F9F,A,Lig,Regulator,2-[[4-(trifluoromethoxy)phenyl]sulfonylamino]ethyl dihydrogen phosphate,1268,Inner Protein Regulator,Inner Protein,17559232,Allosteric Regulation of Substrate Channeling in Tryptophan Synthase: Modulation of the L-Serine Reaction in Stage I of the Beta-Reaction by Alpha-Site Ligands.,Yes,"Chain A:PHE22,GLU49,ALA59,ASP60,ILE64,LEU100,LEU127,ALA129,ILE153,TYR175,THR183,GLY184,PHE212,GLY213,ILE232,SER233,GLY234,SER235; Chain B:PRO18"
ASD02900000_1,trpA,Salmonella typhimurium,P00929,2CLM,ASD02908001,F6F,A,Lig,Regulator,2-[[4-(trifluoromethoxy)phenyl]carbonylamino]ethyl dihydrogen phosphate,1268,Inner Protein Regulator,Inner Protein,17559232,Allosteric Regulation of Substrate Channeling in Tryptophan Synthase: Modulation of the L-Serine Reaction in Stage I of the Beta-Reaction by Alpha-Site Ligands.,Yes,"Chain A:GLU49,ALA59,ASP60,ILE64,LEU100,ALA129,ILE153,TYR175,PHE212,GLY213,GLY234,SER235; Chain B:PRO18"
ASD02900000_1,trpA,Salmonella typhimurium,P00929,2CLO,ASD02900010,F19,A,Lig,Regulator,2-(naphthalen-2-ylsulfonylamino)ethyl dihydrogen phosphate,1268,Inner Protein Regulator,Inner Protein,17559232,Allosteric Regulation of Substrate Channeling in Tryptophan Synthase: Modulation of the L-Serine Reaction in Stage I of the Beta-Reaction by Alpha-Site Ligands.,Yes,"Chain A:PHE22,GLU49,ALA59,ASP60,LEU100,LEU127,ALA129,ILE153,TYR175,THR183,GLY184,PHE212,GLY213,ILE232,GLY234,SER235"
ASD02900000_1,trpA,Salmonella typhimurium,P00929,2J9X,ASD02908005,G3P,A,Lig,Regulator,"[(2R)-2,3-dihydroxypropyl] dihydrogen phosphate",1268,Inner Protein Regulator,Inner Protein,17559232,Allosteric Regulation of Substrate Channeling in Tryptophan Synthase: Modulation of the L-Serine Reaction in Stage I of the Beta-Reaction by Alpha-Site Ligands.,Yes,"Chain A:PHE22,ILE64,LEU100,TYR175,THR183,GLY184,PHE212,GLY213,ILE232,GLY234,SER235"
ASD02900000_1,trpA,Salmonella typhimurium,P00929,2RH9,ASD02900006,IGP,A,Lig,Regulator,"[(2R,3S)-2,3-dihydroxy-3-(1H-indol-3-yl)propyl] dihydrogen phosphate",269,Inner Protein Regulator,Inner Protein,,"Tryptophan synthase complexed with IGP, internal aldimine, pH 9.0.",Yes,"Chain A:PHE22,GLU49,ALA59,ASP60,ILE64,LEU100,ALA129,ILE153,TYR175,PHE212,GLY213,ILE232,SER233,GLY234,SER235"
ASD02900000_1,trpA,Salmonella typhimurium,P00929,3CEP,ASD02908005,G3P,A,Lig,Regulator,"[(2R)-2,3-dihydroxypropyl] dihydrogen phosphate",269,Inner Protein Regulator,Inner Protein,18351684,Structure and mechanistic implications of a tryptophan synthase quinonoid intermediate.,Yes,"Chain A:GLU49,ILE64,TYR175,THR183,GLY184,PHE212,GLY213,ILE232,GLY234,SER235"
ASD02900000_1,trpA,Salmonella typhimurium,P00929,4HN4,ASD02900008,F9F,A,Lig,Regulator,2-[[4-(trifluoromethoxy)phenyl]sulfonylamino]ethyl dihydrogen phosphate,301,Inner Protein Regulator,Inner Protein,23952479,Allostery and substrate channeling in the tryptophan synthase bienzyme complex: evidence for two subunit conformations and four quaternary states.,Yes,"Chain A:PHE22,GLU49,ALA59,ILE64,LEU100,LEU127,ALA129,ILE153,TYR175,ARG179,THR183,GLY184,PHE212,GLY213,ILE232,SER233,GLY234,SER235; Chain B:PRO18"
ASD02900000_1,trpA,Salmonella typhimurium,P00929,4HPJ,ASD02900008,F9F,A,Lig,Regulator,2-[[4-(trifluoromethoxy)phenyl]sulfonylamino]ethyl dihydrogen phosphate,301,Inner Protein Regulator,Inner Protein,23952479,Allostery and substrate channeling in the tryptophan synthase bienzyme complex: evidence for two subunit conformations and four quaternary states.,Yes,"Chain A:PHE22,GLU49,ALA59,ILE64,LEU100,LEU127,ALA129,ILE153,TYR175,THR183,GLY184,PHE212,GLY213,ILE232,SER233,GLY234,SER235; Chain B:PRO18"
ASD02900000_1,trpA,Salmonella typhimurium,P00929,4HPX,ASD02900008,F9F,A,Lig,Regulator,2-[[4-(trifluoromethoxy)phenyl]sulfonylamino]ethyl dihydrogen phosphate,301,Inner Protein Regulator,Inner Protein,23952479,Allostery and substrate channeling in the tryptophan synthase bienzyme complex: evidence for two subunit conformations and four quaternary states.,Yes,"Chain A:PHE22,GLU49,ALA59,ILE64,LEU100,LEU127,ALA129,ILE153,TYR175,THR183,GLY184,PHE212,GLY213,ILE232,SER233,GLY234,SER235; Chain B:PRO18"
ASD02900000_1,trpA,Salmonella typhimurium,P00929,4HT3,ASD02900008,F9F,A,Lig,Regulator,2-[[4-(trifluoromethoxy)phenyl]sulfonylamino]ethyl dihydrogen phosphate,301,Inner Protein Regulator,Inner Protein,23952479,Allostery and substrate channeling in the tryptophan synthase bienzyme complex: evidence for two subunit conformations and four quaternary states.,Yes,"Chain A:PHE22,GLU49,ALA59,ILE64,LEU100,LEU127,ALA129,ILE153,TYR175,LEU177,THR183,GLY184,PHE212,GLY213,ILE232,SER233,GLY234,SER235; Chain B:PRO18"
ASD02900000_1,trpA,Salmonella typhimurium,P00929,4KKX,ASD02908001,F6F,A,Lig,Regulator,2-[[4-(trifluoromethoxy)phenyl]carbonylamino]ethyl dihydrogen phosphate,301,Inner Protein Regulator,Inner Protein,23952479,Allostery and substrate channeling in the tryptophan synthase bienzyme complex: evidence for two subunit conformations and four quaternary states.,Yes,"Chain A:PHE22,GLU49,ALA59,ILE64,LEU100,LEU127,ALA129,ILE153,TYR175,THR183,GLY184,PHE212,GLY213,GLY234,SER235; Chain B:PRO18"
ASD02900000_2,trpB,Salmonella typhimurium,P0A2K1,4WX2,ASD02908001,F6F,"A,B",Lig,,2-{[4-(TRIFLUOROMETHOXY)BENZOYL]AMINO}ETHYL DIHYDROGEN PHOSPHATE,"301A,302A,404B",Protein-Protein Interaction,Protein-Protein Interaction,26708480,Visualizing the tunnel in tryptophan synthase with crystallography: Insights into a selective filter for accommodating indole and rejecting water.,Yes,"Chain B:ASP176,ASN171,GLY193,SER178,CYS170,ALA192,LYS87,TYR186,TYR279,GLY281,PRO194,GLY233,GLY113,THR110,MET282,GLY303,THR190,ILE20,ALA112,GLY116,GLN19,LEU188,LEU174,ALA302,LEU21,GLU109,GLY189,GLY111,PHE306,PHE280,HIS115,PRO18,LEU166,GLN114,ARG175,VAL17"
ASD02910000_1,trpS,Bacillus stearothermophilus,P00953,1I6K,ASD02910001,TYM,A,Lig,Regulator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] (2S)-2-amino-3-(1H-indol-3-yl)propanoate",350,Protein-DNA/RNA Interaction Regulator,Inner Protein,11679724,High-resolution experimental phases for tryptophanyl-tRNA synthetase (TrpRS) complexed with tryptophanyl-5'AMP.,Yes,"Chain A:PHE5,SER6,GLY7,ILE8,GLN9,GLY17,ASN18,GLY21,ALA22,VAL40,HIS43,TYR125,ASP132,ILE133,VAL141,VAL143,GLY144,ASP146,GLN147,GLY180,ALA181,ARG182,ILE183,LYS192"
ASD02910000_1,trpS,Bacillus stearothermophilus,P00953,1I6L,ASD02910001,TYM,A,Lig,Regulator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] (2S)-2-amino-3-(1H-indol-3-yl)propanoate",350,Protein-DNA/RNA Interaction Regulator,Inner Protein,11679724,High-resolution experimental phases for tryptophanyl-tRNA synthetase (TrpRS) complexed with tryptophanyl-5'AMP.,Yes,"Chain A:PHE5,SER6,GLY7,ILE8,GLN9,GLY17,ASN18,GLY21,ALA22,VAL40,HIS43,TYR125,ASP132,ILE133,VAL141,VAL143,GLY144,ASP146,GLN147,GLY180,ALA181,ARG182,ILE183,LYS192,LYS195"
ASD02910000_1,trpS,Bacillus stearothermophilus,P00953,1I6M,ASD02910001,TYM,A,Lig,Regulator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] (2S)-2-amino-3-(1H-indol-3-yl)propanoate",350,Protein-DNA/RNA Interaction Regulator,Inner Protein,11679724,High-resolution experimental phases for tryptophanyl-tRNA synthetase (TrpRS) complexed with tryptophanyl-5'AMP.,Yes,"Chain A:PHE5,SER6,GLY7,ILE8,GLN9,GLY17,ASN18,GLY21,ALA22,VAL40,HIS43,TYR125,MET129,ASP132,ILE133,VAL141,VAL143,GLY144,ASP146,GLN147,GLY180,ALA181,ARG182,ILE183,LYS192,MET193,LYS195"
ASD02910000_1,trpS,Bacillus stearothermophilus,P00953,1M83,ASD00150001,ATP,A,Lig,Regulator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",400,Protein-DNA/RNA Interaction Regulator,Inner Protein,12473451,"Interconversion of ATP binding and conformational free energies by tryptophanyl-tRNA synthetase: structures of ATP bound to open and closed, pre-transition-state conformations.",Yes,"Chain A:GLY7,ILE8,GLN9,SER11,GLY17,ASN18,GLY21,ALA22,LYS111,VAL143,GLY144,ASP146,GLN147,GLY180,ALA181,ARG182,ILE183,LYS192,MET193,SER194,LYS195,SER196"
ASD02910000_1,trpS,Bacillus stearothermophilus,P00953,1MAU,ASD00150001,ATP,A,Lig,Regulator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",400,Protein-DNA/RNA Interaction Regulator,Inner Protein,12473451,"Interconversion of ATP binding and conformational free energies by tryptophanyl-tRNA synthetase: structures of ATP bound to open and closed, pre-transition-state conformations.",Yes,"Chain A:GLY7,ILE8,GLN9,SER11,GLY17,ASN18,GLY21,ALA22,LYS111,VAL143,GLY144,ASP146,GLN147,GLY180,ALA181,ARG182,ILE183,LYS192,MET193,SER194,LYS195,SER196"
ASD02910000_1,trpS,Bacillus stearothermophilus,P00953,1MAW,ASD00150001,ATP,A,Lig,Regulator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",400,Protein-DNA/RNA Interaction Regulator,Inner Protein,12473451,"Interconversion of ATP binding and conformational free energies by tryptophanyl-tRNA synthetase: structures of ATP bound to open and closed, pre-transition-state conformations.",Yes,"Chain A:GLY17,ASN18,GLY21,ALA22,PRO177,ARG182,ILE183,LYS192,MET193,SER194,LYS195,SER196"
ASD02910000_1,trpS,Bacillus stearothermophilus,P00953,2OV4,ASD02910002,AQP,A,Lig,Regulator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl [hydroxy-(hydroxy-phosphonooxy-phosphoryl)oxy-phosphoryl] hydrogen phosphate",400,Protein-DNA/RNA Interaction Regulator,Inner Protein,17428498,Crystal Structure of Tryptophanyl-tRNA Synthetase Complexed with Adenosine-5' Tetraphosphate: Evidence for Distributed Use of Catalytic Binding Energy in Amino Acid Activation by Class I Aminoacyl-tRNA Synthetases.,Yes,"Chain A:GLY7,ILE8,GLN9,SER11,GLY17,ASN18,GLY21,ALA22,LYS111,VAL143,GLY144,ASP146,GLN147,GLY180,ALA181,ARG182,ILE183,LYS192,MET193,SER194,LYS195,SER196"
ASD02910000_1,trpS,Bacillus stearothermophilus,P00953,3FHJ,ASD00030001,AMP,A,Lig,Regulator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",1003,Protein-DNA/RNA Interaction Regulator,Inner Protein,19174517,Independent saturation of three TrpRS subsites generates a partially assembled state similar to those observed in molecular simulations.,Yes,"Chain A:GLY17,ASN18,GLY21,ALA22,PRO142,ASP146,ILE176,ALA181,ARG182,ILE183,LYS192,MET193"
ASD02910000_1,trpS,Bacillus stearothermophilus,P00953,3FI0,ASD00030001,AMP,A,Lig,Regulator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",1003,Protein-DNA/RNA Interaction Regulator,Inner Protein,19174517,Independent saturation of three TrpRS subsites generates a partially assembled state similar to those observed in molecular simulations.,Yes,"Chain A:GLY17,ASN18,GLY21,ALA22,PRO142,ASP146,ILE176,ARG182,ILE183,LYS192"
ASD02980000_1,GNE,Homo sapiens,Q9Y223,4ZHT,ASD02980003,NCC,A,Lig,Inhibitor,CYTIDINE-5'-MONOPHOSPHATE-5-N-ACETYLNEURAMINIC ACID,502,Allosteric function,Allosteric position,26980148,"Mechanism and inhibition of human UDP-GlcNAc 2-epimerase, the key enzyme in sialic acid biosynthesis.",No,4ZHT
ASD02980000_2,BA_5509,Bacillus anthracis,Q81K32,3BEO,ASD10298001,UD1,A,Lig,Activator,"[[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxy-phosphoryl] [(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl hydrogen phosphate",372,Inner Protein Regulator,Inner Protein,18188181,A structural basis for the allosteric regulation of non-hydrolysing UDP-GlcNAc 2-epimerases.,Yes,"Chain A:PRO15,GLN43,HIS44,ARG45,GLN46,MET47,MET66,LYS67,ASP68,ARG69,GLN70,LEU72,ILE75,THR101,THR102,PRO135,GLU136,HIS209,ARG210,ARG211,HIS242,MET243,ASN244,PRO245"
ASD02980000_4,wecB,Methanocaldococcus jannaschii,Q58899,4NES,ASD10298001,UD1,A,Lig,Activator,"[[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxy-phosphoryl] [(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl hydrogen phosphate",400,Inner Protein Regulator,Inner Protein,,Crystal structures of the archaeal UDP-GlcNAc 2-epimerase from Methanocaldococcus jannaschii reveal a conformational change induced by UDP-GlcNAc.,Yes,"Chain A:THR9,PRO11,GLN37,HIS38,TYR39,SER40,SER64,HIS67,GLN70,THR96,ASN97,GLU129,HIS207,ARG208,HIS241,PRO242,ARG243,LYS246"
ASD02980000_5,mnaA,Bacillus subtilis,P39131,4FKZ,ASD10298001,UD1,A,Lig,Activator,"[[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxy-phosphoryl] [(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl hydrogen phosphate",401,Inner Protein Regulator,Inner Protein,,Crystal structure of Bacillus subtilis UDP-GlcNAc 2-epimerase in complex with UDP-GlcNAc and UDP,Yes,"Chain A:PRO14,GLN41,HIS42,ARG43,GLN44,MET45,MET64,LYS65,GLU66,ARG67,GLN68,LEU70,ILE73,THR99,THR100,PRO133,GLU134,HIS207,ARG208,ARG209,HIS240,LEU241,ASN242,PRO243"
ASD02990000_1,pyrH1,Bacillus anthracis,Q81S73,2JJX,ASD00150001,ATP,A,Lig,Regulator,"adenosine 5'-(tetrahydrogen triphosphate) [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1246,Inner Protein Regulator,Protein-Protein Interaction,18625239,The Crystal Structure of Ump Kinase from Bacillus Anthracis (Ba1797) Reveals an Allosteric Nucleotide-Binding Site.,No,"Chain B:HIS120,ILE114,ARG117,ASN124,LEU116"
ASD02990000_2,pyrH,Escherichia coli,P0A7E9,2V4Y,ASD00290006,GTP,A,Lig,Activator,"[[(2R,3S,4R,5R)-5-(2-azanyl-6-oxidanylidene-1H-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate",1242,Inner Protein Regulator,Protein-Protein Interaction,18945668,Structural and Functional Characterization of Escherichia Coli Ump Kinase in Complex with its Allosteric Regulator GTP.,No,"Chain A:ARG92,ASP93,HIS96,ASN101,ALA102,ARG103,ARG130; Chain E:TRP119,ALA120,ILE123,SER124,ARG127; Chain F:ASN72,VAL75"
ASD02990000_3,pyrH,Xanthomonas campestris pv. campestris,P59009,3EK5,ASD00290006,GTP,E,Lig,Activator,"[[(2R,3S,4R,5R)-5-(2-azanyl-6-oxidanylidene-1H-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate",2006,Inner Protein Regulator,Protein-Protein Interaction,19059268,Unique GTP-Binding Pocket and Allostery of Uridylate Kinase from a Gram-Negative Phytopathogenic Bacterium,No,"Chain D:ILE115,ARG117,ARG118,ARG121,LYS125; Chain E:LYS98,ARG100,ASN108,ASP109,VAL110,CYS111,GLU112,ARG118,LYS125,ARG127"
ASD02990000_4,pyrH,Mycobacterium tuberculosis,P9WHK5,3NWY,ASD00290006,GTP,A,Lig,Activator,"[[(2R,3S,4R,5R)-5-(2-azanyl-6-oxidanylidene-1H-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate",262,Inner Protein Regulator,Protein-Protein Interaction,21149268,Structural and functional characterization of the Mycobacterium tuberculosis uridine monophosphate kinase: insights into the allosteric regulation.,No,"Chain A:ARG123,GLY131,GLN132,ALA134,GLU135,PRO136,ARG141,HIS145,LYS148,ARG150; Chain D:LEU138,LEU140,ARG141,ARG144"
ASD02990000_5,pyrH,Helicobacter pylori,P56106,4A7W,ASD00290006,GTP,A,Lig,Activator,"[[(2R,3S,4R,5R)-5-(2-azanyl-6-oxidanylidene-1H-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate",1241,Inner Protein Regulator,Protein-Protein Interaction,22751662,Structures of Helicobacter Pylori Uridylate Kinase: Insight Into Release of the Product Udp,No,"Chain A:ARG102,LYS110,GLU111,ILE112,CYS113,GLU114,LYS120,ARG123,HIS124,LYS127,ARG129"
ASD03000000_1,upp,Sulfolobus solfataricus,Q980Q4,1VST,ASD00290006,GTP,A,Lig,Activator,"[[(2R,3S,4R,5R)-5-(2-azanyl-6-oxidanylidene-1H-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate",301,Inner Protein Regulator,Protein-Protein Interaction,19683539,Structural and kinetic studies of the allosteric transition in Sulfolobus solfataricus uracil phosphoribosyltransferase: Permanent activation by engineering of the C-terminus.,No,"Chain A:LYS30,ARG34,ARG37"
ASD03000000_1,upp,Sulfolobus solfataricus,Q980Q4,1XTU,ASD00150003;ASD00150003;ASD00150003;ASD00150003,CTP;CTP;CTP;CTP,A;D;E;H,Lig;Lig;Lig;Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",1260;4260;5260;8260,Inner Protein Regulator,Protein-Protein Interaction,15654744,Allosteric regulation and communication between subunits in uracil phosphoribosyltransferase from Sulfolobus solfataricus.,No,"Chain A:ARG29,LYS30,VAL33,ARG37,GLU87,LYS91; Chain E:ARG37,LYS91; Chain H:GLU87,LEU90,LYS91,PHE93,PRO94,ALA96"
ASD03000000_1,upp,Sulfolobus solfataricus,Q980Q4,3G6W,ASD00290006;ASD00290006;ASD00290006;ASD00290006,GTP;GTP;GTP;GTP,A;B;D;D,Lig;Lig;Lig;Lig,Activator,"[[(2R,3S,4R,5R)-5-(2-azanyl-6-oxidanylidene-1H-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate",301;301;217;301,Inner Protein Regulator,Protein-Protein Interaction,19683539,Structural and kinetic studies of the allosteric transition in Sulfolobus solfataricus uracil phosphoribosyltransferase: Permanent activation by engineering of the C-terminus.,No,"Chain A:LYS30,ARG34,ARG37; Chain B:ARG37,LYS91,PRO94; Chain D:ILE26,ASN27,LYS30,ARG34"
ASD03000000_2,uprt,Toxoplasma gondii,Q26998,1JLR,ASD00290006,GTP,A,Lig,Activator,"[[(2R,3S,4R,5R)-5-(2-azanyl-6-oxidanylidene-1H-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate",303,Inner Protein Regulator,Protein-Protein Interaction,11773618,The structural mechanism of GTP stabilized oligomerization and catalytic activation of the Toxoplasma gondii uracil phosphoribosyltransferase.,No,"Chain A:LEU78,PHE101,SER103,LYS104,ILE105,VAL124,CYS125,ARG129,ARG158; Chain C:GLN44,TYR65,ARG68; Chain D:LYS59"
ASD03090000_1,CHRNA7,Homo sapiens,P36544,5AFJ,ASD03091859,42R,A,Lig,Regulator,"(3S)-6-(4-bromophenyl)-3-hydroxy-1,3-dimethyl- 2,3-dihydropyridin-4(1H)-one",1205,Allosteric Function,Allosteric Position,25918415,Molecular Blueprint of Allosteric Binding Sites in a Homologue of the Agonist-Binding Domain of the Alpha7 Nicotinic Acetylcholine Receptor.,No,5AFJ
ASD03090000_1,CHRNA7,Homo sapiens,P36544,5AFJ,ASD03091859,42R,A,Lig,Regulator,"(3S)-6-(4-bromophenyl)-3-hydroxy-1,3-dimethyl- 2,3-dihydropyridin-4(1H)-one",1206,Allosteric Function,Allosteric Position,25918415,Molecular Blueprint of Allosteric Binding Sites in a Homologue of the Agonist-Binding Domain of the Alpha7 Nicotinic Acetylcholine Receptor.,No,5AFJ
ASD03090000_1,CHRNA7,Homo sapiens,P36544,5AFK,ASD03091862,5VU,A,Lig,Regulator,"N-(2,4-difluorophenyl)pyrrolidine-1-carboxamide",1207,Allosteric Function,Allosteric Position,25918415,Molecular Blueprint of Allosteric Binding Sites in a Homologue of the Agonist-Binding Domain of the Alpha7 Nicotinic Acetylcholine Receptor.,No,5AFK
ASD03090000_1,CHRNA7,Homo sapiens,P36544,5AFL,ASD03091906,FHV,E,Lig,Regulator,N-(3-METHYLPHENYL)PYRROLIDINE-1-CARBOXAMIDE,1207,Allosteric Function,Allosteric Position,25918415,Molecular Blueprint of Allosteric Binding Sites in a Homologue of the Agonist-Binding Domain of the Alpha7 Nicotinic Acetylcholine Receptor.,No,5AFL
ASD03090000_1,CHRNA7,Homo sapiens,P36544,5AFM,ASD03091903,9Z0,A,Lig,Regulator,"4,5-dibromo-N-(3-hydroxypropyl)-1H-pyrrole- 2-carboxamide",1207,Allosteric Function,Allosteric Position,25918415,Molecular Blueprint of Allosteric Binding Sites in a Homologue of the Agonist-Binding Domain of the Alpha7 Nicotinic Acetylcholine Receptor.,No,5AFM
ASD03090000_1,CHRNA7,Homo sapiens,P36544,5AFN,ASD03091910,OJD,A,Lig,Regulator,(4R)-4-(2-phenylethyl)pyrrolidin-2-one,1215,Allosteric Function,Allosteric Position,25918415,Molecular Blueprint of Allosteric Binding Sites in a Homologue of the Agonist-Binding Domain of the Alpha7 Nicotinic Acetylcholine Receptor.,No,5AFN
ASD03130000_1,ADRB2,Homo sapiens,P07550,5X7D,ASD03130020,8VS,A,Lig,Inhibitor,4-carbamoyl-N-[(2R)-2-cyclohexyl-2-phenylacetyl]- L-phenylalanyl-3-bromo-N-methyl-L-phenylalaninamide,1205,Inner Protein Regulator,Inner Protein,28813418,Mechanism of intracellular allosteric beta 2AR antagonist revealed by X-ray crystal structure.,No,5X7D
ASD03130000_1,ADRB2,Homo sapiens,P07550,6N48,,KBY,A,Lig,Activator,N-[(3R)-4-(4-tert-butylphenyl)-3-({2-[(4-methoxyphenyl)sulfanyl]-5-[methyl(propan-2-yl)sulfamoyl]benzene-1-carbonyl}amino)butanoyl]glycine,1403,Allosteric function,Allosteric position,,,No,6N48
ASD03130000_1,ADRB2,Homo sapiens,P07550,6OBA,,M3J,A,Lig,Inhibitor,"6-bromo-N~2~-phenylquinazoline-2,4-diamine",1402,Allosteric function,Allosteric position,,,No,6OBA
ASD03140000_1,bla,Escherichia coli,P62593,1PZO,ASD03140002;ASD03140002,CBT;CBT,A;A,Lig,Inhibitor,"N,N-bis[(4-chlorophenyl)methyl]-2H-1,2,3,4-tetrazol-5-amine",300;301,Inner Protein Regulator,Inner Protein,15037085,Allosteric inhibition through core disruption.,Yes,"Chain A:VAL216,ALA217,LEU220,LEU221,ALA224,SER235,GLY236,ALA237,ARG244,GLY245,ILE246,VAL261,ILE263,ASN276,ILE279,ALA280,GLY283,LEU286"
ASD03140000_1,bla,Escherichia coli,P62593,1PZP,ASD03140005,FTA,A,Lig,Inhibitor,"(Z)-3-[(4-phenylazanylphenyl)amino]-2-(2H-1,2,3,4-tetrazol-5-yl)prop-2-enenitrile",300,Inner Protein Regulator,Inner Protein,15037085,Allosteric inhibition through core disruption.,Yes,"Chain A:LEU221,ALA224,LEU225,LEU250,VAL261,ILE263,ALA280,GLY283,ALA284,ILE287"
ASD03160000_2,ADORA2A,Escherichia coli,P0ABE7,4EIY,ASD03160008,NA,A,Ion,Inhibitor,sodium(+1) cation,2402,Inner Protein Regulator,Inner Protein,22798613,Structural basis for allosteric regulation of GPCRs by sodium ions.,No,"Chain A:ASP52,SER91,ASN280"
ASD03160000_2,GRM1,Escherichia coli,P0ABE7,4N6H,ASD03160008,NA,A,Ion,Inhibitor,sodium(+1) cation,1220,Inner Protein Regulator,Inner Protein,24413399,Molecular control of delta-opioid receptor signalling.,No,"Chain A:ASP95,ASN131,SER135"
ASD03160000_2,GRM1,Escherichia coli,P0ABE7,4OR2,ASD01870242,FM9,A,Lig,Inhibitor,"4-fluoranyl-N-methyl-N-[4-[6-(propan-2-ylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]benzamide",1901,Inner Protein Regulator,Inner Protein,24603153,Structure of a class C GPCR metabotropic glutamate receptor 1 bound to an allosteric modulator,No,"Chain A:LEU648,GLN660,ARG661,VAL664,GLY665,SER668,THR748,VAL753,PRO756,LEU757,ASN760,THR794,ILE797,TRP798,PHE801,TYR805,LYS811,ILE812,THR815,ALA818,SER822"
ASD03160000_2,cybC,Escherichia coli,P0ABE7,5L32,ASD01310003,ZN,A,Ion,Regulator,ZINC ION,203,Allosteric Function,Allosteric Position,27649076,De Novo Design of an Allosteric Metalloprotein Assembly with Strained Disulfide Bonds.,No,"Chain D:HIS77,LEU78,ASP74"
ASD03160000_2,cybC,Escherichia coli,P0ABE7,5UIG,ASD03160003,8D1,A,Lig,Regulator,"5-amino-N-[(2-methoxyphenyl)methyl]-2-(3- methylphenyl)-2H-1,2,3-triazole-4-carboximidamide",503,Inner Protein Regulator,Inner Protein,28167788,Crystal structure of the adenosine A2A receptor bound to an antagonist reveals a potential allosteric pocket.,No,"Chain A:ASN253,GLU13,THR68,VAL84,HIS264,ALA63,TRP246,LEU249,MET177,HIS278,GLU169,MET174,LEU167,ALA81,ILE274,ASN181,ILE64,LEU267,LEU85,THR88,SER67,HIS250,TYR9,PHE62,TYR271,ILE66,MET270,PHE168"
ASD03160000_2,cybC,Escherichia coli,P0ABE7,5WIV,ASD03160008,NA,A,Ion,Regulator,SODIUM ION,1224,Allosteric function,Allosteric position,29051383,D4 dopamine receptor high-resolution structures enable the discovery of selective agonists.,No,"Chain A:ASP80,LEU118,PHE403,ALA79,TRP407,LEU76,LEU83,SER441,SER122,CYS119,ASN440"
ASD03160000_2,cybC,Escherichia coli,P0ABE7,6C1Q,ASD03160010,9P2,B,Lig,Inhibitor,"1-(1,3-benzodioxol-5-yl)-~{N}-(1,3-benzodioxol-5-ylmethyl)-~{N}-[(3-butyl-2,5-diphenyl-imidazol-4-yl)methyl]methanamine",501,Allosteric function,Allosteric position,29867214,Orthosteric and allosteric action of the C5a receptor antagonists.,No,Chain B:PRO300
ASD03160000_2,cybC,Escherichia coli,P0ABE7,6C1R,ASD03160012,EFD,B,Lig,Inhibitor,"(2R,3S)-2-[4-(cyclopentylamino)phenyl]-1-(2-fluoro-6-methylbenzene-1-carbonyl)-N-[4-methyl-3-(trifluoromethyl)phenyl]piperidine-3-carboxamide",501,Allosteric function,Allosteric position,29867214,Orthosteric and allosteric action of the C5a receptor antagonists.,No,Chain B:TRP299
ASD03200000_1,AURKA,Homo sapiens,O14965,4C3P,,TPX2,"B,E",Pep,Activator,TARGETING PROTEIN FOR XKLP2,1-43,Allosteric function,Allosteric position,24867643,Molecular Mechanism of Aurora a Kinase Autophosphorylation and its Allosteric Activation by Tpx2.,No,4C3P
ASD03200000_1,AURKA,Homo sapiens,O14965,5DN3,ASD03200026,5DN,A,lig,Inhibitor,2-(3-bromophenyl)-8-fluoroquinoline-4-carboxylic acid,402,Allosteric Function,Allosteric Position,27339427,Allosteric modulation of AURKA kinase activity by a small-molecule inhibitor of its protein-protein interaction with TPX2.,No,5DN3
ASD03200000_1,AURKA,Homo sapiens,O14965,5DOS,ASD03200026,5DN,A,Lig,Inhibitor,2-(3-bromophenyl)-8-fluoroquinoline-4-carboxylic acid,402,Protein-Protein interaction regulator,Protein-Protein,27339427,Allosteric modulation of AURKA kinase activity by a small-molecule inhibitor of its protein-protein interaction with TPX2.,No,5DOS
ASD03200000_1,AURKA,Homo sapiens,O14965,5DPV,ASD03200026,5DN,A,Lig,Inhibitor,2-(3-bromophenyl)-8-fluoroquinoline-4-carboxylic acid,401,Protein-Protein interaction regulator,Protein-Protein,27339427,Allosteric modulation of AURKA kinase activity by a small-molecule inhibitor of its protein-protein interaction with TPX2.,No,5DPV
ASD03200000_1,AURKA,Homo sapiens,O14965,5DR2,,5.00E+01,A,Lig,Regulator,2-(3-bromophenyl)quinoline-4-carboxylic acid,401,Protein-Protein interaction regulator,Protein-Protein,27339427,Allosteric modulation of AURKA kinase activity by a small-molecule inhibitor of its protein-protein interaction with TPX2.,No,5DR2
ASD03200000_1,AURKA,Homo sapiens,O14965,5DR6,,5.00E+01,A,Lig,Regulator,2-(3-bromophenyl)quinoline-4-carboxylic acid,401,Protein-Protein interaction regulator,Protein-Protein,27339427,Allosteric modulation of AURKA kinase activity by a small-molecule inhibitor of its protein-protein interaction with TPX2.,No,5DR6
ASD03200000_1,AURKA,Homo sapiens,O14965,5DR9,ASD03200072,5.00E+02,A,Lig,Regulator,2-(3-bromophenyl)-6-chloroquinoline-4-carboxylic acid,402,Protein-Protein interaction regulator,Protein-Protein,27339427,Allosteric modulation of AURKA kinase activity by a small-molecule inhibitor of its protein-protein interaction with TPX2.,No,5DR9
ASD03200000_1,AURKA,Homo sapiens,O14965,5DT4,ASD03200026,5DN,A,Lig,Inhibitor,2-(3-bromophenyl)-8-fluoroquinoline-4-carboxylic acid,402,Protein-Protein interaction regulator,Protein-Protein,27339427,Allosteric modulation of AURKA kinase activity by a small-molecule inhibitor of its protein-protein interaction with TPX2.,No,5DT4
ASD03200000_1,AURKA,Homo sapiens,O14965,5G15,,MB1,,Pep,Activator,MB1 MONOBODY,1-96,,,,"Monobodies as Novel, Highly Potent Allosteric Modulators of Aurora a Kinase",,5G15
ASD03200000_1,AURKA,Homo sapiens,O14965,5L8J,,Ac-MARVDQTPRIATKETGESLTINCVLRDTACALDSTNWYRTKLGSTKEQTISIGGRYSETVDEGSNSASLTIRDLRVEDSGTYKCKAYRRCAFNTGVGYKEGAGTVLTVKG-NH2,,Pep,Inhibitor,New antigen receptor variable domain,,Allosteric Function,Protein-Protein,27411893,Allosteric inhibition of Aurora-A kinase by a synthetic vNAR domain.,No,5L8J
ASD03200000_1,AURKA,Homo sapiens,O14965,5L8K,,Ac-MARVDQTPRIATKETGESLTINCVLRDTACALDSTNWYRTKLGSTKEQTISIGGRYSETVDEGSNSASLTIRDLRVEDSGTYKCKAYRRCAFNTGVGYKEGAGTVLTVKG-NH2,,Pep,Inhibitor,New antigen receptor variable domain,,Allosteric Function,Protein-Protein,27411893,Allosteric inhibition of Aurora-A kinase by a synthetic vNAR domain.,No,5L8K
ASD03200000_1,AURKA,Homo sapiens,O14965,5L8L,,Ac-MARVDQTPRIATKETGESLTINCVLRDTACALDSTNWYRTKLGSTKEQTISIGGRYSETVDEGSNSASLTIRDLRVEDSGTYKCKAYRRCAFNTGVGYKEGAGTVLTVKGGAAA-NH2,,Pep,Inhibitor,New antigen receptor variable domain,,Allosteric Function,Protein-Protein,27411893,Allosteric inhibition of Aurora-A kinase by a synthetic vNAR domain.,No,5L8L
ASD03200000_1,AURKA,Homo sapiens,O14965,5OBJ,ASD03200073,9QK,A,Lig,Inhibitor,2-(3-fluorophenyl)quinoline-4-carboxylic acid,405,Protein-Protein Interaction,Protein-Protein Interaction,28787041,Computationally-guided optimization of small-molecule inhibitors of the Aurora A kinase-TPX2 protein-protein interaction.,No,5OBJ
ASD03200000_1,AURKA,Homo sapiens,O14965,5OBR,ASD03200074,9QT,A,Lig,Inhibitor,2-(3-chloranyl-5-fluoranyl-phenyl)quinoline-4-carboxylic acid,401,Protein-Protein Interaction,Protein-Protein Interaction,28787041,Computationally-guided optimization of small-molecule inhibitors of the Aurora A kinase-TPX2 protein-protein interaction.,No,5OBR
ASD03200000_1,AURKA,Homo sapiens,O14965,5ORL,ASD03200075,A4W,A,Lig,Inhibitor,~{N}-(3-chloranyl-2-fluoranyl-phenyl)-3-sulfanyl-propanamide,404,Protein-Protein Interaction,Protein-Protein Interaction,29045126,"Characterization of Three Druggable Hot-Spots in the Aurora-A/TPX2 Interaction Using Biochemical, Biophysical, and Fragment-Based Approaches.",No,5ORL
ASD03200000_1,AURKA,Homo sapiens,O14965,5ORN,ASD03200076,A5E,A,Lig,Inhibitor,"3-thiophen-2-yl-4,5-dihydro-1~{H}-pyridazin-6-one",404,Protein-Protein Interaction,Protein-Protein Interaction,29045126,"Characterization of Three Druggable Hot-Spots in the Aurora-A/TPX2 Interaction Using Biochemical, Biophysical, and Fragment-Based Approaches.",No,5ORN
ASD03200000_1,AURKA,Homo sapiens,O14965,5ORO,ASD03200077,A5H,A,Lig,Inhibitor,"3-(4-chlorophenyl)-5,6-dihydroimidazo[2,1-b][1,3]thiazole",404,Protein-Protein Interaction,Protein-Protein Interaction,29045126,"Characterization of Three Druggable Hot-Spots in the Aurora-A/TPX2 Interaction Using Biochemical, Biophysical, and Fragment-Based Approaches.",No,5ORO
ASD03200000_1,AURKA,Homo sapiens,O14965,5ORP,ASD03200078,A5K,A,Lig,Inhibitor,"1-[3-chloranyl-5-(trifluoromethyl)pyridin-2-yl]-1,4-diazepane",404,Protein-Protein Interaction,Protein-Protein Interaction,29045126,"Characterization of Three Druggable Hot-Spots in the Aurora-A/TPX2 Interaction Using Biochemical, Biophysical, and Fragment-Based Approaches.",No,5ORP
ASD03200000_1,AURKA,Homo sapiens,O14965,5ORR,ASD03200079,A5Q,A,Lig,Inhibitor,"4-[4-(trifluoromethyl)phenyl]-1,2,3-thiadiazol-5-amine",404,Protein-Protein Interaction,Protein-Protein Interaction,29045126,"Characterization of Three Druggable Hot-Spots in the Aurora-A/TPX2 Interaction Using Biochemical, Biophysical, and Fragment-Based Approaches.",No,5ORR
ASD03200000_1,AURKA,Homo sapiens,O14965,5ORS,ASD03200080,A5W,A,Lig,Inhibitor,cyclobutyl-[4-(2-methoxyphenyl)piperidin-1-yl]methanone,404,Protein-Protein Interaction,Protein-Protein Interaction,29045126,"Characterization of Three Druggable Hot-Spots in the Aurora-A/TPX2 Interaction Using Biochemical, Biophysical, and Fragment-Based Approaches.",No,5ORS
ASD03200000_1,AURKA,Homo sapiens,O14965,5ORT,ASD03200081,A5Z,A,Lig,Inhibitor,"[3-[2,6-bis(chloranyl)phenyl]-5-methyl-1,2-oxazol-4-yl]methanol",406,Protein-Protein Interaction,Protein-Protein Interaction,29045126,"Characterization of Three Druggable Hot-Spots in the Aurora-A/TPX2 Interaction Using Biochemical, Biophysical, and Fragment-Based Approaches.",No,5ORT
ASD03200000_1,AURKA,Homo sapiens,O14965,5ORV,ASD03200082,A65,A,Lig,Inhibitor,"[3,5-bis(methylsulfanyl)-1,2-thiazol-4-yl]methanol",406,Protein-Protein Interaction,Protein-Protein Interaction,29045126,"Characterization of Three Druggable Hot-Spots in the Aurora-A/TPX2 Interaction Using Biochemical, Biophysical, and Fragment-Based Approaches.",No,5ORV
ASD03200000_1,AURKA,Homo sapiens,O14965,5ORW,ASD03200083,A6E,A,Lig,Inhibitor,3-(4-fluoranylphenoxy)-1-thiomorpholin-4-yl-propan-1-one,404,Protein-Protein Interaction,Protein-Protein Interaction,29045126,"Characterization of Three Druggable Hot-Spots in the Aurora-A/TPX2 Interaction Using Biochemical, Biophysical, and Fragment-Based Approaches.",No,5ORW
ASD03200000_1,AURKA,Homo sapiens,O14965,5ORX,ASD03200084,A6H,A,Lig,Inhibitor,"6-[2,6-bis(chloranyl)phenoxy]pyridin-3-amine",404,Protein-Protein Interaction,Protein-Protein Interaction,29045126,"Characterization of Three Druggable Hot-Spots in the Aurora-A/TPX2 Interaction Using Biochemical, Biophysical, and Fragment-Based Approaches.",No,5ORX
ASD03200000_1,AURKA,Homo sapiens,O14965,5ORY,ASD03200096,AY4,A,Lig,Inhibitor,"2,4-bis(fluoranyl)-6-(1~{H}-pyrazol-3-yl)phenol",406,Protein-Protein Interaction,Protein-Protein Interaction,29045126,"Characterization of Three Druggable Hot-Spots in the Aurora-A/TPX2 Interaction Using Biochemical, Biophysical, and Fragment-Based Approaches.",No,5ORY
ASD03200000_1,AURKA,Homo sapiens,O14965,5ORZ,ASD03200085,A6W,A,Lig,Inhibitor,methyl 3-azanyl-5-thiophen-2-yl-thiophene-2-carboxylate,404,Protein-Protein Interaction,Protein-Protein Interaction,29045126,"Characterization of Three Druggable Hot-Spots in the Aurora-A/TPX2 Interaction Using Biochemical, Biophysical, and Fragment-Based Approaches.",No,5ORZ
ASD03200000_1,AURKA,Homo sapiens,O14965,5OS0,ASD03200086,A6Z,A,Lig,Inhibitor,2-[4-(3-chlorophenyl)piperazin-1-ium-1-yl]ethanenitrile,404,Protein-Protein Interaction,Protein-Protein Interaction,29045126,"Characterization of Three Druggable Hot-Spots in the Aurora-A/TPX2 Interaction Using Biochemical, Biophysical, and Fragment-Based Approaches.",No,5OS0
ASD03200000_1,AURKA,Homo sapiens,O14965,5OS1,ASD03200087,A7H,A,Lig,Inhibitor,"6-ethoxy-2-methyl-1,3-benzothiazole",404,Protein-Protein Interaction,Protein-Protein Interaction,29045126,"Characterization of Three Druggable Hot-Spots in the Aurora-A/TPX2 Interaction Using Biochemical, Biophysical, and Fragment-Based Approaches.",No,5OS1
ASD03200000_1,AURKA,Homo sapiens,O14965,5OS2,ASD03200088,A7K,A,Lig,Inhibitor,[2-[4-(hydroxymethyl)piperidin-1-yl]phenyl]methylazanium,404,Protein-Protein Interaction,Protein-Protein Interaction,29045126,"Characterization of Three Druggable Hot-Spots in the Aurora-A/TPX2 Interaction Using Biochemical, Biophysical, and Fragment-Based Approaches.",No,5OS2
ASD03200000_1,AURKA,Homo sapiens,O14965,5OS3,ASD03200089,A7N,A,Lig,Inhibitor,(1~{R})-1-(4-ethoxyphenyl)ethanamine,404,Protein-Protein Interaction,Protein-Protein Interaction,29045126,"Characterization of Three Druggable Hot-Spots in the Aurora-A/TPX2 Interaction Using Biochemical, Biophysical, and Fragment-Based Approaches.",No,5OS3
ASD03200000_1,AURKA,Homo sapiens,O14965,5OS4,ASD03200091,A8H,A,Lig,Inhibitor,"(3~{a}~{R},5~{S},7~{a}~{S})-5-phenyl-3~{a},4,5,6,7,7~{a}-hexahydroisoindole-1,3-dione",404,Protein-Protein Interaction,Protein-Protein Interaction,29045126,"Characterization of Three Druggable Hot-Spots in the Aurora-A/TPX2 Interaction Using Biochemical, Biophysical, and Fragment-Based Approaches.",No,5OS4
ASD03200000_1,AURKA,Homo sapiens,O14965,5OS5,ASD03200092,A8K,A,Lig,Inhibitor,4-(4-hydroxyphenyl)sulfanylphenol,404,Protein-Protein Interaction,Protein-Protein Interaction,29045126,"Characterization of Three Druggable Hot-Spots in the Aurora-A/TPX2 Interaction Using Biochemical, Biophysical, and Fragment-Based Approaches.",No,5OS5
ASD03200000_1,AURKA,Homo sapiens,O14965,5OS6,ASD03200090,A7Q,A,Lig,Inhibitor,(6-phenoxypyridin-3-yl)methanol,404,Protein-Protein Interaction,Protein-Protein Interaction,29045126,"Characterization of Three Druggable Hot-Spots in the Aurora-A/TPX2 Interaction Using Biochemical, Biophysical, and Fragment-Based Approaches.",No,5OS6
ASD03200000_1,AURKA,Homo sapiens,O14965,5OSD,ASD03200094,A9B,A,Lig,Inhibitor,5-(4-chlorophenyl)furan-2-carbohydrazide,404,Protein-Protein Interaction,Protein-Protein Interaction,29045126,"Characterization of Three Druggable Hot-Spots in the Aurora-A/TPX2 Interaction Using Biochemical, Biophysical, and Fragment-Based Approaches.",No,5OSD
ASD03200000_1,AURKA,Homo sapiens,O14965,5OSE,ASD03200093,A98,A,Lig,Inhibitor,"methyl ~{N}-(5-ethylsulfanyl-1,3,4-thiadiazol-2-yl)carbamate",404,Protein-Protein Interaction,Protein-Protein Interaction,29045126,"Characterization of Three Druggable Hot-Spots in the Aurora-A/TPX2 Interaction Using Biochemical, Biophysical, and Fragment-Based Approaches.",No,5OSE
ASD03200000_1,AURKA,Homo sapiens,O14965,5OSF,ASD03200095,A9E,A,Lig,Inhibitor,2-(4-ethylphenoxy)-1-piperidin-1-yl-ethanone,404,Protein-Protein Interaction,Protein-Protein Interaction,29045126,"Characterization of Three Druggable Hot-Spots in the Aurora-A/TPX2 Interaction Using Biochemical, Biophysical, and Fragment-Based Approaches.",No,5OSF
ASD03200000_1,AURKA,Homo sapiens,O14965,6R49,,JSB,A,Lig,Inhibitor,"(1~{S},10~{S})-12-cyclopropyl-1-oxidanyl-10-propan-2-yl-9,12-diazatricyclo[8.2.1.0^{2,7}]trideca-2(7),3,5-trien-11-one",504,,,,,,6R49
ASD03200000_1,AURKA,Homo sapiens,O14965,6R4A,,JRT,A,Lig,Inhibitor,2-(benzimidazol-1-yl)-~{N}-(2-phenylethyl)ethanamide,510,,,,,,6R4A
ASD03200000_1,AURKA,Homo sapiens,O14965,6R4B,,JSN,A,Lig,Inhibitor,"(6~{S})-6-[2,4-bis(fluoranyl)phenyl]-~{N},~{N},4-trimethyl-2-oxidanylidene-5,6-dihydro-1~{H}-pyrimidine-5-carboxamide",508,,,,,,6R4B
ASD03200000_1,AURKA,Homo sapiens,O14965,6R4C,,JRQ,A,Lig,Inhibitor,ethyl 2-[(2~{R})-1-[(4-methylphenyl)methyl]-3-oxidanylidene-piperazin-2-yl]ethanoate,507,,,,,,6R4C
ASD03220000_1,ALOX5,Homo sapiens,P09917,6NCF,,AF7,B,Lig,Inhibitor,"(3alpha,8alpha,17alpha,18alpha)-3-(acetyloxy)-11-oxours-12-en-23-oic acid",702,Allosteric function,Allosteric position,,,No,6NCF
ASD03240000_1,AKT1,Homo sapiens,P31749,3O96,ASD03240213,IQO,A,Lig,Inhibitor,"3-[1-[[4-(7-phenyl-3H-imidazo[4,5-g]quinoxalin-6-yl)phenyl]methyl]piperidin-4-yl]-1H-benzimidazol-2-one",444,Inner Protein Regulator,Inner Protein,20886116,Crystal structure of human AKT1 with an allosteric inhibitor reveals a new mode of kinase inhibition.,No,3O96
ASD03240000_1,AKT1,Homo sapiens,P31749,4EJN,ASD03240214,0R4,A,Lig,Inhibitor,"N-[[4-[5-(3-acetamidophenyl)-2-(2-azanylpyridin-3-yl)imidazo[4,5-b]pyridin-3-yl]phenyl]methyl]-3-fluoranyl-benzamide",501,Inner Protein Regulator,Inner Protein,22533986,"Discovery and optimization of a series of 3-(3-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amines: orally bioavailable, selective, and potent ATP-independent Akt inhibitors.",No,4EJN
ASD03240000_1,AKT1,Homo sapiens,P31749,5KCV,ASD03240239,6S1,A,Lig,Inhibitor,"3-[3-[4-(1-azanylcyclobutyl)phenyl]-5-phenyl-imidazo[4,5-b]pyridin-2-yl]pyridin-2-amine",501,Allosteric Fuction,Allosteric Position,27305487,"Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor.",No,5KCV
ASD03240000_1,AKT1,Homo sapiens,P31749,6HHF,,G4K,A,Lig,Inhibitor,Borussertib,501,Allosteric function,Allosteric position,,,No,6HHF
ASD03240000_1,AKT1,Homo sapiens,P31749,6HHG,,G4T,A,Lig,Inhibitor,"~{N}-[2-chloranyl-5-[[1-[[4-(5-oxidanylidene-3-phenyl-6~{H}-1,6-naphthyridin-2-yl)phenyl]methyl]piperidin-4-yl]carbamoylamino]phenyl]propanamide",501,,,30996949,Structural and chemical insights into the covalent-allosteric inhibition of the protein kinase Akt.,,6HHG
ASD03240000_1,AKT1,Homo sapiens,P31749,6HHH,,G4Q,A,Lig,Inhibitor,"~{N}-[4-[4-[[4-(5-oxidanylidene-3-phenyl-6~{H}-1,6-naphthyridin-2-yl)phenyl]methyl]piperazin-1-yl]phenyl]propanamide",501,,,30996949,Structural and chemical insights into the covalent-allosteric inhibition of the protein kinase Akt.,,6HHH
ASD03240000_1,AKT1,Homo sapiens,P31749,6HHI,,G4N,A,Lig,Inhibitor,"~{N}-[1-[[4-(5-oxidanylidene-3-phenyl-6~{H}-1,6-naphthyridin-2-yl)phenyl]methyl]piperidin-4-yl]-3-(propanoylamino)benzamide",501,,,30996949,Structural and chemical insights into the covalent-allosteric inhibition of the protein kinase Akt.,,6HHI
ASD03240000_1,AKT1,Homo sapiens,P31749,6HHJ,,G4H,A,Lig,Inhibitor,"~{N}-[1-methyl-2-oxidanylidene-3-[1-[[4-(5-oxidanylidene-3-phenyl-6~{H}-1,6-naphthyridin-2-yl)phenyl]methyl]piperidin-4-yl]benzimidazol-5-yl]propanamide",501,,,30996949,Structural and chemical insights into the covalent-allosteric inhibition of the protein kinase Akt.,,6HHJ
ASD03240000_1,AKT1,Homo sapiens,P31749,6S9W,,L1Z,A,Lig,Inhibitor,~{N}-[3-[1-[[4-(5-methyl-6-oxidanylidene-3-phenyl-1~{H}-pyrazin-2-yl)phenyl]methyl]piperidin-4-yl]-2-oxidanylidene-1~{H}-benzimidazol-5-yl]propanamide,501,Allosteric function,Allosteric position,,,No,6S9W
ASD03240000_1,AKT1,Homo sapiens,P31749,6S9X,,L1W,A,Lig,Inhibitor,~{N}-[3-[1-[[4-(5-methyl-6-oxidanylidene-3-phenyl-1~{H}-pyrazin-2-yl)phenyl]methyl]piperidin-4-yl]-2-oxidanylidene-1~{H}-benzimidazol-6-yl]propanamide,501,Allosteric function,Allosteric position,,,No,6S9X
ASD03240000_1,AKT1,Homo sapiens,P31749,7NH4,,UCE,A,Lig,Inhibitor,~{N}-[3-[1-[[4-[5-(hydroxymethyl)-3-phenyl-pyridin-2-yl]phenyl]methyl]piperidin-4-yl]-2-oxidanylidene-1~{H}-benzimidazol-5-yl]propanamide,501,,,,,,7NH4
ASD03240000_1,AKT1,Homo sapiens,P31749,7NH5,,UC8,A,Lig,Inhibitor,~{N}-methyl-6-[4-[[4-[2-oxidanylidene-6-(propanoylamino)-3~{H}-benzimidazol-1-yl]piperidin-1-yl]methyl]phenyl]-5-phenyl-pyridine-3-carboxamide,502,,,,,,7NH5
ASD03310000_1,SRN,Bos taurus,P00669,11BG,ASD03310002,U2G,A,Lig,Activator,"[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl [(2R,3R,4R,5R)-2-(2,4-dioxopyrimidin-1-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate",131,Inner Protein Regulator,Protein-Protein Interaction,10543951,A potential allosteric subsite generated by domain swapping in bovine seminal ribonuclease.,No,"Chain A:ASP14,ASN24,ASN27,LEU28,ASN94,CYS95; Chain B:CYS32,ARG33"
ASD03320000_1,ABL1,Homo sapiens,P00519,1OPL,ASD02400001,MYR,A,Lig,Inhibitor,tetradecanoic acid,538,Inner Protein Regulator,Inner Protein,12654251,Structural basis for the autoinhibition of c-Abl tyrosine kinase.,No,1OPL
ASD03320000_1,ABL1,Homo sapiens,P00519,3PYY,ASD03320008,3YY,A,Lig,Activator,"(5R)-5-[3-(4-fluorophenyl)-1-phenyl-pyrazol-4-yl]imidazolidine-2,4-dione",538,Inner Protein Regulator,Inner Protein,21338916,"Discovery and Characterization of a Cell-Permeable, Small-Molecule c-Abl Kinase Activator that Binds to the Myristoyl Binding Site.",No,3PYY
ASD03320000_1,ABL1,Homo sapiens,P00519,5DC4,,VSSVPTKLEVVAATPTSLLISWDAPAVTVDYYVITYGETGGWSGYQEFEVPGSKSTATISGLSPGVDYTITVYAYGYPYVKYNKSPISINYRT,B,Pep,Inhibitor,AS25 monobody,,Protein-Protein interaction regulator,Protein-Protein,26912659,Allosteric Inhibition of Bcr-Abl Kinase by High Affinity Monobody Inhibitors Directed to the Src Homology 2 (SH2)-Kinase Interface.,No,5DC4
ASD03320000_1,ABL1,Homo sapiens,P00519,5MO4,ASD03320068,AY7,A,Lig,Inhibitor,asciminib,602,Inner Protein Regulator,Inner Protein,28329763,The allosteric inhibitor ABL001 enables dual targeting of BCR-ABL1.,No,5MO4
ASD03320000_2,Abl1,Mus musculus,P00520,3K5V,ASD03320002,STJ,A,Lig,Inhibitor,3-[6-[[4-(trifluoromethoxy)phenyl]amino]pyrimidin-4-yl]benzamide,1,Inner Protein Regulator,Inner Protein,20072125,Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors.,No,"Chain A:ALA356,LEU359,LEU360,ALA363,LEU448,ILE451,ALA452,TYR454,GLU481,GLY482,CYS483,PRO484,VAL487,PHE512,ILE521,VAL525,LEU529"
ASD03320000_2,Abl1,Mus musculus,P00520,6HD4,,FYW,A,Lig,Inhibitor,4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE,603,,,30137981,"Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1.",,
ASD03320000_2,Abl1,Mus musculus,P00520,6HD6,ASD03320240,FYH,A,Lig,Inhibitor,3-(morpholin-4-ylmethyl)-~{N}-[4-(trifluoromethyloxy)phenyl]benzamide,602,Allosteric function,Allosteric position,30137981,"Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1.",No,"Chain A:TYR361,ALA356,PRO484,GLU481,LEU359,VAL525,PHE512,VAL358,CYS483,THR453,MET362,SER355,ARG351,VAL357,VAL354,LEU448,THR364,PRO480,LEU360,MET456,GLY482,TYR454,LEU529,VAL487,MET515,PHE516,ALA363,MET491,ALA452,ILE521,ILE451"
ASD03330000_1,CNR1,Homo sapiens,P21554,6KQI,,9GL,A,Lig,modulator,5-chloro-3-ethyl-N-{2-[4-(piperidin-1-yl)phenyl]ethyl}-1H-indole-2-carboxamide,1202,,,,,,6KQI
ASD03330000_1,CNR1,Homo sapiens,P21554,7FEE,ASD03331915_HJX,7IC,E,,,,,,,35637350,,,7FEE
ASD03330000_1,CNR1,Homo sapiens,P21554,7WV9,ASD03331915_HJX,7IC,E,,,,,,,35637350,,,7WV9
ASD03380000_1,degS,Escherichia coli,P0AEE3,1SOZ,ASD03380004,Chain D,D;D;D;D,Pep,Activator,VYQF,407;408;409;410,Inner Protein Regulator,Inner Protein,15137941,Crystal structure of the DegS stress sensor: How a PDZ domain recognizes misfolded protein and activates a protease,No,"Chain D:GLN409,PHE410,TYR408,VAL407"
ASD03380000_1,degS,Escherichia coli,P0AEE3,2R3Y,ASD03380009,Chain D,D;D;D;D,Pep,Activator,VYWF,407;408;409;410,Inner Protein Regulator,Inner Protein,17938245,Regulation of the sigmaE stress response by DegS: how the PDZ domain keeps the protease inactive in the resting state and allows integration of different OMP-derived stress signals upon folding stress.,No,"Chain D:VAL407,PHE410,TYR408,TRP409"
ASD03380000_1,degS,Escherichia coli,P0AEE3,3GCN,ASD03380005,Chain B,B;B;B,Pep,Activator,YQF,408;409;410,Inner Protein Regulator,Inner Protein,,Mechanisms of allosteric activation of the DegS protease by OMP-peptide binding and protein-substrate binding,No,"Chain B:GLN409,TYR408,PHE410"
ASD03380000_1,degS,Escherichia coli,P0AEE3,3GCO,ASD03380004,Chain B,B;B;B;B,Pep,Activator,VYQF,407;408;409;410,Inner Protein Regulator,Inner Protein,19836340,OMP peptides activate the DegS stress-sensor protease by a relief of inhibition mechanism.,No,"Chain B:GLN409,TYR408,PHE410,VAL407"
ASD03380000_1,degS,Escherichia coli,P0AEE3,3GDS,ASD03380007,Chain B,B;B;B;B,Pep,Activator,VYYF,407;408;409;410,Inner Protein Regulator,Inner Protein,19836340,OMP peptides activate the DegS stress-sensor protease by a relief of inhibition mechanism.,No,"Chain B:TYR409,TYR408,PHE410,VAL407"
ASD03380000_1,degS,Escherichia coli,P0AEE3,3GDU,ASD03380006,Chain D,D;D;D,Pep,Activator,YRF,408;409;410,Inner Protein Regulator,Inner Protein,19836340,OMP peptides activate the DegS stress-sensor protease by a relief of inhibition mechanism.,No,"Chain D:ARG409,PHE410,TYR408"
ASD03380000_1,degS,Escherichia coli,P0AEE3,3GDV,ASD03380005,Chain D,D;D;D,Pep,Activator,YQF,408;409;410,Inner Protein Regulator,Inner Protein,19836340,OMP peptides activate the DegS stress-sensor protease by a relief of inhibition mechanism.,No,"Chain D:GLN409,PHE410,TYR408"
ASD03380000_1,degS,Escherichia coli,P0AEE3,4RQZ,ASD03380005,Chain D,D;D;D,Pep,Activator,YQF,408;409;410,Inner Protein Regulator,Inner Protein,25703375,A Conserved Activation Cluster Is Required for Allosteric Communication in HtrA-Family Proteases.,No,"Chain D:GLN409,TYR408,PHE410"
ASD03430000_2,Hcn2,Mus musculus,O88703,1Q3E,ASD02408002,PCG,A,Lig,Activator,"2-amino-9-[(4R,6S,7R,8R)-4,7-dihydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-8-yl]-1H-purin-6-one",401,Inner Protein Regulator,Inner Protein,12968185,Structural basis for modulation and agonist specificity of HCN pacemaker channels.,No,"Chain A:ILE545,VAL564,THR566,MET572,PHE580,GLY581,GLU582,ILE583,CYS584,ARG591,THR592,ALA593,VAL595,ARG632"
ASD03430000_2,Hcn2,Mus musculus,O88703,1Q43,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",646,Inner Protein Regulator,Inner Protein,12968185,Structural basis for modulation and agonist specificity of HCN pacemaker channels.,No,"Chain A:ILE545,VAL564,LEU574,PHE580,GLY581,GLU582,ILE583,CYS584,ARG591,THR592,ALA593,VAL595,ARG632,ARG635"
ASD03430000_2,PGI,Mus musculus,P42861,1Q5O,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",201,Inner Protein Regulator,Inner Protein,12968185,Structural basis for modulation and agonist specificity of HCN pacemaker channels.,No,"Chain A:ILE545,VAL564,PHE580,GLY581,GLU582,ILE583,CYS584,ARG591,THR592,ALA593,ARG632,ARG635,ILE636"
ASD03430000_2,Hcn2,Mus musculus,O88703,2Q0A,ASD02408002,PCG,A,Lig,Activator,"2-amino-9-[(4R,6S,7R,8R)-4,7-dihydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-8-yl]-1H-purin-6-one",401,Inner Protein Regulator,Inner Protein,17562314,Structure and rearrangements in the carboxy-terminal region of SpIH channels.,No,"Chain A:ILE545,VAL564,THR566,MET572,PHE580,GLY581,GLU582,ILE583,CYS584,ARG591,THR592,ALA593,VAL595,ARG632,ASP636"
ASD03430000_2,Hcn2,Mus musculus,O88703,3BPZ,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",641,Inner Protein Regulator,Inner Protein,18367452,C-terminal movement during gating in cyclic nucleotide-modulated channels.,No,"Chain A:ILE545,VAL564,MET572,LEU574,PHE580,GLY581,GLU582,ILE583,CYS584,ARG591,THR592,ALA593,VAL595,ARG632,ARG635,ILE636"
ASD03430000_2,Hcn2,Mus musculus,O88703,3ETQ,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",1,Inner Protein Regulator,Inner Protein,19525958,Mapping the structure and conformational movements of proteins with transition metal ion FRET.,No,"Chain A:ILE545,VAL564,MET572,LEU574,PHE580,GLY581,GLU582,ILE583,SER584,ARG591,THR592,ALA593,VAL595,ARG632,ARG635,ILE636"
ASD03430000_3,Sp-Hcn1,Strongylocentrotus purpuratus,O76977,2PTM,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",401,Inner Protein Regulator,Inner Protein,17562314,Structure and rearrangements in the carboxy-terminal region of SpIH channels.,No,"Chain A:ILE573,ILE592,THR601,PHE609,GLY610,GLU611,ILE612,CYS613,ARG620,VAL621,ALA622,VAL624,ARG661"
ASD03450000_1,murI,Helicobacter pylori,Q9ZLT0,2JFZ,ASD03450001,3,A,Lig,Inhibitor,"5-methyl-7-(2-methylpropyl)-2-(naphthalen-1-ylmethyl)-3-pyridin-4-yl-pyrazolo[4,3-e]pyrimidine-4,6-dione",1256,Inner Protein Regulator,Inner Protein,17568739,Exploitation of structural and regulatory diversity in glutamate racemases.,No,"Chain A:VAL10,GLY11,PHE13,SER14,ILE149,GLU150,SER152,LEU154,THR182,HIS183,LEU186,GLN248,TRP252"
ASD03450000_1,murI,Helicobacter pylori,Q9ZLT0,2W4I,ASD03450005,VGA,B,Lig,Inhibitor,"1-[(3S)-5-phenyl-3-thiophen-2-yl-3H-1,4-benzodiazepin-2-yl]azetidin-3-ol",1256,Inner Protein Regulator,Protein-Protein Interaction,19097892,Potent and selective inhibitors of Helicobacter pylori glutamate racemase (MurI): pyridodiazepine amines.,No,"Chain A:PRO38,THR41,SER143,VAL146,PRO147,GLU150,GLU151; Chain B:VAL37,PRO38,THR41,LYS117,VAL146,PRO147,GLU150,GLU151"
ASD03450000_1,murI,Helicobacter pylori,Q9ZLT0,4B1F,ASD03450008,KRH,A,Lig,Inhibitor,"5-methyl-3-(3-methylimidazol-4-yl)-7-(2-methylpropyl)-2-(naphthalen-1-ylmethyl)pyrazolo[3,4-d]pyrimidine-4,6-dione",1256,Inner Protein Regulator,Inner Protein,22877632,Design of Inhibitors of Helicobacter Pylori Glutamate Racemase as Selective Antibacterial Agents: Incorporation of Imidazoles Onto a Core Pyrazolopyrimidinedione Scaffold to Improve Bioavailabilty.,No,"Chain A:VAL10,GLY11,PHE13,LYS17,ILE149,GLU150,SER152,LEU154,THR182,HIS183,LEU186,GLN248,TRP252,LEU253"
ASD03450000_3,murI,Escherichia coli,P22634,2JFN,ASD03450006,UMA,A,Lig,Activator,"(2S)-2-[[(2R)-2-[(2R,3R,4R,5S,6R)-3-acetamido-2-[[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxypropanoyl]amino]propanoic acid",1286,Inner Protein Regulator,Inner Protein,17568739,Exploitation of Structural and Regulatory Diversity in Glutamate Racemases,No,"Chain A:LEU100,ARG104,VAL112,GLY113,VAL114,VAL115,PRO116,ALA117,LYS119,PRO120,PHE151,SER227,ALA230,ILE231,ARG233,ARG234"
ASD03450000_4,murI,Listeria monocytogenes serovar 1/2a,Q8Y7N7,3HFR,ASD03450007,6JZ,A,Lig,Inhibitor,1-ethoxy-2-[2-[2-(2-ethoxyethoxy)ethoxy]ethoxy]ethane,270,Inner Protein Regulator,Inner Protein,,Crystal structure of glutamate racemase from Listeria monocytogenes,No,"Chain A:GLY153,TYR155,LYS156,ASP246,ASP250"
ASD03450000_5,murI,Enterococcus faecalis,Q836J0,2VVT,ASD03450004,I24,A,Lig,Inhibitor,"2-butoxy-9-[(2,6-difluorophenyl)methyl]-N-(2-morpholin-4-ylethyl)purin-6-amine",1269,Inner Protein Regulator,Inner Protein,18614367,Exploring 9-Benzyl Purines as Inhibitors of Glutamate Racemase (Muri) in Gram-Positive Bacteria.,No,"Chain A:VAL14,GLY15,THR38,VAL152,GLU153,ASN155,TYR157,HIS187,LEU190,MET246,ILE250,TRP254"
ASD03470000_1,,Human immunodeficiency virus type 1,P12497,3AV9,ASD03470003;ASD03470003;ASD03470003;ASD03470003;ASD03470003;ASD03470003;ASD03470003;ASD03470003,SER;ALA;LYS;ILE;ASP;ASN;LEU;ASP,X;X;X;X;X;X;X;X,Pep,Inhibitor,"(2S)-2-amino-3-hydroxy-propanoic acid;(2S)-2-aminopropanoic acid;[(5S)-5-amino-6-hydroxy-6-oxo-hexyl]azanium;(2S,3S)-2-amino-3-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid;(2S)-2,4-bis(azanyl)-4-oxidanylidene-butanoic acid;(2S)-2-amino-4-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid",1;2;3;4;5;6;7;8,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21850718,Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,THR124,THR125,ALA128,TRP132"
ASD03470000_1,,Human immunodeficiency virus type 1,P12497,3AVA,ASD03470004;ASD03470004;ASD03470004;ASD03470004;ASD03470004;ASD03470004;ASD03470004;ASD03470004,ALA;LEU;LYS;ILE;ASP;ASN;LEU;ASP,X;X;X;X;X;X;X;X,Pep,Inhibitor,"(2S)-2-aminopropanoic acid;(2S)-2-amino-4-methyl-pentanoic acid;[(5S)-5-amino-6-hydroxy-6-oxo-hexyl]azanium;(2S,3S)-2-amino-3-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid;(2S)-2,4-bis(azanyl)-4-oxidanylidene-butanoic acid;(2S)-2-amino-4-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid",1;2;3;4;5;6;7;8,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21850718,Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,THR124,THR125,ALA128,TRP132"
ASD03470000_1,,Human immunodeficiency virus type 1,P12497,3AVB,ASD03470005;ASD03470005;ASD03470005;ASD03470005;ASD03470005;ASD03470005;ASD03470005;ASD03470005,SER;LEU;LYS;ILE;ASP;ASN;LEU;ASP,X;X;X;X;X;X;X;X,Pep,Inhibitor,"(2S)-2-amino-3-hydroxy-propanoic acid;(2S)-2-amino-4-methyl-pentanoic acid;[(5S)-5-amino-6-hydroxy-6-oxo-hexyl]azanium;(2S,3S)-2-amino-3-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid;(2S)-2,4-bis(azanyl)-4-oxidanylidene-butanoic acid;(2S)-2-amino-4-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid",1;2;3;4;5;6;7;8,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21850718,Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,THR124,THR125,ALA128,TRP132"
ASD03470000_1,,Human immunodeficiency virus type 1,P12497,3AVC,ASD03470006;ASD03470006;ASD03470006;ASD03470006;ASD03470006;ASD03470006,SER;ASP;LYS;ILE;ASP;ASN,F;F;F;F;F;F,Pep,Inhibitor,"(2S)-2-amino-3-hydroxy-propanoic acid;(2S)-2-azanylbutanedioic acid;[(5S)-5-amino-6-hydroxy-6-oxo-hexyl]azanium;(2S,3S)-2-amino-3-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid;(2S)-2,4-bis(azanyl)-4-oxidanylidene-butanoic acid",1;2;3;4;5;6,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21850718,Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,THR125,ALA128; Chain F:LEU7,ASP8"
ASD03470000_1,,Human immunodeficiency virus type 1,P12497,3AVF,ASD03470007;ASD03470007;ASD03470007;ASD03470007;ASD03470007;ASD03470007;ASD03470007;ASD03470007,ASP;LEU;LYS;ILE;ASP;ASN;LEU;ASP,D;D;D;D;D;D;D;D,Pep,Inhibitor,"(2S)-2-azanylbutanedioic acid;(2S)-2-amino-4-methyl-pentanoic acid;[(5S)-5-amino-6-hydroxy-6-oxo-hexyl]azanium;(2S,3S)-2-amino-3-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid;(2S)-2,4-bis(azanyl)-4-oxidanylidene-butanoic acid;(2S)-2-amino-4-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid",1;2;3;4;5;6;7;8,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21850718,Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,THR124,THR125,ALA128,TRP131,TRP132"
ASD03470000_1,,Human immunodeficiency virus type 1,P12497,3AVG,ASD03470008;ASD03470008;ASD03470008;ASD03470008;ASD03470008;ASD03470008;ASD03470008;ASD03470008,ALA;ASP;LYS;ILE;ASP;ASN;LEU;ASP,F;F;F;F;F;F;F;F,Pep,Inhibitor,"(2S)-2-aminopropanoic acid;(2S)-2-azanylbutanedioic acid;[(5S)-5-amino-6-hydroxy-6-oxo-hexyl]azanium;(2S,3S)-2-amino-3-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid;(2S)-2,4-bis(azanyl)-4-oxidanylidene-butanoic acid;(2S)-2-amino-4-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid",1;2;3;4;5;6;7;8,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21850718,Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,THR124,THR125"
ASD03470000_1,,Human immunodeficiency virus type 1,P12497,3AVH,ASD03470002;ASD03470002;ASD03470002;ASD03470002;ASD03470002;ASD03470002;ASD03470002;ASD03470002,ALA;ARG;LYS;ILE;ASP;ASN;LEU;ASP,F;F;F;F;F;F;F;F,Pep,Inhibitor,"(2S)-2-aminopropanoic acid;[amino-[[(4S)-4-amino-5-hydroxy-5-oxo-pentyl]amino]methylidene]azanium;[(5S)-5-amino-6-hydroxy-6-oxo-hexyl]azanium;(2S,3S)-2-amino-3-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid;(2S)-2,4-bis(azanyl)-4-oxidanylidene-butanoic acid;(2S)-2-amino-4-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid",1;2;3;4;5;6;7;8,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21850718,Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,THR124,THR125,ALA128,TRP131,TRP132"
ASD03470000_1,,Human immunodeficiency virus type 1,P12497,3AVI,ASD03470009;ASD03470009;ASD03470009;ASD03470009;ASD03470009;ASD03470009;ASD03470009;ASD03470009,SER;LEU;LYS;ILE;ASP;ASN;MET;ASP,F;F;F;F;F;F;F;F,Pep,Inhibitor,"(2S)-2-amino-3-hydroxy-propanoic acid;(2S)-2-amino-4-methyl-pentanoic acid;[(5S)-5-amino-6-hydroxy-6-oxo-hexyl]azanium;(2S,3S)-2-amino-3-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid;(2S)-2,4-bis(azanyl)-4-oxidanylidene-butanoic acid;(2S)-2-amino-4-methylsulfanyl-butanoic acid;(2S)-2-azanylbutanedioic acid",1;2;3;4;5;6;7;8,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21850718,Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,THR124,THR125,ALA128,ALA129,TRP131,TRP132"
ASD03470000_1,,Human immunodeficiency virus type 1,P12497,3AVJ,ASD03470010;ASD03470010;ASD03470010;ASD03470010;ASD03470010;ASD03470010;ASD03470010;ASD03470010,ALA;LEU;LYS;ILE;ASP;ASN;MET;ASP,F;F;F;F;F;F;F;F,Pep,Inhibitor,"(2S)-2-aminopropanoic acid;(2S)-2-amino-4-methyl-pentanoic acid;[(5S)-5-amino-6-hydroxy-6-oxo-hexyl]azanium;(2S,3S)-2-amino-3-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid;(2S)-2,4-bis(azanyl)-4-oxidanylidene-butanoic acid;(2S)-2-amino-4-methylsulfanyl-butanoic acid;(2S)-2-azanylbutanedioic acid",1;2;3;4;5;6;7;8,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21850718,Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,THR124,THR125,ALA128,ALA129,TRP131,TRP132"
ASD03470000_1,,Human immunodeficiency virus type 1,P12497,3AVK,ASD03470011;ASD03470011;ASD03470011;ASD03470011;ASD03470011;ASD03470011;ASD03470011;ASD03470011,SER;LEU;LYS;ILE;ASP;ASN;GLU;ASP,F;F;F;F;F;F;F;F,Pep,Inhibitor,"(2S)-2-amino-3-hydroxy-propanoic acid;(2S)-2-amino-4-methyl-pentanoic acid;[(5S)-5-amino-6-hydroxy-6-oxo-hexyl]azanium;(2S,3S)-2-amino-3-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid;(2S)-2,4-bis(azanyl)-4-oxidanylidene-butanoic acid;(2S)-2-azanylpentanedioic acid;(2S)-2-azanylbutanedioic acid",1;2;3;4;5;6;7;8,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21850718,Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,THR124,THR125,ALA128,ALA129,TRP131,TRP132"
ASD03470000_1,,Human immunodeficiency virus type 1,P12497,3AVL,ASD03470012;ASD03470012;ASD03470012;ASD03470012;ASD03470012;ASD03470012;ASD03470012;ASD03470012,ALA;THR;LYS;ILE;ASP;ASN;LEU;ASP,F;F;F;F;F;F;F;F,Pep,Inhibitor,"(2S)-2-aminopropanoic acid;(2S,3R)-2-amino-3-hydroxy-butanoic acid;[(5S)-5-amino-6-hydroxy-6-oxo-hexyl]azanium;(2S,3S)-2-amino-3-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid;(2S)-2,4-bis(azanyl)-4-oxidanylidene-butanoic acid;(2S)-2-amino-4-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid",1;2;3;4;5;6;7;8,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21850718,Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,THR124,THR125,ALA128,TRP131,TRP132"
ASD03470000_1,,Human immunodeficiency virus type 1,P12497,3AVM,ASD03470013;ASD03470013;ASD03470013;ASD03470013;ASD03470013;ASD03470013;ASD03470013;ASD03470013,SER;ARG;LYS;ILE;ASP;ASN;LEU;ASP,F;F;F;F;F;F;F;F,Pep,Inhibitor,"(2S)-2-amino-3-hydroxy-propanoic acid;[amino-[[(4S)-4-amino-5-hydroxy-5-oxo-pentyl]amino]methylidene]azanium;[(5S)-5-amino-6-hydroxy-6-oxo-hexyl]azanium;(2S,3S)-2-amino-3-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid;(2S)-2,4-bis(azanyl)-4-oxidanylidene-butanoic acid;(2S)-2-amino-4-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid",1;2;3;4;5;6;7;8,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21850718,Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,THR124,THR125,ALA128,TRP131,TRP132"
ASD03470000_1,,Human immunodeficiency virus type 1,P12497,3AVN,ASD03470014;ASD03470014;ASD03470014;ASD03470014;ASD03470014;ASD03470014;ASD03470014;ASD03470014,SER;HIS;LYS;ILE;ASP;ASN;LEU;ASP,H;H;H;H;H;H;H;H,Pep,Inhibitor,"(2S)-2-amino-3-hydroxy-propanoic acid;(2S)-2-amino-3-(1H-imidazol-3-ium-4-yl)propanoic acid;[(5S)-5-amino-6-hydroxy-6-oxo-hexyl]azanium;(2S,3S)-2-amino-3-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid;(2S)-2,4-bis(azanyl)-4-oxidanylidene-butanoic acid;(2S)-2-amino-4-methyl-pentanoic acid;(2S)-2-azanylbutanedioic acid",1;2;3;4;5;6;7;8,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21850718,Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.,No,"Chain A:ASP167,GLN168,ALA169,GLU170,HIS171,THR174,MET178; Chain B:GLN95,THR124,THR125,ALA128,TRP131,TRP132"
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,3LPU,ASD03470001,976,A,Lig,Inhibitor,(2S)-2-(6-chloro-2-methyl-4-phenyl-quinolin-3-yl)pentanoic acid,1,Protein-Protein Interaction Regulator,Protein-Protein Interaction,20473303,Rational design of small molecule inhibitors of the LEDGF/75-integrase interaction and HIV replication,No,"Chain A:GLN95,TYR99,THR124,THR125,ALA128,ALA129"
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,3NF6,ASD01670030,IMV,A,Lig,Inhibitor,"5-[(2-oxo-3H-indol-1-yl)methyl]-1,3-benzodioxole-4-carboxylic acid",230,Inner Protein Regulator,Inner Protein,21602613,Structural basis for a new mechanism of inhibition of HIV-1 integrase identified by fragment screening and structure-based design,Yes,"Chain A:VAL77,VAL79,GLY82,ILE84,VAL150,MET154,GLU157,LEU158,HIS183"
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,3NF7,ASD03470034,CIW,A,Lig,Inhibitor,"5-[(5-chloro-2-oxo-3H-indol-1-yl)methyl]-1,3-benzodioxole-4-carboxylic acid",221,Inner Protein Regulator,Inner Protein,21602613,Structural basis for a new mechanism of inhibition of HIV-1 integrase identified by fragment screening and structure-based design,Yes,"Chain A:GLN62,VAL77,VAL79,GLY82,ILE84,VAL150,ILE151,SER153,MET154,GLU157,LEU158,HIS183"
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,3NF8,ASD03470033,CDQ,A,Lig,Inhibitor,"6-[(5-chloro-2-oxo-3H-indol-1-yl)methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",247,Inner Protein Regulator,Inner Protein,21602613,Structural basis for a new mechanism of inhibition of HIV-1 integrase identified by fragment screening and structure-based design,Yes,"Chain A:GLN62,VAL77,VAL79,GLY82,ILE84,VAL150,MET154,GLU157,LEU158,HIS183"
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,3NF9,ASD03470032,CD9,A,Lig,Inhibitor,"5-[(6-chloro-2-oxo-3H-indol-1-yl)methyl]-1,3-benzodioxole-4-carboxylic acid",220,Inner Protein Regulator,Inner Protein,21602613,Structural basis for a new mechanism of inhibition of HIV-1 integrase identified by fragment screening and structure-based design,Yes,"Chain A:VAL77,VAL79,GLY82,VAL150,ILE151,SER153,MET154,GLU157,HIS183"
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,3NFA,ASD01670008,CBJ,A,Lig,Inhibitor,"6-[(5-bromo-2,3-dioxo-indol-1-yl)methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid",213,Inner Protein Regulator,Inner Protein,21602613,Structural basis for a new mechanism of inhibition of HIV-1 integrase identified by fragment screening and structure-based design,Yes,"Chain A:VAL79,ALA80,SER81,GLY82,ILE84,VAL150,MET154,GLU157,LEU158,HIS183,LYS188,ARG199"
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,4AH9,ASD03470015,0MB,A,Lig,Inhibitor,"5-(1,4-diazepan-1-yl)-3-phenyl-1,2,4-thiadiazole",218,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel Screening of Low Molecular Weight Fragment Libraries: Do Differences in Methodology Affect Hit Identification?,No,"Chain A:GLY106,ARG107,TRP108,PRO109,ILE204,ILE208; Chain B:TYR83,ASN184,HIS185,ARG187,GLY197,GLU198"
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,4AHR,ASD03470016,I2E,A,Lig,Inhibitor,"3-(1,3-benzodioxol-5-yl)propanoic acid",1218,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel Screening of Low Molecular Weight Fragment Libraries: Do Differences in Methodology Affect Hit Identification?,No,"Chain A:ALA105,GLY106,ARG107,TRP108,PRO109,ILE204,ILE208; Chain B:TYR83,ASN184,HIS185,GLY197,GLU198,VAL201"
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,4AHS,ASD03470017,AKH,A,Lig,Inhibitor,1-benzofuran-7-carboxylic acid,1216,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel Screening of Low Molecular Weight Fragment Libraries: Do Differences in Methodology Affect Hit Identification?,No,"Chain A:GLY106,ARG107,TRP108,PRO109,ILE204,ILE208; Chain B:TYR83,HIS185,GLY197,GLU198,VAL201"
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,4AHT,ASD03470018,Q6T,A,Lig,Inhibitor,"1,3-benzodioxole-4-carboxylic acid",1216,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel Screening of Low Molecular Weight Fragment Libraries: Do Differences in Methodology Affect Hit Identification?,No,"Chain A:GLY106,ARG107,TRP108,PRO109,ILE208; Chain B:TYR83,ASN184,HIS185,GLY197,GLU198,VAL201"
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,4AHU,ASD06710009,ICO,A,Lig,Inhibitor,1H-indole-3-carboxylic acid,1217,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel Screening of Low Molecular Weight Fragment Libraries: Do Differences in Methodology Affect Hit Identification?,No,"Chain A:TYR83,ASN184,HIS185,GLY197,GLU198,VAL201; Chain B:GLY106,ARG107,TRP108,PRO109,ILE208"
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,4AHV,ASD03470020,Z5P,A,Lig,Inhibitor,(2-pyrazol-1-ylphenyl)methanamine,1219,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel Screening of Low Molecular Weight Fragment Libraries: Do Differences in Methodology Affect Hit Identification?,No,"Chain A:TYR83,ASN184,HIS185,GLY197,GLU198,VAL201; Chain B:GLY106,ARG107,TRP108,PRO109,ILE204,ILE208"
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,4DMN,ASD05062031,0L9,A,Lig,Inhibitor,(2S)-2-[6-bromanyl-4-(4-chlorophenyl)-2-methyl-quinolin-3-yl]-2-methoxy-ethanoic acid,305,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22437836,"A multimode, cooperative mechanism of action of allosteric HIV-1 integrase inhibitors.",No,"Chain A:GLN95,THR124,THR125,ALA128,ALA129,TRP132"
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,4E1M,ASD05068001,TQ2,A,Lig,Inhibitor,"(2S)-2-[4-(3,4-dimethylphenyl)-2-methyl-quinolin-3-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid",301,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22535962,New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action.,No,"Chain A:GLN168,ALA169,GLU170,HIS171,THR174,MET178"
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,4E1N,ASD05068002,TQX,A,Lig,Inhibitor,"(2S)-2-[4-(8-fluoranyl-5-methyl-3,4-dihydro-2H-chromen-6-yl)-2-methyl-quinolin-3-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid",301,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22535962,New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action.,No,"Chain A:GLN168,ALA169,GLU170,HIS171,THR174,MET178"
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,4GVM,ASD05060053,LF2,A,Lig,Inhibitor,(2S)-2-[6-bromanyl-4-(4-chlorophenyl)-2-methyl-quinolin-3-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid,303,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23615903,The A128T Resistance Mutation Reveals Aberrant Protein Multimerization as the Primary Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors.,No,"Chain A:GLN95,TYR99,THR124,THR125,THR128,ALA129,TRP132"
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,4GW6,ASD05060053,LF2,A,Lig,Inhibitor,(2S)-2-[6-bromanyl-4-(4-chlorophenyl)-2-methyl-quinolin-3-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid,303,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23615903,The A128T Resistance Mutation Reveals Aberrant Protein Multimerization as the Primary Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors.,No,"Chain A:GLN95,LEU102,THR125,ALA128,ALA129,TRP132"
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,4ID1,ASD01670001,LF0,A,Lig,Inhibitor,"(2S)-2-[4-(3,4-dihydro-2H-chromen-6-yl)-2-methyl-quinolin-3-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid",301,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23610442,Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation.,No,"Chain A:GLN95,LEU102,THR124,THR125,ALA128,ALA129,TRP132"
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,4JLH,ASD05062031,0L9,A,Lig,Inhibitor,(2S)-2-[6-bromanyl-4-(4-chlorophenyl)-2-methyl-quinolin-3-yl]-2-methoxy-ethanoic acid,301,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23615903,The A128T Resistance Mutation Reveals Aberrant Protein Multimerization as the Primary Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors.,No,"Chain A:GLN95,THR124,THR125,THR128,ALA129,TRP132"
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,4O0J,ASD03470025,LF8,A,Lig,Inhibitor,"(2S)-2-[4-(4-chlorophenyl)-6-(3,4-dimethylphenyl)-2,5-dimethyl-pyridin-3-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid",301,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24874515,A New Class of Multimerization Selective Inhibitors of HIV-1 Integrase.,No,"Chain A:GLN95,LEU102,THR124,THR125,ALA128,ALA129,TRP132"
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,4O55,ASD03470026,LF9,A,Lig,Inhibitor,"(2S)-2-[6-(5-chloranyl-1H-benzimidazol-2-yl)-2,5-dimethyl-4-phenyl-pyridin-3-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid",301,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24874515,A New Class of Multimerization Selective Inhibitors of HIV-1 Integrase.,No,"Chain A:GLN95,THR124,THR125,ALA128,ALA129"
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,4O5B,ASD03470026,LF9,A,Lig,Inhibitor,"(2S)-2-[6-(5-chloranyl-1H-benzimidazol-2-yl)-2,5-dimethyl-4-phenyl-pyridin-3-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid",301,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24874515,A New Class of Multimerization Selective Inhibitors of HIV-1 Integrase.,No,"Chain A:GLN95,THR124,THR125,THR128,ALA129"
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,6LMI,,EJ9,A,Lig,Inhibitor,"(2S)-2-[2-(3,4-dihydro-2H-chromen-6-yl)-4-(3,4-dimethylphenyl)-3,6-dimethyl-5-(methylsulfonylamino)phenyl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid",304,,,,,,
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,6LMQ,,940,A,Lig,Inhibitor,"(2S)-2-[2-(3,4-dihydro-2H-1,4-benzoxazin-6-yl)-4-(3,4-dimethylphenyl)-3,6-dimethyl-5-(methylsulfonylamino)phenyl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid",304,,,,,,
ASD03470000_1,gag-pol,Human immunodeficiency virus type 1,P12497,6UM8,,QCG,A,Lig,Inhibitor,"(2S)-tert-butoxy[7-(8-fluoro-5-methyl-3,4-dihydro-2H-1-benzopyran-6-yl)-5-methyl-2-phenylpyrazolo[1,5-a]pyrimidin-6-yl]acetic acid",305,Allosteric function,Allosteric position,,,No,
ASD03490000_1,MAPK14,Homo sapiens,Q16539,1KV1,ASD00740008,BMU,A,Lig,Inhibitor,3-(5-tert-butyl-2-methyl-pyrazol-3-yl)-1-(4-chlorophenyl)urea,391,Inner Protein Regulator,Inner Protein,11896401,Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site.,Yes,1KV1
ASD03490000_1,MAPK14,Homo sapiens,Q16539,1KV2,ASD00740009,B96,A,Lig,Inhibitor,3-[5-tert-butyl-2-(4-methylphenyl)pyrazol-3-yl]-1-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]urea,391,Inner Protein Regulator,Inner Protein,11896401,Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site.,Yes,1KV2
ASD03490000_1,MAPK14,Homo sapiens,Q16539,1W82,ASD03490108,L10,A,Lig,Inhibitor,1-(5-tert-butyl-2-phenyl-1H-pyrazol-3-ylidene)-3-(4-chlorophenyl)urea,1356,Inner Protein Regulator,Inner Protein,15658855,Identification of Novel P38Alpha Map Kinase Inhibitors Using Fragment-Based Lead Generation,Yes,1W82
ASD03490000_1,MAPK14,Homo sapiens,Q16539,1W83,ASD03490096,L11,A,Lig,Inhibitor,N-[4-chloro-3-(pyridin-3-yloxymethyl)phenyl]-3-fluoro-5-morpholin-4-yl-cyclohexene-1-carboxamide,1355,Inner Protein Regulator,Inner Protein,15658855,Identification of Novel P38Alpha Map Kinase Inhibitors Using Fragment-Based Lead Generation,Yes,1W83
ASD03490000_1,MAPK14,Homo sapiens,Q16539,1WBN,ASD03490094,L09,A,Lig,Inhibitor,1-(5-tert-butyl-2H-pyrazol-3-yl)-3-[4-chloro-3-(pyridin-3-yloxymethyl)phenyl]urea,1355,Inner Protein Regulator,Inner Protein,15658855,Identification of Novel P38Alpha Map Kinase Inhibitors Using Fragment-Based Lead Generation.,Yes,1WBN
ASD03490000_1,MAPK14,Homo sapiens,Q16539,1WBS,ASD03490101,LI2,A,Lig,Inhibitor,3-fluoro-5-morpholin-4-yl-N-[3-(2-pyridin-4-ylethyl)-1H-indol-5-yl]benzamide,1355,Inner Protein Regulator,Inner Protein,15658855,Identification of Novel P38Alpha Map Kinase Inhibitors Using Fragment-Based Lead Generation.,Yes,1WBS
ASD03490000_1,MAPK14,Homo sapiens,Q16539,1WBT,ASD03490102,WBT,A,Lig,Inhibitor,3-fluoro-5-morpholin-4-yl-N-[1-(2-pyridin-4-ylethyl)indol-6-yl]benzamide,1355,Inner Protein Regulator,Inner Protein,15658855,Identification of Novel P38Alpha Map Kinase Inhibitors Using Fragment-Based Lead Generation.,Yes,1WBT
ASD03490000_1,MAPK14,Homo sapiens,Q16539,1WBV,ASD03490097,LI3,A,Lig,Inhibitor,3-fluoro-N-(1H-indol-5-yl)-5-morpholin-4-yl-benzamide,1355,Inner Protein Regulator,Inner Protein,15658855,Identification of Novel P38Alpha Map Kinase Inhibitors Using Fragment-Based Lead Generation.,Yes,1WBV
ASD03490000_1,MAPK14,Homo sapiens,Q16539,2BAJ,ASD03490106,1PP,A,Lig,Inhibitor,"1-[2,3-bis(chloranyl)phenyl]-3-(5-tert-butyl-2-phenyl-pyrazol-3-yl)urea",401,Inner Protein Regulator,Inner Protein,16342939,Prevention of MKK6-Dependent Activation by Binding to p38alpha MAP Kinase,Yes,2BAJ
ASD03490000_1,MAPK14,Homo sapiens,Q16539,2BAK,ASD03490119,AQZ,A,Lig,Inhibitor,N-[3-[[7-methoxy-6-(2-pyrrolidin-1-ylethoxy)quinazolin-4-yl]amino]-4-methyl-phenyl]-2-morpholin-4-yl-pyridine-4-carboxamide,401,Inner Protein Regulator,Inner Protein,16342939,Prevention of MKK6-Dependent Activation by Binding to p38alpha MAP Kinase,Yes,2BAK
ASD03490000_1,MAPK14,Homo sapiens,Q16539,3D83,ASD03490098,GK6,A,Lig,Inhibitor,N-[3-[4-(cyclopropylmethylcarbamoyl)phenyl]-4-methyl-phenyl]-2-morpholin-4-yl-pyridine-4-carboxamide,401,Inner Protein Regulator,Inner Protein,18602262,Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modes.,Yes,3D83
ASD03490000_1,MAPK14,Homo sapiens,Q16539,3.00E+93,ASD03490099,19B,A,Lig,Inhibitor,"4-methyl-N-(3-morpholin-4-ylphenyl)-3-(3-piperidin-4-yl-1,2-benzoxazol-6-yl)benzamide",361,Inner Protein Regulator,Inner Protein,18789685,"Kinase array design, back to front: Biaryl amides",Yes,3.00E+93
ASD03490000_1,MAPK14,Homo sapiens,Q16539,3GCQ,ASD00740016,1BU,A,Lig,Inhibitor,3-[4-[(6-aminoquinazolin-4-yl)amino]phenyl]-1-[5-tert-butyl-2-(3-methylphenyl)pyrazol-3-yl]urea,401,Inner Protein Regulator,Inner Protein,19572644,Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors.,Yes,3GCQ
ASD03490000_1,MAPK14,Homo sapiens,Q16539,3GCS,ASD00450013,BAX,A,Lig,Inhibitor,4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide,401,Inner Protein Regulator,Inner Protein,19572644,Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors.,Yes,3GCS
ASD03490000_1,MAPK14,Homo sapiens,Q16539,3GCU,ASD03498002,R48,A,Lig,Inhibitor,1-[3-[(6-aminoquinazolin-4-yl)amino]phenyl]-3-[5-tert-butyl-2-(4-methylphenyl)pyrazol-3-yl]urea,401,Inner Protein Regulator,Inner Protein,19572644,Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors.,Yes,3GCU
ASD03490000_1,MAPK14,Homo sapiens,Q16539,3GCV,ASD00740019,SS6,A,Lig,Inhibitor,3-[3-[(6-aminoquinazolin-4-yl)amino]phenyl]-1-[5-tert-butyl-2-(3-methylphenyl)pyrazol-3-yl]urea,361,Inner Protein Regulator,Inner Protein,19572644,Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors.,Yes,3GCV
ASD03490000_1,MAPK14,Homo sapiens,Q16539,3GI3,ASD03490123,B10,A,Lig,Inhibitor,1-[5-tert-butyl-2-methoxy-3-(methylsulfonylamino)phenyl]-3-[4-[6-(morpholin-4-ylmethyl)pyridin-3-yl]naphthalen-1-yl]urea,391,Inner Protein Regulator,Inner Protein,19356929,Discovery and characterization of the N-phenyl-N'-naphthylurea class of p38 kinase inhibitors.,Yes,3GI3
ASD03490000_1,MAPK14,Homo sapiens,Q16539,3HEC,ASD00740007,STI,A,Lig,Inhibitor,4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide,1,Inner Protein Regulator,Inner Protein,Not in PubMed,Analysis of Imatinib and Sorafenib binding in p38 alpha compared with c-Abl and B-Raf provides structural insights into design of inhibitors targeting the DFG-out form of protein kinases,Yes,3HEC
ASD03490000_1,MAPK14,Homo sapiens,Q16539,3HEG,ASD00450013,BAX,A,Lig,Inhibitor,4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide,1,Inner Protein Regulator,Inner Protein,Not in PubMed,Analysis of Imatinib and Sorafenib binding to p38 alpha compared with c-Abl and b-Raf provides structural insights into design of inhibitors targeting the DFG-out form of protein kinases,Yes,3HEG
ASD03490000_1,MAPK14,Homo sapiens,Q16539,3HV3,ASD03490105,R49,A,Lig,Inhibitor,3-[4-[(6-aminoquinolin-4-yl)amino]phenyl]-1-[5-tert-butyl-2-(3-methylphenyl)pyrazol-3-yl]urea,361,Inner Protein Regulator,Inner Protein,19928858,Displacement assay for the detection of stabilizers of inactive kinase conformations.,Yes,3HV3
ASD03490000_1,MAPK14,Homo sapiens,Q16539,3HV4,ASD03490115,L51,A,Lig,Inhibitor,1-[3-[(6-aminoquinolin-4-yl)amino]phenyl]-3-[5-tert-butyl-2-(4-methylphenyl)pyrazol-3-yl]urea,361,Inner Protein Regulator,Inner Protein,19928858,Displacement assay for the detection of stabilizers of inactive kinase conformations.,Yes,3HV4
ASD03490000_1,MAPK14,Homo sapiens,Q16539,3HV5,ASD03490114,R24,A,Lig,Inhibitor,3-[5-tert-butyl-2-(4-methylphenyl)pyrazol-3-yl]-1-[3-[(6-nitroquinolin-4-yl)amino]phenyl]urea,361,Inner Protein Regulator,Inner Protein,19928858,Displacement assay for the detection of stabilizers of inactive kinase conformations.,Yes,3HV5
ASD03490000_1,MAPK14,Homo sapiens,Q16539,3HV6,ASD03490122,R39,A,Lig,Inhibitor,3-[5-tert-butyl-2-(4-methylphenyl)pyrazol-3-yl]-1-[4-(2-morpholin-4-ylethoxy)phenyl]urea,361,Inner Protein Regulator,Inner Protein,19928858,Displacement assay for the detection of stabilizers of inactive kinase conformations.,Yes,3HV6
ASD03490000_1,MAPK14,Homo sapiens,Q16539,3HV7,ASD00740003,1AU,A,Lig,Inhibitor,3-[2-(3-aminophenyl)-5-tert-butyl-pyrazol-3-yl]-1-naphthalen-1-yl-urea,361,Inner Protein Regulator,Inner Protein,19928858,Displacement assay for the detection of stabilizers of inactive kinase conformations.,Yes,3HV7
ASD03490000_1,MAPK14,Homo sapiens,Q16539,3IW8,ASD03490103,HIZ,A,Lig,Inhibitor,"1-[4-[(1S)-1-azanyl-2-phenylmethoxy-ethyl]-1,3-thiazol-2-yl]-3-(3-chloro-4-fluoro-phenyl)urea",361,Inner Protein Regulator,Inner Protein,19950957,High-Throughput Screening To Identify Inhibitors Which Stabilize Inactive Kinase Conformations in p38alpha,Yes,3IW8
ASD03490000_1,MAPK14,Homo sapiens,Q16539,3K3I,ASD03490095,JZJ,A,Lig,Inhibitor,"(3S)-3-[4-(4-bromophenyl)-1H-imidazol-2-yl]-1,2,3,4-tetrahydroisoquinoline",1,Inner Protein Regulator,Inner Protein,19843080,"The design, synthesis and potential utility of fluorescence probes that target DFG-out conformation of p38alpha for high throughput screening binding assay.",Yes,3K3I
ASD03490000_1,MAPK14,Homo sapiens,Q16539,3K3J,ASD03490113,F4C,A,Lig,Inhibitor,2-(4-fluorophenyl)-3-oxo-6-pyridin-4-yl-N-[[2-(trifluoromethyl)phenyl]methyl]pyridazine-4-carboxamide,361,Inner Protein Regulator,Inner Protein,19843080,"The Design, Synthesis and Potential Utility of Fluorescence Probes that Target DFG-out Conformation of p38alpha for High Throughput Screening Binding Assay.",Yes,3K3J
ASD03490000_1,MAPK14,Homo sapiens,Q16539,3KQ7,ASD03490118,KQ7,A,Lig,Inhibitor,"N-[4-methyl-3-[[6-[2-[(1R,2S)-1-methylpyrrolidin-2-yl]ethylamino]pyridin-3-yl]carbonylamino]phenyl]-2-morpholin-4-yl-pyridine-4-carboxamide",361,Inner Protein Regulator,Inner Protein,Not in PubMed,Structure of human p38alpha with N-[4-methyl-3-(6-{[2-(1-methylpyrrolidin-2-yl)ethyl]amino}pyridine-3-amido)phenyl]-2-(morpholin-4-yl)pyridine-4-carboxamide,Yes,3KQ7
ASD03490000_1,MAPK14,Homo sapiens,Q16539,3LFB,ASD03492005,Z87,A,Lig,Inhibitor,"1-[5-tert-butyl-2-(4-methylphenyl)pyrazol-3-yl]-3-(1,3-thiazol-2-yl)urea",361,Inner Protein Regulator,Inner Protein,,Development of novel thiazole-urea compounds which stabalize the inactive conformation of p38 alpha,Yes,3LFB
ASD03490000_1,MAPK14,Homo sapiens,Q16539,3LFD,ASD03492008,Z85,A,Lig,Inhibitor,"1-[5-tert-butyl-2-(4-methylphenyl)pyrazol-3-yl]-3-[4-(2-phenylmethoxyethyl)-1,3-thiazol-2-yl]urea",361,Inner Protein Regulator,Inner Protein,,Development of novel thiazole-urea compounds which stabalize the inactive conformation of p38 alpha,Yes,3LFD
ASD03490000_1,MAPK14,Homo sapiens,Q16539,3LFE,ASD03492010,Z84,A,Lig,Inhibitor,"1-[5-tert-butyl-2-(4-methylphenyl)pyrazol-3-yl]-3-[4-[2-(pyridin-4-ylmethoxy)ethyl]-1,3-thiazol-2-yl]urea",361,Inner Protein Regulator,Inner Protein,,Development of novel thiazole-urea compounds which stabalize the inactive conformation of p38 alpha,Yes,3LFE
ASD03490000_1,MAPK14,Homo sapiens,Q16539,3NEW,ASD03498001,3NE,A,Lig,Inhibitor,"4-(trifluoromethyl)-3-[3-(trifluoromethyl)phenyl]-1,7-dihydropyrazolo[3,4-b]pyridin-6-one",361,Inner Protein Regulator,Inner Protein,21090814,Discovery and Characterization of Non-ATP Site Inhibitors of the Mitogen Activated Protein (MAP) Kinases.,No,3NEW
ASD03490000_1,MAPK14,Homo sapiens,Q16539,3NNU,ASD03490124,EDB,A,Lig,Inhibitor,"2-[3-[(3E)-3-[(2,3-dichlorophenyl)carbamoylimino]-5-thiophen-2-yl-1H-pyrazol-2-yl]phenyl]ethanamide",355,Inner Protein Regulator,Inner Protein,20800479,Switch control pocket inhibitors of p38-MAP kinase. Durable type II inhibitors that do not require binding into the canonical ATP hinge region,Yes,3NNU
ASD03490000_1,MAPK14,Homo sapiens,Q16539,3NNV,ASD03490117,437,A,Lig,Inhibitor,1-[5-tert-butyl-2-[4-(hydroxymethyl)phenyl]pyrazol-3-yl]-3-naphthalen-1-yl-urea,355,Inner Protein Regulator,Inner Protein,20800479,Switch control pocket inhibitors of p38-MAP kinase. Durable type II inhibitors that do not require binding into the canonical ATP hinge region,Yes,3NNV
ASD03490000_1,MAPK14,Homo sapiens,Q16539,3NNW,ASD03490125,EDD,A,Lig,Inhibitor,"2-[3-[5-tert-butyl-3-[(2,3-dichlorophenyl)carbamoylimino]-1H-pyrazol-2-yl]phenyl]ethanamide",355,Inner Protein Regulator,Inner Protein,20800479,Switch control pocket inhibitors of p38-MAP kinase. Durable type II inhibitors that do not require binding into the canonical ATP hinge region,Yes,3NNW
ASD03490000_1,MAPK14,Homo sapiens,Q16539,3NNX,ASD03490125,EDD,A,Lig,Inhibitor,"2-[3-[5-tert-butyl-3-[(2,3-dichlorophenyl)carbamoylimino]-1H-pyrazol-2-yl]phenyl]ethanamide",355,Inner Protein Regulator,Inner Protein,20800479,Switch control pocket inhibitors of p38-MAP kinase. Durable type II inhibitors that do not require binding into the canonical ATP hinge region,Yes,3NNX
ASD03490000_1,MAPK14,Homo sapiens,Q16539,3O8P,ASD00740008,BMU,A,Lig,Inhibitor,3-(5-tert-butyl-2-methyl-pyrazol-3-yl)-1-(4-chlorophenyl)urea,361,Inner Protein Regulator,Inner Protein,,Conformational plasticity of p38 MAP kinase DFG motif mutants in response to inhibitor binding,Yes,3O8P
ASD03490000_1,MAPK14,Homo sapiens,Q16539,3O8T,ASD00740008,BMU,A,Lig,Inhibitor,3-(5-tert-butyl-2-methyl-pyrazol-3-yl)-1-(4-chlorophenyl)urea,361,Inner Protein Regulator,Inner Protein,,Conformational plasticity of p38 MAP kinase DFG motif mutants in response to inhibitor binding,Yes,3O8T
ASD03490000_1,MAPK14,Homo sapiens,Q16539,3O8U,ASD00740008,BMU,A,Lig,Inhibitor,3-(5-tert-butyl-2-methyl-pyrazol-3-yl)-1-(4-chlorophenyl)urea,361,Inner Protein Regulator,Inner Protein,,Conformational plasticity of p38 MAP kinase DFG motif mutants in response to inhibitor binding,Yes,3O8U
ASD03490000_1,MAPK14,Homo sapiens,Q16539,3OBJ,ASD00740008,BMU,A,Lig,Inhibitor,3-(5-tert-butyl-2-methyl-pyrazol-3-yl)-1-(4-chlorophenyl)urea,361,Inner Protein Regulator,Inner Protein,,Conformational plasticity of p38 MAP kinase DFG motif mutants in response to inhibitor binding,Yes,3OBJ
ASD03490000_1,MAPK14,Homo sapiens,Q16539,3OC1,ASD00740008,BMU,A,Lig,Inhibitor,3-(5-tert-butyl-2-methyl-pyrazol-3-yl)-1-(4-chlorophenyl)urea,361,Inner Protein Regulator,Inner Protein,,Conformational plasticity of p38 MAP kinase DFG motif mutants in response to inhibitor binding,Yes,3OC1
ASD03490000_1,MAPK14,Homo sapiens,Q16539,3PG3,ASD03492011,DG7,A,Lig,Inhibitor,"1-[5-tert-butyl-2-(4-methylphenyl)pyrazol-3-yl]-3-[4-[2-(pyridin-3-ylmethoxy)ethyl]-1,3-thiazol-2-yl]urea",362,Inner Protein Regulator,Inner Protein,,"Structure-based design and synthesis of cell active N-pyrazole, N-thiazole urea inhibitors of the MAP kinase p38alpha",Yes,3PG3
ASD03490000_1,MAPK14,Homo sapiens,Q16539,4A9Y,ASD03490119,RNY,A,Lig,Inhibitor,N-[3-[[7-methoxy-6-(2-pyrrolidin-1-ylethoxy)quinazolin-4-yl]amino]-4-methyl-phenyl]-2-morpholin-4-yl-pyridine-4-carboxamide,1354,Inner Protein Regulator,Inner Protein,22608965,"The Discovery of N-Cyclopropyl-4-Methyl-3-[6--(4-Methylpiperazin-1-Yl-4-Oxoquinazolin-3(4H)-Yl]Benzamide (Azd6703), a Clinical P38Alpha Map Kinase Inhibitor for the Treatment of Inflammatory Diseases",Yes,4A9Y
ASD03490000_1,MAPK14,Homo sapiens,Q16539,4AA0,ASD03490109,AA0,A,Lig,Inhibitor,N-[4-methyl-3-[6-(4-methylpiperazin-1-yl)-4-oxidanylidene-quinazolin-3-yl]phenyl]-2-morpholin-4-yl-pyridine-4-carboxamide,1353,Inner Protein Regulator,Inner Protein,22608965,"The Discovery of N-Cyclopropyl-4-Methyl-3-[6--(4-Methylpiperazin-1-Yl-4-Oxoquinazolin-3(4H)-Yl]Benzamide (Azd6703), a Clinical P38Alpha Map Kinase Inhibitor for the Treatment of Inflammatory Diseases",Yes,4AA0
ASD03490000_1,MAPK14,Homo sapiens,Q16539,4E6A,ASD03490132,0O9,A,Lig,Activator,"[(2S)-2-methoxy-3-octadecoxy-propyl] [(1R,2R,3R,4S,6S)-6-(2-methylpropoxy)-2,3,4-tris(oxidanyl)cyclohexyl] hydrogen phosphate",500,Inner Protein Regulator,Inner Protein,23079240,Lipid Molecules Induce p38 alpha Activation via a Novel Molecular Switch.,No,4E6A
ASD03490000_1,MAPK14,Homo sapiens,Q16539,4E6C,ASD03490131,0O8,A,Lig,Activator,"(1,1-dimethylpiperidin-1-ium-4-yl) octadecyl hydrogen phosphate",500,Inner Protein Regulator,Inner Protein,23079240,Lipid Molecules Induce p38 alpha Activation via a Novel Molecular Switch.,No,4E6C
ASD03490000_1,MAPK14,Homo sapiens,Q16539,4E8A,ASD03490130,0OA,A,Lig,Activator,"[6-(cyclohexylmethoxy)-2,3,4-tris(oxidanyl)cyclohexyl] (2-methoxy-3-octadecoxy-propyl) hydrogen phosphate",500,Inner Protein Regulator,Inner Protein,23079240,Lipid Molecules Induce p38 alpha Activation via a Novel Molecular Switch.,No,4E8A
ASD03490000_1,MAPK14,Homo sapiens,Q16539,4EH9,ASD03490133,0OQ,A,Lig,Inhibitor,"(1R,5S)-3-[4-(trifluoromethyl)benzoyl]-1,2,3,4,5,6-hexahydro-8H-1,5-methanopyrido[1,2-a][1,5]diazocin-8-one",402,Inner Protein Regulator,Inner Protein,23247173,Natural-product-derived fragments for fragment-based ligand discovery.,Yes,4EH9
ASD03490000_1,MAPK14,Homo sapiens,Q16539,4EH9,ASD03490134,IRG,A,Lig,Inhibitor,"N4-cyclopropyl-2-phenyl-quinazoline-4,7-diamine",401,Inner Protein Regulator,Inner Protein,23247173,Natural-product-derived fragments for fragment-based ligand discovery.,No,4EH9
ASD03580000_3,pfkA,Escherichia coli,P0A796,1PFK,ASD01720027,ADP,A,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate",326,Inner Protein Regulator,Protein-Protein Interaction,2975709,Crystal structure of the complex of phosphofructokinase from Escherichia coli with its reaction products.,No,"Chain A:ARG154,SER158,GLY185,GLU187,LYS211,GLY212,LYS213,LYS214,HIS215,TYR319; Chain B:ARG21,ARG25,ARG54,TYR55,SER58,ASP59"
ASD03580000_4,pfkA,Geobacillus stearothermophilus,P00512,4PFK,ASD01720027,ADP,A,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate",326,Inner Protein Regulator,Protein-Protein Interaction,6115424,1 - 4PFK : Phosphofructokinase performs the third step of glycolysis. It is an allosteric enzyme that regulates the pathway. This structure is the active form.,No,"Chain A:ARG154,GLY185,GLU187,ARG211,GLY212,LYS213,LYS214,HIS215"
ASD03640000_1,purR,Escherichia coli,P0ACP7,1BDH,ASD03640003,HPA,A,Lig,Activator,"1,7-dihydropurin-6-one",599,Protein-DNA/RNA Interaction Regulator,Inner Protein,,A Positively Charged Residue Bound in the Minor Groove Does not Alter the Bending of a DNA Duplex,No,"Chain A:TYR73,PHE74,ARG190,THR192,ARG196,PHE221,ASP275"
ASD03640000_1,purR,Escherichia coli,P0ACP7,1BDI,ASD03640003,HPA,A,Lig,Activator,"1,7-dihydropurin-6-one",599,Protein-DNA/RNA Interaction Regulator,Inner Protein,,A Positively Charged Residue Bound in the Minor Groove Does not Alter the Bending of a DNA Duplex,No,"Chain A:TYR73,PHE74,ARG190,THR192,ARG196,PHE221,ASP275"
ASD03640000_1,purR,Escherichia coli,P0ACP7,1JFS,ASD03640003,HPA,A,Lig,Activator,"1,7-dihydropurin-6-one",599,Protein-DNA/RNA Interaction Regulator,Inner Protein,11781089,Role of residue 147 in the gene regulatory function of the Escherichia coli purine repressor.,No,"Chain A:TYR73,PHE74,ARG190,THR192,ARG196,PHE221,ASP275"
ASD03640000_1,purR,Escherichia coli,P0ACP7,1JFT,ASD03640003,HPA,A,Lig,Activator,"1,7-dihydropurin-6-one",599,Protein-DNA/RNA Interaction Regulator,Inner Protein,11781089,Role of residue 147 in the gene regulatory function of the Escherichia coli purine repressor.,No,"Chain A:TYR73,PHE74,ARG190,THR192,ARG196,PHE221,ASP275"
ASD03640000_1,purR,Escherichia coli,P0ACP7,1JH9,ASD03640003,HPA,A,Lig,Activator,"1,7-dihydropurin-6-one",599,Protein-DNA/RNA Interaction Regulator,Inner Protein,11781089,Role of residue 147 in the gene regulatory function of the Escherichia coli purine repressor.,No,"Chain A:TYR73,PHE74,SER124,ARG190,THR192,ARG196,PHE221,ASP275"
ASD03640000_1,purR,Escherichia coli,P0ACP7,1PNR,ASD03640003,HPA,A,Lig,Activator,"1,7-dihydropurin-6-one",599,Protein-DNA/RNA Interaction Regulator,Inner Protein,7973627,"Crystal structure of LacI member, PurR, bound to DNA: minor groove binding by alpha helices.",No,"Chain A:TYR73,PHE74,ARG190,THR192,ARG196,PHE221,ASP275"
ASD03640000_1,purR,Escherichia coli,P0ACP7,1QP4,ASD03640003,HPA,A,Lig,Activator,"1,7-dihydropurin-6-one",599,Protein-DNA/RNA Interaction Regulator,Inner Protein,10438625,The role of lysine 55 in determining the specificity of the purine repressor for its operators through minor groove interactions.,No,"Chain A:TYR73,PHE74,SER124,ARG190,THR192,ARG196,PHE221,ASP275"
ASD03640000_1,purR,Escherichia coli,P0ACP7,1QP7,ASD03640003,HPA,A,Lig,Activator,"1,7-dihydropurin-6-one",599,Protein-DNA/RNA Interaction Regulator,Inner Protein,10438625,The role of lysine 55 in determining the specificity of the purine repressor for its operators through minor groove interactions.,No,"Chain A:TYR73,PHE74,ARG190,THR192,ARG196,PHE221,ASP275"
ASD03640000_1,purR,Escherichia coli,P0ACP7,1QPZ,ASD03640003,HPA,A,Lig,Activator,"1,7-dihydropurin-6-one",599,Protein-DNA/RNA Interaction Regulator,Inner Protein,10438625,The role of lysine 55 in determining the specificity of the purine repressor for its operators through minor groove interactions.,No,"Chain A:TYR73,PHE74,ARG190,THR192,ARG196,PHE221,ASP275"
ASD03640000_1,purR,Escherichia coli,P0ACP7,1QQA,ASD03640003,HPA,A,Lig,Activator,"1,7-dihydropurin-6-one",599,Protein-DNA/RNA Interaction Regulator,Inner Protein,10438625,The role of lysine 55 in determining the specificity of the purine repressor for its operators through minor groove interactions.,No,"Chain A:TYR73,PHE74,ARG190,THR192,ARG196,PHE221,ASP275"
ASD03640000_1,purR,Escherichia coli,P0ACP7,1QQB,ASD03640003,HPA,A,Lig,Activator,"1,7-dihydropurin-6-one",599,Protein-DNA/RNA Interaction Regulator,Inner Protein,10438625,The role of lysine 55 in determining the specificity of the purine repressor for its operators through minor groove interactions.,No,"Chain A:TYR73,PHE74,ARG190,THR192,ARG196,PHE221,ASP275"
ASD03640000_1,purR,Escherichia coli,P0ACP7,1VPW,ASD03640003,HPA,A,Lig,Activator,"1,7-dihydropurin-6-one",599,Protein-DNA/RNA Interaction Regulator,Inner Protein,9628480,The structure of PurR mutant L54M shows an alternative route to DNA kinking.,No,"Chain A:TYR73,PHE74,ARG190,THR192,ARG196,PHE221,ASP275"
ASD03640000_1,purR,Escherichia coli,P0ACP7,1WET,ASD03640014,GUN,A,Lig,Activator,"2-amino-1,9-dihydropurin-6-one",599,Protein-DNA/RNA Interaction Regulator,Inner Protein,9278422,The X-ray structure of the PurR-guanine-purF operator complex reveals the contributions of complementary electrostatic surfaces and a water-mediated hydrogen bond to corepressor specificity and binding affinity.,No,"Chain A:ALA71,TYR73,PHE74,ARG190,THR192,ARG196,PHE221,ASP275"
ASD03640000_1,purR,Escherichia coli,P0ACP7,1ZAY,ASD03640003,HPA,A,Lig,Activator,"1,7-dihydropurin-6-one",599,Protein-DNA/RNA Interaction Regulator,Inner Protein,,The Roles of Exocyclic Groups in the Central Base-Pair Step in Modulating the Affinity of PurR for its Operator,No,"Chain A:TYR73,PHE74,ARG190,THR192,ARG196,PHE221,ASP275"
ASD03640000_1,purR,Escherichia coli,P0ACP7,2PUA,ASD03640020,6MP,A,Lig,Activator,6-methyl-7H-purine,599,Protein-DNA/RNA Interaction Regulator,Inner Protein,7973627,"Crystal structure of LacI member, PurR, bound to DNA: minor groove binding by alpha helices.",No,"Chain A:TYR73,PHE74,SER124,THR192,ARG196,PHE221,ASP275"
ASD03640000_1,purR,Escherichia coli,P0ACP7,2PUB,ASD01320045,ADE,A,Lig,Activator,9H-purin-6-amine,599,Protein-DNA/RNA Interaction Regulator,Inner Protein,7973627,"Crystal structure of LacI member, PurR, bound to DNA: minor groove binding by alpha helices.",No,"Chain A:TYR73,PHE74,SER124,THR192,ARG196,PHE221,ASP275"
ASD03640000_1,purR,Escherichia coli,P0ACP7,2PUC,ASD03640014,GUN,A,Lig,Activator,"2-amino-1,9-dihydropurin-6-one",599,Protein-DNA/RNA Interaction Regulator,Inner Protein,7973627,"Crystal structure of LacI member, PurR, bound to DNA: minor groove binding by alpha helices.",No,"Chain A:ALA71,TYR73,PHE74,SER124,THR192,ARG196,PHE221,ASP275"
ASD03640000_1,purR,Escherichia coli,P0ACP7,2PUD,ASD03640003,HPA,A,Lig,Activator,"1,7-dihydropurin-6-one",599,Protein-DNA/RNA Interaction Regulator,Inner Protein,7973627,"Crystal structure of LacI member, PurR, bound to DNA: minor groove binding by alpha helices.",No,"Chain A:TYR73,PHE74,SER124,THR192,ARG196,PHE221,ASP275"
ASD03640000_1,purR,Escherichia coli,P0ACP7,2PUE,ASD01320045,ADE,A,Lig,Activator,9H-purin-6-amine,599,Protein-DNA/RNA Interaction Regulator,Inner Protein,9454587,Structure-based redesign of corepressor specificity of the Escherichia coli purine repressor by substitution of residue 190.,No,"Chain A:TYR73,PHE74,GLN190,THR192,ARG196,PHE221,ASP275"
ASD03640000_1,purR,Escherichia coli,P0ACP7,2PUF,ASD03640014,GUN,A,Lig,Activator,"2-amino-1,9-dihydropurin-6-one",599,Protein-DNA/RNA Interaction Regulator,Inner Protein,9454587,Structure-based redesign of corepressor specificity of the Escherichia coli purine repressor by substitution of residue 190.,No,"Chain A:ALA71,TYR73,PHE74,GLN190,THR192,ARG196,PHE221,ASP275"
ASD03640000_1,purR,Escherichia coli,P0ACP7,2PUG,ASD03640003,HPA,A,Lig,Activator,"1,7-dihydropurin-6-one",599,Protein-DNA/RNA Interaction Regulator,Inner Protein,9454587,Structure-based redesign of corepressor specificity of the Escherichia coli purine repressor by substitution of residue 190.,No,"Chain A:TYR73,PHE74,GLN190,THR192,ARG196,PHE221,ASP275"
ASD03670000_1,rpoA,Escherichia coli,P0A7Z4,5VSW,ASD03670009,G4P,E,Lig,Inhibitor,"GUANOSINE-5',3'-TETRAPHOSPHATE",101,Allosteric function,Allosteric position,29478808,Allosteric Effector ppGpp Potentiates the Inhibition of Transcript Initiation by DksA.,No,"Chain D:HIS364,ILE619,ASP622,TYR626,ARG417,GLU418,LYS615,ARG362,LEU363,GLN623,VAL618"
ASD03670000_4,rpoB,Thermus thermophilus,Q8RQE9,2A68,ASD03670006,RBT,C,Lig,Inhibitor,"(9S,12E,14S,15R,16S,17R,18R,19R,20S,21S,22E,24Z)-6,18,20-trihydroxy-14-methoxy-7,9,15,17,19,21,25-heptamethyl-1'-(2-methylpropyl)-5,10,26-trioxo-3,5,9,10-tetrahydrospiro[9,4-(epoxypentadeca[1,11,13]trienoimino)furo[2',3':7,8]naphtho[1,2-d]imidazole-2,4'-piperidin]-16-yl acetate",8001,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,16096056,Allosteric modulation of the RNA polymerase catalytic reaction is an essential component of transcription control by rifamycins.,No,"Chain C:ARG134,GLN390,SER392,GLN393,PHE394,LYS395,ASP396,HIS406,ARG409,SER411,PRO444,ILE452; Chain F:ASP323"
ASD03670000_4,rpoB,Thermus thermophilus,Q8RQE9,2A69,ASD03670007,RPT,C,Lig,Inhibitor,"(2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-8-{(E)-[(4-cyclopentylpiperazin-1-yl)imino]methyl}-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate",8001,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,16096056,Allosteric modulation of the RNA polymerase catalytic reaction is an essential component of transcription control by rifamycins.,No,"Chain C:ARG134,SER389,GLN390,SER392,GLN393,PHE394,LYS395,ASP396,HIS406,ARG409,SER411,LEU413,PRO444,ILE452; Chain F:ASP323"
ASD03670000_4,rpoB,Thermus thermophilus,Q8RQE9,4OIR,ASD03670008,RFV,C,Lig,Inhibitor,"(1R,2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-1,5,6,9,17,19-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-11-oxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate",1201,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,24755292,GE23077 binds to the RNA polymerase 'i' and 'i+1' sites and prevents the binding of initiating nucleotides.,No,"Chain C:GLN390,LEU391,SER392,GLN393,PHE394,ASP396,ARG405,HIS406,ARG409,SER411,LEU413,ARG420,PRO444,ASN448,ILE452,GLN633; Chain F:ASP323"
ASD03700000_1,KDR,Homo sapiens,P35968,5OYJ,,DARPin,A,Pep,Inhibitor,DARPin D4b,1-169,Allosteric function,Allosteric position,29502220,Characterization of a drug-targetable allosteric site regulating vascular endothelial growth factor signaling.,No,5OYJ
ASD03710000_1,VC_1451,Vibrio cholerae,Q9KS12,3EEB,ASD03710003,IHP,A,Lig,Regulator,"(2,3,4,5,6-pentaphosphonooxycyclohexyl) dihydrogen phosphate",210,Inner Protein Regulator,Inner Protein,18845756,Small molecule-induced allosteric activation of the Vibrio cholerae RTX cysteine protease domain.,No,"Chain A:GLU27,THR28,ARG29,PHE30,LYS54,HIS55,ARG85,SER136,SER169,ARG171,ARG182,LYS183,LYS195,LYS200"
ASD03710000_1,VC_1451,Vibrio cholerae,Q9KS12,3FZY,ASD03710003,IHP,A,Lig,Regulator,"(2,3,4,5,6-pentaphosphonooxycyclohexyl) dihydrogen phosphate",8000,Inner Protein Regulator,Inner Protein,19620709,Structural and molecular mechanism for autoprocessing of MARTX toxin of Vibrio cholerae at multiple sites.,No,"Chain A:GLU3455,THR3456,ARG3457,PHE3458,LYS3482,HIS3483,ARG3513,GLN3515,HIS3562,SER3564,SER3597,ARG3599,GLY3609,ARG3610,LYS3611,LYS3623,LYS3628"
ASD03710000_1,VC_1451,Vibrio cholerae,Q9KS12,3GCD,ASD03710003,IHP,A,Lig,Regulator,"(2,3,4,5,6-pentaphosphonooxycyclohexyl) dihydrogen phosphate",214,Inner Protein Regulator,Inner Protein,19465933,Mechanistic and structural insights into the proteolytic  activation of Vibrio cholerae MARTX toxin.,No,"Chain A:GLU27,THR28,ARG29,PHE30,LYS54,HIS55,ARG85,SER136,SER169,ARG171,ARG182,LYS183,LYS195,LYS200"
ASD03720000_3,vdra,Danio rerio,Q9PTN2,4Q0A,ASD03720014,4OA,C,Lig,Activator,"(4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid",502,Inner Protein Regulator,Inner Protein,24818857,Structural insights into the molecular mechanism of vitamin d receptor activation by lithocholic Acid involving a new mode of ligand recognition.,Yes,"Chain C:ASP181,ARG184,PHE185,ASP260,SER263,TYR264,GLN267"
ASD03740000_2,,Hepatitis C virus,P26663,1NHU,ASD01418002,153,A,Lig,Inhibitor,"(2S)-2-[(2,4-dichlorophenyl)carbonyl-[[3-(trifluoromethyl)phenyl]methyl]amino]-3-phenyl-propanoic acid",5001,Inner Protein Regulator,Inner Protein,12509436,Non-Nucleoside Analogue Inhibitors Bind to an Allosteric Site on   HCV NS5B Polymerase: Crystal Structures and Mechanism of Inhibition,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,LEU497,ARG498,ARG501,TRP528"
ASD03740000_2,,Hepatitis C virus,P26663,1NHV,ASD01410468,154,A,Lig,Inhibitor,"(2S)-2-[[5-(1-benzofuran-2-yl)thiophen-2-yl]methyl-(2,4-dichlorophenyl)carbonyl-amino]-3-phenyl-propanoic acid",5001,Inner Protein Regulator,Inner Protein,12509436,Non-Nucleoside Analogue Inhibitors Bind to an Allosteric Site on HCV NS5B Polymerase: Crystal Structures and Mechanism of Inhibition,No,"Chain A:ARG422,MET423,LEU474,HIS475,SER476,TYR477,LEU497,ARG501,TRP528"
ASD03740000_2,,Hepatitis C virus,P26663,1OS5,ASD03740210,NH1,A,Lig,Inhibitor,(6S)-3-(4-amino-2-tert-butyl-5-methyl-phenyl)sulfanyl-6-cyclopentyl-4-hydroxy-6-[2-(4-hydroxyphenyl)ethyl]-5H-pyran-2-one,901,Inner Protein Regulator,Inner Protein,12805457,Crystallographic identification of a noncompetitive inhibitor binding site on the hepatitis C virus NS5B RNA polymerase enzyme.,No,"Chain A:LEU419,ARG422,MET423,SER473,LEU474,HIS475,SER476,TYR477,ILE482,LEU497,TRP528,LYS533"
ASD03740000_2,,Hepatitis C virus,P26663,2AWZ,ASD01418008,5H,A,Lig,Inhibitor,"N-[(5R)-5-[(4-bromophenyl)methyl]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]benzenesulfonamide",801,Inner Protein Regulator,Inner Protein,16451069,SAR and Mode of Action of Novel Non-Nucleoside Inhibitors of Hepatitis C NS5b RNA Polymerase.,Yes,"Chain A:PHE193,PRO197,ARG200,CYS366,SER368,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449,SER556"
ASD03740000_2,,Hepatitis C virus,P26663,2AX0,ASD01418009,5X,A,Lig,Inhibitor,"N-[(5R)-5-[(E)-2-methyl-3-phenyl-prop-2-enyl]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]benzenesulfonamide",1001,Inner Protein Regulator,Inner Protein,16451069,SAR and Mode of Action of Novel Non-Nucleoside Inhibitors of Hepatitis C NS5b RNA Polymerase.,Yes,"Chain A:PHE193,PRO197,ARG200,ASN316,CYS366,SER368,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,SER556"
ASD03740000_2,,Hepatitis C virus,P26663,2AX1,ASD01418007,5EE,A,Lig,Inhibitor,"N-[(5R)-5-[(3,4-dichlorophenyl)methyl]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]thiophene-2-sulfonamide",1001,Inner Protein Regulator,Inner Protein,16451069,SAR and Mode of Action of Novel Non-Nucleoside Inhibitors of Hepatitis C NS5b RNA Polymerase.,Yes,"Chain A:PHE193,PRO197,ARG200,ASN316,CYS366,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449,SER556"
ASD03740000_2,,Hepatitis C virus,P26663,2BRK,ASD01410351,CMF,A,Lig,Inhibitor,3-cyclohexyl-1-(2-morpholin-4-yl-2-oxo-ethyl)-2-phenyl-indole-6-carboxylic acid,1534,Inner Protein Regulator,Inner Protein,15955819,Interdomain Communication in Hepatitis C Virus Polymerase Abolished by Small-Molecule Inhibitors Bound to a Novel Allosteric Site,No,"Chain A:VAL37,LEU392,ALA393,ALA395,ALA396,ILE424,LEU425,HIS428,PHE429,LEU492,GLY493,VAL494,PRO495,TRP500,ARG503"
ASD03740000_2,,Hepatitis C virus,P26663,2BRL,ASD03740207,POO,A,Lig,Inhibitor,"3-cyclohexyl-1-[2-[methyl-[[(1S,3R)-1-methylpiperidin-3-yl]methyl]amino]-2-oxo-ethyl]-2-phenyl-indole-6-carboxylic acid",1534,Inner Protein Regulator,Inner Protein,15955819,Interdomain Communication in Hepatitis C Virus Polymerase Abolished by Small-Molecule Inhibitors Bound to a Novel Allosteric Site,No,"Chain A:VAL37,LEU392,ALA393,ALA395,ALA396,ILE424,LEU425,HIS428,PHE429,LEU492,GLY493,VAL494,PRO495,TRP500,ARG503"
ASD03740000_2,,Hepatitis C virus,Q99AU2,2D3U,ASD01418011,CCT,A,Lig,Inhibitor,5-(4-cyanophenyl)-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid,1001,Inner Protein Regulator,Inner Protein,16828488,Non-nucleoside Inhibitors Binding to Hepatitis C Virus NS5B Polymerase Reveal a Novel Mechanism of Inhibition,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,ALA486,LEU489,LEU497,TRP528"
ASD03740000_2,,Hepatitis C virus,Q99AU2,2D3Z,ASD01418013,FIH,A,Lig,Inhibitor,5-(4-fluorophenyl)-3-[(4-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid,2001,Inner Protein Regulator,Inner Protein,16828488,Non-nucleoside Inhibitors Binding to Hepatitis C Virus NS5B Polymerase Reveal a Novel Mechanism of Inhibition,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,ALA486,LEU489,LEU497,ARG501,TRP528"
ASD03740000_2,,Hepatitis C virus,Q99AU2,2D41,ASD01418019,SNH,A,Lig,Inhibitor,"3-[(2,4-dimethylphenyl)sulfonylamino]-5-(5-ethanoylthiophen-2-yl)thiophene-2-carboxylic acid",1001,Inner Protein Regulator,Inner Protein,16828488,Non-nucleoside Inhibitors Binding to Hepatitis C Virus NS5B Polymerase Reveal a Novel Mechanism of Inhibition,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,ALA486,LEU489,PRO496,LEU497,ARG501,TRP528"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,2DXS,ASD03740246,JTP,A,Lig,Inhibitor,"N-[(13-cyclohexyl-6,7-dihydroindolo[1,2-d][1,4]benzoxazepin-10-yl)carbonyl]-2-methyl-D-alanine",1000,Inner Protein Regulator,Inner Protein,17125247,Discovery of Conformationally Constrained Tetracyclic Compounds as Potent Hepatitis C Virus NS5B RNA Polymerase Inhibitors,No,"Chain A:VAL37,LEU392,ALA393,ALA395,ALA396,THR399,ILE424,LEU425,HIS428,PHE429,LEU492,GLY493,VAL494,PRO495,TRP500,ARG503"
ASD03740000_2,,Hepatitis C virus,Q99AU2,2FVC,ASD03740228,888,A,Lig,Inhibitor,"3-(1,1-dioxo-4H-benzo[e][1,2,4]thiadiazin-3-yl)-4-hydroxy-1-(3-methylbutyl)quinolin-2-one",901,Inner Protein Regulator,Inner Protein,16451063,"3-(1,1-dioxo-2H-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy-2(1H)-quinolinones, potent inhibitors of hepatitis C virus RNA-dependent RNA polymerase.",Yes,"Chain A:PHE193,PRO197,ARG200,ASN316,CYS366,SER368,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,TYR448,GLY449,SER556"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,2GIQ,ASD03740273,NN2,A,Lig,Inhibitor,"1-(2-cyclopropylethyl)-3-(1,1-dioxo-2H-benzo[e][1,2,4]thiadiazin-3-yl)-6-fluoro-4-hydroxy-quinolin-2-one",1001,Inner Protein Regulator,Inner Protein,16731953,Selection and characterization of replicon variants dually resistant to thumb- and palm-binding nonnucleoside polymerase inhibitors of the hepatitis C virus.,No,"Chain A:PHE193,ARG200,ASN316,ASP318,CYS366,SER368,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,TYR448,GLY449,SER556"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,2GIR,ASD03740241,NN3,A,Lig,Inhibitor,3-[(4-methylcyclohexyl)carbonyl-propan-2-yl-amino]-5-phenyl-thiophene-2-carboxylic acid,1001,Inner Protein Regulator,Inner Protein,16731953,Selection and characterization of replicon variants dually resistant to thumb- and palm-binding nonnucleoside polymerase inhibitors of the hepatitis C virus.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,LEU497,TRP528"
ASD03740000_2,,Hepatitis C virus,Q99AU2,2HAI,ASD01418016,PFI,A,Lig,Inhibitor,(6S)-6-cyclopentyl-6-[2-(3-fluoro-4-propan-2-yloxy-phenyl)ethyl]-4-hydroxy-5H-pyran-2-one,601,Inner Protein Regulator,Inner Protein,16824756,Identification and structure-based optimization of novel dihydropyrones as potent HCV RNA polymerase inhibitors.,No,"Chain A:LEU419,ARG422,MET423,HIS475,SER476,TYR477,ILE482,ALA486,LEU497,ARG501,TRP528"
ASD03740000_2,,Hepatitis C virus,P26663,2HWH,ASD03740218,RNA,A,Lig,Inhibitor,"4-methyl-N-[5-[(5-methylfuran-2-yl)methylidene]-4-oxo-1,3-thiazol-2-yl]benzenesulfonamide",960,Inner Protein Regulator,Inner Protein,16934455,Structure-based design of a novel thiazolone scaffold as HCV NS5B polymerase allosteric inhibitors.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,LEU497,ARG501,TRP528"
ASD03740000_2,,Hepatitis C virus,P26663,2HWI,ASD03740219,VRX,A,Lig,Inhibitor,"(2S)-2-[[(5Z)-5-[(5-ethylfuran-2-yl)methylidene]-4-oxo-1,3-thiazol-2-yl]amino]-2-(4-fluorophenyl)ethanoic acid",600,Inner Protein Regulator,Inner Protein,16934455,Structure-based design of a novel thiazolone scaffold as HCV NS5B polymerase allosteric inhibitors.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,VAL485,ALA486,LEU489,LEU497,ARG501,TRP528,LYS533"
ASD03740000_2,,Hepatitis C virus,P26663,2I1R,ASD01418022,VXR,A,Lig,Inhibitor,"(5Z)-5-[(5-ethylfuran-2-yl)methylidene]-2-[[(S)-(4-fluorophenyl)-(1H-1,2,3,4-tetrazol-5-yl)methyl]amino]-1,3-thiazol-4-one",600,Inner Protein Regulator,Inner Protein,17049849,"Novel thiazolones as HCV NS5B polymerase allosteric inhibitors: Further designs, SAR, and X-ray complex structure.",No,"Chain A:LEU419,ARG422,MET423,LEU474,SER476,TYR477,ILE482,VAL485,LEU497,ARG501,TRP528,LYS533"
ASD03740000_2,,Hepatitis C virus,P26663,2JC0,ASD03740225,699,A,Lig,Inhibitor,"(2S,4S,5R)-2-(2-methylpropyl)-5-thiophen-2-yl-1-[4-(trifluoromethyl)phenyl]carbonyl-pyrrolidine-2,4-dicarboxylic acid",1564,Inner Protein Regulator,Inner Protein,17269759,Optimization of Novel Acyl Pyrrolidine Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase Leading to a Development Candidate.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ARG501,TRP528,LYS533"
ASD03740000_2,,Hepatitis C virus,P26663,2JC0,ASD03740225,699,A,Lig,Inhibitor,"(2S,4S,5R)-2-(2-methylpropyl)-5-thiophen-2-yl-1-[4-(trifluoromethyl)phenyl]carbonyl-pyrrolidine-2,4-dicarboxylic acid",1563,Inner Protein Regulator,Inner Protein,17269759,Optimization of Novel Acyl Pyrrolidine Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase Leading to a Development Candidate.,Yes,"Chain A:ARG200,ASN316,SER365,CYS366,SER368,LEU384,ARG386,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449"
ASD03740000_2,,Hepatitis C virus,P26663,2JC1,ASD03740227,698,A,Lig,Inhibitor,"(2S,4S,5R)-1-(4-tert-butylphenyl)carbonyl-2-(2-methylpropyl)-5-(1,3-thiazol-2-yl)pyrrolidine-2,4-dicarboxylic acid",600,Inner Protein Regulator,Inner Protein,17269759,Optimization of Novel Acyl Pyrrolidine Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase Leading to a Development Candidate.,Yes,"Chain A:PRO197,ARG200,CYS366,SER368,LEU384,ARG386,SER407,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449"
ASD03740000_2,,Hepatitis C virus,P26663,2O5D,ASD03740220,VR1,A,Lig,Inhibitor,"(2S)-2-[[(5Z)-5-[(5-ethylfuran-2-yl)methylidene]-4-oxo-1,3-thiazol-2-yl]amino]-2-(4-fluorophenyl)-N-(4-nitrophenyl)sulfonyl-ethanamide",600,Inner Protein Regulator,Inner Protein,17276060,Thiazolone-acylsulfonamides as novel HCV NS5B polymerase allosteric inhibitors: Convergence of structure-based drug design and X-ray crystallographic study.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,VAL485,ALA486,LEU497,ARG501,TRP528,VAL530,LYS533"
ASD03740000_2,,Hepatitis C virus,Q99AU2,2QE2,ASD01410051,452,A,Lig,Inhibitor,2-[2-[(5-chloro-2-ethanoyl-4-fluoro-phenyl)amino]ethanoylamino]benzoic acid,579,Inner Protein Regulator,Inner Protein,17402724,Identification of Anthranilic Acid Derivatives as a Novel Class of Allosteric Inhibitors of Hepatitis C NS5B Polymerase,Yes,"Chain A:PHE193,PRO197,ARG200,CYS366,SER368,ARG386,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448"
ASD03740000_2,,Hepatitis C virus,Q99AU2,2QE5,ASD01410015,617,A,Lig,Inhibitor,2-[2-(4-chlorophenoxy)ethanoylamino]benzoic acid,579,Inner Protein Regulator,Inner Protein,17402724,Identification of Anthranilic Acid Derivatives as a Novel Class of Allosteric Inhibitors of Hepatitis C NS5B Polymerase,Yes,"Chain A:PRO197,ARG200,CYS366,LEU384,ARG386,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448"
ASD03740000_2,,Hepatitis C virus,P26663,2WCX,ASD01418020,VGC,A,Lig,Inhibitor,"6-cyclohexyl-4-methyl-5-phenyl-thieno[4,5-b]pyrrole-2-carboxylic acid",1534,Inner Protein Regulator,Inner Protein,19672916,Optimization of Thienopyrrole-Based Finger-Loop Inhibitors of the Hepatitis C Virus Ns5B Polymerase.,No,"Chain A:VAL37,LEU392,ALA393,ALA395,ALA396,THR399,ILE424,HIS428,LEU492,GLY493,VAL494,PRO495,TRP500,ARG503"
ASD03740000_2,,Hepatitis C virus,P26663,2WHO,ASD01411053,VGI,A,Lig,Inhibitor,"2-(3-BROMOPHENYL)-6-[(2-HYDROXYETHYL)AMINO]- 1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE",1534,Inner Protein Regulator,Inner Protein,19877603,"Identification and Biological Evaluation of a Series of 1H-Benzo[De]Isoquinoline-1,3(2H)-Diones as Hepatitis C Virus Ns5B Polymerase Inhibitors",No,"Chain A:ARG422,MET423,LEU474,HIS475,ILE482,ALA486,ARG498,ARG501,TRP528"
ASD03740000_2,,Hepatitis C virus,P26663,2WRM,ASD01410467,QQ3,A,Lig,Inhibitor,"(3R)-3-(4-methyl-1,3-dioxo-pyrrolo[3,4-c]quinolin-2-yl)hexanoic acid",1532,Inner Protein Regulator,Inner Protein,,Identification of Novel Allosteric Inhibitors of Hepatitis C Virus Ns5B Polymerase Thumb Domain (Site II) by Structure-Based Design,No,"Chain A:ARG422,MET423,TYR477,LEU497,ARG498,ARG501,TRP528"
ASD03740000_2,,Hepatitis C virus,P26663,2XWY,ASD01418014,IB8,A,Lig,Inhibitor,"(7R)-14-cyclohexyl-7-{[2-(dimethylamino)ethyl](methyl)amino}- 7,8-dihydro-6H-indolo[1,2-e][1,5]benzoxazocine- 11-carboxylic acid",1532,Inner Protein Regulator,Inner Protein,21141896,"Discovery of (7R)-14-Cyclohexyl-7-{[2-(Dimethylamino)Ethyl] (Methyl)Amino}-7,8-Dihydro-6H-Indolo[1,2-E][1,5] Benzoxazocine -11-Carboxylic Acid (Mk-3281), a Potent and Orally Bioavailable Finger-Loop Inhibitor of the Hepatitis C Virus Ns5B Polymerase",No,"Chain A:VAL37,LEU392,ALA395,ALA396,ILE424,HIS428,PHE429,LEU492,GLY493,VAL494,PRO495,ARG503"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3BR9,ASD03740260,DEY,A,Lig,Inhibitor,"(2R)-2-[[3-[5-hydroxy-2-(3-methylbutyl)-3-oxo-6-thiophen-2-yl-pyridazin-4-yl]-1,1-dioxo-2H-benzo[e][1,2,4]thiadiazin-7-yl]oxy]propanamide",579,Inner Protein Regulator,Inner Protein,18242088,"Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 1: exploration of 7'-substitution of benzothiadiazine.",No,"Chain A:PHE193,PRO197,ARG200,ASP225,THR287,SER288,ASN291,ASN316,GLY317,ASP318,CYS366,SER368,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449,SER556"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3BSA,ASD03740270,1PD,A,Lig,Inhibitor,"2-[[3-[5-hydroxy-2-(3-methylbutyl)-3-oxo-6-(1,3-thiazol-5-yl)pyridazin-4-yl]-1,1-dioxo-2H-benzo[e][1,2,4]thiadiazin-7-yl]oxy]ethanamide",579,Inner Protein Regulator,Inner Protein,18242088,"Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 1: exploration of 7'-substitution of benzothiadiazine.",No,"Chain A:PHE193,PRO197,ARG200,THR287,ASN291,ASN316,GLY317,ASP318,CYS366,SER368,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449,SER556"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3BSC,ASD03740259,2PD,A,Lig,Inhibitor,"5-hydroxy-4-(7-methoxy-1,1-dioxo-2H-benzo[e][1,2,4]thiadiazin-3-yl)-2-(3-methylbutyl)-6-phenyl-pyridazin-3-one",579,Inner Protein Regulator,Inner Protein,18242088,"Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 1: exploration of 7'-substitution of benzothiadiazine.",No,"Chain A:PHE193,PRO197,ARG200,ASN316,GLY317,ASP318,CYS366,SER368,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,TYR448,GLY449,SER556"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3CDE,ASD03740248,N3H,A,Lig,Inhibitor,"N-[3-[5-hydroxy-2-(3-methylbutyl)-3-oxo-6-thiophen-2-yl-pyridazin-4-yl]-1,1-dioxo-2H-benzo[e][1,2,4]thiadiazin-7-yl]methanesulfonamide",579,Inner Protein Regulator,Inner Protein,18457949,"Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 3: Further optimization of the 2-, 6-, and 7'-substituents and initial pharmacokinetic assessments.",No,"Chain A:PHE193,PRO197,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,CYS366,SER368,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449,SER556"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3CIZ,ASD03740243,SX1,B,Lig,Inhibitor,2-amino-5-bromo-benzoic acid,572,Inner Protein Regulator,Inner Protein,18400495,Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors.,No,"Chain B:LEU419,ARG422,MET423,LEU474,HIS475,ARG501,TRP528,LYS533"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3CJ0,ASD03740236,SX2,A,Lig,Inhibitor,4-[(5-bromopyridin-2-yl)amino]-4-oxo-butanoic acid,571,Inner Protein Regulator,Inner Protein,18400495,Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ARG501,TRP528"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3CJ2,ASD03740235,SX3,A,Lig,Inhibitor,"(2-amino-5-bromo-phenyl)-[(3R,5S)-3,5-dimethylpiperidin-1-yl]methanone",571,Inner Protein Regulator,Inner Protein,18400495,Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors.,No,"Chain A:ARG422,MET423,LEU474,HIS475,TYR477,ILE482,LEU497,ARG498,ARG501,TRP528"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3CJ3,ASD03740244,SX4,A,Lig,Inhibitor,(2-amino-5-bromo-phenyl)-[(2R)-2-[(2-chlorophenyl)methyl]pyrrolidin-1-yl]methanone,572,Inner Protein Regulator,Inner Protein,18400495,Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,LEU497,ARG498,ARG501,TRP528"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3CJ4,ASD03740237,SX5,A,Lig,Inhibitor,"4-[[4-bromo-2-[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl-phenyl]amino]-4-oxo-butanoic acid",571,Inner Protein Regulator,Inner Protein,18400495,Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,LEU497,ARG498,ARG501,TRP528"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3CJ5,ASD03740234,SX6,A,Lig,Inhibitor,"N-[4-bromo-2-[(3S,5R)-3,5-dimethylpiperidin-1-yl]carbonyl-phenyl]-4-morpholin-4-yl-4-oxo-butanamide",571,Inner Protein Regulator,Inner Protein,18400495,Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,LEU497,ARG498,ARG501,TRP528"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3CO9,ASD03740261,3MS,A,Lig,Inhibitor,"N-[3-[4-hydroxy-1-(3-methylbutyl)-2-oxo-pyrrolo[2,1-f]pyridazin-3-yl]-1,1-dioxo-2H-benzo[e][1,2,4]thiadiazin-7-yl]methanesulfonamide",579,Inner Protein Regulator,Inner Protein,18487044,"Pyrrolo[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase.",No,"Chain A:PHE193,PRO197,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,CYS366,SER368,LEU384,ASN411,MET414,TYR415,ILE447,TYR448,GLY449,SER556"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3CVK,ASD03740267,N34,A,Lig,Inhibitor,"N-[3-[(4aS,8S)-1-(3,3-dimethylbutyl)-4-hydroxy-2-oxo-4a,5,6,7-tetrahydropyrrolo[2,1-f]pyridazin-3-yl]-1,1-dioxo-2H-benzo[e][1,2,4]thiadiazin-7-yl]methanesulfonamide",579,Inner Protein Regulator,Inner Protein,18722768,"Hexahydro-pyrrolo- and hexahydro-1H-pyrido[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase.",No,"Chain A:PHE193,PRO197,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,CYS366,SER368,ASN411,MET414,TYR415,ILE447,TYR448,GLY449,SER556"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3CWJ,ASD03740265,321,A,Lig,Inhibitor,"N-[3-[5-hydroxy-2-(3-methylbutyl)-3-oxo-6-thiophen-2-yl-pyridazin-4-yl]-1,1-dioxo-2H-benzo[b][1,4]thiazin-7-yl]methanesulfonamide",1001,Inner Protein Regulator,Inner Protein,18662878,"4-(1,1-Dioxo-1,4-dihydro-1lambda6-benzo[1,4]thiazin-3-yl)-5-hydroxy-2H-pyridazin-3-ones as potent inhibitors of HCV NS5B polymerase",No,"Chain A:PHE193,PRO197,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,CYS366,SER368,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449,SER556"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3D28,ASD03740268,B34,A,Lig,Inhibitor,"(5S)-3-(1,1-dioxo-1,2-benzothiazol-3-yl)-4-hydroxy-1-(phenylmethyl)-5-propan-2-yl-5H-pyrrol-2-one",579,Inner Protein Regulator,Inner Protein,18554907,"Structure-based design, synthesis, and biological evaluation of 1,1-dioxoisothiazole and benzo[b]thiophene-1,1-dioxide derivatives as novel inhibitors of hepatitis C virus NS5B polymerase.",No,"Chain A:PHE193,PRO197,ARG200,ASN316,CYS366,SER368,LEU384,GLY410,MET414,TYR415,GLN446,ILE447,TYR448,GLY449,SER556"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3D5M,ASD03740275,4MS,A,Lig,Inhibitor,"N-[[3-[(5S)-5-tert-butyl-1-[(3-chloro-4-fluoro-phenyl)methyl]-4-hydroxy-2-oxo-5H-pyrrol-3-yl]-1,1-dioxo-1,2-benzothiazol-7-yl]methyl]methanesulfonamide",579,Inner Protein Regulator,Inner Protein,18554907,"Structure-based design, synthesis, and biological evaluation of 1,1-dioxoisothiazole and benzo[b]thiophene-1,1-dioxide derivatives as novel inhibitors of hepatitis C virus NS5B polymerase.",No,"Chain A:PHE193,PRO197,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,ASP319,CYS366,SER368,LEU384,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449,SER556"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3.00E+51,ASD03740253,N35,A,Lig,Inhibitor,"N-[3-[5-hydroxy-2-(3-methylbutyl)-3-oxo-6-pyrrolidin-1-yl-pyridazin-4-yl]-1,1-dioxo-2H-benzo[e][1,2,4]thiadiazin-7-yl]methanesulfonamide",579,Inner Protein Regulator,Inner Protein,18796353,"Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 5: Exploration of pyridazinones containing 6-amino-substituents.",No,"Chain A:PHE193,PRO197,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,CYS366,SER368,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449,SER556"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3FQK,ASD03740266,79Z,A,Lig,Inhibitor,5-cyclopropyl-2-(4-fluorophenyl)-6-(2-hydroxyethyl-methylsulfonyl-amino)-N-methyl-1-benzofuran-3-carboxamide,571,Inner Protein Regulator,Inner Protein,19246450,Slow binding inhibition and mechanism of resistance of non-nucleoside polymerase inhibitors of hepatitis C virus.,No,"Chain A:PHE193,PRO197,ARG200,LEU204,LEU314,ASN316,ASP319,VAL321,LEU360,ILE363,SER365,CYS366,SER368,ASN369,LEU384,MET414,TYR415,TYR448"
ASD03740000_2,,Hepatitis C virus,P26663,3FRZ,ASD09990001,AG0,A,Lig,Inhibitor,"(6R)-6-cyclopentyl-6-[2-(2,6-diethylpyridin-4-yl)ethyl]-3-[(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl]-4-hydroxy-5H-pyran-2-one",577,Inner Protein Regulator,Inner Protein,19209845,"Discovery of (R)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a potent and orally available hepatitis C virus polymerase inhibitor.",No,"Chain A:LEU419,ARG422,MET423,SER473,HIS475,SER476,TYR477,ILE482,VAL485,LEU497,ARG501,TRP528"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3G86,ASD03740278,T18,A,Lig,Inhibitor,"N-[3-[6-fluoro-1-[(4-fluorophenyl)methyl]-4-hydroxy-2-oxo-quinolin-3-yl]-1,1-dioxo-4H-benzo[b][1,4]thiazin-7-yl]methanesulfonamide",571,Inner Protein Regulator,Inner Protein,19457662,Non-nucleoside inhibitors of HCV polymerase NS5B. Part 2: Synthesis and structure-activity relationships of benzothiazine-substituted quinolinediones,No,"Chain A:PHE193,PRO197,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,CYS366,SER368,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449,SER556"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3GYN,ASD03740280,B42,A,Lig,Inhibitor,"N-[3-[(5R)-1-cyclopentyl-4-hydroxy-5-methyl-5-(3-methylbutyl)-2-oxo-6H-pyridin-3-yl]-1,1-dioxo-4H-benzo[e][1,2,4]thiadiazin-7-yl]methanesulfonamide",579,Inner Protein Regulator,Inner Protein,19796938,"5,5'- and 6,6'-dialkyl-5,6-dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase.",No,"Chain A:PHE193,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,CYS366,SER367,LEU384,ARG386,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449,SER556"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3H2L,ASD03740262,YAK,A,Lig,Inhibitor,"N-[3-[(4aR,7aS)-1-[(4-fluorophenyl)methyl]-4-hydroxy-2-oxo-5,6,7,7a-tetrahydro-4aH-cyclopenta[e]pyridin-3-yl]-1,1-dioxo-2H-benzo[e][1,2,4]thiadiazin-7-yl]methanesulfonamide",601,Inner Protein Regulator,Inner Protein,19818610,"Discovery of tricyclic 5,6-dihydro-1H-pyridin-2-ones as novel, potent, and orally bioavailable inhibitors of HCV NS5B polymerase.",No,"Chain A:PHE193,PRO197,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,ASP319,CYS366,SER368,LEU384,MET414,TYR415,GLN446,ILE447,TYR448,GLY449,SER556"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3H59,ASD03740279,H59,A,Lig,Inhibitor,"N-[3-[(5S)-1-[(4-fluoro-3-methyl-phenyl)methyl]-4-hydroxy-5-(2-methylbutan-2-yl)-2-oxo-5H-pyrrol-3-yl]-1,1-dioxo-4H-benzo[b][1,4]thiazin-7-yl]methanesulfonamide",571,Inner Protein Regulator,Inner Protein,19700319,Non-nucleoside inhibitors of HCV polymerase NS5B. Part 3: synthesis and optimization studies of benzothiazine-substituted tetramic acids,No,"Chain A:PHE193,PRO197,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,CYS366,SER368,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449,SER556"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3H5S,ASD03740277,H5S,A,Lig,Inhibitor,"(5S)-5-tert-butyl-1-[(4-fluoro-3-methyl-phenyl)methyl]-4-hydroxy-3-(8-methylsulfonyl-1,1-dioxo-7,9-dihydro-6H-[1,2]thiazolo[4,5-h]isoquinolin-3-yl)-5H-pyrrol-2-one",571,Inner Protein Regulator,Inner Protein,19709881,"Non-nucleoside inhibitors of HCV polymerase NS5B. Part 4: structure-based design, synthesis, and biological evaluation of benzo[d]isothiazole-1,1-dioxides",No,"Chain A:PHE193,PRO197,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,ASP319,CYS366,SER368,LEU384,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449,SER556"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3H5U,ASD03740276,H5U,A,Lig,Inhibitor,"N-[[3-[(5S)-5-tert-butyl-1-[(4-fluorophenyl)methyl]-4-hydroxy-2-oxo-5H-pyrrol-3-yl]-1,1-dioxo-1,2-benzothiazol-7-yl]methyl]methanesulfonamide",571,Inner Protein Regulator,Inner Protein,19709881,"Non-nucleoside inhibitors of HCV polymerase NS5B. Part 4: structure-based design, synthesis, and biological evaluation of benzo[d]isothiazole-1,1-dioxides",No,"Chain A:PHE193,PRO197,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,ASP319,CYS366,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449,SER556"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3H98,ASD03740258,B5P,A,Lig,Inhibitor,"N-[3-[5-hydroxy-8-(3-methylbutyl)-7-oxo-imidazo[2,1-b]pyrimidin-6-yl]-1,1-dioxo-4H-benzo[e][1,2,4]thiadiazin-7-yl]methanesulfonamide",571,Inner Protein Regulator,Inner Protein,19500983,"HCV NS5B polymerase inhibitors 2: Synthesis and in vitro activity of (1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl) azolo[1,5-a]pyridine and azolo[1,5-a]pyrimidine derivatives.",No,"Chain A:PHE193,SER288,ASN291,ASN316,GLY317,ASP318,CYS366,SER368,LEU384,MET414,TYR415,ILE447,TYR448,GLY449,SER556"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3IGV,ASD03740271,B80,A,Lig,Inhibitor,"N-[3-[(2S)-2-ethyl-1-[(4-fluorophenyl)methyl]-4-hydroxy-6-oxo-2,3-dihydropyridin-5-yl]-1,1-dioxo-2H-benzo[e][1,2,4]thiadiazin-7-yl]methanesulfonamide",579,Inner Protein Regulator,Inner Protein,19796938,"5,5'- and 6,6'-dialkyl-5,6-dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase.",No,"Chain A:PHE193,PRO197,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,CYS366,SER368,LEU384,ASN411,MET414,TYR415,ILE447,TYR448,GLY449,SER556"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3MF5,ASD03740239,HJZ,A,Lig,Inhibitor,3-[2-(4-methylcyclohexyl)phenyl]-5-phenyl-thiophene-2-carboxylic acid,571,Inner Protein Regulator,Inner Protein,20584604,Cyclic amide bioisosterism: Strategic application to the design and synthesis of HCV NS5B polymerase inhibitors.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,ALA486,LEU497,ARG501,TRP528"
ASD03740000_2,,Hepatitis C virus,P26663,3UDL,ASD01418015,KLI,A,Lig,Inhibitor,"6-fluoranyl-1-[[2-fluoranyl-4-(trifluoromethyl)phenyl]methyl]-7-(4-methylpiperazin-1-yl)-3-[5-(phenylmethyl)-1,2,4-oxadiazol-3-yl]quinolin-4-one",571,Inner Protein Regulator,Inner Protein,21145235,Quinolones as HCV NS5B polymerase inhibitors.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,SER478,PRO479,ILE482,ASN483,VAL485,ALA486,LEU489,LEU497,TRP528"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,3VQS,ASD03740281,JT1,A,Lig,Inhibitor,"(2R)-4-(5-cyclopropyl-[1,3]thiazolo[4,5-d]pyrimidin-2-yl)-N-[[3-fluoranyl-4-(trifluoromethyloxy)phenyl]methyl]-1-[4-(trifluoromethyl)phenyl]sulfonyl-piperazine-2-carboxamide",1000,Inner Protein Regulator,Inner Protein,22615294,"Preclinical Characterization of JTK-853, a Novel Nonnucleoside Inhibitor of the Hepatitis C Virus RNA-Dependent RNA Polymerase.",No,"Chain A:VAL179,TYR191,GLY192,PHE193,TYR195,SER196,PRO197,ARG200,SER288,CYS289,ASN316,CYS366,SER368,LEU384,ILE413,MET414,TYR415,ILE447,TYR448,ALA450,TYR452,ILE454,ILE462,LEU466,LEU547,PHE551"
ASD03740000_2,,Hepatitis C virus,P26663,4B6E,ASD03740034,10L,B,Lig,Inhibitor,1H-indazol-7-amine,1722,Inner Protein Regulator,Inner Protein,23023261,Discovery of an Allosteric Mechanism for the Regulation of Hcv Ns3 Protein Function.,Yes,"Chain B:TYR56,HIS57,VAL78,ASP79,ASP81,MET485,VAL524,CYS525,GLN526"
ASD03740000_2,,Hepatitis C virus,P26663,4B6F,ASD03740193,20L,A,Lig,Inhibitor,(4-phenoxyphenyl)methylazanium,1722,Inner Protein Regulator,Inner Protein,23023261,Discovery of an Allosteric Mechanism for the Regulation of Hcv Ns3 Protein Function.,Yes,"Chain A:HIS57,VAL78,ASP79,GLN80,ASP81,ARG155,MET485,PHE486,VAL524,CYS525,GLN526,GLU628,VAL630"
ASD03740000_2,,Hepatitis C virus,P26663,4B71,ASD03740195,DJL,A,Lig,Inhibitor,[(1R)-1-(4-chloranyl-2-fluoranyl-3-phenoxy-phenyl)propyl]azanium,1721,Inner Protein Regulator,Inner Protein,23023261,Discovery of an Allosteric Mechanism for the Regulation of Hcv Ns3 Protein Function.,Yes,"Chain A:TYR56,HIS57,VAL78,ASP79,GLN80,ASP81,ARG155,MET485,PHE486,VAL524,CYS525,GLN526,ASP527,GLU628,VAL630"
ASD03740000_2,,Hepatitis C virus,P26663,4B73,ASD03740202,4VA,A,Lig,Inhibitor,[(2S)-4-azanyl-4-oxidanylidene-butan-2-yl]-[(1R)-1-(4-chloranyl-2-fluoranyl-3-phenoxy-phenyl)propyl]azanium,1721,Inner Protein Regulator,Inner Protein,23023261,Discovery of an Allosteric Mechanism for the Regulation of Hcv Ns3 Protein Function.,Yes,"Chain A:HIS57,VAL78,ASP79,GLN80,ASP81,ARG155,MET485,PHE486,LEU517,ASN518,PRO523,VAL524,CYS525,GLN526,ASP527,GLU628,VAL630"
ASD03740000_2,,Hepatitis C virus,P26663,4B74,ASD03740203,1LH,A,Lig,Inhibitor,[(2S)-4-(2-azaniumylethylamino)-4-oxidanylidene-butan-2-yl]-[(1R)-1-(4-chloranyl-2-fluoranyl-3-phenoxy-phenyl)propyl]azanium,1721,Inner Protein Regulator,Inner Protein,23023261,Discovery of an Allosteric Mechanism for the Regulation of Hcv Ns3 Protein Function,Yes,"Chain A:HIS57,VAL78,ASP79,GLN80,ASP81,ARG155,MET485,PHE486,TYR516,LEU517,THR519,PRO520,GLY521,LEU522,PRO523,VAL524,CYS525,GLN526,ASP527,GLU628,VAL630"
ASD03740000_2,,Hepatitis C virus,P26663,4B75,ASD03740202,4VA,A,Lig,Inhibitor,[(2S)-4-azanyl-4-oxidanylidene-butan-2-yl]-[(1R)-1-(4-chloranyl-2-fluoranyl-3-phenoxy-phenyl)propyl]azanium,1721,Inner Protein Regulator,Inner Protein,23023261,Discovery of an Allosteric Mechanism for the Regulation of Hcv Ns3 Protein Function.,Yes,"Chain A:HIS57,VAL78,ASP79,GLN80,ASP81,ARG155,MET485,PHE486,LEU517,PRO523,VAL524,CYS525,GLN526,ASP527,GLU628,LEU630"
ASD03740000_2,,Hepatitis C virus,P26663,4B76,ASD03740205,PW1,A,Lig,Inhibitor,"[2,4-bis(fluoranyl)-3-phenoxy-phenyl]methylazanium",1721,Inner Protein Regulator,Inner Protein,23023261,Discovery of an Allosteric Mechanism for the Regulation of Hcv Ns3 Protein Function.,Yes,"Chain A:TYR56,HIS57,VAL78,ASP79,ASP81,ARG155,MET485,PHE486,VAL524,CYS525,GLN526,GLU628,VAL630"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4EO6,ASD03740242,0S2,A,Lig,Inhibitor,"5-(3,3-dimethylbut-1-ynyl)-3-[(4-methylcyclohexyl)carbonyl-propan-2-yl-amino]thiophene-2-carboxylic acid",600,Inner Protein Regulator,Inner Protein,22664130,Tri-substituted acylhydrazines as tertiary amide bioisosteres: HCV NS5B polymerase inhibitors.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,VAL485,ALA486,LEU497,TRP528"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4EO8,ASD03740238,0S3,A,Lig,Inhibitor,"3-[dimethylamino-(4-methylcyclohexyl)carbonyl-amino]-5-(3,3-dimethylbut-1-ynyl)thiophene-2-carboxylic acid",600,Inner Protein Regulator,Inner Protein,22664130,Tri-substituted acylhydrazines as tertiary amide bioisosteres: HCV NS5B polymerase inhibitors.,No,"Chain A:LEU419,ARG422,MET423,LEU474,HIS475,SER476,TYR477,ILE482,VAL485,ALA486,LEU497,TRP528"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4IH5,ASD03740254,12R,A,Lig,Inhibitor,"1-phenyl-2-(1H-pyrazolo[3,4-d]pyrimidin-4-yl)diazane",601,Inner Protein Regulator,Inner Protein,23509929,De novo fragment design: a medicinal chemistry approach to fragment-based lead generation.,No,"Chain A:ARG200,CYS366,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4IH6,ASD03740249,1EP,A,Lig,Inhibitor,"(5S)-3-[(4-tert-butylphenyl)methyl]-5-propan-2-yl-imidazolidine-2,4-dione",601,Inner Protein Regulator,Inner Protein,23509929,De novo fragment design: a medicinal chemistry approach to fragment-based lead generation.,No,"Chain A:PRO197,ARG200,CYS366,SER368,LEU384,SER407,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4IH7,ASD03740255,1ER,A,Lig,Inhibitor,3-(3-tert-butylphenyl)-1H-pyridin-2-one,602,Inner Protein Regulator,Inner Protein,23509929,De novo fragment design: a medicinal chemistry approach to fragment-based lead generation.,No,"Chain A:ARG200,CYS366,SER368,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4KAI,ASD03740240,1PV,A,Lig,Inhibitor,[4-[[[5-cyclopropyl-2-(4-fluorophenyl)-3-(methylcarbamoyl)-1-benzofuran-6-yl]-methylsulfonyl-amino]methyl]-2-fluoranyl-phenyl]boronic acid,602,Inner Protein Regulator,Inner Protein,23672667,Discovery of a Potent Boronic Acid Derived Inhibitor of the HCV RNA-Dependent RNA Polymerase.,No,"Chain A:LEU419,MET423,LEU474,HIS475,SER476,TYR477,ILE482,LEU497,ARG498,ARG501,TRP528,LYS533"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4KAI,ASD03740240,1PV,A,Lig,Inhibitor,[4-[[[5-cyclopropyl-2-(4-fluorophenyl)-3-(methylcarbamoyl)-1-benzofuran-6-yl]-methylsulfonyl-amino]methyl]-2-fluoranyl-phenyl]boronic acid,601,Inner Protein Regulator,Inner Protein,23672667,Discovery of a Potent Boronic Acid Derived Inhibitor of the HCV RNA-Dependent RNA Polymerase.,No,"Chain A:PHE193,PRO197,ARG200,LEU204,LEU314,ASN316,ASP319,VAL321,LEU360,ILE363,SER365,CYS366,SER368,LEU384,MET414,TYR415,TYR448,GLY449"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4KB7,ASD03740274,690,A,Lig,Inhibitor,"5-cyclopropyl-2-(4-fluorophenyl)-N-methyl-6-[methylsulfonyl-[2-[(3R)-1-oxidanyl-3H-2,1-benzoxaborol-3-yl]ethyl]amino]-1-benzofuran-3-carboxamide",601,Inner Protein Regulator,Inner Protein,23672667,Discovery of a Potent Boronic Acid Derived Inhibitor of the HCV RNA-Dependent RNA Polymerase.,No,"Chain A:PHE193,PRO197,ARG200,LEU204,LEU314,TYR316,ASP319,VAL321,ILE363,SER365,CYS366,SER368,LEU384,ASN411,MET414,TYR415,GLN446,TYR448"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4KBI,ASD03740269,1C0,A,Lig,Inhibitor,"5-cyclopropyl-6-[(7-fluoranyl-1-oxidanyl-3H-2,1-benzoxaborol-5-yl)methyl-methylsulfonyl-amino]-2-(4-fluorophenyl)-N-methyl-1-benzofuran-3-carboxamide",601,Inner Protein Regulator,Inner Protein,23672667,Discovery of a Potent Boronic Acid Derived Inhibitor of the HCV RNA-Dependent RNA Polymerase.,No,"Chain A:PRO197,ARG200,LEU204,LEU314,TYR316,VAL321,LEU360,ILE363,SER365,CYS366,SER368,LEU384,MET414,TYR415,GLN446,ILE447,TYR448,GLY449"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4KE5,ASD03740240,1PV,A,Lig,Inhibitor,[4-[[[5-cyclopropyl-2-(4-fluorophenyl)-3-(methylcarbamoyl)-1-benzofuran-6-yl]-methylsulfonyl-amino]methyl]-2-fluoranyl-phenyl]boronic acid,602,Inner Protein Regulator,Inner Protein,23672667,Discovery of a Potent Boronic Acid Derived Inhibitor of the HCV RNA-Dependent RNA Polymerase.,No,"Chain A:LEU419,MET423,LEU474,HIS475,SER476,TYR477,ILE482,LEU497,ARG498,ARG501,TRP528,ALA529,VAL530,LYS531"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4KE5,ASD03740240,1PV,A,Lig,Inhibitor,[4-[[[5-cyclopropyl-2-(4-fluorophenyl)-3-(methylcarbamoyl)-1-benzofuran-6-yl]-methylsulfonyl-amino]methyl]-2-fluoranyl-phenyl]boronic acid,601,Inner Protein Regulator,Inner Protein,23672667,Discovery of a Potent Boronic Acid Derived Inhibitor of the HCV RNA-Dependent RNA Polymerase.,No,"Chain A:PRO197,ARG200,LEU204,LEU314,TYR316,ASP319,VAL321,ILE363,SER365,CYS366,SER368,LEU384,MET414,TYR415,TYR448"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4MIA,ASD03740247,28L,A,Lig,Inhibitor,N-[4-[6-tert-butyl-5-methoxy-8-(2-methoxy-6-oxidanylidene-3H-pyridin-5-yl)quinolin-3-yl]phenyl]methanesulfonamide,602,Inner Protein Regulator,Inner Protein,24195700,"Discovery of N-[4-[6-tert-butyl-5-methoxy-8-(6-methoxy-2-oxo-1H-pyridin-3-yl)-3-quinolyl]phenyl]methanesulfonamide (RG7109), a potent inhibitor of the hepatitis C virus NS5B polymerase.",No,"Chain A:PHE193,PRO197,ARG200,ASN291,ASN316,GLY317,ASP318,CYS366,SER368,SER407,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,SER556"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4MIB,ASD03740264,28M,A,Lig,Inhibitor,N-[[(3S)-1-[6-tert-butyl-5-methoxy-8-(2-oxidanylidene-1H-pyridin-3-yl)quinolin-3-yl]pyrrolidin-3-yl]methyl]methanesulfonamide,602,Inner Protein Regulator,Inner Protein,24195700,"Discovery of N-[4-[6-tert-butyl-5-methoxy-8-(6-methoxy-2-oxo-1H-pyridin-3-yl)-3-quinolyl]phenyl]methanesulfonamide (RG7109), a potent inhibitor of the hepatitis C virus NS5B polymerase.",No,"Chain A:PHE193,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,CYS366,SER368,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,SER556"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4MK7,ASD03740256,28O,A,Lig,Inhibitor,3-(3-tert-butyl-4-methoxy-phenyl)-1H-pyridin-2-one,603,Inner Protein Regulator,Inner Protein,24069953,Discovery of a Novel Series of Potent Non-Nucleoside Inhibitors of Hepatitis C Virus NS5B.,No,"Chain A:PHE193,ARG200,ASN316,CYS366,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4MK8,ASD03740257,28Q,A,Lig,Inhibitor,N-[4-[2-[3-tert-butyl-2-methoxy-5-(2-oxidanylidene-1H-pyridin-3-yl)phenyl]ethyl]phenyl]methanesulfonamide,602,Inner Protein Regulator,Inner Protein,24069953,Discovery of a Novel Series of Potent Non-Nucleoside Inhibitors of Hepatitis C Virus NS5B.,No,"Chain A:PHE193,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,ASP319,SER368,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,SER556"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4MK9,ASD03740272,28R,A,Lig,Inhibitor,"N-[2-[3-tert-butyl-2-methoxy-5-(2-oxidanylidene-1H-pyridin-3-yl)phenyl]-1,3-benzoxazol-5-yl]methanesulfonamide",601,Inner Protein Regulator,Inner Protein,24069953,Discovery of a Novel Series of Potent Non-Nucleoside Inhibitors of Hepatitis C Virus NS5B.,No,"Chain A:PHE193,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,ASP319,CYS366,SER368,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,SER556"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4MKA,ASD03740250,2AY,A,Lig,Inhibitor,N-[3-[3-tert-butyl-2-methoxy-5-(2-oxidanylidene-1H-pyridin-3-yl)phenyl]-1-oxidanylidene-isochromen-7-yl]methanesulfonamide,602,Inner Protein Regulator,Inner Protein,24069953,Discovery of a Novel Series of Potent Non-Nucleoside Inhibitors of Hepatitis C Virus NS5B.,No,"Chain A:PHE193,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,ASP319,CYS366,SER368,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,GLY449,SER556"
ASD03740000_2,HCVgp1,Hepatitis C virus,P26663,4MKB,ASD03740263,28V,A,Lig,Inhibitor,N-[4-[(E)-2-[3-tert-butyl-2-methoxy-5-(6-oxidanylidene-1H-pyridazin-5-yl)phenyl]ethenyl]phenyl]methanesulfonamide,601,Inner Protein Regulator,Inner Protein,24069953,Discovery of a Novel Series of Potent Non-Nucleoside Inhibitors of Hepatitis C Virus NS5B.,No,"Chain A:PHE193,ARG200,SER288,ASN291,ASN316,GLY317,ASP318,CYS366,SER368,LEU384,GLY410,ASN411,MET414,TYR415,GLN446,ILE447,TYR448,SER556"
ASD03750000_5,TUBB2B,Bos taurus,Q6B856,5S4Q,,WVD,B,Lig,Regulator,"4-(4-methyl-1,3-thiazole-5-carbonyl)piperazin-2-one",505,,,,,,
ASD03750000_5,TUBB2B,Bos taurus,Q6B856,5S4R,,NW7,B,Lig,Regulator,"3-ethyl-5-methyl-N-(5-methyl-1,2-oxazol-3-yl)-1,2-oxazole-4-carboxamide",,,,,,No,
ASD03750000_5,TUBB2B,Bos taurus,Q6B856,5S4S,,K0M,A,Lig,Regulator,"3-methyl-N-(1-methyl-1H-pyrazol-3-yl)-1,2-oxazole-5-carboxamide",,,,,,No,
ASD03750000_5,TUBB2B,Bos taurus,Q6B856,5S4T,,K1G,B,Lig,Regulator,"N,1-dimethyl-N-(propan-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",,,,,,No,
ASD03750000_5,TUBB2B,Bos taurus,Q6B856,5S4U,,GX4,B,Lig,Regulator,cyclopropyl-[4-(4-fluorophenyl)piperazin-1-yl]methanone,,,,,,No,
ASD03750000_5,TUBB2B,Bos taurus,Q6B856,5S4W,,WZ7,B,Lig,Regulator,2-[(cyclopent-3-en-1-yl)amino]pyridine-4-carboxamide,,,,,,No,
ASD03750000_5,TUBB2B,Bos taurus,Q6B856,5S4X,,JHD,"B, D",Lig,Regulator,"1-(3,4-dimethoxyphenyl)methanamine",,,,,,No,
ASD03750000_5,TUBB2B,Bos taurus,Q6B856,5S4Z,,WN1,B,Lig,Regulator,N-(2-fluorophenyl)-3-methoxybenzamide,,,,,,No,
ASD03750000_6,F2,Bos taurus,P00735,3PMA,ASD03750006,SCR,B,Lig,Inhibitor,"[(2R,3R,4S,5R,6R)-2-[(2S,3S,4R,5R)-3,4-disulfooxy-2,5-bis(sulfooxymethyl)oxolan-2-yl]oxy-4,5-disulfooxy-6-(sulfooxymethyl)oxan-3-yl] hydrogen sulfate",248,Inner Protein Regulator,Protein-Protein Interaction,21736375,Interaction of thrombin with sucrose octasulfate.,No,"Chain B:ASP125,LYS126,PHE232,LYS235,GLN239; Chain D:LYS87,TYR89,TRP237,LYS240,VAL241,ARG244,LEU245"
ASD03910000_1,HBA1,Homo sapiens,P69905,1G9V,ASD03910095,RQ3,A,Lig,Regulator,"2-[4-[2-[(3,5-dimethylphenyl)amino]-2-oxo-ethyl]phenoxy]-2-methyl-propanoic acid",801,Inner Protein Regulator,Protein-Protein Interaction,11316875,High-resolution crystal structure of deoxy hemoglobin complexed with a potent allosteric effector.,No,1G9V
ASD03910000_1,HBA1,Homo sapiens,P69905,2D5Z,ASD03910091,L35,A,Lig,Regulator,"2-[4-[(3,5-dichlorophenyl)carbamoylamino]phenoxy]-2-methyl-propanoic acid",1201,Inner Protein Regulator,Protein-Protein Interaction,16403522,R-state haemoglobin with low oxygen affinity: crystal structures of deoxy human and carbonmonoxy horse haemoglobin bound to the effector molecule L35,No,2D5Z
ASD03910000_1,HBA1,Homo sapiens,P69905,4NI0,ASD03910126,2P3,A,Lig,Activator,"5-[(2S)-2,3-dihydro-1,4-benzodioxin-2-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione",203,Allosteric function,Allosteric position,25061917,Identification of a Small Molecule that Increases Hemoglobin Oxygen Affinity and Reduces SS Erythrocyte Sickling.,No,4NI0
ASD03910000_1,HBA1,Homo sapiens,P69905,5.00E+29,ASD03910095,RQ3,B,Lig,Inhibitor,"2-{4-[(3,5-DIMETHYLANILINO)-CARBONYL-METHYL]-PHENOXY}-2-METHYLPROPIONIC ACID",202,Protein-Protein Interaction,Protein-Protein Interaction,26582149,"Design, Synthesis, and Investigation of Novel Nitric Oxide (NO)-Releasing Prodrugs as Drug Candidates for the Treatment of Ischemic Disorders: Insights into NO-Releasing Prodrug Biotransformation and Hemoglobin-NO Biochemistry.",No,5.00E+29
ASD03910000_1,HBA1,Homo sapiens,P69905,5.00E+29,ASD03910139,5JN,A,Lig,Inhibitor,"2-(nitrooxy)ethyl 2-(4-{2-[(3,5-dimethylphenyl)amino]- 2-oxoethyl}phenoxy)-2-methylpropanoate",203,Allosteric Function,Allosteric Position,26582149,"Design, Synthesis, and Investigation of Novel Nitric Oxide (NO)-Releasing Prodrugs as Drug Candidates for the Treatment of Ischemic Disorders: Insights into NO-Releasing Prodrug Biotransformation and Hemoglobin-NO Biochemistry.",No,5.00E+29
ASD03910000_1,HBA1,Homo sapiens,P69905,5KSI,ASD03910144,S1P,"A,C",Lig,Inhibitor,"(2S,3R,4E)-2-amino-3-hydroxyoctadec-4-en-1-yl dihydrogen phosphate",202,Allosteric Fuction,Allosteric Position,29127281,Structural and Functional Insight of Sphingosine 1-Phosphate-Mediated Pathogenic Metabolic Reprogramming in Sickle Cell Disease.,No,5KSI
ASD03910000_1,HBA1,Homo sapiens,P69905,5U3I,ASD03910140,7SJ,A,Lig,Activator,2-methoxy-5-({2-[1-(propan-2-yl)-1H-pyrazol- 5-yl]pyridin-3-yl}methoxy)pyridine-4-carbaldehyde,203,Inner Protein Regulator,Inner Protein,28337324,"Discovery of GBT440, an Orally Bioavailable R-State Stabilizer of Sickle Cell Hemoglobin.",No,5U3I
ASD03910000_1,HBA1,Homo sapiens,P69905,5UFJ,ASD03910141,86M,A,Lig,Activator,"5-[(imidazo[1,2-a]pyridin-8-yl)methoxy]-2- methoxypyridine-4-carbaldehyde",203,Inner Protein Regulator,Inner Protein,28337324,"Discovery of GBT440, an Orally Bioavailable R-State Stabilizer of Sickle Cell Hemoglobin.",No,5UFJ
ASD03910000_1,HBA1,Homo sapiens,P69905,5X2S,ASD03910090,PEM,I,Lig,Regulator,2-[P-[2-P-CHLOROBENZAMIDO)ETHYL]PHENOXY]-2-METHYLPROPIONIC ACID,202,Allosteric function,Allosteric position,28931607,Direct observation of conformational population shifts in crystalline human hemoglobin.,No,5X2S
ASD03910000_1,HBA1,Homo sapiens,P69905,5X2T,ASD03910090,PEM,I,Lig,Regulator,2-[P-[2-P-CHLOROBENZAMIDO)ETHYL]PHENOXY]-2-METHYLPROPIONIC ACID,202,Allosteric function,Allosteric position,28931607,Direct observation of conformational population shifts in crystalline human hemoglobin.,No,5X2T
ASD03910000_1,HBA1,Homo sapiens,P69905,6BNR,ASD03910142,E0J,A,Lig,Regulator,2-[(4-methoxy-2-methylphenoxy)methyl]pyridine,203,Allosteric function,Allosteric position,29655608,Rational design of pyridyl derivatives of vanillin for the treatment of sickle cell disease.,No,6BNR
ASD03910000_2,HBB,Homo sapiens,P68871,1B86,ASD03910075,DG2,D,Lig,Regulator,"2,3-diphosphonooxypropanoic acid",701,Inner Protein Regulator,Protein-Protein Interaction,8377203,"Human deoxyhaemoglobin-2,3-diphosphoglycerate complex low-salt structure at 2.5 A resolution.",No,1B86
ASD03910000_2,HBB,Homo sapiens,P68871,2D60,ASD03910091,L35,B,Lig,Regulator,"2-[4-[(3,5-dichlorophenyl)carbamoylamino]phenoxy]-2-methyl-propanoic acid",1200,Inner Protein Regulator,Protein-Protein Interaction,16403522,R-state haemoglobin with low oxygen affinity: crystal structures of deoxy human and carbonmonoxy horse haemoglobin bound to the effector molecule L35,No,2D60
ASD03910000_2,HBB,Homo sapiens,P68871,4ROL,ASD03910129,3U7,A,Lig,Regulator,"4-{2,3-dichloro-4-[3-(1H-imidazol-2-yl)propanoyl]phenoxy}butanoic acid",202,Allosteric Function,Inner Protein,25974708,Identification of a novel class of covalent modifiers of hemoglobin as potential antisickling agents.,No,4ROL
ASD03910000_2,HBB,Homo sapiens,P68871,4ROM,ASD03910138,3U8,A,Lig,Regulator,4-{2-chloro-4-[3-(1H-imidazol-2-yl)propanoyl]phenoxy}butanoic acid,202,Allosteric Function,Inner Protein,25974708,Identification of a novel class of covalent modifiers of hemoglobin as potential antisickling agents.,No,4ROM
ASD03910000_2,HBB,Homo sapiens,P68871,5.00E+29,ASD03910095,RQ3,A,Lig,Inhibitor,"2-{4-[(3,5-DIMETHYLANILINO)-CARBONYL-METHYL]-PHENOXY}-2-METHYLPROPIONIC ACID",204,Protein-Protein Interaction,Protein-Protein Interaction,26582149,"Design, Synthesis, and Investigation of Novel Nitric Oxide (NO)-Releasing Prodrugs as Drug Candidates for the Treatment of Ischemic Disorders: Insights into NO-Releasing Prodrug Biotransformation and Hemoglobin-NO Biochemistry.",No,5.00E+29
ASD03910000_2,HBB,Homo sapiens,P68871,5KDQ,ASD03910143,KOH,C,Lig,Activator,3-[2-chloranyl-4-(1~{H}-imidazol-2-yl)phenoxy]propanoic acid,202,Allosteric Fuction,Allosteric Position,27529207,Aryloxyalkanoic Acids as Non-Covalent Modifiers of the Allosteric Properties of Hemoglobin.,No,5KDQ
ASD03910000_2,HBB,Homo sapiens,P68871,7UD7,ASD03910148,MWC,"F,I",compound,,dihydroxy[(5-methylfuran-2-yl)methoxy]amine,,,,35625623,,,7UD7
ASD03910000_2,HBB,Homo sapiens,P68871,7UD8,ASD03910147,MW0,"G,L",compound,,5-hydroxyfuran-2-carbaldehyde,,,,35625623,,,7UD8
ASD03910000_3,HBA,Equus caballus,P01958,1IWH,ASD03910090,PEM,A,Lig,Regulator,2-[4-[2-[(4-chlorophenyl)carbonylamino]ethyl]phenoxy]-2-methyl-propanoic acid,501,Inner Protein Regulator,Inner Protein,12122004,Crystal Structure of Horse Carbonmonoxyhemoglobin-Bezafibrate Complex at 1.55A Resolution. A Novel Allosteric Binding Site in R-State Hemoglobin,No,"Chain A:ALA57,LYS60,LYS61,ASP64,ALA65,LEU83"
ASD03910000_3,HBA,Equus caballus,P01958,2D5X,ASD03910091,L35,A,Lig,Regulator,"2-[4-[(3,5-dichlorophenyl)carbamoylamino]phenoxy]-2-methyl-propanoic acid",1200,Inner Protein Regulator,Inner Protein,16403522,R-state haemoglobin with low oxygen affinity: crystal structures of deoxy human and carbonmonoxy horse haemoglobin bound to the effector molecule L35,No,"Chain A:LYS61,ASP64,ALA65,LEU68,ASN82,LEU83,LEU86,LYS90"
ASD03910000_4,HBB,Equus caballus,P02062,2D5X,ASD03910091,L35,B,Lig,Regulator,"2-[4-[(3,5-dichlorophenyl)carbamoylamino]phenoxy]-2-methyl-propanoic acid",1201,Inner Protein Regulator,Protein-Protein Interaction,16403522,R-state haemoglobin with low oxygen affinity: crystal structures of deoxy human and carbonmonoxy horse haemoglobin bound to the effector molecule L35,No,"Chain A:PHE36,LYS99,LEU100,HIS103,ASP126,SER130; Chain B:TYR35,TRP37,LEU105,ASN108"
ASD03940000_1,clpX,Escherichia coli,P0A6H1,3HWS,ASD01720027,ADP,A,Lig,Regulator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate",600,Protein-Protein Interaction Regulator,Inner Protein,,Structures of Asymmetric ClpX Hexamers  Reveal Nucleotide-Dependent Motions  in a AAA+ Protein-Unfolding Machine,No,"Chain A:TYR77,VAL78,ILE79,PRO120,THR121,GLY122,SER123,GLY124,LYS125,THR126,LEU127,LEU317,ILE325,ALA369"
ASD03940000_1,clpX,Escherichia coli,P0A6H1,4I4L,ASD01720027,ADP,A,Lig,Regulator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate",600,Protein-Protein Interaction Regulator,Inner Protein,23622246,Nucleotide Binding and Conformational Switching in the Hexameric Ring of a AAA+ Machine.,No,"Chain A:TYR77,VAL78,ILE79,PRO120,THR121,GLY122,SER123,GLY124,LYS125,THR126,LEU127,ILE325,ALA369"
ASD03940000_1,clpX,Escherichia coli,P0A6H1,4I81,ASD03940004,AGS,A,Lig,Regulator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] bis(oxidanyl)phosphinothioyl hydrogen phosphate",600,Protein-Protein Interaction Regulator,Inner Protein,23622246,Nucleotide Binding and Conformational Switching in the Hexameric Ring of a AAA+ Machine.,No,"Chain A:TYR77,VAL78,ILE79,PRO120,THR121,GLY122,SER123,GLY124,LYS125,THR126,LEU127,TYR182,ASP184,LEU317,ILE325,ALA369,ARG370"
ASD03940000_2,clpX,Helicobacter pylori,O25926,1UM8,ASD01720027,ADP,A,Lig,Regulator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate",487,Protein-Protein Interaction Regulator,Inner Protein,14514695,Crystal Structure of ClpX Molecular Chaperone from Helicobacter pylori,No,"Chain A:TYR92,VAL93,ILE94,THR151,GLY152,SER153,GLY154,LYS155,THR156,LEU157,ILE343,ILE351,ALA395,ARG396"
ASD04010000_1,ISPD,Arabidopsis thaliana,P69834,2YC3,ASD04010001,MW5,A,Lig,Inhibitor,"5-chloro-6-(phenylmethyl)-3H-[1,2,4]triazolo[1,5-a]pyrimidin-7-one",1301,Inner Protein Regulator,Inner Protein,21766403,Inhibitors of the Herbicidal Target Ispd: Allosteric Site Binding.,Yes,"Chain A:ARG157,ILE177,ALA203,VAL204,GLN238,VAL239,ILE240,LEU245,VAL259,ASP261,ASP262,VAL263,SER264,ILE265,VAL266,VAL273"
ASD04010000_1,ISPD,Arabidopsis thaliana,P69834,2YC5,ASD04010002,6BC,A,Lig,Inhibitor,"5-chloro-7-hydroxy-6-(phenylmethyl)pyrazolo[1,5-a]pyrimidine-3-carbonitrile",1300,Inner Protein Regulator,Inner Protein,21766403,Inhibitors of the Herbicidal Target Ispd: Allosteric Site Binding.,Yes,"Chain A:ARG157,GLN158,ILE177,ALA203,VAL204,GLN238,VAL239,ILE240,LEU245,VAL259,ASP261,ASP262,VAL263,SER264,ILE265,VAL266,VAL273"
ASD04010000_1,ISPD,Arabidopsis thaliana,P69834,2YCM,ASD04010003,30A,A,Lig,Inhibitor,"5-chloro-7-hydroxy-6-(phenylmethyl)pyrazolo[1,5-a]pyrimidine-3-carboxylic acid",1306,Inner Protein Regulator,Inner Protein,21766403,Inhibitors of the Herbicidal Target Ispd: Allosteric Site Binding.,Yes,"Chain A:ARG157,GLN158,ILE177,ALA203,VAL204,GLN238,VAL239,ILE240,VAL259,ASP261,ASP262,VAL263,SER264,ILE265,VAL266,VAL273"
ASD04010000_1,ISPD,Arabidopsis thaliana,P69834,4NAK,ASD05233003,PBQ,A,Lig,Inhibitor,"2,4-dibromo-6-(3,4,5-tribromo-1H-pyrrol-2-yl)phenol",401,Inner Protein Regulator,Inner Protein,24446431,"Pseudilins: Halogenated, Allosteric Inhibitors of the Non-Mevalonate Pathway Enzyme IspD.",Yes,"Chain A:ARG157,VAL161,ALA202,ALA203,GLN238,VAL239,LEU245,PHE249,SER264,ILE265,VAL266"
ASD04010000_1,ISPD,Arabidopsis thaliana,P69834,4NAL,ASD05233007,H70,A,Lig,Inhibitor,"2,4-dichloro-6-(3,4,5-tribromo-1H-pyrrol-2-yl)phenol",401,Inner Protein Regulator,Inner Protein,24446431,"Pseudilins: Halogenated, Allosteric Inhibitors of the Non-Mevalonate Pathway Enzyme IspD.",Yes,"Chain A:ARG157,VAL161,ALA202,ALA203,VAL204,GLN238,VAL239,LEU245,PHE249,SER264,ILE265,VAL266,VAL273"
ASD04010000_1,ISPD,Arabidopsis thaliana,P69834,4NAN,ASD04010006,2JM,A,Lig,Inhibitor,"2-bromanyl-6-[3,4,5-tris(bromanyl)-1H-pyrrol-2-yl]phenol",401,Inner Protein Regulator,Inner Protein,24446431,"Pseudilins: Halogenated, Allosteric Inhibitors of the Non-Mevalonate Pathway Enzyme IspD.",Yes,"Chain A:GLN158,VAL161,ILE177,ALA203,VAL204,GLN238,VAL239,LEU245,PHE249,SER264,ILE265,VAL266,VAL273"
ASD04010000_1,ISPD,Arabidopsis thaliana,P69834,5MRM,ASD04010011,Q9T,A,Lig,Inhibitor,"2,4-bis(bromanyl)-6-[3-(trifluoromethyl)- 1,2-oxazol-5-yl]phenol",401,Inner Protein Regulator,Inner Protein,28686408,Mechanism of Allosteric Inhibition of the Enzyme IspD by Three Different Classes of Ligands.,Yes,"Chain A:LEU245,GLN238,ILE177,TYR162,VAL239,VAL273,PHE249,ASP159,ARG157,VAL266,GLU267,LEU84,GLN158,ALA203,VAL161,ALA202,ILE265,VAL204,SER264,ILE240,VAL259"
ASD04010000_1,ISPD,Arabidopsis thaliana,P69834,5MRO,ASD04012001,Q9P,A,Lig,Inhibitor,Azolopyrimidine,401,Inner Protein Regulator,Inner Protein,28686408,Mechanism of Allosteric Inhibition of the Enzyme IspD by Three Different Classes of Ligands.,Yes,"Chain A:ILE177,ASP261,LEU245,ASP262,TYR274,PHE249,VAL204,ARG157,GLN158,VAL161,GLN238,VAL273,ALA203,VAL266,GLU267,VAL263,ALA202,VAL239,ILE265,SER264,ILE240,VAL259"
ASD04010000_1,ISPD,Arabidopsis thaliana,P69834,5MRP,ASD04010002,6BC,A,Lig,Inhibitor,"5-chloro-7-hydroxy-6-(phenylmethyl)pyrazolo[1,5- a]pyrimidine-3-carbonitrile",401,Inner Protein Regulator,Inner Protein,28686408,Mechanism of Allosteric Inhibition of the Enzyme IspD by Three Different Classes of Ligands.,Yes,"Chain A:ASP159,ASP261,LEU245,ASP262,TYR274,PHE249,VAL204,ARG157,GLN158,GLU156,VAL161,GLN238,ILE177,VAL273,ALA203,VAL266,GLU267,VAL263,ALA202,VAL239,ILE265,SER264,ILE240,VAL259"
ASD04020000_2,kgd,Mycobacterium smegmatis,A0R2B1,2XTA,ASD05550001,ACO,A,Lig,Activator,"S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxy-2-hydroxy-3,3-dimethyl-butanoyl]amino]propanoylamino]ethyl] ethanethioate",2004,Inner Protein Regulator,Inner Protein,21867916,Functional Plasticity and Allosteric Regulation of Alpha-Ketoglutarate Decarboxylase in Central Mycobacterial Metabolism.,No,"Chain A:THR1038,ARG1054,ASP1058,ILE1060,LYS1089,SER1092,GLN1142,PRO1145,PRO1147,ARG1148,ARG1149,ARG1150"
ASD04020000_2,kgd,Mycobacterium smegmatis,A0R2B1,2Y0P,ASD05550001,ACO,A,Lig,Activator,"S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxy-2-hydroxy-3,3-dimethyl-butanoyl]amino]propanoylamino]ethyl] ethanethioate",2228,Inner Protein Regulator,Inner Protein,21867916,Functional Plasticity and Allosteric Regulation of Alpha-Ketoglutarate Decarboxylase in Central Mycobacterial Metabolism.,No,"Chain A:GLU822,ILE827,LYS830,GLY1035,MET1037,THR1038,ARG1054,ASP1058,ILE1060,ARG1062,SER1092,GLN1142,PRO1145,LEU1146,PRO1147,ARG1148,ARG1149,ARG1150"
ASD04020000_2,kgd,Mycobacterium smegmatis,A0R2B1,6I2P,,,,Pep,Inhibitor,Glycogen accumulation regulator GarA,301,Inner Protein Regulator,Protein-Protein Interaction,,,Yes,
ASD04030000_2,,Hepatitis C virus genotype 1b,Q9WMX2,3Q0Z,ASD04030003,23E,A,Lig,Inhibitor,"(E)-3-[4-[[1-[(13-cyclohexyl-6-oxo-5,7-dihydroindolo[1,2-d][1,4]benzodiazepin-10-yl)carbonylamino]cyclopentyl]carbonylamino]phenyl]prop-2-enoic acid",601,Inner Protein Regulator,Inner Protein,21486696,Syntheses and initial evaluation of a series of indolo-fused heterocyclic inhibitors of the polymerase enzyme (NS5B) of the hepatitis C virus.,No,"Chain A:LEU392,ALA393,ALA395,ALA396,THR399,ILE424,HIS428,PHE429,LEU492,GLY493,VAL494,PRO495,PRO496,ARG498,VAL499,TRP500,ARG503"
ASD04030000_2,,Hepatitis C virus genotype 1b,Q9WMX2,4NLD,ASD01410478,2N7,A,Lig,Inhibitor,"(1aR,12bS)-8-cyclohexyl-N-(dimethylsulfamoyl)- 11-methoxy-1a-{[(1R,5S)-3-methyl-3,8-diazabicyclo[3.2.1]oct- 8-yl]carbonyl}-1,1a,2,12b-tetrahydrocyclopropa[d]indolo[2,1- a][2]benzazepine-5-carboxamide",601,Inner Protein Regulator,Inner Protein,24397558,"Discovery and Preclinical Characterization of the Cyclopropylindolobenzazepine BMS-791325, A Potent Allosteric Inhibitor of the Hepatitis C Virus NS5B Polymerase.",No,"Chain A:LEU392,ALA393,ALA395,ALA396,THR399,ALA400,ILE424,LEU425,HIS428,PHE429,LEU492,GLY493,VAL494,PRO495,TRP500,ARG503"
ASD04030000_2,,Hepatitis C virus genotype 1b,Q9WMX2,5PZK,ASD04030002,2N5,A,Lig,Inhibitor,2-(4-fluorophenyl)-N-methyl-6-[(methylsulfonyl)amino]- 5-(propan-2-yloxy)-1-benzofuran-3-carboxamide,602,Inner Protein Regulator,Inner Protein,28430437,Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies.,No,"Chain A:SER368,LEU204,CYS316,ASN369,SER365,VAL370,CYS366,LEU320,ASP319,TYR448,PRO197,TYR415,MET414,ARG200,ILE363,THR364,LEU360,LEU314,SER196,VAL315,TYR195,THR385,VAL321,GLY192,PHE193,LEU384,HIS467,ILE323"
ASD04030000_2,,Hepatitis C virus genotype 1b,Q9WMX2,5PZL,ASD04030012,8XV,A,Lig,Inhibitor,"2-({3-[1-(2-cyclopropylethyl)-6-fluoro-4- hydroxy-2-oxo-1,2-dihydroquinolin-3-yl]-1,1- dioxo-1,4-dihydro-1lambda~6~,2,4-benzothiadiazin- 7-yl}oxy)acetamide",602,Inner Protein Regulator,Inner Protein,28430437,Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies.,No,"Chain A:SER368,CYS316,SER288,TYR555,GLY317,SER365,ILE447,CYS366,GLY449,ASP319,SER556,TYR448,TYR415,ASN291,MET414,ALA450,ASP318,PHE224,ARG200,SER407,ASN411,GLN446,SER196,SER367,GLY410,THR287,PRO197,TYR195,LEU409,ASP225,GLY554,PHE193,LEU384"
ASD04030000_2,,Hepatitis C virus genotype 1b,Q9WMX2,5PZM,ASD04030011,8XS,B,Lig,Inhibitor,3-[2-(4-fluorophenyl)-3-(methylcarbamoyl)- 1-benzofuran-5-yl]benzoic acid,602,Inner Protein Regulator,Inner Protein,28430437,Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies.,No,"Chain B:LEU204,ASN369,LEU384,GLY449,GLY192,SER367,GLN446,ILE447,LEU360,PHE193,VAL321,TYR415,ASP319,MET414,THR364,ARG200,ILE363,SER368,VAL370,SER365,TYR448,LEU320,CYS366,ILE323,VAL315,LEU314,CYS316"
ASD04030000_2,,Hepatitis C virus genotype 1b,Q9WMX2,5PZN,ASD04030010,8XP,A,Lig,Inhibitor,5-[3-(tert-butylcarbamoyl)phenyl]-2-(4-fluorophenyl)- N-methyl-1-benzofuran-3-carboxamide,602,Inner Protein Regulator,Inner Protein,28430437,Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies.,No,"Chain A:ILE413,SER368,LEU204,CYS316,ASN369,SER365,VAL370,ILE447,CYS366,LEU320,ASP319,TYR448,PRO197,TYR415,MET414,TYR452,TRP550,ARG200,ILE363,THR364,PHE551,LEU360,LEU314,SER196,GLY410,GLY449,VAL315,TYR195,VAL321,LEU466,GLY192,PHE193,LEU384,ILE323"
ASD04030000_2,,Hepatitis C virus genotype 1b,Q9WMX2,5PZO,ASD04030009,8XM,A,Lig,Inhibitor,"2-(4-fluorophenyl)-N-methyl-5-[3-({2-methyl- 1-oxo-1-[(1,3,4-thiadiazol-2-yl)amino]propan- 2-yl}carbamoyl)phenyl]-1-benzofuran-3-carboxamide",602,Inner Protein Regulator,Inner Protein,28430437,Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies.,No,"Chain A:ILE413,SER549,TYR415,SER368,LEU204,ASN369,VAL552,SER365,VAL370,ILE447,CYS366,LEU320,ASP319,TYR448,PRO197,GLN194,GLN199,ASN316,MET414,TYR452,TRP550,ARG200,ILE363,THR364,LEU360,LEU314,SER196,SER367,GLY410,GLY449,VAL315,TYR195,ALA553,VAL321,LEU466,GLY192,PHE193,LEU384,LEU547"
ASD04030000_2,,Hepatitis C virus genotype 1b,Q9WMX2,5PZP,ASD14560001,8XJ,A,Lig,Inhibitor,"2-(4-fluorophenyl)-N-methyl-5-[3-({2-methyl- 1-oxo-1-[(1,3,4-thiadiazol-2-yl)amino]propan- 2-yl}carbamoyl)phenyl]-1-benzofuran-3-carboxamide",602,Inner Protein Regulator,Inner Protein,28430437,Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies.,No,"Chain A:ILE413,TYR415,SER368,LEU204,CYS316,ASN369,SER365,VAL370,ILE447,CYS366,LEU320,ASP319,SER556,TYR448,PRO197,GLN194,GLN199,MET414,TYR452,TRP550,ARG200,ILE363,THR364,PHE551,LEU360,LEU314,SER196,SER367,LEU362,VAL315,TYR195,GLY554,VAL321,LEU466,GLY192,PHE193,LEU384,LEU547"
ASD04030000_2,,Hepatitis C virus genotype 1b,Q9WMX2,5TRH,ASD01411144,7HL,A,Lig,Inhibitor,2-[(benzenecarbonyl)amino]-3-[(4-chlorophenyl)methoxy]benzoic acid,602,Inner Protein Regulator,Inner Protein,27908764,Discovery and initial optimization of alkoxyanthranilic acid derivatives as inhibitors of HCV NS5B polymerase.,No,"Chain A:SER368,CYS316,SER288,SER365,ILE447,CYS366,SER556,MET414,TYR415,TYR448,ALA450,ARG200,SER407,ASN411,SER196,SER367,GLY410,GLY449,PRO197,TYR195,GLN446,PHE193,LEU384"
ASD04030000_2,,Hepatitis C virus genotype 1b,Q9WMX2,5TRI,ASD01411149,7HM,A,Lig,Inhibitor,"3-[(4-chlorophenyl)methoxy]-2-(1-oxo-1,3- dihydro-2H-isoindol-2-yl)benzoic acid",602,Inner Protein Regulator,Inner Protein,27908764,Discovery and initial optimization of alkoxyanthranilic acid derivatives as inhibitors of HCV NS5B polymerase.,No,"Chain A:SER368,CYS316,GLY317,SER365,ILE447,CYS366,ASP319,SER556,MET414,TYR415,TYR448,ARG200,SER407,ASN411,SER196,GLY410,GLY449,PRO197,TYR195,THR385,GLN446,PHE193,LEU384,HIS467"
ASD04030000_2,,Hepatitis C virus genotype 1b,Q9WMX2,5TRJ,ASD01411153,7HO,A,Lig,Inhibitor,2-{[2-(carboxymethoxy)benzene-1-carbonyl]amino}- 3-[(4-chlorophenyl)methoxy]benzoic acid,602,Inner Protein Regulator,Inner Protein,27908764,Discovery and initial optimization of alkoxyanthranilic acid derivatives as inhibitors of HCV NS5B polymerase.,No,"Chain A:SER368,CYS316,GLY317,PRO391,SER365,ILE447,CYS366,ASP319,SER556,TYR448,ARG386,TYR415,MET414,ALA450,ARG200,SER407,ASN411,SER196,SER367,GLY410,GLY449,PRO197,TYR195,THR385,GLN446,PHE193,LEU384,HIS467"
ASD04030000_2,,Hepatitis C virus genotype 1b,Q9WMX2,5TRK,ASD04030004,7HH,A,Lig,Inhibitor,N-{3-[(benzenecarbonyl)amino]-4-[(4-chlorophenyl)methoxy]benzene- 1-carbonyl}glycine,602,Inner Protein Regulator,Inner Protein,27908764,Discovery and initial optimization of alkoxyanthranilic acid derivatives as inhibitors of HCV NS5B polymerase.,No,"Chain A:GLY198,SER368,CYS316,SER288,TYR555,GLY317,SER365,ILE447,CYS366,GLY449,ASP319,SER556,TYR448,TYR415,ASN291,MET414,ASP318,ARG200,SER407,THR292,ASN411,SER196,GLY410,THR287,PRO197,TYR195,THR385,GLN446,ASP225,GLY554,PHE193,LEU384,CYS289,HIS467"
ASD04060000_1,PFKP,Homo sapiens,Q01813,4XZ2,ASD00200001,FBP,B,Lig,Regulator,"BETA-FRUCTOSE-1,6-DIPHOSPHATE",802,Inner Protein Regulator,Allosteric Position,26205495,Crystal structure of human platelet phosphofructokinase-1 locked in an activated conformation.,No,4XZ2
ASD04090000_1,argB,Thermotoga maritima,Q9X2A4,2BTY,ASD02000001,ARG,A,Lig,Inhibitor,[amino-[[(4S)-4-amino-5-hydroxy-5-oxo-pentyl]amino]methylidene]azanium,1283,Inner Protein Regulator,Inner Protein,16376937,"Structural Bases of Feed-Back Control of Arginine Biosynthesis, Revealed by the Structure of Two Hexameric N-Acetylglutamate Kinases, from Thermotoga Maritima and Pseudomonas Aeruginosa",No,"Chain A:TYR15,PHE19,LYS196,SER214,HIS253,GLU266,ILE267,SER269,ARG270,LYS271,GLY272,GLY274,THR275,MET276"
ASD04090000_2,NAGK,Arabidopsis thaliana,Q9SCL7,2RD5,ASD02000001,ARG,A,Lig,Inhibitor,[amino-[[(4S)-4-amino-5-hydroxy-5-oxo-pentyl]amino]methylidene]azanium,1000,Inner Protein Regulator,Inner Protein,17913711,Structural Basis for the Regulation of N-Acetylglutamate Kinase by PII in Arabidopsis thaliana.,No,"Chain A:PHE33,LYS210,LYS232,GLU284,ILE285,SER287,ASP288,GLU289,GLY290,ALA291,GLY292,MET294"
ASD04090000_3,"ARG5,6",Saccharomyces cerevisiae,Q01217,3ZZH,ASD02000001,ARG,C,Lig,Inhibitor,[amino-[[(4S)-4-amino-5-hydroxy-5-oxo-pentyl]amino]methylidene]azanium,1362,Inner Protein Regulator,Inner Protein,22529931,Insight on an Arginine Synthesis Metabolon from the Tetrameric Structure of Yeast Acetylglutamate Kinase,No,"Chain C:TYR87,LYS265,SER285,MET286,GLU337,LEU338,PHE339,THR340,ASP341,SER342,GLY343,GLY345,MET347"
ASD04110000_1,acrB,Escherichia coli,P31224,6ZO5,,FUA,B,Lig,Regulator,FUSIDIC ACID,1102,,,,,,
ASD04110000_1,acrB,Escherichia coli,P31224,6ZOD,,FUA,B,Lig,Regulator,FUSIDIC ACID,1213,,,,,,
ASD04110000_1,acrB,Escherichia coli,P31224,6ZOF,,FUA,B,Lig,Regulator,FUSIDIC ACID,1104,,,,,,
ASD04220000_1,SERPINC1,Homo sapiens,P01008,1AZX,ASD04220038,NTP,I,Lig,Activator,"(2S,3S,4S,5R,6R)-6-[(2R,3R,4S,5R,6R)-6-[(2R,3S,4S,5R,6R)-2-carboxy-4-methoxy-6-[(2R,3R,4S,5R,6S)-6-methoxy-4,5-disulfooxy-2-(sulfooxymethyl)oxan-3-yl]oxy-5-sulfooxy-oxan-3-yl]oxy-4,5-disulfooxy-2-(sulfooxymethyl)oxan-3-yl]oxy-3-[(2R,3R,4S,5R,6R)-4,5-dimethoxy-3-sulfooxy-6-(sulfooxymethyl)oxan-2-yl]oxy-4,5-dimethoxy-oxane-2-carboxylic acid",502,Protein-Protein Interaction Regulator,Inner Protein,9405673,The anticoagulant activation of antithrombin by heparin.,No,1AZX
ASD04220000_1,SERPINC1,Homo sapiens,P01008,1.00E+03,ASD04220038,NTP,I,Lig,Activator,"(2S,3S,4S,5R,6R)-6-[(2R,3R,4S,5R,6R)-6-[(2R,3S,4S,5R,6R)-2-carboxy-4-methoxy-6-[(2R,3R,4S,5R,6S)-6-methoxy-4,5-disulfooxy-2-(sulfooxymethyl)oxan-3-yl]oxy-5-sulfooxy-oxan-3-yl]oxy-4,5-disulfooxy-2-(sulfooxymethyl)oxan-3-yl]oxy-3-[(2R,3R,4S,5R,6R)-4,5-dimethoxy-3-sulfooxy-6-(sulfooxymethyl)oxan-2-yl]oxy-4,5-dimethoxy-oxane-2-carboxylic acid",901,Protein-Protein Interaction Regulator,Inner Protein,12581643,Structure of Beta-Antithrombin and the Effect of Glycosylation on Antithrombin'S Heparin Affinity and Activity.,No,1.00E+03
ASD04220000_1,SERPINC1,Homo sapiens,P01008,1NQ9,ASD04220038,NTP,I,Lig,Activator,"(2S,3S,4S,5R,6R)-6-[(2R,3R,4S,5R,6R)-6-[(2R,3S,4S,5R,6R)-2-carboxy-4-methoxy-6-[(2R,3R,4S,5R,6S)-6-methoxy-4,5-disulfooxy-2-(sulfooxymethyl)oxan-3-yl]oxy-5-sulfooxy-oxan-3-yl]oxy-4,5-disulfooxy-2-(sulfooxymethyl)oxan-3-yl]oxy-3-[(2R,3R,4S,5R,6R)-4,5-dimethoxy-3-sulfooxy-6-(sulfooxymethyl)oxan-2-yl]oxy-4,5-dimethoxy-oxane-2-carboxylic acid",901,Protein-Protein Interaction Regulator,Inner Protein,12873131,Crystal Structure of Antithrombin in a Heparin-Bound Intermediate State,No,1NQ9
ASD04220000_1,SERPINC1,Homo sapiens,P01008,1SR5,ASD04220054,NT1,A,Lig,Activator,"[(2R,3R,4S,5R,6R)-6-[(2S,3S,4S,5R,6R)-2-(dihydroxymethyl)-6-[(2R,3R,4S,5R,6R)-6-[(2R,3S,4S,5R,6R)-2-(dihydroxymethyl)-4,5-dimethoxy-6-[(2R,3R,4S,5S)-4-methoxy-5-sulfooxy-2-(sulfooxymethyl)oxan-3-yl]oxy-oxan-3-yl]oxy-4,5-disulfooxy-2-(sulfooxymethyl)oxan-3-yl]oxy-4,5-dimethoxy-oxan-3-yl]oxy-3-[(2S,3R,4S,5R,6R)-5-[(3R,4S,6S)-3,4-dimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-3,4-dimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-4,5-dimethoxy-oxan-2-yl]methyl hydrogen sulfate",601,Protein-Protein Interaction Regulator,Inner Protein,15311268,The ternary complex of antithrombin-anhydrothrombin-heparin reveals the basis of inhibitor specificity.,No,1SR5
ASD04220000_1,SERPINC1,Homo sapiens,P01008,1TB6,ASD04220055;ASD04220056;ASD04220057;ASD04220058;ASD04220059;ASD04220060,GU8;GU5;GU1;GU6;GU2;GU3,I;I;I;I;I;I,Lig,Activator,"(2R,3R,4S,5R,6R)-3,4-dimethoxy-6-(methoxymethyl)oxane-2,5-diol;[(2R,3R,4S,5R,6S)-3,6-dihydroxy-4,5-dimethoxy-oxan-2-yl]methyl sulfate;(2S,3S,4S,5R,6R)-3,6-dihydroxy-4,5-dimethoxy-oxane-2-carboxylic acid;[(2S)-2,5-dihydroxy-4-sulfonatooxy-6-(sulfonatooxymethyl)oxan-3-yl] sulfate;(2R,3S,4S,5R,6R)-3,6-dihydroxy-4,5-dimethoxy-oxane-2-carboxylic acid;[(2R,3R,4S,5R,6S)-3-hydroxy-4,6-dimethoxy-5-sulfooxy-oxan-2-yl]methyl hydrogen sulfate",443;444;445;446;447;448,Protein-Protein Interaction Regulator,Inner Protein,15311269,Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin.,No,1TB6
ASD04220000_1,SERPINC1,Homo sapiens,P01008,3EVJ,ASD04220039,NTO,I,Lig,Activator,"(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5R,6R)-6-[(2R,3S,4S,5R,6R)-2-carboxy-4-hydroxy-6-[(2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfoamino)-2-(sulfooxymethyl)oxan-3-yl]oxy-5-sulfooxy-oxan-3-yl]oxy-5-(sulfoamino)-4-sulfooxy-2-(sulfooxymethyl)oxan-3-yl]oxy-3-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfoamino)-6-(sulfooxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-oxane-2-carboxylic acid",863,Protein-Protein Interaction Regulator,Inner Protein,,Intermediate structure of antithrombin bound to the natural pentasaccharide,No,3EVJ
ASD04220000_1,SERPINC1,Homo sapiens,P01008,3KCG,ASD04220038,NTP,I,Lig,Activator,"(2S,3S,4S,5R,6R)-6-[(2R,3R,4S,5R,6R)-6-[(2R,3S,4S,5R,6R)-2-carboxy-4-methoxy-6-[(2R,3R,4S,5R,6S)-6-methoxy-4,5-disulfooxy-2-(sulfooxymethyl)oxan-3-yl]oxy-5-sulfooxy-oxan-3-yl]oxy-4,5-disulfooxy-2-(sulfooxymethyl)oxan-3-yl]oxy-3-[(2R,3R,4S,5R,6R)-4,5-dimethoxy-3-sulfooxy-6-(sulfooxymethyl)oxan-2-yl]oxy-4,5-dimethoxy-oxane-2-carboxylic acid",433,Protein-Protein Interaction Regulator,Inner Protein,20080729,Molecular basis of factor IXa recognition by heparin-activated antithrombin revealed by a 1.7-A structure of the ternary complex.,No,3KCG
ASD04250000_1,argR,Escherichia coli,P0A6D0,1XXA,ASD02000001,ARG,A,Lig,Activator,[amino-[[(4S)-4-amino-5-hydroxy-5-oxo-pentyl]amino]methylidene]azanium,1,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,8594204,Structure of the oligomerization and L-arginine binding domain of the arginine repressor of Escherichia coli.,No,"Chain A:GLN106,ALA109,ARG110,ASP113,THR124,ILE125,ALA126; Chain C:GLY127,ASP128,ASP129,THR130; Chain D:GLY103,ASP128"
ASD04250000_1,argR,Escherichia coli,P0A6D0,1XXB,ASD02000001,ARG,A,Lig,Activator,[amino-[[(4S)-4-amino-5-hydroxy-5-oxo-pentyl]amino]methylidene]azanium,1,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,8594204,Structure of the oligomerization and L-arginine binding domain of the arginine repressor of Escherichia coli.,No,"Chain A:GLN106,ALA109,ARG110,ASP113,THR124,ILE125,ALA126; Chain C:GLY127,ASP128,ASP129,THR130; Chain D:PRO102,GLY103,ASP128"
ASD04250000_3,argR,Mycobacterium tuberculosis,P9WPY9,2ZFZ,ASD02000001,ARG,A,Lig,Activator,[amino-[[(4S)-4-amino-5-hydroxy-5-oxo-pentyl]amino]methylidene]azanium,300,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,18703843,Structure of the C-terminal domain of the arginine repressor protein from Mycobacterium tuberculosis.,No,"Chain A:HIS125,ALA128,SER129,ASP132,THR142,ILE143,ALA144; Chain C:GLY145,ASP146,ASP147,THR148; Chain F:PRO121,GLY122,ASP146"
ASD04250000_3,argR,Mycobacterium tuberculosis,P9WPY9,3CAG,ASD02000001,ARG,A,Lig,Activator,[amino-[[(4S)-4-amino-5-hydroxy-5-oxo-pentyl]amino]methylidene]azanium,300,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,18703843,Structure of the C-terminal domain of the arginine repressor protein from Mycobacterium tuberculosis.,No,"Chain A:HIS125,ALA128,SER129,ASP132,THR142,ILE143,ALA144; Chain C:GLY145,ASP146,ASP147,THR148; Chain F:PRO121,GLY122,ASP146"
ASD04250000_3,argR,Mycobacterium tuberculosis,P9WPY8,3FHZ,ASD02000001,ARG,A,Lig,Activator,[amino-[[(4S)-4-amino-5-hydroxy-5-oxo-pentyl]amino]methylidene]azanium,200,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,19265706,"The structure of the arginine repressor from Mycobacterium tuberculosis bound with its DNA operator and Co-repressor, L-arginine.",No,"Chain A:HIS125,SER129,ASP132,THR142,ILE143,ALA144; Chain C:GLY145,ASP146,ASP147,THR148; Chain F:PRO121,GLY122,ASP146"
ASD04250000_3,argR,Mycobacterium tuberculosis,P9WPY8,3LAJ,ASD02000001,ARG,A,Lig,Activator,[amino-[[(4S)-4-amino-5-hydroxy-5-oxo-pentyl]amino]methylidene]azanium,200,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,20382162,crystal structure of the intermediate complex of the arginine repressor from Mycobacterium tuberculosis bound with its DNA operator reveals detailed mechanism of arginine repression.,No,"Chain A:HIS125,ALA128,SER129,ASP132,THR142,ILE143,ALA144; Chain C:GLY145,ASP146,ASP147,THR148; Chain F:ASP146"
ASD04250000_3,argR,Mycobacterium tuberculosis,P9WPY8,3LAP,ASD04250001,GGB,A,Lig,Activator,(2S)-2-amino-4-carbamimidamidooxy-butanoic acid,200,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,20382162,crystal structure of the intermediate complex of the arginine repressor from Mycobacterium tuberculosis bound with its DNA operator reveals detailed mechanism of arginine repression.,No,"Chain A:HIS125,ALA128,SER129,ASP132,THR142,ILE143,ALA144; Chain C:GLY145,ASP146,ASP147,THR148; Chain F:PRO121,GLY122,ASP146"
ASD04250000_4,argR,Bacillus subtilis,P17893,2P5M,ASD02000001,ARG,B,Lig,Activator,[amino-[[(4S)-4-amino-5-hydroxy-5-oxo-pentyl]amino]methylidene]azanium,201,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,18007040,Structure of the C-terminal effector-binding domain of AhrC bound to its corepressor L-arginine.,No,"Chain A:GLY124,ASP125,ASP126,THR127; Chain B:GLN104,GLY107,ALA108,ASP111,THR121,ILE122,CYS123"
ASD04250000_5,argR,Geobacillus stearothermophilus,O31408,1B4B,ASD02000001,ARG,A,Lig,Activator,[amino-[[(4S)-4-amino-5-hydroxy-5-oxo-pentyl]amino]methylidene]azanium,1,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,10331868,Structure of the arginine repressor from Bacillus stearothermophilus.,No,"Chain A:HIS104,GLY107,VAL108,ASP111,THR121,ILE122,CYS123; Chain C:GLY124,ASP125,ASP126,THR127"
ASD04260000_3,clpP,Staphylococcus aureus,Q2G036,5DL1,ASD04260001,5C2,A,Lig,Inhibitor,"1-(propan-2-yl)-N-{[2-(thiophen-2-yl)-1,3- oxazol-4-yl]methyl}-1H-pyrazolo[3,4-b]pyridine- 5-carboxamide",201,Allosteric Function,Allosteric Position,26566002,Reversible Inhibitors Arrest ClpP in a Defined Conformational State that Can Be Revoked by ClpX Association.,No,Chain N:ILE136
ASD04270000_2,Ptgs2,Mus musculus,Q05769,3QH0,ASD09270001,PLM,A,Lig,Activator,hexadecanoic acid,625,Inner Protein Regulator,Inner Protein,21467029,Human cyclooxygenase-2 is a sequence homodimer that functions as a conformational heterodimer.,No,"Chain A:VAL116,ARG120,PHE205,TYR348,VAL349,SER353,TYR355,TYR385,TRP387,VAL523,GLY526,ALA527,SER530,LEU531"
ASD04270000_2,Ptgs2,Mus musculus,Q05769,4OTJ,ASD04270003,IXP,"A,B,C,D",Lig,Inhibitor,"(5S,5aS,8aS,9S)-8-oxo-9-(3,4,5-trimethoxyphenyl)- 5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3- d][1,3]dioxol-5-yl 4-{[4-({[1-(4-chlorobenzoyl)- 5-methoxy-2-methyl-1H-indol-3-yl]acetyl}amino)butyl]amino}- 4-oxobutanoate",706,Inner Protein Regulator,Allosteric Position,27588346,Antitumor Activity of Cytotoxic Cyclooxygenase-2 Inhibitors.,No,"Chain D:LYS180,LEU183,MET487,ILE442,ARG438,GLU486,GLU490,GLU179,ARG185,ARG184,VAL181"
ASD04270000_2,Ptgs2,Mus musculus,Q05769,4RUT,ASD05450001,LM8,A,Lig,Activator,"(5Z,8Z,11Z,13S,14Z)-13-methylicosa-5,8,11,14- tetraenoic acid",706,Inner Protein Regulator,Inner Protein,25648895,13-methylarachidonic Acid is a positive allosteric modulator of endocannabinoid oxygenation by cyclooxygenase.,No,"Chain A:LEU534,TYR355,ILE345,LEU359,LEU117,PHE209,SER353,VAL116,TYR348,LEU525,TRP387,ARG120,MET113,VAL349,PHE529,PHE205,MET522,VAL344,LEU352,GLY526,ALA527,LYS360,THR206,PHE518,SER530,LEU531,GLU524,PRO528,TYR385,LEU384,PHE381,VAL523,MET535"
ASD04390000_1,CASP6,Homo sapiens,P55212,4EJF,ASD04390003;ASD04390003;ASD04390003;ASD04390003;ASD04390003;ASD04390003;ASD04390003;ASD04390003;ASD04390003;ASD04390003;ASD04390003;ASD04390003,ARG;LEU;HIS;CYS;VAL;GLU;TRP;THR;ILE;LEU;GLU;ARG,E;E;E;E;E;E;E;E;E;E;E;E,Pep,Inhibitor,"[amino-[[(4S)-4-amino-5-hydroxy-5-oxo-pentyl]amino]methylidene]azanium;(2S)-2-amino-4-methyl-pentanoic acid;(2S)-2-amino-3-(1H-imidazol-3-ium-4-yl)propanoic acid;(2R)-2-amino-3-sulfanyl-propanoic acid;(2S)-2-amino-3-methyl-butanoic acid;(2S)-2-azanylpentanedioic acid;(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid;(2S,3R)-2-amino-3-hydroxy-butanoic acid;(2S,3S)-2-amino-3-methyl-pentanoic acid;(2S)-2-amino-4-methyl-pentanoic acid;(2S)-2-azanylpentanedioic acid;[amino-[[(4S)-4-amino-5-hydroxy-5-oxo-pentyl]amino]methylidene]azanium",39;40;41;42;43;44;45;46;47;48;49;50,Inner Protein Regulator,Protein-Protein Interaction,22683611,Allosteric peptides bind a caspase zymogen and mediate caspase tetramerization.,No,4EJF
ASD04390000_1,CASP6,Homo sapiens,P55212,4FXO,ASD01310003,ZN,A,Ion,Inhibitor,zinc(+2) cation,301,Inner Protein Regulator,Protein-Protein Interaction,22891250,Zinc-mediated Allosteric Inhibition of Caspase-6.,No,4FXO
ASD04390000_1,CASP6,Homo sapiens,P55212,4N5D,ASD04390001,2FQ,A,Lig,Inhibitor,"6-azanyl-2,8-dimethyl-pyrido[2,3-d]pyrimidin-7-one",401,Inner Protein Regulator,Protein-Protein Interaction,24259468,Tailoring small molecules for an allosteric site on procaspase-6.,No,4N5D
ASD04390000_1,CASP6,Homo sapiens,P55212,4N6G,ASD04390002,2GQ,B,Lig,Inhibitor,3-pyrrolidin-1-yl-2H-isoquinolin-1-one,401,Inner Protein Regulator,Protein-Protein Interaction,24259468,Tailoring small molecules for an allosteric site on procaspase-6.,No,4N6G
ASD04390000_1,CASP6,Homo sapiens,P55212,4N7J,ASD04390002,2GQ,B,Lig,Inhibitor,3-pyrrolidin-1-yl-2H-isoquinolin-1-one,401,Inner Protein Regulator,Protein-Protein Interaction,24259468,Tailoring small molecules for an allosteric site on procaspase-6.,No,4N7J
ASD04390000_1,CASP6,Homo sapiens,P55212,4N7M,ASD04390002,2GQ,A,Lig,Inhibitor,3-pyrrolidin-1-yl-2H-isoquinolin-1-one,401,Inner Protein Regulator,Protein-Protein Interaction,24259468,Tailoring small molecules for an allosteric site on procaspase-6.,No,4N7M
ASD04390000_1,CASP6,Homo sapiens,P55212,4NBK,ASD04390010,2J5,A,Lig,Inhibitor,2-[[(3-methylpyridin-2-yl)amino]methyl]phenol,401,Inner Protein Regulator,Protein-Protein Interaction,24259468,Tailoring small molecules for an allosteric site on procaspase-6.,No,4NBK
ASD04390000_1,CASP6,Homo sapiens,P55212,4NBL,ASD04390011,2J6,A,Lig,Inhibitor,5-fluoranyl-2-[[(3-pyrimidin-2-ylpyridin-2-yl)amino]methyl]phenol,401,Inner Protein Regulator,Protein-Protein Interaction,24259468,Tailoring small molecules for an allosteric site on procaspase-6.,No,4NBL
ASD04390000_1,CASP6,Homo sapiens,P55212,4NBN,ASD00530008,2J7,B,Lig,Inhibitor,2-[[[6-[(2-hydroxyphenyl)methylamino]pyrimidin-4-yl]amino]methyl]phenol,401,Inner Protein Regulator,Protein-Protein Interaction,24259468,Tailoring small molecules for an allosteric site on procaspase-6.,No,4NBN
ASD04400000_1,CASP8,Homo sapiens,Q14790,3KJN,ASD04400004,DTT,A,Lig,Inhibitor,"(3S)-3-({[(5S,8R)-2-(3-carboxypropyl)-8-(2- {[(4-chlorophenyl)acetyl]amino}ethyl)-1,3- dioxo-2,3,5,8-tetrahydro-1H-[1,2,4]triazolo[1,2- a]pyridazin-5-yl]carbonyl}amino)-4-oxopentanoic acid",900,Inner Protein Regulator,Protein-Protein Interaction,20580860,Kinetic and structural characterization of caspase-3 and caspase-8 inhibition by a novel class of irreversible inhibitors.,No,3KJN
ASD04400000_1,CASP8,Homo sapiens,Q14790,3KJN,ASD04400002,B93,A,Lig,Inhibitor,"(3S)-3-({[(5S,8R)-2-(3-carboxypropyl)-8-(2- {[(4-chlorophenyl)acetyl]amino}ethyl)-1,3- dioxo-2,3,5,8-tetrahydro-1H-[1,2,4]triazolo[1,2- a]pyridazin-5-yl]carbonyl}amino)-4-oxopentanoic acid",950,Inner Protein Regulator,Protein-Protein Interaction,20580860,Kinetic and structural characterization of caspase-3 and caspase-8 inhibition by a novel class of irreversible inhibitors.,No,3KJN
ASD04400000_1,CASP8,Homo sapiens,Q14790,3KJQ,ASD04400005,B94,A,Lig,Inhibitor,"2,3-DIHYDROXY-1,4-DITHIOBUTANE",480,Inner Protein Regulator,Protein-Protein Interaction,20580860,Kinetic and structural characterization of caspase-3 and caspase-8 inhibition by a novel class of irreversible inhibitors.,No,3KJQ
ASD04400000_1,CASP8,Homo sapiens,Q14790,3KJQ,ASD04400005,B94,A,Lig,Inhibitor,"(3S)-3-({[(5S)-2-{2-[(1H-benzimidazol-5-ylcarbonyl)amino]ethyl}- 7-(cyclohexylmethyl)-1,3-dioxo-2,3,5,8-tetrahydro- 1H-[1,2,4]triazolo[1,2-a]pyridazin-5-yl]carbonyl}amino)- 4-oxopentanoic acid",481,Inner Protein Regulator,Protein-Protein Interaction,20580860,Kinetic and structural characterization of caspase-3 and caspase-8 inhibition by a novel class of irreversible inhibitors.,No,3KJQ
ASD04420000_1,CDC4,Saccharomyces cerevisiae,P07834,3MKS,ASD04420001,C1C,D,Lig,Inhibitor,1-(2-carboxynaphthalen-1-yl)naphthalene-2-carboxylic acid,1,Inner Protein Regulator,Inner Protein,20581844,An allosteric inhibitor of substrate recognition by the SCF(Cdc4) ubiquitin ligase.,No,"Chain D:LEU628,GLN629,GLY630,THR632,LEU634,ALA649,ARG655,GLY656,TRP657,ARG664,PHE666,SER667"
ASD04430000_2,Pde2a,Mus musculus,Q922S4,1MC0,ASD02408002,PCG,A,Lig,Activator,CYCLIC GUANOSINE MONOPHOSPHATE,160,Inner Protein Regulator,Inner Protein,12271124,The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding.,No,"Chain A:CYS423,GLY440,PHE426,PHE490,ILE458,PHE438,THR492,GLY460,VAL484,ASP439,GLY483,ARG482,GLU512,SER424,LEU479,ILE422,PHE480,GLY457,VAL514,ASP485,THR488,GLN456,TYR481,VAL437,ALA459,ILE452,ILE495"
ASD04460000_1,leuA,Leptospira interrogans,Q8F3Q1,3F6G,ASD02780002,ILE,B,Lig,Inhibitor,"(2S,3S)-2-amino-3-methyl-pentanoic acid",1,Inner Protein Regulator,Protein-Protein Interaction,19351325,Molecular basis of the inhibitor selectivity and insights into the feedback inhibition mechanism of citramalate synthase from Leptospira interrogans,No,"Chain A:GLY428,GLY429,TYR430,ASP431,TYR454; Chain B:ILE458,LYS463,THR464,ASP465,ALA466,VAL468,PRO493,ASP494,GLN495"
ASD04460000_1,leuA,Leptospira interrogans,Q8F3Q1,3F6H,ASD02780002,ILE,A,Lig,Inhibitor,"(2S,3S)-2-amino-3-methyl-pentanoic acid",1,Inner Protein Regulator,Protein-Protein Interaction,19351325,Molecular basis of the inhibitor selectivity and insights into the feedback inhibition mechanism of citramalate synthase from Leptospira interrogans,No,"Chain A:GLY428,GLY429,TYR430,ASP431,TYR454"
ASD04480000_1,F7,Homo sapiens,P08709,1DVA,ASD04480002,Ac-ALCDDPRVDRWYCQFVEG-NH2,Y,Pep,Inhibitor,,Chain_Y,Inner Protein Regulator,Protein-Protein Interaction,10761907,Peptide exosite inhibitors of factor VIIa as anticoagulants.,No,1DVA
ASD04480000_1,F7,Homo sapiens,P08709,1YGC,ASD04480003,905,H,Lig,Inhibitor,"(2R)-N-(3-aminophenyl)sulfonyl-2-[(4-carbamimidoyl-3-hydroxy-phenyl)amino]-2-(3,5-diethoxy-2-fluoro-phenyl)ethanamide",1,Inner Protein Regulator,Inner Protein,15632123,"A selective, slow binding inhibitor of factor VIIa binds to a nonstandard active site conformation and attenuates thrombus formation in vivo.",Yes,1YGC
ASD04480000_1,F7,Homo sapiens,P08709,4Z6A,,T,T,Pep,Activator,soluble Tissue factor,1-207,Allosteric Function,Allosteric Position,26694616,Molecular Basis of Enhanced Activity in Factor VIIa-Trypsin Variants Conveys Insights into Tissue Factor-mediated Allosteric Regulation of Factor VIIa Activity.,No,4Z6A
ASD04590000_1,CDK2,Homo sapiens,P24941,3PXF,ASD02210006;ASD02210006,2AN;2AN,A;A,Lig,Inhibitor,8-phenylazanylnaphthalene-1-sulfonic acid,304;305,Inner Protein Regulator,Inner Protein,21291269,Discovery of a potential allosteric ligand binding site in CDK2.,No,3PXF
ASD04590000_1,CDK2,Homo sapiens,P24941,3PXQ,ASD02210006;ASD02210006,2AN;2AN,A;A,Lig,Inhibitor,8-phenylazanylnaphthalene-1-sulfonic acid,301;302,Inner Protein Regulator,Inner Protein,21291269,Discovery of a potential allosteric ligand binding site in CDK2.,No,3PXQ
ASD04590000_1,CDK2,Homo sapiens,P24941,3PXZ,ASD02210006;ASD02210006,2AN;2AN,A;A,Lig,Inhibitor,8-phenylazanylnaphthalene-1-sulfonic acid,299;300,Inner Protein Regulator,Inner Protein,21291269,Discovery of a potential allosteric ligand binding site in CDK2.,No,3PXZ
ASD04590000_1,CDK2,Homo sapiens,P24941,3PY1,ASD02210006;ASD02210006,2AN;2AN,A;A,Lig,Inhibitor,8-phenylazanylnaphthalene-1-sulfonic acid,301;302,Inner Protein Regulator,Inner Protein,21291269,Discovery of a potential allosteric ligand binding site in CDK2.,No,3PY1
ASD04590000_1,CDK2,Homo sapiens,P24941,4EZ7,ASD02210006;ASD02210006,2AN;2AN,A;A,Lig,Inhibitor,8-phenylazanylnaphthalene-1-sulfonic acid,302;303,Inner Protein Regulator,Inner Protein,22893598,A Novel Approach to the Discovery of Small-Molecule Ligands of CDK2.,No,4EZ7
ASD04590000_1,CDK2,Homo sapiens,P24941,6Q3F,,HEW,A,Lig,Inhibitor,4-bromanylpyridin-2-amine,301,,,,,,6Q3F
ASD04590000_1,CDK2,Homo sapiens,P24941,6Q49,,DMS,A,Lig,Inhibitor,DIMETHYL SULFOXIDE,402,,,,,,6Q49
ASD04590000_1,CDK2,Homo sapiens,P24941,6Q4D,,HHT,A,Lig,Inhibitor,2-(4-bromanyl-2-methoxy-phenyl)ethanoic acid,302；303,,,,,,6Q4D
ASD04590000_1,CDK2,Homo sapiens,P24941,6Q4D,,HHT,A,Lig,Inhibitor,2-(4-bromanyl-2-methoxy-phenyl)ethanoic acid,304,,,,,,6Q4D
ASD04590000_1,CDK2,Homo sapiens,P24941,6Q4D,,HHT,A,Lig,Inhibitor,2-(4-bromanyl-2-methoxy-phenyl)ethanoic acid,305,,,,,,6Q4D
ASD04630000_1,rzcA,Staphylococcus aureus,O85142,1R1V,ASD01310003,ZN,A,Ion,Regulator,zinc(+2) cation,501,Protein-DNA/RNA Interaction Regulator,Inner Protein,14568530,A metal-ligand-mediated intersubunit allosteric switch in related SmtB/ArsR zinc sensor proteins.,No,"Chain A:ASP84,HIS86"
ASD04630000_1,rzcA,Staphylococcus aureus,O85142,2M30,ASD01310003,ZN,A,Ion,Regulator,zinc(+2) cation,201,Protein-DNA/RNA Interaction Regulator,Inner Protein,23609042,Solution NMR refinement of a metal ion bound protein using metal ion inclusive restrained molecular dynamics methods.,No,"Chain A:ASP84,HIS86,VAL87,HIS96,HIS97,HIS100; Chain B:ASP84,HIS86,VAL87,HIS96,HIS97,HIS100"
ASD04660000_1,hemB,Pseudomonas aeruginosa,Q59643,1B4K,ASD00330030,MG,A,Ion,Activator,magnesium(+2) cation,402,Inner Protein Regulator,Inner Protein,10356331,High resolution crystal structure of a Mg2+-dependent porphobilinogen synthase.,No,"Chain A:ARG181,GLU245,ASP249"
ASD04660000_1,hemB,Pseudomonas aeruginosa,Q59643,1GZG,ASD00330030,MG,A,Ion,Activator,magnesium(+2) cation,1338,Inner Protein Regulator,Inner Protein,12079382,Structure of Porphobilinogen Synthase from Pseudomonas Aeruginosa in Complex with 5-Fluorolevulinic Acid Suggests a Double Schiff Base Mechanism,No,"Chain A:ARG181,GLU245,ASP249"
ASD04660000_1,hemB,Pseudomonas aeruginosa,Q59643,1W54,ASD00330030,MG,A,Ion,Activator,magnesium(+2) cation,1339,Inner Protein Regulator,Inner Protein,15644204,Tracking the Evolution of Porphobilinogen Synthase Metal Dependence in Vitro,No,"Chain A:ARG181,GLU245,ASP249"
ASD04660000_1,hemB,Pseudomonas aeruginosa,Q59643,1W56,ASD00330030,MG,A,Ion,Activator,magnesium(+2) cation,1338,Inner Protein Regulator,Inner Protein,15644204,Tracking the Evolution of Porphobilinogen Synthase Metal Dependence in Vitro,No,"Chain A:ARG181,GLU245,ASP249"
ASD04660000_1,hemB,Pseudomonas aeruginosa,Q59643,1W5M,ASD00330030,MG,A,Ion,Activator,magnesium(+2) cation,1343,Inner Protein Regulator,Inner Protein,15644204,Tracking the Evolution of Porphobilinogen Synthase Metal Dependence in Vitro,No,"Chain A:LYS273,LYS314,GLY317,ALA318,ASP319"
ASD04660000_1,hemB,Pseudomonas aeruginosa,Q59643,1W5N,ASD00330030,MG,A,Ion,Activator,magnesium(+2) cation,1339,Inner Protein Regulator,Inner Protein,15644204,Tracking the Evolution of Porphobilinogen Synthase Metal Dependence in Vitro,No,"Chain A:ARG181,GLU245,ASP249"
ASD04660000_1,hemB,Pseudomonas aeruginosa,Q59643,1W5O,ASD00330030,MG,A,Ion,Activator,magnesium(+2) cation,1338,Inner Protein Regulator,Inner Protein,15644204,Tracking the Evolution of Porphobilinogen Synthase Metal Dependence in Vitro,No,"Chain A:ARG181,GLU245,ASP249"
ASD04660000_1,hemB,Pseudomonas aeruginosa,Q59643,1W5P,ASD00330030,MG,A,Ion,Activator,magnesium(+2) cation,1342,Inner Protein Regulator,Inner Protein,15644204,Tracking the Evolution of Porphobilinogen Synthase Metal Dependence in Vitro,No,"Chain A:ARG181,GLU245,ASP249"
ASD04660000_1,hemB,Pseudomonas aeruginosa,Q59643,1W5Q,ASD00330030,MG,A,Ion,Activator,magnesium(+2) cation,1338,Inner Protein Regulator,Inner Protein,15644204,Tracking the Evolution of Porphobilinogen Synthase Metal Dependence in Vitro,No,"Chain A:ARG181,GLU245,ASP249"
ASD04660000_1,hemB,Pseudomonas aeruginosa,Q59643,2C13,ASD00330030,MG,A,Ion,Activator,magnesium(+2) cation,1336,Inner Protein Regulator,Inner Protein,16819823,Probing the Active Site of Pseudomonas Aeruginosa Porphobilinogen Synthase Using Newly Developed Inhibitors.,No,"Chain A:ARG181,GLU245,ASP249"
ASD04660000_1,hemB,Pseudomonas aeruginosa,Q59643,2C14,ASD00330030,MG,A,Ion,Activator,magnesium(+2) cation,1336,Inner Protein Regulator,Inner Protein,16819823,Probing the Active Site of Pseudomonas Aeruginosa Porphobilinogen Synthase Using Newly Developed Inhibitors.,No,"Chain A:ARG181,GLU245,ASP249"
ASD04660000_1,hemB,Pseudomonas aeruginosa,Q59643,2C15,ASD00330030,MG,A,Ion,Activator,magnesium(+2) cation,345,Inner Protein Regulator,Inner Protein,16819823,Probing the Active Site of Pseudomonas Aeruginosa Porphobilinogen Synthase Using Newly Developed Inhibitors.,No,"Chain A:ARG181,GLU245,ASP249"
ASD04660000_1,hemB,Pseudomonas aeruginosa,Q59643,2C16,ASD00330030,MG,A,Ion,Activator,magnesium(+2) cation,1336,Inner Protein Regulator,Inner Protein,16819823,Probing the Active Site of Pseudomonas Aeruginosa Porphobilinogen Synthase Using Newly Developed Inhibitors.,No,"Chain A:ARG181,GLU245,ASP249"
ASD04660000_1,hemB,Pseudomonas aeruginosa,Q59643,2C18,ASD00330030,MG,A,Ion,Activator,magnesium(+2) cation,347,Inner Protein Regulator,Inner Protein,16819823,Probing the Active Site of Pseudomonas Aeruginosa Porphobilinogen Synthase Using Newly Developed Inhibitors.,No,"Chain B:ASN31,LYS273,LYS314,GLY317,ALA318,ASP319"
ASD04660000_1,hemB,Pseudomonas aeruginosa,Q59643,2C19,ASD00330030,MG,A,Ion,Activator,magnesium(+2) cation,1336,Inner Protein Regulator,Inner Protein,16819823,Probing the Active Site of Pseudomonas Aeruginosa Porphobilinogen Synthase Using Newly Developed Inhibitors.,No,"Chain A:ARG181,GLU245,ASP249"
ASD04660000_1,hemB,Pseudomonas aeruginosa,Q59643,2WOQ,ASD00330030,MG,A,Ion,Activator,magnesium(+2) cation,1335,Inner Protein Regulator,Inner Protein,19822707,Structure of the Heme Biosynthetic Pseudomonas Aeruginosa Porphobilinogen Synthase in Complex with the Antibiotic Alaremycin.,No,"Chain A:ARG181,GLU245,ASP249"
ASD04660000_2,PBGS,Toxoplasma gondii,S8F7E9,3OBK,ASD00330030,MG,A,Ion,Activator,magnesium(+2) cation,365,Inner Protein Regulator,Inner Protein,21383008,Crystal Structure of Toxoplasma gondii Porphobilinogen Synthase: INSIGHTS ON OCTAMERIC STRUCTURE AND PORPHOBILINOGEN FORMATION.,No,"Chain A:ARG189,GLU252,ASP256"
ASD04670000_2,folA,Escherichia coli,P0ABQ4,5CC9,ASD04670003,NAP,A,Lig,Regulator,NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE,201,Allosteric Function,Allosteric Position,26147643,Cofactor-Mediated Conformational Dynamics Promote Product Release From Escherichia coli Dihydrofolate Reductase via an Allosteric Pathway.,No,"Chain A:ILE14,GLY95,VAL99,TRP74,LEU62,MET42,VAL75,GLY15,SER49,THR46,LYS76,THR123,GLY97,HIS45,SER77,MET16,GLY96,ILE61,ALA19,ASN18,PHE103,GLN102,ASP122,SER64,SER63,ARG44,TYR100,TRP47,GLY121,GLN65,GLY43,VAL78,ARG98"
ASD04670000_2,folA,Escherichia coli,P0ABQ4,5w3Q,ASD13040013,NDP,A,Lig,Regulator,NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE,201,Inner Protein Regulator,Inner Protein,28737940,Defining the Structural Basis for Allosteric Product Release from E. coli Dihydrofolate Reductase Using NMR Relaxation Dispersion.,No,"Chain A:GLU17,SER49,ILE5,ILE14,GLY95,VAL99,TRP74,LEU62,ASP27,MET42,MET20,VAL75,GLY15,ALA6,THR46,LYS76,THR123,TYR100,GLY97,HIS45,SER77,MET16,GLY96,ILE61,ALA7,ASN18,ALA19,PHE103,GLN102,ASP122,PRO21,SER64,SER63,TRP22,ARG44,VAL13,ARG98,TRP47,GLN65,ILE94,GLY43,VAL78,LEU8"
ASD04740000_1,MAP2K4,Homo sapiens,P45985,3ALO,ASD04740001;ASD04740001;ASD04740001;ASD04740001;ASD04740001;ASD04740001;ASD04740001;ASD04740001,ASP;ASP;GLU;MET;TPO;GLY;TYR;ALA,E;E;E;E;E;E;E;E,Pep,Inhibitor,,3;4;5;6;7;8;9;10,Inner Protein Regulator,Inner Protein,20732303,Crystal structures of MKK4 kinase domain reveal that substrate peptide binds to an allosteric site and induces an auto-inhibition state,No,3ALO
ASD04800000_1,CTSK,Homo sapiens,P43235,4LEG,ASD04800001,1XF,A,Lig,Inhibitor,2-{[(carbamoylsulfanyl)acetyl]amino}benzoic acid,301,Inner Protein Regulator,Inner Protein,24518821,A novel allosteric mechanism in the cysteine peptidase cathepsin K discovered by computational methods.,No,4LEG
ASD04800000_1,CTSK,Homo sapiens,P43235,5J94,ASD04800001,1XF,A,Lig,Inhibitor,2-{[(carbamoylsulfanyl)acetyl]amino}benzoic acid,301,Allosteric Function,Allosteric Position,24518821,A novel allosteric mechanism in the cysteine peptidase cathepsin K discovered by computational methods.,No,5J94
ASD04800000_1,CTSK,Homo sapiens,P43235,5JA7,ASD04800005,6HM,A,Lig,Inhibitor,"[([1,1'-biphenyl]-2-yl)methyl]propanedioic acid",301,Allosteric Fuction,Allosteric Position,27859061,An allosteric site enables fine-tuning of cathepsin K by diverse effectors.,No,5JA7
ASD04820000_1,EIF4E,Homo sapiens,P06730,4TPW,ASD04820001,33R,A,Lig,Inhibitor,"(2E)-2-{2-[4-(3,4-dichlorophenyl)-1,3-thiazol- 2-yl]hydrazinylidene}-3-(2-nitrophenyl)propanoic acid",302,Protein-Protein Interaction Regulator,Inner Protein,25049413,Structure of the eukaryotic translation initiation factor eIF4E in complex with 4EGI-1 reveals an allosteric mechanism for dissociating eIF4G.,No,4TPW
ASD04820000_1,EIF4E,Homo sapiens,P06730,4TQB,ASD04820002,34K,A,Lig,Inhibitor,"(2E)-2-{2-[4-(4-bromophenyl)-1,3-thiazol- 2-yl]hydrazinylidene}-3-(2-nitrophenyl)propanoic acid",302,Protein-Protein Interaction Regulator,Inner Protein,25049413,Structure of the eukaryotic translation initiation factor eIF4E in complex with 4EGI-1 reveals an allosteric mechanism for dissociating eIF4G.,No,4TQB
ASD04820000_1,EIF4E,Homo sapiens,P06730,4TQC,ASD04820003,34J,A,Lig,Inhibitor,"(2S)-3-(4-amino-3-nitrophenyl)-2-{2-[4-(3,4- dichlorophenyl)-1,3-thiazol-2-yl]hydrazinyl}propanoic acid",302,Protein-Protein Interaction Regulator,Inner Protein,25049413,Structure of the eukaryotic translation initiation factor eIF4E in complex with 4EGI-1 reveals an allosteric mechanism for dissociating eIF4G.,No,4TQC
ASD04840000_1,FDPS,Homo sapiens,P14324,3N1V,ASD04840002,3N1,F,Lig,Inhibitor,2-(5-chloro-3-methyl-1-benzothiophen-2-yl)ethanoic acid,1,Inner Protein Regulator,Inner Protein,20711197,Allosteric non-bisphosphonate FPPS inhibitors identified by fragment-based discovery.,No,3N1V
ASD04840000_1,FDPS,Homo sapiens,P14324,3N1W,ASD04840001,3N2,F,Lig,Inhibitor,2-(5-chloro-1-benzothiophen-3-yl)ethanoic acid,1,Inner Protein Regulator,Inner Protein,20711197,Allosteric non-bisphosphonate FPPS inhibitors identified by fragment-based discovery.,No,3N1W
ASD04840000_1,FDPS,Homo sapiens,P14324,3N3L,ASD04840003,MS0,F,Lig,Inhibitor,2-(6-methoxy-1-benzofuran-3-yl)ethanoic acid,1,Inner Protein Regulator,Inner Protein,20711197,Allosteric non-bisphosphonate FPPS inhibitors identified by fragment-based discovery.,No,3N3L
ASD04840000_1,FDPS,Homo sapiens,P14324,3N45,ASD04840004,3N3,F,Lig,Inhibitor,"(2S)-1-phenylmethoxycarbonyl-2,3-dihydroindole-2-carboxylic acid",1,Inner Protein Regulator,Inner Protein,20711197,Allosteric non-bisphosphonate FPPS inhibitors identified by fragment-based discovery.,No,3N45
ASD04840000_1,FDPS,Homo sapiens,P14324,3N46,ASD04840008,3N5,F,Lig,Inhibitor,"(2R)-1-phenylmethoxycarbonyl-2,3-dihydroindole-2-carboxylic acid",1,Inner Protein Regulator,Inner Protein,20711197,Allosteric non-bisphosphonate FPPS inhibitors identified by fragment-based discovery.,No,3N46
ASD04840000_1,FDPS,Homo sapiens,P14324,3N49,ASD04840007,3N4,F,Lig,Inhibitor,2-benzo[e][1]benzothiol-1-ylethanoic acid,1,Inner Protein Regulator,Inner Protein,20711197,Allosteric non-bisphosphonate FPPS inhibitors identified by fragment-based discovery.,No,3N49
ASD04840000_1,FDPS,Homo sapiens,P14324,3N5H,ASD04842004,GO0,F,Lig,Inhibitor,"3-(carboxymethyl)-4,7-dichloro-1H-indole-2-carboxylic acid",1,Inner Protein Regulator,Inner Protein,20711197,Allosteric non-bisphosphonate FPPS inhibitors identified by fragment-based discovery.,No,3N5H
ASD04840000_1,FDPS,Homo sapiens,P14324,3N5J,ASD04842005,GO1,F,Lig,Inhibitor,"3-(carboxymethyl)-5,7-dichloro-1H-indole-2-carboxylic acid",1,Inner Protein Regulator,Inner Protein,20711197,Allosteric non-bisphosphonate FPPS inhibitors identified by fragment-based discovery.,No,3N5J
ASD04840000_1,FDPS,Homo sapiens,P14324,3N6K,ASD04842011,BFH,F,Lig,Inhibitor,1-(carboxymethyl)benzo[g]indole-2-carboxylic acid,1,Inner Protein Regulator,Inner Protein,20711197,Allosteric non-bisphosphonate FPPS inhibitors identified by fragment-based discovery.,No,3N6K
ASD04840000_1,FDPS,Homo sapiens,P14324,4LPG,ASD04840042,1MV,F,Lig,Inhibitor,"({[6-(4-methylphenyl)thieno[2,3-d]pyrimidin-4-yl]amino}methanediyl)bis(phosphonic acid)",402,Allosteric Fuction,Allosteric Position,24911527,Multistage screening reveals chameleon ligands of the human farnesyl pyrophosphate synthase: implications to drug discovery for neurodegenerative diseases.,No,4LPG
ASD04840000_1,FDPS,Homo sapiens,P14324,4LPH,ASD04840030,YL3,F,Lig,Inhibitor,"({[6-(4-methylphenyl)thieno[2,3-d]pyrimidin-4-yl]amino}methyl)phosphonic acid",402,Allosteric Fuction,Allosteric Position,24911527,Multistage screening reveals chameleon ligands of the human farnesyl pyrophosphate synthase: implications to drug discovery for neurodegenerative diseases.,No,4LPH
ASD04840000_1,FDPS,Homo sapiens,P14324,4QXS,ASD04840105,WC1,F,Lig,Regulator,"(2-{2-[(2S)-3-methylbutan-2-yl]-5-phenyl- 1H-indol-3-yl}ethane-1,1-diyl)bis(phosphonic acid)",403,Inner Protein Regulator,Allosteric Position,25630225,Probing the molecular and structural elements of ligands binding to the active site versus an allosteric pocket of the human farnesyl pyrophosphate synthase.,No,4QXS
ASD04840000_1,FDPS,Homo sapiens,P14324,4RXA,ASD04840024,3F2,A,Lig,Inhibitor,"N,N'-bis[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]biphenyl- 4,4'-dicarboxamide",1001,Inner Protein Regulator,Allosteric Position,25815158,Farnesyl diphosphate synthase inhibitors with unique ligand-binding geometries.,No,4RXA
ASD04840000_1,FDPS,Homo sapiens,P14324,5DGM,ASD04840085,59Z,F,Lig,Inhibitor,{2-[(phosphonomethyl)carbamoyl]-1H-benzo[g]indol-1-yl}acetic acid,59,Allosteric Function,Allosteric Position,26457482,A General Strategy for Targeting Drugs to Bone.,No,5DGM
ASD04840000_1,FDPS,Homo sapiens,P14324,5DGN,ASD04840078,59Y,F,Lig,Inhibitor,8-(naphthalen-1-yl)quinoline-2-carboxylic acid,401,Allosteric Function,Allosteric Position,26381451,Discovery of Novel Allosteric Non-Bisphosphonate Inhibitors of Farnesyl Pyrophosphate Synthase by Integrated Lead Finding.,No,5DGN
ASD04840000_1,FDPS,Homo sapiens,P14324,5DIQ,ASD04840060,5B9,F,Lig,Inhibitor,2-(naphthalen-1-ylmethoxy)benzoic acid,403,Allosteric Function,Allosteric Position,26381451,Discovery of Novel Allosteric Non-Bisphosphonate Inhibitors of Farnesyl Pyrophosphate Synthase by Integrated Lead Finding.,No,5DIQ
ASD04840000_1,FDPS,Homo sapiens,P14324,5DJP,ASD04840075,5BJ,F,Lig,Inhibitor,4-(naphthalen-1-yl)-1H-indole-2-carboxylic acid,401,Allosteric Function,Allosteric Position,26381451,Discovery of Novel Allosteric Non-Bisphosphonate Inhibitors of Farnesyl Pyrophosphate Synthase by Integrated Lead Finding.,No,5DJP
ASD04840000_1,FDPS,Homo sapiens,P14324,5DJR,ASD04840076,5BK,F,Lig,Inhibitor,"1H,1'H-4,4'-biindole-2-carboxylic acid",403,Allosteric Function,Allosteric Position,26381451,Discovery of Novel Allosteric Non-Bisphosphonate Inhibitors of Farnesyl Pyrophosphate Synthase by Integrated Lead Finding.,No,5DJR
ASD04840000_1,FDPS,Homo sapiens,P14324,5DJV,ASD04840082,5BL,F,Lig,Inhibitor,8-(naphthalen-1-yl)-6-(1H-pyrrol-2-yl)quinoline- 2-carboxylic acid,401,Allosteric Function,Allosteric Position,26381451,Discovery of Novel Allosteric Non-Bisphosphonate Inhibitors of Farnesyl Pyrophosphate Synthase by Integrated Lead Finding.,No,5DJV
ASD04840000_1,FDPS,Homo sapiens,P14324,5JA0,ASD04840104,FPP,F,Lig,Inhibitor,FARNESYL DIPHOSPHATE,402,Allosteric Fuction,Allosteric Position,28098152,Human farnesyl pyrophosphate synthase is allosterically inhibited by its own product.,No,5JA0
ASD04840000_1,FDPS,Homo sapiens,P14324,5JUZ,ASD04840107,YL4,F,Lig,Inhibitor,"[(R)-(2,3-dihydro-1-benzofuran-5-yl){[6-(4-methylphenyl)thieno[2,3-d]pyrimidin-4-yl]amino}methyl]phosphonic acid",403,Allosteric Fuction,Allosteric Position,28208018,Pharmacophore Mapping of Thienopyrimidine-Based Monophosphonate (ThP-MP) Inhibitors of the Human Farnesyl Pyrophosphate Synthase.,No,5JUZ
ASD04840000_1,FDPS,Homo sapiens,P14324,5JV0,ASD04840108,YL5,F,Lig,Inhibitor,"[(1R)-2-(3-fluorophenyl)-1-{[6-(4-methylphenyl)thieno[2,3-d]pyrimidin-4-yl]amino}ethyl]phosphonic acid",403,Allosteric Fuction,Allosteric Position,28208018,Pharmacophore Mapping of Thienopyrimidine-Based Monophosphonate (ThP-MP) Inhibitors of the Human Farnesyl Pyrophosphate Synthase.,No,5JV0
ASD04840000_1,FDPS,Homo sapiens,P14324,5JV1,ASD04840109,YL6,F,Lig,Inhibitor,"[(1R)-1-{[6-(3-chloro-4-methylphenyl)thieno[2,3-d]pyrimidin-4-yl]amino}-2-(3-fluorophenyl)ethyl]phosphonic acid",403,Allosteric Fuction,Allosteric Position,28208018,Pharmacophore Mapping of Thienopyrimidine-Based Monophosphonate (ThP-MP) Inhibitors of the Human Farnesyl Pyrophosphate Synthase.,No,5JV1
ASD04840000_1,FDPS,Homo sapiens,P14324,5JV2,ASD04840099,6O3,F,Lig,Inhibitor,"{[6-(4-methylphenyl)thieno[2,3-d]pyrimidin-5-yl]methyl}phosphonic acid",404,Allosteric Fuction,Allosteric Position,28208018,Pharmacophore Mapping of Thienopyrimidine-Based Monophosphonate (ThP-MP) Inhibitors of the Human Farnesyl Pyrophosphate Synthase.,No,5JV2
ASD04840000_1,FDPS,Homo sapiens,P14324,5KSX,ASD04840103,07:00,F,Lig,Inhibitor,"[[(2~{S})-2-[[6-(4-methylphenyl)thieno[2,3-d]pyrimidin-4-yl]amino]-3-phenyl-propanoyl]amino]phosphonic acid",402,Allosteric Fuction,Allosteric Position,28208018,Pharmacophore Mapping of Thienopyrimidine-Based Monophosphonate (ThP-MP) Inhibitors of the Human Farnesyl Pyrophosphate Synthase.,No,5KSX
ASD04840000_1,FDPS,Homo sapiens,P14324,6N7Y,,KFA,F,lig,Inhibitor,"[(1R)-1-{[6-(4-methylphenyl)thieno[2,3-d]pyrimidin-4-yl]amino}-2-phenylethyl]phosphonic acid",404,Allosteric function,Allosteric position,,,No,6N7Y
ASD04840000_1,FDPS,Homo sapiens,P14324,6N7Z,,KF7,F,lig,Inhibitor,"[(1S)-1-{[6-(4-methylphenyl)thieno[2,3-d]pyrimidin-4-yl]amino}-2-phenylethyl]phosphonic acid",404,Allosteric function,Allosteric position,,,No,6N7Z
ASD04840000_1,FDPS,Homo sapiens,P14324,6N82,,YF7,F,lig,Inhibitor,"[(1S)-1-{[6-(3-chloro-4-methylphenyl)thieno[2,3-d]pyrimidin-4-yl]amino}-2-(3-fluorophenyl)ethyl]phosphonic acid",404,Allosteric function,Allosteric position,,,No,6N82
ASD04840000_1,FDPS,Homo sapiens,P14324,6N83,,YL6,F,lig,Inhibitor,"[(1R)-1-{[6-(3-chloro-4-methylphenyl)thieno[2,3-d]pyrimidin-4-yl]amino}-2-(3-fluorophenyl)ethyl]phosphonic acid",404,Allosteric function,Allosteric position,,,No,6N83
ASD04840000_1,FDPS,Homo sapiens,P14324,6OAG,,M2Y,F,lig,Inhibitor,"[(1S)-1-{[6-(3-chloro-4-methylphenyl)thieno[2,3-d]pyrimidin-4-yl]amino}-2-phenylethyl]phosphonic acid",404,Allosteric function,Allosteric position,,,No,6OAG
ASD04840000_1,FDPS,Homo sapiens,P14324,6OAH,,M2V,F,lig,Inhibitor,"[(1R)-1-{[6-(3-chloro-4-methylphenyl)thieno[2,3-d]pyrimidin-4-yl]amino}-2-phenylethyl]phosphonic acid",404,Allosteric function,Allosteric position,,,No,6OAH
ASD04870000_1,PTK2,Homo sapiens,Q05397,4EBV,ASD04870001,0O7,A,Lig,Inhibitor,"8-(4-ethylphenyl)-5-methyl-2H-pyrazolo[4,3-c][2,1]benzothiazine 4,4-dioxide",700,Inner Protein Regulator,Inner Protein,22819505,Discovery and characterization of novel allosteric FAK inhibitors.,No,4EBV
ASD04870000_1,PTK2,Homo sapiens,Q05397,4EBW,ASD04878002,0PF,A,Lig,Inhibitor,"1-ethyl-8-(4-ethylphenyl)-5-methyl-pyrazolo[4,3-c][2,1]benzothiazine 4,4-dioxide",700,Inner Protein Regulator,Inner Protein,22819505,Discovery and characterization of novel allosteric FAK inhibitors.,No,4EBW
ASD04870000_1,PTK2,Homo sapiens,Q05397,4I4F,ASD04870007,1BR,A,Lig,Inhibitor,"N-[(4-tert-butylphenyl)methyl]-1,5-dimethyl-4,4-bis(oxidanylidene)pyrazolo[4,3-c][2,1]benzothiazin-8-amine",702,Inner Protein Regulator,Inner Protein,23414845,Structure-based discovery of cellular-active allosteric inhibitors of FAK.,No,4I4F
ASD04910000_1,GCGR,Homo sapiens,P47871,5XEZ,ASD01180104,97V,A,Lig,Inhibitor,4-{[(4-cyclohexylphenyl){[3-(methylsulfonyl)phenyl]carbamoyl}amino]methyl}-N-(1H-tetrazol-5-yl)benzamide,1208,Allosteric function,Allosteric position,28514451,Structure of the full-length glucagon class B G-protein-coupled receptor.,No,5XEZ
ASD04910000_1,GCGR,Homo sapiens,P47871,5XF1,ASD01180104,97V,A,Lig,Inhibitor,4-{[(4-cyclohexylphenyl){[3-(methylsulfonyl)phenyl]carbamoyl}amino]methyl}-N-(1H-tetrazol-5-yl)benzamide,1207,Allosteric function,Allosteric position,28514451,Structure of the full-length glucagon class B G-protein-coupled receptor.,No,5XF1
ASD04920000_1,,Rattus norvegicus,Q9Z2W9,3LSW,ASD01230001,4MP,A,Lig,Activator,1-(4-methoxyphenyl)carbonylpyrrolidin-2-one,801,Inner Protein Regulator,Protein-Protein Interaction,20163115,Piracetam Defines a New Binding Site for Allosteric Modulators of alpha-Amino-3-hydroxy-5-methyl-4-isoxazole-propionic Acid (AMPA) Receptors.,No,"Chain A:PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219"
ASD04920000_1,,Rattus norvegicus,Q9Z2W9,3LSX,ASD04920002,PZI,A,Lig,Activator,2-(2-oxopyrrolidin-1-yl)ethanamide,802,Inner Protein Regulator,Protein-Protein Interaction,20163115,Piracetam Defines a New Binding Site for Allosteric Modulators of alpha-Amino-3-hydroxy-5-methyl-4-isoxazole-propionic Acid (AMPA) Receptors.,No,"Chain A:ASP248,ASN252"
ASD04920000_1,Gria3,Rattus norvegicus,P19492,3M3F,ASD04920003,P99,A,Lig,Activator,"2-[2,6-difluoro-4-[2-(phenylsulfonylamino)ethylsulfanyl]phenoxy]ethanamide",800,Inner Protein Regulator,Protein-Protein Interaction,20199107,Molecular mechanism of flop selectivity and subsite recognition for an AMPA receptor allosteric modulator: structures of GluA2 and GluA3 in complexes with PEPA.,No,"Chain A:ILE92,LYS104,PRO105,PHE106,MET107,SER108,SER217,LYS218,GLY219,LEU239,ASN242,LEU247"
ASD04970000_1,HRAS,Homo sapiens,P01112,3K8Y,ASD11630001,CA,A,Ion,Regulator,calcium(+2) cation,169,Inner Protein Regulator,Inner Protein,20194776,Allosteric modulation of Ras positions Q61 for a direct role in catalysis.,No,3K8Y
ASD04970000_1,HRAS,Homo sapiens,P01112,3LBH,ASD11630001,CA,A,Ion,Regulator,calcium(+2) cation,169,Inner Protein Regulator,Inner Protein,20194776,Allosteric modulation of Ras positions Q61 for a direct role in catalysis.,No,3LBH
ASD04970000_1,HRAS,Homo sapiens,P01112,3LBI,ASD11630001,CA,A,Ion,Regulator,calcium(+2) cation,169,Inner Protein Regulator,Inner Protein,20194776,Allosteric modulation of Ras positions Q61 for a direct role in catalysis.,No,3LBI
ASD04970000_1,HRAS,Homo sapiens,P01112,3OIU,ASD11630001,CA,A,Ion,Regulator,calcium(+2) cation,170,Inner Protein Regulator,Inner Protein,21098031,Allosteric Modulation of Ras-GTP Is Linked to Signal Transduction through RAF Kinase.,No,3OIU
ASD04970000_1,HRAS,Homo sapiens,P01112,3OIV,ASD04400004,DTT,A,Lig,Regulator,"(2R,3R)-1,4-bis-sulfanylbutane-2,3-diol",171,Inner Protein Regulator,Inner Protein,21098031,Allosteric Modulation of Ras-GTP Is Linked to Signal Transduction through RAF Kinase.,No,3OIV
ASD04970000_1,HRAS,Homo sapiens,P01112,3OIW,ASD11630001,CA,A,Ion,Regulator,calcium(+2) cation,168,Inner Protein Regulator,Inner Protein,21098031,Allosteric Modulation of Ras-GTP Is Linked to Signal Transduction through RAF Kinase.,No,3OIW
ASD04970000_1,HRAS,Homo sapiens,P01112,4DLR,ASD04978005,DTU,A,Lig,Regulator,"(2S,3R)-1,4-bis-sulfanylbutane-2,3-diol",203,Inner Protein Regulator,Inner Protein,22845804,Shift in the Equilibrium between On and Off States of the Allosteric Switch in Ras-GppNHp Affected by Small Molecules and Bulk Solvent Composition.,No,4DLR
ASD04970000_1,HRAS,Homo sapiens,P01112,4DLT,ASD11630001,CA,A,Ion,Regulator,calcium(+2) cation,204,Inner Protein Regulator,Inner Protein,22845804,Shift in the Equilibrium between On and Off States of the Allosteric Switch in Ras-GppNHp Affected by Small Molecules and Bulk Solvent Composition.,No,4DLT
ASD04970000_1,HRAS,Homo sapiens,P01112,4DLU,ASD11630001,CA,A,Ion,Regulator,calcium(+2) cation,204,Inner Protein Regulator,Inner Protein,22845804,Shift in the Equilibrium between On and Off States of the Allosteric Switch in Ras-GppNHp Affected by Small Molecules and Bulk Solvent Composition.,No,4DLU
ASD04970000_1,HRAS,Homo sapiens,P01112,4DLV,ASD04400004,DTT,A,Lig,Regulator,"(2R,3R)-1,4-bis-sulfanylbutane-2,3-diol",205,Inner Protein Regulator,Inner Protein,22845804,Shift in the Equilibrium between On and Off States of the Allosteric Switch in Ras-GppNHp Affected by Small Molecules and Bulk Solvent Composition.,No,4DLV
ASD04970000_1,HRAS,Homo sapiens,P01112,4DLW,ASD11630001,CA,A,Ion,Regulator,calcium(+2) cation,204,Inner Protein Regulator,Inner Protein,22845804,Shift in the Equilibrium between On and Off States of the Allosteric Switch in Ras-GppNHp Affected by Small Molecules and Bulk Solvent Composition.,No,4DLW
ASD04970000_1,HRAS,Homo sapiens,P01112,4DLX,ASD04978005,DTU,A,Lig,Regulator,"(2S,3R)-1,4-bis-sulfanylbutane-2,3-diol",205,Inner Protein Regulator,Inner Protein,22845804,Shift in the Equilibrium between On and Off States of the Allosteric Switch in Ras-GppNHp Affected by Small Molecules and Bulk Solvent Composition.,No,4DLX
ASD04970000_1,HRAS,Homo sapiens,P01112,4DLY,ASD04400004,DTT,A,Lig,Regulator,"(2R,3R)-1,4-bis-sulfanylbutane-2,3-diol",204,Inner Protein Regulator,Inner Protein,22845804,Shift in the Equilibrium between On and Off States of the Allosteric Switch in Ras-GppNHp Affected by Small Molecules and Bulk Solvent Composition.,No,4DLY
ASD04970000_1,HRAS,Homo sapiens,P01112,4DLZ,ASD04978005,DTU,A,Lig,Regulator,"(2S,3R)-1,4-bis-sulfanylbutane-2,3-diol",204,Inner Protein Regulator,Inner Protein,22845804,Shift in the Equilibrium between On and Off States of the Allosteric Switch in Ras-GppNHp Affected by Small Molecules and Bulk Solvent Composition.,No,4DLZ
ASD04970000_1,HRAS,Homo sapiens,P01112,4G0N,ASD04400004,DTT,A,Lig,Regulator,"(2R,3R)-1,4-bis-sulfanylbutane-2,3-diol",206,Inner Protein Regulator,Inner Protein,25684575,Allosteric Effects of the Oncogenic RasQ61L Mutant on Raf-RBD.,No,4G0N
ASD04970000_1,HRAS,Homo sapiens,P01112,4G0N,ASD11630001,CA,A,Ion,Regulator,calcium(+2) cation,202,Inner Protein Regulator,Inner Protein,25684575,Allosteric Effects of the Oncogenic RasQ61L Mutant on Raf-RBD.,No,4G0N
ASD04970000_1,HRAS,Homo sapiens,P01112,5.00E+95,,NS1,B,Pep,Inhibitor,a synthetic binding protein (monobody),1-97,Allosteric Function,Allosteric Position,27820802,Inhibition of RAS function through targeting an allosteric regulatory site.,No,5.00E+95
ASD04970000_1,HRAS,Homo sapiens,P01112,5ZC6,ASD04970002,KBF,A,Lig,Inhibitor,3-oxidanyl-~{N}-[[(2~{R})-oxolan-2-yl]methyl]naphthalene-2-carboxamide,202,Allosteric function,Allosteric position,30141910,Molecular Basis for Allosteric Inhibition of GTP-Bound H-Ras Protein by a Small-Molecule Compound Carrying a Naphthalene Ring,No,5ZC6
ASD04970000_2,HRAS,Rattus norvegicus,P20171,3V4F,ASD04400004,DTT,A,Lig,Regulator,"(2R,3R)-1,4-bis-sulfanylbutane-2,3-diol",201,Inner Protein Regulator,Inner Protein,22845804,Shift in the Equilibrium between On and Off States of the Allosteric Switch in Ras-GppNHp Affected by Small Molecules and Bulk Solvent Composition.,No,"Chain A:HIS94,ASP92,GLU91,TYR96,GLN99,ARG68,GLN95,ARG102,LYS88"
ASD04990000_1,N/A,Human herpesvirus 8,O36607,2PBK,ASD04990003,chain C,C;C;C;C;C;C;C,Pep,Inhibitor,peptide,1;2;3;4;5;6;7,Inner Protein Regulator,Inner Protein,17870089,Substrate modulation of enzyme activity in the herpesvirus protease family.,No,"Chain B:GLU22,LEU23,HIS46,SER114,LEU115,SER116,SER117,ILE118,HIS119,ARG121,GLU122,SER128,GLY129,PRO130,GLN133,GLY141,ARG142,ARG143"
ASD04990000_1,,Human herpesvirus 8,O36607,4P3H,ASD04990001,25G,A,Lig,Inhibitor,4-[[6-(cyclohexylmethyl)pyridin-2-yl]carbonylamino]-3-(phenylmethyl)benzoic acid,201,Protein-Protein Interaction Regulator,Inner Protein,24977643,Broad-spectrum allosteric inhibition of herpesvirus proteases.,No,"Chain A:ILE44,PHE76,LEU79,ALA80,LEU83,ALA90,ILE105,LEU106,TRP109,LEU110,ALA139,PHE189,PRO192,LEU193"
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3AO1,ASD05062025,BZX,A,Lig,Inhibitor,"1,3-benzodioxol-5-ol",213,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21275048,Fragment-based design of ligands targeting a novel site on the integrase enzyme of human immunodeficiency virus 1,No,"Chain A:TYR83,ASN184,HIS185,GLY197,VAL201; Chain B:GLY106,ARG107,TRP108,PRO109,ILE204"
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3AO3,ASD05060095,BMC,B,Lig,Inhibitor,"5-(1,3-benzodioxol-5-yl)-2-methyl-pyrazole-3-carboxylic acid",1,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21275048,Fragment-based design of ligands targeting a novel site on the integrase enzyme of human immunodeficiency virus 1,No,"Chain A:GLY106,ARG107,TRP108,PRO109,ASP207,ILE208; Chain B:TYR83,TRP108,ASN184,HIS185,ARG187,SER195,GLY197,GLU198,VAL201"
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3AO4,ASD05062026,833,B,Lig,Inhibitor,"5-(1,3-benzodioxol-5-yl)-2-methyl-pyrazol-3-amine",1,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21275048,Fragment-based design of ligands targeting a novel site on the integrase enzyme of human immunodeficiency virus 1,No,"Chain A:ALA105,GLY106,ARG107,TRP108,PRO109,ILE204,ASP207; Chain B:TYR83,ASN184,HIS185,GLY197,GLU198,VAL201"
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3AO5,ASD05062030,BBY,B,Lig,Inhibitor,"5-(7-bromo-1,3-benzodioxol-5-yl)-1-methyl-pyrazol-3-amine",1,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21275048,Fragment-based design of ligands targeting a novel site on the integrase enzyme of human immunodeficiency virus 1,No,"Chain A:GLY106,ARG107,TRP108,PRO109; Chain B:TYR83,TRP108,ASN184,HIS185,ARG187,SER195,GLY197,GLU198,VAL201"
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3L3V,ASD05060082,SUC,A,Lig,Inhibitor,"(2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol",1,Protein-Protein Interaction Regulator,Protein-Protein Interaction,20227411,Crystal structure of the HIV-1 integrase core domain in complex with sucrose reveals details of an allosteric inhibitory binding site,No,"Chain A:GLU87,VAL88,GLU96,TYR99,LYS103,LYS173; Chain B:GLU87,VAL88,GLU96,TYR99,LYS103,LYS173"
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3OVN,ASD05062028,MPV,B,Lig,Inhibitor,2-methyl-5-thiophen-2-yl-pyrazol-3-amine,213,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21275048,Fragment-based design of ligands targeting a novel site on the integrase enzyme of human immunodeficiency virus 1,No,"Chain A:ARG107,TRP108,PRO109,ILE204,THR206; Chain B:TYR83,HIS185,GLY197,GLU198,VAL201"
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3VQ4,ASD05060075,0NX,A,Lig,Inhibitor,"(5-phenyl-1,2-oxazol-3-yl)methanol",305,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?,No,"Chain A:GLN95,ALA98,TYR99,LEU102,THR125,ALA128,ALA129,TRP132; Chain B:GLU170,THR174"
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3VQ4,ASD05060075,0NX,B,Lig,Inhibitor,"(5-phenyl-1,2-oxazol-3-yl)methanol",303,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?,No,"Chain A:TYR83,ASN184,HIS185,GLY197,GLU198; Chain B:GLY106,ARG107,PRO109,ILE204,ILE208"
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3VQ5,ASD05060079,MMJ,A,Lig,Inhibitor,"N-methyl-1-(4-methyl-2-phenyl-1,3-thiazol-5-yl)methanamine",1007,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?,No,"Chain A:GLY106,ARG107,TRP108,PRO109,ILE204,ASP207; Chain B:TYR83,ASN184,HIS185,GLY197,GLU198,VAL201"
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3VQ7,ASD05060080,SNU,B,Lig,Inhibitor,4-pyrrol-1-ylaniline,304,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?,No,"Chain A:GLN95,ALA98,TYR99,THR125,ALA128,ALA129,TRP132; Chain B:THR174,MET178"
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3VQ7,ASD05060080,SNU,A,Lig,Inhibitor,4-pyrrol-1-ylaniline,1004,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?,No,"Chain A:GLY106,ARG107,TRP108,PRO109,ILE204,THR206; Chain B:ASN184,HIS185,GLY197,GLU198,VAL201"
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3VQ7,ASD05060082,SUC,B,Lig,Inhibitor,"(2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol",305,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?,No,"Chain A:GLU87,VAL88,GLU96,TYR99,LYS103,LYS173; Chain B:GLU87,VAL88,ILE89,GLU96,TYR99,LYS103,LYS173"
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3VQ8,ASD05060083,BCU,A,Lig,Inhibitor,"[(3R)-3,4-dihydro-2H-chromen-3-yl]methanol",1006,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?,No,"Chain A:GLN95,ALA98,TYR99,LEU102,THR125,ALA128,ALA129; Chain B:GLN168,THR174"
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3VQA,ASD05060084,MWP,B,Lig,Inhibitor,"1,1-bis(oxidanylidene)-1-benzothiophen-6-amine",303,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?,No,"Chain A:ARG107,TRP108,PRO109,ILE204; Chain B:ASN184,HIS185,GLY197,GLU198,VAL201"
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3VQA,ASD05060082,SUC,B,Lig,Inhibitor,"(2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol",304,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?,No,"Chain A:GLU87,VAL88,GLU96,TYR99,LYS103,LYS173; Chain B:GLU87,VAL88,GLU96,TYR99,LYS103,LYS173"
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3VQB,ASD05060086,FBG,A,Lig,Inhibitor,"[(2R,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate",304,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?,No,"Chain A:TYR83,ASN184,HIS185,SER195,GLY197,GLU198,VAL201; Chain B:GLY106,ARG107,TRP108,PRO109,ILE204,ILE208"
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3VQC,ASD05060087,MPK,A,Lig,Inhibitor,"(5-methyl-3-phenyl-1,2-oxazol-4-yl)methanol",304,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?,No,"Chain A:ASN184,HIS185,SER195,GLY197,GLU198; Chain B:ARG107,PRO109"
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3VQD,ASD05060088,MOK,A,Lig,Inhibitor,"5-methyl-3-phenyl-1,2-oxazole-4-carboxylic acid",304,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?,No,"Chain A:TYR83,ASN184,HIS185,SER195,GLY197,GLU198; Chain B:ARG107,TRP108,PRO109,ILE204,ILE208"
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3VQE,ASD05060089,FMQ,A,Lig,Inhibitor,[1-(4-fluorophenyl)-5-methyl-pyrazol-4-yl]methanol,1006,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?,No,"Chain A:HIS185,ARG187,SER195,GLY197,GLU198,VAL201; Chain B:PRO109,ILE204"
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3VQP,ASD05060090,DBJ,A,Lig,Inhibitor,"2,3-dihydro-1,4-benzodioxin-5-ylmethanol",306,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?,No,"Chain A:TYR83,TRP108,ASN184,HIS185,GLY197,GLU198,VAL201; Chain B:GLY106,ARG107,TRP108,PRO109,ILE204"
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3VQQ,ASD05060091,BTE,A,Lig,Inhibitor,"2,1,3-benzothiadiazol-4-amine",306,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?,No,"Chain A:ASN184,HIS185,GLY197,GLU198,VAL201; Chain B:ARG107,TRP108,PRO109,ILE204,ILE208"
ASD05060000_1,pol,Human immunodeficiency virus type 1,Q72498,3VQQ,ASD05060082,SUC,A,Lig,Inhibitor,"(2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol",304,Protein-Protein Interaction Regulator,Protein-Protein Interaction,23139382,Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?,No,"Chain A:GLU87,VAL88,ILE89,GLU96,TYR99,LYS103,LYS173; Chain B:GLU87,VAL88,ILE89,GLU96,TYR99,LYS103,LYS173"
ASD05100000_1,lysC,Escherichia coli,P08660,2J0X,ASD00910001,LYS,A,Lig,Inhibitor,[(5S)-5-amino-6-hydroxy-6-oxo-hexyl]azanium,1451,Protein-Protein Interaction Regulator,Protein-Protein Interaction,16905770,Structures of R- and T-State Escherichia Coli Aspartokinase III: Mechanisms of the Allosteric Transition and Inhibition by Lysine.,No,"Chain A:MET318,SER321,GLY323,PHE324,LEU325,THR344,SER345,GLU346; Chain B:SER338,VAL339,ASP340"
ASD05120000_1,MIF,Homo sapiens,P14174,3IJG,ASD05120002,AVR,C,Lig,Inhibitor,"(2R)-2-azanyl-1-(2-propan-2-ylpyrazolo[1,5-a]pyridin-3-yl)propan-1-one",200,Inner Protein Regulator,Protein-Protein Interaction,20534506,Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast.,Yes,3IJG
ASD05120000_1,MIF,Homo sapiens,P14174,3IJJ,ASD05120002,AVR,C,Lig,Inhibitor,"(2R)-2-azanyl-1-(2-propan-2-ylpyrazolo[1,5-a]pyridin-3-yl)propan-1-one",200,Inner Protein Regulator,Protein-Protein Interaction,20534506,Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast.,Yes,3IJJ
ASD05120000_1,MIF,Homo sapiens,P14174,3U18,ASD05120001,Y0X,A,Lig,Inhibitor,"4-azanyl-6-[(E)-[4-[4-[(E)-(8-azanyl-1-oxidanyl-5,7-disulfo-naphthalen-2-yl)diazenyl]-3-methoxy-phenyl]-2-methoxy-phenyl]diazenyl]-5-oxidanyl-naphthalene-1,3-disulfonic acid",999,Inner Protein Regulator,Protein-Protein Interaction,22782901,A Novel Allosteric Inhibitor of Macrophage Migration Inhibitory Factor (MIF).,Yes,3U18
ASD05120000_1,MIF,Homo sapiens,P14174,6PEG,,4FQ,E,Lig,Inhibitor,"4-amino-5-hydroxy-6-[(E)-(3-{[3-(2-methylpropanoyl)pyrazolo[1,5-a]pyridin-2-yl]methyl}phenyl)diazenyl]naphthalene-1,3-disulfonic acid",201,,,,,Yes,6PEG
ASD05210000_1,MAPK8,Homo sapiens,P45983,3O2M,ASD05210001,46A,A,Lig,Inhibitor,"N-butyl-4,6-dimethyl-N-[[4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]pyrimidin-2-amine",701,Inner Protein Regulator,Protein-Protein Interaction,21090814,Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases.,No,3O2M
ASD05230000_1,mhcA,Dictyostelium discoideum,P08799,1YV3,ASD05238001,BIT,A,Lig,Inhibitor,"(3aS)-3a-hydroxy-6-methyl-1-phenyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-one",800,Inner Protein Regulator,Inner Protein,15750603,The structural basis of blebbistatin inhibition and specificity for myosin II.,No,"Chain A:ARG238,PHE239,GLY240,TYR261,LEU262,LEU263,GLU264,ILE455,SER456,GLU467,CYS470,ILE471,THR474,TYR634,GLN637,LEU641"
ASD05230000_1,mhcA,Dictyostelium discoideum,P08799,2JHR,ASD05233003,PBQ,A,Lig,Inhibitor,"2,4-dibromo-6-(3,4,5-tribromo-1H-pyrrol-2-yl)phenol",1780,Inner Protein Regulator,Inner Protein,19122661,The Mechanism of Pentabromopseudilin Inhibition of Myosin Motor Activity.,No,"Chain A:LYS265,ALA420,LYS423,ALA424,GLY427,ARG428,LEU431,ASP590,LEU592,ILE617,ALA618,SER619,ARG620"
ASD05230000_1,mhcA,Dictyostelium discoideum,P08799,2XEL,ASD05233008,IA2,A,Lig,Inhibitor,"2,4-dichloro-6-(3,4,5-trichloro-1H-pyrrol-2-yl)phenol",999,Inner Protein Regulator,Inner Protein,21680745,Mechanism and Specificity of Pentachloropseudilin-Mediated Inhibition of Myosin Motor Activity.,No,"Chain A:LYS265,ALA424,GLY427,ARG428,LEU431,ASP590,LEU592,ASN616,ILE617,SER619,ARG620"
ASD05230000_1,mhcA,Dictyostelium discoideum,P08799,2XO8,ASD05233007,H70,A,Lig,Inhibitor,"2,4-dichloro-6-(3,4,5-tribromo-1H-pyrrol-2-yl)phenol",1778,Inner Protein Regulator,Inner Protein,,Inhibition of Myosin ATPase Activity by Halogenated Pseudilins: A Structure-Activity Study.,No,"Chain A:LEU263,LYS265,LYS423,ALA424,GLY427,ARG428,LEU431,ASP590,LEU592,ILE617"
ASD05230000_1,mhcA,Dictyostelium discoideum,P08799,3BZ7,ASD05230005,BL4,A,Lig,Inhibitor,"(3aS)-3a-hydroxy-5-methyl-1-phenyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-one",800,Inner Protein Regulator,Inner Protein,18528569,The small molecule tool (S)-(-)-blebbistatin: novel insights of relevance to myosin inhibitor design.,No,"Chain A:ARG238,PHE239,GLY240,TYR261,LEU262,LEU263,GLU264,ILE455,SER456,GLU467,CYS470,ILE471,THR474,TYR634,GLN637,LEU638"
ASD05230000_1,mhcA,Dictyostelium discoideum,P08799,3BZ8,ASD05230006,BL6,A,Lig,Inhibitor,"(3aS)-3a-hydroxy-7-methyl-1-phenyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-one",800,Inner Protein Regulator,Inner Protein,18528569,The small molecule tool (S)-(-)-blebbistatin: novel insights of relevance to myosin inhibitor design.,No,"Chain A:ARG238,PHE239,GLY240,TYR261,LEU262,LEU263,ILE455,SER456,GLU467,CYS470,ILE471,THR474,TYR634,GLN637,LEU638"
ASD05230000_1,mhcA,Dictyostelium discoideum,P08799,3BZ9,ASD05230007,BL7,A,Lig,Inhibitor,"(3aS)-3a-hydroxy-1-phenyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-one",800,Inner Protein Regulator,Inner Protein,18528569,The small molecule tool (S)-(-)-blebbistatin: novel insights of relevance to myosin inhibitor design.,No,"Chain A:ARG238,PHE239,GLY240,TYR261,LEU262,LEU263,ILE455,SER456,GLU467,CYS470,ILE471,THR474,TYR634,GLN637,LEU638"
ASD05230000_1,mhcA,Dictyostelium discoideum,P08799,3MJX,ASD05238001,BIT,A,Lig,Inhibitor,"(3aS)-3a-hydroxy-6-methyl-1-phenyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-one",902,Inner Protein Regulator,Inner Protein,19122661,The mechanism of pentabromopseudilin inhibition of myosin motor activity.,No,"Chain A:ARG238,PHE239,GLY240,TYR261,LEU262,ILE455,SER456,GLU467,ILE471,THR474,VAL630,TYR634,LEU638,LEU641"
ASD05250000_1,SIRT1,Homo sapiens,Q96EB6,5BTR,ASD05250001,STL,A,Lig,Regulator,RESVERATROL,702,Allosteric Function,Allosteric Position,26109052,"Structural basis for allosteric, substrate-dependent stimulation of SIRT1 activity by resveratrol",No,5BTR
ASD05250000_1,SIRT1,Homo sapiens,Q96EB6,5BTR,ASD05250001,STL,D,Lig,Regulator,RESVERATROL,102,Allosteric Function,Allosteric Position,26109052,"Structural basis for allosteric, substrate-dependent stimulation of SIRT1 activity by resveratrol",No,5BTR
ASD05250000_1,SIRT1,Homo sapiens,Q96EB6,5BTR,ASD05250001,STL,D,Lig,Regulator,RESVERATROL,102,Allosteric Function,Allosteric Position,26109052,"Structural basis for allosteric, substrate-dependent stimulation of SIRT1 activity by resveratrol",No,5BTR
ASD05260000_1,SIRT3,Homo sapiens,Q9NTG7,4C7B,ASD05260002,BVB,A,Lig,Inhibitor,"5-[(E)-2-(4-bromophenyl)ethenyl]benzene-1,3-diol",1395,Inner Protein Regulator,Inner Protein,24211137,Crystal Structures of Sirt3 Complexes with 4'-Bromo-Resveratrol Reveal Binding Sites and Inhibition Mechanism.,No,4C7B
ASD05270000_2,,Alcaligenes faecalis,P38501,1ZDQ,ASD05273001,MSM,A,Lig,Regulator,(METHYLSULFANYL)METHANE,1507,Inner Protein Regulator,Inner Protein,16574144,A rearranging ligand enables allosteric control of catalytic activity in copper-containing nitrite reductase.,No,"Chain A:ALA61,TRP144,LEU93,HIS60,PRO199,HIS95,SER148,HIS145,MET62,GLU47"
ASD05270000_2,nirK,Alcaligenes faecalis,P38501,1ZDS,ASD05273004,ACM,A,Lig,Regulator,ethanamide,2500,Inner Protein Regulator,Inner Protein,16574144,A rearranging ligand enables allosteric control of catalytic activity in copper-containing nitrite reductase.,No,"Chain A:GLU47,HIS60,MET62,LEU93,HIS95,TRP144,HIS145,SER148,PRO199"
ASD05270000_2,nirK,Alcaligenes faecalis,P38501,2B08,ASD05273004,ACM,A,Lig,Regulator,ethanamide,1503,Inner Protein Regulator,Inner Protein,17227014,Effect of the methionine ligand on the reorganization energy of the type-1 copper site of nitrite reductase.,No,"Chain A:GLU47,HIS60,MET62,LEU93,HIS95,TRP144,HIS145,SER148,PRO199"
ASD05390000_1,PIK3CA,Homo sapiens,P42336,5SW8,ASD05390002,70S,A,Lig,Inhibitor,2H-indazol-5-amine,1102,Allosteric function,Allosteric position,28129991,Identification of allosteric binding sites for PI3K alpha oncogenic mutant specific inhibitor design.,No,5SW8
ASD05390000_1,PIK3CA,Homo sapiens,P42336,5SW8,ASD05390016,FB1,A,Lig,Inhibitor,2-CHLOROBENZENESULFONAMIDE,1103,Allosteric function,Allosteric position,28129991,Identification of allosteric binding sites for PI3K alpha oncogenic mutant specific inhibitor design.,No,5SW8
ASD05390000_1,PIK3CA,Homo sapiens,P42336,5SWG,ASD05390014,AX7,A,Lig,Inhibitor,1H-benzimidazol-2-amine,1101,Allosteric function,Allosteric position,28129991,Identification of allosteric binding sites for PI3K alpha oncogenic mutant specific inhibitor design.,No,5SWG
ASD05390000_1,PIK3CA,Homo sapiens,P42336,5SWG,ASD00120003,CAQ,B,Lig,Inhibitor,CATECHOL,701,Allosteric function,Allosteric position,28129991,Identification of allosteric binding sites for PI3K alpha oncogenic mutant specific inhibitor design.,No,5SWG
ASD05390000_1,PIK3CA,Homo sapiens,P42336,5SWO,ASD05390003,70T,A,Lig,Inhibitor,2-methyl-5-nitro-1H-indole,1102,Allosteric function,Allosteric position,28129991,Identification of allosteric binding sites for PI3K alpha oncogenic mutant specific inhibitor design.,No,5SWO
ASD05390000_1,PIK3CA,Homo sapiens,P42336,5SWO,ASD05390001,2ZV,B,Lig,Inhibitor,4-methyl-3-nitropyridin-2-amine,701,Allosteric function,Allosteric position,28129991,Identification of allosteric binding sites for PI3K alpha oncogenic mutant specific inhibitor design.,No,5SWO
ASD05390000_1,PIK3CA,Homo sapiens,P42336,5SWP,ASD05390005,70W,A,Lig,Inhibitor,tert-butyl 4-aminopiperidine-1-carboxylate,1101,Allosteric function,Allosteric position,28129991,Identification of allosteric binding sites for PI3K alpha oncogenic mutant specific inhibitor design.,No,5SWP
ASD05390000_1,PIK3CA,Homo sapiens,P42336,5SWP,ASD05390004,70V,A,Lig,Inhibitor,"2-methylcyclohexane-1,3-dione",1103,Allosteric function,Allosteric position,28129991,Identification of allosteric binding sites for PI3K alpha oncogenic mutant specific inhibitor design.,No,5SWP
ASD05390000_1,PIK3CA,Homo sapiens,P42336,5SWR,ASD01010009,SAL,B,Lig,Inhibitor,2-HYDROXYBENZOIC ACID,701,Allosteric function,Allosteric position,28129991,Identification of allosteric binding sites for PI3K alpha oncogenic mutant specific inhibitor design.,No,5SWR
ASD05390000_1,PIK3CA,Homo sapiens,P42336,5SWT,ASD05390006,71A,A,Lig,Inhibitor,pyridin-3-ol,1101,Allosteric function,Allosteric position,28129991,Identification of allosteric binding sites for PI3K alpha oncogenic mutant specific inhibitor design.,No,5SWT
ASD05390000_1,PIK3CA,Homo sapiens,P42336,5SX8,ASD05390018,LUZ,A,Lig,Inhibitor,"pteridine-2,4(1H,3H)-dione",1102,Allosteric function,Allosteric position,28129991,Identification of allosteric binding sites for PI3K alpha oncogenic mutant specific inhibitor design.,No,5SX8
ASD05390000_1,PIK3CA,Homo sapiens,P42336,5SX8,ASD05390012,71M,A,Lig,Inhibitor,6-methylpyridin-2-amine,1101,Allosteric function,Allosteric position,28129991,Identification of allosteric binding sites for PI3K alpha oncogenic mutant specific inhibitor design.,No,5SX8
ASD05390000_1,PIK3CA,Homo sapiens,P42336,5SX9,ASD05390011,71L,A,Lig,Inhibitor,"4,6-dimethylpyridin-2-amine",1101,Allosteric function,Allosteric position,28129991,Identification of allosteric binding sites for PI3K alpha oncogenic mutant specific inhibitor design.,No,5SX9
ASD05390000_1,PIK3CA,Homo sapiens,P42336,5SXA,ASD05390013,71N,A,Lig,Inhibitor,2-(trifluoromethyl)-1H-benzimidazol-5-amine,1101,Allosteric function,Allosteric position,28129991,Identification of allosteric binding sites for PI3K alpha oncogenic mutant specific inhibitor design.,No,5SXA
ASD05390000_1,PIK3CA,Homo sapiens,P42336,5SXB,ASD05390020,SOA,B,Lig,Inhibitor,ISATOIC ANHYDRIDE,701,Allosteric function,Allosteric position,28129991,Identification of allosteric binding sites for PI3K alpha oncogenic mutant specific inhibitor design.,No,5SXB
ASD05390000_1,PIK3CA,Homo sapiens,P42336,5SXC,ASD01000003,URF,A,Lig,Inhibitor,5-FLUOROURACIL,1101,Allosteric function,Allosteric position,28129991,Identification of allosteric binding sites for PI3K alpha oncogenic mutant specific inhibitor design.,No,5SXC
ASD05390000_1,PIK3CA,Homo sapiens,P42336,5SXD,ASD01010017,71F,B,Lig,Inhibitor,2-methoxybenzoic acid,701,Allosteric function,Allosteric position,28129991,Identification of allosteric binding sites for PI3K alpha oncogenic mutant specific inhibitor design.,No,5SXD
ASD05390000_1,PIK3CA,Homo sapiens,P42336,5SXE,ASD05390008,71G,A,Lig,Inhibitor,3-aminobenzonitrile,1101,Allosteric function,Allosteric position,28129991,Identification of allosteric binding sites for PI3K alpha oncogenic mutant specific inhibitor design.,No,5SXE
ASD05390000_1,PIK3CA,Homo sapiens,P42336,5SXF,ASD05390017,HPP,A,Lig,Inhibitor,HYDROXYPHENYL PROPIONIC ACID,1101,Allosteric function,Allosteric position,28129991,Identification of allosteric binding sites for PI3K alpha oncogenic mutant specific inhibitor design.,No,5SXF
ASD05390000_1,PIK3CA,Homo sapiens,P42336,5SXI,ASD05390009,71J,B,Lig,Inhibitor,"trans-cyclohexane-1,4-diol",701,Allosteric function,Allosteric position,28129991,Identification of allosteric binding sites for PI3K alpha oncogenic mutant specific inhibitor design.,No,5SXI
ASD05390000_1,PIK3CA,Homo sapiens,P42336,5SXK,ASD05390010,71K,B,Lig,Inhibitor,"2-methylbenzene-1,3-diamine",701,Allosteric function,Allosteric position,28129991,Identification of allosteric binding sites for PI3K alpha oncogenic mutant specific inhibitor design.,No,5SXK
ASD05550000_3,pycA,Staphylococcus aureus,Q99UY8,3HO8,ASD05550003,COA,A,Lig,Activator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxy-oxolan-2-yl]methyl [hydroxy-[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-[[3-oxo-3-(2-sulfanylethylamino)propyl]amino]butoxy]phosphoryl] hydrogen phosphate",2001,Inner Protein Regulator,Protein-Protein Interaction,19523900,A Symmetrical Tetramer for S. aureus Pyruvate Carboxylase in Complex with Coenzyme A.,No,"Chain A:ARG398,ARG448,GLU449,ARG451,ARG453,SER493,LEU494,ARG496,GLY497,GLY1055,LYS1056,ARG1057,MET1080,ASN1081,ARG1085; Chain C:ALA57,ARG77,TYR78,LYS79,ALA80,ASP81,GLU82,SER83"
ASD05550000_5,,Listeria monocytogenes R479a,L8DYY9,4QSH,ASD05550002,2BA,A,Lig,Regulator,"(2R,3R,3aS,5R,7aR,9R,10R,10aS,12R,14aR)-2,9- bis(6-amino-9H-purin-9-yl)octahydro-2H,7H- difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine- 3,5,10,12-tetrol 5,12-dioxide",2004,Inner Protein Regulator,Inner Protein,25215494,The Cyclic Dinucleotide c-di-AMP Is an Allosteric Regulator of Metabolic Enzyme Function.,No,Chain D:SER756
ASD05550000_5,,Listeria monocytogenes R479a,L8DYY9,4QSK,ASD05550002,2BA,A,Lig,Regulator,"(2R,3R,3aS,5R,7aR,9R,10R,10aS,12R,14aR)-2,9- bis(6-amino-9H-purin-9-yl)octahydro-2H,7H- difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine- 3,5,10,12-tetrol 5,12-dioxide",2000,Inner Protein Regulator,Inner Protein,25215494,The Cyclic Dinucleotide c-di-AMP Is an Allosteric Regulator of Metabolic Enzyme Function.,No,"Chain A:TYR722,TYR749,LEU785,GLN719,PRO718,ALA754,ASN789,ALA752,ALA753,SER756,ALA757"
ASD05660000_1,,Homo sapiens,P19793,3UVV,ASD05660009,REA,B,Lig,Inhibitor,RETINOIC ACID,501,Protein-Protein Interaction Regulator,Inner Protein,22474364,Structural basis for negative cooperativity within agonist-bound TR:RXR heterodimers.,No,3UVV
ASD05660000_1,RXRA,Homo sapiens,P19793,5LYQ,ASD05660012,7BE,A,Lig,Activator,"(2~{R})-6,6,9,9-tetramethylspiro[3,4,7,8-tetrahydrobenzo[g]chromene-2,2'-3,4-dihydrochromene]-6'-carboxylic acid",501,Allosteric function,Allosteric position,28407400,Designed Spiroketal Protein Modulation.,No,5LYQ
ASD05730000_1,PAK1,Homo sapiens,Q13153,4ZJI,ASD05730030,4OQ,A,Lig,Regulator,2-chloro-5-ethyl-8-fluoro-11-(4-methylpiperazin- 1-yl)-dibenzodiazepine,601,Allosteric Function,Allosteric Position,26191365,Optimization of a Dibenzodiazepine Hit to a Potent and Selective Allosteric PAK1 Inhibitor.,No,4ZJI
ASD05730000_1,PAK1,Homo sapiens,Q13153,4ZJJ,ASD05730163,4OR,A,Lig,Regulator,(S)-N-(tert-butyl)-3-((2-chloro-5-ethyl-8- fluoro-dibenzodiazepin-11-yl)amino)pyrrolidine- 1-carboxamide,601,Allosteric Function,Allosteric Position,26191365,Optimization of a Dibenzodiazepine Hit to a Potent and Selective Allosteric PAK1 Inhibitor.,No,4ZJJ
ASD05730000_1,PAK1,Homo sapiens,Q13153,4ZLO,ASD05730166,4PV,A,Lig,Regulator,"2,8-difluoro-11-(4-methylpiperazin-1-yl)- 5H-dibenzo[b,e][1,4]diazepine",601,Allosteric Function,Allosteric Position,26191365,Optimization of a Dibenzodiazepine Hit to a Potent and Selective Allosteric PAK1 Inhibitor.,No,4ZLO
ASD05790000_1,SMO,Homo sapiens,Q99835,5L7I,ASD05790074,VIS,A,Lig,Inhibitor,2-chloranyl-~{N}-(4-chloranyl-3-pyridin-2-yl-phenyl)-4-methylsulfonyl-benzamide,1202,Allosteric Function,Allosteric Position,27437577,Structural basis of Smoothened regulation by its extracellular domains.,No,5L7I
ASD05850000_1,UBE2I,Homo sapiens,P63279,5F6W,ASD05850001,5VL,A,Lig,Inhibitor,2-(2-hydroxyphenyl)phenol,201,Inner Protein Regulator,Allosteric Position,27038327,Insights Into the Allosteric Inhibition of the SUMO E2 Enzyme Ubc9.,No,5F6W
ASD05850000_1,UBE2I,Homo sapiens,P63279,5F6Y,ASD05850009,5VM,A,Lig,Inhibitor,"5-chloranyl-3~{H}-1,3-benzoxazole-2-thione",201,Inner Protein Regulator,Allosteric Position,27038327,Insights Into the Allosteric Inhibition of the SUMO E2 Enzyme Ubc9.,No,5F6Y
ASD05860000_2,,Escherichia coli,P04483,2NS8,ASD05860010;ASD05860010;ASD05860010;ASD05860010;ASD05860010;ASD05860010;ASD05860010;ASD05860010;ASD05860010;ASD05860010;ASD05860010;ASD05860010,ACE;TRP;THR;TRP;ASN;ALA;TYR;ALA;PHE;ALA;ALA;PRO,E;E;E;E;E;E;E;E;E;E;E;E,Pep,Inhibitor,,0;1;2;3;4;5;6;7;8;9;10;11,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,17374541,How an agonist peptide mimics the antibiotic tetracycline to induce Tet-repressor,No,"Chain E:ASN4,ALA10,PHE8,THR2,TRP3,TYR6,ALA9,PRO11,ALA5,ALA7,TRP1"
ASD05860000_2,,Escherichia coli,P04483,3ZQF,ASD05860006;ASD05860006;ASD05860006;ASD05860006;ASD05860006;ASD05860006;ASD05860006;ASD05860006;ASD05860006;ASD05860006;ASD05860006;ASD05860006;ASD05860006,GLU;GLY;LEU;ALA;ARG;VAL;ALA;ALA;LEU;ALA;ARG;SER;ARG,C;C;C;C;C;C;C;C;C;C;C;C;C,Pep,Inhibitor,,4;5;6;7;8;9;10;11;12;13;14;15;16,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,22178479,An Exclusive Alpha/Beta Code Directs Allostery in Tetr-Peptide Complexes.,No,"Chain C:ALA13,GLY5,ARG14,LEU6,LEU12,SER15,ALA10,VAL9,GLU4,ALA11,ARG16,ALA7,ARG8"
ASD05860000_2,,Escherichia coli,P04483,3ZQG,ASD05860007;ASD05860007;ASD05860007;ASD05860007;ASD05860007;ASD05860007;ASD05860007;ASD05860007;ASD05860007;ASD05860007;ASD05860007;ASD05860007;ASD05860007,ARG;GLY;ARG;TRP;GLN;VAL;TRP;GLY;LEU;ALA;LYS;ARG;CYS,C;C;C;C;C;C;C;C;C;C;C;C;C,Pep,Inhibitor,,4;5;6;7;8;9;10;11;12;13;14;15;16,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,22178479,An Exclusive Alpha/Beta Code Directs Allostery in Tetr-Peptide Complexes.,No,"Chain C:TRP10,ALA13,ARG4,GLY5,LEU12,VAL9,GLY11,GLN8,CYS16,LYS14,ARG15,TRP7,ARG6"
ASD05860000_2,,Escherichia coli,P04483,3ZQH,ASD05860008;ASD05860008;ASD05860008;ASD05860008;ASD05860008;ASD05860008;ASD05860008;ASD05860008;ASD05860008;ASD05860008;ASD05860008;ASD05860008,SER;ARG;VAL;VAL;VAL;TRP;ARG;LEU;PRO;PRO;LEU;HIS,C;C;C;C;C;C;C;C;C;C;C;C,Pep,Inhibitor,,4;5;6;7;8;9;10;11;12;13;14;15,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,22178479,An Exclusive Alpha/Beta Code Directs Allostery in Tetr-Peptide Complexes.,No,"Chain C:PRO13,HIS15,VAL7,ARG5,SER4,VAL8,LEU14,LEU11,VAL6,TRP9,PRO12,ARG10"
ASD05860000_2,,Escherichia coli,P04483,3ZQI,ASD05860009;ASD05860009;ASD05860009;ASD05860009;ASD05860009;ASD05860009;ASD05860009;ASD05860009;ASD05860009;ASD05860009;ASD05860009;ASD05860009;ASD05860009;ASD05860009,SER;VAL;LEU;ALA;ALA;ARG;ALA;ARG;MET;TRP;MET;TRP;HIS;TRP,C;C;C;C;C;C;C;C;C;C;C;C;C;C,Pep,Inhibitor,,3;4;5;6;7;8;9;10;11;12;13;14;15;16,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,22178479,An Exclusive Alpha/Beta Code Directs Allostery in Tetr-Peptide Complexes.,No,"Chain B:HIS151,ASP148,PRO161,GLU156,PHE177,MET166,THR163,SER165,LEU169,LYS155,THR160,ASP164,ASP178,GLU159,ALA173,ARG171,LEU170,GLU147,THR162,ILE174,GLU175,ARG158"
ASD05860000_3,tetR,Escherichia coli,P0ACT4,2XPU,ASD05860005,TDC,A,Lig,Activator,"5A,6-ANHYDROTETRACYCLINE",1209,Allosteric function,Allosteric position,,The Role of the Metal Ion for Induction of Tetr(D) with Anhydrotetracycline.,No,"Chain A:HIS100,SER138,GLN109,THR112,LEU60,ARG104,LEU117,PHE78,ILE134,SER135,LEU79,LEU131,PRO105,VAL113,VAL137,SER67,HIS64,PHE86,GLN116,THR103,TYR66,ASN82,ALA83"
ASD05860000_3,tetR,Escherichia coli,P0ACT4,6FPL,,TAC,A,Lig,Inhibitor,TETRACYCLINE,301,Allosteric function,Allosteric position,,,No,
ASD05860000_3,tetR,Escherichia coli,P0ACT4,6FPM,,TAC,A,Lig,Inhibitor,TETRACYCLINE,301,Allosteric function,Allosteric position,,,No,
ASD05860000_3,tetR,Escherichia coli,P0ACT4,6QJW,,CTC,A,Lig,Inhibitor,7-CHLOROTETRACYCLINE,301,Allosteric function,Allosteric position,,,No,
ASD05860000_3,tetR,Escherichia coli,P0ACT4,6QJX,,MIY,A,Lig,Inhibitor,"(4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2- CARBOXAMIDE",301,Allosteric function,Allosteric position,,,No,
ASD05860000_3,tetR,Escherichia coli,P0ACT4,6RBL,,DXT,A,Lig,Inhibitor,"(4S,4AR,5S,5AR,6R,12AS)-4-(DIMETHYLAMINO)-3,5,10,12,12A-PENTAHYDROXY-6-METHYL-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE",301,Allosteric function,Allosteric position,,,No,
ASD05860000_3,tetR,Escherichia coli,P0ACT4,6RBM,,MIY,A,Lig,Inhibitor,"(4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2- CARBOXAMIDE",301,Allosteric function,Allosteric position,,,No,
ASD05860000_3,tetR,Escherichia coli,P0ACT4,6RCR,,DXT,A,Lig,Inhibitor,"(4S,4AR,5S,5AR,6R,12AS)-4-(DIMETHYLAMINO)-3,5,10,12,12A-PENTAHYDROXY-6-METHYL-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE",301,Allosteric function,Allosteric position,,,No,
ASD05860000_3,tetR,Escherichia coli,P0ACT4,6RGX,,DXT,B,Lig,Inhibitor,"(4S,4AR,5S,5AR,6R,12AS)-4-(DIMETHYLAMINO)-3,5,10,12,12A-PENTAHYDROXY-6-METHYL-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE",301,Allosteric function,Allosteric position,,,No,
ASD05860000_4,tetR,Pasteurella multocida,P51561,2VPR,ASD05860005,TDC,A,Lig,Regulator,"(4S,4aS,12aS)-4-dimethylamino-3,10,11,12a-tetrahydroxy-6-methyl-1,12-dioxo-4a,5-dihydro-4H-tetracene-2-carboxamide",1206,Protein-DNA/RNA Interaction Regulator,Inner Protein,18395746,"Tet Repressor Induction by Tetracycline: A Molecular Dynamics, Continuum Electrostatics, and Crystallographic Study",No,"Chain A:LEU60,HIS64,VAL67,ASN82,PHE86,HIS100,THR103,ARG104,PRO105,GLN109,SER113,GLN116,LEU134,SER135"
ASD05870000_1,F2,Homo sapiens,P00734,1DX5,ASD03160008,NA,M,Ion,Activator,sodium(+1) cation,2001,Inner Protein Regulator,Inner Protein,10761923,Structural Basis for the Anticoagulant Activity of the Thrombin-Thrombomodulin Complex,No,1DX5
ASD05870000_1,F2,Homo sapiens,P00734,1JMO,ASD03160008,NA,H,Ion,Activator,sodium(+1) cation,501,Inner Protein Regulator,Inner Protein,12169660,Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism.,No,1JMO
ASD05870000_1,F2,Homo sapiens,P00734,1JOU,ASD03160008,NA,B,Ion,Activator,sodium(+1) cation,3001,Inner Protein Regulator,Inner Protein,12679024,The molecular basis of thrombin allostery revealed by a 1.8A structure of the slow form,No,1JOU
ASD05870000_1,F2,Homo sapiens,P00734,1SFQ,ASD03160008,NA,E,Ion,Activator,sodium(+1) cation,402,Inner Protein Regulator,Inner Protein,15152000,Molecular dissection of na+ binding to thrombin.,No,1SFQ
ASD05870000_1,F2,Homo sapiens,P00734,1SG8,ASD03160008,NA,B,Ion,Activator,sodium(+1) cation,1701,Inner Protein Regulator,Inner Protein,15152000,Molecular dissection of na+ binding to thrombin.,No,1SG8
ASD05870000_1,F2,Homo sapiens,P00734,3JZ1,ASD03160008,NA,B,Ion,Activator,sodium(+1) cation,401,Inner Protein Regulator,Inner Protein,19846563,Mutant N143P reveals how Na+ activates thrombin,No,3JZ1
ASD05870000_1,F2,Homo sapiens,P00734,3R3G,ASD03160008,NA,B,Ion,Activator,sodium(+1) cation,401,Inner Protein Regulator,Inner Protein,21536369,Rigidification of the autolysis loop enhances Na(+) binding to thrombin.,No,3R3G
ASD05870000_1,F2,Homo sapiens,P00734,4RKO,ASD03160008,NA,B,Ion,Regulator,Sodium ion,305,Inner Protein Regulator,Allosteric Position,25664608,Why ser and not thr brokers catalysis in the trypsin fold.,No,4RKO
ASD05870000_1,F2,Homo sapiens,P00734,6PX5,,0G6,B,pep,Inhibitor,"D-phenylalanyl-N-[(2S,3S)-6-{[amino(iminio)methyl]amino}-1-chloro-2-hydroxyhexan-3-yl]-L-prolinamide",801,Inner Protein Regulator,Allosteric position,,,Yes,6PX5
ASD05950000_1,tcdB,Clostridium difficile,Q189K3,3PA8,ASD03710003,IHP,A,Lig,Activator,"(2,3,4,5,6-pentaphosphonooxycyclohexyl) dihydrogen phosphate",257,Inner Protein Regulator,Inner Protein,21095570,Rational design of inhibitors and activity-based probes targeting Clostridium difficile virulence factor TcdB.,No,"Chain A:ARG28,ARG32,TYR34,LEU54,LYS57,LYS104,GLY207,ARG208,ARG209,LYS221,LYS232,TYR234,LYS249"
ASD05950000_1,tcdB,Clostridium difficile,Q189K3,3PEE,ASD03710003,IHP,A,Lig,Activator,"(2,3,4,5,6-pentaphosphonooxycyclohexyl) dihydrogen phosphate",255,Inner Protein Regulator,Inner Protein,21317893,Defining an allosteric circuit in the cysteine protease domain of Clostridium difficile toxins.,No,"Chain A:ARG28,ARG32,TYR34,LEU54,LYS57,LYS104,GLY207,ARG208,ARG209,LYS221,LYS232,TYR234,LYS249"
ASD05980000_1,RHOA,Homo sapiens,P61586,6KX3,,8ZO,A,Lig,Inhibitor,"prop-2-enyl (3R)-1,1-bis(oxidanylidene)-2,3-dihydro-1-benzothiophene-3-carboxylate",202,,,,,,6KX3
ASD06090000_1,USP7,Homo sapiens,Q93009,5N9R,ASD06090005,8RN,A,Lig,Inhibitor,"7-bromanyl-3-[[4-oxidanyl-1-[(3~{R})-3-phenylbutanoyl]piperidin-4-yl]methyl]thieno[3,2-d]pyrimidin-4-one",1003,Allosteric Fuction,Allosteric Position,29200206,Discovery and characterization of highly potent and selective allosteric USP7 inhibitors.,No,5N9R
ASD06090000_1,USP7,Homo sapiens,Q93009,5N9T,ASD06090004,8QQ,A,Lig,Inhibitor,"3-[4-(aminomethyl)phenyl]-2-methyl-6-[[4-oxidanyl-1-[(3~{R})-4,4,4-tris(fluoranyl)-3-phenyl-butanoyl]piperidin-4-yl]methyl]pyrazolo[4,3-d]pyrimidin-7-one",1005,Allosteric Fuction,Allosteric Position,29200206,Discovery and characterization of highly potent and selective allosteric USP7 inhibitors.,No,5N9T
ASD06090000_1,USP7,Homo sapiens,Q93009,6VN2,,R44,A,Lig,Inhibitor,"1-({7-[(2R)-5-chloro-2-(piperazine-1-carbonyl)-2,3-dihydro-1-benzofuran-7-yl]thieno[3,2-b]pyridin-2-yl}methyl)-1H-pyrrole-2,5-dione",601,Allosteric function,Allosteric position,,,No,6VN2
ASD06090000_1,USP7,Homo sapiens,Q93009,6VN3,,R3Y,A,Lig,Inhibitor,"1-{[7-(5-chloro-2-{[(3R,4S)-4-fluoropyrrolidin-3-yl]oxy}-3-methylphenyl)thieno[3,2-b]pyridin-2-yl]methyl}-1H-pyrrole-2,5-dione",601,Allosteric function,Allosteric position,,,No,6VN3
ASD06090000_1,USP7,Homo sapiens,Q93009,6VN4,,R4D,A,Lig,Inhibitor,3-({4-hydroxy-1-[(2R)-2-methyl-3-phenylpropanoyl]piperidin-4-yl}methyl)quinazolin-4(3H)-one,601,Allosteric function,Allosteric position,,,No,6VN4
ASD06090000_1,USP7,Homo sapiens,Q93009,6VN5,,R41,A,Lig,Inhibitor,"[(2R)-7-(2-aminopyridin-4-yl)-5-chloro-2,3-dihydro-1-benzofuran-2-yl](piperazin-1-yl)methanone",601,Allosteric function,Allosteric position,,,No,6VN5
ASD06090000_1,USP7,Homo sapiens,Q93009,6VN6,,R4J,A,Lig,Inhibitor,"[(2R)-5-chloro-7-{2-[(2S)-1-chloro-2,3-dihydroxypropan-2-yl]thieno[3,2-b]pyridin-7-yl}-2,3-dihydro-1-benzofuran-2-yl](piperazin-1-yl)methanone",601,Allosteric function,Allosteric position,,,No,6VN6
ASD06090000_1,USP7,Homo sapiens,Q93009,7XPY,ASD06090048,EIB,B,compound,,"[(3S,3aR,4R,6Z,9S,10E,11aR)-9-acetyloxy-6-(acetyloxymethyl)-10-methyl-2-oxo-3-(sulfanylmethyl)-3a,4,5,8,9,11a-hexahydro-3H-cyclodeca[b]furan-4-yl] 4-hydroxy-2-methylbutanoate",,,,35947662,,,7XPY
ASD06110000_1,CDC34,Homo sapiens,P49427,3RZ3,ASD06112001,U94,A,Lig,Inhibitor,"(2R,3S,4S)-5-[4-[3,5-bis(chloranyl)phenyl]phenyl]-4-(2-methoxyethanoylamino)-2,3-bis(oxidanyl)pentanoic acid",1,Inner Protein Regulator,Protein-Protein Interaction,21683433,An allosteric inhibitor of the human cdc34 ubiquitin conjugating enzyme,No,3RZ3
ASD06110000_1,CDC34,Homo sapiens,P49427,4MDK,ASD06112001,U94,A,Lig,Inhibitor,"(2R,3S,4S)-5-[4-[3,5-bis(chloranyl)phenyl]phenyl]-4-(2-methoxyethanoylamino)-2,3-bis(oxidanyl)pentanoic acid",201,Inner Protein Regulator,Protein-Protein Interaction,24316736,E2 enzyme inhibition by stabilization of a low-affinity interface with ubiquitin.,No,4MDK
ASD06120000_1,UGDH,Homo sapiens,O60701,3PRJ,ASD06120004,UDX,A,Lig,Regulator,"[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] [(2R,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl] hydrogen phosphate",501,Inner Protein Regulator,Inner Protein,21595445,Role of Packing Defects in the Evolution of Allostery and Induced Fit in Human UDP-Glucose Dehydrogenase.,No,3PRJ
ASD06120000_1,UGDH,Homo sapiens,O60701,3PTZ,ASD06120004,UDX,A,Lig,Regulator,"[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] [(2R,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl] hydrogen phosphate",501,Inner Protein Regulator,Inner Protein,21595445,Role of Packing Defects in the Evolution of Allostery and Induced Fit in Human UDP-Glucose Dehydrogenase.,No,3PTZ
ASD06120000_2,ugd,Klebsiella pneumoniae,C4XAX5,3PJG,ASD06120002,UGA,A,Lig,Inhibitor,"(2S,3S,4S,5R,6R)-6-[[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxy-3,4,5-trihydroxy-oxane-2-carboxylic acid",902,Inner Protein Regulator,Inner Protein,21536136,Conformational change upon product binding to Klebsiella pneumoniae UDP-glucose dehydrogenase: a possible inhibition mechanism for the key enzyme in polymyxin resistance.,No,"Chain A:LYS256,ASP257,LYS259,LYS284,GLN319,GLY320,MET322,LYS323,ARG324,LYS326,PHE345"
ASD06390000_1,KRAS,Homo sapiens,P01116,4LUC,ASD06390028,20G,A,Lig,Inhibitor,"N-[1-[2-[2,4-bis(chloranyl)phenoxy]ethanoyl]piperidin-4-yl]-4-sulfanyl-butanamide",203,Inner Protein Regulator,Inner Protein,24256730,K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.,Yes,4LUC
ASD06390000_1,KRAS,Homo sapiens,P01116,4LV6,ASD06390029,20H,A,Lig,Inhibitor,"1-[2-[2,4-bis(chloranyl)phenoxy]ethanoyl]-N-(2-sulfanylethyl)piperidine-4-carboxamide",203,Inner Protein Regulator,Inner Protein,24256730,K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.,Yes,4LV6
ASD06390000_1,KRAS,Homo sapiens,P01116,4LYF,ASD06390030,21C,B,Lig,Inhibitor,"N-[1-[2-[[4,5-bis(chloranyl)-2-oxidanyl-phenyl]amino]ethanoyl]piperidin-4-yl]ethanesulfonamide",201,Inner Protein Regulator,Inner Protein,24256730,K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.,Yes,4LYF
ASD06390000_1,KRAS,Homo sapiens,P01116,4LYH,ASD06390032,21F,B,Lig,Inhibitor,N-[1-[2-[(4-chloranyl-5-iodanyl-2-methoxy-phenyl)amino]ethanoyl]piperidin-4-yl]ethanesulfonamide,201,Inner Protein Regulator,Inner Protein,24256730,K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.,Yes,4LYH
ASD06390000_1,KRAS,Homo sapiens,P01116,4LYJ,ASD06390032,21F,A,Lig,Inhibitor,N-[1-[2-[(4-chloranyl-5-iodanyl-2-methoxy-phenyl)amino]ethanoyl]piperidin-4-yl]ethanesulfonamide,202,Inner Protein Regulator,Inner Protein,24256730,K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.,Yes,4LYJ
ASD06390000_1,KRAS,Homo sapiens,P01116,4M1O,ASD06390015,21J,B,Lig,Inhibitor,"N-[1-[2-[[5,7-bis(chloranyl)-2,2-dimethyl-1,3-benzodioxol-4-yl]oxy]ethanoyl]piperidin-4-yl]ethanesulfonamide",201,Inner Protein Regulator,Inner Protein,24256730,K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.,Yes,4M1O
ASD06390000_1,KRAS,Homo sapiens,P01116,4M1S,ASD06390020,21K,B,Lig,Inhibitor,"N-[1-[2-[(2,4-dichlorophenyl)amino]ethanoyl]piperidin-4-yl]ethanesulfonamide",201,Inner Protein Regulator,Inner Protein,24256730,K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.,Yes,4M1S
ASD06390000_1,KRAS,Homo sapiens,P01116,4M1T,ASD06390021,21M,B,Lig,Inhibitor,"N-[1-[2-[2,4-bis(chloranyl)phenoxy]ethanoyl]piperidin-4-yl]ethanesulfonamide",201,Inner Protein Regulator,Inner Protein,24256730,K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.,Yes,4M1T
ASD06390000_1,KRAS,Homo sapiens,P01116,4M1W,ASD06390024,21R,A,Lig,Inhibitor,"N-[1-[2-[[4,5-bis(chloranyl)-2-ethyl-phenyl]amino]ethanoyl]piperidin-4-yl]ethanesulfonamide",202,Inner Protein Regulator,Inner Protein,24256730,K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.,Yes,4M1W
ASD06390000_1,KRAS,Homo sapiens,P01116,4M1Y,ASD06390025,21S,B,Lig,Inhibitor,"N-[1-[2-[[5,7-bis(chloranyl)-2,1,3-benzothiadiazol-4-yl]amino]ethanoyl]piperidin-4-yl]ethanesulfonamide",201,Inner Protein Regulator,Inner Protein,24256730,K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.,Yes,4M1Y
ASD06390000_1,KRAS,Homo sapiens,P01116,4M21,ASD06390026,21Y,B,Lig,Inhibitor,"1-[4-[2-[[4,5-bis(chloranyl)-2-methoxy-phenyl]amino]ethanoyl]piperazin-1-yl]propan-1-one",201,Inner Protein Regulator,Inner Protein,24256730,K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.,Yes,4M21
ASD06390000_1,KRAS,Homo sapiens,P01116,4M22,ASD06390014,22C,B,Lig,Inhibitor,"1-[4-[2-[2,4-bis(chloranyl)phenoxy]ethanoyl]piperazin-1-yl]propan-1-one",202,Inner Protein Regulator,Inner Protein,24256730,K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.,Yes,4M22
ASD06390000_1,KRAS,Homo sapiens,P01116,5F2E,ASD06390027,5UT,A,Lig,Inhibitor,1-[3-[4-[2-[[4-chloranyl-5-(1-methylcyclopropyl)-2-oxidanyl-phenyl]amino]ethanoyl]piperazin-1-yl]azetidin-1-yl]prop-2-en-1-one,204,Allosteric function,Allosteric position,26739882,Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive State.,No,5F2E
ASD06390000_1,KRAS,Homo sapiens,P01116,5V9L,ASD06390037,91D,A,Lig,Inhibitor,"N~3~-[6-chloro-7-(2-fluorophenyl)-4-(4-propanoylpiperazin- 1-yl)quinazolin-2-yl]-N,N-dimethyl-beta-alaninamide",203,Inner Protein Regulator,Inner Protein,28781124,Potent and Selective Covalent Quinazoline Inhibitors of KRAS G12C.,Yes,5V9L
ASD06390000_1,KRAS,Homo sapiens,P01116,5V9O,ASD06390038,91G,A,Lig,Inhibitor,"N~3~-[6-chloro-7-(3-hydroxynaphthalen-1-yl)- 4-(4-propanoylpiperazin-1-yl)quinazolin-2- yl]-N,N-dimethyl-beta-alaninamide",203,Inner Protein Regulator,Inner Protein,28781124,Potent and Selective Covalent Quinazoline Inhibitors of KRAS G12C.,Yes,5V9O
ASD06390000_1,KRAS,Homo sapiens,P01116,6T5B,,O7K,A,Lig,Inhibitor,pyrazinoquinolinone,203,,,,,,6T5B
ASD06390000_1,KRAS,Homo sapiens,P01116,6T5U,,MKW,A,Lig,Inhibitor,"1-[(7R)-16-chloro-15-(5-methyl-1H-indazol-4-yl)-9-oxa-2,5,12-triazatetracyclo[8.8.0.02,7.013,18]octadeca-1(10),11,13,15,17-pentaen-5-yl]prop-2-en-1-one",203,,,,,,6T5U
ASD06390000_1,KRAS,Homo sapiens,P01116,6T5V,,MKZ,A,Lig,Inhibitor,1-[4-[6-chloranyl-7-(5-methyl-1~{H}-indazol-4-yl)quinazolin-4-yl]piperazin-1-yl]propan-1-one,203,,,,,,6T5V
ASD06390000_1,KRAS,Homo sapiens,P01116,6TAM,,MZQ,A,Lig,Inhibitor,"7-[2,4-bis(fluoranyl)phenyl]-3-[(3~{R})-1-propanoylpyrrolidin-3-yl]-4~{H}-isoquinolin-1-one",203,Allosteric function,Allosteric position,,,No,6TAM
ASD06390000_1,KRAS,Homo sapiens,P01116,6TAN,,MZN,A,Lig,Inhibitor,"7-(2-fluoranyl-6-oxidanyl-phenyl)-3-[(3~{R})-1-propanoylpyrrolidin-3-yl]-4~{H}-2,6-naphthyridin-1-one",203,Allosteric function,Allosteric position,,,No,6TAN
ASD06390000_1,KRAS,Homo sapiens,P01116,7O70,ASD06390050,V4T,"C,G",compound,,"1-((3R,14aS)-11-chloro-9-fluoro-10-(2-fluoro-6-hydroxyphenyl)-3-methyl-1,3,4,13,14,14a-hexahydro-2H-pyrazino[1',2':5,6][1,5]oxazocino[4,3,2-de]quinazolin-2-yl)prop-2-en-1-one",,,,35471939,,,7O70
ASD06390000_1,KRAS,Homo sapiens,P01116,7O83,ASD06390052,V52,"E,I",compound,,"1-[(8aS)-6-chloro-5-(5-methyl-1H-indazol-4-yl)-8,8a,9,10,11,12-hexahydropyrazino[2',1':3,4][1,4]oxazepino[5,6,7-de]quinazolin-10-yl]prop-2-en-1-one",,,,35471939,,,7O83
ASD06390000_1,KRAS,Homo sapiens,P01116,7OO7,ASD06390057,VLE,"E,H",compound,,"1-((14aS)-11-chloro-10-(5-methyl-1H-indazol-4-yl)-1,3,4,13,14,14a-hexahydro-2Hpyrazino[1',2':5,6][1,5]oxazocino[4,3,2-de]quinazolin-2-yl)prop-2-en-1-one",,,,35471939,,,7OO7
ASD06430000_1,csoR,Mycobacterium tuberculosis,P9WP49,2HH7,ASD06432001,CU1,A,Ion,Inhibitor,copper(+1) cation,120,Protein-DNA/RNA Interaction Regulator,Inner Protein,17143269,CsoR is a novel Mycobacterium tuberculosis copper-sensing transcriptional regulator.,No,"Chain A:TYR35,CYS36"
ASD06550000_1,PANK3,Homo sapiens,Q9H999,2I7P,ASD05550001,ACO,A,Lig,Inhibitor,"S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxy-2-hydroxy-3,3-dimethyl-butanoyl]amino]propanoylamino]ethyl] ethanethioate",1604,Inner Protein Regulator,Protein-Protein Interaction,17631502,Crystal structures of human pantothenate kinases. Insights into allosteric regulation and mutations linked to a neurodegeneration disorder.,No,2I7P
ASD06550000_1,PANK3,Homo sapiens,Q9H999,3MK6,ASD05550001,ACO,A,Lig,Inhibitor,"S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxy-2-hydroxy-3,3-dimethyl-butanoyl]amino]propanoylamino]ethyl] ethanethioate",1901,Inner Protein Regulator,Protein-Protein Interaction,20797618,Modulation of Pantothenate Kinase 3 Activity by Small Molecules that Interact with the Substrate/Allosteric Regulatory Domain.,No,3MK6
ASD06550000_1,PANK3,Homo sapiens,Q9H999,5KQD,ASD06550001,PKZ,A,Lig,Inhibitor,Palmitoyl-CoA,401,Allosteric Fuction,Allosteric Position,27555321,Allosteric Regulation of Mammalian Pantothenate Kinase.,Yes,5KQD
ASD06640000_2,sbcB,Escherichia coli,P04995,3HL8,ASD06640001,BBP,A,Lig,Inhibitor,"5-tert-butyl-2-(6-chloro-1,3-benzothiazol-2-yl)-3,4-dihydropyrazol-3-ol",501,Protein-Protein Interaction Regulator,Inner Protein,20018747,Small-molecule tools for dissecting the roles of SSB/protein interactions in genome maintenance,Yes,"Chain A:PRO228,TRP245,LEU264,ALA312,ASN313,ARG316,PRO317,ARG327,CYS330,LEU331,LEU334"
ASD06680000_2,Rv0998,Mycobacterium tuberculosis,O05581,4AVB,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",400,Inner Protein Regulator,Inner Protein,22773105,Cyclic AMP Regulation of Protein Lysine Acetylation in Mycobacterium Tuberculosis.,No,"Chain A:LEU48,VAL67,ALA79,ARG80,ILE86,VAL87,GLY88,GLU89,ILE90,ALA91,ARG98,SER99,ALA100,VAL102,ARG138,PHE142"
ASD06680000_2,Rv0998,Mycobacterium tuberculosis,O05581,4AVC,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",400,Inner Protein Regulator,Inner Protein,22773105,Cyclic AMP Regulation of Protein Lysine Acetylation in Mycobacterium Tuberculosis.,No,"Chain A:VAL67,ALA79,ARG80,VAL87,GLY88,GLU89,ILE90,ALA91,ARG98,SER99,ALA100,VAL102,ARG138,PHE142"
ASD06680000_3,Dhaf_0733,Desulfitobacterium hafniense,B8FW11,3E5U,ASD06680001,3C4,A,Lig,Activator,2-(3-chloro-4-hydroxy-phenyl)ethanoic acid,501,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,18717788,"Molecular basis of halorespiration control by CprK, a CRP-FNR type transcriptional regulator",No,"Chain A:LEU63,TYR76,LEU83,ILE84,GLY85,LYS86,THR90,ASN92,ILE94,TYR130,LYS133; Chain B:LEU131,VAL134,ALA135"
ASD06680000_3,Dhaf_0733,Desulfitobacterium hafniense,B8FW11,3E5X,ASD06680001,3C4,A,Lig,Activator,2-(3-chloro-4-hydroxy-phenyl)ethanoic acid,501,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,18717788,"Molecular basis of halorespiration control by CprK, a CRP-FNR type transcriptional regulator",No,"Chain A:LEU63,TYR76,LEU83,ILE84,GLY85,LYS86,THR90,ASN92,ILE94,TYR130,LYS133; Chain B:LEU131,VAL134,ALA135"
ASD06680000_3,Dhaf_0733,Desulfitobacterium hafniense,B8FW11,3E6B,ASD06680001,3C4,A,Lig,Activator,2-(3-chloro-4-hydroxy-phenyl)ethanoic acid,301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,18717788,"Molecular basis of halorespiration control by CprK, a CRP-FNR type transcriptional regulator",No,"Chain A:LEU63,LEU75,TYR76,LEU83,ILE84,GLY85,LYS86,THR90,ASN92,ILE94,TYR130,LYS133; Chain B:LEU131,VAL134,ALA135"
ASD06680000_3,Dhaf_0733,Desulfitobacterium hafniense,B8FW11,3E6C,ASD06680001,3C4,C,Lig,Activator,2-(3-chloro-4-hydroxy-phenyl)ethanoic acid,604,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,18717788,"Molecular basis of halorespiration control by CprK, a CRP-FNR type transcriptional regulator",No,"Chain C:LEU63,TYR76,LEU83,ILE84,GLY85,LYS86,THR90,ASN92,ILE94,TYR130,LYS133"
ASD06710000_1,AR,Homo sapiens,P10275,2PIO,ASD06710004,2MI,A,Lig,Inhibitor,2-methyl-1H-indole,933,Protein-Protein Interaction Regulator,Protein-Protein Interaction,17911242,A surface on the androgen receptor that allosterically regulates coactivator binding.,No,2PIO
ASD06710000_1,AR,Homo sapiens,P10275,2PIO,ASD06710004,2MI,A,Lig,Inhibitor,2-methyl-1H-indole,934,Protein-Protein Interaction Regulator,Inner Protein,17911242,A surface on the androgen receptor that allosterically regulates coactivator binding.,No,2PIO
ASD06710000_1,AR,Homo sapiens,P10275,2PIP,ASD06710007,K10,L,Lig,Inhibitor,"1-tert-butyl-3-[(2,5-dimethylphenyl)methyl]pyrazolo[4,5-e]pyrimidin-4-amine",936,Protein-Protein Interaction Regulator,Protein-Protein Interaction,17911242,A surface on the androgen receptor that allosterically regulates coactivator binding.,No,2PIP
ASD06710000_1,AR,Homo sapiens,P10275,2PIP,ASD06710009,ICO,L,Lig,Inhibitor,1H-indole-3-carboxylic acid,935,Protein-Protein Interaction Regulator,Inner Protein,17911242,A surface on the androgen receptor that allosterically regulates coactivator binding.,No,2PIP
ASD06710000_1,AR,Homo sapiens,P10275,2PIQ,ASD06710008,RB1,A,Lig,Inhibitor,"3-[(4-amino-1-tert-butyl-pyrazolo[4,5-e]pyrimidin-3-yl)methyl]phenol",933,Protein-Protein Interaction Regulator,Protein-Protein Interaction,17911242,A surface on the androgen receptor that allosterically regulates coactivator binding.,No,2PIQ
ASD06710000_1,AR,Homo sapiens,P10275,2PIT,ASD06710006,4HY,A,Lig,Inhibitor,"2-[4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]ethanoic acid",933,Protein-Protein Interaction Regulator,Inner Protein,17911242,A surface on the androgen receptor that allosterically regulates coactivator binding.,No,2PIT
ASD06710000_1,AR,Homo sapiens,P10275,2PIU,ASD06710006,4HY,A,Lig,Inhibitor,"2-[4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]ethanoic acid",932,Protein-Protein Interaction Regulator,Protein-Protein Interaction,17911242,A surface on the androgen receptor that allosterically regulates coactivator binding.,No,2PIU
ASD06710000_1,AR,Homo sapiens,P10275,2PIU,ASD06710006,4HY,A,Lig,Inhibitor,"2-[4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]ethanoic acid",933,Protein-Protein Interaction Regulator,Inner Protein,17911242,A surface on the androgen receptor that allosterically regulates coactivator binding.,No,2PIU
ASD06710000_1,AR,Homo sapiens,P10275,2PIV,ASD06718002,T3,A,Lig,Inhibitor,"(2S)-2-amino-3-[4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]propanoic acid",933,Protein-Protein Interaction Regulator,Inner Protein,17911242,A surface on the androgen receptor that allosterically regulates coactivator binding.,No,2PIV
ASD06710000_1,AR,Homo sapiens,P10275,2PIW,ASD06718002,T3,A,Lig,Inhibitor,"(2S)-2-amino-3-[4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]propanoic acid",932,Protein-Protein Interaction Regulator,Protein-Protein Interaction,17911242,A surface on the androgen receptor that allosterically regulates coactivator binding.,No,2PIW
ASD06710000_1,AR,Homo sapiens,P10275,2PIW,ASD06718002,T3,A,Lig,Inhibitor,"(2S)-2-amino-3-[4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]propanoic acid",933,Protein-Protein Interaction Regulator,Inner Protein,17911242,A surface on the androgen receptor that allosterically regulates coactivator binding.,No,2PIW
ASD06710000_1,AR,Homo sapiens,P10275,2PIX,ASD06710002,FLF,A,Lig,Inhibitor,2-[[3-(trifluoromethyl)phenyl]amino]benzoic acid,2386,Protein-Protein Interaction Regulator,Inner Protein,17911242,A surface on the androgen receptor that allosterically regulates coactivator binding.,No,2PIX
ASD06710000_1,AR,Homo sapiens,P10275,2PKL,ASD06710006,4HY,A,Lig,Inhibitor,"2-[4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]ethanoic acid",932,Protein-Protein Interaction Regulator,Inner Protein,17911242,A surface on the androgen receptor that allosterically regulates coactivator binding.,No,2PKL
ASD06710000_1,Ar,Homo sapiens,P19091,2QPY,ASD06710006,4HY,A,Lig,Inhibitor,"2-[4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]ethanoic acid",1,Protein-Protein Interaction Regulator,Inner Protein,17911242,A surface on the androgen receptor that allosterically regulates coactivator binding.,No,2QPY
ASD06710000_1,AR,Homo sapiens,P10275,2YHD,ASD06710053,AV6,A,Lig,Inhibitor,"4-(2,3-dihydro-1H-perimidin-2-yl)benzene-1,2-diol",1921,Protein-Protein Interaction Regulator,Protein-Protein Interaction,21846139,Inhibitors of Androgen Receptor Activation Function-2 (Af2) Site Identified Through Virtual Screening.,No,2YHD
ASD06710000_1,AR,Homo sapiens,P10275,2YLO,ASD06710054,YLO,A,Lig,Inhibitor,1-[2-(4-methylphenoxy)ethyl]-2-(2-phenoxyethylsulfanyl)benzimidazole,1922,Protein-Protein Interaction Regulator,Inner Protein,22047606,Targeting the Binding Function 3 (Bf3) Site of the Human Androgen Receptor Through Virtual Screening.,No,2YLO
ASD06710000_1,AR,Homo sapiens,P10275,2YLP,ASD06710069,56,A,Lig,Inhibitor,"3-[(2,4-dichlorophenyl)methylsulfanylmethyl]benzoic acid",1923,Protein-Protein Interaction Regulator,Protein-Protein Interaction,22047606,Targeting the Binding Function 3 (Bf3) Site of the Human Androgen Receptor Through Virtual Screening.,No,2YLP
ASD06710000_1,AR,Homo sapiens,P10275,2YLP,ASD06710069,56,A,Lig,Inhibitor,"3-[(2,4-dichlorophenyl)methylsulfanylmethyl]benzoic acid",1922,Protein-Protein Interaction Regulator,Inner Protein,22047606,Targeting the Binding Function 3 (Bf3) Site of the Human Androgen Receptor Through Virtual Screening.,No,2YLP
ASD06710000_1,AR,Homo sapiens,P10275,2YLQ,ASD06710071,YLQ,A,Lig,Inhibitor,3-[1-[2-(4-methylphenoxy)ethyl]benzimidazol-2-yl]sulfanylpropanoic acid,1922,Protein-Protein Interaction Regulator,Inner Protein,22047606,Targeting the Binding Function 3 (Bf3) Site of the Human Androgen Receptor Through Virtual Screening.,No,2YLQ
ASD06710000_1,AR,Homo sapiens,P10275,3ZQT,ASD06710072,30Z,A,Lig,Inhibitor,"4-[(2S,3S)-4-[3,4-bis(oxidanyl)phenyl]-2,3-dimethyl-butyl]benzene-1,2-diol",1920,Protein-Protein Interaction Regulator,Inner Protein,22047606,Targeting the Binding Function 3 (Bf3) Site of the Human Androgen Receptor Through Virtual Screening.,No,3ZQT
ASD06710000_1,AR,Homo sapiens,P10275,4HLW,ASD06710073,17W,A,Lig,Inhibitor,2-(2-phenoxyethylsulfanyl)-1H-benzimidazole,1002,Protein-Protein Interaction Regulator,Inner Protein,23301637,Targeting the Binding Function 3 (BF3) Site of the Androgen Receptor Through Virtual Screening. 2. Development of 2-((2-phenoxyethyl) thio)-1H-benzimidazole Derivatives.,No,4HLW
ASD06710000_1,AR,Homo sapiens,P10275,4K7A,ASD06710074,MXD,A,Lig,Inhibitor,"3-oxido-6-piperidin-1-yl-pyrimidin-3-ium-2,4-diamine",1002,Protein-Protein Interaction Regulator,Inner Protein,,Crystal structure of the androgen receptor ligand binding domain in complex with minoxidil,No,4K7A
ASD06820000_1,EF_1143,Enterococcus faecalis,Q836G9,3IRH,ASD09690001,DGT,A,Lig,Activator,"[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",458,Inner Protein Regulator,Protein-Protein Interaction,21757692,Characterization of the deoxynucleotide triphosphate triphosphohydrolase (dNTPase) activity of the EF1143 protein from Enterococcus faecalis and crystal structure of the activator-substrate complex.,No,"Chain A:PHE54,THR55,VAL247,ARG326,LYS330,LYS422; Chain B:LYS14,VAL15,PHE16,ILE35,ASN36,GLN41,ARG44,PHE64"
ASD06820000_1,EF_1143,Enterococcus faecalis,Q836G9,4LRL,ASD09690001,DGT,B,Lig,Activator,"[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",502,Inner Protein Regulator,Protein-Protein Interaction,24338016,Mechanisms of Allosteric Activation and Inhibition of the Deoxyribonucleoside Triphosphate Triphosphohydrolase from Enterococcus faecalis.,No,"Chain A:PHE54,THR55,VAL247,ARG326,LYS330; Chain B:LYS14,VAL15,PHE16,LEU32,ILE35,ASN36,GLN41,ARG44,PHE64"
ASD06820000_1,EF_1143,Enterococcus faecalis,Q836G9,4LRL,ASD02040015,TTP,B,Lig,Inhibitor,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",503,Inner Protein Regulator,Protein-Protein Interaction,24338016,Mechanisms of Allosteric Activation and Inhibition of the Deoxyribonucleoside Triphosphate Triphosphohydrolase from Enterococcus faecalis.,No,"Chain A:THR55,PHE56,THR197,GLN241,HIS245; Chain B:VAL15,PHE16,ARG17; Chain D:ARG206,ARG209,ASN223"
ASD06930000_2,RYR1,Oryctolagus cuniculus,P11716,5J8V,,Ca2+,A,Ion,Activator,Ca2+,,,,27573175,Structural insights into Ca(2+)-activated long-range allosteric channel gating of RyR1,,
ASD06980000_1,fimX,Pseudomonas aeruginosa,Q9HUK6,3HV8,ASD06980001,C2E,A,Lig,Inhibitor,"9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)- 3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro- 2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine- 2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin- 6-one)",900,Inner Protein Regulator,Inner Protein,19679088,Structural analysis of the GGDEF-EAL domain-containing c-di-GMP receptor FimX.,No,"Chain A:GLN461,LEU477,LEU478,ARG479,PRO490,LEU494,ASP507,VAL510,HIS533,LEU534,SER535,GLN596,PHE652,VAL653,GLU654,GLY672,TYR673,PRO678"
ASD06990000_1,mhkA,Dictyostelium discoideum,P42527,3LLA,ASD06990001,PO4,A,Ion,Regulator,PHOSPHATE ION,5954,Inner Protein Regulator,Inner Protein,20197546,Crystal Structure of the {alpha}-Kinase Domain of Dictyostelium Myosin Heavy Chain Kinase A.,No,"Chain A:PRO683,LYS684,ARG734,ASP762,PRO737,THR736,VAL799,ASN733,SER735"
ASD06990000_1,mhkA,Dictyostelium discoideum,P42527,3LMH,ASD06990001,PO4,A,Ion,Regulator,PHOSPHATE ION,842,Inner Protein Regulator,Inner Protein,20197546,Crystal Structure of the {alpha}-Kinase Domain of Dictyostelium Myosin Heavy Chain Kinase A.,No,"Chain A:PRO683,LYS684,ARG734,ASP762,PRO737,THR736,VAL799,ASN733,SER735"
ASD06990000_1,mhkA,Dictyostelium discoideum,P42527,3LMI,ASD06990001,PO4,B,Ion,Regulator,PHOSPHATE ION,5956,Inner Protein Regulator,Inner Protein,20197546,Crystal Structure of the {alpha}-Kinase Domain of Dictyostelium Myosin Heavy Chain Kinase A.,No,"Chain B:SER735,ASN733,ARG734,PRO737,ASP762,VAL799,THR736,PRO683,LYS684"
ASD06990000_1,mhkA,Dictyostelium discoideum,P42527,3PDT,ASD06990001,PO4,A,Ion,Regulator,PHOSPHATE ION,810,Inner Protein Regulator,Inner Protein,21071445,Autophosphorylation Activates Dictyostelium Myosin II Heavy Chain Kinase A by Providing a Ligand for an Allosteric Binding Site in the {alpha}-Kinase Domain.,No,"Chain A:PRO683,LYS684,ARG734,ASP762,PRO737,THR736,VAL799,ASN733,SER735"
ASD07000000_1,MAOB,Homo sapiens,P27338,1OJ9,ASD07000016,1PB,A,Lig,Inhibitor,[(E)-4-phenylbut-3-enyl]benzene,1503,Inner Protein Regulator,Inner Protein,12913124,Insights Into the Mode of Inhibition of Human Mitochondrial Monoamine Oxidase B from High-Resolution Crystal Structures,Yes,1OJ9
ASD07000000_1,MAOB,Homo sapiens,P27338,2BK3,ASD07000015,FOH,A,Lig,Inhibitor,"(2Z,6Z)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol",1503,Inner Protein Regulator,Inner Protein,15710600,Demonstration of Isoleucine 199 as a Structural Determinant for the Selective Inhibition of Human Monoamine Oxidase B by Specific Reversible Inhibitors,Yes,2BK3
ASD07000000_1,MAOB,Homo sapiens,P27338,2BYB,ASD07000014,DPK,A,Lig,Inhibitor,(2R)-N-methyl-1-phenyl-N-prop-2-enyl-propan-2-amine,601,Inner Protein Regulator,Inner Protein,16129825,Three-Dimensional Structure of Human Monoamine Oxidase a (Mao A): Relation to the Structures of Rat Mao a and Human Mao B,Yes,2BYB
ASD07000000_1,MAOB,Homo sapiens,P27338,2C65,ASD07000013,4CR,A,Lig,Inhibitor,"(E)-[(1R)-4-(ethyl-methyl-carbamoyl)oxy-2,3-dihydro-1H-inden-1-yl]-methyl-prop-2-enylidene-azanium",601,Inner Protein Regulator,Inner Protein,16366596,Binding of Rasagiline-Related Inhibitors to Human Monoamine Oxidases: A Kinetic and Crystallographic Analysis.,Yes,2C65
ASD07000000_1,MAOB,Homo sapiens,P27338,2V5Z,ASD07000012,SAG,A,Lig,Inhibitor,(2S)-2-[[4-[(3-fluorophenyl)methoxy]phenyl]methylideneamino]propanamide,1503,Inner Protein Regulator,Inner Protein,17915852,Structures of Human Monoamine Oxidase B Complexes with Selective Noncovalent Inhibitors: Safinamide and Coumarin Analogs.,Yes,2V5Z
ASD07000000_1,MAOB,Homo sapiens,P27338,2V60,ASD07000011,C17,A,Lig,Inhibitor,7-[(3-chlorophenyl)methoxy]-2-oxo-chromene-4-carbaldehyde,1503,Inner Protein Regulator,Inner Protein,17915852,Structures of Human Monoamine Oxidase B Complexes with Selective Noncovalent Inhibitors: Safinamide and Coumarin Analogs.,Yes,2V60
ASD07000000_1,MAOB,Homo sapiens,P27338,2V61,ASD07000010,C18,A,Lig,Inhibitor,7-[(3-chlorophenyl)methoxy]-4-(methylaminomethyl)chromen-2-one,1503,Inner Protein Regulator,Inner Protein,17915852,Structures of Human Monoamine Oxidase B Complexes with Selective Noncovalent Inhibitors: Safinamide and Coumarin Analogs.,Yes,2V61
ASD07000000_1,MAOB,Homo sapiens,P27338,2XCG,ASD07000001,XCG,A,Lig,Inhibitor,2-(1-benzofuran-2-yl)-1H-imidazole,602,Inner Protein Regulator,Inner Protein,20855894,Potentiation of Ligand Binding Through Cooperative Effects in Monoamine Oxidase B.,Yes,2XCG
ASD07000000_1,MAOB,Homo sapiens,P27338,2XFN,ASD07000001,XCG,A,Lig,Inhibitor,2-(1-benzofuran-2-yl)-1H-imidazole,1501,Inner Protein Regulator,Inner Protein,20855894,Potentiation of Ligand Binding Through Cooperative Effects in Monoamine Oxidase B.,Yes,2XFN
ASD07000000_1,MAOB,Homo sapiens,P27338,2XFO,ASD07000001,XCG,A,Lig,Inhibitor,2-(1-benzofuran-2-yl)-1H-imidazole,1504,Inner Protein Regulator,Inner Protein,20855894,Potentiation of Ligand Binding Through Cooperative Effects in Monoamine Oxidase B.,Yes,2XFO
ASD07000000_1,MAOB,Homo sapiens,P27338,2XFP,ASD07000001,XCG,A,Lig,Inhibitor,2-(1-benzofuran-2-yl)-1H-imidazole,602,Inner Protein Regulator,Inner Protein,20855894,Potentiation of Ligand Binding Through Cooperative Effects in Monoamine Oxidase B.,Yes,2XFP
ASD07000000_1,MAOB,Homo sapiens,P27338,2XFQ,ASD07000001,XCG,A,Lig,Inhibitor,2-(1-benzofuran-2-yl)-1H-imidazole,602,Inner Protein Regulator,Inner Protein,20855894,Potentiation of Ligand Binding Through Cooperative Effects in Monoamine Oxidase B.,Yes,2XFQ
ASD07000000_1,MAOB,Homo sapiens,P27338,3ZYX,ASD07000006,MBT,A,Lig,Inhibitor,"N,N,N',N'-tetramethylphenothiazin-5-ium-3,7-diamine",601,Inner Protein Regulator,Inner Protein,21978362,The 'Gating' Residues Ile199 and Tyr326 in Human Monoamine Oxidase B Function in Substrate and Inhibitor Recognition.,Yes,3ZYX
ASD07000000_1,MAOB,Homo sapiens,P27338,4A79,ASD07000008,P1B,A,Lig,Inhibitor,"(5R)-5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione",601,Inner Protein Regulator,Inner Protein,22282722,Molecular Insights Into Human Monoamine Oxidase B Inhibition by the Glitazone Anti-Diabetes Drugs,Yes,4A79
ASD07000000_1,MAOB,Homo sapiens,P27338,4A7A,ASD07000009,RGZ,A,Lig,Inhibitor,"(5R)-5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione",601,Inner Protein Regulator,Inner Protein,22282722,Molecular Insights Into Human Monoamine Oxidase B Inhibition by the Glitazone Anti-Diabetes Drugs,Yes,4A7A
ASD07000000_1,MAOB,Homo sapiens,P27338,4CRT,ASD07000007,ASS,A,Lig,Inhibitor,(E)-N-methyl-N-[[1-methyl-5-[3-[1-(phenylmethyl)piperidin-4-yl]propoxy]indol-2-yl]methyl]prop-1-en-1-amine,601,Inner Protein Regulator,Inner Protein,24642166,"Kinetic and Structural Analysis of the Irreversible Inhibition of Human Monoamine Oxidases by Ass234, a Multi-Target Compound Designed for Use in Alzheimer'S Disease.",Yes,4CRT
ASD07020000_1,Nos2,Mus musculus,P29477,1DD7,ASD07020002,13:00,A,Lig,Inhibitor,"methyl (3S)-3-[2-(1,3-benzodioxol-5-ylmethylamino)-2-oxo-ethyl]-4-(2-imidazol-1-ylpyrimidin-4-yl)piperazine-1-carboxylate",601,Protein-Protein Interaction Regulator,Inner Protein,10677491,Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistry.,Yes,"Chain A:ARG193,GLN257,PRO344,ALA345,VAL346,PHE363,ASN364,GLY365,TRP366,TYR367,MET368,TYR485"
ASD07020000_1,Nos2,Mus musculus,P29477,2ORO,ASD07020004,228,A,Lig,Inhibitor,"methyl (3S)-3-[2-(1,3-benzodioxol-5-ylmethylamino)-2-oxo-ethyl]-4-(2-imidazol-1-ylpyrimidin-4-yl)piperazine-1-carboxylate",601,Protein-Protein Interaction Regulator,Inner Protein,17315988,"Design, Synthesis, and Activity of 2-Imidazol-1-ylpyrimidine Derived Inducible Nitric Oxide Synthase Dimerization Inhibitors",Yes,"Chain A:ASN364,GLY365,ALA345,GLN257,TYR485,PRO344,TYR341,ILE259,TRP366,TYR367,VAL346,MET368,LEU343,PHE363,GLY369,ARG260,CYS194"
ASD07020000_1,Nos2,Mus musculus,P29477,2ORP,ASD07020009,R86,A,Lig,Inhibitor,"methyl (3S)-3-[2-(1,3-benzodioxol-5-ylmethylamino)-2-oxo-ethyl]-4-(2-imidazol-1-ylpyrimidin-4-yl)piperazine-1-carboxylate",601,Protein-Protein Interaction Regulator,Inner Protein,17315988,"Design, Synthesis, and Activity of 2-Imidazol-1-ylpyrimidine Derived Inducible Nitric Oxide Synthase Dimerization Inhibitors",Yes,"Chain A:ASN364,TYR367,GLY365,PHE363,ILE372,ARG260,GLU371,MET368,GLN257,GLY373,ILE259,CYS194,VAL346,PRO344,TYR341,ARG193,TRP366,THR370,LEU343,GLY369,ALA345,TYR485"
ASD07020000_1,Nos2,Mus musculus,P29477,2ORQ,ASD07020008,MSR,A,Lig,Inhibitor,"methyl (3S)-3-[2-(1,3-benzodioxol-5-ylmethylamino)-2-oxo-ethyl]-4-(2-imidazol-1-ylpyrimidin-4-yl)piperazine-1-carboxylate",601,Protein-Protein Interaction Regulator,Inner Protein,17315988,"Design, Synthesis, and Activity of 2-Imidazol-1-ylpyrimidine Derived Inducible Nitric Oxide Synthase Dimerization Inhibitors",Yes,"Chain A:ASN364,ALA345,GLN257,PRO344,TRP366,GLU371,TYR367,VAL346,GLY365,PHE363,ARG260,CYS194"
ASD07020000_1,Nos2,Mus musculus,P29477,2ORR,ASD07020007,333,A,Lig,Inhibitor,"methyl (3S)-3-[2-(1,3-benzodioxol-5-ylmethylamino)-2-oxo-ethyl]-4-(2-imidazol-1-ylpyrimidin-4-yl)piperazine-1-carboxylate",601,Protein-Protein Interaction Regulator,Inner Protein,17315988,"Design, Synthesis, and Activity of 2-Imidazol-1-ylpyrimidine Derived Inducible Nitric Oxide Synthase Dimerization Inhibitors",Yes,"Chain A:ASN364,ALA345,GLN257,PRO344,TYR341,TRP366,TYR367,VAL346,TRP340,GLY365,PHE363,MET368,ARG260,CYS194"
ASD07020000_1,Nos2,Mus musculus,P29477,2ORS,ASD07020006,391,A,Lig,Inhibitor,"methyl (3S)-3-[2-(1,3-benzodioxol-5-ylmethylamino)-2-oxo-ethyl]-4-(2-imidazol-1-ylpyrimidin-4-yl)piperazine-1-carboxylate",601,Protein-Protein Interaction Regulator,Inner Protein,17315988,"Design, Synthesis, and Activity of 2-Imidazol-1-ylpyrimidine Derived Inducible Nitric Oxide Synthase Dimerization Inhibitors",Yes,"Chain A:ASN364,ALA345,GLN257,PRO344,TYR341,TRP366,TYR367,VAL346,TRP340,GLY365,PHE363,MET368,ARG260,CYS194"
ASD07020000_1,Nos2,Mus musculus,P29477,2ORT,ASD07020005,342,A,Lig,Inhibitor,"methyl (3S)-3-[2-(1,3-benzodioxol-5-ylmethylamino)-2-oxo-ethyl]-4-(2-imidazol-1-ylpyrimidin-4-yl)piperazine-1-carboxylate",601,Protein-Protein Interaction Regulator,Inner Protein,17315988,"Design, Synthesis, and Activity of 2-Imidazol-1-ylpyrimidine Derived Inducible Nitric Oxide Synthase Dimerization Inhibitors",Yes,"Chain A:ASN364,ALA345,GLN257,PRO344,TYR341,TRP366,TYR367,VAL346,TRP340,GLY365,PHE363,MET368,GLY369,ASP274,ARG260,CYS194"
ASD07020000_1,Nos2,Mus musculus,P29477,3NQS,ASD07020010,AT2,A,Lig,Inhibitor,"methyl (3S)-3-[2-(1,3-benzodioxol-5-ylmethylamino)-2-oxo-ethyl]-4-(2-imidazol-1-ylpyrimidin-4-yl)piperazine-1-carboxylate",906,Protein-Protein Interaction Regulator,Inner Protein,20659888,"Nitric-oxide synthase forms N-NO-pterin and S-NO-cys: implications for activity, allostery, and regulation.",Yes,"Chain A:ASN364,GLY365,ALA345,GLN257,ASP376,PRO344,TYR341,ILE259,TRP366,ARG382,TYR367,VAL346,TRP340,LEU343,PHE363,MET368,ASP274,ARG260,GLU371"
ASD07130000_1,,Trypanosoma brucei brucei,Q9TZZ6,1NJJ,ASD07130013,GET,A,Lig,Inhibitor,"(2R,3S,4R,5R,6S)-5-amino-6-[(1R,2S,3S,4R,6S)-4,6-diamino-3-[(2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-methylamino-oxan-2-yl]oxy-2-hydroxy-cyclohexyl]oxy-2-(1-hydroxyethyl)oxane-3,4-diol",601,Inner Protein Regulator,Protein-Protein Interaction,12672797,X-ray Structure Determination of Trypanosoma brucei Ornithine Decarboxylase Bound to D-Ornithine and to G418: INSIGHTS INTO SUBSTRATE BINDING AND ODC CONFORMATIONAL FLEXIBILITY.,No,"Chain A:ARG22,ASP243,LEU339,PRO340,GLN341,LEU382,GLU384,ASP385"
ASD07260000_1,CPS1,Homo sapiens,P31327,5DOU,ASD07260001,NLG,A,Lig,Regulator,N-ACETYL-L-GLUTAMATE,2010,Allosteric Function,Allosteric Position,26592762,Structure of human carbamoyl phosphate synthetase: deciphering the on/off switch of human ureagenesis.,No,5DOU
ASD07260000_1,CPS1,Homo sapiens,P31327,6UEL,,Q5A,"A, B",Lig,Inhibitor,"N~1~-[(4-fluorophenyl)methyl]-N~1~-methyl-N~4~-(4-methyl-1,3-thiazol-2-yl)piperidine-1,4-dicarboxamide",1494,Allosteric function,Allosteric position,,,Yes,6UEL
ASD07260000_1,CPS1,Homo sapiens,P31327,6W2J,,374,A,Lig,Inhibitor,"(2-fluoranyl-4-methoxy-phenyl)-[(3~{R},5~{R})-4-(2-fluoranyl-4-methoxy-phenyl)carbonyl-3,5-dimethyl-piperazin-1-yl]methanone",1601,,,,,,6W2J
ASD07300000_1,PDE10A,Homo sapiens,Q9Y233,2ZMF,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",2001,Inner Protein Regulator,Inner Protein,18477562,"Crystal Structure of the GAF-B Domain from Human Phosphodiesterase 10A Complexed with Its Ligand, cAMP",No,2ZMF
ASD07400000_1,,Thermotoga maritima,Q9WZ31,2BBH,ASD00330030,MG,A,Ion,Regulator,MAGNESIUM ION,302,Inner Protein Regulator,Inner Protein,16598263,Crystal structure of the CorA Mg2+ transporter.,No,"Chain A:GLU88,ARG96,LYS98,GLN95,LEU85,ASP89"
ASD07400000_1,,Thermotoga maritima,Q9WZ31,2IUB,ASD00330030,MG,A,Ion,Regulator,MAGNESIUM ION,1351,Inner Protein Regulator,Inner Protein,16857941,Crystal Structure of a Divalent Metal Ion Transporter Cora at 2.9 Angstrom Resolution.,No,"Chain B:GLU88,ASN92,LYS98,GLN95,LEU85,ASP89"
ASD07400000_1,,Thermotoga maritima,Q9WZ31,4EED,ASD00330030,MG,A,Ion,Regulator,MAGNESIUM ION,404,Inner Protein Regulator,Inner Protein,23112165,Structural asymmetry in the magnesium channel CorA points to sequential allosteric regulation.,No,"Chain E:HIS257,ASP256,ASP253"
ASD07400000_1,,Thermotoga maritima,Q9WZ31,4I0U,ASD00330030,MG,A,Ion,Regulator,MAGNESIUM ION,401,Inner Protein Regulator,Inner Protein,23425532,Exploring the structure and function of Thermotoga maritima CorA reveals the mechanism of gating and ion selectivity in Co2+/Mg2+ transport.,No,"Chain D:ASP253,ASP179,ASP175,TYR171,HIS257"
ASD07450000_1,pleD,Caulobacter crescentus,B8GZM2,1W25,ASD06980001;ASD06980001,C2E;C2E,A;A,Lig;Lig,Inhibitor,"9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)- 3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro- 2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine- 2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin- 6-one)",503;505,Inner Protein Regulator,Inner Protein,15569936,Structural Basis of Activity and Allosteric Control of Diguanylate Cyclase,No,"Chain A:ARG148,GLY153,GLY174,VAL175,HIS177,ARG178,SER356,ASN357,VAL358,ARG359,ALA360,ASP362,PRO377,THR379,ASP383,ILE387,ARG390"
ASD07450000_1,pleD,Caulobacter crescentus,B8GZM2,2V0N,ASD06980001;ASD06980001,C2E;C2E,A;A,Lig;Lig,Inhibitor,"9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)- 3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro- 2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine- 2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin- 6-one)",503;505,Inner Protein Regulator,Protein-Protein Interaction,17697997,"Structure of Bef3--Modified Response Regulator Pled: Implications for Diguanylate Cyclase Activation, Catalysis, and Feedback Inhibition",No,"Chain A:SER356,ASN357,VAL358,ARG359,ALA360,ASP362,THR379,ASP383,ARG386,ILE387,ARG390; Chain B:SER309,LYS312,ARG313,LEU316,GLY318"
ASD07480000_1,NTRK1,Homo sapiens,P04629,5H3Q,ASD07480050,7HF,A,Lig,Inhibitor,"1-[(3S,4R)-4-[3,4-bis(fluoranyl)phenyl]-1-(2-methoxyethyl)pyrrolidin-3-yl]-3-(5-ethoxy-4-methyl-2-phenyl-pyrazol-3-yl)urea",1001,Allosteric function,Allosteric position,28159414,The juxtamembrane region of TrkA kinase is critical for inhibitor selectivity,No,5H3Q
ASD07480000_1,NTRK1,Homo sapiens,P04629,6D1Y,ASD07480053,FQJ,A,Lig,Inhibitor,"2,4-dichloro-N-(3-methyl-1-phenyl-1H-pyrazol-5-yl)benzamide",801,Allosteric function,Allosteric position,29672039,"Discovery of Allosteric, Potent, Subtype Selective, and Peripherally Restricted TrkA Kinase Inhibitors.",No,6D1Y
ASD07480000_1,NTRK1,Homo sapiens,P04629,6D1Z,ASD07480054,FQM,A,Lig,Inhibitor,5-{[5-(6-aminopyridin-2-yl)-2-chlorobenzene-1-carbonyl]amino}-1-phenyl-1H-pyrazole-3-carboxamide,803,Allosteric function,Allosteric position,29672039,"Discovery of Allosteric, Potent, Subtype Selective, and Peripherally Restricted TrkA Kinase Inhibitors.",No,6D1Z
ASD07480000_1,NTRK1,Homo sapiens,P04629,6D20,ASD07480052,FQG,A,Lig,Inhibitor,"5-{[2,4-dichloro-5-(pyridin-2-yl)benzene-1-carbonyl]amino}-N-(2-hydroxy-2-methylpropyl)-1-phenyl-1H-pyrazole-3-carboxamide",801,Allosteric function,Allosteric position,29672039,"Discovery of Allosteric, Potent, Subtype Selective, and Peripherally Restricted TrkA Kinase Inhibitors.",No,6D20
ASD07480000_1,NTRK1,Homo sapiens,P04629,6D22,,,,,,,,,,29672039,,,6D22
ASD07480000_1,NTRK1,Homo sapiens,P04629,6NPT,,KWY,A,Lig,Inhibitor,"4-tert-butyl-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide",801,Allosteric function,Allosteric position,,,No,6NPT
ASD07480000_1,NTRK1,Homo sapiens,P04629,6NSP,,L0P,A,Lig,Inhibitor,"N-(8-methyl-2-phenylimidazo[1,2-a]pyridin-3-yl)-2-(3-oxo-2,3-dihydro-4H-1,4-benzothiazin-4-yl)acetamide",801,Allosteric function,Allosteric position,,,No,6NSP
ASD07480000_1,NTRK1,Homo sapiens,P04629,6NSS,,L0M,A,Lig,Inhibitor,"N-(8-methyl-2-phenylimidazo[1,2-a]pyrazin-3-yl)-2-(10H-phenoxazin-10-yl)acetamide",801,Allosteric function,Allosteric position,,,No,6NSS
ASD07500000_2,RSP_0333,Rhodobacter sphaeroides,Q3J125,4P02,ASD06980001;ASD06980001,C2E;C2E,A;A,Lig,Activator,"9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin-6-one)",918;919,Inner Protein Regulator,Inner Protein,24704788,Mechanism of activation of bacterial cellulose synthase by cyclic di-GMP.,No,"Chain A:VAL615,GLY614,ILE672,GLN577,VAL671,ARG584,GLY670,ALA582,VAL669,ARG658,PHE673,GLN578,SER611,LEU512,SER659,ASP609,ARG580,ARG656,ARG579,ALA581,ALA610,ARG616,SER613,ARG661"
ASD07590000_1,SOAT1,Homo sapiens,P35610,6VUM,,CLR,A,Ion,Activator,CHOLESTEROL,702,,,,,,6VUM
ASD07600000_1,SOAT2,Homo sapiens,O75908,7N6Q,ASD07600002,7T8,"A,B,C,D",compound,,"rac-(3R,4S,4aR,6R,6aR,12S,12aS,12bR)-4-(acetoxymethyl)-12-hydroxy-4,6a,12b-trimethyl-11-oxo-9-(pyridin-3-yl)-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-2H,11H-benzo[f]pyrano[4,3-b]chromene-3,6-diyl diacetate",,,,34520735,,,7N6Q
ASD07600000_1,SOAT2,Homo sapiens,O75908,7N6R,ASD07600001,ROV,"A,B,C,D",compound,,"1-(2,6-diisopropylphenyl)-3-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea",,,,34520735,,,7N6R
ASD07670000_1,prfA,Listeria monocytogenes,P22262,5LRS,ASD07770001,GSH,A,Lig,Activator,GLUTATHIONE,301,Allosteric function,Allosteric position,27930316,Structural basis for glutathione-mediated activation of the virulence regulatory protein PrfA in Listeria.,No,"Chain A:ILE149,TYR154,LEU60,GLN123,TYR115,LYS130,ALA66,TYR62,GLN146,LEU150,PHE67,VAL153,PHE225,LYS122,THR232,ASN2,GLN61,TRP224,THR119,LYS64,CYS229,SER127,ALA228,LEU41,TYR63,TYR126,GLY65"
ASD07730000_2,fabG,Pseudomonas aeruginosa,O54438,4BNT,ASD07730030,36E,B,Lig,Inhibitor,2-(trifluoromethyl)-1H-benzimidazole,1248,Inner Protein Regulator,Protein-Protein Interaction,24015914,Discovery of an Allosteric Inhibitor Binding Site in 3-Oxo-Acyl-Acp Reductase from Pseudomonas Aeruginosa,No,"Chain A:VAL110,ASN111,LEU114,ALA156,GLY160; Chain B:TRP106,PHE107,VAL110,ASN111,LEU114,GLY160,PHE164"
ASD07730000_2,fabG,Pseudomonas aeruginosa,O54438,4BNU,ASD07730031,9KQ,B,Lig,Inhibitor,"2-phenyl-4-(1,2,4-triazol-4-yl)quinazoline",1248,Inner Protein Regulator,Protein-Protein Interaction,24015914,Discovery of an Allosteric Inhibitor Binding Site in 3-Oxo-Acyl-Acp Reductase from Pseudomonas Aeruginosa,No,"Chain A:TRP106,PHE107,VAL110,ASN111,LEU114,ALA156,ALA159,GLY160,GLY163,PHE164; Chain B:TRP106,PHE107,VAL110,ASN111,LEU114,ALA156,GLY160,GLY163,PHE164"
ASD07730000_2,fabG,Pseudomonas aeruginosa,O54438,4BNV,ASD07730032,Q7U,B,Lig,Inhibitor,1-(2-chlorophenyl)-3-(1-methylbenzimidazol-2-yl)urea,1247,Inner Protein Regulator,Protein-Protein Interaction,24015914,Discovery of an Allosteric Inhibitor Binding Site in Resolution,No,"Chain A:TRP106,PHE107,VAL110,ASN111,LEU114,ALA156,ALA159,GLY160,GLY163,PHE164; Chain B:TRP106,PHE107,VAL110,ASN111,LEU114,ALA156,ALA159,GLY160,GLY163,PHE164"
ASD07730000_2,fabG,Pseudomonas aeruginosa,O54438,4BNX,ASD07730029,O74,A,Lig,Inhibitor,"(6E)-6-[4-[(2-chlorophenyl)amino]-1H-quinazolin-2-ylidene]cyclohexa-2,4-dien-1-one",1247,Inner Protein Regulator,Protein-Protein Interaction,24015914,Discovery of an Allosteric Inhibitor Binding Site in 3-Oxo-Acyl-Acp Reductase from Pseudomonas Aeruginosa,No,"Chain A:TRP106,PHE107,VAL110,ASN111,LEU114,ALA156,ALA159,GLY160,GLY163,PHE164; Chain B:TRP106,PHE107,VAL110,ASN111,LEU114,ALA156,GLY160,GLY163,PHE164"
ASD07730000_2,fabG,Pseudomonas aeruginosa,O54438,4BNY,ASD07730028,36I,B,Lig,Inhibitor,"4-(2-phenylthieno[3,2-d]pyrimidin-4-yl)morpholine",1248,Inner Protein Regulator,Protein-Protein Interaction,24015914,Discovery of an Allosteric Inhibitor Binding Site in 3-Oxo-Acyl-Acp Reductase from Pseudomonas Aeruginosa,No,"Chain A:TRP106,PHE107,VAL110,ASN111,LEU114,ALA156,GLY160,GLY163,PHE164; Chain B:TRP106,PHE107,VAL110,ASN111,LEU114,ALA156,ALA159,GLY160,GLY163,PHE164"
ASD07730000_2,fabG,Pseudomonas aeruginosa,O54438,4BNZ,ASD07730009,8M5,A,Lig,Inhibitor,1-methyl-N-phenyl-indole-3-carboxamide,1248,Inner Protein Regulator,Protein-Protein Interaction,24015914,Discovery of an Allosteric Inhibitor Binding Site in 3-Oxo-Acyl-Acp Reductase from Pseudomonas Aeruginosa,No,"Chain A:PHE107,VAL110,LEU114,ALA156,GLY160,GLY163,PHE164; Chain B:TRP106,VAL110,LEU114,ALA156,GLY160,GLY163,PHE164"
ASD07730000_2,fabG,Pseudomonas aeruginosa,O54438,4BO0,ASD07730001,FXE,A,Lig,Inhibitor,1-(4-methoxy-1-methyl-indazol-3-yl)-3-(2-methoxyphenyl)urea,1248,Inner Protein Regulator,Protein-Protein Interaction,24015914,Discovery of an Allosteric Inhibitor Binding Site in 3-Oxo-Acyl-Acp Reductase from Pseudomonas Aeruginosa,No,"Chain A:TRP106,PHE107,VAL110,LEU114,ALA156,ALA159,GLY160,GLY163,PHE164; Chain B:PHE107,VAL110,ASN111,LEU114,ALA156,ALA159,GLY160,GLY163,PHE164"
ASD07730000_2,fabG,Pseudomonas aeruginosa,O54438,4BO1,ASD07730003,NKH,B,Lig,Inhibitor,"N-(4-chloranyl-2,5-dimethoxy-phenyl)quinoline-8-carboxamide",1248,Inner Protein Regulator,Protein-Protein Interaction,24015914,Discovery of an Allosteric Inhibitor Binding Site in 3-Oxo-Acyl-Acp Reductase from Pseudomonas Aeruginosa,No,"Chain A:TRP106,PHE107,VAL110,ASN111,LEU114,ALA156,ALA159,GLY160,GLY163,PHE164; Chain B:TRP106,PHE107,VAL110,ASN111,LEU114,ALA156,GLY160,GLY163,PHE164"
ASD07730000_2,fabG,Pseudomonas aeruginosa,O54438,4BO2,ASD07730004,36K,A,Lig,Inhibitor,1-(1-ethylbenzimidazol-2-yl)-3-(2-methoxyphenyl)urea,1248,Inner Protein Regulator,Protein-Protein Interaction,24015914,Discovery of an Allosteric Inhibitor Binding Site in 3-Oxo-Acyl-Acp Reductase from Pseudomonas Aeruginosa,No,"Chain A:TRP106,PHE107,VAL110,ASN111,LEU114,ALA156,ALA159,GLY160,GLY163,PHE164; Chain B:TRP106,PHE107,VAL110,ASN111,LEU114,ALA156,GLY160,GLY163,PHE164"
ASD07730000_2,fabG,Pseudomonas aeruginosa,O54438,4BO3,ASD07730013,U98,A,Lig,Inhibitor,2-[[3-(trifluoromethyl)phenyl]amino]pyridine-3-sulfonamide,1248,Inner Protein Regulator,Protein-Protein Interaction,24015914,Discovery of an Allosteric Inhibitor Binding Site in 3-Oxo-Acyl-Acp Reductase from Pseudomonas Aeruginosa,No,"Chain A:TRP106,PHE107,VAL110,ASN111,LEU114,ALA156,ALA159,GLY160,GLY163,PHE164; Chain B:TRP106,VAL110,LEU114,ALA156,GLY163,PHE164"
ASD07730000_2,fabG,Pseudomonas aeruginosa,O54438,4BO4,ASD07730016,36G,A,Lig,Inhibitor,"N-(2-methoxyphenyl)-3,4-dihydro-2H-quinoline-1-carboxamide",1248,Inner Protein Regulator,Protein-Protein Interaction,24015914,Discovery of an Allosteric Inhibitor Binding Site in 3-Oxo-Acyl-Acp Reductase from Pseudomonas Aeruginosa,No,"Chain A:TRP106,PHE107,ASN111,LEU114,ALA159,GLY160,GLY163,PHE164; Chain B:PHE107,VAL110,ASN111,LEU114,ALA156,ALA159,GLY160,GLY163"
ASD07730000_2,fabG,Pseudomonas aeruginosa,O54438,4BO5,ASD07730022,WI4,B,Lig,Inhibitor,"N-(2-chlorophenyl)-4-pyrrol-1-yl-1,3,5-triazin-2-amine",1248,Inner Protein Regulator,Protein-Protein Interaction,24015914,Discovery of an Allosteric Inhibitor Binding Site in 3-Oxo-Acyl-Acp Reductase from Pseudomonas Aeruginosa,No,"Chain A:TRP106,PHE107,VAL110,LEU114,ALA156,ALA159,GLY160,GLY163,PHE164; Chain B:TRP106,VAL110,LEU114,ALA156,ALA159,GLY160,GLY163,PHE164"
ASD07730000_2,fabG,Pseudomonas aeruginosa,O54438,4BO6,ASD07730023,36P,A,Lig,Inhibitor,"2,3-dihydroindol-1-yl-(2-thiophen-3-yl-1,3-thiazol-4-yl)methanone",1248,Inner Protein Regulator,Protein-Protein Interaction,24015914,Discovery of an Allosteric Inhibitor Binding Site in 3-Oxo-Acyl-Acp Reductase from Pseudomonas Aeruginosa,No,"Chain A:TRP106,PHE107,VAL110,ASN111,LEU114,GLY160,GLY163,PHE164; Chain B:PHE107,VAL110,ASN111,LEU114,ALA156,GLY160,GLY163,PHE164"
ASD07730000_2,fabG,Pseudomonas aeruginosa,O54438,4BO7,ASD07730024,J2T,A,Lig,Inhibitor,"N-(2,3-dihydro-1H-inden-5-yl)-[1,2,3,4]tetrazolo[1,5-b]pyridazin-6-amine",1248,Inner Protein Regulator,Protein-Protein Interaction,24015914,Discovery of an Allosteric Inhibitor Binding Site in 3-Oxo-Acyl-Acp Reductase from Pseudomonas Aeruginosa,No,"Chain A:TRP106,PHE107,VAL110,ASN111,LEU114,ALA156,GLY160,GLY163,PHE164; Chain B:TRP106,PHE107,VAL110,ASN111,LEU114,ALA156,GLY160"
ASD07730000_2,fabG,Pseudomonas aeruginosa,O54438,4BO8,ASD07730018,34X,B,Lig,Inhibitor,1-(2-azanyl-4-phenyl-imidazol-1-yl)-3-(2-fluorophenyl)urea,1248,Inner Protein Regulator,Protein-Protein Interaction,24015914,Discovery of an Allosteric Inhibitor Binding Site in 3-Oxo-Acyl-Acp Reductase from Pseudomonas Aeruginosa,No,"Chain A:TRP106,PHE107,VAL110,ASN111,LEU114,ALA156,GLY163,PHE164; Chain B:TRP106,PHE107,VAL110,ASN111,LEU114,ALA156,GLY160,GLY163,PHE164"
ASD07730000_2,fabG,Pseudomonas aeruginosa,O54438,4BO9,ASD07730019,3X3,A,Lig,Inhibitor,"5-[2-(furan-2-ylmethoxy)phenyl]-2-phenyl-1,2,3,4-tetrazole",1248,Inner Protein Regulator,Protein-Protein Interaction,24015914,Discovery of an Allosteric Inhibitor Binding Site in 3-Oxo-Acyl-Acp Reductase from Pseudomonas Aeruginosa,No,"Chain A:TRP106,VAL110,ASN111,LEU114,ALA156,ALA159,GLY160,GLY163,PHE164; Chain B:TRP106,VAL110,ASN111,LEU114,ALA156,ALA159,GLY160,GLY163,PHE164"
ASD07760000_2,,Streptomyces griseus,P00775,3BEU,ASD03160008,NA,A,Ion,Activator,SODIUM ION,248,Inner Protein Regulator,Inner Protein,18377928,Engineering protein allostery: 1.05 A resolution structure and enzymatic properties of a Na+-activated trypsin.,No,"Chain A:THR185,LYS223,LYS186,TYR225,LYS224,GLN187,ASP185,ALA221,GLY184,ARG222,GLY223,TYR185"
ASD07760000_2,,Streptomyces griseus,P00775,3I78,ASD03160008,NA,A,Ion,Activator,SODIUM ION,301,Inner Protein Regulator,Inner Protein,20399789,Combinatorial Enzyme Design Probes Allostery and Cooperativity in the Trypsin Fold.,No,"Chain A:THR185,LYS223,LYS186,TYR225,LYS224,GLN187,ASP185,ALA221,GLY184,ASP189,ARG222,GLY223,TYR185,GLU188"
ASD07800000_1,FASN,Homo sapiens,P49327,4W9N,ASD07800001,TCL,B,Lig,Inhibitor,TRICLOSAN,1905,Protein-Protein Interaction,Protein-Protein Interaction,25301948,Crystal structure of the human Fatty Acid synthase enoyl-acyl carrier protein-reductase domain complexed with triclosan reveals allosteric protein-protein interface inhibition.,No,4W9N
ASD07820000_2,hisG,Mycobacterium tuberculosis,P9WMN1,1NH8,ASD01580014,HIS,A,Lig,Inhibitor,histidine,289,Inner Protein Regulator,Inner Protein,12511575,Crystal structure of ATP phosphoribosyltransferase from Mycobacterium tuberculosis,No,"Chain A:ASP216,TYR217,ASP218,LEU242,ALA273,LEU275"
ASD07820000_2,hisG,Mycobacterium tuberculosis,P9WMN1,5LHT,ASD07820002,TIH,A,Lig,Activator,BETA(2-THIENYL)ALANINE,301,Allosteric Fuction,Allosteric Position,28781362,Uncoupling conformational states from activity in an allosteric enzyme.,No,"Chain A:ASP218,ASP216,LEU242,LEU275,ALA273,ILE274,TYR217,ILE250,ALA249,LYS272"
ASD07820000_2,hisG,Mycobacterium tuberculosis,P9WMN1,5LHU,ASD01580014,HIS,A,Lig,Inhibitor,L-HISTIDINE,301,Allosteric Fuction,Allosteric Position,28781362,Uncoupling conformational states from activity in an allosteric enzyme.,No,"Chain A:ASP218,ASP216,LEU242,LEU275,ALA273,ILE274,TYR217,ILE250,ALA249,LYS272"
ASD07820000_3,hisG,Methanothermobacter thermautotrophicus,O27550,2VD3,ASD01580014,HIS,A,Lig,Inhibitor,histidine,1290,Inner Protein Regulator,Inner Protein,,The Structure of Histidine Inhibited Hisg from Methanobacterium Thermoautotrophicum,No,"Chain A:GLY235,MET236,THR237,GLY238,THR240,HIS254,ALA255,VAL256"
ASD07970000_1,,Caenorhabditis elegans,O17793,3RHW,ASD07970001,IVM,B,Lig,Activator,"(2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)- 6'-[(2S)-butan-2-yl]-20,20b-dihydroxy-5',6,8,19- tetramethyl-17-oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b- tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2- pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]- 7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl- alpha-L-arabino-hexopyranosyl)-3-O-methyl- alpha-L-arabino-hexopyranoside",348,Inner Protein Regulator,Protein-Protein Interaction,21572436,Principles of activation and permeation in an anion-selective Cys-loop receptor.,No,"Chain A:THR257,SER260,ILE273,ASP277,ILE280,GLY281,MET284,THR285,PHE288; Chain B:LEU217,LEU218,GLN219,ILE222,PRO223,MET226"
ASD07970000_1,,Caenorhabditis elegans,O17793,3RI5,ASD07970001,IVM,B,Lig,Activator,"(2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)- 6'-[(2S)-butan-2-yl]-20,20b-dihydroxy-5',6,8,19- tetramethyl-17-oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b- tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2- pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]- 7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl- alpha-L-arabino-hexopyranosyl)-3-O-methyl- alpha-L-arabino-hexopyranoside",349,Inner Protein Regulator,Protein-Protein Interaction,21572436,Principles of activation and permeation in an anion-selective Cys-loop receptor.,No,"Chain A:THR257,SER260,ASN264,ILE273,ASP277,ILE280,GLY281,MET284,THR285,PHE288; Chain B:LEU217,LEU218,GLN219,ILE222,PRO223,MET226,ILE229"
ASD07970000_1,,Caenorhabditis elegans,O17793,3RIA,ASD07970001,IVM,A,Lig,Activator,"(2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)- 6'-[(2S)-butan-2-yl]-20,20b-dihydroxy-5',6,8,19- tetramethyl-17-oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b- tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2- pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]- 7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl- alpha-L-arabino-hexopyranosyl)-3-O-methyl- alpha-L-arabino-hexopyranoside",348,Inner Protein Regulator,Protein-Protein Interaction,21572436,Principles of activation and permeation in an anion-selective Cys-loop receptor.,No,"Chain A:THR257,SER260,ILE273,ASP277,ILE280,GLY281,MET284,THR285,PHE288; Chain B:LEU217,LEU218,GLN219,ILE222,PRO223,MET226"
ASD07970000_1,,Caenorhabditis elegans,O17793,3RIF,ASD07970001,IVM,A,Lig,Activator,"(2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)- 6'-[(2S)-butan-2-yl]-20,20b-dihydroxy-5',6,8,19- tetramethyl-17-oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b- tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2- pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]- 7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl- alpha-L-arabino-hexopyranosyl)-3-O-methyl- alpha-L-arabino-hexopyranoside",402,Inner Protein Regulator,Protein-Protein Interaction,21572436,Principles of activation and permeation in an anion-selective Cys-loop receptor.,No,"Chain A:THR257,SER260,ASN264,ILE273,ASP277,ILE280,GLY281,MET284,THR285,PHE288; Chain B:LEU217,LEU218,GLN219,ILE222,PRO223,MET226"
ASD07980000_1,glvI,Gloeobacter violaceus,Q7NDN8,3P4W,ASD07980004,DSF,A,Lig,Inhibitor,"(2S)-2-(difluoromethoxy)-1,1,1,2-tetrafluoro-ethane",319,Inner Protein Regulator,Inner Protein,21248852,X-ray structures of general anaesthetics bound to a pentameric ligand-gated ion channel,No,"Chain A:TYR119,PRO120,TYR197,ILE201,ILE202,VAL242,TYR254,THR255,ILE258"
ASD07980000_1,glvI,Gloeobacter violaceus,Q7NDN8,3P50,ASD01140031,PFL,A,Lig,Inhibitor,"2,6-di(propan-2-yl)phenol",319,Inner Protein Regulator,Inner Protein,21248852,X-ray structures of general anaesthetics bound to a pentameric ligand-gated ion channel,No,"Chain A:PRO120,ILE202,LEU206,TYR254,THR255,ILE258,ASN307"
ASD07980000_1,glvI,Gloeobacter violaceus,Q7NDN8,4F8H,ASD07980005,RKE,A,Lig,Inhibitor,(2R)-2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one,401,Inner Protein Regulator,Protein-Protein Interaction,22958642,Structure of the Pentameric Ligand-Gated Ion Channel GLIC Bound with Anesthetic Ketamine.,No,"Chain A:TYR23,ASN152,ASP153,ASP154; Chain B:VAL79,PHE174,LEU176,LYS183"
ASD07980000_1,glvI,Gloeobacter violaceus,Q7NDN8,5HCJ,ASD01630001,MBR,E,Lig,Regulator,tribromomethane,402,Inner Protein Regulator,Allosteric Position,27021161,Sites of Anesthetic Inhibitory Action on a Cationic Ligand-Gated Ion Channel.,No,"Chain D:ILE233,SER230"
ASD07980000_1,glvI,Gloeobacter violaceus,Q7NDN8,5HCM,ASD01630001,MBR,D,Lig,Regulator,tribromomethane,401,Inner Protein Regulator,Allosteric Position,27021161,Sites of Anesthetic Inhibitory Action on a Cationic Ligand-Gated Ion Channel.,No,"Chain D:ILE233,SER230"
ASD07980000_1,glvI,Gloeobacter violaceus,Q7NDN8,5MUO,ASD01140031,PFL,D,Lig,Inhibitor,"2,6-BIS(1-METHYLETHYL)PHENOL",402,Allosteric function,Allosteric position,29694907,Structural Basis for a Bimodal Allosteric Mechanism of General Anesthetic Modulation in Pentameric Ligand-Gated Ion Channels.,No,"Chain D:THR226,VAL229,SER230,ILE233"
ASD07980000_1,glvI,Gloeobacter violaceus,Q7NDN8,5MUR,ASD01140031,PFL,B,Lig,Inhibitor,"2,6-BIS(1-METHYLETHYL)PHENOL",407,Allosteric function,Allosteric position,29694907,Structural Basis for a Bimodal Allosteric Mechanism of General Anesthetic Modulation in Pentameric Ligand-Gated Ion Channels.,No,"Chain B:ILE262,ILE202,LEU203,PRO120,TYR119,MET205,TYR254,VAL242,THR255,ILE201,ASN307,PHE303,ILE198,TYR197,PHE121,LEU206,ILE258,ILE259"
ASD07980000_1,glvI,Gloeobacter violaceus,Q7NDN8,5MVN,ASD01140031,PFL,B,Lig,Inhibitor,"2,6-BIS(1-METHYLETHYL)PHENOL",410,Allosteric function,Allosteric position,29694907,Structural Basis for a Bimodal Allosteric Mechanism of General Anesthetic Modulation in Pentameric Ligand-Gated Ion Channels.,No,"Chain B:ASN307,ILE202,PRO120,TYR119,TYR254,VAL242,ILE262,ILE201,LEU246,TRP205,TYR197,PHE121,THR255,ILE258,ILE259"
ASD07980000_1,glvI,Gloeobacter violaceus,Q7NDN8,5MZQ,ASD01630001,MBR,A,Lig,Regulator,TRIBROMOMETHANE,411,Allosteric function,Allosteric position,29694907,Structural Basis for a Bimodal Allosteric Mechanism of General Anesthetic Modulation in Pentameric Ligand-Gated Ion Channels.,No,"Chain A:ILE201,ILE258,ILE262,ILE259,TYR254,TRP205,PRO120,VAL242,TYR197,TYR119,PHE121,ILE202,THR255"
ASD07980000_1,glvI,Gloeobacter violaceus,Q7NDN8,6EMX,ASD01630001,MBR,A,Lig,Regulator,TRIBROMOMETHANE,404,Allosteric function,Allosteric position,29694907,Structural Basis for a Bimodal Allosteric Mechanism of General Anesthetic Modulation in Pentameric Ligand-Gated Ion Channels.,No,"Chain A:ILE201,ILE262,ILE259,TYR254,VAL242,PRO120,ILE258,TYR197,TYR119,PHE121,ILE202,MET205,THR255"
ASD07990000_1,snf,Aquifex aeolicus,O67854,2Q6H,ASD07990004,CXX,A,Lig,Inhibitor,"3-(9-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethyl-propan-1-amine",801,Inner Protein Regulator,Inner Protein,17687333,Antidepressant binding site in a bacterial homologue of neurotransmitter transporters.,Yes,"Chain A:LEU25,LEU29,ARG30,VAL33,GLN34,TYR107,ILE111,PHE253,ALA319,PHE320,LEU400,ASP401,ASP404"
ASD07990000_1,snf,Aquifex aeolicus,O67854,2Q72,ASD07990005,IXX,A,Lig,Inhibitor,"3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethyl-propan-1-amine",801,Inner Protein Regulator,Inner Protein,17687333,Antidepressant binding site in a bacterial homologue of neurotransmitter transporters.,Yes,"Chain A:LEU25,LEU29,ARG30,VAL33,GLN34,TYR107,ILE111,PHE253,ALA319,PHE320,LEU400,ASP401,ASP404"
ASD07990000_1,snf,Aquifex aeolicus,O67854,2QB4,ASD07998004,DSM,A,Lig,Inhibitor,"3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methyl-propan-1-amine",801,Inner Protein Regulator,Inner Protein,17687333,Antidepressant binding site in a bacterial homologue of neurotransmitter transporters.,Yes,"Chain A:LEU25,LEU29,ARG30,VAL33,GLN34,TYR107,ILE111,PHE253,ALA319,PHE320,LEU400,ASP401,ASP404"
ASD07990000_1,snf,Aquifex aeolicus,O67854,2QEI,ASD07990004,CXX,A,Lig,Inhibitor,"3-(9-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethyl-propan-1-amine",801,Inner Protein Regulator,Inner Protein,17687333,Antidepressant binding site in a bacterial homologue of neurotransmitter transporters.,Yes,"Chain A:LEU25,LEU29,ARG30,VAL33,GLN34,TYR107,ILE111,PHE253,ALA319,PHE320,LEU400,ASP401,ASP404"
ASD07990000_1,snf,Aquifex aeolicus,O67854,3F48,ASD07990006,BOG,A,Lig,Inhibitor,"(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-octoxy-oxane-3,4,5-triol",706,Inner Protein Regulator,Inner Protein,19074341,A competitive inhibitor traps LeuT in an open-to-out conformation.,Yes,"Chain A:LEU25,GLY26,TYR108,ILE111,PHE253,GLY318,ALA319,PHE320,ASP401,ASP404"
ASD08000000_1,aceK,Escherichia coli,Q8X607,3EPS,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",1604,Inner Protein Regulator,Inner Protein,20505668,Structure of the bifunctional isocitrate dehydrogenase kinase/phosphatase.,No,"Chain A:SER101,ASN104,SER105,HIS113,LEU116,LYS291,LYS294,THR295,TYR298,PHE375,GLU376,ASN377,PHE378"
ASD08000000_1,aceK,Escherichia coli,Q8X607,3LC6,ASD00030001,AMP,B,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",1604,Inner Protein Regulator,Inner Protein,20505668,Structure of the bifunctional isocitrate dehydrogenase kinase/phosphatase.,No,"Chain B:TYR54,SER101,ASN104,SER105,CYS108,HIS113,ILE123,LYS291,LYS294,THR295,PHE375,ASN377"
ASD08000000_1,aceK,Escherichia coli,Q8X607,3LCB,ASD00030001,AMP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate",1604,Inner Protein Regulator,Inner Protein,20505668,Structure of the bifunctional isocitrate dehydrogenase kinase/phosphatase.,No,"Chain A:ASN104,SER105,CYS108,HIS113,LEU116,LEU121,LYS291,LYS294,THR295,TYR298,PHE375,GLU376,ASN377,PHE378"
ASD08170000_1,GLS,Homo sapiens,O94925,3UO9,ASD08170001,04A,B,Lig,Inhibitor,"2-phenyl-N-[5-[2-[2-[5-(2-phenylethanoylamino)-1,3,4-thiadiazol-2-yl]ethylsulfanyl]ethyl]-1,3,4-thiadiazol-2-yl]ethanamide",2,Inner Protein Regulator,Protein-Protein Interaction,,Full-Length Human Glutaminase in Complex with an Allosteric Inhibitor.,No,3UO9
ASD08170000_1,GLS,Homo sapiens,O94925,3VOZ,ASD08170001,04A,A,Lig,Inhibitor,"2-phenyl-N-[5-[2-[2-[5-(2-phenylethanoylamino)-1,3,4-thiadiazol-2-yl]ethylsulfanyl]ethyl]-1,3,4-thiadiazol-2-yl]ethanamide",601,Inner Protein Regulator,Protein-Protein Interaction,22538822,Structural basis for the allosteric inhibitory mechanism of human kidney-type glutaminase (KGA) and its regulation by Raf-Mek-Erk signaling in cancer cell metabolism.,No,3VOZ
ASD08170000_1,GLS,Homo sapiens,O94925,3VP1,ASD08170001,04A,A,Lig,Inhibitor,"2-phenyl-N-[5-[2-[2-[5-(2-phenylethanoylamino)-1,3,4-thiadiazol-2-yl]ethylsulfanyl]ethyl]-1,3,4-thiadiazol-2-yl]ethanamide",601,Inner Protein Regulator,Protein-Protein Interaction,22538822,Structural basis for the allosteric inhibitory mechanism of human kidney-type glutaminase (KGA) and its regulation by Raf-Mek-Erk signaling in cancer cell metabolism.,No,3VP1
ASD08170000_1,GLS,Homo sapiens,O94925,3VP2,ASD08170085,BP0,A,Lig,Inhibitor,"5-[2-[2-(5-azanyl-1,3,4-thiadiazol-2-yl)ethylsulfanyl]ethyl]-1,3,4-thiadiazol-2-amine",601,Inner Protein Regulator,Protein-Protein Interaction,22538822,Structural basis for the allosteric inhibitory mechanism of human kidney-type glutaminase (KGA) and its regulation by Raf-Mek-Erk signaling in cancer cell metabolism.,No,3VP2
ASD08170000_1,GLS,Homo sapiens,O94925,3VP3,ASD08170097,BP8,A,Lig,Inhibitor,"5-[5-(5-azanyl-1,3,4-thiadiazol-2-yl)pentyl]-1,3,4-thiadiazol-2-amine",601,Inner Protein Regulator,Protein-Protein Interaction,22538822,Structural basis for the allosteric inhibitory mechanism of human kidney-type glutaminase (KGA) and its regulation by Raf-Mek-Erk signaling in cancer cell metabolism.,No,3VP3
ASD08170000_1,GLS,Homo sapiens,O94925,3VP4,ASD08170123,BP9,A,Lig,Inhibitor,"5-[4-(5-azanyl-1,3,4-thiadiazol-2-yl)butyl]-1,3,4-thiadiazol-2-amine",601,Inner Protein Regulator,Protein-Protein Interaction,22538822,Structural basis for the allosteric inhibitory mechanism of human kidney-type glutaminase (KGA) and its regulation by Raf-Mek-Erk signaling in cancer cell metabolism.,No,3VP4
ASD08170000_1,GLS,Homo sapiens,O94925,5JYO,,63J,"C,D,F",Lig,Inhibitor,"2-(pyridin-2-yl)-N-(5-{4-[6-({[3-(trifluoromethoxy)phenyl]acetyl}amino)pyridazin-3-yl]butyl}-1,3,4-thiadiazol-2-yl)acetamide",601,Allosteric Fuction,Allosteric Position,,Allosteric inhibition of KGA,No,5JYO
ASD08170000_1,GLS,Homo sapiens,O94925,5JYP,ASD08170047,ZBS,A,Lig,Inhibitor,"2-phenyl-~{N}-[5-[(1~{S},3~{S})-3-[5-(2-phenylethanoylamino)-1,3,4-thiadiazol-2-yl]cyclohexyl]-1,3,4-thiadiazol-2-yl]ethanamide",601,Allosteric Fuction,Allosteric Position,,Allosteric inhibition of KGA,No,5JYP
ASD08170000_1,GLS,Homo sapiens,O94925,5WJ6,ASD08170129,B4A,A,,,"2-phenyl-N-{5-[4-({5-[(phenylacetyl)amino]-1,3,4-thiadiazol-2-yl}amino)piperidin-1-yl]-1,3,4-thiadiazol-2-yl}acetamide",601,,,29317493,"Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism.",,5WJ6
ASD08170000_2,Gls,Mus musculus,D3Z7P3,4JKT,ASD08170001,04A,D,Lig,Inhibitor,"2-phenyl-N-[5-[2-[2-[5-(2-phenylethanoylamino)-1,3,4-thiadiazol-2-yl]ethylsulfanyl]ethyl]-1,3,4-thiadiazol-2-yl]ethanamide",701,Inner Protein Regulator,Protein-Protein Interaction,23935106,Active Glutaminase C Self-assembles into a Supratetrameric Oligomer That Can Be Disrupted by an Allosteric Inhibitor.,No,"Chain A:ARG322,LYS325,LEU326,PHE327,LEU328,ASN329,GLU330,TYR399; Chain C:ARG322; Chain D:ARG322,LYS325,LEU326,PHE327,LEU328,ASN329,GLU330,TYR399"
ASD08190000_2,MYH7,Homo sapiens,P12883,4PA0,ASD05230002,2OW,A,Lig,Regulator,methyl 4-(2-fluoro-3-{[(6-methylpyridin-3- yl)carbamoyl]amino}benzyl)piperazine-1-carboxylateomecamtiv mercarbil (Synonym),1101,Allosteric Function,Allosteric Position,26246073,Structural basis for drug-induced allosteric changes to human beta-cardiac myosin motor activity.,No,4PA0
ASD08310000_1,SSE1,Saccharomyces cerevisiae,P32589,2QXL,ASD00150001,ATP,A,Lig,Regulator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1002,Protein-Protein Interaction Regulator,Inner Protein,17923091,Insights into hsp70 chaperone activity from a crystal structure of the yeast hsp110 Sse1.,No,"Chain A:GLY10,ASN11,ASN12,ASN13,LYS69,GLY205,HIS206,SER207,SER208,GLY234,GLU272,LYS275,LYS276,SER279,GLY342,GLY343,THR344,ARG346,ILE347"
ASD08310000_1,SSE1,Saccharomyces cerevisiae,P32589,3D2E,ASD00150001,ATP,A,Lig,Regulator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1001,Protein-Protein Interaction Regulator,Inner Protein,,Structural Basis for the Cooperation of Hsp70 and Hsp110 Chaperones in Protein Folding,No,"Chain A:GLY10,ASN11,ASN12,ASN13,LYS69,ILE204,GLY205,HIS206,SER207,SER208,GLY234,GLU272,LYS275,LYS276,SER279,GLY342,GLY343,THR344,ARG346,ILE347; Chain B:GLN33"
ASD08310000_1,SSE1,Saccharomyces cerevisiae,P32589,3D2F,ASD00150001,ATP,A,Lig,Regulator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",1001,Protein-Protein Interaction Regulator,Inner Protein,,Structural Basis for the Cooperation of Hsp70 and Hsp110 Chaperones in Protein Folding,No,"Chain A:GLY10,ASN11,ASN12,ASN13,LYS69,GLY205,HIS206,SER207,SER208,GLY234,GLU272,LYS275,LYS276,SER279,GLY342,GLY343,THR344,ARG346,ILE347; Chain B:GLN33"
ASD08370000_1,rad50,Pyrococcus furiosus,P58301,1F2U,ASD00150001,ATP,A,Lig,Activator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",901,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,10892749,Structural biology of Rad50 ATPase: ATP-driven conformational control in DNA double-strand break repair and the ABC-ATPase superfamily.,No,"Chain A:ARG12,SER13,GLN31,ASN32,GLY33,SER34,GLY35,LYS36,SER37,SER38,GLU60,THR62,LYS63,VAL64,GLN140; Chain B:GLU823; Chain D:LYS763,TYR764,PHE791,SER793,GLY794,GLY795,GLU796"
ASD08370000_1,rad50,Pyrococcus furiosus,P58301,3QKU,ASD00498001,ANP,A,Lig,Regulator,"[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]amino]phosphonic acid",1001,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,21441914,ABC ATPase signature helices in Rad50 link nucleotide state to Mre11 interface for DNA repair.,No,"Chain A:ARG12,SER13,GLN31,ASN32,GLY33,SER34,GLY35,LYS36,SER37,SER38,GLU60,THR62,LYS63,VAL64,GLN140,GLU823"
ASD08370000_1,rad50,Pyrococcus furiosus,P58301,4NCJ,ASD01720027,ADP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate",901,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,24493214,"ATP-driven Rad50 conformations regulate DNA tethering, end resection, and ATM checkpoint signaling.",No,"Chain A:ARG12,SER13,GLN31,ASN32,GLY33,SER34,GLY35,LYS36,SER37,SER38,GLU60,PHE61,THR62,LYS63,VAL64,LEU871; Chain C:LYS763,TYR764,TRP782,PHE791,LEU792,SER793,GLU796"
ASD08370000_2,rad50,Methanocaldococcus jannaschii,Q58718,3AUX,ASD01720027,ADP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate",1006,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,,Crystal Structure of the Mre11-Rad50-ATP S Complex:Understanding the Interplay between Mre11 and Rad50,No,"Chain A:LYS14,SER15,ASN34,GLY35,SER36,GLY37,LYS38,SER39,SER40,ASP59,THR60,ILE62,THR63,LYS64,LYS994"
ASD08370000_2,rad50,Methanocaldococcus jannaschii,Q58718,3AUY,ASD01720027,ADP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate",1006,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,,Crystal Structure of the Mre11-Rad50-ATP S Complex: Understanding the Interplay between Mre11 and Rad50,No,"Chain A:LYS14,SER15,GLU33,ASN34,GLY35,SER36,GLY37,LYS38,SER39,SER40,ASP59,THR60,ILE62,THR63,LYS64,LYS994,ASN997"
ASD08370000_2,rad50,Methanocaldococcus jannaschii,Q58718,3AV0,ASD03940004,AGS,B,Lig,Activator,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] bis(oxidanyl)phosphinothioyl hydrogen phosphate",1006,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,,Crystal Structure of the Mre11-Rad50-ATP  S Complex: Understanding the Interplay between Mre11 and Rad50,No,"Chain B:LYS14,SER15,ASN34,GLY35,SER36,GLY37,LYS38,SER39,SER40,THR60,ILE62,THR63,LYS64,GLN134,GLU947,LYS994"
ASD08370000_3,rad50,Thermotoga maritima,Q9X1X1,3THO,ASD01720027,ADP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate",1452,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,21937514,ATP driven structural changes of the bacterial Mre11:Rad50 catalytic head complex.,No,"Chain A:LEU12,GLY13,PRO31,ASN32,GLY33,ALA34,GLY35,LYS36,SER37,SER38,ARG53,TYR54,ASP59,VAL61,ASN62,ARG63,GLU798"
ASD08570000_1,IDO1,Homo sapiens,P14902,5WMV,ASD08570001,ZCW,A,Lig,Regulator,2-(1H-indol-3-yl)ethanol,503,Allosteric position,Allosteric position,29167421,"Structural insights into substrate and inhibitor binding sites in human indoleamine 2,3-dioxygenase 1.",Yes,5WMV
ASD08570000_1,IDO1,Homo sapiens,P14902,5WMX,ASD08570001,ZCW,A,Lig,Regulator,2-(1H-indol-3-yl)ethanol,503,Allosteric position,Allosteric position,29167421,"Structural insights into substrate and inhibitor binding sites in human indoleamine 2,3-dioxygenase 1.",Yes,5WMX
ASD08770000_1,AMY2A,Homo sapiens,P04746,1B2Y,ASD01630003,CL,A,Ion,Activator,chloride,498,Inner Protein Regulator,Inner Protein,10657258,Crystal structures of human pancreatic alpha-amylase in complex with carbohydrate and proteinaceous inhibitors.,Yes,1B2Y
ASD08770000_1,AMY2A,Homo sapiens,P04746,1BSI,ASD01630003,CL,A,Ion,Activator,chloride,499,Inner Protein Regulator,Inner Protein,10091666,"Cloning, mutagenesis, and structural analysis of human pancreatic alpha-amylase expressed in Pichia pastoris.",Yes,1BSI
ASD08770000_1,AMY2A,Homo sapiens,P04746,1CPU,ASD01630003,CL,A,Ion,Activator,chloride,499,Inner Protein Regulator,Inner Protein,10769135,"Subsite mapping of the human pancreatic alpha-amylase active site through structural, kinetic, and mutagenesis techniques.",Yes,1CPU
ASD08770000_1,AMY2A,Homo sapiens,P04746,1HNY,ASD01630003,CL,A,Ion,Activator,chloride,498,Inner Protein Regulator,Inner Protein,8528071,The structure of human pancreatic alpha-amylase at 1.8 A resolution and comparisons with related enzymes.,Yes,1HNY
ASD08770000_1,AMY2A,Homo sapiens,P04746,1KBB,ASD01630003,CL,A,Ion,Activator,chloride,498,Inner Protein Regulator,Inner Protein,11914097,Mechanistic analyses of catalysis in human pancreatic alpha-amylase: detailed kinetic and structural studies of mutants of three conserved carboxylic acids.,Yes,1KBB
ASD08770000_1,AMY2A,Homo sapiens,P04746,1KBK,ASD01630003,CL,A,Ion,Activator,chloride,498,Inner Protein Regulator,Inner Protein,11914097,Mechanistic analyses of catalysis in human pancreatic alpha-amylase: detailed kinetic and structural studies of mutants of three conserved carboxylic acids.,Yes,1KBK
ASD08770000_1,AMY2A,Homo sapiens,P04746,1U2Y,ASD01630003,CL,A,Ion,Activator,chloride,498,Inner Protein Regulator,Inner Protein,15304511,In Situ Extension as an Approach for Identifying Novel alpha-Amylase Inhibitors.,Yes,1U2Y
ASD08770000_1,AMY2A,Homo sapiens,P04746,1U30,ASD01630003,CL,A,Ion,Activator,chloride,498,Inner Protein Regulator,Inner Protein,15304511,In Situ Extension as an Approach for Identifying Novel alpha-Amylase Inhibitors.,Yes,1U30
ASD08770000_1,AMY2A,Homo sapiens,P04746,1U33,ASD01630003,CL,A,Ion,Activator,chloride,499,Inner Protein Regulator,Inner Protein,15304511,In Situ Extension as an Approach for Identifying Novel alpha-Amylase Inhibitors.,Yes,1U33
ASD08770000_1,AMY2A,Homo sapiens,P04746,1XCW,ASD01630003,CL,A,Ion,Activator,chloride,498,Inner Protein Regulator,Inner Protein,15736945,Acarbose Rearrangement Mechanism Implied by the Kinetic and Structural Analysis of Human Pancreatic alpha-Amylase in Complex with Analogues and Their Elongated Counterparts,Yes,1XCW
ASD08770000_1,AMY2A,Homo sapiens,P04746,1XCX,ASD01630003,CL,A,Ion,Activator,chloride,498,Inner Protein Regulator,Inner Protein,15736945,Acarbose Rearrangement Mechanism Implied by the Kinetic and Structural Analysis of Human Pancreatic alpha-Amylase in Complex with Analogues and Their Elongated Counterparts,Yes,1XCX
ASD08770000_1,AMY2A,Homo sapiens,P04746,1XD0,ASD01630003,CL,A,Ion,Activator,chloride,500,Inner Protein Regulator,Inner Protein,15736945,Acarbose Rearrangement Mechanism Implied by the Kinetic and Structural Analysis of Human Pancreatic alpha-Amylase in Complex with Analogues and Their Elongated Counterparts,Yes,1XD0
ASD08770000_1,AMY2A,Homo sapiens,P04746,1XD1,ASD01630003,CL,A,Ion,Activator,chloride,498,Inner Protein Regulator,Inner Protein,15736945,Acarbose Rearrangement Mechanism Implied by the Kinetic and Structural Analysis of Human Pancreatic alpha-Amylase in Complex with Analogues and Their Elongated Counterparts,Yes,1XD1
ASD08770000_1,AMY2A,Homo sapiens,P04746,1XH1,ASD01630003,CL,A,Ion,Activator,chloride,499,Inner Protein Regulator,Inner Protein,15722449,Structural and mechanistic studies of chloride induced activation of human pancreatic alpha-amylase,Yes,1XH1
ASD08770000_1,AMY2A,Homo sapiens,P04746,1XH2,ASD01630003,CL,A,Ion,Activator,chloride,499,Inner Protein Regulator,Inner Protein,15722449,Structural and mechanistic studies of chloride induced activation of human pancreatic alpha-amylase,Yes,1XH2
ASD08770000_1,AMY2A,Homo sapiens,P04746,2CPU,ASD01630003,CL,A,Ion,Activator,chloride,499,Inner Protein Regulator,Inner Protein,10769135,"Subsite mapping of the human pancreatic alpha-amylase active site through structural, kinetic, and mutagenesis techniques.",Yes,2CPU
ASD08770000_1,AMY2A,Homo sapiens,P04746,2QMK,ASD05273011,NO2,A,Ion,Activator,nitrite,499,Inner Protein Regulator,Inner Protein,18284212,Alternative catalytic anions differentially modulate human alpha-amylase activity and specificity,Yes,2QMK
ASD08770000_1,AMY2A,Homo sapiens,P04746,2QV4,ASD05273011,NO2,A,Ion,Activator,nitrite,499,Inner Protein Regulator,Inner Protein,18284212,Alternative catalytic anions differentially modulate human alpha-amylase activity and specificity,Yes,2QV4
ASD08770000_1,AMY2A,Homo sapiens,P04746,3BAI,ASD08770047,NO3,A,Ion,Activator,nitrate,500,Inner Protein Regulator,Inner Protein,18284212,Alternative catalytic anions differentially modulate human alpha-amylase activity and specificity,Yes,3BAI
ASD08770000_1,AMY2A,Homo sapiens,P04746,3BAJ,ASD08770047,NO3,A,Ion,Activator,nitrate,501,Inner Protein Regulator,Inner Protein,18284212,Alternative catalytic anions differentially modulate human alpha-amylase activity and specificity,Yes,3BAJ
ASD08770000_1,AMY2A,Homo sapiens,P04746,3BAK,ASD08770047,NO3,A,Ion,Activator,nitrate,500,Inner Protein Regulator,Inner Protein,18284212,Alternative catalytic anions differentially modulate human alpha-amylase activity and specificity,Yes,3BAK
ASD08770000_1,AMY2A,Homo sapiens,P04746,3BAW,ASD01630003,CL,A,Ion,Activator,chloride,499,Inner Protein Regulator,Inner Protein,18284212,Alternative catalytic anions differentially modulate human alpha-amylase activity and specificity,Yes,3BAW
ASD08770000_1,AMY2A,Homo sapiens,P04746,3BAX,ASD01630003,CL,A,Ion,Activator,chloride,499,Inner Protein Regulator,Inner Protein,18284212,Alternative catalytic anions differentially modulate human alpha-amylase activity and specificity,Yes,3BAX
ASD08770000_1,AMY2A,Homo sapiens,P04746,3BAY,ASD08770047,NO3,A,Ion,Activator,nitrate,501,Inner Protein Regulator,Inner Protein,18284212,Alternative catalytic anions differentially modulate human alpha-amylase activity and specificity,Yes,3BAY
ASD08770000_1,AMY2A,Homo sapiens,P04746,3CPU,ASD01630003,CL,A,Ion,Activator,chloride,498,Inner Protein Regulator,Inner Protein,10769135,"Subsite mapping of the human pancreatic alpha-amylase active site through structural, kinetic, and mutagenesis techniques.",Yes,3CPU
ASD08770000_1,AMY2A,Homo sapiens,P04746,3IJ7,ASD01630003,CL,A,Ion,Activator,chloride,498,Inner Protein Regulator,Inner Protein,19803533,Directed,Yes,3IJ7
ASD08770000_1,AMY2A,Homo sapiens,P04746,3IJ8,ASD01630003,CL,A,Ion,Activator,chloride,498,Inner Protein Regulator,Inner Protein,19803533,Directed,Yes,3IJ8
ASD08770000_1,AMY2A,Homo sapiens,P04746,3IJ9,ASD01630003,CL,A,Ion,Activator,chloride,498,Inner Protein Regulator,Inner Protein,19803533,Directed,Yes,3IJ9
ASD08770000_1,AMY2A,Homo sapiens,P04746,3OLD,ASD01630003,CL,A,Ion,Activator,chloride,498,Inner Protein Regulator,Inner Protein,21111049,Structures of human pancreatic alpha-amylase in complex with acarviostatins: Implications for drug design against type II diabetes,Yes,3OLD
ASD08770000_1,AMY2A,Homo sapiens,P04746,3OLE,ASD01630003,CL,A,Ion,Activator,chloride,498,Inner Protein Regulator,Inner Protein,21111049,Structures of human pancreatic alpha-amylase in complex with acarviostatins: Implications for drug design against type II diabetes.,Yes,3OLE
ASD08770000_1,AMY2A,Homo sapiens,P04746,3OLG,ASD01630003,CL,A,Ion,Activator,chloride,498,Inner Protein Regulator,Inner Protein,21111049,Structures of human pancreatic alpha-amylase in complex with acarviostatins: Implications for drug design against type II diabetes.,Yes,3OLG
ASD08770000_1,AMY2A,Homo sapiens,P04746,3OLI,ASD01630003,CL,A,Ion,Activator,chloride,498,Inner Protein Regulator,Inner Protein,21111049,Structures of human pancreatic alpha-amylase in complex with acarviostatins: Implications for drug design against type II diabetes.,Yes,3OLI
ASD08770000_1,AMY2A,Homo sapiens,P04746,4GQQ,ASD08770020,0XR,A,Lig,Inhibitor,"ethyl (2E)-3-(3,4-dihydroxyphenyl)prop-2- enoate",502,Inner Protein Regulator,Inner Protein,23050660,"Order and disorder: differential structural impacts of myricetin and ethyl caffeate on human amylase, an antidiabetic target.",No,4GQQ
ASD08770000_1,AMY2A,Homo sapiens,P04746,4GQQ,ASD08770020,0XR,A,Lig,Inhibitor,"ethyl (2E)-3-(3,4-dihydroxyphenyl)prop-2- enoate",503,Inner Protein Regulator,Inner Protein,23050660,"Order and disorder: differential structural impacts of myricetin and ethyl caffeate on human amylase, an antidiabetic target.",No,4GQQ
ASD08770000_1,AMY2A,Homo sapiens,P04746,4GQQ,ASD08770020,0XR,A,Lig,Inhibitor,"ethyl (2E)-3-(3,4-dihydroxyphenyl)prop-2- enoate",504,Inner Protein Regulator,Inner Protein,23050660,"Order and disorder: differential structural impacts of myricetin and ethyl caffeate on human amylase, an antidiabetic target.",No,4GQQ
ASD08770000_1,AMY2A,Homo sapiens,P04746,4GQQ,ASD01630003,CL,A,Ion,Activator,chloride,505,Inner Protein Regulator,Inner Protein,23050660,"Order and disorder: differential structural impacts of myricetin and ethyl caffeate on human amylase, an antidiabetic target.",Yes,4GQQ
ASD08770000_1,AMY2A,Homo sapiens,P04746,4GQR,ASD01630003,CL,A,Ion,Activator,chloride,503,Inner Protein Regulator,Inner Protein,23050660,"Order and disorder: differential structural impacts of myricetin and ethyl caffeate on human amylase, an antidiabetic target.",Yes,4GQR
ASD08770000_2,AMY2,Sus scrofa,P00690,1BVN,ASD01630003,CL,P,Ion,Activator,chloride,2002,Inner Protein Regulator,Inner Protein,7897663,The crystal structure of porcine pancreatic alpha-amylase in complex with the microbial inhibitor Tendamistat.,Yes,"Chain P:ARG195,THR254,PHE256,ASN298,ARG337"
ASD08770000_2,AMY2,Sus scrofa,P00690,1DHK,ASD01630003,CL,A,Ion,Activator,chloride,498,Inner Protein Regulator,Inner Protein,8994970,Substrate mimicry in the active center of a mammalian alpha-amylase: structural analysis of an enzyme-inhibitor complex.,Yes,"Chain A:ARG195,ASN298,ARG337"
ASD08770000_2,AMY2,Sus scrofa,P00690,1HX0,ASD01630003,CL,A,Ion,Activator,chloride,498,Inner Protein Regulator,Inner Protein,11412124,Enzyme-catalyzed condensation reaction in a mammalian alpha-amylase. High-resolution structural analysis of an enzyme-inhibitor complex,Yes,"Chain A:ARG195,THR254,ASN298,ARG337"
ASD08770000_2,AMY2,Sus scrofa,P00690,1JFH,ASD01630003,CL,A,Ion,Activator,chloride,498,Inner Protein Regulator,Inner Protein,9385631,Structure of a pancreatic alpha-amylase bound to a substrate analogue at 2.03 A resolution.,Yes,"Chain A:ARG195,GLU233,THR254,ASN298,ARG337"
ASD08770000_2,AMY2,Sus scrofa,P00690,1KXQ,ASD01630003,CL,A,Ion,Activator,chloride,4002,Inner Protein Regulator,Inner Protein,11960990,Three camelid VHH domains in complex with porcine pancreatic alpha-amylase. Inhibition and versatility of binding topology.,Yes,"Chain A:ARG195,THR254,PHE256,ASN298,ARG337"
ASD08770000_2,AMY2,Sus scrofa,P00690,1KXT,ASD01630003,CL,A,Ion,Activator,chloride,4002,Inner Protein Regulator,Inner Protein,11960990,Three camelid VHH domains in complex with porcine pancreatic alpha-amylase. Inhibition and versatility of binding topology.,Yes,"Chain A:ARG195,GLU233,THR254,ARG337"
ASD08770000_2,AMY2,Sus scrofa,P00690,1OSE,ASD01630003,CL,A,Ion,Activator,chloride,498,Inner Protein Regulator,Inner Protein,8681972,"Crystal structure of pig pancreatic alpha-amylase isoenzyme II, in complex with the carbohydrate inhibitor acarbose.",Yes,"Chain A:ARG195,THR254,ASN298,ARG337"
ASD08770000_2,AMY2,Sus scrofa,P00690,1PIF,ASD01630003,CL,A,Ion,Activator,chloride,600,Inner Protein Regulator,Inner Protein,8757803,Carbohydrate and protein-based inhibitors of porcine pancreatic alpha-amylase: structure analysis and comparison of their binding characteristics.,Yes,"Chain A:ARG195,THR254,ASN298,ARG337"
ASD08770000_2,AMY2,Sus scrofa,P00690,1PIG,ASD01630003,CL,A,Ion,Activator,chloride,600,Inner Protein Regulator,Inner Protein,8757803,Carbohydrate and protein-based inhibitors of porcine pancreatic alpha-amylase: structure analysis and comparison of their binding characteristics.,Yes,"Chain A:ARG195,ASN298,ARG337"
ASD08770000_2,AMY2,Sus scrofa,P00690,1PPI,ASD01630003,CL,A,Ion,Activator,chloride,498,Inner Protein Regulator,Inner Protein,8193143,1 - 1PPI : Amylase is an enzyme that breaks down starch. This structure includes the enzyme and a small starch chain.,Yes,"Chain A:ARG195,GLU233,THR254,ASN298,ARG337"
ASD08770000_2,AMY2,Sus scrofa,P00690,1UA3,ASD01630003,CL,A,Ion,Activator,chloride,498,Inner Protein Regulator,Inner Protein,12962327,Crystal Structure of the Pig Pancreatic alpha-Amylase Complexed with Malto-Oligosaccharides,Yes,"Chain A:ARG195,GLU233,THR254,ASN298,ARG337"
ASD08770000_2,AMY2,Sus scrofa,P00690,1VAH,ASD01630003,CL,A,Ion,Activator,chloride,498,Inner Protein Regulator,Inner Protein,15517985,Crystal structure of the pig pancreatic alpha-amylase complexed with rho-nitrophenyl-alpha-D-maltoside-flexibility in the active site,Yes,"Chain A:ARG195,GLU233,THR254,ASN298,ARG337"
ASD08770000_2,AMY2,Sus scrofa,P00690,1WO2,ASD01630003,CL,A,Ion,Activator,chloride,498,Inner Protein Regulator,Inner Protein,15736930,Molecular Basis of the Effects of Chloride Ion on the Acid-Base Catalyst in the Mechanism of Pancreatic alpha-Amylase,Yes,"Chain A:ARG195,GLU233,PHE256,ASN298,ARG337"
ASD08770000_2,AMY2,Sus scrofa,P00690,3L2L,ASD01630003,CL,A,Ion,Activator,chloride,502,Inner Protein Regulator,Inner Protein,20222716,"X-ray crystallographic analyses of pig pancreatic alpha-amylase with limit dextrin, oligosaccharide, and alpha-cyclodextrin.",Yes,"Chain A:ARG195,GLU233,THR254,PHE256,ASN298,ARG337"
ASD08770000_2,AMY2,Sus scrofa,P00690,3L2M,ASD01630003,CL,A,Ion,Activator,chloride,502,Inner Protein Regulator,Inner Protein,20222716,"X-ray crystallographic analyses of pig pancreatic alpha-amylase with limit dextrin, oligosaccharide, and alpha-cyclodextrin.",Yes,"Chain A:ARG195,GLU233,THR254,PHE256,ASN298,ARG337"
ASD08780000_1,MMP9,Homo sapiens,P14780,5TH9,,GS-5745,"L,M,N,H,I,J",antibody,Inhibitor,GS-5745 Fab,,Allosteric function,Allosteric position,28235803,"Biochemical characterization and structure determination of a potent, selective antibody inhibitor of human MMP9.",No,5TH9
ASD08780000_1,MMP9,Homo sapiens,P14780,5UE4,ASD08780002,5XQ,B,Lig,Inhibitor,"~{N}-[5-[2-[(2-methoxyphenyl)amino]-1,3-thiazol-4-yl]-4-methyl-1,3-thiazol-2-yl]ethanamide",307,Allosteric function,Allosteric position,28860188,Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (MMP-9) that allosterically inhibits zymogen activation.,No,5UE4
ASD08820000_2,ITK,Homo sapiens,Q08881,4M0Y,ASD08820002,M0Y,A,Lig,Inhibitor,4-(aminocarbonylamino)-1-naphthalen-1-yl-pyrazole-3-carboxamide,702,Inner Protein Regulator,Inner Protein,24593284,Selectively targeting an inactive conformation of interleukin-2-inducible T-cell kinase by allosteric inhibitors.,Yes,4M0Y
ASD08820000_2,ITK,Homo sapiens,Q08881,4M0Z,ASD08820001,M0Z,A,Lig,Inhibitor,4-(aminocarbonylamino)-1-(7-methoxynaphthalen-1-yl)pyrazole-3-carboxamide,701,Inner Protein Regulator,Inner Protein,24593284,Selectively targeting an inactive conformation of interleukin-2-inducible T-cell kinase by allosteric inhibitors.,Yes,4M0Z
ASD08820000_2,ITK,Homo sapiens,Q08881,4M12,ASD08820006,1YZ,A,Lig,Inhibitor,4-(aminocarbonylamino)-1-(7-ethoxynaphthalen-1-yl)pyrazole-3-carboxamide,701,Inner Protein Regulator,Inner Protein,24593284,Selectively targeting an inactive conformation of interleukin-2-inducible T-cell kinase by allosteric inhibitors.,Yes,4M12
ASD08820000_2,ITK,Homo sapiens,Q08881,4M13,ASD08820003,1.00E+00,A,Lig,Inhibitor,4-(aminocarbonylamino)-1-(7-propoxynaphthalen-1-yl)pyrazole-3-carboxamide,701,Inner Protein Regulator,Inner Protein,24593284,Selectively targeting an inactive conformation of interleukin-2-inducible T-cell kinase by allosteric inhibitors.,Yes,4M13
ASD08820000_2,ITK,Homo sapiens,Q08881,4M14,ASD08820004,QWS,A,Lig,Inhibitor,4-(aminocarbonylamino)-1-(7-propan-2-yloxynaphthalen-1-yl)pyrazole-3-carboxamide,702,Inner Protein Regulator,Inner Protein,24593284,Selectively targeting an inactive conformation of interleukin-2-inducible T-cell kinase by allosteric inhibitors.,Yes,4M14
ASD08820000_2,ITK,Homo sapiens,Q08881,4M15,ASD08820004,QWS,A,Lig,Inhibitor,4-(aminocarbonylamino)-1-(7-propan-2-yloxynaphthalen-1-yl)pyrazole-3-carboxamide,701,Inner Protein Regulator,Inner Protein,24593284,Selectively targeting an inactive conformation of interleukin-2-inducible T-cell kinase by allosteric inhibitors.,Yes,4M15
ASD08830000_1,BTK,Homo sapiens,Q06187,6HTF,,rF10 repebody,B,Pep,Inhibitor,rF10 repebody,1-266,Allosteric function,Protein-Protein Interaction,,,No,6HTF
ASD08840000_1,radA,Methanococcus voltae,O73948,1T4G,ASD00498001,ANP,A,Lig,Regulator,"[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]amino]phosphonic acid",401,Protein-DNA/RNA Interaction Regulator,Inner Protein,15304222,Crystal Structure of Archaeal Recombinase RadA; A Snapshot of Its Extended Conformation.,No,"Chain A:VAL106,PHE107,GLY108,SER109,GLY110,LYS111,THR112,GLN113,ARG158,GLN161,GLN257,ARG296,ILE315,THR316,GLU317"
ASD08840000_1,radA,Methanococcus voltae,O73948,2FPK,ASD01720027,ADP,A,Lig,Regulator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate",401,Protein-DNA/RNA Interaction Regulator,Inner Protein,16229465,Crystal Structure of Methanococcus Voltae Rada in Complex with Adp: hydrolysis-induced conformational change,No,"Chain A:VAL106,PHE107,GLY108,SER109,GLY110,LYS111,THR112,GLN113,ARG158,GLN161,ARG296,ILE315,THR316,GLU317"
ASD08840000_1,radA,Methanococcus voltae,O73948,2FPL,ASD00498001,ANP,A,Lig,Regulator,"[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]amino]phosphonic acid",401,Protein-DNA/RNA Interaction Regulator,Inner Protein,16229465,Crystal Structure of Methanococcus Voltae Rada in Complex with Adp: hydrolysis-induced conformational change,No,"Chain A:VAL106,PHE107,GLY108,SER109,GLY110,LYS111,THR112,GLN113,ARG158,GLN161,GLN257,ARG296,THR316,GLU317"
ASD08840000_1,radA,Methanococcus voltae,O73948,2FPM,ASD00498001,ANP,A,Lig,Regulator,"[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]amino]phosphonic acid",401,Protein-DNA/RNA Interaction Regulator,Inner Protein,16229465,Crystal Structure of Methanoccocus Voltae Rada in Complex with Adp: hydrolysis-induced conformational change,No,"Chain A:VAL106,PHE107,GLY108,SER109,GLY110,LYS111,THR112,GLN113,GLU151,ARG158,GLN161,ILE315,THR316,GLU317"
ASD08840000_1,radA,Methanococcus voltae,O73948,2GDJ,ASD00498001,ANP,A,Lig,Regulator,"[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]amino]phosphonic acid",401,Protein-DNA/RNA Interaction Regulator,Inner Protein,16765891,The Rad51/RadA N-Terminal Domain Activates Nucleoprotein Filament ATPase Activity.,No,"Chain A:VAL106,PHE107,GLY108,SER109,GLY110,LYS111,THR112,GLN113,ARG158,GLN161,GLN257,ARG296,ILE315,THR316,GLU317"
ASD08840000_1,radA,Methanococcus voltae,O73948,3FYH,ASD01720027,ADP,A,Lig,Regulator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate",401,Protein-DNA/RNA Interaction Regulator,Inner Protein,19555119,Crystal structure of an archaeal Rad51 homologue in complex with a metatungstate inhibitor.,No,"Chain A:VAL106,PHE107,GLY108,SER109,GLY110,LYS111,THR112,GLN113,ARG158,GLN161,ILE315,THR316,GLU317"
ASD08840000_1,radA,Methanococcus voltae,O73948,3FYH,ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007;ASD08840007,W;W;W;W;W;W;W;W;W;W;W;W;W;W;W;W;W;W;W;W;W;W;W;W,A;A;A;A;A;A;A;A;A;A;A;A;A;A;A;A;A;A;A;A;A;A;A;A,Ion,Regulator,tungsten(6+),534;511;512;513;514;515;516;517;518;519;520;521;522;523;524;525;526;527;528;529;530;531;532;533,Protein-DNA/RNA Interaction Regulator,Inner Protein,19555119,Crystal structure of an archaeal Rad51 homologue in complex with a metatungstate inhibitor.,No,"Chain A:ARG218,ARG230"
ASD08840000_1,radA,Methanococcus voltae,O73948,3NTU,ASD00498001,ANP,A,Lig,Regulator,"[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]amino]phosphonic acid",401,Protein-DNA/RNA Interaction Regulator,Inner Protein,,The RAD51 ATP cap regulates nucleoprotein filament stability.,No,"Chain A:VAL106,PHE107,GLY108,SER109,GLY110,LYS111,THR112,GLN113,GLU151,ARG158,GLN161,ARG296,THR316,GLU317"
ASD08840000_2,radA,Methanococcus maripaludis,P0CW58,3ETL,ASD00498001,ANP,A,Lig,Regulator,"[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]amino]phosphonic acid",401,Protein-DNA/RNA Interaction Regulator,Inner Protein,19465774,Conservation of a conformational switch in RadA recombinase from Methanococcus maripaludis.,No,"Chain A:PHE107,GLY108,SER109,GLY110,LYS111,THR112,GLN113,ARG158,GLN161,GLN257,ILE315,THR316,GLU317"
ASD08890000_1,cnrR,Ralstonia metallidurans,P37975,2Y39,ASD08890001,NI,A,Ion,Activator,nickel(+2) cation,150,Inner Protein Regulator,Inner Protein,21414325,Structural Basis for Metal Sensing by Cnrx.,No,"Chain A:HIS42,HIS46,GLU63,HIS119,MET123"
ASD08890000_1,cnrR,Ralstonia metallidurans,P37975,2Y3B,ASD08890003,CO,A,Ion,Activator,cobalt(+2) cation,1149,Inner Protein Regulator,Inner Protein,21414325,Structural Basis for Metal Sensing by Cnrx.,No,"Chain A:HIS42,HIS46,GLU63,HIS119,MET123"
ASD08890000_1,cnrR,Ralstonia metallidurans,P37975,3EPV,ASD06430001,CU,A,Ion,Activator,copper(+2) cation,1,Inner Protein Regulator,Inner Protein,18992246,X-ray structure of the metal-sensor CnrX in both the apo- and copper-bound forms.,No,"Chain A:HIS12,HIS16,GLU33,HIS89"
ASD08890000_1,cnrR,Ralstonia metallidurans,P37975,3ZG1,ASD08890001,NI,A,Ion,Activator,nickel(+2) cation,150,Inner Protein Regulator,Inner Protein,24154823,"Metal Sensing and Signal Transduction by Cnrx from Cupriavidus Metallidurans Ch34: Role of the Only Methionine Assessed by a Functional, Spectroscopic, and Theoretical Study",No,"Chain A:HIS42,GLU63,HIS119"
ASD09090000_4,PDE6C,Gallus gallus,P52731,3DBA,ASD09090001,35G,A,Lig,Activator,"GUANOSINE-3',5'-MONOPHOSPHATE",1,Inner Protein Regulator,Inner Protein,18614542,"The Structure of the GAF A Domain from Phosphodiesterase 6C Reveals Determinants of cGMP Binding, a Conserved Binding Surface, and a Large cGMP-dependent Conformational Change.",No,"Chain A:ARG95,SER97,PHE99,LEU115,ASN116,PHE136,GLY141,ILE142,ALA143,HIS163,PHE164,SER165,LEU168,ASP169,THR172,TYR174,THR176,MET195,LEU197"
ASD09120000_1,PPARG,Homo sapiens,P37231,3K8S,ASD09120003,Z27,B,Lig,Activator,"2-chloro-N-[3-chloro-4-[(5-chloro-1,3-benzothiazol-2-yl)sulfanyl]phenyl]-4-(trifluoromethyl)benzenesulfonamide",2,Inner Protein Regulator,Inner Protein,18263587,"T2384, a novel antidiabetic agent with unique peroxisome proliferator-activated receptor gamma binding properties",Yes,3K8S
ASD09120000_1,PPARG,Homo sapiens,P37231,6MS7,,V77,A,Lig,Activator,{[(1S)-1-(4-chlorophenyl)octyl]oxy}acetic acid,600,Allosteric function,Allosteric position,,,No,6MS7
ASD09200000_1,PTPN11,Homo sapiens,Q06124,5EHP,ASD09200042,5OA,"A,B",Lig,Inhibitor,"5-[2,3-bis(chloranyl)phenyl]-2-[(3~{R},5~{S})- 3,5-dimethylpiperazin-1-yl]pyrimidin-4-amine",601,Inner Protein Regulator,Allosteric Position,27347692,"Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor.",No,5EHP
ASD09200000_1,PTPN11,Homo sapiens,Q06124,5EHR,ASD09200001,5OD,"A,B",Lig,Inhibitor,"6-(4-azanyl-4-methyl-piperidin-1-yl)-3-[2,3- bis(chloranyl)phenyl]pyrazin-2-amine",601,Inner Protein Regulator,Allosteric Position,27362227,Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases.,No,5EHR
ASD09200000_1,PTPN11,Homo sapiens,Q06124,5XZR,ASD09200058,8J6,A,Lig,Inhibitor,"4-(3-phenylphenyl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3-thiazol-2-amine",601,Allosteric function,Allosteric position,29155585,Allosteric Inhibitors of SHP2 with Therapeutic Potential for Cancer Treatment.,No,5XZR
ASD09200000_1,PTPN11,Homo sapiens,Q06124,6BMR,ASD09200043,DZV,A,Lig,Inhibitor,"4-[(2-chlorophenyl)methyl]-1-(2-hydroxy-3-methoxyphenyl)[1,2,4]triazolo[4,3-a]quinazolin-5(4H)-one",601,Inner Protein regulator,Inner Protein,29304282,Dual Allosteric Inhibition of SHP2 Phosphatase.,No,6BMR
ASD09200000_1,PTPN11,Homo sapiens,Q06124,6BMU,ASD09200043,DZV,A,Lig,Inhibitor,"4-[(2-chlorophenyl)methyl]-1-(2-hydroxy-3-methoxyphenyl)[1,2,4]triazolo[4,3-a]quinazolin-5(4H)-one",602,Inner Protein regulator,Inner Protein,29304282,Dual Allosteric Inhibition of SHP2 Phosphatase.,No,6BMU
ASD09200000_1,PTPN11,Homo sapiens,Q06124,6BMU,ASD09200001,5OD,A,Lig,Inhibitor,"6-(4-azanyl-4-methyl-piperidin-1-yl)-3-[2,3-bis(chloranyl)phenyl]pyrazin-2-amine",601,Inner Protein regulator,Inner Protein,29304282,Dual Allosteric Inhibition of SHP2 Phosphatase.,No,6BMU
ASD09200000_1,PTPN11,Homo sapiens,Q06124,6BMV,ASD09200045,DZS,A,Lig,Inhibitor,"3-{4-[(2-chlorophenyl)methyl]-5-oxo-4,5-dihydro[1,2,4]triazolo[4,3-a]quinazolin-1-yl}-4-hydroxybenzoic acid",601,Inner Protein regulator,Inner Protein,29304282,Dual Allosteric Inhibition of SHP2 Phosphatase.,No,6BMV
ASD09200000_1,PTPN11,Homo sapiens,Q06124,6BMW,ASD09200045,DZS,A,Lig,Inhibitor,"3-{4-[(2-chlorophenyl)methyl]-5-oxo-4,5-dihydro[1,2,4]triazolo[4,3-a]quinazolin-1-yl}-4-hydroxybenzoic acid",602,Inner Protein regulator,Inner Protein,29304282,Dual Allosteric Inhibition of SHP2 Phosphatase.,No,6BMW
ASD09200000_1,PTPN11,Homo sapiens,Q06124,6BMW,ASD09200001,5OD,A,Lig,Inhibitor,"6-(4-azanyl-4-methyl-piperidin-1-yl)-3-[2,3-bis(chloranyl)phenyl]pyrazin-2-amine",601,Inner Protein regulator,Inner Protein,29304282,Dual Allosteric Inhibition of SHP2 Phosphatase.,No,6BMW
ASD09200000_1,PTPN11,Homo sapiens,Q06124,6BMX,ASD09200044,DYV,A,Lig,Inhibitor,"1-(3-chloro-4-{[1-(2-hydroxy-3-methoxyphenyl)-5-oxo[1,2,4]triazolo[4,3-a]quinazolin-4(5H)-yl]methyl}benzene-1-carbonyl)-L-proline",601,Inner Protein regulator,Inner Protein,29304282,Dual Allosteric Inhibition of SHP2 Phosphatase.,No,6BMX
ASD09200000_1,PTPN11,Homo sapiens,Q06124,6BMY,ASD09200044,DYV,A,Lig,Inhibitor,"1-(3-chloro-4-{[1-(2-hydroxy-3-methoxyphenyl)-5-oxo[1,2,4]triazolo[4,3-a]quinazolin-4(5H)-yl]methyl}benzene-1-carbonyl)-L-proline",602,Inner Protein regulator,Inner Protein,29304282,Dual Allosteric Inhibition of SHP2 Phosphatase.,No,6BMY
ASD09200000_1,PTPN11,Homo sapiens,Q06124,6BMY,ASD09200001,5OD,A,Lig,Inhibitor,"6-(4-azanyl-4-methyl-piperidin-1-yl)-3-[2,3-bis(chloranyl)phenyl]pyrazin-2-amine",601,Inner Protein regulator,Inner Protein,29304282,Dual Allosteric Inhibition of SHP2 Phosphatase.,No,6BMY
ASD09200000_1,PTPN11,Homo sapiens,Q06124,6BN5,ASD09200061,DZJ,A,Lig,Inhibitor,"3-benzyl-8-chloro-2-hydroxy-4H-pyrimido[2,1-b][1,3]benzothiazol-4-one",601,Allosteric function,Allosteric position,29089257,Identification of an allosteric benzothiazolopyrimidone inhibitor of the oncogenic protein tyrosine phosphatase SHP2.,No,6BN5
ASD09200000_1,PTPN11,Homo sapiens,Q06124,6CMR,,5OD,A,Lig,Inhibitor,"6-(4-azanyl-4-methyl-piperidin-1-yl)-3-[2,3-bis(chloranyl)phenyl]pyrazin-2-amine",601,,,30375376,Mechanism of activating mutations and allosteric drug inhibition of the phosphatase SHP2.,,6CMR
ASD09200000_1,PTPN11,Homo sapiens,Q06124,6CMS,,5OD,A,Lig,Inhibitor,"6-(4-azanyl-4-methyl-piperidin-1-yl)-3-[2,3-bis(chloranyl)phenyl]pyrazin-2-amine",601,,,30375376,Mechanism of activating mutations and allosteric drug inhibition of the phosphatase SHP2.,,6CMS
ASD09200000_1,PTPN11,Homo sapiens,Q06124,6CRG,,5OD,A,Lig,Inhibitor,"6-(4-azanyl-4-methyl-piperidin-1-yl)-3-[2,3-bis(chloranyl)phenyl]pyrazin-2-amine",601,,,30375388,Structural reorganization of SHP2 by oncogenic mutations and implications for oncoprotein resistance to allosteric inhibition.,,6CRG
ASD09200000_1,PTPN11,Homo sapiens,Q06124,6MD7,,JE1,A,Lig,Inhibitor,2-[4-(aminomethyl)-4-methylpiperidin-1-yl]-5-{[2-(trifluoromethyl)pyridin-3-yl]sulfanyl}pyrimidin-4(3H)-one,601,,,30688459,"6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors.",,6MD7
ASD09200000_1,PTPN11,Homo sapiens,Q06124,6MD9,,JEJ,A,Lig,Inhibitor,"3-(2-chlorophenyl)-6-{4-[(dimethylamino)methyl]phenyl}-5-methyl[1,2]oxazolo[4,5-c]pyridin-4(5H)-one",601,,,30688462,Optimization of Fused Bicyclic Allosteric SHP2 Inhibitors.,,6MD9
ASD09200000_1,PTPN11,Homo sapiens,Q06124,6MDA,,JED,A,Lig,Inhibitor,"3-(4-bromophenyl)-6-(4-methylphenyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid",601,,,30688462,Optimization of Fused Bicyclic Allosteric SHP2 Inhibitors.,,6MDA
ASD09200000_1,PTPN11,Homo sapiens,Q06124,6MDB,,JE4,A,Lig,Inhibitor,"6-(4-amino-4-methylpiperidin-1-yl)-3-(2,3-dichlorophenyl)-5-methyl-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one",601,,,30688459,"6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors.",,6MDB
ASD09200000_1,PTPN11,Homo sapiens,Q06124,6MDC,,JEA,A,Lig,Inhibitor,"6-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-3-[3-chloro-2-(cyclopropylamino)pyridin-4-yl]-5-methyl-2,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one",601,,,30688462,Optimization of Fused Bicyclic Allosteric SHP2 Inhibitors.,,6MDC
ASD09200000_1,PTPN11,Homo sapiens,Q06124,6MDD,,JE7,A,Lig,Inhibitor,"5-[(2,3-dichlorophenyl)sulfanyl]-3H-imidazo[4,5-b]pyridin-2-amine",601,,,30688462,Optimization of Fused Bicyclic Allosteric SHP2 Inhibitors.,,6MDD
ASD09200000_1,PTPN11,Homo sapiens,Q06124,6WU8,,U9Y,A,Lig,Inhibitor,"1-[3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-amine",601,,,,,,6WU8
ASD09200000_1,PTPN11,Homo sapiens,Q06124,7JVM,,VKS,A,Lig,Inhibitor,"(3S,4S)-8-{6-amino-5-[(2-amino-3-chloropyridin-4-yl)sulfanyl]pyrazin-2-yl}-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine",601,,,,,,7JVM
ASD09200000_1,PTPN11,Homo sapiens,Q06124,7JVN,,VKP,A,Lig,Inhibitor,"6-(4-amino-4-methylpiperidin-1-yl)-3-[(2,3-dichlorophenyl)sulfanyl]pyrazin-2-amine",601,,,,,,7JVN
ASD09200000_1,PTPN11,Homo sapiens,Q06124,7R75,,33I,A,Lig,Inhibitor,"6-(4-amino-4-methylpiperidin-1-yl)-3-(3-chlorophenyl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one",601,,,,,,7R75
ASD09200000_1,PTPN11,Homo sapiens,Q06124,7R7D,,37I,A,Lig,Inhibitor,"4-[6-(4-amino-4-methylpiperidin-1-yl)-1H-pyrazolo[3,4-b]pyrazin-3-yl]-3-chloro-N-methylpyridin-2-amine",601,,,,,,7R7D
ASD09200000_1,PTPN11,Homo sapiens,Q06124,7R7I,,3CW,A,Lig,Inhibitor,"[3-(4-amino-4-methylpiperidin-1-yl)-6-(2,3-dichlorophenyl)-5-methylpyrazin-2-yl]methanol",601,,,,,,7R7I
ASD09200000_1,PTPN11,Homo sapiens,Q06124,7R7L,,3ED,A,Lig,Inhibitor,"6-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-3-(2,3-dichlorophenyl)-2-methylpyrimidin-4(3H)-one",601,,,,,,7R7L
ASD09200000_1,PTPN11,Homo sapiens,Q06124,7RCT,,4Q4,A,Lig,Inhibitor,"{3-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-6-(2,3-dichlorophenyl)-5-methylpyrazin-2-yl}methanol",601,,,,,,7RCT
ASD09200000_1,PTPN11,Homo sapiens,Q06124,7VXG,ASD09200050,83Q,"E,F,G,H",compound,,"6-(4-(aminomethyl)-4-methylpiperidin-1-yl)-3-((2,3-dichlorophenyl)thio)pyrazin-2-amine",,,,35310939,,,7VXG
ASD09330000_1,dasR,Streptomyces coelicolor,Q9K492,4ZSI,ASD80050001,GLP,A,Lig,Regulator,GLUCOSAMINE 6-PHOSPHATE,301,Allosteric Function,Allosteric Position,27337024,Crystal Structures of the Global Regulator DasR from Streptomyces coelicolor: Implications for the Allosteric Regulation of GntR/HutC Repressors.,No,"Chain A:THR178,THR174,THR96,VAL234,GLU193,SER236,LEU176,LEU219,TYR98,THR99,TYR177,ARG142,GLU154,THR156,SER223,GLN91,TYR238,GLU100,SER175,ARG144,ASP101,SER97,ARG221,GLU232"
ASD09330000_1,dasR,Streptomyces coelicolor,Q9K492,4ZSI,ASD09330003,4R1,B,Lig,Regulator,beta-glucosamine-6-phosphate,301,Allosteric Function,Allosteric Position,27337024,Crystal Structures of the Global Regulator DasR from Streptomyces coelicolor: Implications for the Allosteric Regulation of GntR/HutC Repressors.,No,"Chain B:ARG144,ARG142,VAL234,GLN91,LEU176,TYR238,GLU193,ASP101,TYR98,LEU219,SER111,SER175,THR156,THR178,LEU170,GLU232,TYR177,ARG221,THR174,GLU100,THR96,SER223,SER236,SER97,THR99,GLU154"
ASD09330000_1,dasR,Streptomyces coelicolor,Q9K492,4ZSK,ASD01218001,16G,A,Lig,Regulator,N-ACETYL-D-GLUCOSAMINE-6-PHOSPHATE,301,Allosteric Function,Allosteric Position,27337024,Crystal Structures of the Global Regulator DasR from Streptomyces coelicolor: Implications for the Allosteric Regulation of GntR/HutC Repressors.,No,"Chain A:THR178,THR174,THR96,VAL234,GLU193,SER236,SER220,LEU176,LEU219,TYR98,THR99,TYR177,ARG142,GLU154,THR156,SER223,TYR238,ARG235,GLU100,SER175,ARG144,ASP101,SER97,ARG221,GLU232"
ASD09330000_1,dasR,Streptomyces coelicolor,Q9K492,4ZSK,ASD09330002,4QY,B,Lig,Regulator,beta-N-acetylglucosamine-6-phosphate,301,Allosteric Function,Allosteric Position,27337024,Crystal Structures of the Global Regulator DasR from Streptomyces coelicolor: Implications for the Allosteric Regulation of GntR/HutC Repressors.,No,"Chain B:ARG144,ARG142,GLN91,LEU176,TYR238,GLU193,ASP101,TYR98,LEU219,SER175,THR156,THR178,SER220,LEU170,GLU232,TYR177,ARG221,VAL234,THR174,GLU100,THR96,ARG235,SER223,SER236,SER97,THR99,GLU154"
ASD09380000_1,FFAR1,Homo sapiens,O14842,5KW2,ASD09380008,6XQ,A,Lig,Activator,"(3~{S})-3-cyclopropyl-3-[2-[1-[2-[2,2-dimethylpropyl-(6-methylpyridin-2-yl)carbamoyl]-5-methoxy-phenyl]piperidin-4-yl]-1-benzofuran-6-yl]propanoic acid",2401,Allosteric Fuction,Allosteric Position,29695780,Structural basis for GPR40 allosteric agonism and incretin stimulation.,No,5KW2
ASD09380000_1,FFAR1,Homo sapiens,O14842,5TZR,ASD09380011,MK6,A,Lig,,"(5aR,6S,6aS)-3-({2',6'-dimethyl-4'-[3-(methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl}methoxy)-5,5a,6,6a-tetrahydrocyclopropa[4,5]cyclopenta[1,2-c]pyridine-6-carboxylic acid",2402,Inner Protein Regulator,Inner Protein,28581512,Structural basis for the cooperative allosteric activation of the free fatty acid receptor GPR40.,No,5TZR
ASD09380000_1,FFAR1,Homo sapiens,O14842,5TZY,ASD09380009,7OS,A,Lig,Activator,"(2S,3R)-3-cyclopropyl-3-[(2R)-2-(1-{(1S)- 1-[5-fluoro-2-(trifluoromethoxy)phenyl]ethyl}piperidin- 4-yl)-3,4-dihydro-2H-1-benzopyran-7-yl]-2- methylpropanoic acid",2403,Inner Protein Regulator,Inner Protein,28581512,Structural basis for the cooperative allosteric activation of the free fatty acid receptor GPR40.,No,5TZY
ASD09420000_1,HDAC1,Homo sapiens,Q13547,5ICN,ASD03710003,I6P,A,Lig,Inhibitor,"INOSITOL 1,2,3,4,5,6-HEXAKISPHOSPHATE",401,Protein-Protein Interaction,Protein-Protein Interaction,27109927,Insights into the activation mechanism of class I HDAC complexes by inositol phosphates.,No,5ICN
ASD09460000_1,pelD,Pseudomonas aeruginosa,Q02PM6,4DN0,ASD06980001;ASD06980001,C2E;C2E,A;A,Lig,Inhibitor,"9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)- 3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro- 2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine- 2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin- 6-one)",501;502,Inner Protein Regulator,Inner Protein,22605337,"Structure of the Cytoplasmic Region of PelD, a Degenerate Diguanylate Cyclase Receptor That Regulates Exopolysaccharide Production in Pseudomonas aeruginosa.",No,"Chain A:ARG161,LEU165,GLN366,ARG367,GLY368,ASP370,LEU388,THR391,GLY395,GLY398,TYR399,ARG402"
ASD09460000_1,pelD,Pseudomonas aeruginosa,Q9HZE7,4ETZ,ASD06980001,C2E,A,Lig,Inhibitor,"9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)- 3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro- 2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine- 2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin- 6-one)",501,Inner Protein Regulator,Inner Protein,22810222,Structures of the PelD Cyclic Diguanylate Effector Involved in Pellicle Formation in Pseudomonas aeruginosa PAO1.,No,"Chain A:GLN158,ARG161,ARG367,ASP370,LEU388,THR391,GLY395,GLY398,TYR399,ARG402"
ASD09460000_1,pelD,Pseudomonas aeruginosa,Q9HZE7,4EU0,ASD06980001,C2E,A,Lig,Inhibitor,"9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)- 3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro- 2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine- 2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin- 6-one)",501,Inner Protein Regulator,Inner Protein,22810222,Structures of the PelD Cyclic Diguanylate Effector Involved in Pellicle Formation in Pseudomonas aeruginosa PAO1.,No,"Chain A:ARG161,ARG367,ASP370,LEU388,THR391,GLY395,GLY398,TYR399,ARG402"
ASD09460000_1,pelD,Pseudomonas aeruginosa,Q9HZE7,4EUV,ASD06980001,C2E,A,Lig,Inhibitor,"9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)- 3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro- 2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine- 2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin- 6-one)",501,Inner Protein Regulator,Inner Protein,22810222,Structures of the PelD Cyclic Diguanylate Effector Involved in Pellicle Formation in Pseudomonas aeruginosa PAO1.,No,"Chain A:ARG161,ARG367,ASP370,LEU388,THR391,GLY395,GLY398,TYR399,ARG402"
ASD09490000_1,PRMT3,Homo sapiens,O60678,3SMQ,ASD09490001,TDU,A,Lig,Inhibitor,"1-(1,2,3-benzothiadiazol-6-yl)-3-[2-(cyclohexen-1-yl)ethyl]urea",1,Inner Protein Regulator,Inner Protein,,Crystal structure of protein arginine methyltransferase 3,No,3SMQ
ASD09490000_1,PRMT3,Homo sapiens,O60678,4HSG,ASD09490009,KTD,A,Lig,Inhibitor,"1-(1,2,3-benzothiadiazol-6-yl)-3-phenacyl-urea",601,Inner Protein Regulator,Inner Protein,,Crystal structure of human PRMT3 in complex with an allosteric inhibitor (PRMT3- KTD),No,4HSG
ASD09490000_1,PRMT3,Homo sapiens,O60678,4QQN,ASD09490010,3BQ,,Lig,Inhibitor,1-{2-[1-(aminomethyl)cyclohexyl]ethyl}-3-isoquinolin-6-ylurea,601,Allosteric function,Allosteric position,29244490,Discovery of Potent and Selective Allosteric Inhibitors of Protein Arginine Methyltransferase 3 (PRMT3).,No,4QQN
ASD09490000_1,PRMT3,Homo sapiens,O60678,4RYL,ASD09490008,3ZG,A,Lig,Inhibitor,1-isoquinolin-6-yl-3-[2-oxo-2-(pyrrolidin- 1-yl)ethyl]urea,601,Inner Protein Regulator,Allosteric Position,25728001,"A Potent, Selective and Cell-Active Allosteric Inhibitor of Protein Arginine Methyltransferase 3 (PRMT3).",No,4RYL
ASD09500000_1,,Pyrococcus horikoshii,O57946,3ATH,,AKG,A,Lig,Inhibitor,2-OXOGLUTARIC ACID,430,Inner Protein Regulator,Inner Protein,,Characterization of kynurenine aminotransferase from hyperthermophilic archaeon: enzymatic activity for conversion to kynurenic acid is allosterically regulated by alpha-ketoglutaric acid cooperatively with kynurenine,No,
ASD09650000_1,ABCG2,Homo sapiens,Q9UNQ0,5NJ3,,5D3,"C,D,E,F",Pep,Inhibitor,5D3-Fab,,Allosteric function,Allosteric position,28554189,Structure of the human multidrug transporter ABCG2.,No,5NJ3
ASD09690000_1,SAMHD1,Homo sapiens,Q9Y3Z3,4BZB,ASD09690001;ASD09690001,DGT;DGT,A;A,Lig,Activator,"[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate;[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",800;900,Inner Protein Regulator,Protein-Protein Interaction,24141705,Mechanism of Allosteric Activation of Samhd1 by Dgtp,No,4BZB
ASD09690000_1,,Homo sapiens,Q9Y3Z3,4BZC,ASD09690012;ASD09690012,T8T;T8T,A;A,Lig,Activator,2'-deoxyguanosine-5'-O-(1-thiotriphosphate);2'-deoxyguanosine-5'-O-(1-thiotriphosphate),800;900,Inner Protein Regulator,Protein-Protein Interaction,24141705,Mechanism of Allosteric Activation of Samhd1 by Dgtp,No,4BZC
ASD09690000_1,SAMHD1,Homo sapiens,Q9Y3Z3,4MZ7,ASD09690001;ASD09690001,DGT;DGT,A;A,Lig,Activator,"[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate;[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate",703;704,Inner Protein Regulator,Protein-Protein Interaction,24217394,Structural insight into dGTP-dependent activation of tetrameric SAMHD1 deoxynucleoside triphosphate triphosphohydrolase,No,4MZ7
ASD09690000_1,,Homo sapiens,Q9Y3Z3,4QFX,ASD09690001,DGT,A,Lig,Activator,2'-DEOXYGUANOSINE-5'-TRIPHOSPHATE,701,Inner Protein Regulator,Protein-Protein Interaction,25288794,Structural Basis of Allosteric Activation of Sterile alpha Motif and Histidine-Aspartate Domain-containing Protein 1 (SAMHD1) by Nucleoside Triphosphates.,No,4QFX
ASD09690000_1,,Homo sapiens,Q9Y3Z3,4QFY,ASD09690001,DGT,A,Lig,Activator,2'-DEOXYGUANOSINE-5'-TRIPHOSPHATE,701,Inner Protein Regulator,Protein-Protein Interaction,25288794,Structural Basis of Allosteric Activation of Sterile alpha Motif and Histidine-Aspartate Domain-containing Protein 1 (SAMHD1) by Nucleoside Triphosphates.,No,4QFY
ASD09690000_1,,Homo sapiens,Q9Y3Z3,4QFZ,ASD09690001,DGT,A,Lig,Activator,2'-DEOXYGUANOSINE-5'-TRIPHOSPHATE,701,Inner Protein Regulator,Protein-Protein Interaction,25288794,Structural Basis of Allosteric Activation of Sterile alpha Motif and Histidine-Aspartate Domain-containing Protein 1 (SAMHD1) by Nucleoside Triphosphates.,No,4QFZ
ASD09690000_1,,Homo sapiens,Q9Y3Z3,4QG0,ASD09690001,DGT,A,Lig,Activator,2'-DEOXYGUANOSINE-5'-TRIPHOSPHATE,701,Inner Protein Regulator,Protein-Protein Interaction,25288794,Structural Basis of Allosteric Activation of Sterile alpha Motif and Histidine-Aspartate Domain-containing Protein 1 (SAMHD1) by Nucleoside Triphosphates.,No,4QG0
ASD09690000_1,SAMHD1,Homo sapiens,Q9Y3Z3,4QG1,,GTP,,,Activator,GUANOSINE-5'-TRIPHOSPHATE,,,,25288794,Structural Basis of Allosteric Activation of Sterile alpha Motif and Histidine-Aspartate Domain-containing Protein 1 (SAMHD1) by Nucleoside Triphosphates.,,4QG1
ASD09690000_1,,Homo sapiens,Q9Y3Z3,4QG2,ASD00290006,GTP,A,Lig,Activator,GUANOSINE-5'-TRIPHOSPHATE,701,Inner Protein Regulator,Protein-Protein Interaction,25288794,Structural Basis of Allosteric Activation of Sterile alpha Motif and Histidine-Aspartate Domain-containing Protein 1 (SAMHD1) by Nucleoside Triphosphates.,No,4QG2
ASD09690000_1,,Homo sapiens,Q9Y3Z3,4QG4,ASD00290006,GTP,A,Lig,Activator,GUANOSINE-5'-TRIPHOSPHATE,701,Inner Protein Regulator,Protein-Protein Interaction,25288794,Structural Basis of Allosteric Activation of Sterile alpha Motif and Histidine-Aspartate Domain-containing Protein 1 (SAMHD1) by Nucleoside Triphosphates.,No,4QG4
ASD09690000_1,SAMHD1,Homo sapiens,Q9Y3Z3,4RXO,ASD00290006,GTP,"B,C,D",Lig,Activator,GUANOSINE-5'-TRIPHOSPHATE,702,Inner Protein Regulator,Allosteric Position,25760601,The mechanism of substrate-controlled allosteric regulation of SAMHD1 activated by GTP.,No,4RXO
ASD09690000_1,SAMHD1,Homo sapiens,Q9Y3Z3,4RXP,ASD00290006,GTP,"A,B",Lig,Activator,GUANOSINE-5'-TRIPHOSPHATE,703,Inner Protein Regulator,Allosteric Position,25760601,The mechanism of substrate-controlled allosteric regulation of SAMHD1 activated by GTP.,No,4RXP
ASD09690000_1,SAMHD1,Homo sapiens,Q9Y3Z3,4RXQ,ASD00290006,GTP,A,Lig,Activator,GUANOSINE-5'-TRIPHOSPHATE,804,Inner Protein Regulator,Allosteric Position,25760601,The mechanism of substrate-controlled allosteric regulation of SAMHD1 activated by GTP.,No,4RXQ
ASD09690000_1,SAMHD1,Homo sapiens,Q9Y3Z3,4RXR,ASD00290006,GTP,B,Lig,Activator,GUANOSINE-5'-TRIPHOSPHATE,801,Inner Protein Regulator,Allosteric Position,25760601,The mechanism of substrate-controlled allosteric regulation of SAMHD1 activated by GTP.,No,4RXR
ASD09690000_1,SAMHD1,Homo sapiens,Q9Y3Z3,4RXS,ASD00290006,GTP,A,Lig,Activator,GUANOSINE-5'-TRIPHOSPHATE,801,Inner Protein Regulator,Allosteric Position,25760601,The mechanism of substrate-controlled allosteric regulation of SAMHD1 activated by GTP.,No,4RXS
ASD09690000_1,SAMHD1,Homo sapiens,Q9Y3Z3,4TNP,ASD02588003,DCP,A,Lig,Activator,2'-DEOXYCYTIDINE-5'-TRIPHOSPHATE,701,Allosteric function,Allosteric position,25267621,Structural basis of cellular dNTP regulation by SAMHD1.,Yes,4TNP
ASD09690000_1,SAMHD1,Homo sapiens,Q9Y3Z3,4TNQ,ASD02040015,TTP,A,Lig,Activator,THYMIDINE-5'-TRIPHOSPHATE,701,Allosteric function,Allosteric position,25267621,Structural basis of cellular dNTP regulation by SAMHD1.,Yes,4TNQ
ASD09690000_1,SAMHD1,Homo sapiens,Q9Y3Z3,4TNR,ASD00870004,DTP,A,Lig,Activator,2'-DEOXYADENOSINE 5'-TRIPHOSPHATE,701,Allosteric function,Allosteric position,25267621,Structural basis of cellular dNTP regulation by SAMHD1.,Yes,4TNR
ASD09690000_1,SAMHD1,Homo sapiens,Q9Y3Z3,4TNX,ASD09690001,DGT,A,Lig,Activator,2'-DEOXYGUANOSINE-5'-TRIPHOSPHATE,701,Allosteric function,Allosteric position,25267621,Structural basis of cellular dNTP regulation by SAMHD1.,Yes,4TNX
ASD09690000_1,SAMHD1,Homo sapiens,Q9Y3Z3,5AO0,ASD09690004,DG3,"A,B",Lig,Regulator,2'-3'-DIDEOXYGUANOSINE-5'-TRIPHOSPHATE,2002,Inner Protein Regulator,Allosteric Position,26431200,Phospho-Dependent Regulation of Samhd1 Oligomerisation Couples Catalysis and Restriction.,No,5AO0
ASD09690000_1,SAMHD1,Homo sapiens,Q9Y3Z3,5AO1,ASD09690004,DG3,B,Lig,Regulator,2'-3'-DIDEOXYGUANOSINE-5'-TRIPHOSPHATE,1584,Inner Protein Regulator,Allosteric Position,26431200,Phospho-Dependent Regulation of Samhd1 Oligomerisation Couples Catalysis and Restriction.,No,5AO1
ASD09690000_1,SAMHD1,Homo sapiens,Q9Y3Z3,5AO2,ASD09690001,DGT,B,Lig,Regulator,2'-DEOXYGUANOSINE-5'-TRIPHOSPHATE,1583,Inner Protein Regulator,Allosteric Position,26431200,Phospho-Dependent Regulation of Samhd1 Oligomerisation Couples Catalysis and Restriction.,No,5AO2
ASD09690000_1,SAMHD1,Homo sapiens,Q9Y3Z3,5AO3,,GTP,"A,C,D",Lig,Regulator,GUANOSINE-5'-TRIPHOSPHATE,1585,Inner Protein Regulator,Allosteric Position,26431200,Phospho-Dependent Regulation of Samhd1 Oligomerisation Couples Catalysis and Restriction.,No,5AO3
ASD09690000_1,SAMHD1,Homo sapiens,Q9Y3Z3,5AO4,ASD00290006,GTP,"A,C,D",Lig,Regulator,GUANOSINE-5'-TRIPHOSPHATE,1585/1586,Inner Protein Regulator,Allosteric Position,26431200,Phospho-Dependent Regulation of Samhd1 Oligomerisation Couples Catalysis and Restriction.,No,5AO4
ASD09690000_1,SAMHD1,Homo sapiens,Q9Y3Z3,6DW4,,HF7,A,Lig,Inhibitor,2'-deoxy-2-methyladenosine 5'-(tetrahydrogen triphosphate),705,,,30305425,The structural basis for cancer drug interactions with the catalytic and allosteric sites of SAMHD1.,,6DW4
ASD09690000_1,SAMHD1,Homo sapiens,Q9Y3Z3,6DWD,,HDV,A,Lig,Inhibitor,9-{2-deoxy-2-fluoro-5-O-[(R)-hydroxy{[(S)-hydroxy(phosphonooxy)phosphoryl]oxy}phosphoryl]-beta-D-arabinofuranosyl}-2-me thyl-9H-purin-6-amine,704,,,30305425,The structural basis for cancer drug interactions with the catalytic and allosteric sites of SAMHD1.,,6DWD
ASD09690000_1,SAMHD1,Homo sapiens,Q9Y3Z3,6U6Y,,DTP,A,Lig,activator,2'-DEOXYADENOSINE 5'-TRIPHOSPHATE,702,,,,,,6U6Y
ASD09690000_1,SAMHD1,Homo sapiens,Q9Y3Z3,7A5Y,,MG,A,Ion,Regulator,MAGNESIUM ION,703,,,,,,7A5Y
ASD09700000_1,Plau,Mus musculus,P06869,5LHN,,Nb7,B,Pep,Inhibitor,Camelid-Derived Antibody Fragment Nb7,1-247,Allosteric Fuction,Allosteric Position,28611361,Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator.,No,
ASD09700000_1,Plau,Mus musculus,P06869,5LHP,,Nb7,B,Pep,Inhibitor,Camelid-Derived Antibody Fragment Nb7,1-247,Allosteric Fuction,Allosteric Position,28611361,Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator.,No,
ASD09700000_1,Plau,Mus musculus,P06869,5LHQ,,Nb7,B,Pep,Inhibitor,Camelid-Derived Antibody Fragment Nb7,1-247,Allosteric Fuction,Allosteric Position,28611361,Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator.,No,
ASD09790000_1,GAA,Homo sapiens,P10253,5NN4,ASD09790001,SC2,A,Lig,Regulator,N-ACETYL-L-CYSTEINE,1016,Allosteric function,Allosteric position,29061980,Structure of human lysosomal acid alpha-glucosidase-a guide for the treatment of Pompe disease.,No,5NN4
ASD09800000_1,ERN1,Homo sapiens,O75460,6HV0,,GUK,A,Lig,Inhibitor,"6-chloranyl-3-(2~{H}-indazol-5-yl)-~{N}-propan-2-yl-imidazo[1,2-b]pyridazin-8-amine",1001,,,30779566,Binding to an Unusual Inactive Kinase Conformation by Highly Selective Inhibitors of Inositol-Requiring Enzyme 1 alpha Kinase-Endoribonuclease.,,6HV0
ASD09800000_1,ERN1,Homo sapiens,O75460,6HX1,,GXK,A,Lig,Inhibitor,"6-chloranyl-~{N}-(cyclopropylmethyl)-3-(2~{H}-indazol-5-yl)imidazo[1,2-b]pyridazin-8-amine",1001,,,30779566,Binding to an Unusual Inactive Kinase Conformation by Highly Selective Inhibitors of Inositol-Requiring Enzyme 1 alpha Kinase-Endoribonuclease.,,6HX1
ASD09890000_1,VCP,Homo sapiens,P55072,5FTJ,ASD09890124,OJA,A,Lig,Inhibitor,1-(3-(5-FLUORO-1H-INDOL-2-YL)PHENYL)PIPERIDIN- 4-YL)(2-(4-ISOPROPYL-PIPERAZIN1-YL)ETHYL)- CARBAMATE,1001,Allosteric Function,Allosteric Position,26822609,2.3 A Resolution Cryo-Em Structure of Human P97 and Mechanism of Allosteric Inhibition,No,5FTJ
ASD09890000_1,VCP,Homo sapiens,P55072,7LMY,,Y6Y,A,Lig,Inhibitor,"3-[3-cyclopentylsulfanyl-5-[[3-methyl-4-(4-methylsulfonylphenyl)phenoxy]methyl]-1,2,4-triazol-4-yl]pyridine",903,,,,,,7LMY
ASD09890000_1,VCP,Homo sapiens,P55072,7NEC,,U95,A,Lig,Inhibitor,"4-[[3-[2-chloranyl-6-(trifluoromethyl)phenyl]-5-(1~{H}-pyrrol-2-yl)-1,2-oxazol-4-yl]methoxy]benzoic acid",601,,,,,,7NEC
ASD09970000_1,aroG,Mycobacterium tuberculosis,O53512,2YPO,ASD02170001,PHE,A,Lig,Inhibitor,(2S)-2-amino-3-phenyl-propanoic acid,900,Inner Protein Regulator,Protein-Protein Interaction,,Three Sites and You are Out: Ternary Synergistic Allostery Controls Aromatic Aminoacid Biosynthesis in Mycobacterium Tuberculosis.,No,"Chain A:PHE91,MET92,ARG171,ALA174,ASN175,ALA178; Chain B:TRP3,VAL5,ASP6,VAL55,TYR173"
ASD09970000_1,aroG,Mycobacterium tuberculosis,O53512,2YPO,ASD02170001,PHE,B,Lig,Inhibitor,(2S)-2-amino-3-phenyl-propanoic acid,900,Inner Protein Regulator,Protein-Protein Interaction,,Three Sites and You are Out: Ternary Synergistic Allostery Controls Aromatic Aminoacid Biosynthesis in Mycobacterium Tuberculosis.,No,Chain B:ARG171
ASD09970000_1,aroG,Mycobacterium tuberculosis,O53512,3KGF,ASD00320001,TRP,B,Lig,Inhibitor,(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid,9004,Inner Protein Regulator,Inner Protein,20667835,"Synergistic allostery, a sophisticated regulatory network for the control of aromatic amino acid biosynthesis in Mycobacterium tuberculosis",No,"Chain A:PHE91,MET92,ARG171,ALA174,ASN175,ALA178; Chain B:TRP3,VAL5,ASP6,VAL55,TYR173"
ASD09970000_1,aroG,Mycobacterium tuberculosis,O53512,3KGF,ASD02170001,PHE,B,Lig,Inhibitor,(2S)-2-amino-3-phenyl-propanoic acid,9001,Inner Protein Regulator,Protein-Protein Interaction,20667835,"Synergistic allostery, a sophisticated regulatory network for the control of aromatic amino acid biosynthesis in Mycobacterium tuberculosis",No,"Chain A:LEU107,ALA110,VAL111,LYS123,ALA192,LEU194,ASN237,LEU238,THR240,ALA241"
ASD09970000_1,aroG,Mycobacterium tuberculosis,O53512,3KGF,ASD02170001,PHE,B,Lig,Inhibitor,(2S)-2-amino-3-phenyl-propanoic acid,4188,Inner Protein Regulator,Inner Protein,20667835,"Synergistic allostery, a sophisticated regulatory network for the control of aromatic amino acid biosynthesis in Mycobacterium tuberculosis",No,Chain B:ARG256
ASD09970000_1,aroG,Mycobacterium tuberculosis,O53512,3NUD,ASD02170001,PHE,B,Lig,Inhibitor,(2S)-2-amino-3-phenyl-propanoic acid,467,Inner Protein Regulator,Inner Protein,20667835,"Synergistic allostery, a sophisticated regulatory network for the control of aromatic amino acid biosynthesis in Mycobacterium tuberculosis",No,"Chain A:PHE91,ARG171,ALA174,ASN175; Chain B:VAL5,VAL55"
ASD09970000_1,aroG,Mycobacterium tuberculosis,O53512,3NUD,ASD02170001,PHE,B,Lig,Inhibitor,(2S)-2-amino-3-phenyl-propanoic acid,466,Inner Protein Regulator,Protein-Protein Interaction,20667835,"Synergistic allostery, a sophisticated regulatory network for the control of aromatic amino acid biosynthesis in Mycobacterium tuberculosis",No,Chain B:ARG171
ASD09970000_1,aroG,Mycobacterium tuberculosis,O53512,3NUD,ASD02170001,PHE,B,Lig,Inhibitor,(2S)-2-amino-3-phenyl-propanoic acid,468,Inner Protein Regulator,Inner Protein,20667835,"Synergistic allostery, a sophisticated regulatory network for the control of aromatic amino acid biosynthesis in Mycobacterium tuberculosis",No,Chain B:ARG256
ASD09970000_1,aroG,Mycobacterium tuberculosis,O53512,3NUE,ASD00320001,TRP,B,Lig,Inhibitor,(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid,9004,Inner Protein Regulator,Inner Protein,20667835,"Synergistic allostery, a sophisticated regulatory network for the control of aromatic amino acid biosynthesis in Mycobacterium tuberculosis",No,"Chain A:LEU107,VAL111,LYS123,ALA192,LEU194,ASN237,LEU238,THR240,ALA241"
ASD09970000_1,aroG,Mycobacterium tuberculosis,O53512,3NUE,ASD00320001,TRP,A,Lig,Inhibitor,(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid,9004,Inner Protein Regulator,Inner Protein,20667835,"Synergistic allostery, a sophisticated regulatory network for the control of aromatic amino acid biosynthesis in Mycobacterium tuberculosis",No,Chain A:ASN237
ASD09970000_1,aroG,Mycobacterium tuberculosis,O53512,3RZI,ASD00320001,TRP,B,Lig,Inhibitor,(2S)-2-amino-3-phenyl-propanoic acid,466,Inner Protein Regulator,Inner Protein,,Dynamic Cross-Talk among Remote Binding Sites: The Molecular Basis for Unusual Synergistic Allostery.,No,"Chain A:PHE91,MET92,ARG171,ALA174,ASN175,ALA178; Chain B:VAL5,ASP6,VAL55,TYR173"
ASD09970000_1,aroG,Mycobacterium tuberculosis,O53512,3RZI,ASD02170001,PHE,B,Lig,Inhibitor,(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid,465,Inner Protein Regulator,Protein-Protein Interaction,,Dynamic Cross-Talk among Remote Binding Sites: The Molecular Basis for Unusual Synergistic Allostery.,No,"Chain A:LEU107,ALA110,VAL111,LYS123,ALA192,LEU194,ASN237,LEU238,THR240,ALA241"
ASD09970000_1,aroG,Mycobacterium tuberculosis,O53512,5E7Z,ASD05860010,TRP,"A,B",Lig,Regulator,TRYPTOPHAN,505,Inner Protein Regulator,Allosteric Position,27128682,Probing the Sophisticated Synergistic Allosteric Regulation of Aromatic Amino Acid Biosynthesis in Mycobacterium tuberculosis Using -Amino Acids.,No,"Chain B:THR240,ALA192,ALA110,LEU238,ALA241,LEU194,SER193,VAL197,VAL111,THR114,VAL121,ASN237,GLN239,PRO120,GLN108,GLU242,LEU107,LYS123"
ASD09970000_1,aroG,Mycobacterium tuberculosis,O53512,5EX4,ASD05860010,TRP,A,Lig,Regulator,TRYPTOPHAN,502,Allosteric Function,Allosteric Position,,3-deoxy-d-arabino-heptulosonate 7-phosphate synthase from Mycobacterium tuberculosis complexed with tryptophan in all three allosteric binding sites,No,"Chain A:LEU107,GLU242,ALA192,ALA110,LEU194,GLN239,LEU238,PRO120,VAL197,THR240,VAL111,ALA241,LYS123,ASN237,THR114,VAL121,GLN108,SER193"
ASD09970000_1,aroG,Mycobacterium tuberculosis,O53512,5EX4,ASD05860010,TRP,A,Lig,Regulator,TRYPTOPHAN,504,Allosteric Function,Allosteric Position,,3-deoxy-d-arabino-heptulosonate 7-phosphate synthase from Mycobacterium tuberculosis complexed with tryptophan in all three allosteric binding sites,No,"Chain B:ALA174,SER54,PRO8,VAL51,VAL170,PRO56,TYR173,SER177,ILE7,ASP6,VAL55"
ASD09970000_1,aroG,Mycobacterium tuberculosis,O53512,5EX4,ASD05860010,TRP,B,Lig,Regulator,TRYPTOPHAN,508,Allosteric Function,Allosteric Position,,3-deoxy-d-arabino-heptulosonate 7-phosphate synthase from Mycobacterium tuberculosis complexed with tryptophan in all three allosteric binding sites,No,"Chain B:ASP27,ALA257,ARG260,LEU261,ARG49,MET258,PRO16,LEU259,ARG256,LEU15,LEU18,LEU26,PRO17,GLU53,LEU271,ARG23,LEU30"
ASD10010000_1,SLC1A3,Homo sapiens,P43003,5LLM,,6Z6,A,Lig,Inhibitor,"2-Amino-5,6,7,8-tetrahydro-4-(4-methoxyphenyl)- 7-(naphthalen-1-yl)-5-oxo-4H-chromene-3-carbonitrile",603,Inner Protein Regulator,Inner Protein,28424515,Structure and allosteric inhibition of excitatory amino acid transporter 1.,No,5LLM
ASD10010000_1,SLC1A3,Homo sapiens,P43003,5LM4,ASD10010007,6Z6,A,Lig,Inhibitor,"2-Amino-5,6,7,8-tetrahydro-4-(4-methoxyphenyl)- 7-(naphthalen-1-yl)-5-oxo-4H-chromene-3-carbonitrile",603,Inner Protein Regulator,Inner Protein,28424515,Structure and allosteric inhibition of excitatory amino acid transporter 1.,No,5LM4
ASD10010000_1,SLC1A3,Homo sapiens,P43003,5MJU,ASD10010007,6Z6,A,Lig,Inhibitor,"2-Amino-5,6,7,8-tetrahydro-4-(4-methoxyphenyl)- 7-(naphthalen-1-yl)-5-oxo-4H-chromene-3-carbonitrile",601,Inner Protein Regulator,Inner Protein,28424515,Structure and allosteric inhibition of excitatory amino acid transporter 1.,No,5MJU
ASD10090000_1,MAPK10,Homo sapiens,P53779,4H36,ASD10090001;ASD10090001;ASD10090001;ASD10090001;ASD10090001;ASD10090001;ASD10090001;ASD10090001,LYS;HIS;GLU;MET;THR;LEU;LYS;PHE,B;B;B;B;B;B;B;B,Pep,Inhibitor,,48;49;50;51;52;53;54;55,Inner Protein Regulator,Inner Protein,23142346,Structural Mechanisms of Allostery and Autoinhibition in JNK Family Kinases.,No,4H36
ASD10090000_1,MAPK10,Homo sapiens,P53779,4H39,ASD10090002;ASD10090002;ASD10090002;ASD10090002;ASD10090002;ASD10090002;ASD10090002;ASD10090002;ASD10090002;ASD10090002,PRO;LYS;ARG;PRO;THR;THR;LEU;ASN;LEU;PHE,B;B;B;B;B;B;B;B;B;B,Pep,Inhibitor,,158;159;160;161;162;163;164;165;166;167,Inner Protein Regulator,Inner Protein,23142346,Structural Mechanisms of Allostery and Autoinhibition in JNK Family Kinases.,No,4H39
ASD10090000_1,MAPK10,Homo sapiens,P53779,4H3B,ASD10090003;ASD10090003;ASD10090003;ASD10090003;ASD10090003;ASD10090003;ASD10090003;ASD10090003;ASD10090003;ASD10090003,VAL;VAL;ARG;PRO;GLY;SER;LEU;ASP;LEU;PRO,B;B;B;B;B;B;B;B;B;B,Pep,Inhibitor,,341;342;343;344;345;346;347;348;349;350,Inner Protein Regulator,Inner Protein,23142346,Structural Mechanisms of Allostery and Autoinhibition in JNK Family Kinases.,No,4H3B
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,1FXO,ASD10100014,TMP,A,Lig,Inhibitor,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl dihydrogen phosphate",9507,Inner Protein Regulator,Protein-Protein Interaction,11118200,The structural basis of the catalytic mechanism and regulation of glucose-1-phosphate thymidylyltransferase (RmlA).,No,"Chain A:LEU45,TYR114,GLY115,HIS116,ASP117,PHE118,VAL250,ALA251,GLU255,ILE256,ARG259; Chain C:GLY218,ARG219,GLY220"
ASD10100000_1,,Pseudomonas aeruginosa,Q9HU22,1G0R,ASD01320159,THM,A,Lig,Inhibitor,THYMIDINE,2538,Inner Protein Regulator,Protein-Protein Interaction,11118200,The structural basis of the catalytic mechanism and regulation of glucose-1-phosphate thymidylyltransferase (RmlA).,No,"Chain C:GLY220,TYR221,GLY218,ARG219"
ASD10100000_1,,Pseudomonas aeruginosa,Q9HU22,1G1L,ASD10100039,DAU,A,Lig,Inhibitor,2'DEOXY-THYMIDINE-5'-DIPHOSPHO-ALPHA-D-GLUCOSE,3501,Inner Protein Regulator,Protein-Protein Interaction,11118200,The structural basis of the catalytic mechanism and regulation of glucose-1-phosphate thymidylyltransferase (RmlA).,No,"Chain C:GLY220,MET217,ILE216,GLY218,ARG219,TYR221"
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,1G2V,ASD02040015,TTP,A,Lig,Inhibitor,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",3501,Inner Protein Regulator,Protein-Protein Interaction,11118200,The structural basis of the catalytic mechanism and regulation of glucose-1-phosphate thymidylyltransferase (RmlA).,No,"Chain A:LEU45,TYR114,GLY115,HIS116,ASP117,PHE118,HIS119,VAL250,ALA251,GLU255,ILE256,ARG259,TYR293; Chain C:GLY218,ARG219,GLY220"
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,1G3L,ASD10100031,TRH,A,Lig,Inhibitor,"[hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] [(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-oxan-2-yl] hydrogen phosphate",501,Inner Protein Regulator,Protein-Protein Interaction,11118200,The structural basis of the catalytic mechanism and regulation of glucose-1-phosphate thymidylyltransferase (RmlA).,No,"Chain A:LEU45,TYR114,GLY115,HIS116,ASP117,PHE118,HIS119,GLU120,VAL250,ALA251,GLU255,ILE256,ARG259,TYR293; Chain C:ILE216,GLY218,ARG219,GLY220"
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,3ZLK,ASD10100004,Y46,A,Lig,Inhibitor,"N-[6-azanyl-2,4-bis(oxidanylidene)-1-(phenylmethyl)pyrimidin-5-yl]benzenesulfonamide",400,Inner Protein Regulator,Protein-Protein Interaction,23138692,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,No,"Chain A:TYR38,SER41,THR42,LEU45,TYR113,TYR114,GLY115,PHE118,HIS119,LYS249,VAL250,ALA251,GLU255,ILE256,ARG259"
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,3ZLL,ASD10100019,4WF,A,Lig,Inhibitor,"5-azanyl-6-oxidanyl-1-(phenylmethyl)pyrimidine-2,4-dione",400,Inner Protein Regulator,Protein-Protein Interaction,23138692,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,No,"Chain A:LEU45,VAL250,ALA251,GLU255,ILE256,ARG259"
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,4ARW,ASD10100001,HNR,A,Lig,Inhibitor,"N-[6-azanyl-1-butyl-2,4-bis(oxidanylidene)pyrimidin-5-yl]-N-methyl-benzenesulfonamide",400,Inner Protein Regulator,Protein-Protein Interaction,23138692,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,No,"Chain A:TYR38,SER41,THR42,LEU45,TYR113,TYR114,GLY115,PHE118,LYS249,VAL250,ALA251,GLU255,ILE256,ARG259"
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,4ASJ,ASD10100003,N6A,A,Lig,Inhibitor,"N-[6-azanyl-2,4-bis(oxidanylidene)-1-(phenylmethyl)pyrimidin-5-yl]-N-methyl-benzenesulfonamide",1294,Inner Protein Regulator,Protein-Protein Interaction,23138692,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,No,"Chain A:TYR38,SER41,THR42,LEU45,TYR113,TYR114,GLY115,PHE118,HIS119,LYS249,VAL250,ALA251,GLU255,ILE256,ARG259"
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,4ASY,ASD10100005,N5Y,A,Lig,Inhibitor,"N-[6-azanyl-2,4-bis(oxidanylidene)-1-(phenylmethyl)pyrimidin-5-yl]-N-methyl-benzamide",1294,Inner Protein Regulator,Protein-Protein Interaction,23138692,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,No,"Chain A:SER41,THR42,LEU45,TYR113,TYR114,GLY115,LYS249,VAL250,ALA251,GLU255,ILE256,ARG259; Chain B:ARG219"
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,4B2W,ASD10100013,BZ0,A,Lig,Inhibitor,"N-[6-azanyl-2,4-bis(oxidanylidene)-1-(phenylmethyl)pyrimidin-5-yl]benzamide",1294,Inner Protein Regulator,Protein-Protein Interaction,23138692,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,No,"Chain A:SER41,THR42,LEU45,TYR113,PHE118,LYS249,VAL250,ALA251,GLU255,ILE256,ARG259,GLN260"
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,4B2X,ASD10100023,NIQ,A,Lig,Inhibitor,"6-azanyl-1-butyl-5-(cyclopentylamino)pyrimidine-2,4-dione",400,Inner Protein Regulator,Protein-Protein Interaction,23138692,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,No,"Chain A:THR42,LEU45,TYR113,TYR114,GLY115,LYS249,VAL250,ALA251,GLU255,ILE256,ARG259,GLN260"
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,4B3U,ASD10100007,NWL,A,Lig,Inhibitor,"6-azanyl-5-(ethylamino)-1-(phenylmethyl)pyrimidine-2,4-dione",400,Inner Protein Regulator,Protein-Protein Interaction,23138692,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,No,"Chain A:LEU45,GLY115,HIS119,LYS249,VAL250,ALA251,GLU255,ILE256,ARG259,GLN260"
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,4B42,ASD10108001,942,A,Lig,Inhibitor,"N-[6-azanyl-1-butyl-2,4-bis(oxidanylidene)pyrimidin-5-yl]-N-methyl-benzamide",1294,Inner Protein Regulator,Protein-Protein Interaction,23138692,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,No,"Chain A:SER41,THR42,TYR113,TYR114,GLY115,PHE118,LYS249,VAL250,ALA251,GLU255,ILE256,ARG259"
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,4B4B,ASD10100009,GJB,A,Lig,Inhibitor,"1-(2-phenylethyl)-1,3-diazinane-2,4,6-trione",400,Inner Protein Regulator,Protein-Protein Interaction,23138692,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,No,"Chain A:LEU45,VAL250,ALA251,GLU255,ILE256,ARG259"
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,4B4G,ASD10100027,KKT,A,Lig,Inhibitor,"N-[6-azanyl-2,4-bis(oxidanylidene)-1-(phenylmethyl)pyrimidin-5-yl]-N-methyl-butane-1-sulfonamide",400,Inner Protein Regulator,Protein-Protein Interaction,23138692,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,No,"Chain A:SER41,THR42,LEU45,TYR113,TYR114,GLY115,PHE118,LYS249,VAL250,ALA251,GLU255,ILE256,ARG259"
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,4B4M,ASD10100011,JWT,A,Lig,Inhibitor,"N-[6-azanyl-2,4-bis(oxidanylidene)-1-(phenylmethyl)pyrimidin-5-yl]-4-fluoranyl-N-methyl-benzenesulfonamide",400,Inner Protein Regulator,Protein-Protein Interaction,23138692,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,No,"Chain A:TYR38,SER41,THR42,LEU45,TYR113,TYR114,GLY115,PHE118,HIS119,LYS249,VAL250,ALA251,GLU255,ILE256,ARG259"
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,4B5B,ASD10100043,BBE,A,Lig,Inhibitor,"N-[6-azanyl-2,4-bis(oxidanylidene)-1-(phenylmethyl)pyrimidin-5-yl]-N,3-dimethyl-benzenesulfonamide",400,Inner Protein Regulator,Protein-Protein Interaction,23138692,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,No,"Chain A:TYR38,SER41,THR42,LEU45,TYR113,TYR114,GLY115,PHE118,HIS119,LYS249,VAL250,ALA251,GLU255,ILE256,ARG259"
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,5FTS,,P3I,A,,Inhibitor,"N-(6-Amino-1-(2-bromobenzyl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-N-methylbenzenesulfonamide",,,,,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,,
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,5FTV,ASD10100021,KDT,A,Lig,Inhibitor,"N-(6-AMINO-1-(4-BROMOBENZYL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL)-N-METHYLBENZENESULFONAMIDE",1294,Allosteric Function,Allosteric Position,,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,No,"Chain A:HIS116,GLN260,ILE256,LYS249,ASP117,HIS119,TYR37,TYR283,TYR114,ARG259,TYR38,LEU45,ALA251,CYS252,SER41,GLU255,PHE118,VAL250,THR42,TYR113,GLY115"
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,5FU0,ASD10100018,FKH,A,Lig,Inhibitor,"N-(6-AMINO-1-(3-METHYLBENZYL)-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL)-N-METHYLBENZENESULFONAMIDE",1294,Allosteric Function,Allosteric Position,,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,No,Chain A:GLU115
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,5FU8,ASD10100017,DHS,A,Lig,Inhibitor,"N-(6-amino-1-(4-bromo-3-methylbenzyl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-N-methylbenzenesulfonamide",500,Allosteric Function,Allosteric Position,,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,No,"Chain A:HIS116,GLN260,ILE256,LYS249,ASP117,HIS119,TYR37,GLU120,TYR114,ARG259,TYR38,LEU45,ALA251,CYS252,SER41,GLU255,PHE118,VAL250,THR42,TYR113,GLY115"
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,5FUH,ASD10100020,HKX,A,Lig,Inhibitor,"N-[6-amino-1-(3-bromobenzyl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl]-N-methylbenzenesulfonamide",400,Allosteric Function,Allosteric Position,,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,No,"Chain A:HIS116,GLN260,ASP117,GLU255,GLU120,LYS249,THR42,LEU112,TYR38,CYS252,PHE118,VAL250,ILE256,TYR113,MET44,ALA251,ARG259,SER41,HIS119,GLN246,TYR114,LEU45,GLY115"
ASD10100000_1,rmlA,Pseudomonas aeruginosa,Q9HU22,5FYE,,LD6,,,Inhibitor,"N-(6-Amino-1-(3-fluorobenzyl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-N-methylbenzenesulfonamide",,,,,Allosteric Competitive Inhibitors of the Glucose-1-Phosphate Thymidylyltransferase (Rmla) from Pseudomonas Aeruginosa.,,
ASD10100000_2,rmlA1,Escherichia coli,P37744,1H5R,ASD01320159,THM,A,Lig,Inhibitor,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione",1292,Inner Protein Regulator,Protein-Protein Interaction,11697907,Kinetic and Crystallographic Analyses Support a Sequential-Ordered Bi Bi Catalytic Mechanism for Escherichia Coli Glucose-1-Phosphate Thymidylyltransferase,No,"Chain A:LEU46,TYR115,GLY116,LEU119,LYS250,VAL251,SER252,GLU256,ILE257,ARG260; Chain D:ARG220,GLY221"
ASD10100000_2,rmlA1,Escherichia coli,P37744,1H5S,ASD10100014,TMP,A,Lig,Inhibitor,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl dihydrogen phosphate",1292,Inner Protein Regulator,Protein-Protein Interaction,11697907,Kinetic and Crystallographic Analyses Support a Sequential-Ordered Bi Bi Catalytic Mechanism for Escherichia Coli Glucose-1-Phosphate Thymidylyltransferase,No,"Chain A:LEU46,TYR115,GLY116,HIS117,ASP118,LYS250,VAL251,SER252,GLU256,ILE257,ARG260; Chain D:GLY219,ARG220,GLY221"
ASD10100000_3,MTH_1791,Methanothermobacter thermautotrophicus,O27819,1LVW,ASD10100015,TYD,A,Lig,Inhibitor,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl phosphono hydrogen phosphate",3002,Inner Protein Regulator,Protein-Protein Interaction,,"Crystal structure of glucose-1-phosphate thymidylyltransferase, RmlA, complex with dTDP",No,"Chain A:LEU43,TYR112,GLY113,HIS114,ARG115,PHE116,SER117,TYR247,ILE248,ALA249,GLU253,ILE254; Chain C:ARG217"
ASD10100000_4,SPAB_00935,Salmonella paratyphi B,A9N7P9,1MP3,ASD02040015,TTP,A,Lig,Inhibitor,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",504,Inner Protein Regulator,Protein-Protein Interaction,12374866,Expanding pyrimidine diphosphosugar libraries via structure-based nucleotidylyltransferase engineering,No,"Chain A:LEU46,TYR115,GLY116,HIS117,ASP118,LEU119,PRO120,SER252,GLU256,ILE257,ARG260; Chain B:GLY219,ARG220,GLY221"
ASD10100000_5,rmlA,Aneurinibacillus thermoaerophilus,Q9AGY4,4HO2,ASD01320159,THM,A,Lig,Inhibitor,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione",301,Inner Protein Regulator,Protein-Protein Interaction,,Crystal structure of glucose 1-phosphate thymidylyltransferase from Aneurinibacillus thermoaerophilus complexed with thymidine,No,"Chain A:LEU43,TYR112,GLY113,PHE116,THR117,VAL248,ALA249,GLU253,ILE254,ARG257"
ASD10100000_5,rmlA,Aneurinibacillus thermoaerophilus,Q9AGY4,4HO3,ASD02040015,TTP,A,Lig,Inhibitor,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",301,Inner Protein Regulator,Protein-Protein Interaction,,Crystal structure of glucose 1-phosphate thymidylyltransferase from Aneurinibacillus thermoaerophilus complexed with thymidine triphosphate,No,"Chain A:LEU43,TYR112,GLY113,HIS114,GLY115,PHE116,THR117,VAL248,ALA249,GLU253,ILE254,ARG257"
ASD10100000_5,rmlA,Aneurinibacillus thermoaerophilus,Q9AGY4,4HO4,ASD01320159,THM,A,Lig,Inhibitor,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione",303,Inner Protein Regulator,Protein-Protein Interaction,,Crystal structure of glucose 1-phosphate thymidylyltransferase from Aneurinibacillus thermoaerophilus complexed with thymidine and glucose-1-phosphate,No,"Chain A:LEU43,TYR112,GLY113,PHE116,THR117,VAL248,ALA249,GLU253,ILE254,ARG257; Chain B:ARG217,GLY218"
ASD10100000_5,rmlA,Aneurinibacillus thermoaerophilus,Q9AGY4,4HO5,ASD10100039,DAU,A,Lig,Inhibitor,"[(2R,3R,4S,5S,6R)-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl] [[(2R,3S,5R)-5-[5-methyl-2,4-bis(oxidanylidene)pyrimidin-1-yl]-3-oxidanyl-oxolan-2-yl]methoxy-oxidanyl-phosphoryl] hydrogen phosphate",301,Inner Protein Regulator,Protein-Protein Interaction,,Crystal structure of glucose 1-phosphate thymidylyltransferase from Aneurinibacillus thermoaerophilus complexed with TDP-glucose,No,"Chain A:LEU43,TYR112,GLY113,HIS114,GLY115,PHE116,THR117,VAL248,ALA249,GLU253,ILE254,ARG257; Chain B:GLY216,ARG217,GLY218"
ASD10100000_5,rmlA,Aneurinibacillus thermoaerophilus,Q9AGY4,4HO6,ASD00150002,UTP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",301,Inner Protein Regulator,Protein-Protein Interaction,,Crystal structure of glucose 1-phosphate thymidylyltransferase from Aneurinibacillus thermoaerophilus complexed with UDP-glucose and UTP,No,"Chain A:LEU43,TYR112,GLY113,HIS114,GLY115,PHE116,THR117,VAL248,ALA249,GLU253,ILE254,ARG257"
ASD10100000_5,rmlA,Aneurinibacillus thermoaerophilus,Q9AGY4,4HO8,ASD01320159,THM,A,Lig,Inhibitor,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione",301,Inner Protein Regulator,Protein-Protein Interaction,,Crystal structure of glucose 1-phosphate thymidylyltransferase from Aneurinibacillus thermoaerophilus complexed with UDP-glucose and thymidine,No,"Chain A:LEU43,TYR112,GLY113,PHE116,THR117,VAL248,ALA249,GLU253,ILE254,ARG257; Chain B:ARG217,GLY218"
ASD10100000_5,rmlA,Aneurinibacillus thermoaerophilus,Q9AGY4,4HO9,ASD00150002,UTP,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl (hydroxy-phosphonooxy-phosphoryl) hydrogen phosphate",301,Inner Protein Regulator,Protein-Protein Interaction,,Crystal structure of glucose 1-phosphate thymidylyltransferase from Aneurinibacillus thermoaerophilus complexed with UDP-galactose and UTP,No,"Chain A:LEU43,TYR112,GLY113,HIS114,GLY115,PHE116,THR117,GLU118,VAL248,ALA249,GLU253,ILE254,ARG257; Chain B:GLY216,ARG217,GLY218"
ASD10220000_1,PG_0396,Escherichia coli,Q7MAW7,4GAU,ASD10228001,NMY,A,Lig,Inhibitor,"(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-oxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxy-cyclohexyl]oxy-oxane-3,4-diol",3184,Protein-DNA/RNA Interaction Regulator,Inner DNA/RNA,22902368,Allosteric control of the ribosome by small-molecule antibiotics.,No,Chain A:SEC1923
ASD10240000_1,ANXA5,Homo sapiens,P08758,1HAK,ASD10240001,K21,A,Lig,Inhibitor,"4-[3-{1-(4-BENZYL)PIPERODINYL}PROPIONYL]- 7-METHOXY-2,3,4,5-TERTRAHYDRO-1,4-BENZOTHIAZEPINE",901,Inner Protein Regulator,Protein-Protein Interaction,9398511,Crystal structure of annexin V with its ligand K-201 as a calcium channel activity inhibitor.,No,1HAK
ASD10250000_1,allC,Escherichia coli,P77425,1Z2L,ASD02880002,SO4,A,Ion,Regulator,sulfate,513,Inner Protein Regulator,Inner Protein,17362992,Structural analysis of a ternary complex of allantoate amidohydrolase from Escherichia coli reveals its mechanics.,Yes,"Chain A:GLN215,ARG217,ARG290,ALA358,GLY359; Chain B:HIS228"
ASD10290000_1,GFA1,Candida albicans,P53704,2POC,ASD10298001,UD1,A,Lig,Inhibitor,"[[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxy-phosphoryl] [(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl hydrogen phosphate",5002,Inner Protein Regulator,Inner Protein,17681543,The Crystal and Solution Studies of Glucosamine-6-phosphate Synthase from Candida albicans,No,"Chain A:ARG372,GLY383,GLY384,GLY474,VAL476,VAL479,SER484,THR487,HIS488,CYS489,GLY490,VAL491,HIS492"
ASD10290000_1,GFA1,Candida albicans,P53704,2PUT,ASD10298001,UD1,B,Lig,Inhibitor,"[[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxy-phosphoryl] [(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl hydrogen phosphate",5003,Inner Protein Regulator,Inner Protein,17681543,The Crystal and Solution Studies of Glucosamine-6-phosphate Synthase from Candida albicans,No,"Chain B:ARG372,GLY383,GLY384,GLY474,VAL476,VAL479,SER484,THR487,HIS488,CYS489,GLY490,VAL491,HIS492"
ASD10290000_1,GFA1,Candida albicans,P53704,2PUV,ASD10298001,UD1,B,Lig,Inhibitor,"[[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxy-phosphoryl] [(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl hydrogen phosphate",5003,Inner Protein Regulator,Inner Protein,17681543,The Crystal and Solution Studies of Glucosamine-6-phosphate Synthase from Candida albicans,No,"Chain B:ARG372,GLY383,GLY384,GLY474,VAL476,VAL479,SER484,THR487,HIS488,CYS489,GLY490,VAL491,HIS492"
ASD10400000_1,BLM,Homo sapiens,P54132,7AUD,,RY8,A,Lig,Inhibitor,"N-(2,3-dimethyl-5-sulfamoylphenyl)-4-(2-methylthiazol-4-yl)benzamide",1303,,,,,,7AUD
ASD10420000_1,TTR,Homo sapiens,P02766,1BM7,ASD06710002,FLF,A,Lig,Inhibitor,2-[[3-(trifluoromethyl)phenyl]amino]benzoic acid,501,Inner Protein Regulator,Protein-Protein Interaction,9789022,Inhibiting transthyretin conformational changes that lead to amyloid fibril formation.,No,1BM7
ASD10420000_1,TTR,Homo sapiens,P02766,1DVS,ASD05250001,STL,A,Lig,Inhibitor,"5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol",125,Inner Protein Regulator,Protein-Protein Interaction,10742177,Rational design of potent human transthyretin amyloid disease inhibitors.,No,1DVS
ASD10420000_1,TTR,Homo sapiens,P02766,1DVT,ASD10420045,FLP,A,Lig,Inhibitor,(2S)-2-(3-fluoro-4-phenyl-phenyl)propanoic acid,125,Inner Protein Regulator,Protein-Protein Interaction,10742177,Rational design of potent human transthyretin amyloid disease inhibitors.,No,1DVT
ASD10420000_1,TTR,Homo sapiens,P02766,1DVU,ASD10420050,DBF,B,Lig,Inhibitor,"dibenzofuran-4,6-dicarboxylic acid",125,Inner Protein Regulator,Protein-Protein Interaction,10742177,Rational design of potent human transthyretin amyloid disease inhibitors.,No,1DVU
ASD10420000_1,TTR,Homo sapiens,P02766,1DVX,ASD10420139,DIF,B,Lig,Inhibitor,"2-[2-[(2,6-dichlorophenyl)amino]phenyl]ethanoic acid",125,Inner Protein Regulator,Protein-Protein Interaction,10742177,Rational design of potent human transthyretin amyloid disease inhibitors.,No,1DVX
ASD10420000_1,TTR,Homo sapiens,P02766,1DVY,ASD10420055,BPD,A,Lig,Inhibitor,"10-[3-(trifluoromethyl)phenyl]phenoxazine-4,6-dicarboxylic acid",125,Inner Protein Regulator,Protein-Protein Interaction,10742177,Rational design of potent human transthyretin amyloid disease inhibitors.,No,1DVY
ASD10420000_1,TTR,Homo sapiens,P02766,1DVZ,ASD10420059,OFL,A,Lig,Inhibitor,2-[[2-(trifluoromethyl)phenyl]amino]benzoic acid,125,Inner Protein Regulator,Protein-Protein Interaction,10742177,Rational design of potent human transthyretin amyloid disease inhibitors.,No,1DVZ
ASD10420000_1,TTR,Homo sapiens,P02766,1E4H,ASD10420060,PBR,A,Lig,Inhibitor,"2,3,4,5,6-pentabromophenol",998,Inner Protein Regulator,Protein-Protein Interaction,10957627,Structure of Human Transthyretin Complexed with Bromophenols : A New Mode of Binding,No,1E4H
ASD10420000_1,TTR,Homo sapiens,P02766,1ETA,ASD06898001,T44,1,Lig,Inhibitor,"(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoic acid",128,Inner Protein Regulator,Protein-Protein Interaction,8428915,The x-ray crystal structure refinements of normal human transthyretin and the amyloidogenic Val-30-->Met variant to 1.7-A resolution.,No,1ETA
ASD10420000_1,TTR,Homo sapiens,P02766,1ETB,ASD06898001,T44,1,Lig,Inhibitor,"(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoic acid",128,Inner Protein Regulator,Protein-Protein Interaction,8428915,The x-ray crystal structure refinements of normal human transthyretin and the amyloidogenic Val-30-->Met variant to 1.7-A resolution.,No,1ETB
ASD10420000_1,TTR,Homo sapiens,P02766,1F86,ASD06898001,T44,A,Lig,Inhibitor,"(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoic acid",428,Inner Protein Regulator,Protein-Protein Interaction,11243784,Transthyretin stability as a key factor in amyloidogenesis: X-ray analysis at atomic resolution.,No,1F86
ASD10420000_1,TTR,Homo sapiens,P02766,1THA,ASD10420082,T33,A,Lig,Inhibitor,(2S)-2-amino-3-[4-(4-hydroxy-3-iodo-phenoxy)-3-iodo-phenyl]propanoic acid,130,Inner Protein Regulator,Protein-Protein Interaction,1730601,"Mechanism of molecular recognition. Structural aspects of 3,3'-diiodo-L-thyronine binding to human serum transthyretin.",No,1THA
ASD10420000_1,TTR,Homo sapiens,P02766,1THC,ASD10420084,FL9,A,Lig,Inhibitor,"2-[(3,5-dibromo-2,4-dihydroxy-phenyl)methylidene]-4,6-dihydroxy-1-benzofuran-3-one",131,Inner Protein Regulator,Protein-Protein Interaction,1631168,"Crystal structure determination at 2.3-A resolution of human transthyretin-3',5'-dibromo-2',4,4',6-tetrahydroxyaurone complex.",No,1THC
ASD10420000_1,TTR,Homo sapiens,P02766,1TLM,ASD10420088,MIL,A,Lig,Inhibitor,6-methyl-2-oxo-5-pyridin-4-yl-1H-pyridine-3-carbonitrile,128,Inner Protein Regulator,Protein-Protein Interaction,8454595,Structural aspects of inotropic bipyridine binding. Crystal structure determination to 1.9 A of the human serum transthyretin-milrinone complex.,No,1TLM
ASD10420000_1,TTR,Homo sapiens,P02766,1TT6,ASD01240003,DES,A,Lig,Inhibitor,4-[(E)-4-(4-hydroxyphenyl)hex-3-en-3-yl]phenol,129,Inner Protein Regulator,Protein-Protein Interaction,15469931,The crystal structure of transthyretin in complex with diethylstilbestrol: a promising template for the design of amyloid inhibitors,No,1TT6
ASD10420000_1,TTR,Homo sapiens,P02766,1TYR,ASD05660009,REA,A,Lig,Inhibitor,"(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenoic acid",131,Inner Protein Regulator,Protein-Protein Interaction,8536704,Crystal structure of the transthyretin--retinoic-acid complex,No,1TYR
ASD10420000_1,TTR,Homo sapiens,P02766,1U21,ASD10420106,P2C,A,Lig,Inhibitor,"2-[(3,5-dichloro-4-hydroxyperoxy-phenyl)amino]benzoic acid",211,Inner Protein Regulator,Protein-Protein Interaction,15826192,Kinetic stabilization of an oligomeric protein by a single ligand binding event,No,1U21
ASD10420000_1,TTR,Homo sapiens,P02766,1Y1D,ASD10420118,FHI,A,Lig,Inhibitor,"5-(2,4-difluorophenyl)-2-hydroxy-3-iodo-benzoic acid",2000,Inner Protein Regulator,Protein-Protein Interaction,15689188,Human transthyretin in complex with iododiflunisal: structural features associated with a potent amyloid inhibitor.,No,1Y1D
ASD10420000_1,TTR,Homo sapiens,P02766,1Z7J,ASD10420119,T4A,A,Lig,Inhibitor,"2-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]ethanoic acid",128,Inner Protein Regulator,Protein-Protein Interaction,16204882,Ligand binding at the transthyretin dimer-dimer interface: structure of the transthyretin-T4Ac complex at 2.2 Angstrom resolution.,No,1Z7J
ASD10420000_1,TTR,Homo sapiens,P02766,2B14,ASD10420120,DNF,A,Lig,Inhibitor,"2,4-dinitrophenol",128,Inner Protein Regulator,Protein-Protein Interaction,16627944,"The binding of 2,4-dinitrophenol to wild-type and amyloidogenic transthyretin",No,2B14
ASD10420000_1,TTR,Homo sapiens,P02766,2B15,ASD10420120,DNF,A,Lig,Inhibitor,"2,4-dinitrophenol",130,Inner Protein Regulator,Protein-Protein Interaction,16627944,"The binding of 2,4-dinitrophenol to wild-type and amyloidogenic transthyretin",No,2B15
ASD10420000_1,TTR,Homo sapiens,P02766,2B16,ASD10420120,DNF,A,Lig,Inhibitor,"2,4-dinitrophenol",128,Inner Protein Regulator,Protein-Protein Interaction,16627944,"The binding of 2,4-dinitrophenol to wild-type and amyloidogenic transthyretin",No,2B16
ASD10420000_1,TTR,Homo sapiens,P02766,2B77,ASD10420123,3CA,A,Lig,Inhibitor,"5-(2,4-dichlorophenyl)-2-hydroxy-benzoic acid",240,Inner Protein Regulator,Protein-Protein Interaction,14711308,Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis.,No,2B77
ASD10420000_1,TTR,Homo sapiens,P02766,2B9A,ASD10420124,FBC,A,Lig,Inhibitor,"4-(3,5-difluorophenyl)benzoic acid",301,Inner Protein Regulator,Protein-Protein Interaction,14711308,Diflunisal Analogues Stabilize the Native State of Transthyretin. Potent Inhibition of Amyloidogenesis.,No,2B9A
ASD10420000_1,TTR,Homo sapiens,P02766,2F7I,ASD10420125,26C,A,Lig,Inhibitor,"4-(2,6-difluorophenyl)benzoic acid",326,Inner Protein Regulator,Protein-Protein Interaction,14711308,Diflunisal Analogues Stabilize the Native State of Transthyretin. Potent Inhibition of Amyloidogenesis.,No,2F7I
ASD10420000_1,TTR,Homo sapiens,P02766,2F8I,ASD10420126,205,A,Lig,Inhibitor,"2-(2,6-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid",1002,Inner Protein Regulator,Protein-Protein Interaction,12820260,"Benzoxazoles as transthyretin amyloid fibril inhibitors: synthesis, evaluation, and mechanism of action",No,2F8I
ASD10420000_1,TTR,Homo sapiens,P02766,2FBR,ASD10420127,44C,A,Lig,Inhibitor,4-[4-[4-[4-[(2-carboxyphenyl)amino]phenoxy]butoxy]phenyl]benzoic acid,173,Inner Protein Regulator,Protein-Protein Interaction,14583036,Synthesis and characterization of potent bivalent amyloidosis inhibitors that bind prior to transthyretin tetramerization.,No,2FBR
ASD10420000_1,TTR,Homo sapiens,P02766,2FLM,ASD10420128,6CA,A,Lig,Inhibitor,2-[[4-[6-[4-(4-carboxyphenyl)phenoxy]hexoxy]phenyl]amino]benzoic acid,201,Inner Protein Regulator,Protein-Protein Interaction,14583036,Synthesis and characterization of potent bivalent amyloidosis inhibitors that bind prior to transthyretin tetramerization.,No,2FLM
ASD10420000_1,TTR,Homo sapiens,P02766,2G5U,ASD10420129,PCQ,A,Lig,Inhibitor,"2,6-dichloro-4-(3,5-dichloro-4-hydroxy-phenyl)phenol",240,Inner Protein Regulator,Protein-Protein Interaction,15610856,Hydroxylated polychlorinated biphenyls selectively bind transthyretin in blood and inhibit amyloidogenesis: rationalizing rodent PCB toxicity,No,2G5U
ASD10420000_1,TTR,Homo sapiens,P02766,2G9K,ASD10420130,NE1,A,Lig,Inhibitor,"2,6-dichloro-4-(2,3,4-trichlorophenyl)phenol",501,Inner Protein Regulator,Protein-Protein Interaction,15610856,Hydroxylated polychlorinated biphenyls selectively bind transthyretin in blood and inhibit amyloidogenesis: rationalizing rodent PCB toxicity,No,2G9K
ASD10420000_1,TTR,Homo sapiens,P02766,2GAB,ASD10420131,NE2,A,Lig,Inhibitor,"2,6-dichloro-4-(3,4-dichlorophenyl)phenol",502,Inner Protein Regulator,Protein-Protein Interaction,15610856,Hydroxylated polychlorinated biphenyls selectively bind transthyretin in blood and inhibit amyloidogenesis: rationalizing rodent PCB toxicity,No,2GAB
ASD10420000_1,TTR,Homo sapiens,P02766,2QGC,ASD10420132,MR4,A,Lig,Inhibitor,"4-(1,3-benzoxazol-2-yl)-2,6-dimethyl-phenol",128,Inner Protein Regulator,Protein-Protein Interaction,18095641,Biochemical and structural evaluation of highly selective 2-arylbenzoxazole-based transthyretin amyloidogenesis inhibitors.,No,2QGC
ASD10420000_1,TTR,Homo sapiens,P02766,2QGD,ASD10420133,MR5,A,Lig,Inhibitor,"4-(1,3-benzoxazol-2-yl)-2,6-dibromo-phenol",200,Inner Protein Regulator,Protein-Protein Interaction,18095641,Biochemical and structural evaluation of highly selective 2-arylbenzoxazole-based transthyretin amyloidogenesis inhibitors.,No,2QGD
ASD10420000_1,TTR,Homo sapiens,P02766,2QGE,ASD10420134,MR6,A,Lig,Inhibitor,"2-(3,5-dimethylphenyl)-1,3-benzoxazole",201,Inner Protein Regulator,Protein-Protein Interaction,18095641,Biochemical and structural evaluation of highly selective 2-arylbenzoxazole-based transthyretin amyloidogenesis inhibitors.,No,2QGE
ASD10420000_1,TTR,Homo sapiens,P02766,2ROX,ASD06898001,T44,A,Lig,Inhibitor,"(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoic acid",128,Inner Protein Regulator,Protein-Protein Interaction,15299640,"Structures of human transthyretin complexed with thyroxine at 2.0 A resolution and 3',5'-dinitro-N-acetyl-L-thyronine at 2.2 A resolution.",No,2ROX
ASD10420000_1,TTR,Homo sapiens,P02766,2ROY,ASD10420136,P28,A,Lig,Inhibitor,"(2S)-2-acetamido-3-[4-(4-hydroxy-3,5-dinitro-phenoxy)phenyl]propanoic acid",128,Inner Protein Regulator,Protein-Protein Interaction,15299640,"Structures of human transthyretin complexed with thyroxine at 2.0 A resolution and 3',5'-dinitro-N-acetyl-L-thyronine at 2.2 A resolution.",No,2ROY
ASD10420000_1,TTR,Homo sapiens,P02766,3B56,ASD01010031,DIU,A,Lig,Inhibitor,"2-hydroxy-3,5-diiodo-benzoic acid",2000,Inner Protein Regulator,Protein-Protein Interaction,18155178,Iodination of salicylic acid improves its binding to transthyretin,No,3B56
ASD10420000_1,TTR,Homo sapiens,P02766,3CFN,ASD02210006,2AN,A,Lig,Inhibitor,8-phenylazanylnaphthalene-1-sulfonic acid,1,Inner Protein Regulator,Protein-Protein Interaction,19954984,Identification of a novel ligand binding motif in the transthyretin channel.,No,3CFN
ASD10420000_1,TTR,Homo sapiens,P02766,3CFQ,ASD10420139,DIF,A,Lig,Inhibitor,"2-[2-[(2,6-dichlorophenyl)amino]phenyl]ethanoic acid",1,Inner Protein Regulator,Protein-Protein Interaction,19954984,Identification of a novel ligand binding motif in the transthyretin channel.,No,3CFQ
ASD10420000_1,TTR,Homo sapiens,P02766,3CFT,ASD10420140,5NS,A,Lig,Inhibitor,5-aminonaphthalene-1-sulfonic acid,1,Inner Protein Regulator,Protein-Protein Interaction,19954984,Identification of a novel ligand binding motif in the transthyretin channel.,No,3CFT
ASD10420000_1,TTR,Homo sapiens,P02766,3CN0,ASD10420141,LJ1,A,Lig,Inhibitor,"2,6-dimethyl-4-[(E)-2-phenylethenyl]phenol",128,Inner Protein Regulator,Protein-Protein Interaction,18811132,Toward optimization of the linker substructure common to transthyretin amyloidogenesis inhibitors using biochemical and structural studies.,No,3CN0
ASD10420000_1,TTR,Homo sapiens,P02766,3CN1,ASD10420142,LJ2,A,Lig,Inhibitor,"2,6-dibromo-4-[(E)-2-phenylethenyl]phenol",128,Inner Protein Regulator,Protein-Protein Interaction,18811132,Toward optimization of the linker substructure common to transthyretin amyloidogenesis inhibitors using biochemical and structural studies.,No,3CN1
ASD10420000_1,TTR,Homo sapiens,P02766,3CN2,ASD10420143,LJ3,A,Lig,Inhibitor,"2,6-dibromo-4-phenyl-phenol",128,Inner Protein Regulator,Protein-Protein Interaction,18811132,Toward optimization of the linker substructure common to transthyretin amyloidogenesis inhibitors using biochemical and structural studies.,No,3CN2
ASD10420000_1,TTR,Homo sapiens,P02766,3CN3,ASD10420144,LJ4,A,Lig,Inhibitor,"2,6-dibromo-4-phenoxy-phenol",128,Inner Protein Regulator,Protein-Protein Interaction,18811132,Toward optimization of the linker substructure common to transthyretin amyloidogenesis inhibitors using biochemical and structural studies.,No,3CN3
ASD10420000_1,TTR,Homo sapiens,P02766,3CN4,ASD10420145,LJ5,A,Lig,Inhibitor,"N-(3,5-dibromo-4-hydroxy-phenyl)benzamide",128,Inner Protein Regulator,Protein-Protein Interaction,18811132,Toward optimization of the linker substructure common to transthyretin amyloidogenesis inhibitors using biochemical and structural studies.,No,3CN4
ASD10420000_1,TTR,Homo sapiens,P02766,3D2T,ASD01140129,1FL,A,Lig,Inhibitor,"5-(2,4-difluorophenyl)-2-hydroxy-benzoic acid",502,Inner Protein Regulator,Protein-Protein Interaction,14711308,Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis.,No,3D2T
ASD10420000_1,TTR,Homo sapiens,P02766,3ESN,ASD10420147,DZ1,A,Lig,Inhibitor,"N-(3,5-dibromo-4-hydroxy-phenyl)-2,6-dimethyl-benzamide",128,Inner Protein Regulator,Protein-Protein Interaction,19191553,Toward optimization of the second aryl substructure common to transthyretin amyloidogenesis inhibitors using biochemical and structural studies.,No,3ESN
ASD10420000_1,TTR,Homo sapiens,P02766,3ESO,ASD10420148,DZ2,A,Lig,Inhibitor,"2,5-dichloro-N-(3,5-dibromo-4-hydroxy-phenyl)benzamide",128,Inner Protein Regulator,Protein-Protein Interaction,19191553,Toward optimization of the second aryl substructure common to transthyretin amyloidogenesis inhibitors using biochemical and structural studies.,No,3ESO
ASD10420000_1,TTR,Homo sapiens,P02766,3ESP,ASD10420149,DZ3,A,Lig,Inhibitor,"N-(3,5-dibromo-4-hydroxy-phenyl)-4-hydroxy-3,5-dimethyl-benzamide",128,Inner Protein Regulator,Protein-Protein Interaction,19191553,Toward optimization of the second aryl substructure common to transthyretin amyloidogenesis inhibitors using biochemical and structural studies.,No,3ESP
ASD10420000_1,TTR,Homo sapiens,P02766,3FC8,ASD10420150,IFA,A,Lig,Inhibitor,"methyl 3-[[5-(2,4-difluorophenyl)-2-hydroxy-3-iodo-phenyl]carbonylamino]propanoate",3000,Inner Protein Regulator,Protein-Protein Interaction,19125186,Iodine atoms: a new molecular feature for the design of potent transthyretin fibrillogenesis inhibitors.,No,3FC8
ASD10420000_1,TTR,Homo sapiens,P02766,3FCB,ASD10420151,IFB,A,Lig,Inhibitor,"3-[[5-(2,4-difluorophenyl)-2-hydroxy-3-iodo-phenyl]carbonylamino]propanoic acid",3000,Inner Protein Regulator,Protein-Protein Interaction,19125186,Iodine atoms: a new molecular feature for the design of potent transthyretin fibrillogenesis inhibitors.,No,3FCB
ASD10420000_1,TTR,Homo sapiens,P02766,3GLZ,ASD10420152,1BD,A,Lig,Inhibitor,3-[[2-(trifluoromethyl)phenyl]methylideneamino]oxypropanoic acid,500,Inner Protein Regulator,Protein-Protein Interaction,19621084,"Novel transthyretin amyloid fibril formation inhibitors: synthesis, biological evaluation, and X-ray structural analysis",No,3GLZ
ASD10420000_1,TTR,Homo sapiens,P02766,3GS0,ASD10420153,6BD,A,Lig,Inhibitor,(2S)-3-(fluoren-9-ylideneamino)oxy-2-methyl-propanoic acid,128,Inner Protein Regulator,Protein-Protein Interaction,19621084,"Novel transthyretin amyloid fibril formation inhibitors: synthesis, biological evaluation, and X-ray structural analysis.",No,3GS0
ASD10420000_1,TTR,Homo sapiens,P02766,3GS4,ASD10420154,7BD,A,Lig,Inhibitor,3-(fluoren-9-ylideneamino)oxypropanoic acid,501,Inner Protein Regulator,Protein-Protein Interaction,19621084,"Novel transthyretin amyloid fibril formation inhibitors: synthesis, biological evaluation, and X-ray structural analysis.",No,3GS4
ASD10420000_1,TTR,Homo sapiens,P02766,3GS7,ASD10420155,8BD,A,Lig,Inhibitor,3-[(2-methoxyphenyl)methylideneamino]oxypropanoic acid,128,Inner Protein Regulator,Protein-Protein Interaction,19621084,"Novel transthyretin amyloid fibril formation inhibitors: synthesis, biological evaluation, and X-ray structural analysis.",No,3GS7
ASD10420000_1,TTR,Homo sapiens,P02766,3HJ0,ASD10420156,A93,A,Lig,Inhibitor,"(4-fluorophenyl) 3-[(E)-2-(4-hydroxy-3,5-dimethyl-phenyl)ethenyl]benzoate",128,Inner Protein Regulator,Protein-Protein Interaction,20081815,Chemoselective small molecules that covalently modify one lysine in a non-enzyme protein in plasma.,No,3HJ0
ASD10420000_1,TTR,Homo sapiens,P02766,3IMR,ASD10420157,IW1,A,Lig,Inhibitor,"2,6-dibromo-4-[(E)-2-(2,6-dichlorophenyl)ethenyl]phenol",128,Inner Protein Regulator,Protein-Protein Interaction,20043671,A substructure combination strategy to create potent and selective transthyretin kinetic stabilizers that prevent amyloidogenesis and cytotoxicity.,No,3IMR
ASD10420000_1,TTR,Homo sapiens,P02766,3IMS,ASD10420158,IW2,A,Lig,Inhibitor,"2,6-dibromo-4-[2-(2,6-dichlorophenyl)ethyl]phenol",128,Inner Protein Regulator,Protein-Protein Interaction,20043671,A substructure combination strategy to create potent and selective transthyretin kinetic stabilizers that prevent amyloidogenesis and cytotoxicity.,No,3IMS
ASD10420000_1,TTR,Homo sapiens,P02766,3IMT,ASD10420159,IW3,A,Lig,Inhibitor,"4-[(E)-2-(4-aminophenyl)ethenyl]-2,6-dibromo-phenol",128,Inner Protein Regulator,Protein-Protein Interaction,20043671,A substructure combination strategy to create potent and selective transthyretin kinetic stabilizers that prevent amyloidogenesis and cytotoxicity.,No,3IMT
ASD10420000_1,TTR,Homo sapiens,P02766,3IMU,ASD10420160,IW4,A,Lig,Inhibitor,"4-[(E)-2-(3-aminophenyl)ethenyl]-2,6-dibromo-aniline",128,Inner Protein Regulator,Protein-Protein Interaction,20043671,A substructure combination strategy to create potent and selective transthyretin kinetic stabilizers that prevent amyloidogenesis and cytotoxicity.,No,3IMU
ASD10420000_1,TTR,Homo sapiens,P02766,3IMV,ASD10420161,IW5,A,Lig,Inhibitor,"4-[(E)-2-(4-aminophenyl)ethenyl]-2,6-dibromo-aniline",128,Inner Protein Regulator,Protein-Protein Interaction,20043671,A substructure combination strategy to create potent and selective transthyretin kinetic stabilizers that prevent amyloidogenesis and cytotoxicity.,No,3IMV
ASD10420000_1,TTR,Homo sapiens,P02766,3IMW,ASD10420162,IW6,A,Lig,Inhibitor,"2,6-dibromo-4-[(E)-2-(2,6-dimethoxyphenyl)ethenyl]aniline",128,Inner Protein Regulator,Protein-Protein Interaction,20043671,A substructure combination strategy to create potent and selective transthyretin kinetic stabilizers that prevent amyloidogenesis and cytotoxicity.,No,3IMW
ASD10420000_1,TTR,Homo sapiens,P02766,3IPB,ASD10420163,JZD,A,Lig,Inhibitor,"2-[[4-[11-[4-[(2-carboxyphenyl)amino]-2,6-dichloro-phenoxy]undecoxy]-3,5-dichloro-phenyl]amino]benzoic acid",128,Inner Protein Regulator,Protein-Protein Interaction,21059958,Trapping of palindromic ligands within native transthyretin prevents amyloid formation.,No,3IPB
ASD10420000_1,TTR,Homo sapiens,P02766,3KGT,ASD03090008,GEN,A,Lig,Inhibitor,"5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one",3071,Inner Protein Regulator,Protein-Protein Interaction,20211733,Conformational differences between the wild type and V30M mutant transthyretin modulate its binding to genistein: implications to tetramer stability and ligand-binding.,No,3KGT
ASD10420000_1,TTR,Homo sapiens,P02766,3KGU,ASD03090008,GEN,A,Lig,Inhibitor,"5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one",3071,Inner Protein Regulator,Protein-Protein Interaction,20211733,Conformational differences between the wild type and V30M mutant transthyretin modulate its binding to genistein: implications to tetramer stability and ligand-binding.,No,3KGU
ASD10420000_1,TTR,Homo sapiens,P02766,3M1O,ASD10420165,CJZ,A,Lig,Inhibitor,"2-[(3,5-dichloro-4-hydroxy-phenyl)amino]benzoic acid",128,Inner Protein Regulator,Protein-Protein Interaction,21059958,Trapping of palindromic ligands within native transthyretin prevents amyloid formation.,No,3M1O
ASD10420000_1,TTR,Homo sapiens,P02766,3NEO,ASD10420166,G24,A,Lig,Inhibitor,"2-[4-[[4-hydroxy-3-(phenylmethyl)phenyl]methyl]-3,5-dimethyl-phenoxy]ethanoic acid",1,Inner Protein Regulator,Protein-Protein Interaction,20937391,The binding of synthetic triiodo l-thyronine analogs to human transthyretin: molecular basis of cooperative and non-cooperative ligand recognition.,No,3NEO
ASD10420000_1,TTR,Homo sapiens,P02766,3NES,ASD10420167,B72,A,Lig,Inhibitor,"2-[4-[(4-hydroxy-3-propan-2-yl-phenyl)methyl]-3,5-dimethyl-phenoxy]ethanoic acid",1,Inner Protein Regulator,Protein-Protein Interaction,20937391,The binding of synthetic triiodo l-thyronine analogs to human transthyretin: molecular basis of cooperative and non-cooperative ligand recognition.,No,3NES
ASD10420000_1,TTR,Homo sapiens,P02766,3NEX,ASD10420166,G24,A,Lig,Inhibitor,"2-[4-[[4-hydroxy-3-(phenylmethyl)phenyl]methyl]-3,5-dimethyl-phenoxy]ethanoic acid",126,Inner Protein Regulator,Protein-Protein Interaction,20937391,The binding of synthetic triiodo l-thyronine analogs to human transthyretin: molecular basis of cooperative and non-cooperative ligand recognition.,No,3NEX
ASD10420000_1,TTR,Homo sapiens,P02766,3NG5,ASD04320001,KDH,A,Lig,Inhibitor,"[(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 3,4,5-trihydroxybenzoate",128,Inner Protein Regulator,Protein-Protein Interaction,,Crystal structure of green tea polyphenol(-)-epigallocatechin gallate (EGCG)-transthyretin complex reveals novel binding site distinct from thyroxine binding site,No,3NG5
ASD10420000_1,TTR,Homo sapiens,P02766,3NG5,ASD04320001,KDH,A,Lig,Inhibitor,"[(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 3,4,5-trihydroxybenzoate",129,Inner Protein Regulator,Inner Protein,,Crystal structure of green tea polyphenol(-)-epigallocatechin gallate (EGCG)-transthyretin complex reveals novel binding site distinct from thyroxine binding site,No,3NG5
ASD10420000_1,TTR,Homo sapiens,P02766,3OZK,ASD06898001,T44,A,Lig,Inhibitor,"(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoic acid",128,Inner Protein Regulator,Protein-Protein Interaction,,Crystal structure of human transthyretin variant A25T in complex with thyroxine (T4),No,3OZK
ASD10420000_1,TTR,Homo sapiens,P02766,3OZL,ASD06710002,FLF,A,Lig,Inhibitor,2-[[3-(trifluoromethyl)phenyl]amino]benzoic acid,501,Inner Protein Regulator,Protein-Protein Interaction,,Crystal structure of human transthyretin variant A25T in complex with flufenamic acid.,No,3OZL
ASD10420000_1,TTR,Homo sapiens,P02766,3P3R,ASD10420173,3M1,A,Lig,Inhibitor,"(3,4-dihydroxy-5-nitro-phenyl)-(2-fluorophenyl)methanone",128,Inner Protein Regulator,Protein-Protein Interaction,21865539,Potent kinetic stabilizers that prevent transthyretin-mediated cardiomyocyte proteotoxicity.,No,3P3R
ASD10420000_1,TTR,Homo sapiens,P02766,3P3S,ASD10420174,3M2,A,Lig,Inhibitor,"(5Z)-2-azanyl-5-[(3,5-dibromo-4-hydroxy-phenyl)methylidene]-1-methyl-imidazol-4-one",128,Inner Protein Regulator,Protein-Protein Interaction,21865539,Potent kinetic stabilizers that prevent transthyretin-mediated cardiomyocyte proteotoxicity.,No,3P3S
ASD10420000_1,TTR,Homo sapiens,P02766,3P3T,ASD10420175,3M3,A,Lig,Inhibitor,"4-[3-(2-fluorophenoxy)propyl]-3,5-dimethyl-1H-pyrazole",128,Inner Protein Regulator,Protein-Protein Interaction,21865539,Potent kinetic stabilizers that prevent transthyretin-mediated cardiomyocyte proteotoxicity.,No,3P3T
ASD10420000_1,TTR,Homo sapiens,P02766,3P3U,ASD10420176,3M4,A,Lig,Inhibitor,"5-(2-ethoxyphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole",128,Inner Protein Regulator,Protein-Protein Interaction,21865539,Potent kinetic stabilizers that prevent transthyretin-mediated cardiomyocyte proteotoxicity.,No,3P3U
ASD10420000_1,TTR,Homo sapiens,P02766,3TCT,ASD10420194,3MI,A,Lig,Inhibitor,"2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid",128,Inner Protein Regulator,Protein-Protein Interaction,22645360,"Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade.",No,3TCT
ASD10420000_1,TTR,Homo sapiens,P02766,4ABQ,ASD10420178,4V2,A,Lig,Inhibitor,"3-(5-sulfanyl-1,3,4-oxadiazol-2-yl)phenol",1125,Inner Protein Regulator,Protein-Protein Interaction,22973437,Crystallographic Study of Novel Transthyretin Ligands Exhibiting Negative-Cooperativity between Two Thyroxine Binding Sites.,No,4ABQ
ASD10420000_1,TTR,Homo sapiens,P02766,4ABU,ASD10420179,FT1,A,Lig,Inhibitor,"4-[2,4-bis(chloranyl)phenoxy]-3-oxidanyl-benzaldehyde",1125,Inner Protein Regulator,Protein-Protein Interaction,22973437,Crystallographic Study of Novel Transthyretin Ligands Exhibiting Negative-Cooperativity between Two Thyroxine Binding Sites.,No,4ABU
ASD10420000_1,TTR,Homo sapiens,P02766,4ABV,ASD10420180,FT2,A,Lig,Inhibitor,"5-(chloromethyl)-2-(2,4-dichlorophenoxy)phenol",1125,Inner Protein Regulator,Protein-Protein Interaction,22973437,Crystallographic Study of Novel Transthyretin Ligands Exhibiting Negative-Cooperativity between Two Thyroxine Binding Sites.,No,4ABV
ASD10420000_1,TTR,Homo sapiens,P02766,4ABW,ASD10420181,42M,A,Lig,Inhibitor,[2-[4-(hydroxymethyl)-2-methoxy-phenoxy]-5-[oxidanyl(oxidanylidene)azaniumyl]phenyl]-oxidanyl-oxidanylidene-azanium,1125,Inner Protein Regulator,Protein-Protein Interaction,22973437,Crystallographic Study of Novel Transthyretin Ligands Exhibiting Negative-Cooperativity between Two Thyroxine Binding Sites.,No,4ABW
ASD10420000_1,TTR,Homo sapiens,P02766,4AC2,ASD10420182,43F,A,Lig,Inhibitor,"2,4-bis(chloranyl)-1-[4-(chloromethyl)-2-methoxy-phenoxy]benzene",1125,Inner Protein Regulator,Protein-Protein Interaction,22973437,Crystallographic Study of Novel Transthyretin Ligands Exhibiting Negative-Cooperativity between Two Thyroxine Binding Sites.,No,4AC2
ASD10420000_1,TTR,Homo sapiens,P02766,4AC4,ASD10420183,HKA,A,Lig,Inhibitor,3-methoxy-4-phenoxy-benzoic acid,1125,Inner Protein Regulator,Protein-Protein Interaction,,Crystallographic Study of Novel Transthyretin Inhibitors: Unique Mechanism of Negative-Cooperativity between Two T4 Binding Sites,No,4AC4
ASD10420000_1,TTR,Homo sapiens,P02766,4ACT,ASD10420184,FT0,A,Lig,Inhibitor,3-hydroxy-4-phenoxy-benzaldehyde,1125,Inner Protein Regulator,Protein-Protein Interaction,,Crystallographic Study of Novel Transthyretin Inhibitors: Unique Mechanism of Negative-Cooperativity between Two T4 Binding Sites,No,4ACT
ASD10420000_1,TTR,Homo sapiens,P02766,4DER,ASD10420185,AGI,A,Lig,Inhibitor,"5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one",201,Inner Protein Regulator,Protein-Protein Interaction,22842046,Flavonoid interactions with human transthyretin: Combined structural and thermodynamic analysis.,No,4DER
ASD10420000_1,TTR,Homo sapiens,P02766,4DES,ASD01328023,57D,A,Lig,Inhibitor,"5,7-dihydroxy-2-phenyl-chromen-4-one",201,Inner Protein Regulator,Protein-Protein Interaction,22842046,Flavonoid interactions with human transthyretin: Combined structural and thermodynamic analysis.,No,4DES
ASD10420000_1,TTR,Homo sapiens,P02766,4DET,ASD11030079,KMP,A,Lig,Inhibitor,"3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one",201,Inner Protein Regulator,Protein-Protein Interaction,22842046,Flavonoid interactions with human transthyretin: Combined structural and thermodynamic analysis.,No,4DET
ASD10420000_1,TTR,Homo sapiens,P02766,4DEU,ASD10420188,NAR,A,Lig,Inhibitor,"(2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one",205,Inner Protein Regulator,Protein-Protein Interaction,22842046,Flavonoid interactions with human transthyretin: Combined structural and thermodynamic analysis.,No,4DEU
ASD10420000_1,TTR,Homo sapiens,P02766,4DEW,ASD10420189,LU2,A,Lig,Inhibitor,"2-[3,4-bis(oxidanyl)phenyl]-5,7-bis(oxidanyl)chromen-4-one",201,Inner Protein Regulator,Protein-Protein Interaction,22842046,Flavonoid interactions with human transthyretin: Combined structural and thermodynamic analysis.,No,4DEW
ASD10420000_1,TTR,Homo sapiens,P02766,4FI6,ASD10420190,0U7,A,Lig,Inhibitor,"3-[5-[3,5-bis(chloranyl)phenyl]-1,3,4-oxadiazol-2-yl]benzenesulfonyl fluoride",301,Inner Protein Regulator,Protein-Protein Interaction,23350654,Aromatic Sulfonyl Fluorides Covalently Kinetically Stabilize Transthyretin to Prevent Amyloidogenesis while Affording a Fluorescent Conjugate.,No,4FI6
ASD10420000_1,TTR,Homo sapiens,P02766,4FI7,ASD10420191,0UA,A,Lig,Inhibitor,"3-[5-[3,5-bis(chloranyl)-4-oxidanyl-phenyl]-1,3,4-oxadiazol-2-yl]benzenesulfonyl fluoride",301,Inner Protein Regulator,Protein-Protein Interaction,23350654,Aromatic Sulfonyl Fluorides Covalently Kinetically Stabilize Transthyretin to Prevent Amyloidogenesis while Affording a Fluorescent Conjugate.,No,4FI7
ASD10420000_1,TTR,Homo sapiens,P02766,4FI8,ASD10420192,0UC,A,Lig,Inhibitor,"3-[5-[3,5-bis(chloranyl)-4-oxidanyl-phenyl]-1,3,4-oxadiazol-2-yl]-4-bromanyl-benzenesulfonyl fluoride",301,Inner Protein Regulator,Protein-Protein Interaction,23350654,Aromatic Sulfonyl Fluorides Covalently Kinetically Stabilize Transthyretin to Prevent Amyloidogenesis while Affording a Fluorescent Conjugate.,No,4FI8
ASD10420000_1,TTR,Homo sapiens,P02766,4HIQ,ASD10420193,16V,A,Lig,Inhibitor,"3-[3-(3,5-dimethyl-1H-pyrazol-4-yl)propoxy]-4-fluoranyl-benzoic acid",201,Inner Protein Regulator,Protein-Protein Interaction,23716704,AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin.,No,4HIQ
ASD10420000_1,TTR,Homo sapiens,P02766,4HIS,ASD10420194,3MI,A,Lig,Inhibitor,"2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid",201,Inner Protein Regulator,Protein-Protein Interaction,23716704,AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin.,No,4HIS
ASD10420000_1,TTR,Homo sapiens,P02766,4HJS,ASD10420195,18J,A,Lig,Inhibitor,"N-[4-[(E)-2-(3,5-dimethyl-4-oxidanyl-phenyl)ethenyl]phenyl]ethanesulfonamide",201,Inner Protein Regulator,Protein-Protein Interaction,24180271,Stilbene vinyl sulfonamides as fluorogenic sensors of and traceless covalent kinetic stabilizers of transthyretin that prevent amyloidogenesis.,No,4HJS
ASD10420000_1,TTR,Homo sapiens,P02766,4HJT,ASD10420196,18A,A,Lig,Inhibitor,"N-[4-[(E)-2-(3,5-dimethyl-4-oxidanyl-phenyl)ethenyl]phenyl]propanamide",201,Inner Protein Regulator,Protein-Protein Interaction,24180271,Stilbene vinyl sulfonamides as fluorogenic sensors of and traceless covalent kinetic stabilizers of transthyretin that prevent amyloidogenesis.,No,4HJT
ASD10420000_1,TTR,Homo sapiens,P02766,4HJU,ASD10420197,16L,A,Lig,Inhibitor,"N-[3-[(E)-2-(3,5-dimethyl-4-oxidanyl-phenyl)ethenyl]phenyl]prop-2-enamide",201,Inner Protein Regulator,Protein-Protein Interaction,24180271,Stilbene vinyl sulfonamides as fluorogenic sensors of and traceless covalent kinetic stabilizers of transthyretin that prevent amyloidogenesis.,No,4HJU
ASD10420000_1,TTR,Homo sapiens,P02766,4I85,ASD10420198,H50,A,Lig,Inhibitor,"1-[4-(3,4-dichlorophenyl)-3-fluoranyl-phenyl]cyclopropane-1-carboxylic acid",201,Inner Protein Regulator,Protein-Protein Interaction,23792159,Structural evidence for native state stabilization of a conformationally labile amyloidogenic transthyretin variant by fibrillogenesis inhibitors.,No,4I85
ASD10420000_1,TTR,Homo sapiens,P02766,4I87,ASD10420198,H50,A,Lig,Inhibitor,"1-[4-(3,4-dichlorophenyl)-3-fluoranyl-phenyl]cyclopropane-1-carboxylic acid",201,Inner Protein Regulator,Protein-Protein Interaction,23792159,Structural evidence for native state stabilization of a conformationally labile amyloidogenic transthyretin variant by fibrillogenesis inhibitors.,No,4I87
ASD10420000_1,TTR,Homo sapiens,P02766,4I89,ASD01140129,1FL,A,Lig,Inhibitor,"5-(2,4-difluorophenyl)-2-hydroxy-benzoic acid",201,Inner Protein Regulator,Protein-Protein Interaction,23792159,Structural evidence for native state stabilization of a conformationally labile amyloidogenic transthyretin variant by fibrillogenesis inhibitors.,No,4I89
ASD10420000_1,TTR,Homo sapiens,P02766,4IIZ,ASD10420201,LUR,A,Lig,Inhibitor,2-[2-[(2-chloranyl-6-fluoranyl-phenyl)amino]-5-methyl-phenyl]ethanoic acid,201,Inner Protein Regulator,Protein-Protein Interaction,,Crystal structure of wild-type human transthyretin in complex with lumiracoxib,No,4IIZ
ASD10420000_1,TTR,Homo sapiens,P02766,4IK6,ASD10420201,LUR,A,Lig,Inhibitor,2-[2-[(2-chloranyl-6-fluoranyl-phenyl)amino]-5-methyl-phenyl]ethanoic acid,201,Inner Protein Regulator,Protein-Protein Interaction,,Crystal structure of human transthyretin in complex with lumiracoxib,No,4IK6
ASD10420000_1,TTR,Homo sapiens,P02766,4IK7,ASD10420203,IMN,A,Lig,Inhibitor,2-[1-(4-chlorophenyl)carbonyl-5-methoxy-2-methyl-indol-3-yl]ethanoic acid,201,Inner Protein Regulator,Protein-Protein Interaction,,Crystal structure of human transthyretin in complex with indomethacin,No,4IK7
ASD10420000_1,TTR,Homo sapiens,P02766,4IKI,ASD10420203,IMN,A,Lig,Inhibitor,2-[1-(4-chlorophenyl)carbonyl-5-methoxy-2-methyl-indol-3-yl]ethanoic acid,201,Inner Protein Regulator,Protein-Protein Interaction,,Crystal structure of wild-type human transthyretin in complex with indomethacin,No,4IKI
ASD10420000_1,TTR,Homo sapiens,P02766,4IKJ,ASD10420205,SUZ,A,Lig,Inhibitor,2-[(3Z)-6-fluoro-2-methyl-3-[[4-[methylsulfinyl]phenyl]methylidene]inden-1-yl]ethanoic acid,201,Inner Protein Regulator,Protein-Protein Interaction,,Crystal structure of wild-type human transthyretin in complex with sulindac,No,4IKJ
ASD10420000_1,TTR,Homo sapiens,P02766,4IKK,ASD10420205,SUZ,A,Lig,Inhibitor,2-[(3Z)-6-fluoro-2-methyl-3-[[4-[methylsulfinyl]phenyl]methylidene]inden-1-yl]ethanoic acid,201,Inner Protein Regulator,Protein-Protein Interaction,,Crystal structure of wild-type human transthyretin in complex with sulindac,No,4IKK
ASD10420000_1,TTR,Homo sapiens,P02766,4IKL,ASD10420205,SUZ,A,Lig,Inhibitor,2-[(3Z)-6-fluoro-2-methyl-3-[[4-[methylsulfinyl]phenyl]methylidene]inden-1-yl]ethanoic acid,201,Inner Protein Regulator,Protein-Protein Interaction,,Crystal structure of wild-type human transthyretin in complex with sulindac,No,4IKL
ASD10420000_1,TTR,Homo sapiens,P02766,4KY2,ASD10420208,1W3,A,Lig,Inhibitor,"3-[(E)-2-(3,5-dimethyl-4-oxidanyl-phenyl)ethenyl]-4-methyl-7-oxidanyl-chromen-2-one",201,Inner Protein Regulator,Protein-Protein Interaction,23989101,Bifunctional coumarin derivatives that inhibit transthyretin amyloidogenesis and serve as fluorescent transthyretin folding sensors.,No,4KY2
ASD10420000_1,TTR,Homo sapiens,P02766,4L1S,ASD10420209,1W4,A,Lig,Inhibitor,"S-(4-fluorophenyl) 3-(dimethylamino)-5-[(E)-2-(3,5-dimethyl-4-oxidanyl-phenyl)ethenyl]benzenecarbothioate",201,Inner Protein Regulator,Protein-Protein Interaction,24105107,Fluorogenic small molecules requiring reaction with a specific protein to create a fluorescent conjugate for biological imaging-what we know and what we need to learn.,No,4L1S
ASD10420000_1,TTR,Homo sapiens,P02766,4L1T,ASD10420210,1WZ,A,Lig,Inhibitor,"3-(dimethylamino)-5-[(E)-2-(3,5-dimethyl-4-oxidanyl-phenyl)ethenyl]benzoic acid",201,Inner Protein Regulator,Protein-Protein Interaction,24105107,Fluorogenic small molecules requiring reaction with a specific protein to create a fluorescent conjugate for biological imaging-what we know and what we need to learn.,No,4L1T
ASD10420000_1,TTR,Homo sapiens,P02766,4MAS,ASD10420129,PCQ,A,Lig,Inhibitor,"2,6-dichloro-4-(3,5-dichloro-4-hydroxy-phenyl)phenol",201,Inner Protein Regulator,Protein-Protein Interaction,,"High Resolution Structure of Wild Type Human Transthyretin in Complex with 3,3',5,5'-tetrachloro-[1,1'-biphenyl]-4,4'diol",No,4MAS
ASD10420000_1,TTR,Homo sapiens,P02766,4N86,ASD10420212,GBJ,A,Lig,Inhibitor,"4-[(3R)-8,8-dimethyl-3,4-dihydro-2H-pyrano[2,3-f]chromen-3-yl]benzene-1,3-diol",201,Inner Protein Regulator,Protein-Protein Interaction,24422526,Crystal structures of human transthyretin complexed with glabridin,No,4N86
ASD10420000_1,TTR,Homo sapiens,P02766,4N87,ASD10420212,GBJ,A,Lig,Inhibitor,"4-[(3R)-8,8-dimethyl-3,4-dihydro-2H-pyrano[2,3-f]chromen-3-yl]benzene-1,3-diol",201,Inner Protein Regulator,Protein-Protein Interaction,24422526,Crystal structures of human transthyretin complexed with glabridin,No,4N87
ASD10420000_1,TTR,Homo sapiens,P02766,6IMX,,O4B,A,Lig,Inhibitor,"1,4,7,10,13,16-HEXAOXACYCLOOCTADECANE",201,Allosteric function,Allosteric position,,,No,6IMX
ASD10420000_1,TTR,Homo sapiens,P02766,6IMY,,AJU,A,Lig,Inhibitor,"2,3,5,6,8,9,11,12,14,15-decahydro-1,4,7,10,13,16-benzohexaoxacyclooctadecine-18-carboxylic acid",201,Allosteric function,Allosteric position,,,No,6IMY
ASD10420000_2,Ttr,Rattus norvegicus,P02767,1IE4,ASD06898001,T44,A,Lig,Inhibitor,"(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoic acid",128,Inner Protein Regulator,Protein-Protein Interaction,11468389,Structure of rat transthyretin (rTTR) complex with thyroxine at 2.5 A resolution: first non-biased insight into thyroxine binding reveals different hormone orientation in two binding sites.,No,"Chain A:LYS15,LEU17,GLU54,ALA108,ALA109,LEU110; Chain C:LYS15,LEU17,GLU54,ALA108,LEU110"
ASD10430000_1,LTA4H,Homo sapiens,P09960,3FUD,ASD10438009,692,A,Lig,Inhibitor,N-methyl-1-(2-thiophen-2-ylphenyl)methanamine,710,Inner Protein Regulator,Protein-Protein Interaction,19618939,Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.,No,3FUD
ASD10470000_1,GRESAG,Trypanosoma brucei brucei,Q99279,1FX2,ASD04400004,DTT,A,Lig,Regulator,"(2R,3R)-1,4-bis-sulfanylbutane-2,3-diol",1124,Inner Protein Regulator,Inner Protein,11157750,Structural analysis of adenylate cyclases from Trypanosoma brucei in their monomeric state.,No,"Chain A:GLN969,PHE972,LEU973,TRP1016,ASN1017,GLY1018,LEU1019,ARG1020,VAL1021,GLY1061,ARG1109"
ASD10710000_1,GSU0527,Geobacter sulfurreducens,Q74FS9,4GVL,ASD11630001,CA,A,Ion,Inhibitor,calcium(+2) cation,603,Inner Protein Regulator,Protein-Protein Interaction,23240087,Distinct gating mechanisms revealed by the structures of a multi-ligand gated K(+) channel.,No,"Chain A:GLU449,ASN450,GLN453; Chain B:THR183,ASN210,THR214"
ASD10710000_1,GSU0527,Geobacter sulfurreducens,Q74FS9,4GX0,ASD11630001,CA,A,Ion,Inhibitor,calcium(+2) cation,607,Inner Protein Regulator,Protein-Protein Interaction,23240087,Distinct gating mechanisms revealed by the structures of a multi-ligand gated K(+) channel.,No,"Chain A:GLU449,ASN450,GLN453; Chain B:THR183,ASN210,THR214"
ASD10710000_1,GSU0527,Geobacter sulfurreducens,Q74FS9,4GX1,ASD11630001,CA,A,Ion,Inhibitor,calcium(+2) cation,605,Inner Protein Regulator,Protein-Protein Interaction,23240087,Distinct gating mechanisms revealed by the structures of a multi-ligand gated K(+) channel.,No,"Chain A:GLU449,ASN450,GLN453; Chain B:THR183,ASN210,THR214"
ASD10710000_1,GSU0527,Geobacter sulfurreducens,Q74FS9,4GX2,ASD11630001,CA,A,Ion,Inhibitor,calcium(+2) cation,607,Inner Protein Regulator,Protein-Protein Interaction,23240087,Distinct gating mechanisms revealed by the structures of a multi-ligand gated K(+) channel.,No,"Chain A:GLU449,ASN450,GLN453; Chain B:THR183,ASN210,THR214"
ASD10710000_1,GSU0527,Geobacter sulfurreducens,Q74FS9,4GX5,ASD11630001,CA,A,Ion,Inhibitor,calcium(+2) cation,606,Inner Protein Regulator,Protein-Protein Interaction,23240087,Distinct gating mechanisms revealed by the structures of a multi-ligand gated K(+) channel.,No,"Chain A:GLU449,ASN450,GLN453; Chain B:THR183,ASN210,THR214"
ASD10860000_1,ydeH,Escherichia coli,P31129,4H54,ASD01310003,ZN,A,Ion,Inhibitor,zinc(+2) cation,401,Inner Protein Regulator,Inner Protein,23769666,Structure and signaling mechanism of a zinc-sensory diguanylate cyclase.,No,"Chain A:HIS22,HIS79,HIS83"
ASD10910000_1,CCR2,Homo sapiens,P41597,5T1A,ASD10910002,VT5,A,Lig,Inhibitor,(2~{R})-1-(4-chloranyl-2-fluoranyl-phenyl)-2-cyclohexyl-3-ethanoyl-4-oxidanyl-2~{H}-pyrrol-5-one,1202,Allosteric function,Allosteric position,27926736,Structure of CC chemokine receptor 2 with orthosteric and allosteric antagonists.,No,5T1A
ASD11000000_1,GRIN2B,Homo sapiens,Q13224,5EWJ,ASD11000034,QEL,B,Lig,Inhibitor,"4-[(1R,2S)-2-(4-benzylpiperidin-1-yl)-1-hydroxypropyl]phenol",501,Inner Protein regulator,Inner Protein,26912815,A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists.,,5EWJ
ASD11000000_1,GRIN2B,Homo sapiens,Q13224,5EWL,ASD11000264,5SL,A,Lig,Inhibitor,"~{N}-[(1~{S},3~{S})-3-[3-[(4-methylphenyl)methyl]-1,2,4-oxadiazol-5-yl]cyclopentyl]-1~{H}-pyrazolo[3,4-d]pyrimidin-4-amine",508,Inner Protein regulator,Inner Protein,26912815,A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists.,,5EWL
ASD11000000_1,GRIN2B,Homo sapiens,Q13224,5EWM,ASD11000303,5SM,B,Lig,Inhibitor,5-[3-[bis(fluoranyl)methyl]-4-fluoranyl-phenyl]-3-[(2-methylimidazol-1-yl)methyl]pyridazine,503,Inner Protein regulator,Inner Protein,26912815,A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists.,,5EWM
ASD11000000_2,Grin2b,Rattus norvegicus,Q00960,3JPY,ASD01310003,ZN,A,Ion,Inhibitor,zinc(+2) cation,901,Inner Protein Regulator,Protein-Protein Interaction,19910922,Structure of the zinc-bound amino-terminal domain of the NMDA receptor NR2B subunit.,No,"Chain A:HIS127,GLU284"
ASD11000000_2,Grin2b,Rattus norvegicus,Q00960,3QEL,ASD11000034,QEL,B,Lig,Inhibitor,4-[(2S)-1-hydroxy-2-[4-(phenylmethyl)piperidin-1-yl]propyl]phenol,1,Inner Protein Regulator,Protein-Protein Interaction,21677647,Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors.,No,"Chain A:TYR109,THR110,ARG115,SER132,ILE133,LEU135; Chain B:ALA107,GLN110,ILE111,PHE114,THR174,TYR175,PHE176,PRO177,GLU236"
ASD11000000_2,Grin2b,Rattus norvegicus,Q00960,3QEM,ASD11000047,QEM,B,Lig,Inhibitor,"4-[(1R,2S)-1-hydroxy-2-methyl-3-[4-(phenylmethyl)piperidin-1-yl]propyl]phenol",396,Inner Protein Regulator,Protein-Protein Interaction,21677647,Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors.,No,"Chain A:TYR109,THR110,ARG115,LYS131,SER132,ILE133,LEU135; Chain B:PRO78,ALA107,GLN110,ILE111,PHE114,THR174,TYR175,PHE176,PRO177,GLU236"
ASD11000000_2,Grin2b,Rattus norvegicus,Q00960,6E7R,,HYS,B,Lig,Inhibitor,"N-{4-[(2S)-3-{[2-(3,4-dichlorophenyl)ethyl]amino}-2-hydroxypropoxy]phenyl}methanesulfonamide",503,Protein-Protein interaction,Protein-Protein,,Structural elements of a pH-sensitive inhibitor binding site in NMDA receptors,,
ASD11000000_2,Grin2b,Rattus norvegicus,Q00960,6E7S,,HZ4,B,Lig,Inhibitor,"N-{4-[(2S)-3-{[2-(3,4-dichlorophenyl)ethyl](ethyl)amino}-2-hydroxypropoxy]phenyl}methanesulfonamide",503,Protein-Protein interaction,Protein-Protein,,Structural elements of a pH-sensitive inhibitor binding site in NMDA receptors,,
ASD11000000_2,Grin2b,Rattus norvegicus,Q00960,6E7T,,HYY,B,Lig,Inhibitor,"N-{4-[(2S)-3-{[2-(3,4-dichlorophenyl)ethyl](propyl)amino}-2-hydroxypropoxy]phenyl}methanesulfonamide",506,Protein-Protein interaction,Protein-Protein,,Structural elements of a pH-sensitive inhibitor binding site in NMDA receptors,,
ASD11000000_2,Grin2b,Rattus norvegicus,Q00960,6E7U,,HX7,B,Lig,Inhibitor,"N-{4-[(2S)-3-{butyl[2-(3,4-dichlorophenyl)ethyl]amino}-2-hydroxypropoxy]phenyl}methanesulfonamide",503,Protein-Protein interaction,Protein-Protein,,Structural elements of a pH-sensitive inhibitor binding site in NMDA receptors,,
ASD11000000_2,Grin2b,Rattus norvegicus,Q00960,6E7V,,T88,B,Lig,Inhibitor,"N-{4-[(2R)-3-{butyl[2-(3,4-dichlorophenyl)ethyl]amino}-2-hydroxypropoxy]phenyl}methanesulfonamide",502,Protein-Protein interaction,Protein-Protein,,Structural elements of a pH-sensitive inhibitor binding site in NMDA receptors,,
ASD11000000_2,Grin2b,Rattus norvegicus,Q00960,6E7W,,HXM,B,Lig,Inhibitor,"N-{4-[(2S)-3-{[2-(3,4-dichlorophenyl)ethyl](propan-2-yl)amino}-2-hydroxypropoxy]phenyl}methanesulfonamide",503,Protein-Protein interaction,Protein-Protein,,Structural elements of a pH-sensitive inhibitor binding site in NMDA receptors,,
ASD11000000_2,Grin2b,Rattus norvegicus,Q00960,6E7X,,T97,B,Lig,Inhibitor,"N-{4-[(2S)-3-{[2-(3,4-dichlorophenyl)ethyl](2-methylpropyl)amino}-2-hydroxypropoxy]phenyl}methanesulfonamide",503,Protein-Protein interaction,Protein-Protein,,Structural elements of a pH-sensitive inhibitor binding site in NMDA receptors,,
ASD11010000_1,MALT1,Homo sapiens,Q9UDY8,4I1R,ASD11010001,LZU,A,Lig,Inhibitor,10-[2-[(2S)-1-methylpiperidin-2-yl]ethyl]-2-methylsulfanyl-phenothiazine,801,Inner Protein Regulator,Inner Protein,23946259,Structural Analysis of Phenothiazine Derivatives as Allosteric Inhibitors of the MALT1 Paracaspase.,No,4I1R
ASD11010000_1,MALT1,Homo sapiens,Q9UDY8,6F7I,,CW5,A,Lig,Inhibitor,"1-[2-chloranyl-7-[(1~{S})-1-methoxyethyl]pyrazolo[1,5-a]pyrimidin-6-yl]-3-(5-chloranyl-6-pyrrolidin-1-ylcarbonyl-pyridin-3-yl)urea",801,,Allosteric position,30692685,An allosteric MALT1 inhibitor is a molecular corrector rescuing function in an immunodeficient patient.,,6F7I
ASD11010000_1,MALT1,Homo sapiens,Q9UDY8,6H4A,,FNB,A,Lig,Inhibitor,"1-[2-chloranyl-7-[(1~{R},2~{R})-1,2-dimethoxypropyl]pyrazolo[1,5-a]pyrimidin-6-yl]-3-[5-chloranyl-6-(1,2,3-triazol-2-yl)pyridin-3-yl]urea",801,,Allosteric position,30692685,An allosteric MALT1 inhibitor is a molecular corrector rescuing function in an immunodeficient patient.,,6H4A
ASD11010000_1,MALT1,Homo sapiens,Q9UDY8,7AK0,,RJK,A,Lig,Inhibitor,"1-[4-[4-(aminomethyl)pyrazol-1-yl]-3-chloranyl-phenyl]-3-[(3~{R})-6-bromanyl-3,4-dihydro-2~{H}-chromen-3-yl]urea",801,,,,,,7AK0
ASD11010000_1,MALT1,Homo sapiens,Q9UDY8,7AK1,,RJH,A,Lig,Inhibitor,"1-(3-chloranyl-4-methoxy-phenyl)-3-[7-[(3~{S})-3-(methoxymethyl)morpholin-4-yl]-2-methyl-pyrazolo[1,5-a]pyrimidin-6-yl]urea",801,,,,,,7AK1
ASD11200000_1,TNF,Homo sapiens,P01375,6X81,,UTJ,A,Lig,Inhibitor,[4-(isoquinolin-8-yl)phenyl]acetonitrile,201,,,,,,6X81
ASD11200000_1,TNF,Homo sapiens,P01375,6X82,,UTM,"A, D",Lig,Inhibitor,"8-[4-(2-{5-[(4-methylpiperazin-1-yl)methyl]-2-(1H-pyrrolo[3,2-c]pyridin-3-yl)phenoxy}ethyl)phenyl]isoquinoline",,,,,,,6X82
ASD11200000_1,TNF,Homo sapiens,P01375,6X83,,UTS,A,Lig,Inhibitor,1-benzyl-1H-benzimidazole,201,,,,,,6X83
ASD11200000_1,TNF,Homo sapiens,P01375,6X85,,UTV,B,Lig,Inhibitor,"1-{[2-(difluoromethoxy)phenyl]methyl}-2,2-dimethyl-1,2-dihydro-3H-indol-3-one",901,,,,,,6X85
ASD11200000_1,TNF,Homo sapiens,P01375,6X86,,UTY,B,Lig,Inhibitor,"3-[(6-{2-[(3R)-4-(hydroxyacetyl)-3-methylpiperazin-1-yl]pyrimidin-5-yl}-2,2-dimethyl-3-oxo-2,3-dihydro-1H-indol-1-yl)methyl]pyridine-2-carbonitrile",901,,,,,,6X86
ASD11510000_1,S100G,Bos taurus,P02633,1IG5,ASD00330030,MG,A,Ion,Inhibitor,magnesium(+2) cation,78,Inner Protein Regulator,Inner Protein,9194174,Structural basis for the negative allostery between Ca(2+)- and Mg(2+)-binding in the intracellular Ca(2+)-receptor calbindin D9k.,No,"Chain A:ASP54,ASN56,ASP58,GLU60"
ASD11510000_1,S100G,Bos taurus,P02633,1IGV,ASD00890024,MN,A,Ion,Inhibitor,manganese(+2) cation,76,Inner Protein Regulator,Inner Protein,9194174,Structural basis for the negative allostery between Ca(2+)- and Mg(2+)-binding in the intracellular Ca(2+)-receptor calbindin D9k.,No,"Chain A:ASP54,ASN56,ASP58,GLU60"
ASD11510000_1,S100G,Bos taurus,P02633,3ICB,ASD11630001,CA,A,Ion,Inhibitor,calcium(+2) cation,77,Inner Protein Regulator,Inner Protein,3722173,"The refined structure of vitamin D-dependent calcium-binding protein from bovine intestine. Molecular details, ion binding, and implications for the structure of other calcium-binding proteins.",No,"Chain A:ASP54,ASN56,ASP58,GLU60,GLU65"
ASD11520000_1,fadR,Escherichia coli,P0A8V6,1H9G,ASD11520001;ASD03320088,COA;MYR,A;A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxy-oxolan-2-yl]methyl [hydroxy-[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-[[3-oxo-3-(2-sulfanylethylamino)propyl]amino]butoxy]phosphoryl] hydrogen phosphate;tetradecanoic acid",1228;1229,Protein-DNA/RNA Interaction Regulator,Inner Protein,11296236,The Structural Basis of Acyl Coenzyme A-Dependent Regulation of the Transcription Factor Fadr,No,"Chain A:ASP99,LEU101,LEU102,SER103,VAL104,ARG105,THR106,ASN107,ILE108,ASP145,ILE164,LEU165,MET168,TYR172,ILE175,GLY176,TYR179,PHE180,ARG213,GLY216,HIS217,SER219,GLY220,TRP223,HIS224"
ASD11530000_1,EPAS1,Homo sapiens,Q99814,3F1O,ASD11530005,2XY,A,Lig,Inhibitor,N-[2-nitro-4-(trifluoromethyl)phenyl]morpholin- 4-amine,1,Inner Protein Regulator,Inner Protein,19129502,Artificial ligand binding within the HIF2alpha PAS-B domain of the HIF2 transcription factor.,No,3F1O
ASD11530000_1,EPAS1,Homo sapiens,Q99814,3H7W,ASD11530004,18,A,Lig,Inhibitor,2-nitro-N-(thiophen-3-ylmethyl)-4-(trifluoromethyl)aniline,1,Inner Protein Regulator,Inner Protein,19950993,Principles of ligand binding within a completely buried cavity in HIF2alpha PAS-B,No,3H7W
ASD11530000_1,EPAS1,Homo sapiens,Q99814,3H82,ASD11530008,20,A,Lig,Inhibitor,N-(furan-2-ylmethyl)-2-nitro-4-(trifluoromethyl)aniline,351,Inner Protein Regulator,Inner Protein,19950993,Principles of ligand binding within a completely buried cavity in HIF2alpha PAS-B,No,3H82
ASD11530000_1,EPAS1,Homo sapiens,Q99814,4GHI,ASD11530009,0X3,A,Lig,Inhibitor,"N-(3-chloranyl-5-fluoranyl-phenyl)-4-nitro-2,1,3-benzoxadiazol-5-amine",401,Inner Protein Regulator,Inner Protein,23434853,Allosteric inhibition of hypoxia inducible factor-2 with small molecules.,No,4GHI
ASD11530000_1,EPAS1,Homo sapiens,Q99814,4GS9,ASD11530010,0XB,A,Lig,Inhibitor,"N-(3-fluorophenyl)-4-nitro-2,1,3-benzoxadiazol-5-amine",401,Inner Protein Regulator,Inner Protein,23363003,Development of Inhibitors of the PAS-B Domain of the HIF-2 alpha Transcription Factor,No,4GS9
ASD11530000_1,EPAS1,Homo sapiens,Q99814,5TBM,ASD11530011,79A,A,Lig,Inhibitor,"3-{[(1S)-2,2-difluoro-1-hydroxy-7-(methylsulfonyl)- 2,3-dihydro-1H-inden-4-yl]oxy}-5-fluorobenzonitrile",401,Inner Protein Regulator,Inner Protein,27635045,A Small-Molecule Antagonist of HIF2 alpha Is Efficacious in Preclinical Models of Renal Cell Carcinoma.,No,5TBM
ASD11540000_1,CHKA,Homo sapiens,P35790,3ZM9,ASD11540001,QMQ,A,Lig,Inhibitor,9-[[4-[4-[4-[[4-(dimethylamino)pyridin-1-ium-1-yl]methyl]phenyl]butyl]phenyl]methyl]purin-6-amine,1458,Inner Protein Regulator,Inner Protein,23441033,The Mechanism of Allosteric Coupling in Choline Kinase A1 Revealed by a Rationally Designed Inhibitor,Yes,3ZM9
ASD11580000_1,dgt,Escherichia coli,P15723,4X9E,ASD11580001,DNA,G,Lig,Activator,RNA (5'-R(P*CP*CP*C)-3'),1,Allosteric function,Allosteric position,25694425,Structure of Escherichia coli dGTP Triphosphohydrolase: A HEXAMERIC ENZYME WITH DNA EFFECTOR MOLECULES.,No,"Chain G:  C1,  C2"
ASD11600000_1,SIRT2,Homo sapiens,Q8IXJ6,6QCN,,QUE,A,Lig,Inhibitor,"3,5,7,3',4'-PENTAHYDROXYFLAVONE",403,Inner Protein Regulator,Inner Protein,,,No,6QCN
ASD11630000_1,,Homo sapiens,Q9UM07,1WD9,ASD11630001,CA,A,Ion,Activator,CALCIUM ION,903,Inner Protein Regulator,Inner Protein,15247907,Structural basis for Ca(2+)-induced activation of human PAD4,No,1WD9
ASD11630000_1,,Homo sapiens,Q9UM07,1WD9,ASD11630001;ASD11630001;ASD11630001,CA;CA;CA,A;A;A,Ion,Activator,CALCIUM ION;CALCIUM ION;CALCIUM ION,901;902;904,Inner Protein Regulator,Inner Protein,15247907,Structural basis for Ca(2+)-induced activation of human PAD4,No,1WD9
ASD11630000_1,,Homo sapiens,Q9UM07,1WDA,ASD11630001,CA,A,Ion,Activator,CALCIUM ION,903,Inner Protein Regulator,Inner Protein,15247907,Structural basis for Ca(2+)-induced activation of human PAD4,No,1WDA
ASD11630000_1,,Homo sapiens,Q9UM07,1WDA,ASD11630001;ASD11630001;ASD11630001,CA;CA;CA,A;A;A,Ion,Activator,CALCIUM ION;CALCIUM ION;CALCIUM ION,901;902;904,Inner Protein Regulator,Inner Protein,15247907,Structural basis for Ca(2+)-induced activation of human PAD4,No,1WDA
ASD11630000_1,,Homo sapiens,Q9UM07,2DEW,ASD11630001,CA,X,Ion,Activator,CALCIUM ION,903,Inner Protein Regulator,Inner Protein,16567635,Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4,No,2DEW
ASD11630000_1,,Homo sapiens,Q9UM07,2DEW,ASD11630001;ASD11630001;ASD11630001,CA;CA;CA,X;X;X,Ion,Activator,CALCIUM ION;CALCIUM ION;CALCIUM ION,901;902;904,Inner Protein Regulator,Inner Protein,16567635,Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4,No,2DEW
ASD11630000_1,,Homo sapiens,Q9UM07,2DEX,ASD11630001,CA,X,Ion,Activator,CALCIUM ION,903,Inner Protein Regulator,Inner Protein,16567635,Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4,No,2DEX
ASD11630000_1,,Homo sapiens,Q9UM07,2DEX,ASD11630001;ASD11630001;ASD11630001,CA;CA;CA,X;X;X,Ion,Activator,CALCIUM ION;CALCIUM ION;CALCIUM ION,901;902;904,Inner Protein Regulator,Inner Protein,16567635,Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4,No,2DEX
ASD11630000_1,,Homo sapiens,Q9UM07,2DEY,ASD11630001,CA,X,Ion,Activator,CALCIUM ION,903,Inner Protein Regulator,Inner Protein,16567635,Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4,No,2DEY
ASD11630000_1,,Homo sapiens,Q9UM07,2DEY,ASD11630001;ASD11630001;ASD11630001,CA;CA;CA,X;X;X,Ion,Activator,CALCIUM ION;CALCIUM ION;CALCIUM ION,901;902;904,Inner Protein Regulator,Inner Protein,16567635,Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4,No,2DEY
ASD11630000_1,,Homo sapiens,Q9UM07,2DW5,ASD11630001,CA,A,Ion,Activator,CALCIUM ION,903,Inner Protein Regulator,Inner Protein,17002273,Inhibitors and Inactivators of Protein Arginine Deiminase 4: Functional and Structural Characterization,No,2DW5
ASD11630000_1,,Homo sapiens,Q9UM07,2DW5,ASD11630001;ASD11630001;ASD11630001,CA;CA;CA,A;A;A,Ion,Activator,CALCIUM ION;CALCIUM ION;CALCIUM ION,901;902;904,Inner Protein Regulator,Inner Protein,17002273,Inhibitors and Inactivators of Protein Arginine Deiminase 4: Functional and Structural Characterization,No,2DW5
ASD11630000_1,,Homo sapiens,Q9UM07,3B1T,ASD11630001,CA,A,Ion,Activator,CALCIUM ION,903,Inner Protein Regulator,Inner Protein,21882827,The Development of N-alpha-(2-Carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine Amide (o-F-amidine) and N-alpha-(2-Carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine Amide (o-Cl-amidine) As Second Generation Protein Arginine Deiminase (PAD) Inhibitors,No,3B1T
ASD11630000_1,,Homo sapiens,Q9UM07,3B1T,ASD11630001;ASD11630001;ASD11630001,CA;CA;CA,A;A;A,Ion,Activator,CALCIUM ION;CALCIUM ION;CALCIUM ION,901;902;904,Inner Protein Regulator,Inner Protein,21882827,The Development of N-alpha-(2-Carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine Amide (o-F-amidine) and N-alpha-(2-Carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine Amide (o-Cl-amidine) As Second Generation Protein Arginine Deiminase (PAD) Inhibitors,No,3B1T
ASD11630000_1,,Homo sapiens,Q9UM07,3B1U,ASD11630001,CA,A,Ion,Activator,CALCIUM ION,903,Inner Protein Regulator,Inner Protein,21882827,The Development of N-alpha-(2-Carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine Amide (o-F-amidine) and N-alpha-(2-Carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine Amide (o-Cl-amidine) As Second Generation Protein Arginine Deiminase (PAD) Inhibitors,No,3B1U
ASD11630000_1,,Homo sapiens,Q9UM07,3B1U,ASD11630001;ASD11630001;ASD11630001,CA;CA;CA,A;A;A,Ion,Activator,CALCIUM ION;CALCIUM ION;CALCIUM ION,901;902;904,Inner Protein Regulator,Inner Protein,21882827,The Development of N-alpha-(2-Carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine Amide (o-F-amidine) and N-alpha-(2-Carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine Amide (o-Cl-amidine) As Second Generation Protein Arginine Deiminase (PAD) Inhibitors,No,3B1U
ASD11630000_1,,Homo sapiens,Q9UM07,4DKT,ASD11630001,CA,A,Ion,Activator,CALCIUM ION,704,Inner Protein Regulator,Inner Protein,22004374,Synthesis and Screening of a Haloacetamidine Containing Library To Identify PAD4 Selective Inhibitors.,No,4DKT
ASD11630000_1,,Homo sapiens,Q9UM07,4DKT,ASD11630001;ASD11630001;ASD11630001,CA;CA;CA,A;A;A,Ion,Activator,CALCIUM ION;CALCIUM ION;CALCIUM ION,702;703;705,Inner Protein Regulator,Inner Protein,22004374,Synthesis and Screening of a Haloacetamidine Containing Library To Identify PAD4 Selective Inhibitors.,No,4DKT
ASD11700000_1,,Homo sapiens,P34896,1BJ4,ASD11700001,PLP,A,Lig,Regulator,PYRIDOXAL-5'-PHOSPHATE,500,Inner Protein Regulator,Inner Protein,9753690,The crystal structure of human cytosolic serine hydroxymethyltransferase: a target for cancer chemotherapy,No,1BJ4
ASD11710000_1,,Homo sapiens,P53671,4TPT,ASD11710019,35H,A,Lig,Inhibitor,"N-{4-[(1S)-1,2-dihydroxyethyl]benzyl}-N-methyl- 4-(phenylsulfamoyl)benzamide",701,Inner Protein Regulator,Inner Protein,25589930,Discovery of a Type III Inhibitor of LIM Kinase 2 That Binds in a DFG-Out Conformation.,No,4TPT
ASD11760000_1,,Bacillus caldovelox,P53608,2CEV,ASD11760001,GAI,A,Lig,Activator,GUANIDINE,1001,Inner Protein Regulator,Protein-Protein Interaction,10196128,"Crystal structures of Bacillus caldovelox arginase in complex with substrate and inhibitors reveal new insights into activation, inhibition and catalysis in the arginase superfamily.",No,"Chain B:HIS196,MET195,ASP199,GLU197,GLY244"
ASD11760000_1,,Bacillus caldovelox,P53608,3CEV,ASD02000001,ARG,B,Lig,Activator,ARGININE,402,Inner Protein Regulator,Protein-Protein Interaction,10196128,"Crystal structures of Bacillus caldovelox arginase in complex with substrate and inhibitors reveal new insights into activation, inhibition and catalysis in the arginase superfamily.",No,"Chain B:GLU250,GLY291,LEU298,HIS252,GLU296,LEU253,GLU256,ARG35,ARG249,TYR248,LYS297,SER292,ALA288"
ASD11760000_1,,Bacillus caldovelox,P53608,4CEV,ASD11760001,GAI,A,Lig,Activator,GUANIDINE,407,Inner Protein Regulator,Protein-Protein Interaction,10196128,"Crystal structures of Bacillus caldovelox arginase in complex with substrate and inhibitors reveal new insights into activation, inhibition and catalysis in the arginase superfamily.",No,"Chain B:HIS196,MET195,ASP199,GLU197,GLY244"
ASD11790000_1,cg0350,Corynebacterium glutamicum,Q79VI7,3R6S,ASD00480003,CMP,A,Lig,Activator,"(1R,4R,6S,7R,8R)-8-(6-aminopurin-9-yl)-4-hydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-7-ol",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,,Crystal structure of GlxR transcription factor from Corynebacterium glutamicum with cAMP,No,"Chain A:PHE41,LEU60,LEU72,MET75,PHE81,GLY82,GLU83,LEU84,SER85,ARG92,THR93,SER94,ARG133,THR137; Chain C:LEU134,ASN138"
ASD11860000_1,ntcA,Nostoc sp.,P0A4U6,3LA2,ASD00710001,AKG,A,Lig,Activator,2-OXOGLUTARIC ACID,224,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,20616047,Structural basis for the allosteric control of the global transcription factor NtcA by the nitrogen starvation signal 2-oxoglutarate.,No,"Chain B:GLU134,LEU131,ILE130"
ASD11860000_1,ntcA,Nostoc sp.,P0A4U6,3LA3,ASD11860001,2FT,A,Lig,Activator,"2,2-difluoropentanedioic acid",224,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,20616047,Structural basis for the allosteric control of the global transcription factor NtcA by the nitrogen starvation signal 2-oxoglutarate.,No,"Chain B:GLU134,LEU131,ILE130"
ASD11870000_1,mecA,Staphylococcus aureus,Q54113,3ZFZ,ASD11870002,1W8,A,Lig,Activator,"4-(2-{[(6R,7R)-7-{[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(ethoxyimino)acetyl]amino}-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]sulfanyl}-1,3-thiazol-4-yl)-1-methylpyridinium (6R,7R)-7-[[(2Z)-2-(5-azanyl-1,2,4-thiadiazol-3-yl)-2-ethoxyimino-ethanoyl]amino]-3-[[4-(1-methylpyridin-1-ium-4-yl)-1,3-thiazol-2-yl]sulfanyl]-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",1669,Inner Protein Regulator,Protein-Protein Interaction,24085846,How Allosteric Control of Staphylococcus Aureus Penicillin Binding Protein 2A Enables Methicillin Resistance and Physiological Function,No,"Chain B:ILE309,ASN305,LEU147,ASN146,ASN307,ARG298,THR308,SER306,GLU145"
ASD11870000_1,mecA,Staphylococcus aureus,Q54113,3ZFZ,ASD11870001,MUR,A,Lig,Activator,"2-amino-3-O-[(1R)-1-carboxyethyl]-2-deoxy-beta-D-glucopyranose (2R)-2-[(2R,3R,4R,5S,6R)-3-amino-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxypropanoic acid",1670,Inner Protein Regulator,Inner Protein,24085846,How Allosteric Control of Staphylococcus Aureus Penicillin Binding Protein 2A Enables Methicillin Resistance and Physiological Function,No,"Chain A:THR165,GLU239,VAL256,GLY257,TYR373,THR238,ARG241,PRO258,VAL277,GLY166,GLU150,HIS293,ARG151,SER240,MET372,ASN164,SER149"
ASD11870000_1,mecA,Staphylococcus aureus,Q54113,3ZG0,ASD11870002,1W8,A,Lig,Activator,"4-(2-{[(6R,7R)-7-{[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(ethoxyimino)acetyl]amino}-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]sulfanyl}-1,3-thiazol-4-yl)-1-methylpyridinium (6R,7R)-7-[[(2Z)-2-(5-azanyl-1,2,4-thiadiazol-3-yl)-2-ethoxyimino-ethanoyl]amino]-3-[[4-(1-methylpyridin-1-ium-4-yl)-1,3-thiazol-2-yl]sulfanyl]-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",1676,Inner Protein Regulator,Protein-Protein Interaction,24085846,How Allosteric Control of Staphylococcus Aureus Penicillin Binding Protein 2A Enables Methicillin Resistance and Physiological Function,No,"Chain B:ILE309,LEU147,THR308,ASN307,ARG298,GLU315,THR300,SER306,GLU145"
ASD11870000_1,mecA,Staphylococcus aureus,Q54113,3ZG0,ASD11870001,MUR,A,Lig,Activator,"2-amino-3-O-[(1R)-1-carboxyethyl]-2-deoxy-beta-D-glucopyranose (2R)-2-[(2R,3R,4R,5S,6R)-3-amino-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxypropanoic acid",1677,Inner Protein Regulator,Inner Protein,24085846,How Allosteric Control of Staphylococcus Aureus Penicillin Binding Protein 2A Enables Methicillin Resistance and Physiological Function,No,"Chain A:THR165,GLU239,VAL256,ILE278,ALA163,LYS153,ARG241,VAL277,GLN292,GLY166,GLU150,LYS148,HIS293,ARG151,SER240,GLY152,ALA276,ASN242,ASN164,SER149"
ASD11890000_1,NLn,Rattus norvegicus,P42676,4FXY,ASD11890002,0W2,P,Lig,Inhibitor,"1-{(2S)-1-[(3R)-3-(2-chlorophenyl)-2-(2-fluorophenyl)pyrazolidin- 1-yl]-1-oxopropan-2-yl}-3-[(1R,3S,5R,7R)- tricyclo[3.3.1.1~3,7~]dec-2-yl]urea",701,Inner Protein Regulator,Inner Protein,25378390,Allosteric inhibition of the neuropeptidase neurolysin.,No,"Chain P:TYR142,MET113,GLU73,LEU69,VAL74,ARG491,MET149,PHE109,SER114,ILE77,ARG80,ILE72,MET115,TYR49,THR45,ASP110,GLU117,PHE120,ILE123,ILE147,GLY150,VAL119,LEU155,ARG116,LYS145,ASN153,LEU106,TYR76,ALA70,SER146,ILE111"
ASD11900000_1,,Geobacillus thermodenitrificans,A4INJ9,4M1P,ASD06432001,CU1,A,Ion,Regulator,COPPER (I) ION,201,Inner Protein Regulator,Inner Protein,24831014,Cu(I)-mediated allosteric switching in a copper-sensing operon repressor (CsoR).,No,"Chain A:ARG18,HIS75,ALA76,CYS79,THR14,MET15,LEU71,ILE16,ARG74,VAL80"
ASD11910000_1,folP,Bacillus anthracis,Q81VW8,4NHV,ASD11910004,2O6,A,Lig,Inhibitor,"5-(trifluoromethyl)-1,2-benzoxazol-3-amine",308,Inner Protein Regulator,Protein-Protein Interaction,24650357,Identification and characterization of an allosteric inhibitory site on dihydropteroate synthase.,No,"Chain A:GLU233,LEU235,MET264,MET261,GLY237,GLY239,GLU260,GLU236"
ASD11910000_1,folP,Bacillus anthracis,Q81VW8,4NIL,ASD11910003,208,A,Lig,Inhibitor,"(2S)-3-[1-[[2-(2-chlorophenyl)-5-methyl-1,3-oxazol-4-yl]methyl]indol-5-yl]-2-ethoxy-propanoic acid",306,Inner Protein Regulator,Protein-Protein Interaction,24650357,Identification and characterization of an allosteric inhibitory site on dihydropteroate synthase.,No,"Chain A:LEU235,MET264,MET261,GLU260,GLY239,GLU236"
ASD11910000_1,folP,Bacillus anthracis,Q81VW8,4NIR,ASD11910007,6DH,A,Lig,Inhibitor,3-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]propan-1-ol,308,Inner Protein Regulator,Protein-Protein Interaction,24650357,Identification and characterization of an allosteric inhibitory site on dihydropteroate synthase.,No,"Chain A:ARG263,LYS259,MET264,MET261,LEU235,GLY237,GLY239,GLU260,GLU236"
ASD11910000_1,folP,Bacillus anthracis,Q81VW8,4NL1,ASD11910008,Z13,A,Lig,Inhibitor,1-[4-(trifluoromethyl)phenyl]-N-[[4-(trifluoromethyl)phenyl]methyl]methanimine,301,Inner Protein Regulator,Protein-Protein Interaction,24650357,Identification and characterization of an allosteric inhibitory site on dihydropteroate synthase.,No,"Chain A:LEU235,MET264,MET261,GLY237,GLY239,GLU260,GLU236"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,1BQM,ASD11920019,HBY,A,Lig,Inhibitor,"propan-2-yl (2S)-7-methoxy-2-(methylsulfanylmethyl)-3-sulfanylidene-2,4-dihydroquinoxaline-1-carboxylate",557,Inner Protein Regulator,Inner Protein,9813120,Structures of Tyr188Leu mutant and wild-type HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor HBY 097: inhibitor flexibility is a useful design feature for reducing drug resistance.,No,"Chain A:PRO95,LEU100,LYS101,VAL179,TYR181,TYR188,VAL189,GLY190,PRO225,PHE227,TRP229,LEU234,HIS235,TYR318"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,1BQN,ASD11920019,HBY,A,Lig,Inhibitor,"propan-2-yl (2S)-7-methoxy-2-(methylsulfanylmethyl)-3-sulfanylidene-2,4-dihydroquinoxaline-1-carboxylate",559,Inner Protein Regulator,Inner Protein,9813120,Structures of Tyr188Leu mutant and wild-type HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor HBY 097: inhibitor flexibility is a useful design feature for reducing drug resistance.,No,"Chain A:LEU100,LYS101,VAL106,VAL179,TYR181,LEU188,VAL189,GLY190,TRP229,LEU234,HIS235,PRO236,TYR318"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,1EET,ASD11920021,BFU,A,Lig,Inhibitor,"1-(5-bromopyridin-2-yl)-3-[(1S,2S)-2-(6-fluoro-2-hydroxy-3-propanoyl-phenyl)cyclopropyl]urea",2000,Inner Protein Regulator,Inner Protein,10514285,Urea-PETT compounds as a new class of HIV-1 reverse transcriptase inhibitors. 3. Synthesis and further structure-activity relationship studies of PETT analogues.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL106,VAL179,TYR181,TYR188,PRO225,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU1138"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,1HNI,ASD11920022,AAA,A,Lig,Inhibitor,"(2S)-2-(2,6-dibromophenyl)-2-[(2-ethanoyl-5-methyl-phenyl)amino]ethanamide",559,Inner Protein Regulator,Inner Protein,7542140,Structure of HIV-1 reverse transcriptase in a complex with the non-nucleoside inhibitor alpha-APA R 95845 at 2.8 A resolution.,No,"Chain A:LEU100,LYS101,LYS103,VAL106,THR107,VAL179,TYR181,TYR188,VAL189,GLY190,TRP229,LEU234,HIS235,TYR318; Chain B:GLU138"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,1HNV,ASD02560018,TBO,A,Lig,Inhibitor,"(5S)-8-chloro-5-methyl-6-(3-methylbut-2-en-1-yl)-4,5,6,7-tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepine-2(1H)-thione",559,Inner Protein Regulator,Inner Protein,7545077,Structure of HIV-1 RT/TIBO R 86183 complex reveals similarity in the binding of diverse nonnucleoside inhibitors.,No,"Chain A:LEU100,LYS101,LYS103,VAL179,ILE180,TYR181,TYR188,PHE227,TRP229,HIS235,TYR318"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,1HPZ,ASD11920024,AAP,A,Lig,Inhibitor,"(2S)-2-(2,6-dichlorophenyl)-2-[(2-ethanoyl-5-methyl-phenyl)amino]ethanamide",561,Inner Protein Regulator,Inner Protein,11371163,The Lys103Asn mutation of HIV-1 RT: a novel mechanism of drug resistance.,No,"Chain A:LEU100,LYS101,VAL106,VAL179,TYR181,TYR188,VAL189,GLY190,TRP229,LEU234,TYR318; Chain B:GLU138"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,1HQU,ASD11920019,HBY,A,Lig,Inhibitor,"propan-2-yl (2S)-7-methoxy-2-(methylsulfanylmethyl)-3-sulfanylidene-2,4-dihydroquinoxaline-1-carboxylate",561,Inner Protein Regulator,Inner Protein,11371163,The Lys103Asn mutation of HIV-1 RT: a novel mechanism of drug resistance.,No,"Chain A:LEU100,LYS101,ASN103,VAL106,VAL179,ILE180,TYR181,TYR188,VAL189,GLY190,PHE227,TRP229,LEU234,HIS235,TYR318"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,1IKV,ASD02562083,EFZ,A,Lig,Inhibitor,"(4S)-6-chloranyl-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one",2000,Inner Protein Regulator,Inner Protein,11895437,"Structural basis for the inhibitory efficacy of efavirenz (DMP-266), MSC194 and PNU142721 towards the HIV-1 RT K103N mutant.",No,"Chain A:LEU100,LYS101,VAL106,VAL179,TYR181,TYR188,VAL189,GLY190,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,1IKW,ASD02562083,EFZ,A,Lig,Inhibitor,"(4S)-6-chloranyl-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one",2000,Inner Protein Regulator,Inner Protein,11895437,"Structural basis for the inhibitory efficacy of efavirenz (DMP-266), MSC194 and PNU142721 towards the HIV-1 RT K103N mutant.",No,"Chain A:LEU100,LYS101,LYS103,VAL106,VAL179,TYR181,TYR188,VAL189,GLY190,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,1IKX,ASD11920028,PNU,A,Lig,Inhibitor,"6-chloro-2-[(1S)-1-furo[3,2-d]pyridin-5-ylethyl]sulfanyl-pyrimidin-4-amine",2000,Inner Protein Regulator,Inner Protein,11895437,"Structural basis for the inhibitory efficacy of efavirenz (DMP-266), MSC194 and PNU142721 towards the HIV-1 RT K103N mutant.",No,"Chain A:PRO95,LEU100,LYS101,LYS102,ASN103,VAL106,VAL179,TYR181,TYR188,GLY190,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,1IKY,ASD11920029,MSD,A,Lig,Inhibitor,"1-(5-cyanopyridin-2-yl)-3-[(1R,2R)-2-(3-ethanoyl-2-hydroxy-6-methoxy-phenyl)cyclopropyl]thiourea",2000,Inner Protein Regulator,Inner Protein,11895437,"Structural basis for the inhibitory efficacy of efavirenz (DMP-266), MSC194 and PNU142721 towards the HIV-1 RT K103N mutant.",No,"Chain A:PRO95,LEU100,LYS101,ASN103,VAL106,VAL179,TYR181,TYR188,GLY190,PRO225,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU1138"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,1S6P,ASD11920030,IET,A,Lig,Inhibitor,"3-(4-cyanophenyl)-1-[2-(2,6-dichlorophenyl)ethanimidoyl]thiourea",701,Inner Protein Regulator,Inner Protein,15115397,Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants.,No,"Chain A:LEU100,LYS101,LYS103,VAL106,VAL179,TYR181,TYR188,GLY190,PHE227,LEU234,HIS235,PRO236,TYR318"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,1S6Q,ASD02560063,TPB,A,Lig,Inhibitor,"4-[[4-[(2,4,6-trimethylphenyl)amino]pyrimidin-2-yl]amino]benzonitrile",701,Inner Protein Regulator,Inner Protein,15115397,Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL106,VAL179,TYR181,TYR188,PHE227,LEU234,HIS235,TYR318"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,1S9E,ASD11920032,ADB,A,Lig,Inhibitor,"4-[[4-amino-6-(2,6-dichlorophenoxy)-1,3,5-triazin-2-yl]amino]benzonitrile",701,Inner Protein Regulator,Inner Protein,15115397,Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL106,VAL179,TYR181,TYR188,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU138"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,1S9G,ASD02560059,ABZ,A,Lig,Inhibitor,"4-[[4-amino-6-[(5-chloro-1H-indol-4-yl)methyl]-1,3,5-triazin-2-yl]amino]benzonitrile",701,Inner Protein Regulator,Inner Protein,15115397,Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants.,No,"Chain A:PRO95,GLY99,LEU100,LYS101,LYS103,VAL106,TYR181,TYR188,PHE227,TRP229,LEU234,TYR318; Chain B:GLU138"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,1SUQ,ASD11920034,185,A,Lig,Inhibitor,"4-[5-bromo-2-[(4-cyanophenyl)amino]-6-(hydroxymethyl)pyrimidin-4-yl]oxy-3,5-dimethyl-benzonitrile",600,Inner Protein Regulator,Inner Protein,15115397,Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants.,No,"Chain A:LEU100,LYS101,LYS103,VAL106,VAL179,TYR188,VAL189,GLY190,PHE227,LEU234,HIS235,PRO236,TYR318; Chain B:GLU138"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,1SV5,ASD02560064,65B,A,Lig,Inhibitor,"4-[6-azanyl-5-bromanyl-2-[(4-cyanophenyl)amino]pyrimidin-4-yl]oxy-3,5-dimethyl-benzenecarbonitrile",600,Inner Protein Regulator,Inner Protein,15115397,Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants.,No,"Chain A:LEU100,LYS101,LYS102,ASN103,VAL106,VAL179,TYR181,TYR188,PRO225,PHE227,TRP229,LEU234,HIS235,TYR318"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,1TV6,ASD02560169,CP9,A,Lig,Inhibitor,"3-[[4-(2-methylimidazo[4,5-c]pyridin-1-yl)phenyl]methyl]-1,3-benzothiazol-2-one",561,Inner Protein Regulator,Inner Protein,15249669,Structure of HIV-1 reverse transcriptase bound to an inhibitor active against mutant reverse transcriptases resistant to other nonnucleoside inhibitors.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL106,VAL108,TYR181,TYR183,ASP186,TYR188,PRO225,TRP229,LEU234,HIS235,PRO236,TYR318"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,1TVR,ASD11920037,TB9,A,Lig,Inhibitor,"(5S)-9-chloro-5-methyl-6-(3-methylbut-2-en-1-yl)-4,5,6,7-tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepine-2(1H)-thione",600,Inner Protein Regulator,Inner Protein,9000632,Crystal structures of 8-Cl and 9-Cl TIBO complexed with wild-type HIV-1 RT and 8-Cl TIBO complexed with the Tyr181Cys HIV-1 RT drug-resistant mutant.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL106,VAL179,ILE180,TYR181,TYR188,TRP229,LEU234,HIS235,TYR318"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,1UWB,ASD02560018,TBO,A,Lig,Inhibitor,"(5S)-8-chloro-5-methyl-6-(3-methylbut-2-en-1-yl)-4,5,6,7-tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepine-2(1H)-thione",559,Inner Protein Regulator,Inner Protein,9000632,Crystal structures of 8-Cl and 9-Cl TIBO complexed with wild-type HIV-1 RT and 8-Cl TIBO complexed with the Tyr181Cys HIV-1 RT drug-resistant mutant.,No,"Chain A:LEU100,LYS101,LYS103,VAL106,CYS181,TYR188,PHE227,TRP229,TYR318"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,2B5J,ASD11920039,3AC,A,Lig,Inhibitor,3-[3-[(3-ethyl-5-iodo-2-methyl-6-oxo-1H-pyridin-4-yl)oxy]phenyl]prop-2-enenitrile,562,Inner Protein Regulator,Inner Protein,16302798,Crystal structures for HIV-1 reverse transcriptase in complexes with three pyridinone derivatives: a new class of non-nucleoside inhibitors effective against a broad range of drug-resistant strains.,No,"Chain A:LEU100,LYS101,LYS103,VAL106,VAL108,TYR188,VAL189,GLY190,PHE227,TRP229,LEU234,HIS235,TYR318"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,2B6A,ASD11920040,T50,A,Lig,Inhibitor,"2-(2,6-difluorophenyl)-1-[(2,6-difluorophenyl)methyl]-4-methyl-benzimidazole",561,Inner Protein Regulator,Inner Protein,,Crystal structure of HIV-1 reverse transcriptase (RT) in complex with THR-50,No,"Chain A:LEU100,LYS101,LYS103,VAL106,VAL179,ILE180,TYR181,TYR188,VAL189,GLY190,TRP229,LEU234,HIS235,TYR318; Chain B:GLU138"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,2BAN,ASD11920041,357,A,Lig,Inhibitor,5-ethyl-3-(2-methoxyethyl-methyl-amino)-6-methyl-4-[(3-methylphenyl)methyl]-1H-pyridin-2-one,562,Inner Protein Regulator,Inner Protein,16302798,Crystal structures for HIV-1 reverse transcriptase in complexes with three pyridinone derivatives: a new class of non-nucleoside inhibitors effective against a broad range of drug-resistant strains.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL179,TYR181,TYR188,VAL189,GLY190,TRP229,LEU234,TYR318; Chain B:GLU138"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,2BE2,ASD02560073,R22,A,Lig,Inhibitor,"4-(3,5-dimethylphenoxy)-5-(furan-2-ylmethylsulfanylmethyl)-3-iodo-6-methyl-1H-pyridin-2-one",4002,Inner Protein Regulator,Inner Protein,16302798,Crystal structures for HIV-1 reverse transcriptase in complexes with three pyridinone derivatives: a new class of non-nucleoside inhibitors effective against a broad range of drug-resistant strains.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL106,VAL179,TYR181,TYR188,GLY190,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,2IC3,ASD11920019,HBY,A,Lig,Inhibitor,"propan-2-yl (2S)-7-methoxy-2-(methylsulfanylmethyl)-3-sulfanylidene-2,4-dihydroquinoxaline-1-carboxylate",562,Inner Protein Regulator,Inner Protein,17056061,Crystal structures of clinically relevant Lys103Asn/Tyr181Cys double mutant HIV-1 reverse transcriptase in complexes with ATP and non-nucleoside inhibitor HBY 097.,No,"Chain A:LEU100,LYS101,VAL106,VAL179,CYS181,TYR188,VAL189,GLY190,PHE227,TRP229,LEU234,HIS235,TYR318"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,2VG5,ASD11920044,NNC,A,Lig,Inhibitor,"O-[2-(1,3-dioxoisoindol-2-yl)ethyl] [(4-chlorophenyl)amino]methanethioate",1551,Inner Protein Regulator,Inner Protein,18035053,Crystal structures of HIV-1 reverse transcriptase complexes with thiocarbamate non-nucleoside inhibitors.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL106,VAL179,TYR181,TYR188,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU1138"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,2VG6,ASD11920045,NNB,A,Lig,Inhibitor,"O-[2-(1,3-dioxoisoindol-2-yl)ethyl] [(4-bromophenyl)amino]methanethioate",1551,Inner Protein Regulator,Inner Protein,18035053,Crystal structures of HIV-1 reverse transcriptase complexes with thiocarbamate non-nucleoside inhibitors.,No,"Chain A:LEU100,LYS101,LYS103,VAL106,VAL179,TYR181,TYR188,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU1138"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,2VG7,ASD11920046,NNI,A,Lig,Inhibitor,"O-[2-(1,3-dioxoisoindol-2-yl)ethyl] [(4-iodophenyl)amino]methanethioate",1551,Inner Protein Regulator,Inner Protein,18035053,Crystal structures of HIV-1 reverse transcriptase complexes with thiocarbamate non-nucleoside inhibitors.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL106,VAL179,TYR181,TYR188,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU1138"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,2YKM,ASD11920047,YKN,A,Lig,Inhibitor,"2-[bis(fluoranyl)-(4-methylpyrimidin-2-yl)sulfanyl-methyl]-1,3-benzoxazole",1559,Inner Protein Regulator,Inner Protein,22017513,Difluoromethylbenzoxazole Pyrimidine Thioether Derivatives: A Novel Class of Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL106,VAL179,TYR181,TYR188,VAL189,GLY190,TRP229,LEU234,HIS235,PRO236,TYR318"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,2YKN,ASD11920047,YKN,A,Lig,Inhibitor,"2-[bis(fluoranyl)-(4-methylpyrimidin-2-yl)sulfanyl-methyl]-1,3-benzoxazole",1559,Inner Protein Regulator,Inner Protein,22017513,Difluoromethylbenzoxazole Pyrimidine Thioether Derivatives: A Novel Class of Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL106,VAL179,TYR181,TYR188,VAL189,GLY190,TRP229,LEU234,HIS235,TYR318"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,2ZD1,ASD02560066,T27,A,Lig,Inhibitor,"4-[[4-[[4-[(E)-2-cyanoethenyl]-2,6-dimethyl-phenyl]amino]pyrimidin-2-yl]amino]benzenecarbonitrile",557,Inner Protein Regulator,Inner Protein,18230722,High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: strategic flexibility explains potency against resistance mutations.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL106,VAL179,TYR181,TYR188,PRO225,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU138"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,2ZE2,ASD02560066,T27,A,Lig,Inhibitor,"4-[[4-[[4-[(E)-2-cyanoethenyl]-2,6-dimethyl-phenyl]amino]pyrimidin-2-yl]amino]benzenecarbonitrile",556,Inner Protein Regulator,Inner Protein,18230722,High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: strategic flexibility explains potency against resistance mutations.,No,"Chain A:PRO95,ILE100,LYS101,ASN103,VAL179,TYR181,TYR188,PRO225,PHE227,LEU228,TRP229,LEU234,HIS235,PRO236,TYR318"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,3BGR,ASD02560066,T27,A,Lig,Inhibitor,"4-[[4-[[4-[(E)-2-cyanoethenyl]-2,6-dimethyl-phenyl]amino]pyrimidin-2-yl]amino]benzenecarbonitrile",556,Inner Protein Regulator,Inner Protein,18230722,High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: strategic flexibility explains potency against resistance mutations.,No,"Chain A:LEU100,LYS101,ASN103,VAL179,CYS181,TYR183,TYR188,GLY190,PHE227,LEU228,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU138"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,3HVT,ASD02560019,NVP,A,Lig,Inhibitor,"11-cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one",557,Inner Protein Regulator,Inner Protein,7513427,Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1.,No,"Chain A:LEU100,LYS101,LYS103,VAL106,TYR181,TYR188,GLY190,PHE227,TRP229,LEU234,PRO236,TYR319"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,3IRX,ASD11920053,UDR,A,Lig,Inhibitor,"S-methyl 5-[(E)-1-(3,7-dimethyl-2-oxo-1,3-benzoxazol-5-yl)-5-(5-methyl-1,3,4-oxadiazol-2-yl)pent-1-enyl]-2-methoxy-3-methyl-benzenecarbothioate",556,Inner Protein Regulator,Inner Protein,19775161,Crystallographic study of a novel subnanomolar inhibitor provides insight on the binding interactions of alkenyldiarylmethanes with human immunodeficiency virus-1 reverse transcriptase.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL106,VAL108,TYR181,TYR188,VAL189,GLY190,PHE227,LEU228,TRP229,LEU234,HIS235,TYR318"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,3IS9,ASD11920054,AC7,A,Lig,Inhibitor,"dimethyl 5,5'-(6-methoxy-6-oxohex-1-ene-1,1-diyl)bis(3-cyano-2-methoxybenzoate)",556,Inner Protein Regulator,Inner Protein,19775161,Crystallographic study of a novel subnanomolar inhibitor provides insight on the binding interactions of alkenyldiarylmethanes with human immunodeficiency virus-1 reverse transcriptase.,No,"Chain A:PRO95,LEU100,LYS101,VAL106,VAL108,VAL179,TYR181,TYR188,VAL189,GLY190,LYS223,PHE227,LEU228,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU138"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P12499,3KF0,ASD11920008,4DX,A,Lig,Inhibitor,"(1S,2S)-2-methylcyclohexan-1-ol",201,Inner Protein Regulator,Inner Protein,Not in PubMed,Fragment-Based Screen against HIV Protease,No,"Chain A:LYS14,ILE15,GLY16,GLY17,LEU63,ILE64,GLU65"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P12499,3KFN,ASD11920008,4DX,A,Lig,Inhibitor,"(1S,2S)-2-methylcyclohexan-1-ol",201,Inner Protein Regulator,Inner Protein,Not in PubMed,Fragment-Based Screen against HIV Protease,No,"Chain A:LYS14,ILE15,GLY16,GLY17,LEU63,ILE64,GLU65"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P12499,3KFR,ASD11920004,1F1,B,Lig,Inhibitor,1H-indole-6-carboxylic acid,201,Inner Protein Regulator,Inner Protein,Not in PubMed,Fragment-Based Screen against HIV Protease,No,"Chain B:TRP42,PRO44,LYS45,MET46,LYS55,VAL56,ARG57"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P12499,3KFS,ASD11920006,2FX,B,Lig,Inhibitor,2-(1-benzothiophen-2-yl)ethanoic acid,201,Inner Protein Regulator,Inner Protein,Not in PubMed,Fragment-Based Screen against HIV Protease,No,"Chain B:TRP42,PRO44,LYS45,LYS55,VAL56,ARG57"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,3QLH,ASD02560066,T27,A,Lig,Inhibitor,"4-[[4-[[4-[(E)-2-cyanoethenyl]-2,6-dimethyl-phenyl]amino]pyrimidin-2-yl]amino]benzenecarbonitrile",555,Inner Protein Regulator,Inner Protein,21568335,"Synthesis, activity, and structural analysis of novel alpha-hydroxytropolone inhibitors of human immunodeficiency virus reverse transcriptase-associated ribonuclease H.",No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL179,TYR181,TYR188,PRO225,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,3QO9,ASD11920056,QO9,A,Lig,Inhibitor,"1-[(5R,6R,8R,9R)-4-azanyl-9-[tert-butyl(dimethyl)silyl]oxy-6-[[tert-butyl(dimethyl)silyl]oxymethyl]-2,2-dioxo-1,7-dioxa-2$l^{6}-thiaspiro[4.4]non-3-en-8-yl]-5-methyl-pyrimidine-2,4-dione",556,Inner Protein Regulator,Inner Protein,21446702,Crystal Structure of tert-Butyldimethylsilyl-spiroaminooxathioledioxide-thymine (TSAO-T) in Complex with HIV-1 Reverse Transcriptase (RT) Redefines the Elastic Limits of the Non-nucleoside Inhibitor-Binding Pocket.,No,"Chain A:PRO95,LEU100,LYS101,LYS102,LYS103,VAL106,VAL179,TYR181,TYR183,TYR188,GLY190,LYS220,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU138"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,3V81,ASD02560019,NVP,A,Lig,Inhibitor,"11-cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one",901,Inner Protein Regulator,Inner Protein,22266819,HIV-1 reverse transcriptase complex with DNA and nevirapine reveals non-nucleoside inhibition mechanism.,No,"Chain A:LEU100,LYS101,LYS103,VAL179,TYR181,TYR188,GLY190,TRP229,LEU234,TYR318"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P12499,4EJ8,ASD11920004,1F1,A,Lig,Inhibitor,1H-indole-6-carboxylic acid,106,Inner Protein Regulator,Inner Protein,23540839,Small molecule regulation of protein conformation by binding in the Flap of HIV protease.,No,"Chain A:TRP42,PRO44,LYS45,LYS55,VAL56,ARG57"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P12499,4EJD,ASD11920004,1F1,A,Lig,Inhibitor,1H-indole-6-carboxylic acid,102,Inner Protein Regulator,Inner Protein,23540839,Small molecule regulation of protein conformation by binding in the Flap of HIV protease.,No,"Chain A:TRP42,PRO44,LYS45,MET46,LYS55,VAL56,ARG57"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P12499,4EJK,ASD11920002,IOP,A,Lig,Inhibitor,3-(1H-indol-3-yl)propanoic acid,101,Inner Protein Regulator,Inner Protein,23540839,Small molecule regulation of protein conformation by binding in the Flap of HIV protease.,No,"Chain A:TRP42,PRO44,LYS45,MET46,LYS55,VAL56,ARG57"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P12499,4EJL,ASD11920002,IOP,A,Lig,Inhibitor,3-(1H-indol-3-yl)propanoic acid,106,Inner Protein Regulator,Inner Protein,23540839,Small molecule regulation of protein conformation by binding in the Flap of HIV protease.,No,"Chain A:TRP42,PRO44,LYS45,LYS55,VAL56,ARG57"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4G1Q,ASD02560066,T27,A,Lig,Inhibitor,"4-[[4-[[4-[(E)-2-cyanoethenyl]-2,6-dimethyl-phenyl]amino]pyrimidin-2-yl]amino]benzenecarbonitrile",601,Inner Protein Regulator,Inner Protein,23422558,Snapshot of the equilibrium dynamics of a drug bound to HIV-1 reverse transcriptase.,No,"Chain A:PRO95,LEU100,LYS101,LYS102,LYS103,VAL106,VAL179,TYR181,TYR188,GLY190,PRO225,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU138"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4H4M,ASD02560102,494,A,Lig,Inhibitor,"(E)-3-[3-[2-[2-[2,4-bis(oxidanylidene)pyrimidin-1-yl]ethoxy]-4-chloranyl-phenoxy]-5-chloranyl-phenyl]prop-2-enenitrile",601,Inner Protein Regulator,Inner Protein,23163887,Crystal Structures of HIV-1 Reverse Transcriptase with Picomolar Inhibitors Reveal Key Interactions for Drug Design.,No,"Chain A:PRO95,LEU100,LYS101,LYS102,LYS103,VAL106,VAL108,VAL179,TYR181,TYR188,LYS223,PHE227,TRP229,LEU234,PRO236,TYR318"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4H4O,ASD02560175,506,A,Lig,Inhibitor,"(E)-3-[3-[2-[2-[2,4-bis(oxidanylidene)pyrimidin-1-yl]ethoxy]-4-fluoranyl-phenoxy]-5-fluoranyl-phenyl]prop-2-enenitrile",601,Inner Protein Regulator,Inner Protein,23163887,Crystal Structures of HIV-1 Reverse Transcriptase with Picomolar Inhibitors Reveal Key Interactions for Drug Design.,No,"Chain A:PRO95,LEU100,LYS101,LYS102,LYS103,VAL106,VAL108,VAL179,TYR181,TYR188,GLY190,TRP229,LEU234,HIS235,PRO236,TYR318"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4I2P,ASD11920061,G73,A,Lig,Inhibitor,"(E)-3-[4-[[6-[(4-methoxyphenyl)amino]-7H-purin-2-yl]amino]-3,5-dimethyl-phenyl]prop-2-enenitrile",601,Inner Protein Regulator,Inner Protein,23217210,A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL179,TYR181,TYR188,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU138"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4I2Q,ASD02562101,1BT,A,Lig,Inhibitor,"(E)-3-[4-[[6-(1,3-benzothiazol-5-ylamino)-9H-purin-2-yl]amino]-3,5-dimethyl-phenyl]prop-2-enenitrile",601,Inner Protein Regulator,Inner Protein,23217210,A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants.,No,"Chain A:PRO95,LEU100,LYS101,ASN103,VAL106,VAL179,CYS181,TYR183,TYR188,PHE227,LEU228,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU138"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4ICL,ASD02560066,T27,A,Lig,Inhibitor,"4-[[4-[[4-[(E)-2-cyanoethenyl]-2,6-dimethyl-phenyl]amino]pyrimidin-2-yl]amino]benzenecarbonitrile",601,Inner Protein Regulator,Inner Protein,23342998,Detecting Allosteric Sites of HIV-1 Reverse Transcriptase by X-ray Crystallographic Fragment Screening.,No,"Chain A:PRO95,LEU100,LYS101,LYS102,LYS103,VAL106,VAL179,TYR181,TYR188,GLY190,PRO225,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU138"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4ID5,ASD02560066,T27,A,Lig,Inhibitor,"4-[[4-[[4-[(E)-2-cyanoethenyl]-2,6-dimethyl-phenyl]amino]pyrimidin-2-yl]amino]benzenecarbonitrile",601,Inner Protein Regulator,Inner Protein,23342998,Detecting Allosteric Sites of HIV-1 Reverse Transcriptase by X-ray Crystallographic Fragment Screening.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL106,VAL179,TYR181,TYR188,PRO225,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU138"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4IDK,ASD02560066,T27,A,Lig,Inhibitor,"4-[[4-[[4-[(E)-2-cyanoethenyl]-2,6-dimethyl-phenyl]amino]pyrimidin-2-yl]amino]benzenecarbonitrile",601,Inner Protein Regulator,Inner Protein,23342998,Detecting Allosteric Sites of HIV-1 Reverse Transcriptase by X-ray Crystallographic Fragment Screening.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL106,VAL179,TYR181,TYR188,PRO225,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU138"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4IFY,ASD02560066,T27,A,Lig,Inhibitor,"4-[[4-[[4-[(E)-2-cyanoethenyl]-2,6-dimethyl-phenyl]amino]pyrimidin-2-yl]amino]benzenecarbonitrile",601,Inner Protein Regulator,Inner Protein,23342998,Detecting Allosteric Sites of HIV-1 Reverse Transcriptase by X-ray Crystallographic Fragment Screening.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL106,VAL179,TYR181,TYR188,PRO225,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU138"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4IG3,ASD02560066,T27,A,Lig,Inhibitor,"4-[[4-[[4-[(E)-2-cyanoethenyl]-2,6-dimethyl-phenyl]amino]pyrimidin-2-yl]amino]benzenecarbonitrile",601,Inner Protein Regulator,Inner Protein,23342998,Detecting Allosteric Sites of HIV-1 Reverse Transcriptase by X-ray Crystallographic Fragment Screening.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL106,VAL179,TYR181,TYR188,PRO225,PHE227,LEU228,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU138"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4IG3,ASD11920073,J94,A,Lig,Inhibitor,"(6R)-6-[(5S)-6,6-dimethyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-6-ium-5-yl]-6H-furo[3,4-g][1,3]benzodioxol-8-one",609,Inner Protein Regulator,Protein-Protein Interaction,23342998,Detecting Allosteric Sites of HIV-1 Reverse Transcriptase by X-ray Crystallographic Fragment Screening.,No,"Chain A:ILE5,GLU6,VAL8,SER162,SER163,LYS166; Chain B:LYS49,ILE50,GLY51,PRO52"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P12499,4K4Q,ASD01470057,06B,B,Lig,Inhibitor,"3-bromanyl-2,6-dimethoxy-benzoic acid",102,Inner Protein Regulator,Inner Protein,23998903,Crystallographic Fragment-Based Drug Discovery: Use of a Brominated Fragment Library Targeting HIV Protease.,No,"Chain B:PRO44,LYS45,LYS55,VAL56,ARG57"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P12499,4K4R,ASD01470058,27B,A,Lig,Inhibitor,1-bromanylnaphthalene-2-carboxylic acid,102,Inner Protein Regulator,Inner Protein,23998903,Crystallographic Fragment-Based Drug Discovery: Use of a Brominated Fragment Library Targeting HIV Protease.,No,"Chain A:LYS14,LEU63,ILE64,GLU65,LYS70,ALA71"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4KFB,ASD02560066,T27,A,Lig,Inhibitor,"4-[[4-[[4-[(E)-2-cyanoethenyl]-2,6-dimethyl-phenyl]amino]pyrimidin-2-yl]amino]benzenecarbonitrile",607,Inner Protein Regulator,Inner Protein,23342998,Detecting Allosteric Sites of HIV-1 Reverse Transcriptase by X-Ray Crystallographic Fragment Screening.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL106,VAL179,TYR181,TYR188,PRO225,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU138"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4KFB,ASD11920014,1QP,A,Lig,Inhibitor,"ethyl pyrazolo[1,5-a]pyridine-3-carboxylate",601,Inner Protein Regulator,Inner Protein,23342998,Detecting Allosteric Sites of HIV-1 Reverse Transcriptase by X-Ray Crystallographic Fragment Screening.,No,"Chain A:GLN91,GLN161,MET164,THR165,LEU168,GLU169,ALA172,ILE180,TYR181,GLN182; Chain B:GLU138,THR139,PRO140"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4KKO,ASD11920063,1RE,A,Lig,Inhibitor,"4-[[4-methoxy-6-(2-morpholin-4-ylethoxy)-1,3,5-triazin-2-yl]amino]-2-(3-methylbutoxy)benzenecarbonitrile",601,Inner Protein Regulator,Inner Protein,23899617,Extension into the entrance channel of HIV-1 reverse transcriptase-Crystallography and enhanced solubility.,No,"Chain A:LEU100,LYS101,LYS102,LYS103,VAL106,VAL179,ILE180,TYR181,TYR188,PHE227,LEU234,HIS235,PRO236,TYR318; Chain B:GLU28,ILE135,GLU138"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4KO0,ASD11920064,JLJ,A,Lig,Inhibitor,4-[(4-methoxypyrimidin-2-yl)amino]-2-(3-methylbut-2-enoxy)benzenecarbonitrile,601,Inner Protein Regulator,Inner Protein,23899617,Extension into the entrance channel of HIV-1 reverse transcriptase-Crystallography and enhanced solubility.,No,"Chain A:LEU100,LYS101,LYS103,VAL106,VAL179,TYR181,TYR188,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU138"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4LSL,ASD11920065,1YQ,A,Lig,Inhibitor,"(E)-3-[3-[2-[2-[2,4-bis(oxidanylidene)pyrimidin-1-yl]ethoxy]-4-chloranyl-phenoxy]phenyl]prop-2-enenitrile",601,Inner Protein Regulator,Inner Protein,24289305,Structure-Based Evaluation of C5 Derivatives in the Catechol Diether Series Targeting HIV-1 Reverse Transcriptase.,No,"Chain A:LEU100,LYS101,LYS102,LYS103,VAL106,VAL108,VAL179,TYR181,TYR188,LYS223,PHE227,TRP229,LEU234,PRO236,TYR318"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4LSN,ASD11920066,1YR,A,Lig,Inhibitor,"(E)-3-[3-[2-[2-[2,4-bis(oxidanylidene)pyrimidin-1-yl]ethoxy]-4-chloranyl-phenoxy]-5-bromanyl-phenyl]prop-2-enenitrile",601,Inner Protein Regulator,Inner Protein,24289305,Structure-Based Evaluation of C5 Derivatives in the Catechol Diether Series Targeting HIV-1 Reverse Transcriptase.,No,"Chain A:PRO95,LEU100,LYS101,LYS103,VAL106,VAL108,VAL179,TYR181,TYR188,PRO225,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4MFB,ASD11920067,29T,A,Lig,Inhibitor,"8-[2-[2-[2,4-bis(oxidanylidene)pyrimidin-1-yl]ethoxy]phenoxy]indolizine-2-carbonitrile",601,Inner Protein Regulator,Inner Protein,24151856,Picomolar Inhibitors of HIV Reverse Transcriptase Featuring Bicyclic Replacement of a Cyanovinylphenyl Group.,No,"Chain A:LEU100,LYS101,LYS102,LYS103,VAL106,VAL108,VAL179,TYR181,TYR188,VAL189,GLY190,PHE227,TRP229,HIS235,PRO236,TYR318"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P0C6F2,4NYF,ASD11920001,4BI,A,Lig,Inhibitor,(2S)-tert-butoxy[4-(4-chlorophenyl)-2-methylquinolin- 3-yl]ethanoic acid,301,Inner Protein Regulator,Inner Protein,24900852,"Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1.",No,"Chain B:GLU96,ALA129,GLY94,ALA124,GLN95,TYR99,THR125,ALA133,ALA128,LEU102,ALA98,TRP132"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4O44,ASD11920068,2RS,A,Lig,Inhibitor,"4-[[4-(3-morpholin-4-ylpropoxy)-6-[(2,4,6-trimethylphenyl)amino]-1,3,5-triazin-2-yl]amino]benzenecarbonitrile",601,Inner Protein Regulator,Inner Protein,24726448,A mechanistic and structural investigation of modified derivatives of the diaryltriazine class of NNRTIs targeting HIV-1 reverse transcriptase.,No,"Chain A:LEU100,LYS101,LYS103,VAL106,THR107,VAL108,VAL179,TYR181,TYR188,PRO225,PHE227,TRP229,LEU234,HIS235,PRO236,TYR318; Chain B:GLU138"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4OJR,ASD05060022,2SQ,A,Lig,Inhibitor,"(2S)-2-[4-(8-fluoranyl-5-methyl-3,4-dihydro-2H-chromen-6-yl)-2-methyl-1-oxidanylidene-isoquinolin-3-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid",301,Protein-Protein Interaction Regulator,Protein-Protein Interaction,24904063,Allosteric Inhibition of Human Immunodeficiency Virus Integrase: LATE BLOCK DURING VIRAL REPLICATION AND ABNORMAL MULTIMERIZATION INVOLVING SPECIFIC PROTEIN DOMAINS.,No,"Chain A:GLN168,ALA169,GLU170,HIS171,THR174,MET178"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4PUO,ASD02560019,NVP,A,Lig,Inhibitor,"11-cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one",901,Inner Protein Regulator,Inner Protein,24880687,Structures of HIV-1 RT-RNA/DNA ternary complexes with dATP and nevirapine reveal conformational flexibility of RNA/DNA: insights into requirements for RNase H cleavage.,No,"Chain A:PRO95,LEU100,LYS101,VAL106,VAL179,TYR181,TYR188,PHE227,TRP229,LEU234,PRO236,TYR318"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4PWD,ASD02560019,NVP,A,Lig,Inhibitor,"11-cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one",901,Inner Protein Regulator,Inner Protein,24880687,Structures of HIV-1 RT-RNA/DNA ternary complexes with dATP and nevirapine reveal conformational flexibility of RNA/DNA: insights into requirements for RNase H cleavage.,No,"Chain A:PRO95,LEU100,LYS101,VAL106,VAL179,TYR181,TYR188,GLY190,PHE227,TRP229,LEU234,PRO236,TYR318"
ASD11920000_1,gag-pol,Human immunodeficiency virus type 1 group M subtype B,P03366,4Q0B,ASD02560019,NVP,A,Lig,Inhibitor,"11-cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one",901,Inner Protein Regulator,Inner Protein,24880687,Structures of HIV-1 RT-RNA/DNA ternary complexes with dATP and nevirapine reveal conformational flexibility of RNA/DNA: insights into requirements for RNase H cleavage.,No,"Chain A:LEU100,LYS101,LYS103,VAL106,VAL179,ILE180,TYR181,TYR188,GLY190,PHE227,TRP229,LEU234,PRO236"
ASD11920000_1,,Human immunodeficiency virus type 1 group M subtype B,Q90EA1,4TVG,ASD11920074,K97,A,Lig,Inhibitor,3-(morpholin-4-ylmethyl)-1H-indole-6-carboxylic acid,101,Inner Protein Regulator,Inner Protein,25189630,Distinguishing Binders from False Positives by Free Energy Calculations: Fragment Screening Against the Flap Site of HIV Protease.,No,"Chain A:ILE54,LYS45,ARG57,TRP42,MET46,LYS43,LYS55,VAL56,PRO44"
ASD11930000_1,lpg0095,Legionella pneumophila subsp. pneumophila,Q5ZZB6,4OHF,ASD00860008,5GP,A,Lig,Activator,"5'-guanylic acid [(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl dihydrogen phosphate",501,Inner Protein Regulator,Protein-Protein Interaction,24456211,Allosteric regulation and substrate activation in cytosolic nucleotidase II from Legionella pneumophila.,No,"Chain B:TYR421,ASP308,TYR418,LEU116,TYR87,LEU310,ARG425,ARG86"
ASD11940000_1,,Homo sapiens,Q96PN6,4CLL,ASD01400003,BCT,A,Lig,Activator,BICARBONATE ION,1470,Inner Protein Regulator,Inner Protein,24567411,Crystal Structures of Human Soluble Adenylyl Cyclase Reveal Mechanisms of Catalysis and of its Activation Through Bicarbonate.,No,4CLL
ASD11940000_1,,Homo sapiens,Q96PN6,4CLP,ASD01100001,ACT,A,Lig,Activator,ACETATE ION,1470,Inner Protein Regulator,Inner Protein,24567411,Crystal Structures of Human Soluble Adenylyl Cyclase Reveal Mechanisms of Catalysis and of its Activation Through Bicarbonate.,No,4CLP
ASD11940000_1,,Homo sapiens,Q96PN6,4CLW,ASD11940014,SO3,A,Lig,Activator,SULFITE ION,1468,Inner Protein Regulator,Inner Protein,24567411,Crystal Structures of Human Soluble Adenylyl Cyclase Reveal Mechanisms of Catalysis and of its Activation Through Bicarbonate.,No,4CLW
ASD11940000_1,,Homo sapiens,Q96PN6,4CLY,ASD11940015,BSY,A,Lig,Activator,BISELENITE ION,1469,Inner Protein Regulator,Inner Protein,24567411,Crystal Structures of Human Soluble Adenylyl Cyclase Reveal Mechanisms of Catalysis and of its Activation Through Bicarbonate.,No,4CLY
ASD11940000_1,,Homo sapiens,Q96PN6,4CLZ,ASD01100001,ACT,A,Lig,Activator,ACETATE ION,1469,Inner Protein Regulator,Inner Protein,24567411,Crystal Structures of Human Soluble Adenylyl Cyclase Reveal Mechanisms of Catalysis and of its Activation Through Bicarbonate.,No,4CLZ
ASD11940000_1,,Homo sapiens,Q96PN6,4CM2,ASD11940014,SO3,A,Lig,Activator,SULFITE ION,1470,Inner Protein Regulator,Inner Protein,24567411,Crystal Structures of Human Soluble Adenylyl Cyclase Reveal Mechanisms of Catalysis and of its Activation Through Bicarbonate.,No,4CM2
ASD11940000_1,,Homo sapiens,Q96PN6,4OYA,ASD11940004,1VE,A,Lig,Inhibitor,"(4-azanyl-1,2,5-oxadiazol-3-yl)-[3-(1H-benzimidazol- 2-ylmethoxy)phenyl]methanone",501,Inner Protein Regulator,Inner Protein,24616449,"Crystal structure of human soluble adenylate cyclase reveals a distinct, highly flexible allosteric bicarbonate binding pocket.",No,4OYA
ASD11940000_1,,Homo sapiens,Q96PN6,4OYB,ASD11940005,1VJ,A,Lig,Inhibitor,"ethyl 2-[3-[(4-azanyl-1,2,5-oxadiazol-3-yl)carbonyl]phenoxy]ethanoate",502,Inner Protein Regulator,Inner Protein,24616449,"Crystal structure of human soluble adenylate cyclase reveals a distinct, highly flexible allosteric bicarbonate binding pocket.",No,4OYB
ASD11940000_1,,Homo sapiens,Q96PN6,4OYI,ASD11940006,1VK,A,Lig,Inhibitor,"(4-azanyl-1,2,5-oxadiazol-3-yl)-phenyl-methanone",501,Inner Protein Regulator,Inner Protein,24616449,"Crystal structure of human soluble adenylate cyclase reveals a distinct, highly flexible allosteric bicarbonate binding pocket.",No,4OYI
ASD11940000_1,,Homo sapiens,Q96PN6,4OYM,ASD11940007,1ZC,A,Lig,Inhibitor,"(4-azanyl-1,2,5-oxadiazol-3-yl)-(3-methoxyphenyl)methanone",501,Inner Protein Regulator,Inner Protein,24616449,"Crystal structure of human soluble adenylate cyclase reveals a distinct, highly flexible allosteric bicarbonate binding pocket.",No,4OYM
ASD11940000_1,,Homo sapiens,Q96PN6,4OYO,ASD11940024,1WC,A,Lig,Inhibitor,4-(2-chlorophenyl)-5-methyl-1H-pyrazole,502,Inner Protein Regulator,Inner Protein,24616449,"Crystal structure of human soluble adenylate cyclase reveals a distinct, highly flexible allosteric bicarbonate binding pocket.",No,4OYO
ASD11940000_1,,Homo sapiens,Q96PN6,4OYP,ASD11940009,BZ2,A,Lig,Inhibitor,1-benzofuran-2-carboxylic acid,502,Inner Protein Regulator,Inner Protein,24616449,"Crystal structure of human soluble adenylate cyclase reveals a distinct, highly flexible allosteric bicarbonate binding pocket.",No,4OYP
ASD11940000_1,,Homo sapiens,Q96PN6,4OYZ,ASD01400003,BCT,A,Lig,Activator,BICARBONATE ION,502,Inner Protein Regulator,Inner Protein,24616449,"Crystal structure of human soluble adenylate cyclase reveals a distinct, highly flexible allosteric bicarbonate binding pocket.",No,4OYZ
ASD11940000_1,,Homo sapiens,Q96PN6,4OZ2,ASD11940026,1Z6,A,Lig,Inhibitor,4-(4-fluorophenyl)-3-methyl-1H-pyrazole,501,Inner Protein Regulator,Inner Protein,24616449,"Crystal structure of human soluble adenylate cyclase reveals a distinct, highly flexible allosteric bicarbonate binding pocket.",No,4OZ2
ASD11940000_1,,Homo sapiens,Q96PN6,4OZ3,ASD11940011,1Z8,A,Lig,Inhibitor,4-phenyl-3-(trifluoromethyl)-1H-pyrazole,501,Inner Protein Regulator,Inner Protein,24616449,"Crystal structure of human soluble adenylate cyclase reveals a distinct, highly flexible allosteric bicarbonate binding pocket.",No,4OZ3
ASD11940000_1,,Homo sapiens,Q96PN6,4USW,ASD01100001,ACT,A,Lig,Activator,ACETATE ION,1470,Inner Protein Regulator,Inner Protein,25040695,Structural Analysis of Human Soluble Adenylyl Cyclase and Crystal Structures of its Nucleotide Complexes -Implications for Cyclase Catalysis and Evolution.,No,4USW
ASD11940000_1,ADCY10,Homo sapiens,Q96PN6,5D0R,ASD01240023,B1T,A,Lig,Inhibitor,"2,2'-sulfanediylbis(4,6-dichlorophenol)",501,Allosteric Function,Allosteric Position,26961873,Bithionol Potently Inhibits Human Soluble Adenylyl Cyclase through Binding to the Allosteric Activator Site.,No,5D0R
ASD11940000_1,ADCY10,Homo sapiens,Q96PN6,5IV3,ASD11940012,LRI,A,Lig,Inhibitor,"6-chloro-N~4~-cyclopropyl-N~4~-[(thiophen- 2-yl)methyl]pyrimidine-2,4-diamine",506,Allosteric Function,Allosteric Position,27547922,Discovery of LRE1 as a specific and allosteric inhibitor of soluble adenylyl cyclase.,No,5IV3
ASD11940000_1,ADCY10,Homo sapiens,Q96PN6,5IV4,ASD11940012,LRI,A,Lig,Inhibitor,"6-chloro-N~4~-cyclopropyl-N~4~-[(thiophen- 2-yl)methyl]pyrimidine-2,4-diamine",501,Allosteric Function,Allosteric Position,27547922,Discovery of LRE1 as a specific and allosteric inhibitor of soluble adenylyl cyclase.,No,5IV4
ASD11950000_1,CM1,Arabidopsis thaliana,P42738,4PPU,ASD00690002,TYR,A,Lig,Activator,TYROSINE,401,Inner Protein Regulator,Inner Protein,25160622,Structural evolution of differential amino Acid effector regulation in plant chorismate mutases.,No,"Chain A:LEU172,ASP81,VAL148,SER153,ASP155,HIS145,GLU156,ARG150,TYR174,LEU169,PHE151,ARG79,GLY149"
ASD11950000_1,CM1,Arabidopsis thaliana,P42738,4PPV,ASD02170001,PHE,A,Lig,Inhibitor,PHENYLALANINE,401,Inner Protein Regulator,Inner Protein,25160622,Structural evolution of differential amino Acid effector regulation in plant chorismate mutases.,No,"Chain A:LEU172,VAL148,SER153,HIS145,GLU156,ARG150,TYR174,LEU169,PHE151,ARG79,GLY149"
ASD11960000_1,uppS,Streptococcus pneumoniae,Q8DRB3,4Q9M,ASD08550002,2ZW,A,Lig,Inhibitor,"3-(2-chlorophenyl)-5-methyl-N-(4-propan-2-ylphenyl)-1,2-oxazole-4-carboxamide",301,Inner Protein Regulator,Inner Protein,25287857,Discovery and structural characterization of an allosteric inhibitor of bacterial cis-prenyltransferase.,Yes,"Chain A:VAL99,LEU102,GLN53,THR122,LEU141,TYR95,LEU52,PHE72,ILE87,ILE109,ASP96,GLY48,ALA125,ASN89,VAL92,ALA129,LEU90,MET88,LEU118,GLU50,PHE143,PRO91,ALA71,PHE94,LEU145,TYR98,MET49,LEU126"
ASD11960000_1,uppS,Streptococcus pneumoniae,Q8DRB3,4Q9O,ASD08550002,2ZW,A,Lig,Inhibitor,"3-(2-chlorophenyl)-5-methyl-N-(4-propan-2-ylphenyl)-1,2-oxazole-4-carboxamide",301,Inner Protein Regulator,Inner Protein,25287857,Discovery and structural characterization of an allosteric inhibitor of bacterial cis-prenyltransferase.,Yes,"Chain A:VAL99,LEU102,GLN53,THR122,LEU141,THR56,LEU52,PHE72,ILE87,ILE109,ASP96,GLY48,ALA125,ASN89,VAL92,ALA129,LEU90,MET88,LEU118,GLU50,PHE143,PRO91,ALA71,PHE94,LEU145,TYR98,MET49,TYR95,LEU126"
ASD11990000_1,ADORA2A,Enterobacteria phage T4,P00720,3QAK,ASD11990002,UKA,A,Lig,Activator,"6-(2,2-diphenylethylamino)-9-[(2R,3R,4S,5S)-5-(ethylcarbamoyl)-3,4-dihydroxy-oxolan-2-yl]-N-[2-[(1-pyridin-2-ylpiperidin-4-yl)carbamoylamino]ethyl]purine-2-carboxamide",1200,Inner Protein Regulator,Inner Protein,21393508,Structure of an agonist-bound human A2A adenosine receptor.,Yes,"Chain A:ILE66,VAL84,LEU85,THR88,GLN89,ILE92,LEU167,PHE168,GLU169,MET177,ASN181,TRP246,LEU249,HIS250,ASN253,THR256,HIS264,LEU267,MET270,TYR271,ILE274,SER277,HIS278"
ASD11990000_1,GRM5,Enterobacteria phage T4,P00720,4OO9,ASD01916286,2U8,A,Lig,Inhibitor,"methyl (3aR,4S,7aR)-4-[2-(3-methylphenyl)ethynyl]-4-oxidanyl-3,3a,5,6,7,7a-hexahydro-2H-indole-1-carboxylate",4005,Inner Protein Regulator,Inner Protein,25042998,Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain.,No,"Chain A:GLY624,ILE625,ILE651,SER654,PRO655,SER658,TYR659,VAL740,PRO743,LEU744,ASN747,ILE751,TRP785,PHE788,MET802,SER805,VAL806,SER809,ALA810,ALA813"
ASD11990000_1,GPR40 E,Enterobacteria phage T4,P00720,4PHU,ASD09380007,2YB,A,Lig,Activator,"[(3S)-6-({2',6'-dimethyl-4'-[3-(methylsulfonyl)propoxy]biphenyl- 3-yl}methoxy)-2,3-dihydro-1-benzofuran-3- yl]acetic acid",2401,Inner Protein Regulator,Inner Protein,25043059,High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875.,No,"Chain A:VAL81,VAL84,LEU171,PHE142,TYR2240,LEU158,PRO80,ALA179,TYR91,PHE87,LEU135,ARG183,HIS137,VAL141,ASN2244,TRP174,ALA182,GLY139,VAL134,LEU90,LEU140,GLY143,ARG2258,CYS136,GLU172,LEU138,ALA83"
ASD11990000_1,E,Enterobacteria phage T4,P00720,5EE7,,5MV,A,Lig,Inhibitor,"3-[[4-[(1~{S})-1-[3-[3,5-bis(chloranyl)phenyl]- 5-(6-methoxynaphthalen-2-yl)pyrazol-1-yl]ethyl]phenyl]carbonylamino]propanoic acid",1201,Inner Protein Regulator,Allosteric Position,27111510,Extra-helical binding site of a glucagon receptor antagonist.,No,
ASD11990000_1,E,Enterobacteria phage T4,P00720,5JQH,,Nb60,"C,D",Pep,Inhibitor,Nb60,,Allosteric Function,Allosteric Position,27409812,Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation.,No,
ASD11990000_1,E,Enterobacteria phage T4,P00720,5NDD,ASD11990004,8TZ,A,Lig,Inhibitor,(~{S})-(4-fluoranyl-2-propyl-phenyl)-(1~{H}- imidazol-2-yl)methanol,2201,Inner Protein Regulator,Inner Protein,28445455,Structural insight into allosteric modulation of protease-activated receptor 2.,No,"Chain A:VAL328,TYR156,LEU130,TRP141,CYS148,TYR82,LYS131,TYR134,LEU330,ASP228,ILE327,HIS227,CYS331,LEU151,LEU78,TYR326,GLY153,ILE152,HIS135,PHE155,CYS226"
ASD11990000_1,E,Enterobacteria phage T4,P00720,5NDZ,ASD14550001,8UN,A,Lig,Inhibitor,"2-(6-bromanyl-1,3-benzodioxol-5-yl)-~{N}- (4-cyanophenyl)-1-[(1~{S})-1-cyclohexylethyl]benzimidazole- 5-carboxamide",2201,Inner Protein Regulator,Inner Protein,28445455,Structural insight into allosteric modulation of protease-activated receptor 2.,No,"Chain A:SER124,THR206,TYR210,VAL211,TRP199,CYS161,ILE198,LEU123,GLY153,LEU204,ASP121,ASN158,ALA157,LEU203,PHE154,ILE202,LEU119,ALA120,LEU200,ILE207"
ASD12010000_1,SERPINE1,Homo sapiens,P05121,3UT3,ASD12010003,EMJ,B,Lig,Inhibitor,"2,5-bis(oxidanyl)-3-undecyl-cyclohexa-2,5-diene-1,4-dione",401,Protein-Protein Interaction Regulator,Inner Protein,,A novel PAI-I inhibitor and its structural mechanism,No,3UT3
ASD12010000_1,SERPINE1,Homo sapiens,P05121,4AQH,ASD12010002,TB7,A,Lig,Inhibitor,"tert-butyl 3-[(4-oxidanylidene-3H-pyrido[2,3-d]pyrimidin-2-yl)amino]azetidine-1-carboxylate",1380,Protein-Protein Interaction Regulator,Inner Protein,23155046,Characterization of a Small Molecule Inhibitor of Plasminogen Activator Inhibitor Type 1 that Accelerates the Transition Into the Latent Conformation,No,4AQH
ASD12010000_1,SERPINE1,Homo sapiens,P05121,4G8O,ASD05872047,96P,D,Lig,Inhibitor,"[(2S)-3-[[3-(trifluoromethyl)phenoxy]carbonylamino]-2-[3,4,5-tris(oxidanyl)phenyl]carbonyloxy-propyl] 3,4,5-tris(oxidanyl)benzoate",403,Protein-Protein Interaction Regulator,Inner Protein,24297881,Mechanistic characterization and crystal structure of a small molecule inactivator bound to plasminogen activator inhibitor-1.,No,4G8O
ASD12010000_1,SERPINE1,Homo sapiens,P05121,4G8R,ASD05872047,96P,B,Lig,Inhibitor,"[(2S)-3-[[3-(trifluoromethyl)phenoxy]carbonylamino]-2-[3,4,5-tris(oxidanyl)phenyl]carbonyloxy-propyl] 3,4,5-tris(oxidanyl)benzoate",403,Protein-Protein Interaction Regulator,Inner Protein,24297881,Mechanistic characterization and crystal structure of a small molecule inactivator bound to plasminogen activator inhibitor-1.,No,4G8R
ASD12030000_1,purN,Escherichia coli,P08179,4GAR,ASD10228001,NMY,A,Lig,Inhibitor,"(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-oxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxy-cyclohexyl]oxy-oxane-3,4-diol",3161,Protein-DNA/RNA Interaction Regulator,Inner DNA/RNA,22902368,Allosteric control of the ribosome by small-molecule antibiotics.,No,Chain A:SEC1923
ASD12070000_1,bla,Klebsiella pneumoniae,P0AD64,1VM1,ASD12070001,MA4,A,Lig,Inhibitor,"(2R,3R,4S,5S,6R)-2-[(2R,3S,4R,5R,6R)-6-(6-cyclohexylhexoxy)-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol",300,Inner Protein Regulator,Inner Protein,11327849,Inhibition of the SHV-1 beta-lactamase by sulfones: crystallographic observation of two reaction intermediates with tazobactam.,Yes,"Chain A:SER26,VAL224,PRO226,ILE231,ILE246,ALA248,LEU250,VAL261,ILE263,ALA280,GLY283,ALA284,ILE287,GLU288"
ASD12080000_1,MSH2,Homo sapiens,P43246,2O8B,ASD01720027,ADP,A,Lig,Regulator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate",936,Protein-Protein Interaction Regulator,Inner Protein,17531815,Structure of the Human MutSalpha DNA Lesion Recognition Complex.,No,2O8B
ASD12080000_1,MSH2,Homo sapiens,P43246,2O8C,ASD01720027,ADP,A,Lig,Regulator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate",936,Protein-Protein Interaction Regulator,Inner Protein,17531815,Structure of the Human MutSalpha DNA Lesion Recognition Complex.,No,2O8C
ASD12080000_1,MSH2,Homo sapiens,P43246,2O8D,ASD01720027,ADP,A,Lig,Regulator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate",936,Protein-Protein Interaction Regulator,Inner Protein,17531815,Structure of the Human MutSalpha DNA Lesion Recognition Complex.,No,2O8D
ASD12080000_1,MSH2,Homo sapiens,P43246,2O8E,ASD01720027,ADP,A,Lig,Regulator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate",936,Protein-Protein Interaction Regulator,Inner Protein,17531815,Structure of the Human MutSalpha DNA Lesion Recognition Complex.,No,2O8E
ASD12080000_1,MSH2,Homo sapiens,P43246,2O8F,ASD01720027,ADP,A,Lig,Regulator,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl phosphono hydrogen phosphate",936,Protein-Protein Interaction Regulator,Inner Protein,17531815,Structure of the Human MutSalpha DNA Lesion Recognition Complex.,No,2O8F
ASD12110000_1,ldh2,Bifidobacterium longum subsp. longum,E8ME30,1LTH,ASD00200001,FBP,R,Lig,Activator,"[(2R,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate",320,Inner Protein Regulator,Inner Protein,7656036,"1 - 1LTH : Lactate dehydrogenase creates lactic acid as part of anaerobic respiration. This structure includes two molecules of a bacterial LDH, one in the active state and one in the inactive state.",No,"Chain R:ARG158,LYS170,ASN171,HIS173,TYR175"
ASD12130000_1,ORF17,Human herpesvirus 8 type P,Q2HRB6,4P2T,ASD12130001,24Q,A,Lig,Inhibitor,4-[[6-(cyclohexylmethyl)pyridin-2-yl]carbonylamino]-3-(phenylmethyl)benzoic acid,201,Protein-Protein Interaction Regulator,Inner Protein,24977643,Broad-spectrum allosteric inhibition of herpesvirus proteases.,No,"Chain A:ILE44,PHE76,LEU79,ALA80,LEU83,ALA90,ILE105,LEU106,TRP109,LEU110,ALA139,PHE189,PRO192,LEU193,LEU196"
ASD12140000_1,,Human herpesvirus 8 type M,P88911,3NJQ,ASD04992001,NJQ,A,Lig,Inhibitor,4-[[6-(cyclohexylmethyl)pyridin-2-yl]carbonylamino]-3-(phenylmethyl)benzoic acid,197,Protein-Protein Interaction Regulator,Inner Protein,21723875,Enzyme inhibition by allosteric capture of an inactive conformation.,No,"Chain A:ILE44,PHE76,LEU79,ALA80,LEU83,ILE105,TRP109,LEU110,ALA139,PHE189,PRO192,LEU193"
ASD12150000_1,amy,Pseudoalteromonas haloplanktis,P29957,1AQM,ASD01630003,CL,A,Ion,Activator,chloride,900,Inner Protein Regulator,Inner Protein,9541387,Crystal structures of the psychrophilic alpha-amylase from Alteromonas haloplanctis in its native form and complexed with an inhibitor.,Yes,"Chain A:ARG172,THR221,ASN262,LYS300"
ASD12150000_1,amy,Pseudoalteromonas haloplanktis,P29957,1JD7,ASD01630003,CL,A,Ion,Activator,chloride,900,Inner Protein Regulator,Inner Protein,12021442,Structural basis of alpha-amylase activation by chloride,Yes,"Chain A:ARG172,THR221,ASN262,ARG300"
ASD12150000_1,amy,Pseudoalteromonas haloplanktis,P29957,1L0P,ASD08770047,NO3,A,Ion,Activator,nitrate,901,Inner Protein Regulator,Inner Protein,12021442,Structural basis of alpha-amylase activation by chloride.,Yes,"Chain A:ARG172,PHE198,GLU200,THR221,PHE223,PHE259,ASN262,LYS300"
ASD12150000_2,,Tenebrio molitor,P56634,1JAE,ASD01630003,CL,A,Ion,Activator,chloride,501,Inner Protein Regulator,Inner Protein,9600843,Crystal structure of yellow meal worm alpha-amylase at 1.64 A resolution.,Yes,"Chain A:ARG183,LEU243,ASN285,ARG321"
ASD12150000_2,,Tenebrio molitor,P56634,1VIW,ASD01630003,CL,A,Ion,Activator,chloride,498,Inner Protein Regulator,Inner Protein,10089450,A plant-seed inhibitor of two classes of alpha-amylases: X-ray analysis of Tenebrio molitor larvae alpha-amylase in complex with the bean Phaseolus vulgaris inhibitor.,Yes,"Chain A:ARG183,LEU243,ASN285,ARG321"
ASD12170000_1,,Pyrococcus furiosus,Q8U0A9,4GRS,ASD00690002,TYR,A,Lig,Inhibitor,(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid,401,Inner Protein Regulator,Protein-Protein Interaction,23345433,Engineering allosteric control to an unregulated enzyme by transfer of a regulatory domain,No,"Chain A:MET1,GLY40,ILE41,ILE42,GLY43,ASP45,LEU66; Chain C:SER31,GLY33,GLN34,GLU35,ARG36,VAL38"
ASD12180000_1,,Dickeya chrysanthemi,P0C7B7,3ZKR,ASD01630001,MBR,A,Lig,Inhibitor,tris(bromanyl)methane,401,Inner Protein Regulator,Protein-Protein Interaction,23364792,Multisite Binding of a General Anesthetic to the Prokaryotic Pentameric Erwinia Chrysanthemi Ligand-Gated Ion Channel (Elic).,No,Chain A:ALA217
ASD12180000_1,,Dickeya chrysanthemi,P0C7B7,5LG3,,Z80,A,Lig,Inhibitor,"3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine(chlorpromazine)",401,Allosteric Fuction,Allosteric Position,27791038,Allosteric binding site in a Cys-loop receptor ligand-binding domain unveiled in the crystal structure of ELIC in complex with chlorpromazine.,No,"Chain A:GLU150,TYR24,LYS22,ASP196,ASN21,ASN154,ILE20,TRP161,TYR148,ASP158,VAL26,VAL147,THR149,ASP153,GLY25,ILE195,ILE162,ILE23,ASN151,TRP160,PHE126,ALA197,GLU159,GLU155"
ASD12180000_1,,Dickeya chrysanthemi,P0C7B7,5LID,,6XY,A,Lig,Inhibitor,bromopromazine,401,Allosteric Fuction,Allosteric Position,27791038,Allosteric binding site in a Cys-loop receptor ligand-binding domain unveiled in the crystal structure of ELIC in complex with chlorpromazine.,No,
ASD12200000_1,toxA,Peptoclostridium difficile,P16154,3HO6,ASD03710003,IHP,A,Lig,Activator,"(2,3,4,5,6-pentaphosphonooxycyclohexyl) dihydrogen phosphate",270,Inner Protein Regulator,Inner Protein,19553670,Structure-function analysis of inositol hexakisphosphate-induced autoprocessing in Clostridium difficile toxin A.,No,"Chain A:LYS35,TYR37,LEU57,LYS60,ASN61,LYS105,LYS107,ASN154,ARG211,LYS212,LYS224,LYS235,LYS252,ASN253"
ASD12210000_1,crp,Escherichia coli,C3SQJ7,4N9I,ASD02408002,PCG,A,Lig,Activator,"2-amino-9-[(4R,6S,7R,8R)-4,7-dihydroxy-4-oxo-3,5,9-trioxa-4$l^{5}-phosphabicyclo[4.3.0]nonan-8-yl]-1H-purin-6-one",301,Protein-DNA/RNA Interaction Regulator,Protein-Protein Interaction,24914983,Structures of inactive CRP species reveal the atomic details of the allosteric transition that discriminates cyclic nucleotide second messengers.,No,"Chain A:VAL49,LEU61,SER62,ILE70,GLY71,GLU72,ARG82,SER83,ALA84,VAL86,ARG123; Chain B:GLN125,THR127,LYS130"
ASD12220000_1,VC0395_0091,Vibrio cholerae serotype O1,A5F1K1,2RDE,ASD06980001,C2E,A,Lig,Activator,"9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)- 3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro- 2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine- 2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin- 6-one)",301,Protein-Protein Interaction Regulator,Inner Protein,18034161,The structural basis of cyclic diguanylate signal transduction by PilZ domains.,No,"Chain A:ILE96,LEU135,ARG136,LYS137,ARG140,ASP162,LEU163,SER164,SER166,GLY167,CYS168,ARG169,CYS207,ASN208,GLY219,LEU220,GLU221"
ASD12230000_1,nadC,Mycobacterium tuberculosis,P9WJJ7,1QP0,ASD03640003,HPA,A,Lig,Activator,"1,7-dihydropurin-6-one",599,Protein-DNA/RNA Interaction Regulator,Inner Protein,10438625,The role of lysine 55 in determining the specificity of the purine repressor for its operators through minor groove interactions.,No,"Chain A:TYR73,PHE74,ARG190,THR192,ARG196,PHE221,ASP275"
ASD12240000_1,S100B,Bos taurus,P02638,1MHO,ASD11630001,CA,A,Ion,Inhibitor,calcium(+2) cation,91,Inner Protein Regulator,Inner Protein,9519413,A novel mode of target recognition suggested by the 2.0 A structure of holo S100B from bovine brain.,No,"Chain A:ASP61,ASP63,ASP65,GLU67,GLU72"
ASD12260000_1,PPCA,Flaveria trinervia,P30694,4BXC,ASD00360002,G6P,A,Lig,Activator,"[(2R,3S,4S,5R,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl dihydrogen phosphate",1967,Inner Protein Regulator,Inner Protein,24043710,Resolving the Activation Site of Positive Regulators in Plant Phosphoenolpyruvate Carboxylase.,Yes,"Chain A:THR170,TRP283,ARG450,MET592,ASP597,GLY634,ARG635,THR665,ARG753,ARG767,ALA768,ILE769"
ASD12260000_1,,Flaveria trinervia,P30694,4BXH,ASD12260002,EDO,A,Lig,Activator,"1,2-ETHANEDIOL",1002,Inner Protein Regulator,Inner Protein,24043710,Resolving the Activation Site of Positive Regulators in Plant Phosphoenolpyruvate Carboxylase.,No,"Chain A:ARG767,TRP283,ASP287,ASP597,ARG450,ASP289,ALA768,PRO770,ARG635,ILE769"
ASD12280000_1,,Conus purpurascens,P56529,1JL0,ASD00240001,PUT,A,Lig,Activator,"butane-1,4-diamine",2010,Inner Protein Regulator,Inner Protein,11583148,Structure of a human S-adenosylmethionine decarboxylase self-processing ester intermediate and mechanism of putrescine stimulation of processing as revealed by the H243A mutant.,No,"Chain A:LEU13,GLU15,PHE111,ASP174,THR176,PHE285,TYR318"
ASD12310000_1,FKBP1A,Homo sapiens,P62942,1FAP,ASD12310001,RAP,A,Lig,Inhibitor,"(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone",108,Protein-Protein Interaction Regulator,Protein-Protein Interaction,8662507,Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP.,No,1FAP
ASD12310000_1,FKBP1A,Homo sapiens,P62942,1NSG,ASD12310002,RAD,A,Lig,Inhibitor,"(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-21-ethoxy-9,27-dihydroxy-3-{(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl}-10-methoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone",108,Protein-Protein Interaction Regulator,Protein-Protein Interaction,10089303,Refined structure of the FKBP12-rapamycin-FRB ternary complex at 2.2 A resolution.,No,1NSG
ASD12310000_1,FKBP1A,Homo sapiens,P62942,2FAP,ASD12310002,RAD,A,Lig,Inhibitor,"(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-21-ethoxy-9,27-dihydroxy-3-{(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl}-10-methoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone",108,Protein-Protein Interaction Regulator,Protein-Protein Interaction,10089303,Refined structure of the FKBP12-rapamycin-FRB ternary complex at 2.2 A resolution.,No,2FAP
ASD12310000_1,FKBP1A,Homo sapiens,P62942,3FAP,ASD12310004,ARD,A,Lig,Inhibitor,"(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21R,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl}-10-methoxy-6,8,12,14,20,26-hexamethyl-21-(5-methylthiophen-2-yl)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone",402,Protein-Protein Interaction Regulator,Protein-Protein Interaction,10089303,Refined structure of the FKBP12-rapamycin-FRB ternary complex at 2.2 A resolution.,No,3FAP
ASD12310000_1,FKBP1A,Homo sapiens,P62942,4FAP,ASD12310004,ARD,A,Lig,Inhibitor,"(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21R,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl}-10-methoxy-6,8,12,14,20,26-hexamethyl-21-(5-methylthiophen-2-yl)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone",402,Protein-Protein Interaction Regulator,Protein-Protein Interaction,10089303,Refined structure of the FKBP12-rapamycin-FRB ternary complex at 2.2 A resolution.,No,4FAP
ASD12320000_1,PRE1,Saccharomyces cerevisiae,P22141,4QBY,ASD12320001,BOC AA 2A1,2,Pep,Inhibitor,Boc-Ala-Ala-Ala-Al-CHO,,Inner Protein Regulator,Protein-Protein Interaction,24979800,Differential global structural changes in the core particle of yeast and mouse proteasome induced by ligand binding.,No,"Chain L:SER130,VAL128,ASP126,ARG101,PRO127"
ASD12340000_1,Grik1,Rattus norvegicus,P22756,3C31,ASD12340001,LI,A,Ion,Regulator,lithium(+1) cation,301,Inner Protein Regulator,Protein-Protein Interaction,18549784,Molecular basis of kainate receptor modulation by sodium.,No,"Chain A:GLU96,ILE99,ASP100"
ASD12340000_1,Grik1,Rattus norvegicus,P22756,3C31,ASD01630003,CL,A,Ion,Regulator,chloride,303,Inner Protein Regulator,Protein-Protein Interaction,18549784,Molecular basis of kainate receptor modulation by sodium.,No,"Chain A:LYS103; Chain B:LYS103,ARG227"
ASD12340000_1,Grik1,Rattus norvegicus,P22756,3C32,ASD03160008,NA,A,Ion,Regulator,sodium(+1) cation,301,Inner Protein Regulator,Protein-Protein Interaction,18549784,Molecular basis of kainate receptor modulation by sodium.,No,"Chain A:GLU96,ILE99,ASP100"
ASD12340000_1,Grik1,Rattus norvegicus,P22756,3C32,ASD01630003,CL,A,Ion,Regulator,chloride,303,Inner Protein Regulator,Protein-Protein Interaction,18549784,Molecular basis of kainate receptor modulation by sodium.,No,"Chain A:LYS103,ARG227; Chain B:LYS103,ARG227"
ASD12340000_1,Grik1,Rattus norvegicus,P22756,3C33,ASD12340005,K,A,Ion,Regulator,potassium(+1) cation,302,Inner Protein Regulator,Protein-Protein Interaction,18549784,Molecular basis of kainate receptor modulation by sodium.,No,"Chain A:GLU96,ILE99,ASP100,ILE222"
ASD12340000_1,Grik1,Rattus norvegicus,P22756,3C33,ASD01630003,CL,A,Ion,Regulator,chloride,304,Inner Protein Regulator,Protein-Protein Interaction,18549784,Molecular basis of kainate receptor modulation by sodium.,No,"Chain A:LYS103,ARG227; Chain B:LYS103,ARG227"
ASD12340000_1,Grik1,Rattus norvegicus,P22756,3C34,ASD12340007,Rb,A,Ion,Regulator,RUBIDIUM ION,302,Inner Protein Regulator,Protein-Protein Interaction,18549784,Molecular basis of kainate receptor modulation by sodium.,No,"Chain A:GLU96,ILE99,ASP100"
ASD12340000_1,Grik1,Rattus norvegicus,P22756,3C34,ASD01630003,CL,A,Ion,Regulator,chloride,307,Inner Protein Regulator,Protein-Protein Interaction,18549784,Molecular basis of kainate receptor modulation by sodium.,No,"Chain A:LYS103,ARG227; Chain B:LYS103,ARG227"
ASD12340000_1,Grik1,Rattus norvegicus,P22756,3C35,ASD12340009,Cs,A,Ion,Regulator,CESIUM ION,301,Inner Protein Regulator,Protein-Protein Interaction,18549784,Molecular basis of kainate receptor modulation by sodium.,No,"Chain A:GLU96,ILE99,ASP100"
ASD12340000_1,Grik1,Rattus norvegicus,P22756,3C35,ASD01630003,CL,A,Ion,Regulator,chloride,314,Inner Protein Regulator,Protein-Protein Interaction,18549784,Molecular basis of kainate receptor modulation by sodium.,No,"Chain A:LYS103,ARG227; Chain B:LYS103"
ASD12340000_1,Grik1,Rattus norvegicus,P22756,3C36,ASD12340011,NH4,A,Ion,Regulator,azanium,301,Inner Protein Regulator,Protein-Protein Interaction,18549784,Molecular basis of kainate receptor modulation by sodium.,No,"Chain A:GLU96,ILE99,ASP100"
ASD12340000_1,Grik1,Rattus norvegicus,P22756,3C36,ASD01630003,CL,A,Ion,Regulator,chloride,303,Inner Protein Regulator,Protein-Protein Interaction,18549784,Molecular basis of kainate receptor modulation by sodium.,No,"Chain A:LYS103,ARG227; Chain B:LYS103,ARG227"
ASD12340000_1,Grik1,Rattus norvegicus,P22756,5MFQ,ASD01200253,2J9,A,Lig,Regulator,"4-cyclopropyl-7-fluoro-3,4-dihydro-2H-1,2,4- benzothiadiazine 1,1-dioxide",901;902,Inner Protein Regulator,Protein-Protein Interaction,28360094,Identification and Structure-Function Study of Positive Allosteric Modulators of Kainate Receptors.,No,"Chain B:THR520,LEU536,SER761,ILE519,LYS531,PHE533,LEU783,TYR764,PRO532,GLY763,MET534,GLN786,LYS762,ILE782,THR535,LEU791"
ASD12340000_1,Grik1,Rattus norvegicus,P22756,5MFV,ASD01230232,5PX,A,Lig,Regulator,"4-Cyclopropyl-3,4-dihydro-7-hydroxy-2H-1,2,4- benzothiadiazine 1,1-dioxide",901;902,Inner Protein Regulator,Protein-Protein Interaction,28360094,Identification and Structure-Function Study of Positive Allosteric Modulators of Kainate Receptors.,No,"Chain B:THR520,LEU536,SER761,ILE519,LYS531,PHE533,LEU783,TYR764,PRO532,GLY763,MET534,GLN786,LYS762,ILE782,THR535,LEU791"
ASD12340000_1,Grik1,Rattus norvegicus,P22756,5MFW,ASD01230049,7M6,A,Lig,Regulator,"7-chloro-4-(2-fluoroethyl)-2,3-dihydro-1,2,4- benzothiadiazine 1,1-dioxide",901,Inner Protein Regulator,Protein-Protein Interaction,28360094,Identification and Structure-Function Study of Positive Allosteric Modulators of Kainate Receptors.,No,"Chain B:PRO532,LEU536,GLY763,LYS762,MET534,THR520,THR535,SER761,TYR764,ILE519,LYS531"
ASD12350000_1,Dda3937_00520,Dickeya dadantii,E0SJQ4,2YN6,ASD12350001,BA,A,Ion,Inhibitor,barium(+2) cation,1318,Inner Protein Regulator,Protein-Protein Interaction,23185134,Inhibition of the Prokaryotic Pentameric Ligand-Gated Ion Channel Elic by Divalent Cations.,No,Chain A:THR149; Chain B:ASP113
ASD12360000_1,UBE2D1,Homo sapiens,P51668,4QPL,ASD12360001,V3L,A,Lig,Activator,2'-O-(5-O-phosphono-alpha-D-ribofuranosyl)adenosine 5'- (dihydrogen phosphate),201,Inner Protein Regulator,Inner Protein,25327252,Allosteric activation of the RNF146 ubiquitin ligase by a poly(ADP-ribosyl)ation signal.,No,4QPL
ASD12370000_1,PRKAR1A,Bos taurus,P00514,3PNA,ASD00480003,CMP,A,Lig,Activator,"ADENOSINE-3',5'-CYCLIC-MONOPHOSPHATE",250,Protein-Protein Interaction Regulator,Inner Protein,21081668,Cyclic AMP Analog Blocks Kinase Activation by Stabilizing Inactive Conformation: Conformational Selection Highlights a New Concept in Allosteric Inhibitor Design.,No,"Chain A:GLY169,VAL192,ALA202,SER197,VAL213,THR212,PRO208,PHE198,VAL184,ALA211,GLU200,THR190,ALA210,LEU201,ILE163,GLY199,VAL182,LEU203,ALA189,ARG209"
ASD12370000_1,PRKAR1A,Bos taurus,P00514,7LZ4,,CMP,A,Lig,Activator,"ADENOSINE-3',5'-CYCLIC-MONOPHOSPHATE",401,,,,,,
ASD12490000_1,speG,Vibrio cholerae serotype O1,Q9KL03,4MHD,ASD02100005,SPD,A,Lig,Regulator,SPERMIDINE,201,Allosteric function,Allosteric position,25623305,A Novel Polyamine Allosteric Site of SpeG from Vibrio cholerae Is Revealed by Its Dodecameric Structure.,Yes,Chain C:TYR78
ASD12490000_1,speG,Vibrio cholerae serotype O1,Q9KL03,4MI4,ASD09710001,SPM,A,Lig,Regulator,SPERMINE,201,Allosteric function,Allosteric position,25623305,A Novel Polyamine Allosteric Site of SpeG from Vibrio cholerae Is Revealed by Its Dodecameric Structure.,Yes,"Chain A:GLU33,GLU34,PRO35,MET28,GLU37,TYR36,GLU41,ARG57,TRP31,ASN22,GLU72"
ASD12490000_1,speG,Vibrio cholerae serotype O1,Q9KL03,4R87,ASD09710001,SPM,E,Lig,Regulator,SPERMINE,202,Allosteric Function,Allosteric Position,25623305,A Novel Polyamine Allosteric Site of SpeG from Vibrio cholerae Is Revealed by Its Dodecameric Structure.,No,"Chain E:SER38,LEU45,ARG57,TYR36,GLU72,MET28,GLU41,ASN22,TRP31,GLU34,GLU37,GLN86,GLU33"
ASD12630000_1,MAPK7,Homo sapiens,Q13164,4ZSG,ASD12630001,4QX,A,Lig,Inhibitor,"3-amino-5-[(4-chlorophenyl)amino]-N-(propan- 2-yl)-1H-1,2,4-triazole-1-carboxamide",406,Inner Protein Regulator,Allosteric Position,27139631,Discovery of a novel allosteric inhibitor-binding site in ERK5: comparison with the canonical kinase hinge ATP-binding site.,No,4ZSG
ASD12630000_1,MAPK7,Homo sapiens,Q13164,4ZSJ,ASD12630002,4R0,A,Lig,Inhibitor,"3-amino-5-[(4-chloro-3-methylphenyl)amino]- N-(propan-2-yl)-1H-1,2,4-triazole-1-carboxamide",405,Inner Protein Regulator,Allosteric Position,27139631,Discovery of a novel allosteric inhibitor-binding site in ERK5: comparison with the canonical kinase hinge ATP-binding site.,No,4ZSJ
ASD12630000_1,MAPK7,Homo sapiens,Q13164,4ZSL,ASD12630005,4QZ,A,Lig,Inhibitor,"3-amino-5-[(4-chlorophenyl)amino]-N-[(1S)- 1-phenylethyl]-1H-1,2,4-triazole-1-carboxamide",401,Inner Protein Regulator,Allosteric Position,27139631,Discovery of a novel allosteric inhibitor-binding site in ERK5: comparison with the canonical kinase hinge ATP-binding site.,No,4ZSL
ASD13000000_1,eutL,Clostridium perfringens,B1BQ33,4TME,ASD13000001,ETA,"A,B,C",Lig,Inhibitor,ETHANOLAMINE,219/220,Inner Protein Regulator,Allosteric Position,25752492,An allosteric model for control of pore opening by substrate binding in the EutL microcompartment shell protein,No,"Chain B:HIS220,LEU218,GLU219,HIS221"
ASD13010000_1,RORC,Homo sapiens,P51449,4YPQ,,4F1,A,Lig,Inhibitor,4-{1-[2-chloro-6-(trifluoromethyl)benzoyl]- 1H-indazol-3-yl}benzoic acid,508,Inner Protein Regulator,Allosteric Position,26640126,Identification of an allosteric binding site for ROR gamma t inhibition.,No,4YPQ
ASD13010000_1,RORC,Homo sapiens,P51449,5C4O,,4F1,A,Lig,Inhibitor,4-{1-[2-chloro-6-(trifluoromethyl)benzoyl]- 1H-indazol-3-yl}benzoic acid,601,Inner Protein Regulator,Allosteric Position,26640126,Identification of an allosteric binding site for ROR gamma t inhibition.,No,5C4O
ASD13010000_1,RORC,Homo sapiens,P51449,5C4S,ASD13010050,4Y5,A,Lig,Inhibitor,4-{1-[2-chloro-6-(trifluoromethyl)benzoyl]- 4-fluoro-1H-indazol-3-yl}-3-fluorobenzoic acid,601,Allosteric Function,Allosteric Position,26640126,Identification of an allosteric binding site for ROR gamma t inhibition.,No,5C4S
ASD13010000_1,RORC,Homo sapiens,P51449,5C4T,ASD13010061,4Y6,A,Lig,Inhibitor,(1S)-4-{1-[2-chloro-6-(trifluoromethyl)benzoyl]- 4-fluoro-1H-indazol-3-yl}-1-methylcyclohex- 3-ene-1-carboxylic acid,601,Allosteric Function,Allosteric Position,26640126,Identification of an allosteric binding site for ROR gamma t inhibition.,No,5C4T
ASD13010000_1,RORC,Homo sapiens,P51449,5C4U,ASD13010053,4Y7,A,Lig,Inhibitor,"4-{1-[2-chloro-6-(trifluoromethyl)benzoyl]- 1H-pyrazolo[4,3-b]pyridin-3-yl}-5-fluoro- 2-hydroxybenzoic acid",601,Inner Protein Regulator,Allosteric Position,26640126,Identification of an allosteric binding site for ROR gamma t inhibition.,No,5C4U
ASD13010000_1,RORC,Homo sapiens,P51449,5LWP,ASD13010001,79U,A,Lig,Activator,4-[3-[2-chloranyl-6-(trifluoromethyl)phenoxy]-5-(dimethylcarbamoyl)indazol-1-yl]benzoic acid,601,Allosteric Fuction,Allosteric Position,27815118,Discovery of phenoxyindazoles and phenylthioindazoles as ROR gamma inverse agonists.,No,5LWP
ASD13010000_1,RORC,Homo sapiens,P51449,6SAL,,L3E,A,Lig,Activator,"4-[(~{E})-[3-[2-chloranyl-6-(trifluoromethyl)phenyl]-5-(1~{H}-pyrrol-3-yl)-1,2-oxazol-4-yl]methylideneamino]benzoic acid",601,Allosteric function,Allosteric position,,,No,6SAL
ASD13010000_1,RORC,Homo sapiens,P51449,6T4G,,L3E,A,Lig,Regulator,"4-[(~{E})-[3-[2-chloranyl-6-(trifluoromethyl)phenyl]-5-(1~{H}-pyrrol-3-yl)-1,2-oxazol-4-yl]methylideneamino]benzoic acid",602,,,,,,6T4G
ASD13010000_1,RORC,Homo sapiens,P51449,6T4I,,4F1,A,Lig,Regulator,4-{1-[2-chloro-6-(trifluoromethyl)benzoyl]-1H-indazol-3-yl}benzoic acid,602,,,,,,6T4I
ASD13010000_1,RORC,Homo sapiens,P51449,6T4J,,MHQ,A,Lig,Regulator,desmosterol,601,,,,,,6T4J
ASD13010000_1,RORC,Homo sapiens,P51449,6T4K,,MHQ,A,Lig,Regulator,desmosterol,601,,,,,,6T4K
ASD13010000_1,RORC,Homo sapiens,P51449,6T4T,,L3E,A,Lig,Regulator,"4-[(~{E})-[3-[2-chloranyl-6-(trifluoromethyl)phenyl]-5-(1~{H}-pyrrol-3-yl)-1,2-oxazol-4-yl]methylideneamino]benzoic acid",803,,,,,,6T4T
ASD13010000_1,RORC,Homo sapiens,P51449,6T4U,,4F1,A,Lig,Regulator,4-{1-[2-chloro-6-(trifluoromethyl)benzoyl]-1H-indazol-3-yl}benzoic acid,803,,,,,,6T4U
ASD13010000_1,RORC,Homo sapiens,P51449,6T4W,,MJE,A,Lig,Regulator,"4-[1-[2,6-bis(chloranyl)phenyl]carbonyl-5-methyl-thieno[3,2-c]pyrazol-3-yl]benzoic acid",803,,,,,,6T4W
ASD13010000_1,RORC,Homo sapiens,P51449,6T4X,,L3E,A,Lig,Regulator,"4-[(~{E})-[3-[2-chloranyl-6-(trifluoromethyl)phenyl]-5-(1~{H}-pyrrol-3-yl)-1,2-oxazol-4-yl]methylideneamino]benzoic acid",602,,,,,,6T4X
ASD13010000_1,RORC,Homo sapiens,P51449,6T4Y,,4F1,A,Lig,Regulator,4-{1-[2-chloro-6-(trifluoromethyl)benzoyl]-1H-indazol-3-yl}benzoic acid,602,,,,,,6T4Y
ASD13010000_1,RORC,Homo sapiens,P51449,6T50,,MJE,A,Lig,Regulator,"4-[1-[2,6-bis(chloranyl)phenyl]carbonyl-5-methyl-thieno[3,2-c]pyrazol-3-yl]benzoic acid",602,,,,,,6T50
ASD13010000_1,RORC,Homo sapiens,P51449,6TLM,,MJE,A,Lig,Activator,"4-[1-[2,6-bis(chloranyl)phenyl]carbonyl-5-methyl-thieno[3,2-c]pyrazol-3-yl]benzoic acid",601,Allosteric function,Allosteric position,,,No,6TLM
ASD13010000_1,RORC,Homo sapiens,P51449,6TLQ,,MJE,A,Lig,Regulator,"4-[1-[2,6-bis(chloranyl)phenyl]carbonyl-5-methyl-thieno[3,2-c]pyrazol-3-yl]benzoic acid",602,,,,,,6TLQ
ASD13010000_1,RORC,Homo sapiens,P51449,6TLT,,MJE,A,Lig,Regulator,"4-[1-[2,6-bis(chloranyl)phenyl]carbonyl-5-methyl-thieno[3,2-c]pyrazol-3-yl]benzoic acid",601,,,,,,6TLT
ASD13010000_1,RORC,Homo sapiens,P51449,6UCG,,Q3Y,A,Lig,Inhibitor,"(3S,4R)-1-[1-(2-chloro-6-cyclopropylbenzene-1-carbonyl)-4-fluoro-1H-indazol-3-yl]-3-hydroxypiperidine-4-carboxylic acid",601,Allosteric function,Allosteric position,,,No,6UCG
ASD13010000_1,RORC,Homo sapiens,P51449,7NP5,,UKB,A,Lig,Inhibitor,"4-[[3-[2-chloranyl-6-(trifluoromethyl)phenyl]-5-(1~{H}-pyrrol-3-yl)-1,2-oxazol-4-yl]methoxy]-2-fluoranyl-benzoic acid",601,,,,,,7NP5
ASD13010000_1,RORC,Homo sapiens,P51449,7NP6,,UK8,A,Lig,Inhibitor,"4-[[3-[2-chloranyl-6-(trifluoromethyl)phenyl]-5-(1~{H}-pyrazol-4-yl)-1,2-oxazol-4-yl]methoxy]benzoic acid",601,,,,,,7NP6
ASD13010000_1,RORC,Homo sapiens,P51449,7NPC,,ULT,A,Lig,Inhibitor,"4-[[3-[2-chloranyl-6-(trifluoromethyl)phenyl]-5-(1~{H}-pyrrol-3-yl)-1,2-oxazol-4-yl]methoxy]benzoic acid",601,,,,,,7NPC
ASD13020000_1,Pck1,Rattus norvegicus,P07379,4YW8,ASD10200001,1WD,A,Lig,Regulator,3-sulfanylpyridine-2-carboxylic acid,708,Allosteric Function,Allosteric Position,26322521,Inhibition and Allosteric Regulation of Monomeric Phosphoenolpyruvate Carboxykinase by 3-Mercaptopicolinic Acid.,No,"Chain A:ARG437,PHE284,ARG518,ASN515,ALA287,PHE517,TRP516,VAL514,GLY289,GLY434,PRO285,CYS288,PHE525,GLY435,PHE433,SER462,ARG436"
ASD13030000_1,yjbM,Bacillus subtilis,O31611,5DED,ASD13030001,0O2,A,Lig,Activator,guanosine 5'-(tetrahydrogen triphosphate) 3'- (trihydrogen diphosphate),302,Allosteric Function,Allosteric Position,https://www.ncbi.nlm.nih.gov/pubmed/26460002,Catalytic mechanism and allosteric regulation of an oligomeric (p)ppGpp synthetase by an alarmone,No,"Chain C:THR44,GLU18,LYS21,VAL43,ASN148,THR152,PHE42,GLU41,ARG28,LYS25,GLY45,MET79"
ASD13040000_1,IDH1,Homo sapiens,O75874,4UMX,ASD01720001,VVS,A,Lig,Inhibitor,"2,6-bis(1H-imidazol-1-ylmethyl)-4-(2,4,4-trimethylpentan-2-yl)phenol",1415,Allosteric Function,Allosteric Position,25391653,Selective Inhibition of Mutant Isocitrate Dehydrogenase 1 (Idh1) Via Disruption of a Metal Binding Network by an Allosteric Small Molecule.,No,4UMX
ASD13040000_1,IDH1,Homo sapiens,O75874,5DE1,ASD01720009,59D,A,Lig,Inhibitor,"(7R)-1-(4-fluorobenzyl)-N-{3-[(1S)-1-hydroxyethyl]phenyl}- 7-methyl-5-(1H-pyrrol-2-ylcarbonyl)-4,5,6,7- tetrahydro-1H-pyrazolo[4,3-c]pyridine-3-carboxamide",502,Allosteric Function,Allosteric Position,26436839,New IDH1 mutant inhibitors for treatment of acute myeloid leukemia.,No,5DE1
ASD13040000_1,IDH1,Homo sapiens,O75874,5K11,ASD13040013,NDP,A,Lig,Inhibitor,NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE,501,Allosteric function,Allosteric position,27238019,Breaking Cryo-EM Resolution Barriers to Facilitate Drug Discovery.,No,5K11
ASD13040000_1,IDH1,Homo sapiens,O75874,5L57,ASD13040005,6N3,A,Lig,Inhibitor,"(1~{R},5~{S})-3-[6-(3-methylbutoxy)-5-[[(1~{R},3~{S})-5-oxidanyl-2-adamantyl]carbamoyl]pyridin-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxylic acid",502,Allosteric Fuction,Allosteric Position,28002956,Discovery and Optimization of Allosteric Inhibitors of Mutant Isocitrate Dehydrogenase 1 (R132H IDH1) Displaying Activity in Human Acute Myeloid Leukemia Cells.,No,5L57
ASD13040000_1,IDH1,Homo sapiens,O75874,5L58,ASD13040004,6MX,A,Lig,Inhibitor,"2-[(3~{R})-1-[6-cyclohexylsulfanyl-5-[[(1~{R},3~{S})-5-oxidanyl-2-adamantyl]carbamoyl]pyridin-2-yl]pyrrolidin-3-yl]ethanoic acid",502,Allosteric Function,Allosteric Position,28002956,Discovery and Optimization of Allosteric Inhibitors of Mutant Isocitrate Dehydrogenase 1 (R132H IDH1) Displaying Activity in Human Acute Myeloid Leukemia Cells.,No,5L58
ASD13040000_1,IDH1,Homo sapiens,O75874,5LGE,ASD13040006,6VN,B,Lig,Inhibitor,"2-[(4-propan-2-ylphenyl)amino]-1-[(1~{S},5~{S})-3,3,5-trimethylcyclohexyl]benzimidazole-5-carboxylic acid",502,Allosteric Fuction,Allosteric Position,28124097,Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivo.,No,5LGE
ASD13040000_1,IDH1,Homo sapiens,O75874,5SUN,ASD13040008,70Q,B,Lig,Inhibitor,"3-benzyl-N-[3-(dimethylsulfamoyl)phenyl]- 4-oxo-3,4-dihydrophthalazine-1-carboxamide",502,Inner Protein Regulator,Inner Protein,28132785,Allosteric Mutant IDH1 Inhibitors Reveal Mechanisms for IDH1 Mutant and Isoform Selectivity.,No,5SUN
ASD13040000_1,IDH1,Homo sapiens,O75874,5SVF,ASD01720159,70P,A,Lig,Inhibitor,"(4S)-3-(2-{[(1S)-1-phenylethyl]amino}pyrimidin- 4-yl)-4-(propan-2-yl)-1,3-oxazolidin-2-one",502,Inner Protein Regulator,Inner Protein,28132785,Allosteric Mutant IDH1 Inhibitors Reveal Mechanisms for IDH1 Mutant and Isoform Selectivity.,No,5SVF
ASD13040000_1,IDH1,Homo sapiens,O75874,5TQH,ASD01720187,7J2,A,Lig,Inhibitor,"(4S)-3-[2-({(1S)-1-[5-(4-fluoro-3-methylphenyl)pyrimidin- 2-yl]ethyl}amino)pyrimidin-4-yl]-4-(propan- 2-yl)-1,3-oxazolidin-2-one",502,Inner Protein Regulator,Inner Protein,28197303,Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Allosteric and Mutant Specific Inhibitors of IDH1.,No,5TQH
ASD13040000_1,IDH1,Homo sapiens,O75874,6B0Z,ASD01720194,C81,A,Lig,Inhibitor,"(4R)-4-[(1S)-1-fluoroethyl]-3-[2-({(1S)-1-[4-methyl-2'-(trifluoromethyl)[3,4'-bipyridin]-6-yl]ethyl}amino)pyrimidin-4-yl]-1,3-oxazolidin-2-one",502,Allosteric function,Allosteric position,29057061,"Discovery and Evaluation of Clinical Candidate IDH305, a Brain Penetrant Mutant IDH1 Inhibitor.",No,6B0Z
ASD13040000_1,IDH1,Homo sapiens,O75874,6BKY,ASD13040012,K32,A,Lig,Inhibitor,"4,5,6,7-TETRABROMO-1H,3H-BENZIMIDAZOL-2-ONE",503,Allosteric function,Allosteric position,30004704,Novel Modes of Inhibition of Wild-Type Isocitrate Dehydrogenase 1 (IDH1): Direct Covalent Modification of His315.,No,6BKY
ASD13040000_1,IDH1,Homo sapiens,O75874,6BKZ,ASD13040001,DWM,A,Lig,Inhibitor,"(7R)-1-[(4-fluorophenyl)methyl]-N-{3-[(1R)-1-hydroxyethyl]phenyl}-7-methyl-5-(1H-pyrrole-2-carbonyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine-3-carboxamide",502,Allosteric function,Allosteric position,30004704,Novel Modes of Inhibition of Wild-Type Isocitrate Dehydrogenase 1 (IDH1): Direct Covalent Modification of His315.,No,6BKZ
ASD13040000_1,IDH1,Homo sapiens,O75874,6O2Y,,LJY,A,lig,Inhibitor,"4-{[(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)methyl]amino}-2-methoxybenzonitrile",500,Allosteric function,Allosteric position,,,No,6O2Y
ASD13040000_1,IDH1,Homo sapiens,O75874,6O2Z,,LJV,A,lig,Inhibitor,"6-{[(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)methyl]amino}-2-methylpyridine-3-carbonitrile",500,Allosteric function,Allosteric position,,,No,6O2Z
ASD13050000_1,,Ashbya gossypii,Q756Z6,4Z87,ASD00860009,GDP,A,Lig,Inhibitor,GUANOSINE-5'-DIPHOSPHATE,602,Allosteric Function,Allosteric Position,26558346,Guanine nucleotide binding to the Bateman domain mediates the allosteric inhibition of eukaryotic IMP dehydrogenases.,No,"Chain B:LYS208,ARG167,LYS207,THR206"
ASD13050000_1,,Ashbya gossypii,Q756Z6,4Z87,ASD00860009,GDP,A,Lig,Inhibitor,GUANOSINE-5'-DIPHOSPHATE,603,Allosteric Function,Allosteric Position,26558346,Guanine nucleotide binding to the Bateman domain mediates the allosteric inhibition of eukaryotic IMP dehydrogenases.,No,"Chain A:MET223,SER166,LYS115,ASN118,GLY147,ILE121,PHE148,LYS210,PRO124,ALA146,SER225,PHE145,THR227,VAL125,LYS140,GLY144,LYS231,ALA123,PRO149,TYR116,GLU117,ARG226,THR165,PHE143,ASP228,ASN122,GLY209"
ASD13050000_1,,Ashbya gossypii,Q756Z6,4Z87,ASD00860009,GDP,A,Lig,Inhibitor,GUANOSINE-5'-DIPHOSPHATE,604,Allosteric Function,Allosteric Position,26558346,Guanine nucleotide binding to the Bateman domain mediates the allosteric inhibition of eukaryotic IMP dehydrogenases.,No,"Chain A:GLU197,ALA242,ASN118,LYS231,GLU117,SER241,PRO236,PHE120,LYS245,ASN232,LEU229,LEU224,LYS204,LEU203,THR244,GLN246,ASP228,ALA238,ASN200,GLY119,LYS240,SER225,LEU196,TYR235"
ASD13050000_1,,Ashbya gossypii,Q756Z6,5MCP,ASD00150001,ATP,A,Lig,Inhibitor,ADENOSINE-5'-TRIPHOSPHATE,601,Inner Protein Regulator,Inner Protein,28572600,A nucleotide-controlled conformational switch modulates the activity of eukaryotic IMP dehydrogenases.,No,"Chain E:SER166,GLN170,ARG167,PHE171"
ASD13050000_1,,Ashbya gossypii,Q756Z6,5MCP,ASD00150001,ATP,A,Lig,Inhibitor,ADENOSINE-5'-TRIPHOSPHATE,602,Inner Protein Regulator,Inner Protein,28572600,A nucleotide-controlled conformational switch modulates the activity of eukaryotic IMP dehydrogenases.,No,"Chain E:GLN170,PHE171"
ASD13050000_1,,Ashbya gossypii,Q756Z6,5TC3,ASD00150001,ATP,A,Lig,Inhibitor,ADENOSINE-5'-TRIPHOSPHATE,601,Inner Protein Regulator,Inner Protein,28572600,A nucleotide-controlled conformational switch modulates the activity of eukaryotic IMP dehydrogenases.,No,"Chain B:ARG226,MET230,ARG167,LYS207"
ASD13050000_1,,Ashbya gossypii,Q756Z6,5TC3,ASD00860009,GDP,A,Lig,Inhibitor,GUANOSINE-5'-DIPHOSPHATE,602,Inner Protein Regulator,Inner Protein,28572600,A nucleotide-controlled conformational switch modulates the activity of eukaryotic IMP dehydrogenases.,No,"Chain A:MET223,SER166,LYS115,ASN118,GLY147,ILE121,PHE148,LYS210,PRO124,ALA146,PHE145,THR227,VAL125,LYS140,GLY144,LYS231,ALA123,PRO149,TYR116,GLU117,ARG226,THR165,PHE143,ASP228,SER225,GLY209"
ASD13050000_1,,Ashbya gossypii,Q756Z6,5TC3,ASD00860009,GDP,A,Lig,Inhibitor,GUANOSINE-5'-DIPHOSPHATE,603,Inner Protein Regulator,Inner Protein,28572600,A nucleotide-controlled conformational switch modulates the activity of eukaryotic IMP dehydrogenases.,No,"Chain A:GLU197,ALA242,GLN233,ASN118,LYS231,GLU117,PRO236,PHE120,LYS245,ASN232,LEU237,LEU229,LEU224,LYS204,LEU203,ASP228,ALA238,ASN200,GLY119,LYS240,SER225,ASN68,LEU196,TYR235"
ASD13050000_1,,Ashbya gossypii,Q756Z6,6RPU,,G5P,A,Lig,Inhibitor,P1-(5'-ADENOSYL)-P5-(5'-GUANOSYL) PENTAPHOSPHATE,503,Allosteric function,Allosteric position,,,No,
ASD13070000_1,,Hepatitis C virus genotype 1b,P26663,5FPT,ASD13070001,3VY,A,Lig,Regulator,(1-methyl-1H-indol-3-yl)acetic acid,1721,Allosteric Function,Allosteric Position,26655740,Detection of Secondary Binding Sites in Proteins Using Fragment Screening.,No,"Chain A:VAL256,TYR502,VAL232,GLY255,ARG253,GLY271,ALA275,LYS272,PRO230,THR298,TYR270,THR269,TRP501,THR254"
ASD13070000_1,,Hepatitis C virus genotype 1b,P26663,5FPY,ASD13070002,R2N,A,Lig,Regulator,5-bromo-1-methyl-1H-indole-2-carboxylic acid,1721,Allosteric Function,Allosteric Position,26655740,Detection of Secondary Binding Sites in Proteins Using Fragment Screening.,No,"Chain A:ASN556,GLN434,THR448,LYS372,THR411,TYR392,SER370,VAL432,THR433,LYS371,HIS369"
ASD13080000_1,HSPA5,Homo sapiens,P11021,5.00E+84,ASD00150001,ATP,A,Lig,Regulator,ADENOSINE-5'-TRIPHOSPHATE,801,Allosteric Function,Allosteric Position,26655470,Close and Allosteric Opening of the Polypeptide-Binding Site in a Human Hsp70 Chaperone BiP.,No,5.00E+84
ASD13090000_1,C,Hepatitis B virus genotype D subtype adw,P03147,5D7Y,ASD13090001,58H,B,Lig,Regulator,"methyl (4R)-4-(2-chloro-4-fluorophenyl)-6- {[4-(3-hydroxypenta-1,4-diyn-3-yl)piperidin- 1-yl]methyl}-2-(pyridin-2-yl)-1,4-dihydropyrimidine- 5-carboxylate",201,Allosteric Function,Allosteric Position,26842475,Hepatitis B Virus Capsids Have Diverse Structural Responses to Small-Molecule Ligands Bound to the Heteroaryldihydropyrimidine Pocket.,No,"Chain B:PHE23,LEU101,TYR118,TRP102,ILE105,PRO25,PHE110,SER106,ALA34,SER26,PRO138,THR109,THR33,THR142,LEU30,TYR38,ASP29,ILE139,LEU31,LEU140,ALA107,SER141,LEU37"
ASD13090000_1,C,Hepatitis B virus genotype D subtype adw,P03147,5D7Y,ASD13090001,58H,C,Lig,Regulator,"methyl (4R)-4-(2-chloro-4-fluorophenyl)-6- {[4-(3-hydroxypenta-1,4-diyn-3-yl)piperidin- 1-yl]methyl}-2-(pyridin-2-yl)-1,4-dihydropyrimidine- 5-carboxylate",201,Allosteric Function,Allosteric Position,26842475,Hepatitis B Virus Capsids Have Diverse Structural Responses to Small-Molecule Ligands Bound to the Heteroaryldihydropyrimidine Pocket.,No,"Chain C:SER141,PHE110,PHE122,SER106,THR33,ASP29,TYR118,LEU140,PRO25,ILE105,THR142,ILE139,TRP102,LEU30,PHE23"
ASD13090000_1,C,Hepatitis B virus genotype D subtype adw,P03147,6BVF,ASD13090003,E9D,B,Lig,Regulator,Heteroaryldihydropyrimidine tetramethylrodamine,201,Allosteric function,Allosteric position,29377794,Hepatitis B virus core protein allosteric modulators can distort and disrupt intact capsids.,No,"Chain B:PHE24,PHE23,TYR118,TRP102,ILE105,PRO25,PHE110,SER106,ALA34,PRO138,THR109,THR33,LEU30,ASP29,ILE139,LEU31,LEU140,ALA107,ALA137,ASN136,SER141,LEU37,PHE122"
ASD13090000_1,C,Hepatitis B virus genotype D subtype adw,P03147,6BVN,ASD13090003,E9D,B,Lig,Regulator,Heteroaryldihydropyrimidine tetramethylrodamine,201,Allosteric function,Allosteric position,29377794,Hepatitis B virus core protein allosteric modulators can distort and disrupt intact capsids.,No,"Chain B:PHE24,ILE139,TYR118,TRP102,ILE105,PRO25,PHE110,SER106,ALA34,SER26,PRO138,THR109,THR33,LEU101,LEU30,ASP29,PHE23,LEU31,LEU140,ASP32,ASN136,SER141,LEU37,PHE122"
ASD13100000_1,,Thermotoga maritima,Q9WYL6,4COJ,ASD00870004,DTP,A,Lig,Regulator,2'-DEOXYADENOSINE 5'-TRIPHOSPHATE,654,Allosteric Function,Allosteric Position,https://www.ncbi.nlm.nih.gov/pubmed/26147435,The Crystal Structure of Thermotoga maritima Class III Ribonucleotide Reductase Lacks a Radical Cysteine Pre-Positioned in the Active Site.,No,"Chain B:HIS151,LYS145,HIS158,ALA149,THR154,SER146,PHE155,PRO148,GLU147,SER153,LEU138,LYS150,GLN161,ILE144,GLN157"
ASD13110000_1,DRD1,Homo sapiens,P21728,7CKZ,,G4C,R,Lig,Regulator,"2-[2,6-bis(chloranyl)phenyl]-1-[(1S,3R)-3-(hydroxymethyl)-1-methyl-5-(3-methyl-3-oxidanyl-butyl)-3,4-dihydro-1H-isoquinolin-2-yl]ethanone",503,,,,,,7CKZ
ASD13110000_1,DRD1,Homo sapiens,P21728,7LJC,,G4C,R,Lig,Regulator,"2-[2,6-bis(chloranyl)phenyl]-1-[(1S,3R)-3-(hydroxymethyl)-1-methyl-5-(3-methyl-3-oxidanyl-butyl)-3,4-dihydro-1H-isoquinolin-2-yl]ethanone",502,,,,,,7LJC
ASD13110000_1,DRD1,Homo sapiens,P21728,7LJD,,G4C,R,Lig,Regulator,"2-[2,6-bis(chloranyl)phenyl]-1-[(1S,3R)-3-(hydroxymethyl)-1-methyl-5-(3-methyl-3-oxidanyl-butyl)-3,4-dihydro-1H-isoquinolin-2-yl]ethanone",502,,,,,,7LJD
ASD13110000_1,DRD1,Homo sapiens,P21728,7X2F,ASD13110004,G4C,F,Compound,,"2-(2,6-dichlorophenyl)-1-[(1S,3R)-3-(hydroxymethyl)-5-(3-hydroxy-3-methyl-butyl)-1-methyl-3,4-dihydro-1H-isoquinolin-2-yl]ethanone",,,,35676276,,,7X2F
ASD13140000_1,TYK2,Homo sapiens,P29597,5TKD,ASD13140001,7GL,A,Lig,Inhibitor,"6-[(3,5-dimethylphenyl)amino]-8-(methylamino)imidazo[1,2-b]pyridazine-3-carboxamide",901,Allosteric function,Allosteric position,30108788,"Identification of imidazo[1,2-b]pyridazine TYK2 pseudokinase ligands as potent and selective allosteric inhibitors of TYK2 signalling.",No,5TKD
ASD13140000_1,TYK2,Homo sapiens,P29597,6NZE,,L8Y,A,Lig,Inhibitor,4-[(2-carbamoylphenyl)amino]-6-[(5-fluoropyridin-2-yl)amino]-N-methylpyridine-3-carboxamide,901,,,,,,6NZE
ASD13140000_1,TYK2,Homo sapiens,P29597,6NZF,,L91,A,Lig,Inhibitor,6-[(5-fluoropyridin-2-yl)amino]-N-methyl-4-{[2-(methylsulfonyl)phenyl]amino}pyridine-3-carboxamide,901,,,,,,6NZF
ASD13140000_1,TYK2,Homo sapiens,P29597,6NZH,,L9A,A,Lig,Inhibitor,6-[(cyclopropanecarbonyl)amino]-N-methyl-4-{[2-(methylsulfonyl)phenyl]amino}pyridine-3-carboxamide,4000,,,,,,6NZH
ASD13140000_1,TYK2,Homo sapiens,P29597,6NZQ,,LB4,A,lig,Inhibitor,6-[(5-fluoro-4-methylpyridin-2-yl)amino]-4-[(2-methoxy-3-{[(pyridin-2-yl)methyl]carbamoyl}phenyl)amino]-N-methylpyridine-3-carboxamide,868,Allosteric position,Allosteric position,,,Yes,6NZQ
ASD13140000_1,TYK2,Homo sapiens,P29597,6NZR,,LAJ,A,lig,Inhibitor,N-methyl-4-{[2-(methylsulfonyl)phenyl]amino}-6-[(pyridin-2-yl)amino]pyridazine-3-carboxamide,868,Allosteric position,Allosteric position,,,Yes,6NZR
ASD13160000_1,ACACB,Homo sapiens,O00763,5KKN,ASD00430002,6U3,B,Lig,Inhibitor,"2-[1-[(2~{R})-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-5-methyl-6-(1,3-oxazol-2-yl)-2,4-bis(oxidanylidene)thieno[2,3-d]pyrimidin-3-yl]-2-methyl-propanamide",801,Protein-Protein Interaction,Protein-Protein Interaction,26976583,"Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats.",No,5KKN
ASD13220000_1,,Pseudomonas syringae pv. syringae,Q6VE93,5KLP,ASD03710003,IHP,"A,B,C",Lig,Activator,inositol hexakisphosphate,401,Allosteric Function,Allosteric Position,27525589,Structure of a pathogen effector reveals the enzymatic mechanism of a novel acetyltransferase family.,No,"Chain B:ARG49,ARG106,SER314,GLU103,HIS290,GLU359,GLN358,ILE225,PHE355,VAL312,HIS317,ARG326,PHE330,LYS226,LYS229,GLU321,LYS53,LYS361,ASN222,SER351,LYS289,ARG362,ASN313,ASN107,GLU315"
ASD13220000_1,,Pseudomonas syringae pv. syringae,Q6VE93,5KLQ,ASD03710003,IHP,"A,B,C",Lig,Activator,inositol hexakisphosphate,401,Allosteric Function,Allosteric Position,27525589,Structure of a pathogen effector reveals the enzymatic mechanism of a novel acetyltransferase family.,No,"Chain B:ARG49,GLY316,LYS289,ARG311,GLU103,GLU315,HIS290,GLU359,ILE225,SER351,PHE355,VAL312,ASN107,HIS317,ARG326,PHE330,LYS229,GLY354,LYS53,ARG106,LYS361,ASN222,ASP286,GLN358,SER314,ARG362,ASN313,LYS226"
ASD13230000_1,CASTOR1,Homo sapiens,Q8WTX7,5I2C,,ARG,"A,B,C,D",Lig,Regulator,Arginine,323,Inner Protein Regulator,Allosteric Position,27487210,Mechanism of arginine sensing by CASTOR1 upstream of mTORC1.,No,5I2C
ASD13370000_1,EP300,Homo sapiens,Q09472,6PF1,,OJ7,A,Lig,Inhibitor,3-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]-2-methyl-1H-indole,1702,Allosteric function,Allosteric position,,,No,6PF1
ASD13370000_1,EP300,Homo sapiens,Q09472,6PGU,,OK7,A,Lig,Inhibitor,N-(thiophen-2-yl)acetamide,1702,,,,,,6PGU
ASD13510000_1,KCNQ2,Homo sapiens,O43526,7CR2,,FBX,A,Lig,Activator,ethyl N-[2-azanyl-4-[(4-fluorophenyl)methylamino]phenyl]carbamate,801,,,,,,7CR2
ASD13510000_1,KCNQ2,Homo sapiens,O43526,7CR7,,FBX,A,Lig,Activator,ethyl N-[2-azanyl-4-[(4-fluorophenyl)methylamino]phenyl]carbamate,1001,,,,,,7CR7
ASD13620000_1,GLRA3,Homo sapiens,O75311,5VDH,ASD07970001,IVM,A,Lig,Regulator,"(2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)-6'-[(2S)-butan-2-yl]-20,20b-dihydroxy-5',6,8,19-tetramethyl-17-oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-3-O-methyl-alpha-L-arabino-hexopyranoside",403,Inner Protein Regulator,Inner Protein,28479061,Crystal Structures of Human GlyR alpha 3 Bound to Ivermectin.,No,5VDH
ASD13620000_1,GLRA3,Homo sapiens,O75311,5VDI,ASD07970001,IVM,A,Lig,Regulator,"(2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)-6'-[(2S)-butan-2-yl]-20,20b-dihydroxy-5',6,8,19-tetramethyl-17-oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-3-O-methyl-alpha-L-arabino-hexopyranoside",403,Inner Protein Regulator,Inner Protein,28479061,Crystal Structures of Human GlyR alpha 3 Bound to Ivermectin.,No,5VDI
ASD13680000_2,gag-pol,Human immunodeficiency virus type 1 group M subtype B (isolate BH10),P03366,4R5P,ASD13680038,3JY,,Lig,Inhibitor,"[(1R)-2-methoxy-1-{[(1S,3R)-3-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)cyclopentyl]oxy}-2-oxoethyl]phosphonic acid",602,Allosteric function,Allosteric position,25733891,Alpha-carboxy nucleoside phosphonates as universal nucleoside triphosphate mimics.,No,"Chain T: DA705, DC706"
ASD13680000_2,gag-pol,Human immunodeficiency virus type 1 group M subtype B (isolate BH10),P03366,4RW4,ASD02560102,494,A,Lig,Inhibitor,"(2E)-3-(3-chloro-5-{4-chloro-2-[2-(2,4-dioxo- 3,4-dihydropyrimidin-1(2H)-yl)ethoxy]phenoxy}phenyl)prop- 2-enenitrile",601,Inner Protein Regulator,Allosteric Position,25700160,Structure-Based Evaluation of Non-nucleoside Inhibitors with Improved Potency and Solubility That Target HIV Reverse Transcriptase Variants.,No,Chain A:TYR318
ASD13680000_2,gag-pol,Human immunodeficiency virus type 1 group M subtype B (isolate BH10),P03366,4RW6,ASD02560102,494,A,Lig,Inhibitor,"(2E)-3-(3-chloro-5-{4-chloro-2-[2-(2,4-dioxo- 3,4-dihydropyrimidin-1(2H)-yl)ethoxy]phenoxy}phenyl)prop- 2-enenitrile",601,Inner Protein Regulator,Allosteric Position,25700160,Structure-Based Evaluation of Non-nucleoside Inhibitors with Improved Potency and Solubility That Target HIV Reverse Transcriptase Variants.,No,Chain A:TYR318
ASD13680000_2,gag-pol,Human immunodeficiency virus type 1 group M subtype B (isolate BH10),P03366,4RW7,ASD02560136,3X6,A,Lig,Inhibitor,"(2E)-3-(3-chloro-5-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin- 1(2H)-yl)ethoxy]phenoxy}phenyl)prop-2-enenitrile",601,Inner Protein Regulator,Allosteric Position,25700160,Structure-Based Evaluation of Non-nucleoside Inhibitors with Improved Potency and Solubility That Target HIV Reverse Transcriptase Variants.,No,Chain A:TYR318
ASD13680000_2,gag-pol,Human immunodeficiency virus type 1 group M subtype B (isolate BH10),P03366,4RW8,ASD02560136,3X6,A,Lig,Inhibitor,"(2E)-3-(3-chloro-5-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin- 1(2H)-yl)ethoxy]phenoxy}phenyl)prop-2-enenitrile",601,Inner Protein Regulator,Allosteric Position,25700160,Structure-Based Evaluation of Non-nucleoside Inhibitors with Improved Potency and Solubility That Target HIV Reverse Transcriptase Variants.,No,Chain A:TYR181
ASD13680000_2,gag-pol,Human immunodeficiency virus type 1 group M subtype B (isolate BH10),P03366,4RW9,ASD02560136,3X6,A,Lig,Inhibitor,"(2E)-3-(3-chloro-5-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin- 1(2H)-yl)ethoxy]phenoxy}phenyl)prop-2-enenitrile",601,Inner Protein Regulator,Allosteric Position,25700160,Structure-Based Evaluation of Non-nucleoside Inhibitors with Improved Potency and Solubility That Target HIV Reverse Transcriptase Variants.,No,Chain A:TYR318
ASD13680000_2,gag-pol,Human immunodeficiency virus type 1 group M subtype B (isolate BH10),P03366,5OI2,ASD13680044,9VN,A,Lig,Inhibitor,"(2~{S})-2-[4-(4,4-dimethylcyclohexen-1-yl)-2-methyl-5-pyridin-4-yl-thiophen-3-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid",305,Allosteric Fuction,Allosteric Position,29507092,Structure-function analyses unravel distinct effects of allosteric inhibitors of HIV-1 integrase on viral maturation and integration.,No,"Chain A:GLU96,ALA98,GLY94,TYR99,LEU102,ALA129,ALA128,TRP132,GLN95,THR125,TRP131,THR124"
ASD13680000_2,gag-pol,Human immunodeficiency virus type 1 group M subtype B (isolate BH10),P03366,5OI5,ASD13680042,9VK,A,Lig,Inhibitor,"(2~{S})-2-[4-(4,4-dimethylcyclohexen-1-yl)-2-methyl-5-pyridin-2-yl-thiophen-3-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid",501,Allosteric Fuction,Allosteric Position,29507092,Structure-function analyses unravel distinct effects of allosteric inhibitors of HIV-1 integrase on viral maturation and integration.,No,"Chain A:LEU172,MET178,ALA169,ALA175,GLN168,LYS173,GLU170,HIS171,THR174"
ASD13680000_2,gag-pol,Human immunodeficiency virus type 1 group M subtype B (isolate BH10),P03366,5OI8,ASD13680044,9VN,A,Lig,Inhibitor,"(2~{S})-2-[4-(4,4-dimethylcyclohexen-1-yl)-2-methyl-5-pyridin-4-yl-thiophen-3-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid",302,Allosteric Fuction,Allosteric Position,29507092,Structure-function analyses unravel distinct effects of allosteric inhibitors of HIV-1 integrase on viral maturation and integration.,No,"Chain A:GLU96,ALA98,GLY94,VAL126,TYR99,LEU102,ALA129,ALA128,TRP132,GLN95,TRP131,ALA125,ALA124"
ASD13680000_2,gag-pol,Human immunodeficiency virus type 1 group M subtype B (isolate BH10),P03366,5OIA,ASD13680042,9VK,A,Lig,Inhibitor,"(2~{S})-2-[4-(4,4-dimethylcyclohexen-1-yl)-2-methyl-5-pyridin-2-yl-thiophen-3-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid",303,Allosteric Fuction,Allosteric Position,29507092,Structure-function analyses unravel distinct effects of allosteric inhibitors of HIV-1 integrase on viral maturation and integration.,No,"Chain A:LEU172,MET178,ALA169,ALA175,GLN168,LYS173,GLU170,HIS171,THR174"
ASD13680000_2,gag-pol,Human immunodeficiency virus type 1 group M subtype B (isolate BH10),P03366,6OE3,,M9A,A,Lig,Inhibitor,"5-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]phenoxy}-7-fluoronaphthalene-2-carbonitrile C23 H16 F N3 O4 CZZSYVLCOGCXLL-UHFFFAOYSA-N",601,Protein-DNA/RNA Interaction Regulator,Inner Protein,,,No,
ASD13730000_1,P2RX3,Homo sapiens,P56373,5YVE,ASD13730001,AF9,A,Lig,Inhibitor,"5-[2,4-bis(azanyl)pyrimidin-5-yl]oxy-2-methoxy-4-propan-2-yl-benzenesulfonamide",405,Allosteric function,Allosteric position,29674445,Druggable negative allosteric site of P2X3 receptors.,No,5YVE
ASD14120000_1,FBP2,Homo sapiens,O00757,5ET6,ASD00030001,AMP,"A,B,C,D",Lig,Inhibitor,ADENOSINE MONOPHOSPHATE,"401,401,401,401",Inner Protein Regulator,Allosteric Position,27050133,"T-to-R switch of muscle fructose-1,6-bisphosphatase involves fundamental changes of secondary and quaternary structure.",No,5ET6
ASD14120000_1,FBP2,Homo sapiens,O00757,5ET8,ASD01260013,F6P,A,Lig,Activator,FRUCTOSE-6-PHOSPHATE,401,Allosteric Function,Allosteric Position,,T-to-R switch of muscle FBPase involves extreme changes of secondary and quaternary structure,No,5ET8
ASD14170000_1,proRS,Plasmodium falciparum,Q8I5R7,4WI1,ASD14170001,3O6,"A,B",Lig,Inhibitor,1-(4-fluorophenyl)-3-[4-(4-fluorophenyl)- 1-methyl-3-(trifluoromethyl)-1H-pyrazol-5- yl]urea,"801,801",Inner Protein Regulator,Allosteric Position,27798837,"Biochemical and Structural Characterization of Selective Allosteric Inhibitors of the Plasmodium falciparum Drug Target, Prolyl-tRNA-synthetase.",No,Chain A:GLU404
ASD14170000_1,proRS,Plasmodium falciparum,Q8I5R7,5IFU,ASD14170002,GBM,"A,B",Lig,Inhibitor,5-chloro-N-(2-{4-[(cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-2-methoxybenzamide,801,Allosteric Function,Allosteric Position,27798837,"Biochemical and Structural Characterization of Selective Allosteric Inhibitors of the Plasmodium falciparum Drug Target, Prolyl-tRNA-synthetase.",yes,"Chain B:GLY517,TYR285,ILE270,GLU404,ARG403,SER515,ARG514,THR513,LEU287,ILE276,MET521,PHE262,ILE520,SER263,ILE474,ALA291,TYR266,TYR746,ILE516,LEU275,ILE518"
ASD14190000_1,KLK4,Homo sapiens,Q9Y5K2,4KGA,ASD08890001,NI,A,Ion,Inhibitor,NICKEL (II) ION,301,Allosteric function,Allosteric position,27767076,Direct and indirect mechanisms of KLK4 inhibition revealed by structure and dynamics,Yes,4KGA
ASD14300000_1,ppa,Mycobacterium tuberculosis,P9WI55,5KDE,ASD14300001,6RT,A,Lig,Inhibitor,"2,4-bis(aziridin-1-yl)-6-(1-phenylpyrrol-2-yl)-1,3,5-triazine",201,Allosteric Fuction,Allosteric Position,27622287,Discovery of Allosteric and Selective Inhibitors of Inorganic Pyrophosphatase from Mycobacterium tuberculosis.,No,"Chain A:ASP110,ARG101,TRP102,LEU61,PRO63,GLU115,VAL111,HIS104,ASP103,ASP99,LEU62,PHE114,VAL105,PRO112"
ASD14300000_1,ppa,Mycobacterium tuberculosis,P9WI55,5KDF,ASD14300002,6RU,A,Lig,Inhibitor,"~{N}2,~{N}2,~{N}4,~{N}4-tetramethyl-6-(1-phenylpyrrol-2-yl)-1,3,5-triazine-2,4-diamine",201,Allosteric Fuction,Allosteric Position,27622287,Discovery of Allosteric and Selective Inhibitors of Inorganic Pyrophosphatase from Mycobacterium tuberculosis.,No,"Chain A:ARG101,TRP102,PRO63,HIS104,LEU62,VAL105"
ASD14350000_1,WNK1,Homo sapiens,Q9H4A3,5TF9,ASD14350001,7AV,A,Lig,Inhibitor,"{2-[(4-chlorophenyl)methoxy]phenyl}{5-[2- (methylamino)-1,3-thiazol-4-yl]-2,3-dihydro- 1H-indol-1-yl}methanone",501,Inner Protein Regulator,Inner Protein,27712055,Discovery and Characterization of Allosteric WNK Kinase Inhibitors.,No,5TF9
ASD14350000_1,WNK1,Homo sapiens,Q9H4A3,5WDY,ASD14350004,A6S,A,Lig,Inhibitor,1-cyclohexyl-N-({6-fluoro-1-[2-(3-methoxyphenyl)pyridin- 4-yl]-1H-indol-3-yl}methyl)methanamine,902,Inner Protein Regulator,Inner Protein,28771350,Optimization of Allosteric With-No-Lysine (WNK) Kinase Inhibitors and Efficacy in Rodent Hypertension Models.,No,5WDY
ASD14350000_1,WNK1,Homo sapiens,Q9H4A3,5WE8,ASD14350005,A7Y,A,Lig,Inhibitor,N-{(3R)-1-[(4-chlorophenyl)methyl]pyrrolidin-3-yl}-2-(3-methoxyphenyl)-N-methylquinoline-4-carboxamide,503,Inner Protein Regulator,Inner Protein,28771350,Optimization of Allosteric With-No-Lysine (WNK) Kinase Inhibitors and Efficacy in Rodent Hypertension Models.,No,5WE8
ASD14360000_1,PRMT6,Homo sapiens,Q96LA8,6W6D,ASD14360004,T9A,A,compound,,"(R)-4-(5-bromothiophene-2-carbonyl)-5-(3,5-dimethylphenyl)-7-methyl-1,3,4,5-tetrahydro-2H-benzo[e][1,4]diazepin-2-one",,,,33591753,,,6W6D
ASD14460000_1,SIRT6,Homo sapiens,Q8N6T7,5Y2F,ASD14460001,8L9,A,Lig,Activator,"5-[[3,5-bis(chloranyl)phenyl]sulfonylamino]-2-[(5-bromanyl-4-fluoranyl-2-methyl-phenyl)sulfamoyl]benzoic acid",402,Allosteric function,Allosteric position,30374165,Identification of a cellularly active SIRT6 allosteric activator.,No,5Y2F
ASD14460000_1,SIRT6,Homo sapiens,Q8N6T7,6QCE,,HW2,A,Lig,Activator,isoquercetin,408,Inner Protein Regulator,Inner Protein,,,No,6QCE
ASD14460000_1,SIRT6,Homo sapiens,Q8N6T7,6QCH,,HWB,A,Lig,Activator,cyanidin,410,Inner Protein Regulator,Inner Protein,,,No,6QCH
ASD14460000_1,SIRT6,Homo sapiens,Q8N6T7,6QCJ,,XEG,A,Lig,Inhibitor,"(2R,3S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate",407,Inner Protein Regulator,Inner Protein,,,No,6QCJ
ASD14570000_1,MAT2A,Homo sapiens,P31153,5UGH,ASD14570001,8AJ,A;C,Lig,Inhibitor,"2-(7-chloro-5-phenyl[1,2,4]triazolo[4,3-a]quinolin- 1-yl)-N,N-dimethylethan-1-amine",401;401,Inner Protein Regulator,Inner Protein,28553945,Targeting S-adenosylmethionine biosynthesis with a novel allosteric inhibitor of Mat2A.,No,5UGH
ASD14570000_1,MAT2A,Homo sapiens,P31153,7BHR,,TQE,A,Lig,Inhibitor,"4-(dimethylamino)-6-ethoxy-1~{H}-1,3,5-triazin-2-one",401,,,,,,7BHR
ASD14570000_1,MAT2A,Homo sapiens,P31153,7BHS,,TNZ,A,Lig,Inhibitor,6-chloranyl-2-methoxy-4-phenyl-quinazoline,401,,,,,,7BHS
ASD14570000_1,MAT2A,Homo sapiens,P31153,7BHT,,TO8,A,Lig,Inhibitor,7-chloranyl-4-(dimethylamino)-1~{H}-quinazolin-2-one,402,,,,,,7BHT
ASD14570000_1,MAT2A,Homo sapiens,P31153,7BHU,,TOW,A,Lig,Inhibitor,7-chloranyl-4-(dimethylamino)-1-(2-hydroxyethyl)quinazolin-2-one,401,,,,,,7BHU
ASD14570000_1,MAT2A,Homo sapiens,P31153,7BHV,,TQB,A,Lig,Inhibitor,7-chloranyl-4-(dimethylamino)-1-phenyl-quinazolin-2-one,401,,,,,,7BHV
ASD14570000_1,MAT2A,Homo sapiens,P31153,7BHW,,TNW,A,Lig,Inhibitor,7-chloranyl-4-(dimethylamino)-1-(3-methylphenyl)quinazolin-2-one,401,,,,,,7BHW
ASD14570000_1,MAT2A,Homo sapiens,P31153,7BHX,,TO5,A,Lig,Inhibitor,7-chloranyl-4-(dimethylamino)-1-pyridin-3-yl-quinazolin-2-one,402,,,,,,7BHX
ASD14570000_1,MAT2A,Homo sapiens,P31153,7KCC,,WBG,A,Lig,Inhibitor,"3-(cyclohex-1-en-1-yl)-6-(4-methoxyphenyl)-2-phenyl-5-[(pyridin-2-yl)amino]pyrazolo[1,5-a]pyrimidin-7(4H)-one",408,,,,,,7KCC
ASD14570000_1,MAT2A,Homo sapiens,P31153,7KCE,,J41,A,Lig,Inhibitor,"5-methyl-2,3-diphenylpyrazolo[1,5-a]pyrimidin-7(4H)-one",401,,,,,,7KCE
ASD14570000_1,MAT2A,Homo sapiens,P31153,7KCF,,J4A,A,Lig,Inhibitor,"6-(4-hydroxyphenyl)-5-methyl-2-phenyl-3-(piperidin-1-yl)pyrazolo[1,5-a]pyrimidin-7(4H)-one",401,,,,,,7KCF
ASD14570000_1,MAT2A,Homo sapiens,P31153,7KDA,,WBM,A,Lig,Inhibitor,"2,3-diphenyl-5-[(1H-pyrazol-3-yl)amino]pyrazolo[1,5-a]pyrimidin-7(4H)-one",505,,,,,,7KDA
ASD14570000_1,MAT2A,Homo sapiens,P31153,7KDB,,WBS,A,Lig,Inhibitor,"6-(4-hydroxyphenyl)-2,3-diphenyl-5-[(1H-pyrazol-3-yl)amino]pyrazolo[1,5-a]pyrimidin-7(4H)-one",401,,,,,,7KDB
ASD14580000_1,fbpC,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),P9WQN9,5KWI,ASD14580001,6Y1,A,Lig,Inhibitor,~{N}-(1-adamantyl)-2-selanyl-benzamide,401,Allosteric Fuction,Allosteric Position,28285521,Exploring Covalent Allosteric Inhibition of Antigen 85C from Mycobacterium tuberculosis by Ebselen Derivatives.,No,"Chain A:PHE252,GLN236,PRO255,ASN235,VAL207,LEU232,CYS209,ARG239,ASN253,PHE254,TYR208"
ASD14580000_1,fbpC,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),P9WQN9,5KWJ,ASD14580005,6Y3,A,Lig,Inhibitor,~{N}-(4-aminophenyl)-2-selanyl-benzamide,401,Allosteric Fuction,Allosteric Position,28285521,Exploring Covalent Allosteric Inhibition of Antigen 85C from Mycobacterium tuberculosis by Ebselen Derivatives.,No,"Chain A:PHE252,GLN236,ASN235,VAL207,LEU232,CYS209,ARG239,ASN253,PHE254,TYR208"
ASD14610000_1,UL44,Human cytomegalovirus (strain AD169),P16790,5IWD,ASD14610002,6EV,A,Lig,Inhibitor,5-methylidene-3-(methylsulfanyl)-2-benzothiophen-4(5H)-one,301,Allosteric Fuction,Allosteric Position,28183184,A Small Covalent Allosteric Inhibitor of Human Cytomegalovirus DNA Polymerase Subunit Interactions.,No,"Chain A:ARG3,LYS4"
ASD14640000_1,EED,Homo sapiens,O75530,5GSA,ASD14640003,73K,"A,B",Lig,Inhibitor,"N-(furan-2-ylmethyl)-8-(4-methylsulfonylphenyl)- [1,2,4]triazolo[4,3-c]pyrimidin-5-amine",501,Inner Protein Regulator,Allosteric Position,28135235,An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of,No,5GSA
ASD14640000_1,EED,Homo sapiens,O75530,5H13,ASD14640029,LQA,A,Lig,Inhibitor,"4-azanylidene-2-(3-methoxy-4-propan-2-yloxy- phenyl)-6,7-dihydro-[1,3]benzodioxolo[6,5- a]quinolizine-3-carbonitrile",503,Inner Protein Regulator,Allosteric Position,28072869,Discovery and Molecular Basis of a Diverse Set of Polycomb Repressive Complex 2 Inhibitors Recognition by EED,No,5H13
ASD14640000_1,EED,Homo sapiens,O75530,5H14,,LQB,"A,B",Lig,Inhibitor,"2-[3-(3,5-dimethylpyrazol-1-yl)-4-nitro-phenyl]- 3,4-dihydro-1H-isoquinoline",502,Inner Protein Regulator,Allosteric Position,28072869,Discovery and Molecular Basis of a Diverse Set of Polycomb Repressive Complex 2 Inhibitors Recognition by EED,No,5H14
ASD14640000_1,EED,Homo sapiens,O75530,5H15,,LQD,"A,B",Lig,Inhibitor,"(3R,4S)-1-[(2-methoxyphenyl)methyl]-N,N-dimethyl- 4-(1-methylindol-3-yl)pyrrolidin-3-amine",501,Inner Protein Regulator,Allosteric Position,28072869,Discovery and Molecular Basis of a Diverse Set of Polycomb Repressive Complex 2 Inhibitors Recognition by EED,No,5H15
ASD14640000_1,EED,Homo sapiens,O75530,5H17,,LQE,A,Lig,Inhibitor,"(3R,4aS,10aS)-6-methoxy-3-[(3-methoxyphenyl)methyl]- 1-methyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinoline",501,Inner Protein Regulator,Allosteric Position,28072869,Discovery and Molecular Basis of a Diverse Set of Polycomb Repressive Complex 2 Inhibitors Recognition by EED,No,5H17
ASD14640000_1,EED,Homo sapiens,O75530,5H19,,LQF,A,Lig,Inhibitor,"5-(furan-2-ylmethylamino)-9-(phenylmethyl)- 8,10-dihydro-7H-[1,2,4]triazolo[3,4-a][2,7]naphthyridine- 6-carbonitrile",501,Inner Protein Regulator,Allosteric Position,28072869,Discovery and Molecular Basis of a Diverse Set of Polycomb Repressive Complex 2 Inhibitors Recognition by EED,No,5H19
ASD14640000_1,EED,Homo sapiens,O75530,5H24,ASD14640034,LQG,A,Lig,Inhibitor,"5-(furan-2-ylmethylamino)-[1,2,4]triazolo[4,3-a]pyridine-6-carbonitrile",501,Allosteric Function,Allosteric Position,28092155,"Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer Efficacy",No,5H24
ASD14640000_1,EED,Homo sapiens,O75530,5H25,ASD14640035,LQH,,Lig,InhibitorA,"5-(2-fluorophenyl)-2,3-dihydroimidazo[2,1-a]isoquinoline",501,Allosteric Function,Allosteric Position,28092155,"Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer Efficacy",No,5H25
ASD14640000_1,EED,Homo sapiens,O75530,5TTW,,UNC4859,B,Pep,Inhibitor,Peptidomimetic Ligands,"1,2,3,4,5",Protein-Protein Interaction,Protein-Protein Interaction,28165227,Discovery of Peptidomimetic Ligands of EED as Allosteric Inhibitors of PRC2.,0,5TTW
ASD14640000_1,EED,Homo sapiens,O75530,5U5H,ASD14640025,7VV,A,Lig,Inhibitor,"(6S)-6-[(2-fluoro-5-methoxyphenyl)methyl]- 1-(propan-2-yl)-5,6,7,8-tetrahydroimidazo[1,5- a]pyridin-3-amine",501,Inner Protein Regulator,Inner Protein,27992714,Structure-Guided Design of EED Binders Allosterically Inhibiting the Epigenetic Polycomb Repressive Complex 2 (PRC2) Methyltransferase.,No,5U5H
ASD14640000_1,EED,Homo sapiens,O75530,5U5K,ASD14640026,7VY,A,Lig,Inhibitor,(3R)-3-[(3-methoxyphenyl)methyl]piperidine,502,Inner Protein Regulator,Inner Protein,27992714,Structure-Guided Design of EED Binders Allosterically Inhibiting the Epigenetic Polycomb Repressive Complex 2 (PRC2) Methyltransferase.,No,5U5K
ASD14640000_1,EED,Homo sapiens,O75530,5U5T,ASD14640027,7W7,B,Lig,Inhibitor,"(3R)-3-[(2H-1,3-benzodioxol-4-yl)methyl]piperidine- 1-carboximidamide",503,Inner Protein Regulator,Inner Protein,27992714,Structure-Guided Design of EED Binders Allosterically Inhibiting the Epigenetic Polycomb Repressive Complex 2 (PRC2) Methyltransferase.,No,5U5T
ASD14640000_1,EED,Homo sapiens,O75530,5U62,ASD14640028,7WD,B,Lig,Inhibitor,"(6S)-6-[(2H-1,3-benzodioxol-4-yl)methyl]- 5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-3- amine",501,Inner Protein Regulator,Inner Protein,27992714,Structure-Guided Design of EED Binders Allosterically Inhibiting the Epigenetic Polycomb Repressive Complex 2 (PRC2) Methyltransferase.,No,5U62
ASD14640000_1,EED,Homo sapiens,O75530,5WUK,ASD14640003,73K,A,Lig,Inhibitor,"N-(furan-2-ylmethyl)-8-(4-methylsulfonylphenyl)- [1,2,4]triazolo[4,3-c]pyrimidin-5-amine",502,Inner Protein Regulator,Inner Protein,28111304,Split luciferase-based biosensors for characterizing EED binders,No,5WUK
ASD14640000_1,EED,Homo sapiens,O75530,6SFB,,L9K,A,lig,Inhibitor,"(~{E})-~{N}-(1-benzofuran-4-ylmethyl)-8-(4-methylsulfonylphenyl)-6~{H}-[1,2,4]triazolo[4,3-c]pyrimidin-5-imine",501,Allosteric function,Allosteric position,,,Yes,6SFB
ASD14640000_1,EED,Homo sapiens,O75530,6SFC,,L9M,A,lig,Inhibitor,"~{N}-(1-benzofuran-4-ylmethyl)-8-(4-methylsulfonylphenyl)-[1,2,4]triazolo[4,3-c]pyrimidin-5-amine",503,Allosteric function,Allosteric position,,,Yes,6SFC
ASD14880000_1,LGMN,Homo sapiens,Q99538,5LU8,ASD14880010,5KN,A,Lig,Inhibitor,"2,4-di(morpholin-4-yl)aniline",306,Allosteric Fuction,Allosteric Position,28345579,Inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer's disease.,No,5LU8
ASD14880000_1,LGMN,Homo sapiens,Q99538,5LU9,ASD14880005,3Y7,A,Lig,Inhibitor,"7-(morpholin-4-yl)-2,1,3-benzoxadiazol-4-amine",305,Allosteric Fuction,Allosteric Position,28345579,Inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer's disease.,No,5LU9
ASD14880000_1,LGMN,Homo sapiens,Q99538,5LUA,ASD14880010,5KN,B,Lig,Inhibitor,"2,4-di(morpholin-4-yl)aniline",304,Allosteric Fuction,Allosteric Position,28345579,Inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer's disease.,No,5LUA
ASD14880000_1,LGMN,Homo sapiens,Q99538,5LUB,ASD14880005,3Y7,B,Lig,Inhibitor,"7-(morpholin-4-yl)-2,1,3-benzoxadiazol-4-amine",304,Allosteric Fuction,Allosteric Position,28345579,Inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer's disease.,No,5LUB
ASD15100000_1,SNRNP200,Homo sapiens,O75643,5URJ,ASD15100001,8LS,A,Lig,Inhibitor,"6-benzyl-3-[(2R)-2-(3-fluoropyridin-2-yl)- 6-methyl-3,4-dihydro-2H-1-benzopyran-7-yl]- 4,6-dihydropyrido[4,3-d]pyrimidine-2,7(3H,8H)- dione",2202,Inner Protein Regulator,Inner Protein,28586220,Discovery of Allosteric Inhibitors Targeting the Spliceosomal RNA Helicase Brr2.,No,5URJ
ASD15100000_1,SNRNP200,Homo sapiens,O75643,5URK,ASD15100002,8LP,A,Lig,Inhibitor,"6-benzyl-3-[3-(benzyloxy)phenyl]-4,6-dihydropyrido[4,3- d]pyrimidine-2,7(1H,3H)-dione",2202,Inner Protein Regulator,Inner Protein,28586220,Discovery of Allosteric Inhibitors Targeting the Spliceosomal RNA Helicase Brr2.,No,5URK
ASD15110000_1,,Plasmodium falciparum (isolate 3D7),Q8I302,5JWC,ASD15110001,4W0,H,Lig,Inhibitor,5-fluoro-3-methyl-2-{4-[4-(trifluoromethoxy)benzyl]phenyl}quinolin-4(1H)-one,609,Allosteric function,Allosteric position,28195463,Target Elucidation by Cocrystal Structures of NADH-Ubiquinone Oxidoreductase of Plasmodium falciparum (PfNDH2) with Small Molecule To Eliminate Drug-Resistant Malaria,No,Chain H:PRO530
ASD15130000_1,,Streptococcus mutans serotype c (strain ATCC 700610 / UA159),Q8DW05,5XE9,ASD15130001,6CH,B,Lig,Inhibitor,"[(1~{S},2~{R},4~{S},5~{R})-5-[5-(4-methoxyphenyl)-2-methyl-pyrazol-3-yl]-1-azabicyclo[2.2.2]octan-2-yl]methyl ~{N}-propylcarbamate",201,Inner Protein Regulator,Inner Protein,28642545,High-throughput Screening of Small Molecule Inhibitors of the Streptococcus Quorum-sensing Signal Pathway,No,"Chain B:LEU138,LEU80,LEU74,GLU64,ALA139,THR73,ILE68,TYR77,ARG66,THR81,ASP79,ALA70,LYS69,ASP71,PHE137,THR65"
ASD15140000_1,Itpr1,Mus musculus,P11881,5GUG,ASD07660002,I3P,"A,B",Lig,Activator,"D-MYO-INOSITOL-1,4,5-TRIPHOSPHATE","30,003,000",Inner Protein Regulator,Allosteric Position,28416699,IP3-mediated gating mechanism of the IP3 receptor revealed by mutagenesis and X-ray crystallography,No,Chain A:THR267
ASD15140000_1,Itpr1,Mus musculus,P11881,5XA1,ASD07660002,I3P,A,Lig,Regulator,"D-MYO-INOSITOL-1,4,5-TRIPHOSPHATE",3000,Inner Protein Regulator,Inner Protein,28416699,IP3-mediated gating mechanism of the IP3 receptor revealed by mutagenesis and X-ray crystallography,No,"Chain A:ARG568,SER274,LYS508,LYS569,THR276,ARG265,SER277,THR267,ARG269,ALA275,THR266,ARG504,VAL414,TYR567,ARG511,GLY268,GLU512"
ASD15160000_1,popp,Ralstonia solanacearum,A0A0S4VB05,5W3T,ASD03710003,IHP,A,Lig,Activator,INOSITOL HEXAKISPHOSPHATE,501,Inner Protein Regulator,Inner Protein,28737762,Mechanism of host substrate acetylation by a YopJ family effector.,No,"Chain A:ASP334,VAL406,ARG416,GLU205,ARG419,LYS408,ARG208,SER327,HIS420,LYS383,HIS384,GLU411,ARG380,LEU457,ASN407,LYS453,ARG409,ASN209,ARG460,SER449,LEU330,LYS331"
ASD15160000_1,popp,Ralstonia solanacearum,A0A0S4VB05,5W3X,ASD03710003,IHP,A,Lig,Activator,INOSITOL HEXAKISPHOSPHATE,501,Inner Protein Regulator,Inner Protein,28737762,Mechanism of host substrate acetylation by a YopJ family effector.,No,"Chain A:ASP334,VAL406,ARG416,GLU205,ARG419,LYS408,ARG208,SER327,HIS420,LYS383,HIS384,GLU411,ARG380,LEU457,ASN407,LYS453,ARG409,ASN209,ARG460,SER449,LEU330,LYS331"
ASD15160000_1,popp,Ralstonia solanacearum,A0A0S4VB05,5W3Y,ASD03710003,IHP,A,Lig,Activator,INOSITOL HEXAKISPHOSPHATE,501,Inner Protein Regulator,Inner Protein,28737762,Mechanism of host substrate acetylation by a YopJ family effector.,No,Chain B:SER389
ASD15160000_1,popp,Ralstonia solanacearum,A0A0S4VB05,5W40,ASD03710003,IHP,A,Lig,Activator,INOSITOL HEXAKISPHOSPHATE,501,Inner Protein Regulator,Inner Protein,28737762,Mechanism of host substrate acetylation by a YopJ family effector.,No,Chain B:SER389
ASD15170000_1,ORF17,Human herpesvirus 8,O40922,5UR3,ASD15170006,8OY,A,Lig,Inhibitor,4-{[6-(cyclohexylmethyl)pyridine-2-carbonyl]amino}-3-(phenylamino)benzoic acid,201,Allosteric function,Allosteric position,,Kaposi's Sarcoma Herpesvirus Protease in Complex with Allosteric Inhibitor,No,"Chain A:PRO192,ILE105,TRP109,ILE44,LEU106,PHE189,ALA139,SER191,LEU110,LEU83,ALA80,PHE76,THR50,VAL52,ALA90,LEU79"
ASD15170000_1,ORF17,Human herpesvirus 8,O40922,5UTE,ASD15170001,8M4,A,Lig,Inhibitor,4-{[6-(cyclohexylmethyl)pyridine-2-carbonyl]amino}-3-[(4-methoxyphenyl)amino]benzoic acid,201,Allosteric function,Allosteric position,,Kaposi's Sarcoma Herpesvirus Protease in Complex with Allosteric Inhibitor,No,"Chain A:ALA75,ILE105,TRP109,PRO192,ILE44,LEU106,PHE189,ALA139,LEU110,LEU83,ALA80,PHE76,ALA90,LEU79"
ASD15170000_1,ORF17,Human herpesvirus 8,O40922,5UTN,ASD15170002,8MA,A,Lig,Inhibitor,4-{[6-(cyclohexylmethyl)pyridine-2-carbonyl]amino}-3-[(4-fluorophenyl)amino]benzoic acid,201,Allosteric function,Allosteric position,,Kaposi's Sarcoma Herpesvirus Protease in Complex with Allosteric Inhibitor,No,"Chain A:PRO192,ILE105,TRP109,ILE44,LEU106,PHE189,ALA139,LEU110,LEU83,ALA80,PHE76,THR50,ALA90,LEU79"
ASD15170000_1,ORF17,Human herpesvirus 8,O40922,5UV3,ASD15170003,8N4,A,Lig,Inhibitor,4-{[6-(cyclohexylmethyl)pyridine-2-carbonyl]amino}-3-{[3-(trifluoromethoxy)phenyl]amino}benzoic acid,201,Allosteric function,Allosteric position,,Kaposi's Sarcoma Herpesvirus Protease in Complex with Allosteric Inhibitor,No,"Chain A:PRO192,ILE105,TRP109,LEU47,ILE44,LEU106,PHE189,ALA139,SER191,LEU110,LEU83,ALA80,PHE76,THR50,LEU193,ALA90,LEU79"
ASD15170000_1,ORF17,Human herpesvirus 8,O40922,5UVP,ASD15170005,8N7,A,Lig,Inhibitor,6-(cyclohexylmethyl)-N-{2-[(oxan-4-yl)oxy]-4-(1H-tetrazol-5-yl)phenyl}pyridine-2-carboxamide,"201,202",Allosteric function,Allosteric position,,Kaposi's Sarcoma Herpesvirus Protease in Complex with Allosteric Inhibitor,No,"Chain A:SER87,VAL89,ILE105,TRP109,SER191,PRO192,ILE44,ARG91,PHE189,LEU106,ALA80,LEU110,LEU83,ARG82,PHE76,LEU193,ALA90,LEU79"
ASD15170000_1,ORF17,Human herpesvirus 8,O40922,5V5D,ASD15170006,8OY,A,Lig,Inhibitor,4-{[6-(cyclohexylmethyl)pyridine-2-carbonyl]amino}-3-(phenylamino)benzoic acid,201,Inner Protein Regulator,Inner Protein,28759216,"Allosteric Inhibitors, Crystallography, and Comparative Analysis Reveal Network of Coordinated Movement across Human Herpesvirus Proteases.",No,"Chain A:PRO192,ILE105,TRP109,ILE44,LEU106,PHE189,ALA139,LEU110,LEU83,ALA80,PHE76,THR50,ALA90,LEU79"
ASD15170000_1,ORF17,Human herpesvirus 8,O40922,5V5E,ASD15170003,8N4,A,Lig,Inhibitor,4-{[6-(cyclohexylmethyl)pyridine-2-carbonyl]amino}- 3-{[3-(trifluoromethoxy)phenyl]amino}benzoic acid,201,Inner Protein Regulator,Inner Protein,28759216,"Allosteric Inhibitors, Crystallography, and Comparative Analysis Reveal Network of Coordinated Movement across Human Herpesvirus Proteases.",No,"Chain A:PRO192,ILE105,TRP109,LEU47,LEU110,ILE44,LEU106,PHE189,ALA139,SER191,GLU45,LEU83,ALA80,PHE76,THR50,LEU193,ALA90,LEU79"
ASD15180000_1,JAK2,Homo sapiens,O60674,5UT4,ASD15180003,DQX,A,Lig,Inhibitor,"8-[3,5-difluoro-4-(morpholin-4-ylmethyl)phenyl]- 2-(1-piperidin-4-yl-1H-pyrazol-4-yl)quinoxaline",901,Inner Protein Regulator,Inner Protein,28626520,JAK2 JH2 Fluorescence Polarization Assay and Crystal Structures for Complexes with Three Small Molecules.,No,5UT4
ASD15180000_1,JAK2,Homo sapiens,O60674,5UT5,ASD15180001,2HB,A,Lig,Inhibitor,"N-(5-{4-[(1,1-dioxidothiomorpholin-4-yl)methyl]phenyl}[1,2,4]triazolo[1,5- a]pyridin-2-yl)cyclopropanecarboxamide",905,Inner Protein Regulator,Inner Protein,28626520,JAK2 JH2 Fluorescence Polarization Assay and Crystal Structures for Complexes with Three Small Molecules.,No,5UT5
ASD15180000_1,JAK2,Homo sapiens,O60674,5UT6,ASD15180002,8MY,A,Lig,Inhibitor,"8-[3,5-difluoro-4-(morpholin-4-ylmethyl)phenyl]- 2-(1-piperidin-4-yl-1H-pyrazol-4-yl)quinoxaline",901,Inner Protein Regulator,Inner Protein,28626520,JAK2 JH2 Fluorescence Polarization Assay and Crystal Structures for Complexes with Three Small Molecules.,No,5UT6
ASD15180000_1,JAK2,Homo sapiens,O60674,6D2I,,35R,A,lig,Inhibitor,1-cyclopropyl-3-{3-[5-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl}urea,901,Allosteric function,Allosteric position,,,Yes,6D2I
ASD15190000_1,MMP7,Homo sapiens,P09237,5UE5,ASD15190001;ASD15190002,IDS;SGN,A,Lig,Regulator,"N,O6-DISULFO-GLUCOSAMINE, 2-O-sulfo-alpha-L-idopyranuronic acid",305-312,Inner Protein Regulator,Inner Protein,28648610,Glycan Activation of a Sheddase: Electrostatic Recognition between Heparin and proMMP-7.,No,5UE5
ASD15200000_1,env,Human immunodeficiency virus 1,Q2N0S5,5U7M,ASD04780001,83G,G,Lig,Inhibitor,"1-[(2R)-4-(benzenecarbonyl)-2-methylpiperazin- 1-yl]-2-(4-methoxy-1H-pyrrolo[2,3-b]pyridin- 3-yl)ethane-1,2-dione",657,Inner Protein Regulator,Inner Protein,28825711,Crystal structures of trimeric HIV envelope with entry inhibitors BMS-378806 and BMS-626529.,No,"Chain G:GLN432,PHE376,ALA433,ASN425,TRP112,GLN428,SER375,ASP113,TYR384,TRP427,SER256,MET426,ILE424,ASN377,LEU116,THR257,SER110,MET434,GLU370,PHE382,MET475,PHE383,ILE109,ILE108,VAL255"
ASD15200000_1,env,Human immunodeficiency virus 1,Q2N0S5,5U7O,ASD15200002,83J,G,Lig,Inhibitor,"1-[4-(benzenecarbonyl)piperazin-1-yl]-2-[4- methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)- 1H-pyrrolo[2,3-c]pyridin-3-yl]ethane-1,2- dione",659,Inner Protein Regulator,Inner Protein,28825711,Crystal structures of trimeric HIV envelope with entry inhibitors BMS-378806 and BMS-626529.,No,"Chain G:GLN432,PHE376,ALA433,ASN425,TRP112,GLN428,THR202,SER375,ASP113,ALA200,TYR384,TRP427,SER256,MET426,ILE424,ASN377,LEU116,THR257,LYS117,SER110,MET434,GLU370,PHE382,MET475,PHE383,ILE109,ILE108,VAL255"
ASD15220000_1,trpB,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),P9WFX9,5TCI,ASD02900012,79V,,Lig,Inhibitor,"(2R,3S,4R)-3-(2'-fluoro[1,1'-biphenyl]-4- yl)-4-(hydroxymethyl)azetidine-2-carbonitrile",501,Inner Protein Regulator,Inner Protein,28671682,A small-molecule allosteric inhibitor of Mycobacterium tuberculosis tryptophan synthase.,No,"Chain B:PRO208,ILE38,HIS294,ALA206,GLY207,PHE293,PHE211,TYR200,LEU34,TYR29,TRP191,GLY295,PRO31,VAL30,ILE184,PHE202,PHE188"
ASD15220000_1,trpB,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),P9WFX9,5TCJ,ASD02900012,79V,,Lig,Inhibitor,"(2R,3S,4R)-3-(2'-fluoro[1,1'-biphenyl]-4- yl)-4-(hydroxymethyl)azetidine-2-carbonitrile",505,Inner Protein Regulator,Inner Protein,28671682,A small-molecule allosteric inhibitor of Mycobacterium tuberculosis tryptophan synthase.,No,"Chain B:PRO208,ASN185,ILE38,HIS294,ALA206,GLY207,PHE293,PHE211,TYR200,ALA292,LEU34,TYR29,TRP191,GLY295,PRO31,VAL30,ILE184,PHE202,PHE188"
ASD15220000_1,trpB,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),P9WFX9,6U6C,,PZV,B,Lig,Inhibitor,"1-(2-fluorobenzene-1-carbonyl)-N-methyl-2,3-dihydro-1H-indole-5-sulfonamide",501,,,,,,
ASD15220000_1,trpB,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),P9WFX9,6USA,,PZJ,B,Lig,Inhibitor,"(3R,4R)-4-[4-(2-Chlorophenyl)piperazin-1-yl]-1,1-dioxothiolan-3-ol",501,,,,,,
ASD15230000_1,,Arcobacter butzleri (strain RM4018),A8EVM5,5KLG,ASD15230003,6UC,D,Lig,Inhibitor,"O3-ethyl O5-methyl (4R)-4-(2-bromophenyl)- 2-[2-(dimethylamino)ethoxymethyl]-6-methyl- 1,4-dihydropyridine-3,5-dicarboxylate",1305,Allosteric Function,Allosteric Position,27556947,Structural basis for inhibition of a voltage-gated Ca(2+) channel by Ca(2+) antagonist drugs.,No,"Chain D:PRO1200,TYR1195,PRO1192,PHE1203,MET1188,ILE1199,VAL1196"
ASD15230000_1,,Arcobacter butzleri (strain RM4018),A8EVM5,5KLS,ASD15230003,6UC,C,Lig,Inhibitor,"O3-ethyl O5-methyl (4R)-4-(2-bromophenyl)- 2-[2-(dimethylamino)ethoxymethyl]-6-methyl- 1,4-dihydropyridine-3,5-dicarboxylate",1304,Allosteric Function,Allosteric Position,27556947,Structural basis for inhibition of a voltage-gated Ca(2+) channel by Ca(2+) antagonist drugs.,No,"Chain B:ILE1199,TRP1195,PHE1203,PRO1192"
ASD15230000_1,,Arcobacter butzleri (strain RM4018),A8EVM5,5KMD,ASD15230002,6UB,C,Lig,Inhibitor,"5-dicarboxylate,,4-dihydropyridine- 3",1304,Allosteric Function,Allosteric Position,27556947,Structural basis for inhibition of a voltage-gated Ca(2+) channel by Ca(2+) antagonist drugs.,No,"Chain D:TYR1168,PHE1167,PHE1171,GLU1165,TYR1142,GLY1164,LEU1163,THR1162"
ASD15230000_1,,Arcobacter butzleri (strain RM4018),A8EVM5,5KMF,ASD15230001,6U9,A,Lig,Inhibitor,"5-dicarboxylate,,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine- 3",1301,Allosteric Function,Allosteric Position,27556947,Structural basis for inhibition of a voltage-gated Ca(2+) channel by Ca(2+) antagonist drugs.,No,Chain B:SER1034
ASD15230000_1,,Arcobacter butzleri (strain RM4018),A8EVM5,6KE5,,6UB,B,Lig,Inhibitor,amlodipine,1301,Allosteric function,Inner Protein,,,No,
ASD15240000_1,coaD,Pseudomonas aeruginosa 2192,A0A0X1KGP2,3X1M,ASD11520001,COA,"A,B,C",Lig,Inhibitor,COENZYME A,201,Inner Protein Regulator,Allosteric Position,27041211,Transition of phosphopantetheine adenylyltransferase from catalytic to allosteric state is characterized by ternary complex formation in Pseudomonas aeruginosa,No,"Chain B:PHE10,ARG87,MET104,SER127,PHE69,LYS40,LEU130,ARG132,PRO7,ALA74,SER128,SER93,GLU133,ASN105,THR71,LEU73,ILE134,THR129,HIS17,LEU137,GLN100,LEU108,LEU101,SER38,THR9,LYS41,ILE126,LEU72,TYR97,ASP11,ALA34,ALA36,GLU98,ARG90,ASP94,GLY8"
ASD15240000_1,coaD,Pseudomonas aeruginosa 2192,A0A0X1KGP2,4RUK,ASD11520001,COA,"A,B,C,D,E,F",Lig,Inhibitor,COENZYME A,201,Inner Protein Regulator,Allosteric Position,27041211,Transition of phosphopantetheine adenylyltransferase from catalytic to allosteric state is characterized by ternary complex formation in Pseudomonas aeruginosa,No,"Chain F:LEU73,LEU130,ASN105,LEU108,ARG132,SER128,ALA34,TYR6,ILE126,PRO12,ARG90,ILE134,PHE69,THR71,ALA36,THR9,GLU133,GLN100,GLY8,THR129,TYR97,LYS41,LEU137,SER38,ASN42,LYS40,HIS17,ARG87,PHE10,PRO7,LEU101,PRO39,ASP94,LEU72,SER127,GLU98,ASP11,ALA74,SER70,ALA37"
ASD15250000_1,PKG,Plasmodium falciparum (isolate 3D7),Q8I719,4OFG,ASD02408002,PCG,A,Lig,Activator,CYCLIC GUANOSINE MONOPHOSPHATE,601,Inner Protein Regulator,Allosteric Position,25646845,Crystal Structures of the Carboxyl cGMP Binding Domain of the Plasmodium falciparum cGMP-dependent Protein Kinase Reveal a Novel Capping Triad Crucial for Merozoite Egress.,No,"Chain A:ALA485,PHE481,LEU472,ALA494,VAL496,GLU483,LEU486,THR493,ARG473,LEU475,PRO491,ILE446,TYR480,VAL536,SER495,GLY482,ILE465,ARG484,ARG492,GLU490,ASP533,LYS467,GLN532"
ASD15260000_1,mltF,Pseudomonas aeruginosa BWHPSA013,A0A1I9GEN8,5AA4,,6X4,A,Lig,Activator,[6-[[(2~{R})-1-azanyl-1-oxidanylidene-propan- 2-yl]amino]-6-oxidanylidene-5-[[(4~{R})-5- oxidanyl-5-oxidanylidene-4-[[(2~{S})-2-[[(2~{R})- 2-oxidanylpropanoyl]amino]propanoyl]amino]pentanoyl]amino]hexyl]azanium,1458,Inner Protein Regulator,Allosteric Position,,,No,"Chain A:TYR122,LEU127,ALA208,LEU93,GLY109,SER52,ASP203,TYR265,VAL155,GLU206,MET209,GLY158,LEU188,ALA54,ARG50,LEU156,LEU110,PRO112,TYR94,ASN205,ALA108,ALA162,GLU184,THR111,VAL202,MET154,HIS161,LEU229,SER160,VAL129,LEU90,SER204,LEU201,LYS262,SER159,VAL185,PHE66,TYR266,GLU67,THR55,PRO53,TYR126,THR200,LEU261"
ASD15270000_1,merR,Pseudomonas aeruginosa,P0A183,5CRL,ASD08960001,HG,A,Ion,Regulator,Mercury (II) Ion,201,Inner Protein Regulator,Allosteric Position,27641146,Structural Analysis of the Hg(II)-Regulatory Protein Tn501 MerR from Pseudomonas aeruginosa.,No,"Chain B:GLU83,SER86,ALA85,HIS81,CYS82"
ASD15440000_1,UHRF1,Homo sapiens,Q96T88,5C6D,,USP7,"A,B",Pep,modulator,Ubiquitin carboxyl-terminal hydrolase 7,1-322,Protein-Protein Interaction,Protein-Protein Interaction,26299963,An Allosteric Interaction Links USP7 to Deubiquitination and Chromatin Targeting of UHRF1.,No,5C6D
ASD15510000_1,PARP14,Homo sapiens,Q460N5,5O2D,ASD15510002,9HH,A,Lig,Inhibitor,~{N}-[2-(9~{H}-carbazol-1-yl)phenyl]methanesulfonamide,1201,Allosteric function,Allosteric position,28991428,Discovery of a Selective Allosteric Inhibitor Targeting Macrodomain 2 of Polyadenosine-Diphosphate-Ribose Polymerase 14.,No,5O2D
ASD15530000_1,PTPRZ1,Homo sapiens,P23471,5H08,ASD15530001,7WL,A,Lig,Inhibitor,3-{[2-Ethoxy-5-(trifluoromethyl)benzyl]sulfanyl}- N-(phenylsulfonyl)thiophene-2-carboxamide,2101,Inner Protein Regulator,Allosteric Position,28717188,Targeting PTPRZ inhibits stem cell-like properties and tumorigenicity in glioblastoma cells,No,5H08
ASD15680000_1,RET,Homo sapiens,P07949,5FM2,ASD15680001,PP1,A,Lig,Inhibitor,"1-TER-BUTYL-3-P-TOLYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-YLAMINE",2012,Allosteric Function,Allosteric Position,28009299,RET Functions as a Dual-Specificity Kinase that Requires Allosteric Inputs from Juxtamembrane Elements.,No,5FM2
ASD15680000_1,RET,Homo sapiens,P07949,5FM3,ASD15680001,PP1,A,Lig,Inhibitor,"1-TER-BUTYL-3-P-TOLYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-YLAMINE",2012,Allosteric Function,Allosteric Position,28009299,RET Functions as a Dual-Specificity Kinase that Requires Allosteric Inputs from Juxtamembrane Elements.,No,5FM3
ASD15970000_1,FLT3,Homo sapiens,P36888,4RT7,ASD15970001,P30,A,Lig,Inhibitor,"1-(5-tert-butyl-1,2-oxazol-3-yl)-3-(4-{7-[2-(morpholin-4-yl)ethoxy]imidazo[2,1-b][1,3]benzothiazol-2-yl}phenyl)urea",1001,Allosteric function,Allosteric position,25847190,Characterizing and Overriding the Structural Mechanism of the Quizartinib-Resistant FLT3 'Gatekeeper' F691L Mutation with PLX3397.,No,4RT7
ASD15990000_1,amtB,Escherichia coli (strain K12),P69681,6B21,ASD15990001,C9V,A,Lig,Regulator,"[(2R,5R,11R,14S,24E)-14-[(acetyloxy)methyl]-8-{[5-(3,5-dimethyl-1H-pyrrol-2-yl-kappaN)-5-(3,5-dimethyl-2H-pyrrol-2-ylidene-kappaN)pentanoyl]oxy}-5,11-dihydroxy-2-{[(9E)-octadec-9-enoyl]oxy}-5,11,16-trioxo-4,6,10,12,15-pentaoxa-5lambda~5~,11lambda~5~-diphosphatritriacont-24-en-1-yl (9E)-octadec-9-enoatato]",501,Allosteric function,Allosteric position,29507234,Allostery revealed within lipid binding events to membrane proteins.,No,"Chain A:GLY157,ASN73,VAL364,GLU357,HIS156,GLY151,VAL368,PHE75,HIS350,VAL354,ASN72,LEU356,TRP365,ALA360,ILE361,VAL369,LEU152,SER155,LEU353,PHE74,LEU138,PRO142"
ASD16170000_1,pol,Human immunodeficiency virus 1,Q72498,5HOT,ASD05060022,2SQ,A,Lig,Inhibitor,"(2S)-tert-butoxy[4-(8-fluoro-5-methyl-3,4-dihydro-2H-chromen-6-yl)-2-methyl-1-oxo-1,2-dihydroisoquinolin-3-yl]ethanoic acid",301,Allosteric function,Allosteric position,27935939,Structural Basis for Inhibitor-Induced Aggregation of HIV Integrase.,No,"Chain B:LEU102,GLY94,THR125,TRP132,THR124,ALA98,ALA133,CYS130,TYR99,VAL126,GLU96,ALA129,GLN95,ALA128"
ASD16230000_1,pyrH,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),P9WHK5,7BES,ASD16230001,UTP,"E,F",compound,,"[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate",,,,35152545,,,
ASD16240000_1,PRKAG1,Homo sapiens,P54619,4REW,ASD00030001,AMP,,Lig,Regulator,ADENOSINE MONOPHOSPHATE,401,Protein-Protein Interaction,Protein-Protein Interaction,25412657,Structural basis of AMPK regulation by adenine nucleotides and glycogen.,No,4REW
ASD16300000_1,guaB,Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1),Q9HXM5,6GK9,,F2K,A,lig,Inhibitor,"(5~{S})-7-azanyl-5-(4-chlorophenyl)-2,4-bis(oxidanylidene)-1,5-dihydropyrano[2,3-d]pyrimidine-6-carbonitrile",501,Allosteric function,Allosteric position,30769241,First-in-class allosteric inhibitors of bacterial IMPDHs.,Yes,
ASD16330000_1,prs,Thermus thermophilus (strain HB8 / ATCC 27634 / DSM 579),Q5SHU3,5T3O,ASD02880002,SO4,B,Ion,Regulator,SULFATE ION,402,Inner Protein Regulator,Inner Protein,28580926,Crystal structure of recombinant phosphoribosylpyrophosphate synthetase 2 from Thermus thermophilus HB27 complexed with ADP and sulfate ions.,No,"Chain B:VAL305,SER307,SER306,SER304,ASP144,GLY302,GLU303"
ASD16340000_1,LDHA,Oryctolagus cuniculus,P13491,5NQB,ASD16340001,MLI,C,Lig,Inhibitor,MALONATE ION,402,Inner Protein Regulator,Inner Protein,28691704,The self-inhibitory nature of metabolic networks and its alleviation through compartmentalization.,No,Chain D:ASP63
ASD16340000_1,LDHA,Oryctolagus cuniculus,P13491,5NQQ,ASD16340002,OAA,C,Lig,Inhibitor,OXALOACETATE ION,402,Inner Protein Regulator,Inner Protein,28691704,The self-inhibitory nature of metabolic networks and its alleviation through compartmentalization.,No,"Chain C:ALA237,THR247,ILE241,HIS192,ILE251,LEU108,TYR246,ASP165,VAL30,ARG105,ASN137,GLN99,ALA250,VAL139,ARG98,LEU164,SER236,VAL240,ARG168"
ASD16350000_1,gyrB,Staphylococcus aureus (strain N315),P66937,5NPK,ASD16350001,94H,b,Lig,Inhibitor,"~{N}-[(1~{R})-2-azanyl-1-phenyl-ethyl]-4- (1~{H}-pyrrolo[2,3-b]pyridin-3-yl)thiophene- 2-carboxamide",1502,Inner Protein Regulator,Protein-Protein Interaction,28507124,Thiophene antibacterials that allosterically stabilize DNA-cleavage complexes with DNA gyrase.,No,"Chain b:LYS1344,ILE1030,ILE633,GLY1341,MET1027,PRO1343,ALA637,ARG1342,ILE1336,MET1179,GLY1178,LEU1345,GLN631,VAL1031,ARG630,VAL638,GLU634"
ASD16350000_1,gyrB,Staphylococcus aureus (strain N315),P66937,5NPP,ASD08520007,94K,B,Lig,Inhibitor,~{N}-[(1~{R})-2-azanyl-1-phenyl-ethyl]-5- (2-chlorophenyl)-2-methyl-thiophene-3-carboxamide,1502,Inner Protein Regulator,Protein-Protein Interaction,28507124,Thiophene antibacterials that allosterically stabilize DNA-cleavage complexes with DNA gyrase.,No,"Chain B:LYS1344,ILE1030,ILE633,TYR639,GLY1341,MET1027,PRO1343,ALA637,VAL1177,ARG1342,ILE1336,MET1179,LEU1345,GLN631,VAL1031,ARG630,VAL638,GLU634"
ASD16360000_1,UBE2T,Homo sapiens,Q9NPD8,5NGZ,ASD16360001,2BG,A,Lig,Regulator,"1-(1,3-benzothiazol-2-yl)methanamine",201,Inner Protein Regulator,Inner Protein,28437106,Allosteric Targeting of the Fanconi Anemia Ubiquitin-Conjugating Enzyme Ube2T by Fragment Screening.,No,5NGZ
ASD16370000_1,MYH7,Bos taurus,Q9BE39,5N69,ASD05230002,2OW,A,Lig,Activator,methyl 4-(2-fluoro-3-{[(6-methylpyridin-3- yl)carbamoyl]amino}benzyl)piperazine-1-carboxylate,904,Inner Protein Regulator,Inner Protein,28775348,Mechanistic and structural basis for activation of cardiac myosin force production by omecamtiv mecarbil.,No,"Chain A:TYR722,LEU120,HIS492,ARG721,ARG712,ARG147,LYS146,GLN163,LYS145,GLU774,PHE765,ASN711,THR167,HIS666,ASP168,LEU770,PRO710,GLU497,PRO667,ASN160,GLU170,ILE713,TYR164"
ASD16380000_1,mecA,Staphylococcus aureus,Q7DHH4,5M18,ASD11870001,MUR,A,Lig,Regulator,MURAMIC ACID,703,Inner Protein Regulator,Inner Protein,28099001,"Conformational Dynamics in Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus aureus, Allosteric Communication Network and Enablement of Catalysis.",No,"Chain A:VAL256,GLN292,GLU150,ARG151,ASP275,ASN164,SER149,GLY279,LEU291,VAL277,GLY166,GLU239,HIS293,GLY152,ALA276,TYR373,ASP288,ILE278,MET372,THR165,ARG241,SER240"
ASD16380000_1,mecA,Staphylococcus aureus,Q7DHH4,5M19,ASD11870001,MUR,A,Lig,Regulator,MURAMIC ACID,703,Inner Protein Regulator,Inner Protein,28099001,"Conformational Dynamics in Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus aureus, Allosteric Communication Network and Enablement of Catalysis.",No,"Chain A:THR165,GLU239,VAL256,GLY257,TYR373,MET372,ARG241,PRO258,VAL277,GLY166,GLU150,LYS148,HIS293,ARG151,SER240,GLY152,ASN242,ASN164"
ASD16380000_1,mecA,Staphylococcus aureus,Q7DHH4,5M1A,ASD11870001,MUR,A,Lig,Regulator,MURAMIC ACID,703,Inner Protein Regulator,Inner Protein,28099001,"Conformational Dynamics in Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus aureus, Allosteric Communication Network and Enablement of Catalysis.",No,"Chain A:THR165,GLU239,VAL256,GLY257,TYR373,MET372,THR216,ARG241,PRO258,VAL277,GLY166,GLU150,LYS148,HIS293,ARG151,SER240,GLY152,ASN242,ASN164"
ASD16390000_1,trpB1,Pyrococcus furiosus (strain ATCC 43587 / DSM 3638 / JCM 8422 / Vc1),Q8U093,5DW0,ASD03160008,NA,"A,B,C,D",Ion,Regulator,Sodium ion,402,Inner Protein Regulator,Allosteric Position,26553994,Directed evolution of the tryptophan synthase beta-subunit for stand-alone function recapitulates allosteric activation.,No,"Chain D:GLY228,THR292,VAL226,ASP300,GLY227,LEU282,ALA264,SER265,PRO302,LEU299,VAL304,TYR301,SER263,GLU251,GLY303"
ASD16400000_1,Ywhab,Mus musculus,Q9CQV8,5F74,,AMP,A,Lig,Inhibitor,ADENOSINE MONOPHOSPHATE,233,Protein-Protein interaction regulator,Allosteric Position,26984404,Metabolite Regulation of Nuclear Localization of Carbohydrate-response Element-binding Protein (ChREBP): ROLE OF AMP AS AN ALLOSTERIC INHIBITOR.,No,
ASD16420000_1,IDH3A,Homo sapiens,P50213,5GRE,ASD00360007,CIT,B,Lig,Activator,citric acid,403,Inner Protein Regulator,Allosteric Position,28098230,Molecular mechanism of the allosteric regulation of the alpha gamma heterodimer of human NAD-dependent isocitrate dehydrogenase.,No,5GRE
ASD16420000_1,IDH3A,Homo sapiens,P50213,5GRF,ASD00360007,CIT,B,Lig,Activator,citric acid,401,Inner Protein Regulator,Allosteric Position,28098230,Molecular mechanism of the allosteric regulation of the alpha gamma heterodimer of human NAD-dependent isocitrate dehydrogenase.,No,5GRF
ASD16420000_1,IDH3A,Homo sapiens,P50213,5GRI,ASD00360007,CIT,B,Lig,Activator,citric acid,401,Inner Protein Regulator,Allosteric Position,28098230,Molecular mechanism of the allosteric regulation of the alpha gamma heterodimer of human NAD-dependent isocitrate dehydrogenase.,No,5GRI
ASD16420000_1,IDH3A,Homo sapiens,P50213,5YVT,ASD06128001,NAI,A,Lig,Regulator,"1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE",402,Allosteric function,Allosteric position,29453450,Insights into the inhibitory mechanisms of NADH on the alpha gamma heterodimer of human NAD-dependent isocitrate dehydrogenase.,No,5YVT
ASD16420000_1,IDH3A,Homo sapiens,P50213,6L57,,Mg,A,Ion,Regulator,MAGNESIUM ION,401,,,,,,6L57
ASD16430000_1,pol,Dengue virus type 3 (strain Sri Lanka/1266/2000),Q6YMS4,5I3P,ASD16440001,68T,A,Lig,Inhibitor,"5-[5-(3-hydroxyprop-1-yn-1-yl)thiophen-2- yl]-2,4-dimethoxy-N-[(3-methoxyphenyl)sulfonyl]benzamide",1003,Inner Protein Regulator,Allosteric Position,27500641,Potent Allosteric Dengue Virus NS5 Polymerase Inhibitors: Mechanism of Action and Resistance Profiling,No,"Chain A:HIS801,THR794,HIS800,TYR758,ASP664,MET765,GLN802,SER796,ARG737,GLU509,ALA799,HIS512,SER710,LEU764,TYR766,LEU511,HIS711,TRP795,HIS798,GLY510,PHE708,CYS709,THR793,LEU514,TRP803,ARG729,MET761"
ASD16430000_1,pol,Dengue virus type 3 (strain Sri Lanka/1266/2000),Q6YMS4,5I3Q,ASD16430001,68E,A,Lig,Inhibitor,5-[5-(3-hydroxyprop-1-yn-1-yl)thiophen-2- yl]-4-methoxy-2-methyl-N-[(quinolin-8-yl)sulfonyl]benzamide,1003,Inner Protein Regulator,Allosteric Position,27500641,Potent Allosteric Dengue Virus NS5 Polymerase Inhibitors: Mechanism of Action and Resistance Profiling,No,"Chain A:HIS801,THR794,GLU733,TYR758,HIS800,MET765,GLN802,SER796,ARG737,ALA799,HIS512,SER710,LEU764,TYR766,LEU511,HIS711,TRP795,HIS798,GLY510,MET340,PHE708,CYS709,THR793,LEU514,TRP803,ARG729,MET761"
ASD16430000_1,pol,Dengue virus type 3 (strain Sri Lanka/1266/2000),Q6YMS4,5JJR,ASD16430001,68E,A,Lig,Inhibitor,5-[5-(3-hydroxyprop-1-yn-1-yl)thiophen-2- yl]-4-methoxy-2-methyl-N-[(quinolin-8-yl)sulfonyl]benzamide,1004,Inner Protein Regulator,Allosteric Position,27500641,Potent Allosteric Dengue Virus NS5 Polymerase Inhibitors: Mechanism of Action and Resistance Profiling,No,"Chain A:HIS801,THR794,GLU733,TYR758,HIS800,MET765,GLN802,SER796,ARG737,ALA799,HIS512,SER710,LEU764,TYR766,LEU511,HIS711,TRP795,HIS798,GLY510,MET340,PHE708,CYS709,THR793,LEU514,TRP803,ARG729,MET761"
ASD16430000_1,pol,Dengue virus type 3 (strain Sri Lanka/1266/2000),Q6YMS4,5JJS,ASD16430004,6L2,A,Lig,Inhibitor,"5-[5-(3-hydroxyprop-1-yn-1-yl)thiophen-2- yl]-2,4-dimethoxy-N-{[(1R,3R)-3-methoxycyclohexyl]sulfonyl}benzamide",1004,Inner Protein Regulator,Allosteric Position,27500641,Potent Allosteric Dengue Virus NS5 Polymerase Inhibitors: Mechanism of Action and Resistance Profiling,No,"Chain A:HIS801,THR794,TYR758,HIS800,MET765,GLN802,SER796,ARG737,ALA799,HIS512,SER710,LEU764,TYR766,LEU511,HIS711,TRP795,HIS798,GLY510,ILE797,PHE708,CYS709,THR793,LEU514,TRP803,ARG729,MET761"
ASD16430000_1,pol,Dengue virus type 3 (strain Sri Lanka/1266/2000),Q6YMS4,6XD0,,V0M,A,Lig,Inhibitor,"2-[({2-[(2,6-dichlorophenyl)amino]phenyl}acetyl)amino]-2,3-dihydro-1H-indene-2-carboxylic acid",1008,,,,,,
ASD16430000_1,pol,Dengue virus type 3 (strain Sri Lanka/1266/2000),Q6YMS4,6XD1,,V0J,A,Lig,Inhibitor,"(2R)-4-(butyl{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}carbamoyl)-1-(2,2-diphenylpropanoyl)piperazine-2-carboxylic acid",1003,,,,,,
ASD16440000_1,,Dengue virus 2,A0A097PIE2,5K5M,ASD16440001,68T,A,Lig,Inhibitor,"5-[5-(3-hydroxyprop-1-yn-1-yl)thiophen-2- yl]-2,4-dimethoxy-N-[(3-methoxyphenyl)sulfonyl]benzamide",1003,Inner Protein Regulator,Allosteric Position,27500641,Potent Allosteric Dengue Virus NS5 Polymerase Inhibitors: Mechanism of Action and Resistance Profiling.,No,"Chain A:HIS801,ALA799,LEU515,TYR758,TRP803,GLU802,MET765,LEU512,SER796,ARG737,GLY511,SER710,LEU764,TYR766,THR793,HIS711,HIS513,TRP795,HIS798,PHE708,CYS709,THR794,LYS800,ARG729,MET761"
ASD16450000_1,HSPA1A,Homo sapiens,P0DMV8,4WV7,,3UM,A,Lig,Inhibitor,"(5beta,6alpha,8alpha,14alpha)-13-ethenyl-5,6-dihydroxy-14-methylpodocarp-12-en-15-oic acid",601,Allosteric Function,Allosteric Position,25544045,The novolactone natural product disrupts the allosteric regulation of hsp70.,No,4WV7
ASD16450000_1,HSPA1A,Homo sapiens,P0DMV8,6FHK,,ADP,A,Lig,modulator,ADENOSINE-5'-DIPHOSPHATE,401,,,30108182,Mitotic phosphorylation regulates Hsp72 spindle localization by uncoupling ATP binding from substrate release.,,6FHK
ASD16500000_1,UGP,Leishmania major,Q4QDU3,5NZK,ASD10090002,PHE,A,Lig,Inhibitor,PHENYLALANINE,601,Allosteric function,Allosteric position,,Decoding Allosteric Networks in Biocatalysts: Rational Approach to Therapies and Biotechnologies,No,"Chain A:CYS247,ARG249,ARG248,PHE305,VAL246,THR250,ARG373,PRO372,GLY409,ASP62,VAL370,SER374,ASP253,VAL371,HIS410"
ASD16500000_1,UGP,Leishmania major,Q4QDU3,5NZL,ASD05250001,STL,A,Lig,Inhibitor,RESVERATROL,601,Allosteric function,Allosteric position,,Decoding Allosteric Networks in Biocatalysts: Rational Approach to Therapies and Biotechnologies,No,"Chain A:CYS247,ARG249,ARG248,GLY409,VAL246,THR250,ARG373,ASP62,ARG375,VAL370,SER374,VAL371,PRO372"
ASD16500000_1,UGP,Leishmania major,Q4QDU3,5NZM,ASD16500001,9ET,A,Lig,Inhibitor,Murrayamine-I,601,Allosteric function,Allosteric position,,Decoding Allosteric Networks in Biocatalysts: Rational Approach to Therapies and Biotechnologies,No,"Chain A:CYS247,ARG249,SER252,ARG248,GLY409,THR250,ARG373,PRO411,VAL370,SER374,VAL413,VAL371,PRO372,HIS410"
ASD16510000_1,KCNN2,Homo sapiens,Q9H2S1,5V02,ASD01730075,657,R,Lig,Regulator,"6-(trifluoromethoxy)-1,3-benzothiazol-2-amine",201,Protein-Protein Interaction,Protein-Protein Interaction,29576321,An Intracellular Allosteric Modulator Binding Pocket in SK2 Ion Channels Is Shared by Multiple Chemotypes.,No,5V02
ASD16510000_1,KCNN2,Homo sapiens,Q9H2S1,5V03,ASD16510002,658,R,Lig,Regulator,"N-(4-chlorophenyl)-2-(3,5-dimethyl-1H-pyrazol-1-yl)pyrimidin-4-amine",201,Protein-Protein Interaction,Protein-Protein Interaction,29576321,An Intracellular Allosteric Modulator Binding Pocket in SK2 Ion Channels Is Shared by Multiple Chemotypes.,No,5V03
ASD16520000_1,mecA,Staphylococcus aureus (strain Mu50 / ATCC 700699),A0A0H3JPA5,6Q9N,,QLN,A,Lig,Inhibitor,3-[2-[(~{E})-2-(4-ethynylphenyl)ethenyl]-4-oxidanylidene-quinazolin-3-yl]benzoic acid,701,Allosteric function,Allosteric position,,,No,
ASD16530000_1,MYH11,Gallus gallus,P10587,5M05,ASD16530001,52E,A,Lig,Inhibitor,"4-{[(2-chloro-3-fluorobenzyl)carbamoyl](methyl)amino}- 3,4-dideoxy-5-O-(isoquinolin-3-ylcarbamoyl)- D-erythro-pentitol",901,Inner Protein Regulator,Inner Protein,27815532,Highly selective inhibition of myosin motors provides the basis of potential therapeutic application.,No,"Chain A:LEU95,CYS717,VAL710,PHE517,LYS773,MET497,SER117,VAL100,LEU92,PHE120,GLY709,ASN708,ARG146,PRO722,ALA90,ASP88,ASN723,PHE721,ASN494,ARG724,TYR116,LEU711,GLY118,MET89,TYR586,PHE493,PHE498,GLY713,GLU501,ILE714,GLN490,LEU119,GLU712,ILE716,GLU504"
ASD16530000_1,MYH11,Gallus gallus,P10587,5T45,ASD16530001,52E,A,Lig,Inhibitor,"4-{[(2-chloro-3-fluorobenzyl)carbamoyl](methyl)amino}- 3,4-dideoxy-5-O-(isoquinolin-3-ylcarbamoyl)- D-erythro-pentitol",901,Inner Protein Regulator,Inner Protein,27815532,Highly selective inhibition of myosin motors provides the basis of potential therapeutic application.,No,"Chain A:LEU95,CYS717,VAL710,PHE517,MET497,SER117,VAL100,LEU92,PHE120,GLY709,ASN708,ARG146,PRO722,ALA90,ASP88,ASN723,PHE721,ASN494,ARG724,TYR116,LEU711,GLY118,MET89,TYR586,PHE493,PHE498,GLY713,GLU501,ILE714,GLN490,LEU119,GLU712,ILE716"
ASD16540000_1,pyrR,Bacillus subtilis (strain 168),P39765,4P86,,5GP,A,Lig,Regulator,GUANOSINE-5'-MONOPHOSPHATE,182 183,Allosteric Function,Allosteric Position,,,No,"Chain A:VAL107,THR113,GLY111,LYS40,PRO85,THR110,LEU108,ILE39,TYR178,VAL164,VAL114,ASP106,LYS161,ASP105,THR156,TYR109,ARG42,ARG112,GLU160,MET163,ARG138,VAL162"
ASD16560000_1,GMDS,Homo sapiens,O60547,5IN4,ASD16560001,6CK,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl (2R,3S,4R,5S,6R)-3,4,5-trihydroxy-6-(trifluoromethyl)tetrahydro-2H-pyran-2-yl dihydrogen diphosphate",1003,Allosteric function,Allosteric position,27434622,"Facile Modulation of Antibody Fucosylation with Small Molecule Fucostatin Inhibitors and Cocrystal Structure with GDP-Mannose 4,6-Dehydratase.",No,5IN4
ASD16570000_1,GBA,Homo sapiens,P04062,5LVX,ASD16570001,79B,A,Lig,Inhibitor,"11-[(2~{R})-2-[(2-pyridin-3-ylquinazolin-4-yl)amino]-2,3-dihydro-1~{H}-inden-5-yl]undec-10-ynoic acid",507,Allosteric Fuction,Allosteric Position,29676907,beta-Glucocerebrosidase Modulators Promote Dimerization of beta-Glucocerebrosidase and Reveal an Allosteric Binding Site.,No,5LVX
ASD16580000_1,CCR9,Homo sapiens,P51686,5LWE,ASD16580001,79K,"A,B",Lig,Inhibitor,Vercirnon,401,Allosteric function,Allosteric position,27926729,Intracellular allosteric antagonism of the CCR9 receptor.,No,5LWE
ASD16590000_1,Enpp2,Rattus norvegicus,Q64610,5M0E,ASD16590002,7CR,A,Lig,Inhibitor,"[3,5-bis(chloranyl)phenyl]methyl 4-[(3~{R})-3-oxidanyl-3-(2-oxidanylidene-3~{H}-1,3-benzoxazol-6-yl)propyl]piperazine-1-carboxylate",922,Allosteric function,Allosteric position,28165241,Rational Design of Autotaxin Inhibitors by Structural Evolution of Endogenous Modulators.,No,"Chain A:ASP171,GLU308,TYR214,ARG244,LEU243,THR209,VAL277,ALA304,ASN230,TYR306,PHE210,MET512,ILE167,HIS474,ARG284,TRP260,SER276,LEU216,LYS208,HIS359,TRP275,TRP254,ASP311,PHE274,VAL356,ALA217,PHE305,SER169,HIS315,LEU213,PHE273,ASP473"
ASD16590000_1,Enpp2,Rattus norvegicus,Q64610,5M0M,ASD16590001,7CF,A,Lig,Inhibitor,"[3,5-bis(chloranyl)phenyl]methyl (3~{R})-3-[[(4~{R})-4-[(3~{R},5~{S},7~{S},8~{R},9~{S},10~{S},13~{R},14~{S},17~{R})-10,13-dimethyl-3,7-bis(oxidanyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1~{H}-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]pyrrolidine-1-carboxylate",925,Allosteric function,Allosteric position,28165241,Rational Design of Autotaxin Inhibitors by Structural Evolution of Endogenous Modulators.,No,"Chain A:ASP171,HIS251,TRP275,PHE241,LEU243,THR209,PHE249,ASN250,PRO258,VAL277,ALA304,TYR306,PHE210,ARG74,ILE167,ARG284,THR272,TRP260,SER276,LEU216,LEU78,TRP254,ILE261,TYR214,PHE274,VAL356,SER81,ALA217,PHE305,PHE273,TYR82,SER169,LEU213,LYS248"
ASD16590000_1,Enpp2,Rattus norvegicus,Q64610,5M0S,ASD16590003,7CW,A,Lig,Inhibitor,"[3,5-bis(chloranyl)phenyl]methyl ~{N}-[2-[[(4~{R})-4-[(3~{R},5~{S},7~{S},8~{R},9~{S},10~{S},13~{R},14~{S},17~{R})-10,13-dimethyl-3,7-bis(oxidanyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1~{H}-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethyl]carbamate",925,Allosteric function,Allosteric position,28165241,Rational Design of Autotaxin Inhibitors by Structural Evolution of Endogenous Modulators.,No,"Chain A:HIS251,TRP275,LYS248,LEU243,PHE249,ASN250,PRO258,VAL277,ALA304,TYR306,PHE210,ILE167,ARG284,THR272,TRP260,SER276,LEU216,LEU78,TRP254,ILE261,TYR214,PHE274,VAL356,SER81,ALA217,PHE305,TYR82,SER169,LEU213,PHE273"
ASD16600000_1,kmo,Pseudomonas fluorescens,Q84HF5,5Y66,,7ZR,A,Lig,Inhibitor,"3,4-dimethoxy-N-[4-(3-nitrophenyl)-1,3-thiazol-2-yl]benzenesulfonamide",502,Allosteric function,Allosteric position,29208702,Biochemistry and structural studies of kynurenine 3-monooxygenase reveal allosteric inhibition by Ro 61-8048,No,"Chain A:ASN369,LEU388,GLU425,GLN96,GLY389,GLY99,PHE400,LEU428,ARG386,ILE401,TYR404,ILE423,GLN424,ARG84,GLU385,ARG100,MET406,GLU368,ARG403,TYR382,GLN390,PRO402,GLU372,GLN422,GLU387,GLY421,ARG420"
ASD16610000_1,KDM4A,Homo sapiens,O75164,5VAR,ASD16610001,92Y,A,Lig,Inhibitor,"(1R,2S,3R,4S)-3-[(dimethylamino)methyl]-1-phenylbicyclo[2.2.1]heptan-2-ol",1101,Allosteric function,Allosteric position,29691138,Targeting lysine specific demethylase 4A (KDM4A) tandem TUDOR domain - A fragment based approach.,No,5VAR
ASD16620000_1,glgC,Escherichia coli (strain K12),P0A6V1,5L6S,ASD00200001,FBP,C,Lig,Activator,"BETA-FRUCTOSE-1,6-DIPHOSPHATE",504,Allosteric Fuction,Allosteric Position,27545622,Structural Basis of Glycogen Biosynthesis Regulation in Bacteria.,No,Chain C:LYS39
ASD16620000_1,glgC,Escherichia coli (strain K12),P0A6V1,5L6V,ASD00030001,AMP,A,Lig,Inhibitor,ADENOSINE MONOPHOSPHATE,501,Allosteric Fuction,Allosteric Position,27545622,Structural Basis of Glycogen Biosynthesis Regulation in Bacteria.,No,"Chain C:ARG130,ILE127"
ASD16620000_1,glgC,Escherichia coli (strain K12),P0A6V1,6SHJ,,FBP,D,Lig,Activator,"1,6-di-O-phosphono-beta-D-fructofuranose",501,,,,,,
ASD16620000_1,glgC,Escherichia coli (strain K12),P0A6V1,6SHN,,FBP,D,Lig,Activator,"1,6-di-O-phosphono-beta-D-fructofuranose",501,,,,,,
ASD16620000_1,glgC,Escherichia coli (strain K12),P0A6V1,6SHQ,,AMP,A,Lig,Inhibitor,ADENOSINE MONOPHOSPHATE,501,,,,,,
ASD16620000_1,glgC,Escherichia coli (strain K12),P0A6V1,6SI8,,AMP,A,Lig,Inhibitor,ADENOSINE MONOPHOSPHATE,501,,,,,,
ASD16630000_1,pyk,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),P9WKE5,5WSB,ASD00030001,AMP,A,Lig,Activator,ADENOSINE MONOPHOSPHATE,503,Allosteric function,Allosteric position,29215013,Allosteric pyruvate kinase-based 'logic gate' synergistically senses energy and sugar levels in Mycobacterium tuberculosis.,No,"Chain A:LYS72,LYS218,ASP244,GLY243,SER191,ALA241,PHE192,GLU220"
ASD16630000_1,pyk,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),P9WKE5,5WSB,ASD00360002,G6P,A,Lig,Activator,ALPHA-D-GLUCOSE-6-PHOSPHATE,501,Allosteric function,Allosteric position,29215013,Allosteric pyruvate kinase-based 'logic gate' synergistically senses energy and sugar levels in Mycobacterium tuberculosis.,No,"Chain A:PRO453,PRO452,ALA397,MET419,GLY450,GLY377,LYS418,ASN460,VAL456,MET425,VAL416,THR396,GLN420,ARG351,ASP378,THR374,GLN375,GLY457,PHE395,THR459,PRO417,ALA451,SER376,VAL380,THR455,ALA449,TRP398,THR379,GLY454,PHE373,SER458"
ASD16630000_1,pyk,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),P9WKE5,6ITO,,R5P,A,Lig,Inhibitor,RIBOSE-5-PHOSPHATE,503,Allosteric function,Allosteric position,,,No,
ASD16640000_1,FBP,Leishmania major,O97193,5OFU,ASD00030001,AMP,A,Lig,Inhibitor,ADENOSINE MONOPHOSPHATE,401,Inner Protein regulator,Inner Protein,28882541,"Structures of Leishmania Fructose-1,6-Bisphosphatase Reveal Species-Specific Differences in the Mechanism of Allosteric Inhibition.",No,"Chain A:ARG25,VAL166,SER19,PHE28,THR29,TYR113,TYR15,HIS23,SER24,ASP112,ARG140,LYS18,GLY26,ILE16,ILE17,PRO21,ASP27,GLN20,MET32,SER183"
ASD16660000_1,msbA,Escherichia coli O157:H7,P60753,6BPL,ASD16660001,AU7,A,Lig,Inhibitor,(2E)-3-{6-[(1S)-1-(2-chloro-6-cyclopropylphenyl)ethoxy]-4-cyclopropylquinolin-3-yl}prop-2-enoic acid,602,Allosteric function,Allosteric position,,,No,"Chain A:VAL178,ILE292,MET160,ILE172,ALA259,LEU171,LEU263,SER260,SER290,LEU174,ILE258,MET291,PRO176,SER168,ILE182,ILE170,SER179,ALA175,PHE157,ARG296,MET295,LYS299,SER186,LEU298,ILE255,LEU294,ARG190,ALA262,ASN303,THR302"
ASD16660000_1,msbA,Escherichia coli O157:H7,P60753,6BPP,ASD16660002,E1M,A,Lig,Inhibitor,"(2E)-3-{6-[(1S)-1-(3-amino-2,6-dichlorophenyl)ethoxy]-4-cyclopropylquinolin-3-yl}prop-2-enoic acid",601,Allosteric function,Allosteric position,,,No,"Chain A:VAL178,ILE292,ILE172,ALA259,LEU171,LEU263,SER260,SER290,LEU174,ILE258,MET291,PRO176,GLN256,ILE182,ILE170,SER179,ALA175,PHE157,ARG296,MET295,LYS299,LEU298,ILE255,LEU294,ARG190,ALA262,ASN303,THR302"
ASD16670000_1,IDH3G,Homo sapiens,P51553,6L57,,CIT,B,Lig,Regulator,CITRIC ACID,401,,,,,,6L57
ASD16670000_1,IDH3G,Homo sapiens,P51553,6L57,,ATP,B,Lig,Activator,ADENOSINE-5'-TRIPHOSPHATE,403,Allosteric function,Allosteric position,,,No,6L57
ASD16680000_1,,Corynebacterium glutamicum,H7C677,4CYD,ASD00860002,CMP,A,Lig,Inhibitor,"ADENOSINE-3',5'-CYCLIC-MONOPHOSPHATE",1228,Allosteric function,Allosteric position,25469635,The Crystal Structures of Apo and Camp-Bound Glxr from Corynebacterium Glutamicum Reveal Structural and Dynamic Changes Upon Camp Binding in Crp/Fnr Family Transcription Factors.,No,"Chain C:LEU134,ARG135,ASN138"
ASD16690000_1,ATCase,Plasmodium falciparum,O15804,6FBA,ASD00330004,D48,A,Lig,Inhibitor,"naphthalene-2,3-diol",402,Allosteric function,Allosteric position,29476738,Identification of a non-competitive inhibitor of Plasmodium falciparum aspartate transcarbamoylase.,No,"Chain B:PRO335,LEU334,THR110,SER113,PRO333,CYS112,ARG109,ALA356,ARG336,THR108"
ASD16700000_1,nrdE,Bacillus subtilis (strain 168),P50620,6CGL,ASD03910004,DA,A,Lig,Regulator,2'-DEOXYADENOSINE-5'-MONOPHOSPHATE,801,Allosteric function,Allosteric position,29712847,An endogenous dAMP ligand inBacillus subtilisclass Ib RNR promotes assembly of a noncanonical dimer for regulation by dATP.,No,"Chain A:PRO92,ARG90,PHE91,ASN42,VAL33,HIS34,VAL38,ARG117,ALA97,TYR101,PHE89,PHE37,LYS30"
ASD16700000_1,nrdE,Bacillus subtilis (strain 168),P50620,6CGN,ASD03910004,DA,A,Lig,Regulator,2'-DEOXYADENOSINE-5'-MONOPHOSPHATE,801,Allosteric function,Allosteric position,29712847,An endogenous dAMP ligand inBacillus subtilisclass Ib RNR promotes assembly of a noncanonical dimer for regulation by dATP.,No,"Chain A:PRO92,ARG90,SER35,PHE91,ASN42,VAL33,SER93,HIS34,VAL38,ARG117,ALA97,PHE89,PHE37,LYS30,LYS88"
ASD16710000_1,,Leeuwenhoekiella blandensis (strain CECT 7118 / CCUG 51940 / MED217),A3XHF9,5OLK,ASD00870004,DTP,A,Lig,Inhibitor,2'-DEOXYADENOSINE 5'-TRIPHOSPHATE,1001,Protein-Protein Interaction,Protein-Protein Interaction,29388911,Novel ATP-cone-driven allosteric regulation of ribonucleotide reductase via the radical-generating subunit.,No,"Chain A:VAL75,GLN72,ARG12,VAL20,ILE9,VAL68,ALA27,VAL71,TYR91,LYS23,ILE24,LEU21,LYS11,PRO18,ALA17,PHE19,ARG102"
ASD16720000_1,,Schistosoma mansoni,G4V8J4,6FMU,ASD16720001,DVK,A,Lig,Inhibitor,2-[4-(4-azanylbutyl)piperazin-1-yl]ethanol,602,Allosteric function,Allosteric position,29800515,Fragment-Based Discovery of a Regulatory Site in Thioredoxin Glutathione Reductase Acting as 'Doorstop' for NADPH Entry.,No,"Chain A:ASP325,VAL469,LEU537,ALA470,LEU321,GLY536,TYR479,ARG322,GLY483,HIS538,SER485,GLY323,TYR296,ALA481,THR471,PRO439,LEU484,PHE324,GLN440,SER295,CYS482"
ASD16720000_1,,Schistosoma mansoni,G4V8J4,6FMZ,ASD16720002,DVQ,A,Lig,Inhibitor,2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanol,601,Allosteric function,Allosteric position,29800515,Fragment-Based Discovery of a Regulatory Site in Thioredoxin Glutathione Reductase Acting as 'Doorstop' for NADPH Entry.,No,"Chain A:ILE431,LEU120,LYS399,LEU441,ARG229,CYS159,VAL297,SER117,ASN156,TRP148,VAL155,LYS163,THR257,GLN440,ILE113,TYR296,GLU140,GLY114,CYS301,LEU150,ARG260,THR442,VAL444,PHE280,GLY228,ASP137,GLY151,GLY152,ALA256,PRO439,VAL157,LYS162,GLY149,GLY258,ALA226,SER276,ASP277,THR471,THR472,GLU259,LEU397,GLY432,ILE160,VAL400,ALA445,GLY118,GLY158,PRO443,ARG393,ASP433,ILE434,THR153,VAL139,GLU300,TYR138,PRO261,LYS227,PHE474,GLY119,CYS154,LEU136,GLY115,GLY116"
ASD16720000_1,,Schistosoma mansoni,G4V8J4,6FP4,ASD16720003,E1T,A,Lig,Inhibitor,"1,8-naphthyridine-2-carboxylic acid",604,Allosteric function,Allosteric position,29800515,Fragment-Based Discovery of a Regulatory Site in Thioredoxin Glutathione Reductase Acting as 'Doorstop' for NADPH Entry.,No,"Chain A:GLU300,LEU321,THR472,LYS438,VAL473,GLN440,PHE474,TYR296,LEU441,THR471,PRO439,PHE324,LYS162"
ASD16720000_1,,Schistosoma mansoni,G4V8J4,6FTC,ASD03080094,EPE,A,Lig,Inhibitor,4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID,602,Allosteric function,Allosteric position,29800515,Fragment-Based Discovery of a Regulatory Site in Thioredoxin Glutathione Reductase Acting as 'Doorstop' for NADPH Entry.,No,"Chain A:ASP325,VAL469,LEU537,ALA470,LEU321,TYR479,ARG322,GLY483,HIS538,GLY323,TYR296,SER485,THR471,ALA481,LEU484,PHE324,GLN440,SER295,CYS482"
ASD16730000_1,FCGRT,Homo sapiens,P55899,6C98,ASD16730002,ER7,B,Lig,Inhibitor,"1-[7-(3-fluorophenyl)-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-6-yl]ethan-1-one",101,Protein-Protein Interaction,Protein-Protein Interaction,29782488,Insight into small molecule binding to the neonatal Fc receptor by X-ray crystallography and 100 kHz magic-angle-spinning NMR.,No,6C98
ASD16730000_1,FCGRT,Homo sapiens,P55899,6C99,ASD16730001,EQY,A,Lig,Inhibitor,"methyl 7-(3,5-difluorophenyl)-5-(pyridin-3-yl)[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylate",301,Protein-Protein Interaction,Protein-Protein Interaction,29782488,Insight into small molecule binding to the neonatal Fc receptor by X-ray crystallography and 100 kHz magic-angle-spinning NMR.,No,6C99
ASD16740000_1,,Trypanosoma cruzi (strain CL Brener),Q4D9Z4,4KS0,ASD01120132,FDP,A,Lig,Activator,"FRUCTOSE-2,6-DIPHOSPHATE",1004,Allosteric Function,Allosteric Position,26064527,Structures of pyruvate kinases display evolutionarily divergent allosteric strategies.,No,"Chain A:PRO490,VAL480,ALA407,LYS487,TYR489,GLY488,THR424,VAL399,ARG457,SER401,ARG405,HIS481,ASP451,ASP483,ARG425,GLY404,GLU452,ASN402,LEU400,SER403,ALA482,LYS454,SER406,VAL486"
ASD16750000_1,padR,Bacillus subtilis subsp. spizizenii (strain ATCC 23059 / NRRL B-14472 / W23),E0TW95,5X13,ASD10030001,HC4,A,Lig,Regulator,4'-HYDROXYCINNAMIC ACID,301,Allosteric function,Allosteric position,29136175,Structural basis of effector and operator recognition by the phenolic acid-responsive transcriptional regulator PadR,No,"Chain A:ARG164,LYS160,ALA161"
ASD16750000_1,padR,Bacillus subtilis subsp. spizizenii (strain ATCC 23059 / NRRL B-14472 / W23),E0TW95,5X14,ASD10030003,FER,A,Lig,Regulator,3-(4-HYDROXY-3-METHOXYPHENYL)-2-PROPENOIC ACID,201,Allosteric function,Allosteric position,29136175,Structural basis of effector and operator recognition by the phenolic acid-responsive transcriptional regulator PadR,No,"Chain A:TYR135,LEU158,ASP130,SER134,PHE33,VAL157,HIS154,ALA161,GLU165,GLN32,ARG164,GLU29,LYS127,LEU30,LEU131"
ASD16750000_1,padR,Bacillus subtilis subsp. spizizenii (strain ATCC 23059 / NRRL B-14472 / W23),E0TW95,5Y8T,ASD10030001,HC4,A,Lig,Regulator,4'-HYDROXYCINNAMIC ACID,301,Allosteric function,Allosteric position,29136175,Structural basis of effector and operator recognition by the phenolic acid-responsive transcriptional regulator PadR.,No,"Chain A:TYR135,LEU158,SER134,PHE33,HIS154,ALA161,GLU165,GLN32,ARG164,GLU29,LYS127,VAL157,LEU131"
ASD16760000_1,PTPN5,Homo sapiens,P54829,6H8R,ASD16760001,FWB,A,Lig,Activator,3-[(2~{S})-2-azanylpropyl]-5-(trifluoromethyl)phenol,602,Allosteric function,Allosteric position,30207464,"Allosteric Activation of Striatal-Enriched Protein Tyrosine Phosphatase (STEP, PTPN5) by a Fragment-like Molecule.",No,6H8R
ASD16770000_1,Ptpn5,Mus musculus,P54830,6H8S,ASD16770001,FSZ,A,Lig,Activator,1-[3-piperidin-4-yl-5-(trifluoromethyl)phenyl]guanidine,601,Allosteric function,Allosteric position,30207464,"Allosteric Activation of Striatal-Enriched Protein Tyrosine Phosphatase (STEP, PTPN5) by a Fragment-like Molecule.",No,"Chain A:ILE370,ARG494,GLU341,PHE482,HIS464,ILE487,ARG493,CYS465,ALA458,TYR345,VAL454,SER486,LYS343,GLU456,VAL344,VAL451,ILE468,GLY462,GLU342,SER466,GLN490,GLN459,GLU455"
ASD16780000_1,11438625,Medicago truncatula,G7JFL4,6CZM,ASD01580014,HIS,A,Lig,Inhibitor,HISTIDINE,402,Allosteric function,Allosteric position,30072492,Guarding the gateway to histidine biosynthesis in plants:Medicago truncatulaATP-phosphoribosyltransferase in relaxed and tense states.,No,"Chain C:VAL309,ALA278,SER346,VAL277,ALA323,ILE324,LEU349,GLY347,ASN279,VAL348"
ASD16790000_1,hisG,Campylobacter jejuni (strain RM1221),Q5HSJ4,4YB5,ASD01580014,HIS,"A,B,C,D,E,F",Lig,Inhibitor,HISTIDINE,304,Allosteric Function,Allosteric Position,27191057,Campylobacter jejuni adenosine triphosphate phosphoribosyltransferase is an active hexamer that is allosterically controlled by the twisting of a regulatory tail.,No,"Chain F:HIS266,LEU290,VAL248,LEU231,MET230,GLY247,SER288,SER269,VAL268,GLU249,ALA264,TYR228,THR252,ARG250,LEU256,ILE289,SER287,MET267,PRO251,LEU265,PRO246,HIS232"
ASD16800000_1,pol,Human immunodeficiency virus 1,F2WR39,4TSX,ASD01670001,LF0,A,Lig,Inhibitor,"(2S)-tert-butoxy[4-(3,4-dihydro-2H-chromen-6-yl)-2-methylquinolin-3-yl]ethanoic acid",301,Allosteric Function,Allosteric Position,25421939,The mechanism of H171T resistance reveals the importance of N -protonated His171 for the binding of allosteric inhibitor BI-D to HIV-1 integrase.,No,"Chain A:GLU96,ALA98,GLY94,VAL126,TYR99,LEU102,ALA129,ALA128,TRP132,GLN95,THR125,TRP131,THR124,ALA133"
ASD16820000_1,aroA,Geobacillus sp. GHH01,L8A208,5J6F,ASD16820001,PRE,A,Lig,Inhibitor,PREPHENIC ACID,404,Protein-Protein Interaction,Protein-Protein Interaction,27502275,Interdomain Conformational Changes Provide Allosteric Regulation en Route to Chorismate.,No,"Chain A:ASP47,MET54,PHE79,LYS80,ARG27,GLN86,ILE78,LEU83,ALA82,ARG50,GLY35,VAL31,GLU51,LYS38,TYR46,ILE34,PRO48,ARG45"
ASD16830000_1,,Staphylococcus aureus (strain Mu50 / ATCC 700699),A0A0J9X1X5,4CJN,ASD16830001,QNZ,B,Lig,Inhibitor,quinazolinone,1673,Allosteric Function,Allosteric Position,25629446,Discovery of Antibiotic (E)-3-(3-Carboxyphenyl)-2-(4-Cyanostyryl)Quinazolin-4(3H)-One.,No,"Chain B:GLU294,TYR297,GLY296,ILE144,ASN104,TYR105,ASP295,GLU145,ASN146,LYS316,LYS273"
ASD16840000_1,qdtf,Providencia alcalifaciens,F8RC03,4XCZ,ASD16840001,T3Q,A,Lig,Regulator,"[(3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl][hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] hydrogen phosphate",403,Allosteric function,Allosteric position,25574689,New Role for the Ankyrin Repeat Revealed by a Study of the N-Formyltransferase from Providencia alcalifaciens.,No,"Chain A:LYS336,ASP346,GLY337,GLU280,TYR380,MET342,THR338,ASN334,ILE309,HIS314,TYR343,LYS345,TRP305,THR339,LEU303,ASP371,ILE310,TYR313"
ASD16850000_1,,Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1),Q9I000,5UXM,ASD05860010,TRP,A,Lig,Inhibitor,TRYPTOPHAN,502,Allosteric function,Allosteric position,29608284,A Pseudoisostructural Type II DAH7PS Enzyme from Pseudomonas aeruginosa: Alternative Evolutionary Strategies to Control Shikimate Pathway Flux.,No,"Chain A:THR227,TRP185,LEU224,ALA177,LEU89,ASP178,PRO102,LYS105,LEU88,GLN223,VAL103,THR96,ARG225,GLU226,GLN90,ALA92,PRO222,LEU179,SER228,VAL93"
ASD16860000_1,,Corynebacterium glutamicum (strain ATCC 13032 / DSM 20300 / JCM 1318 / LMG 3730 / NCIMB 10025),Q8NNL5,5HUD,ASD05860010,TRP,"A,B,C,D",Lig,Activator,TRYPTOPHAN,"A:509,B:515,C:532,D:528",Allosteric Function,Allosteric Position,29178787,Inter-Enzyme Allosteric Regulation of Chorismate Mutase in Corynebacterium glutamicum: Structural Basis of Feedback Activation by Trp.,No,"Chain D:ALA251,GLY242,LEU117,ALA202,ARG249,ALA120,GLN118,PRO130,VAL121,ASP203,LEU248,CYS241,THR124,SER247,LYS133,LEU207,ALA240,ALA250,VAL131,LEU204,LEU116,ASP252"
ASD16860000_1,,Corynebacterium glutamicum (strain ATCC 13032 / DSM 20300 / JCM 1318 / LMG 3730 / NCIMB 10025),Q8NNL5,5HUE,ASD05860010,TRP,A,Lig,Activator,TRYPTOPHAN,503,Allosteric Function,Allosteric Position,29178787,Inter-Enzyme Allosteric Regulation of Chorismate Mutase in Corynebacterium glutamicum: Structural Basis of Feedback Activation by Trp.,No,"Chain A:VAL121,ALA202,LEU204,ALA250,LYS133,VAL131,PRO130,GLN118,ASP252,ALA251,ARG249,LEU117,LEU207,SER247,LEU248,ASP203,ALA120,THR124"
ASD16870000_1,,Physcomitrella patens subsp. patens,A9S498,5W6Y,ASD05860010,TRP,A,Lig,Activator,TRYPTOPHAN,401,Allosteric function,Allosteric position,28963347,Evolution of allosteric regulation in chorismate mutases from early plants.,No,"Chain B:HIS130,TYR136,VAL133,ARG134,GLU141,ARG135,ALA138,ASP140"
ASD16880000_1,,Cyanophage S-TIM5,H6WFU3,4P9D,ASD02040015,TTP,A,Lig,Inhibitor,THYMIDINE-5'-TRIPHOSPHATE,203,Allosteric function,Allosteric position,25404739,The First Crystal Structure of a dTTP-bound Deoxycytidylate Deaminase Validates and Details the Allosteric-Inhibitor Binding Site.,No,Chain B:LYS2
ASD16900000_1,ispA,Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1),Q9HWY4,3ZL6,ASD01670005,NVU,A,Lig,Inhibitor,"2-(1,2-benzoxazol-3-yl)ethanoic acid",1297,Allosteric function,Allosteric position,25760619,Structural Characterization of Substrate and Inhibitor Binding to Farnesyl Pyrophosphate Synthase from Pseudomonas Aeruginosa.,No,"Chain A:ILE290,ARG293,LEU286,PHE218,TYR289,LEU50,HIS76,GLY215,LYS44,VAL46,ARG47,ILE185,ILE214,ARG45"
ASD16900000_1,ispA,Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1),Q9HWY4,3ZOU,,6H6,A,Lig,Inhibitor,"3-(2-oxo-1,3-benzoxazol-3(2H)-yl)propanoic acid",1299,Allosteric function,Allosteric position,25760619,Structural Characterization of Substrate and Inhibitor Binding to Farnesyl Pyrophosphate Synthase from Pseudomonas Aeruginosa,No,
ASD16910000_1,pol,Human immunodeficiency virus 1,F2WR52,6EB1,,J3M,A,lig,Inhibitor,"(2S)-tert-butoxy[3-(3,4-dihydro-2H-1-benzopyran-6-yl)-1-phenylisoquinolin-4-yl]acetic acid",208,Allosteric function,Allosteric position,30783506,An Isoquinoline Scaffold as a Novel Class of Allosteric HIV-1 Integrase Inhibitors.,yes,
ASD16910000_1,pol,Human immunodeficiency virus 1,F2WR52,6EB2,,J3P,A,lig,Inhibitor,"(2S)-[1-(1-benzyl-1H-pyrazol-4-yl)-3-(3,4-dihydro-2H-1-benzopyran-6-yl)isoquinolin-4-yl](tert-butoxy)acetic acid",301,Allosteric function,Allosteric position,30783506,An Isoquinoline Scaffold as a Novel Class of Allosteric HIV-1 Integrase Inhibitors.,yes,
ASD16910000_1,pol,Human immunodeficiency virus 1,F2WR52,6NCJ,ASD16910001,KJJ,A,Lig,Inhibitor,"(2~{S})-2-[4-(8-fluoranyl-5-methyl-3,4-dihydro-2~{H}-chromen-6-yl)-2-methyl-6-[[(1~{S},2~{R})-2-phenylcyclopropyl]methyl]-7,8-dihydro-5~{H}-1,6-naphthyridin-3-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid",305,Allosteric function,Allosteric position,30609350,"5,6,7,8-Tetrahydro-1,6-naphthyridine Derivatives as Potent HIV-1-Integrase-Allosteric-Site Inhibitors.",No,"Chain A:GLU96,ALA98,GLY94,VAL126,CYS130,TYR99,LEU102,ALA129,ALA128,TRP132,GLN95,THR125,TRP131,LYS127,THR124"
ASD16910000_1,pol,Human immunodeficiency virus 1,F2WR52,6NUJ,,L3D,A,lig,Inhibitor,"(2S)-tert-butoxy[4-(2,3-dihydropyrano[4,3,2-de]quinolin-7-yl)-2-methylquinolin-3-yl]acetic acid",300,Protein-Protein Interaction,Protein-Protein Interaction,,,yes,
ASD16910000_1,pol,Human immunodeficiency virus 1,F2WR52,7KE0,,WBV,A,Lig,Inhibitor,"(2S)-tert-butoxy{4-(4-chlorophenyl)-2,3,6-trimethyl-1-[(1-methyl-1H-pyrazol-4-yl)methyl]-1H-pyrrolo[2,3-b]pyridin-5-yl}acetic acid",301,,,,,,
ASD16920000_1,USP14,Homo sapiens,P54578,6IIK,ASD16920001,IU1,A,Lig,Inhibitor,"1-[1-(4-fluorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]-2-(pyrrolidin-1-yl)ethan-1-one",501,Allosteric function,Allosteric position,30254335,Small molecule inhibitors reveal allosteric regulation of USP14 via steric blockade.,No,6IIK
ASD16920000_1,USP14,Homo sapiens,P54578,6IIL,,A8F,A,Lig,Inhibitor,"1-[1-(4-chlorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]-2-(piperidin-1-yl)ethan-1-one",501,Allosteric function,Allosteric position,30254335,Small molecule inhibitors reveal allosteric regulation of USP14 via steric blockade.,No,6IIL
ASD16920000_1,USP14,Homo sapiens,P54578,6IIM,,A8L,A,Lig,Inhibitor,"1-[1-(4-chlorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]-2-(4-hydroxypiperidin-1-yl)ethan-1-one",501,Allosteric function,Allosteric position,30254335,Small molecule inhibitors reveal allosteric regulation of USP14 via steric blockade.,No,6IIM
ASD16920000_1,USP14,Homo sapiens,P54578,6IIN,,A8O,A,Lig,Inhibitor,"4-{3-[(4-hydroxypiperidin-1-yl)acetyl]-2,5-dimethyl-1H-pyrrol-1-yl}benzonitrile",501,Allosteric function,Allosteric position,30254335,Small molecule inhibitors reveal allosteric regulation of USP14 via steric blockade.,No,6IIN
ASD16930000_1,nrdA,Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1),Q9I4I1,5IM3,ASD00870004,DTP,"A,B",Lig,Regulator,2'-DEOXYADENOSINE 5'-TRIPHOSPHATE,"1,001",Allosteric Fuction,Allosteric Position,27133024,Structural Mechanism of Allosteric Activity Regulation in a Ribonucleotide Reductase with Double ATP Cones.,No,"Chain B:LYS48,ILE101,PRO43,TYR44,VAL34,ALA52,ILE98,ASP46,GLN102,ARG37,THR45,TYR121,ILE49,VAL105,LYS55,VAL42,LYS36"
ASD16940000_1,,Plasmodium falciparum (isolate 3D7),Q7KQK0,5T3N,ASD16940001,75G,A,Lig,Inhibitor,"(2S,4aR,6R,7R,7aS)-6-(6-amino-2-chloro-9H-purin-9-yl)-7-hydroxy-2-sulfanyltetrahydro-2H,4H-2lambda~5~-furo[3,2-d][1,3,2]dioxaphosphinin-2-one",503,Inner Protein regulator,Inner Protein,27738107,Disrupting the Allosteric Interaction between the Plasmodium falciparum cAMP-dependent Kinase and Its Regulatory Subunit.,Yes,"Chain A:GLU377,ILE366,ILE340,ALA359,ASN423,ALA387,ALA379,LEU428,ARG386,LEU380,PRO385,ILE438,CYS437,LYS425,ILE390,ALA388,LYS361,TYR374,LEU378,GLY376,LYS367,TYR424,VAL427,LYS384,THR389,TYR369,PHE375"
ASD17000000_1,e,Enterobacteria phage RB55,A0A097J792,5X33,ASD17000001,7Y9,A,Lig,Inhibitor,4-[[3-[[4-[2-(4-hydroxyphenyl)propan-2-yl]phenoxy]methyl]phenyl]methoxy]benzenecarboximidamide,2001,Allosteric function,Allosteric position,29309055,Na+-mimicking ligands stabilize the inactive state of leukotriene B4receptor BLT1.,No,"Chain A:HIS96,CYS99,LEU171,PHE79,LEU62,SER102,GLY100,ALA271,PHE76,LYS267,SER276,ALA65,LEU80,SER277,ILE19,TYR239,ALA23,LEU77,VAL69,ASP66,MET103,PHE274,ILE270,CYS269,LEU67,TRP236,ALA273,LEU275,ARG263,PRO20,SER106,PHE232,CYS95,LEU27,ARG158"
ASD17010000_1,pbpX_2,Streptococcus pneumoniae,A0A0E8T757,5OJ0,ASD17010001,9WT,A,Lig,Regulator,Cefepime,801,Allosteric function,Allosteric position,29357220,"Allostery, Recognition of Nascent Peptidoglycan, and Cross-linking of the Cell Wall by the Essential Penicillin-Binding Protein 2x of Streptococcus pneumoniae.",No,"Chain A:ILE371,ASN397,GLY336,SER337,GLY453,ASP373,THR526,ALA551,PHE450,SER395,SER396,GLN552,GLU334,GLY549,TRP374,ASN377,TYR568,THR370,SER548,GLN447,ARG372,THR550,PHE570,LYS547,LYS340,GLN452"
ASD17020000_1,rex,Thermoanaerobacter ethanolicus JW 200,D5KM69,3WGG,ASD17020001,8NA,A,Lig,Regulator,alpha-Diphosphopyridine nucleotide,301,Allosteric function,Allosteric position,25527330,"Binding mode of the oxidized alpha-anomer of NAD(+) to RSP, a Rex-family repressor",No,"Chain B:ASN101,GLN97,TYR102,PHE105,THR103,ALA98,SER104,ARG128"
ASD17030000_1,Trpv1,Rattus norvegicus,O35433,5IRZ,ASD17030001,6ES,D,Lig,Inhibitor,"(2S)-1-{[(R)-hydroxy{[(1R,2R,3S,4S,5S,6S)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}-3-(pentanoyloxy)propan-2-yl decanoate",802,Allosteric function,Allosteric position,,,No,"Chain D:SER404,ARG409,LEU574,ILE703,LEU699,LEU515,SER510,ASP509,VAL508,ALA546,ILE514,THR550,LEU553,TYR511,GLU513,ARG557,ILE569,ASN551,LYS571,TYR554,GLN700,HIS410,GLU570,ALA566,MET547,ILE696,SER512,ILE573"
ASD17040000_1,RIPK2,Homo sapiens,O43353,4C8B,ASD10310001,0LI,A,Lig,Inhibitor,"3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide",1000,Allosteric function,Allosteric position,26320862,Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors.,No,4C8B
ASD17050000_1,glra1,Danio rerio,O93430,3JAF,ASD07970001,IVM,A,Lig,Activator,"(2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)-6'-[(2S)-butan-2-yl]-20,20b-dihydroxy-5',6,8,19-tetramethyl-17-oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-3-O-methyl-alpha-L-arabino-hexopyranoside",503,Allosteric function,Allosteric position,,,No,"Chain B:PRO246,LEU248,MET236,ILE252,GLN282,GLY237,ILE245,LEU240,ILE241,LYS362,LEU249,GLN242"
ASD17060000_1,NRAS,Homo sapiens,P01111,5UHV,ASD04978008,GNP,A,Lig,Inhibitor,PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER��GTP analogue),201,Allosteric function,Allosteric position,28630043,"The small GTPases K-Ras, N-Ras, and H-Ras have distinct biochemical properties determined by allosteric effects.",No,5UHV
ASD17070000_1,PYGB,Homo sapiens,P11216,5IKP,ASD00030001,AMP,A,Lig,Activator,C10H14N5O7P,902,Allosteric Fuction,Allosteric Position,27402852,Insights into Brain Glycogen Metabolism: THE STRUCTURE OF HUMAN BRAIN GLYCOGEN PHOSPHORYLASE.,No,5IKP
ASD17080000_1,DYN1,Saccharomyces cerevisiae (strain ATCC 204508 / S288c),P36022,4W8F,ASD00498001,ANP,A,Lig,Regulator,PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER,5001,Allosteric Function,Allosteric Position,25417161,Allosteric communication in the Dynein motor domain.,No,"Chain A:LEU1774,GLU1804,PRO1797,LYS1974,THR1897,ASP1848,TYR1771,ASN1899,LEU1769,PRO1924,THR1800,ILE1929,GLN1925,ALA1798,ILE1770,GLY1796,LEU1970,THR1805,GLY1799,MET1921,GLN1849,LYS1802,LEU1775,THR1772,GLY1801,ARG1971,ARG1768,ILE1933,THR1803"
ASD17080000_1,DYN1,Saccharomyces cerevisiae (strain ATCC 204508 / S288c),P36022,7MI3,,ATP,A,Lig,Inhibitor,ADENOSINE-5'-TRIPHOSPHATE,4203,,,,,,
ASD17080000_1,DYN1,Saccharomyces cerevisiae (strain ATCC 204508 / S288c),P36022,7MI6,,ATP,A,Lig,Inhibitor,ADENOSINE-5'-TRIPHOSPHATE,4203,,,,,,
ASD17090000_1,ENT2,Saccharomyces cerevisiae (strain ATCC 204508 / S288c),Q05785,5ON7,ASD17090001,PIO,A,Lig,Regulator,"[(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate",901,Protein-Protein Interaction,Protein-Protein Interaction,29362354,Epsin and Sla2 form assemblies through phospholipid interfaces.,No,"Chain B:TYR100,LYS61,VAL101,ASP60,ASN64,ASN98"
ASD17100000_1,PRKG1,Homo sapiens,Q13976,4Z07,ASD02408002,PCG,A,Lig,Activator,CYCLIC GUANOSINE MONOPHOSPHATE,"401,402",Protein-Protein Interaction,Protein-Protein Interaction,27066748,Crystal Structure of PKG I:cGMP Complex Reveals a cGMP-Mediated Dimeric Interface that Facilitates cGMP-Induced Activation.,No,4Z07
ASD17110000_1,,Carboxydothermus hydrogenoformans (strain ATCC BAA-161 / DSM 6008 / Z-2901),Q3AF10,5X9U,ASD00870006,ADP,A,Lig,Regulator,ADENOSINE-5'-DIPHOSPHATE,601,Allosteric function,Allosteric position,29018216,Structural and mechanistic characterization of an archaeal-like chaperonin from a thermophilic bacterium,No,"Chain A:PRO37,PHE461,ASN55,VAL58,VAL475,ASP373,GLY389,LEU35,GLY88,PRO388,PHE394,ASP87,LEU459,THR89,ASP460,THR91,VAL474,GLY57,SER34,ALA392,GLY86,GLY391,MET430,GLY36,MET469,ASP476,THR90,ASP56,ILE152,GLY390"
ASD17120000_1,KIF18A,Homo sapiens,Q8NI77,5OGC,ASD17120001,9V5,K,Lig,Inhibitor,4-chloranyl-2-nitro-1-(phenylsulfonyl)benzene,401,Allosteric function,Allosteric position,,,No,5OGC
ASD17130000_1,Trpv6,Rattus norvegicus,Q9R186,6D7O,ASD13540001,FZ4,A,Lig,Inhibitor,2-aminoethyl diphenylborinate,702,Allosteric function,Allosteric position,29941865,Structural bases of TRP channel TRPV6 allosteric modulation by 2-APB.,No,"Chain A:VAL401,GLU402,MET602,ILE428,TYR466,PHE424,PHE467,THR599,ALA598,PRO423,ASN463,TYR335,ARG469,ILE398,LEU331,GLY422,HIS425"
ASD17140000_1,grin1,Xenopus laevis,A0A1L8F5J9,5IOV,ASD11000047,QEM,B,Lig,Inhibitor,"4-[(1R,2S)-3-(4-benzylpiperidin-1-yl)-1-hydroxy-2-methylpropyl]phenol",901,Allosteric Fuction,Allosteric Position,27062927,Mechanism of NMDA Receptor Inhibition and Activation.,No,"Chain B:PHE109,PRO172,ILE103,THR169,GLU101,GLN105,THR228,ASP108,ILE110,TYR170,ILE106,PHE171,ALA102"
ASD17140000_1,grin1,Xenopus laevis,A0A1L8F5J9,5TPW,ASD01310003,ZN,B,Ion,Inhibitor,ZINC ION,401,Inner Protein regulator,Inner Protein,27916457,Molecular Basis for Subtype Specificity and High-Affinity Zinc Inhibition in the GluN1-GluN2A NMDA Receptor Amino-Terminal Domain.,No,"Chain B:HIS44,SER43,HIS128,ARG291,ASN264,THR265,GLU266,TRP284,ASP283,ASP282"
ASD17140000_1,grin1,Xenopus laevis,A0A1L8F5J9,5TQ2,,ZN,"A,B",Ion,,ZINC ION,501,Inner Protein regulator,Inner Protein,27916457,Molecular Basis for Subtype Specificity and High-Affinity Zinc Inhibition in the GluN1-GluN2A NMDA Receptor Amino-Terminal Domain.,No,
ASD17150000_1,Samhd1,Mus musculus,Q60710,6BRH,ASD09690001,DGT,A,Lig,Activator,2'-DEOXYGUANOSINE-5'-TRIPHOSPHATE,702,Allosteric function,Allosteric position,29379009,The SAM domain of mouse SAMHD1 is critical for its activation and regulation.,No,"Chain B:TYR187,LEU496,TYR186,PRO190,HIS419,VAL188,PHE189,LYS498,ARG494,ILE421,ILE425,LYS420"
ASD17150000_1,Samhd1,Mus musculus,Q60710,6BRK,ASD09690001,DGT,A,Lig,Activator,2'-DEOXYGUANOSINE-5'-TRIPHOSPHATE,701,Allosteric function,Allosteric position,29379009,The SAM domain of mouse SAMHD1 is critical for its activation and regulation.,No,"Chain A:ALA416,TYR417,GLY185,ASN423,HIS194,LYS336,LYS344,GLN181,GLN418,HIS413,ARG252,ASP426,ARG238,GLU266,GLY183,HIS265,HIS199,SER246,ARG409,HIS419,GLY184,HIS242,HIS247,LEU182,ARG196,SER422,ASP351,ASP343,TYR347,ASN239"
ASD17160000_1,P2RX7,Ailuropoda melanoleuca,G1M6C4,5U1U,ASD17160006,7S4,A,Lig,Inhibitor,"N-{(1R)-1-[N''-cyano-N'-(quinolin-5-yl)carbamimidamido]-2,2-dimethylpropyl}-2-(3,4-dimethoxyphenyl)acetamide",404,Allosteric function,Allosteric position,27935479,Structural basis for subtype-specific inhibition of the P2X7 receptor.,No,"Chain A:TRP167,ALA296,TYR298,GLN116,LYS297,PHE293,ARG294,TYR295,GLU305"
ASD17160000_1,P2RX7,Ailuropoda melanoleuca,G1M6C4,5U1V,ASD17160004,7S1,A,Lig,Inhibitor,N-cyano-N'-[(1R)-1-phenylethyl]-N''-quinolin-5-ylguanidine,405,Allosteric function,Allosteric position,27935479,Structural basis for subtype-specific inhibition of the P2X7 receptor.,No,"Chain A:GLU305,GLN116,TRP167,ALA296,TYR298"
ASD17160000_1,P2RX7,Ailuropoda melanoleuca,G1M6C4,5U1W,ASD17160003,7RY,A,Lig,Inhibitor,"N-[2-({2-[(2-hydroxyethyl)amino]ethyl}amino)quinolin-5-yl]-2-[(3s,5s,7s)-tricyclo[3.3.1.1~3,7~]decan-1-yl]acetamide",405,Allosteric function,Allosteric position,27935479,Structural basis for subtype-specific inhibition of the P2X7 receptor.,No,"Chain A:GLU305,GLN116,TRP167,ALA296,TYR298"
ASD17160000_1,P2RX7,Ailuropoda melanoleuca,G1M6C4,5U1X,ASD05310005,7RV,A,Lig,Inhibitor,N-{[4-(4-phenylpiperazin-1-yl)oxan-4-yl]methyl}-2-(phenylsulfanyl)pyridine-3-carboxamide,405,Allosteric function,Allosteric position,27935479,Structural basis for subtype-specific inhibition of the P2X7 receptor.,No,"Chain A:TRP167,ALA296,TYR298,PHE95,GLN116,PHE293,ARG294,TYR295,GLU305"
ASD17160000_1,P2RX7,Ailuropoda melanoleuca,G1M6C4,5U1Y,ASD17160001,7RS,A,Lig,Inhibitor,"N~2~-(3,4-difluorophenyl)-N-{2-methyl-5-[(piperazin-1-yl)methyl]phenyl}glycinamide",401,Allosteric function,Allosteric position,27935479,Structural basis for subtype-specific inhibition of the P2X7 receptor.,No,"Chain A:ALA185,SER184,ASN183,GLU186,ARG230,ASN187"
ASD17160000_1,P2RX7,Ailuropoda melanoleuca,G1M6C4,5U2H,ASD17160004,7S1,A,Lig,Inhibitor,N-cyano-N'-[(1R)-1-phenylethyl]-N''-quinolin-5-ylguanidine,403,Allosteric function,Allosteric position,27935479,Structural basis for subtype-specific inhibition of the P2X7 receptor.,No,"Chain A:GLU305,GLN116,TRP167,TYR298"
ASD17170000_1,ARF6,Homo sapiens,P62330,6BBP,ASD00290006,GTP,,Lig,Activator,GUANOSINE-5'-TRIPHOSPHATE,601,Allosteric function,Allosteric position,,,No,6BBP
ASD17170000_1,ARF6,Homo sapiens,P62330,6BBQ,ASD00290006,GTP,,Lig,Activator,GUANOSINE-5'-TRIPHOSPHATE,601,Allosteric function,Allosteric position,,,No,6BBQ
ASD17180000_1,NR5A2,Homo sapiens,O00482,4PLE,ASD17180001,CPS,A,Lig,activator,3-[(3-CHOLAMIDOPROPYL)DIMETHYLAMMONIO]-1-PROPANESULFONATE,603,,,26553876,Unexpected Allosteric Network Contributes to LRH-1 Co-regulator Selectivity.,,4PLE
ASD17200000_1,ASH2L,Homo sapiens,Q9UBL3,4RIQ,,DPY30,A,Pep,Regulator,Protein dpy-30 homolog,,Protein-Protein Interaction,Protein-Protein Interaction,25456412,Molecular Basis for DPY-30 Association to COMPASS-like and NURF Complexes.,No,4RIQ
ASD17210000_1,tdcG,Legionella pneumophila,A0A130G9H0,4RQO,,Cys,,Lig,Inhibitor,C-Terminal Cysteine residue,458,Allosteric Function,Allosteric Position,,,Yes,
ASD17220000_1,cueR,Escherichia coli (strain K12),P0A9G4,4WLW,ASD17220001,AG,A,Ion,Activator,SILVER ION,200,Allosteric Function,Allosteric Position,26293965,TRANSCRIPTION. Allosteric transcriptional regulation via changes in the overall topology of the core promoter.,No,"Chain A:GLY114,PRO113,PRO121,ILE123,ILE122,ASP119,CYS120,CYS112,LEU108"
ASD17230000_1,CDPK1,Toxoplasma gondii,Q9BJF5,4YGA,,1B7,"B, D, F, H",Pep,Inhibitor,VHH-1B7,1-141,Allosteric Function,Allosteric Position,26305940,Allosteric activation of apicomplexan calcium-dependent protein kinases.,No,
ASD17240000_1,lonA1,Meiothermus taiwanensis,A0A059VAZ3,4YPL,ASD17240001,4KZ,A,Lig,Activator,N-[(1R)-1-(dihydroxyboranyl)-2-phenylethyl]-Nalpha-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide,801,Allosteric Function,Allosteric Position,27041592,Structural Insights into the Allosteric Operation of the Lon AAA+ Protease,Yes,Chain F:ALA671
ASD17250000_1,PSKR,Daucus carota,Q8LPB4,4Z61,,PSK,P,Pep,Activator,Phytosulfokine,28-31,Protein-Protein Interaction,Protein-Protein Interaction,26308901,Allosteric receptor activation by the plant peptide hormone phytosulfokine,No,
ASD17270000_1,malE,Escherichia coli O157:H7,P0AEY0,5BJZ,,sAB-11M,,Pep,,Synthetic antibody,,,,,,,
ASD17280000_1,VPS4,Saccharomyces cerevisiae (strain ATCC 204508 / S288c),P52917,5FVL,,VPS20,"C,D",Pep,Inhibitor,27 peptide,27,Protein-Protein Interaction,Protein-Protein Interaction,27075672,Structural Fine-Tuning of Mit Interacting Motif 2 (Mim2) and Allosteric Regulation of Escrt-III by Vps4 in Yeast.,No,
ASD17290000_1,HASPIN,Homo sapiens,Q8TF76,5HTB,ASD17290002,6L5,C,Lig,Inhibitor,"(3R)-4-amino-3-{[6-({[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]carbonyl}amino)hexanoyl]amino}-4-oxobutanoic acid (non-preferred name)",101,Allosteric Function,Allosteric Position,27139824,Co-crystal structures of the protein kinase haspin with bisubstrate inhibitors.,Yes,5HTB
ASD17290000_1,HASPIN,Homo sapiens,Q8TF76,5HTC,ASD17290001,66M,C,Lig,Inhibitor,"(2R)-2-{[6-({[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]carbonyl}amino)hexanoyl]amino}butanedioic acid (non-preferred name)",101,Allosteric Function,Allosteric Position,27139824,Co-crystal structures of the protein kinase haspin with bisubstrate inhibitors.,Yes,5HTC
ASD17300000_1,lacS,Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2),P22498,5IXE,ASD10438004,14O,,Lig,ActivatorA,5-fluoro-1H-indole,501,Allosteric Fuction,Allosteric Position,27389009,Full and Partial Agonism of a Designed Enzyme Switch.,No,"Chain A:TRP433,LEU153,SER435,PHE222,VAL37,VAL48,TRP151,GLY33,SER220,PHE17,GLY221,ASP32,TYR431,ALA434,PRO152,TRP36,TYR34,PRO223,HIS150"
ASD17310000_1,USP12,Homo sapiens,O75317,5K1A,,UAF1,"B,D,F,H",Pep,Activator,WD repeat-containing protein 48,1-677,Protein-Protein Interaction,Protein-Protein Interaction,27373336,Allosteric Activation of Ubiquitin-Specific Proteases by beta-Propeller Proteins UAF1 and WDR20.,No,5K1A
ASD17310000_1,USP12,Homo sapiens,O75317,5K1C,,WDR20,B,Pep,Activator,WD repeat-containing protein 20,1-563,Protein-Protein Interaction,Protein-Protein Interaction,27373336,Allosteric Activation of Ubiquitin-Specific Proteases by beta-Propeller Proteins UAF1 and WDR20.,No,5K1C
ASD17320000_1,PRKDC,Homo sapiens,P78527,5LUQ,,KU80ct194,"K,S",Pep,Activator,C-terminal fragment of KU80?,194,Protein-Protein Interaction,Protein-Protein Interaction,28154079,DNA-PKcs structure suggests an allosteric mechanism modulating DNA double-strand break repair.,No,5LUQ
ASD17330000_1,,Ixodes ricinus,V5HCK7,5N70,,PROPEPTID,B,Pep,Inhibitor,ALA-PHE-ARG-ILE-PRO-LEU-THR-ARG,8,Allosteric Fuction,Allosteric Position,29396291,Novel Structural Mechanism of Allosteric Regulation of Aspartic Peptidases via an Evolutionarily Conserved Exosite.,Yes,"Chain B:PHE6,LEU10,PRO9,ILE8,ARG7"
ASD17340000_1,SCL1,Saccharomyces cerevisiae (strain ATCC 204508 / S288c),P21243,5NIF,,Blm-pep,,Pep,Activator,Blm-pep,14,Allosteric Fuction,Allosteric Position,28733623,Crystal structure of a low molecular weight activator Blm-pep with yeast 20S proteasome - insights into the enzyme activation mechanism.,No,
ASD17350000_1,Rps6ka3,Mus musculus,P18654,5O1S,ASD17350001,9HB,A,Lig,Inhibitor,Dimethyl fumarate,802,Allosteric function,Allosteric position,30341347,Dimethyl fumarate is an allosteric covalent inhibitor of the p90 ribosomal S6 kinases.,No,"Chain A:TYR595,ARG667,LEU660,VAL662,CYS599,HIS661,SER603,ASP600,ALA598,ILE633,LEU710,TRP602"
ASD17360000_1,SMPD3,Homo sapiens,Q9NY59,5UVG,,CAT,A,Pep,Activator,soluble catalytic domain of nSMase2,,Inner Protein regulator,Inner Protein,28652336,Structure of human nSMase2 reveals an interdomain allosteric activation mechanism for ceramide generation.,No,5UVG
ASD17370000_1,ambP1,Fischerella ambigua UTEX 1903,V5TDZ4,5Z45,ASD00330030,MG,A,Ion,modulator,MAGNESIUM ION,402,Allosteric function,Allosteric position,29677386,Molecular Insight into the Mg2+-Dependent Allosteric Control of Indole Prenylation by Aromatic Prenyltransferase AmbP1,No,"Chain A:GLU63,ASP40,GLU64,ASP65,ASN41,GLN68,HIS62"
ASD17370000_1,ambP1,Fischerella ambigua UTEX 1903,V5TDZ4,5Z46,ASD00330030,MG,A,Ion,modulator,MAGNESIUM ION,402,Allosteric function,Allosteric position,29677386,Molecular Insight into the Mg2+-Dependent Allosteric Control of Indole Prenylation by Aromatic Prenyltransferase AmbP1,No,"Chain A:GLU63,ASP40,GLU64,ASP65,ASN41,GLN68,HIS62"
ASD17380000_1,PARP1,Homo sapiens,P09874,6BHV,ASD17380001,DQV,A,Lig,Inhibitor,"[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl [(2R,3S,4R,5S)-5-(3-carbamoylphenyl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate (non-preferred name)",1101,Allosteric function,Allosteric position,29487285,NAD+analog reveals PARP-1 substrate-blocking mechanism and allosteric communication from catalytic center to DNA-binding domains.,Yes,6BHV
ASD17380000_1,PARP1,Homo sapiens,P09874,6VKK,,RPB,A,Lig,Inhibitor,Rucaparib,1101,,,,,,6VKK
ASD17400000_1,leuA2,Leptospira biflexa serovar Patoc (strain Patoc 1 / ATCC 23582 / Paris),B0SN40,4OV4,ASD02470006,KIV,A,Lig,Regulator,3-METHYL-2-OXOBUTANOIC ACID,402,Allosteric function,Allosteric position,25128527,Subdomain II of alpha-isopropylmalate synthase is essential for activity: inferring a mechanism of feedback inhibition.,Yes,"Chain A:LEU75,THR178,HIS99,GLU231,ASN177,HIS147,ASN243,HIS207,ASN174,GLU146,VAL179,GLY145,GLU45,PRO176,ARG14,VAL101,HIS209,ASP15,SER144"
ASD17400000_1,leuA2,Leptospira biflexa serovar Patoc (strain Patoc 1 / ATCC 23582 / Paris),B0SN40,4OV9,ASD17400002,VPM,A,Lig,Regulator,(2S)-2-hydroxy-2-(propan-2-yl)butanedioic acid,402,Allosteric function,Allosteric position,25128527,Subdomain II of alpha-isopropylmalate synthase is essential for activity: inferring a mechanism of feedback inhibition.,Yes,"Chain A:LEU75,THR178,HIS99,ASN177,HIS207,GLY145,GLU239,ASN174,VAL179,GLU45,PRO176,VAL101,GLU146,PHE48,GLU231,HIS147,ARG14,ASN243,GLN18,SER144,ASP15,HIS209"
ASD17410000_1,,Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1),Q9HV27,4R8Z,,NI,,Ion,,NICKEL (II) ION,401,Allosteric function,Allosteric position,25691523,"Structural basis of functional diversification of the HD-GYP domain revealed by the Pseudomonas aeruginosa PA4781 protein, which displays an unselective bimetallic binding site.",No,
ASD17420000_1,,Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1),Q9HVB9,5BQ1,ASD17420001,CO2,A,Gas,Regulator,CARBON DIOXIDE,"302,303",Allosteric function,Allosteric position,26457866,Carbon Dioxide 'Trapped' in a beta-Carbonic Anhydrase.,No,"Chain A:GLY103,VAL104,ASN65,ALA45,ARG64,HIS98,ARG46,CYS42,VAL62,TRP39,SER43,CYS101,VAL47,ASN50,ASP44,GLY102,PRO48,ALA49,ALA67,VAL66"
ASD17430000_1,ERBB3,Homo sapiens,P21860,5CUS,,KTN3379,"L,M,N,O",Pep,Inhibitor,Fab LC region of KTN3379,1-216,Allosteric function,Allosteric position,26460020,Inhibition of ErbB3 by a monoclonal antibody that locks the extracellular domain in an inactive configuration.,No,5CUS
ASD17440000_1,,Zika virus,A0A146CJG7,5K8T,,MG,A,Ion,Regulator,MAGNESIUM ION,703,Allosteric function,Allosteric position,27915293,Molecular mechanism of divalent-metal-induced activation of NS3 helicase and insights into Zika virus inhibitor design.,No,
ASD17450000_1,,Norwalk virus,Q5F4T5,5O03,,Nano-32,"C,D",Pep,,Nanobody (VHH) Nano-32,,,,29095961,Nanobodies targeting norovirus capsid reveal functional epitopes and potential mechanisms of neutralization.,,
ASD17460000_1,DPP8,Homo sapiens,Q6V1X1,6EOP,,SUMO1,D,Pep,Inhibitor,SER-LEU-ARG-PHE-LEU-TYR-GLU-GLY,8,Allosteric function,Allosteric position,29382749,"Structures and mechanism of dipeptidyl peptidases 8 and 9, important players in cellular homeostasis and cancer.",No,6EOP
ASD17500000_1,PRMT5,Homo sapiens,O14744,6UXX,,QL1,A,Lig,Inhibitor,"(5R)-2-amino-5-(4-methoxyphenyl)-3-methyl-5-[(3S,5S,7S)-tricyclo[3.3.1.1~3,7~]decan-1-yl]-3,5-dihydro-4H-imidazol-4-one",701,,,,,,6UXX
ASD17500000_1,PRMT5,Homo sapiens,O14744,6UXY,,QKY,A,Lig,Inhibitor,"(5R)-2-amino-5-(2-cyclohexylethyl)-3-methyl-5-phenyl-3,5-dihydro-4H-imidazol-4-one",701,,,,,,6UXY
ASD17660000_1,spuE,Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1),Q9I6J0,6IKM,,,,Pep,Inhibitor,Anti-SpuE Antibody,,,,,,,
ASD17720000_1,lpxD,Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1),Q9HXY6,6UEC,,,,Lig,,,,Inner Protein Regulator,Inner Protein,,,No,
ASD17740000_1,THRB,Homo sapiens,P10828,6KKB,,8HO,X,lig,activator,2-[(1-methyl-4-oxidanyl-7-phenoxy-isoquinolin-3-yl)carbonylamino]ethanoic acid,501,Allosteric function,Allosteric position,,,No,6KKB
ASD17760000_1,PCSK9,Homo sapiens,Q8NBP7,6U26,,63,B,Lig,Activator,"4'-{[(1R)-6-{2-[2-({N~5~-[N,N'-bis(tert-butoxycarbonyl)carbamimidoyl]-N~2~-(tert-butoxycarbonyl)-L-ornithyl}amino)ethoxy]ethoxy}-1-methyl-1-{2-oxo-2-[(1,3-thiazol-2-yl)amino]ethyl}-1,2,3,4-tetrahydroisoquinolin-7-yl]oxy}-2'-fluoro[1,1'-biphenyl]-4-carboxylic acid",801,Allosteric function,Allosteric position,,,No,6U26
ASD17760000_1,PCSK9,Homo sapiens,Q8NBP7,6U2N,,PV7,B,Lig,Activator,"4-{[(1R)-6-methoxy-1-methyl-1-{2-oxo-2-[(1,3-thiazol-2-yl)amino]ethyl}-1,2,3,4-tetrahydroisoquinolin-7-yl]oxy}benzoic acid",801,Allosteric function,Allosteric position,,,No,6U2N
ASD17760000_1,PCSK9,Homo sapiens,Q8NBP7,6U2P,,PUV,B,Lig,Activator,"2-fluoro-4-{[(1R)-6-methoxy-1-methyl-1-{2-oxo-2-[(1,3-thiazol-2-yl)amino]ethyl}-1,2,3,4-tetrahydroisoquinolin-7-yl]oxy}benzoic acid",804,Allosteric function,Allosteric position,,,No,6U2P
ASD17760000_1,PCSK9,Homo sapiens,Q8NBP7,6U36,,PVM,A,Lig,Regulator,"2-fluoro-4-{[(1R)-6-(2-{4-[1-(4-methoxyphenyl)-5-methyl-6-oxo-1,6-dihydropyridazin-3-yl]-1H-1,2,3-triazol-1-yl}ethoxy)-1-methyl-1-{2-oxo-2-[(1,3-thiazol-2-yl)amino]ethyl}-1,2,3,4-tetrahydroisoquinolin-7-yl]oxy}benzoic acid",801,,,,,,6U36
ASD17760000_1,PCSK9,Homo sapiens,Q8NBP7,6U38,,PVJ,B,Lig,Activator,"2-fluoro-4-{[(1R)-1-methyl-6-{[(2S)-oxan-2-yl]methoxy}-1-{2-oxo-2-[(1,3-thiazol-2-yl)amino]ethyl}-1,2,3,4-tetrahydroisoquinolin-7-yl]oxy}benzoic acid",801,Allosteric function,Allosteric position,,,No,6U38
ASD17760000_1,PCSK9,Homo sapiens,Q8NBP7,6U3X,,PVV,B,Lig,Activator,"2-[(1R)-6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl]-N-(1,3-thiazol-2-yl)acetamide",801,Allosteric function,Allosteric position,,,No,6U3X
ASD17910000_1,mglA,Myxococcus xanthus (strain DK1622),Q1DB04,6IZW,,GSP,A,pep,activator,5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE,301,Allosteric function,Allosteric position,,,yes,
ASD17970000_1,rep,Severe acute respiratory syndrome coronavirus 2,P0DTD1,7ABU,,R6Q,A,Lig,Inhibitor,"1'-[2-[4-(trifluoromethyl)phenyl]ethyl]spiro[1~{H}-3,1-benzoxazine-4,4'-piperidine]-2-one",401,,,,,,
ASD17970000_1,rep,Severe acute respiratory syndrome coronavirus 2,P0DTD1,7AGA,,LZE,A,Lig,Inhibitor,"4-{[(2,6-dichlorophenyl)carbonyl]amino}-N-piperidin-4-yl-1H-pyrazole-3-carboxamide",401,,,,,,
ASD17970000_1,rep,Severe acute respiratory syndrome coronavirus 2,P0DTD1,7AMJ,,RMZ,A,Lig,Inhibitor,"(3~{S})-3-[2-[4-(3,4-dimethylphenyl)piperazin-1-yl]ethyl]-2,3-dihydroisoindol-1-one",409,,,,,,
ASD17970000_1,rep,Severe acute respiratory syndrome coronavirus 2,P0DTD1,7APH,,RT2,A,Lig,Inhibitor,Tofogliflozin,401,,,,,,
ASD17970000_1,rep,Severe acute respiratory syndrome coronavirus 2,P0DTD1,7AQI,,QEL,A,Lig,Inhibitor,"4-[(1R,2S)-2-(4-benzylpiperidin-1-yl)-1-hydroxypropyl]phenol",401,,,,,,
ASD17970000_1,rep,Severe acute respiratory syndrome coronavirus 2,P0DTD1,7AXM,,93J,A,Lig,Inhibitor,(2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxyquinolin-6-yl}-4-(dimethylamino)but-2-enamide,502,,,,,,
ASD17970000_1,rep,Severe acute respiratory syndrome coronavirus 2,P0DTD1,7OFS,ASD17970002,YRL,E,compound,,4-(2-hydroxyethyl)phenol,,,,35953531,,,
ASD17970000_1,rep,Severe acute respiratory syndrome coronavirus 2,P0DTD1,7OFT,ASD17970003,HBA,K,compound,,4-hydroxybenzaldehyde,,,,35953531,,,
ASD17970000_1,rep,Severe acute respiratory syndrome coronavirus 2,P0DTD1,7OFU,ASD11670002,HE9,B,Compound,,"methyl 3,4-dihydroxybenzoate",,,,35953531,,,
ASD17980000_1,INPPL1,Homo sapiens,O15357,6SQU,,D7I,B,Lig,Regulator,"5,5'-(ethane-1,2-diylbis(oxy))bis(benzene-5,4,2,1,-tetrayl)hexakisphosphate",801,,,,,,6SQU
ASD17990000_1,GALK1,Homo sapiens,P51570,6ZGV,,QKZ,D,Lig,Inhibitor,2-(4-chlorophenyl)-~{N}-pyrimidin-2-yl-ethanamide,401,,,,,,6ZGV
ASD17990000_1,GALK1,Homo sapiens,P51570,6ZGX,,S6V,D,Lig,Inhibitor,1-[2-(2-oxidanylidenepyrrolidin-1-yl)ethyl]-3-phenyl-urea,401,,,,,,6ZGX
ASD17990000_1,GALK1,Homo sapiens,P51570,6ZGY,,QL5,A,Lig,Inhibitor,"(2,5-dimethylphenyl) pyridine-4-carboxylate",403,,,,,,6ZGY
ASD17990000_1,GALK1,Homo sapiens,P51570,6ZGZ,,SSY,D,Lig,Inhibitor,"~{N}-(3-ethanoylphenyl)-2,2,2-tris(fluoranyl)ethanamide",401,,,,,,6ZGZ
ASD18080000_1,coaBC,Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155),A0QWT2,6THC,,N9N,B,Lig,Inhibitor,"(4-hydroxyphenyl)-[2,3,4-tris(oxidanyl)phenyl]methanone",503,,,,,,
ASD18100000_1,SMYD3,Homo sapiens,Q9H7B4,6YUH,,POW,A,Lig,Regulator,Diperodon,503,,,,,,6YUH
ASD18130000_1,5565629,Aedes aegypti,Q16F38,6DU6,,FBP,A,Lig,Activator,"1,6-di-O-phosphono-beta-D-fructofuranose",601,,,,,,
ASD18320000_1,TEAD2,Homo sapiens,Q15562,6E5G,,HUY,B,Lig,Inhibitor,1-(2-{[3-(trifluoromethyl)phenyl]amino}phenyl)ethan-1-one,501,,,,,,6E5G
ASD18390000_1,Tc00.1047053505183.30,Trypanosoma cruzi (strain CL Brener),Q4DJ68,6W29,,SEV,A,Lig,Inhibitor,"3,5-bis(fluoranyl)-~{N}-[3-[(4-methoxyphenyl)sulfamoyl]phenyl]benzamide",601,,,,,,
ASD18390000_1,Tc00.1047053505183.30,Trypanosoma cruzi (strain CL Brener),Q4DJ68,6W2N,,SJD,A,Lig,Inhibitor,"3,5-bis(fluoranyl)-~{N}-[3-[(2-fluoranyl-4-methoxy-phenyl)sulfamoyl]phenyl]benzamide",601,,,,,,
ASD18390000_1,Tc00.1047053505183.30,Trypanosoma cruzi (strain CL Brener),Q4DJ68,6W49,,SWV,A,Lig,Inhibitor,~{N}-[3-[(2-fluorophenyl)sulfamoyl]phenyl]pyrazine-2-carboxamide,603,,,,,,
ASD18390000_1,Tc00.1047053505183.30,Trypanosoma cruzi (strain CL Brener),Q4DJ68,6W53,,SZP,A,Lig,Inhibitor,"N-(2-chloro-5-{[4-(trifluoromethoxy)phenyl]sulfamoyl}phenyl)-3,5-difluorobenzamide",601,,,,,,
ASD18390000_1,Tc00.1047053505183.30,Trypanosoma cruzi (strain CL Brener),Q4DJ68,6W56,,SZJ,A,Lig,Inhibitor,"~{N}-[3-[[4-[bis(fluoranyl)methoxy]phenyl]sulfamoyl]phenyl]-3,5-bis(fluoranyl)benzamide",602,,,,,,
ASD18390000_1,Tc00.1047053505183.30,Trypanosoma cruzi (strain CL Brener),Q4DJ68,6W57,,SZG,A,Lig,Inhibitor,"~{N}-[5-[[4-[bis(fluoranyl)methoxy]phenyl]sulfamoyl]-2-chloranyl-phenyl]-3,5-bis(fluoranyl)benzamide",602,,,,,,
ASD18390000_1,Tc00.1047053505183.30,Trypanosoma cruzi (strain CL Brener),Q4DJ68,6W59,,SZD,A,Lig,Inhibitor,"3,5-bis(fluoranyl)-~{N}-[3-[[4-(trifluoromethyloxy)phenyl]sulfamoyl]phenyl]benzamide",602,,,,,,
ASD18420000_1,DHPS,Homo sapiens,P49366,6P4V,,8XY,A,,Inhibitor,6-bromo-N-(1H-indol-4-yl)-1-benzothiophene-2-carboxamide,401,,,,,,6PGR
ASD18420000_1,DHPS,Homo sapiens,P49366,6PGR,,8XY,A,Lig,Inhibitor,6-bromo-N-(1H-indol-4-yl)-1-benzothiophene-2-carboxamide,401,Allosteric function,Allosteric position,,,No,6PGR
ASD18420000_1,DHPS,Homo sapiens,P49366,6WKZ,,8Y1,A,Lig,Inhibitor,"6-[(1R)-2-amino-1-phenylethyl]-3-(pyridin-3-yl)-5,6-dihydrothieno[2,3-c]pyridin-7(4H)-one",701,,,,,,6WKZ
ASD18420000_1,DHPS,Homo sapiens,P49366,6WL6,,91A,A,Lig,Inhibitor,"6-[(2R)-1-amino-4-methylpentan-2-yl]-3-(pyridin-3-yl)-5,6-dihydrothieno[2,3-c]pyridin-7(4H)-one",701,,,,,,6WL6
ASD18480000_1,Pkd2l1,Mus musculus,A2A259,7D7F,,CA,B,Ion,Activator,CALCIUM ION,704,,,,,,
ASD18490000_1,MTHFD2,Homo sapiens,P13995,7EHM,,J4C,A,Lig,Inhibitor,"(2S)-2-[[4-[[1-[(3,4-dichlorophenyl)methyl]-3,7-dimethyl-2,6-bis(oxidanylidene)purin-8-yl]amino]phenyl]carbonylamino]pentanedioic acid",401,,,,,,7EHM
ASD18500000_1,PFKL,Homo sapiens,P17858,7LW1,ASD18500006,YG1,A@@D@@E@@F,compound,,"N-(2-(2-(5-hydroxypent-1-yn-1-yl)phenyl)-4H,10H-benzo[f]pyrazolo[5,1-c][1,4]oxazepin-7-yl)acetamide",,,,34320407,,,7LW1
ASD18520000_1,Sarm,Drosophila melanogaster,Q6IDD9,7RTC,,NCN,A,Lig,Inhibitor,NICOTINATE MONONUCLEOTIDE,701,,,,,,
ASD18740000_1,PF3D7_1206100,Plasmodium falciparum (isolate 3D7),A0A144A134,6RMD,,ATP,D,Lig,Activator,ADENOSINE-5'-TRIPHOSPHATE,501,,,,,,
ASD18780000_1,GA2OX3,Oryza sativa subsp. japonica,Q8S0S6,6KU3,,GA4,A,Lig,Activator,GIBBERELLIN A4,401,Allosteric function,Allosteric position,,,No,
ASD18980000_1,speG,Bacillus thuringiensis,A0A0G3E2X5,6VFN,,SPM,A,Lig,,SPERMINE,201,,,,,,
ASD18990000_1,LMJF_21_0810,Leishmania major,Q4QCD2,6SWX,,LWN,A,Lig,Inhibitor,"methyl 2-[[6-[[3,4-bis(fluoranyl)phenyl]amino]-1-methyl-pyrazolo[3,4-d]pyrimidin-4-yl]amino]ethanoate",801,,,,,,
ASD19110000_1,Gpr52,Homo sapiens,Q9Y2T5,6LI0,,EN6,A,,Activator,N-(2-hydroxyethyl)-5-(hydroxymethyl)-3-methyl-1-[2-[[3-(trifluoromethyl)phenyl]methyl]-1-benzothiophen-7-yl]pyrazole-4-carboxamide,1401,,,,,,6LI0
ASD19220000_1,RPA1163,Rhodopseudomonas palustris (strain ATCC BAA-98 / CGA009),Q6NAM1,6QKU,,R3W,A,Lig,Regulator,chloroacetic acid,402,Allosteric function,Allosteric position,,,Yes,
ASD19220000_1,RPA1163,Rhodopseudomonas palustris (strain ATCC BAA-98 / CGA009),Q6NAM1,6QKW,,FAH,B,Lig,Regulator,fluoroacetic acid,402,Allosteric function,Allosteric position,,,Yes,
ASD19360000_1,SERPINA3,Homo sapiens,P01011,6HGF,,HCY,B,lig,Inhibitor,"(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione",501,Allosteric function,Allosteric position,,,Yes,6HGF
ASD19360000_1,SERPINA3,Homo sapiens,P01011,6HGG,,HCY,A,lig,Inhibitor,"(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione",401,Allosteric function,Allosteric position,,,Yes,6HGG
ASD19360000_1,SERPINA3,Homo sapiens,P01011,6HGI,,C0R,A,lig,Inhibitor,CORTICOSTERONE,401,Allosteric function,Allosteric position,,,Yes,6HGI
ASD19360000_1,SERPINA3,Homo sapiens,P01011,6HGJ,,AS4,A,lig,Inhibitor,ALDOSTERONE,401,Allosteric function,Allosteric position,,,Yes,6HGJ
ASD19360000_1,SERPINA3,Homo sapiens,P01011,6HGK,,STR,A,lig,Inhibitor,PROGESTERONE,401,Allosteric function,Allosteric position,,,Yes,6HGK
ASD19360000_1,SERPINA3,Homo sapiens,P01011,6HGL,,TES,B,lig,Inhibitor,TESTOSTERONE,401,Allosteric function,Allosteric position,,,Yes,6HGL
ASD19370000_1,TEL1,Saccharomyces cerevisiae (strain ATCC 204508 / S288c),P38110,6S8F,,ANP,F,lig,Regulator,PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER,2788,Allosteric position,Allosteric position,,,No,
ASD19530000_1,Arnt,Mus musculus,P53762,6E3S,,79A,A,Lig,Inhibitor,"3-{[(1S)-2,2-difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1H-inden-4-yl]oxy}-5-fluorobenzonitrile",401,,,,,,
ASD19580000_1,SARM1,Homo sapiens,Q6SZW1,7ANW,,NAD,,Lig,,NICOTINAMIDE-ADENINE-DINUCLEOTIDE,,,,,,,7ANW
ASD19580000_1,SARM1,Homo sapiens,Q6SZW1,7DJT,,H8L,G,Lig,Inhibitor,"O3-methyl O5-(2-methylpropyl) 2,6-dimethyl-4-[2-(oxidanylamino)phenyl]pyridine-3,5-dicarboxylate",1001,,,,,,7DJT
ASD19580000_1,SARM1,Homo sapiens,Q6SZW1,7NAL,ASD19580004,NMN,"I,J,K,L,M",compound,,"[(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate",,,,35334231,,,7NAL
ASD20100000_1,H2AC4,Homo sapiens,P04908,6IQ4,,D0X,G,lig,Inhibitor,[Ru(eta(6)-p-cymene)Cl-2(pta),201,Allosteric function,Allosteric position,,,No,6IQ4
ASD20150000_1,CAMKK2,Homo sapiens,Q96RR4,2ZV2,ASD19890001,609,A,compound,,"(4R)-4-((2S)-2-((2R)-2-(((3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl)oxy)propanamido)propanamido)-5-amino-5-oxopentanoic acid",,,,31444000,,,2ZV2
ASD20220000_1,TOP2A,Homo sapiens,P11388,1ZXM,ASD19980001,ANP,A,,,,,,,31374424,,,1ZXM
ASD20380000_1,EYM_03995,Ignicoccus islandicus DSM 13165,A0A0U3FQH7,6QSS,,7MT,A,Lig,Activator,Tb-Xo4,401,Allosteric function,Allosteric position,,,No,
ASD20420000_1,EYA2,Homo sapiens,O00167,5ZMA,,9FX,A,lig,Inhibitor,3-fluoro-N'-[(E)-{5-[(pyrimidin-2-yl)sulfanyl]furan-2-yl}methylidene]benzohydrazide,601,Allosteric function,Allosteric position,,,No,5ZMA
ASD20570000_1,None,Dengue virus type 2,Q91H74,6MO0,,JVJ,A,lig,Inhibitor,1-(4-{3-[4-(furan-3-yl)phenyl]-5-[(piperidin-4-yl)methoxy]pyrazin-2-yl}phenyl)methanamine,1158,Allosteric function,Allosteric position,,,No,
ASD20570000_1,None,Dengue virus type 2,Q91H74,6MO1,,I16,A,lig,Inhibitor,5-[4-(aminomethyl)phenyl]-6-[4-(furan-3-yl)phenyl]-N-[(piperidin-4-yl)methyl]pyrazin-2-amine,1158,Allosteric function,Allosteric position,,,No,
ASD20570000_1,None,Dengue virus type 2,Q91H74,6MO2,,JVM,A,lig,Inhibitor,1-(4-{5-[(piperidin-4-yl)methoxy]-3-[4-(1H-pyrazol-4-yl)phenyl]pyrazin-2-yl}phenyl)methanamine,1158,Allosteric function,Allosteric position,,,No,
ASD20680000_1,DUSP10,Homo sapiens,Q9Y6W6,6MC1,,CJA,A,Lig,Inhibitor,"3,3-dimethyl-1-{[9-(methylsulfanyl)-5,6-dihydrothieno[3,4-h]quinazolin-2-yl]sulfanyl}butan-2-one",500,,,,,,6MC1
ASD20800000_1,OXTR,Homo sapiens,P30559,6TPK,,CLR,A,Lig,Regulator,CHOLESTEROL,1502,,,,,,6TPK
ASD20880000_1,DHDPS1,Arabidopsis thaliana,Q9LZX6,6VVH,,LYS,"AAA, BBB, CCC, DDD",Lig,Regulator,LYSINE,,,,,,,
ASD20920000_1,ASIC1,Gallus gallus,Q1XA76,6X9H,,UZG,A,Lig,Inhibitor,"2-[4-(3,4-dimethoxyphenoxy)phenyl]-1H-benzimidazole-6-carboximidamide",502,,,,,,
ASD21010000_1,fabG,Acinetobacter baumannii,V5VHN7,6T65,,MLH,C,Lig,Inhibitor,ethyl 6-bromanyl-2-[(dimethylamino)methyl]-5-oxidanyl-1-phenyl-indole-3-carboxylate,301,,,,,,
ASD21020000_1,fabG,Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720),P0A2C9,6T5X,,NDP,A,Lig,Inhibitor,NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE,301,,,,,,
ASD21280000_1,GCH1,Homo sapiens,P30793,6Z88,,QBK,A,Lig,,"5-azanyl-[1,3]thiazolo[5,4-d]pyrimidine-2,7-dione",301,,,,,,6Z88
ASD21280000_1,GCH1,Homo sapiens,P30793,6Z89,,QBK,A,Lig,Inhibitor,"5-azanyl-[1,3]thiazolo[5,4-d]pyrimidine-2,7-dione",301,,,,,,6Z89
ASD21320000_1,GABRB2,Homo sapiens,P47870,6X3U,,FYP,D,Lig,Activator,"ethyl 8-fluoro-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate",402,,,,,,6X3U
ASD21320000_1,GABRB2,Homo sapiens,P47870,6X3X,,DZP,C,Lig,Activator,"7-CHLORO-1-METHYL-5-PHENYL-1,3-DIHYDRO-2H-1,4-BENZODIAZEPIN-2-ONE",406,,,,,,6X3X
ASD21370000_1,pvdP,Pseudomonas aeruginosa,Q9I188,6RRP,,URS,A,Lig,Inhibitor,N-PHENYLTHIOUREA,601,Allosteric function,Allosteric position,,,No,
ASD21390000_1,fumC,Mycobacterium tuberculosis,P9WN93,5F91,,5WJ,"A,C",Lig,Inhibitor,~{N}-[5-(azepan-1-ylsulfonyl)-2-methoxy-phenyl]- 2-(4-oxidanylidene-3~{H}-phthalazin-1-yl)ethanamide,468,Inner Protein Regulator,Allosteric Position,,,No,
ASD21390000_1,fumC,Mycobacterium tuberculosis,P9WN93,6S43,,KUE,A,lig,Inhibitor,~{N}-[5-(azocan-1-ylsulfonyl)-2-methoxy-phenyl]-2-(4-oxidanylidene-3~{H}-phthalazin-1-yl)ethanamide,468,Allosteric function,Allosteric position,,,Yes,
ASD21390000_1,fumC,Mycobacterium tuberculosis,P9WN93,6S7K,,KYZ,A,lig,Inhibitor,~{N}-[2-methoxy-5-(methylsulfamoyl)phenyl]-2-(4-oxidanylidene-3~{H}-phthalazin-1-yl)ethanamide,468,Allosteric function,Allosteric position,,,Yes,
ASD21390000_1,fumC,Mycobacterium tuberculosis,P9WN93,6S7S,,KZ8,A,lig,Inhibitor,~{N}-[2-methoxy-5-(phenylsulfamoyl)phenyl]-2-(4-oxidanylidene-3~{H}-phthalazin-1-yl)ethanamide,468,Allosteric function,Allosteric position,,,Yes,
ASD21390000_1,fumC,Mycobacterium tuberculosis,P9WN93,6S7U,,KZK,A,lig,Inhibitor,~{N}-[5-(azepan-1-ylsulfonyl)-2-methoxy-phenyl]-2-(1~{H}-indol-3-yl)ethanamide,468,Allosteric function,Allosteric position,,,Yes,
ASD21390000_1,fumC,Mycobacterium tuberculosis,P9WN93,6S7W,,KZT,A,lig,Inhibitor,~{N}-[5-(azepan-1-ylsulfonyl)-2-methoxy-phenyl]-2-quinolin-4-yl-ethanamide,468,Allosteric function,Allosteric position,,,Yes,
ASD21390000_1,fumC,Mycobacterium tuberculosis,P9WN93,6S88,,L0K,A,lig,Inhibitor,"~{N}-[2-methoxy-5-(1,2,4,5-tetrahydro-3-benzazepin-3-ylsulfonyl)phenyl]-2-(4-oxidanylidene-3~{H}-phthalazin-1-yl)ethanamide",468,Allosteric function,Allosteric position,,,Yes,
ASD21400000_1,pfkA,Staphylococcus aureus,P99165,5XZ9,,ATP,A,lig,activator,ADENOSINE-5'-TRIPHOSPHATE,322,Protein-Protein Interaction,Allosteric position,,,No,
ASD21400000_1,pfkA,Staphylococcus aureus,P99165,5XZA,,ADP-Mg,A,lig,activator,ADENOSINE-5'-DIPHOSPHATE-MG,323,Protein-Protein Interaction,Allosteric position,,,No,
ASD21410000_1,KMT5A,Homo sapiens,Q9NQR1,6BOZ,,E1J,A,lig,Inhibitor,N-(3-{[7-(2-aminoethoxy)-6-methoxy-2-(pyrrolidin-1-yl)quinazolin-4-yl]amino}propyl)prop-2-enamide,402,Protein-Protein Interaction,Allosteric position,,,yes,6BOZ
ASD21420000_1,DKFZp686C11235,Homo sapiens,Q6MZV7,6CJX,,NAG,A,Lig,Activator,2-acetamido-2-deoxy-beta-D-glucopyranose,501,Allosteric function,Allosteric position,,,No,6CJX
ASD21430000_1,SAE1,Homo sapiens,Q9UBE0,6CWY,,FHJ,D,Lig,Inhibitor,"dimethyl (1S,2S,3R,4R)-1-[(1S)-2-(4-methylphenyl)-1-(phenylamino)ethyl]-7-oxabicyclo[2.2.1]hept-5-ene-2,3-dicarboxylate",707,,,,,,6CWY
ASD21440000_1,hpt,Bacillus anthracis,B9ZW32,6D9S,,G4P,A,lig,Inhibitor,"GUANOSINE-5',3'-TETRAPHOSPHATE",201,Allosteric function,Allosteric position,,,Yes,
ASD21450000_1,,Bacillus cereus,P14488,6DJA,,ZN,A,ion,activator,ZINC ION,258,Allosteric function,Allosteric position,,,Yes,
ASD21460000_1,SMARCA2,Homo sapiens,P51531,6EG2,,J7J,A,Lig,Inhibitor,"N-(5-amino-2-chloropyridin-4-yl)-N'-(4-bromo-3-{[3-(hydroxymethyl)phenyl]ethynyl}-1,2-thiazol-5-yl)urea",1001,,Allosteric position,,,,6EG2
ASD21460000_1,SMARCA2,Homo sapiens,P51531,6EG3,,J7G,A,Lig,Inhibitor,3-[(4-{[(2-chloropyridin-4-yl)carbamoyl]amino}pyridin-2-yl)ethynyl]benzoic acid,1001,,Allosteric position,,,,6EG3
ASD21470000_1,Cgl1925,Corynebacterium glutamicum,Q8NP91,6G1B,,PEO,J,Lig,modulator,HYDROGEN PEROXIDE,405,,,,,,
ASD21480000_1,ppnN,Escherichia coli,P0ADR8,6GFM,,0O2,A,,Regulator,guanosine 5'-(tetrahydrogen triphosphate) 3'-(trihydrogen diphosphate),501,,,,,,
ASD21490000_1,purL,Salmonella typhimurium,P74881,6JTA,,GLN,A,Lig,Activator,GLUTAMINE,1302,Allosteric function,Allosteric position,,,No,
ASD21500000_1,cysE,Klebsiella pneumoniae subsp. pneumoniae,A6TFK2,6JVU,,CYS,B,Lig,Inhibitor,CYSTEINE,701,Protein-Protein Interaction,Protein-Protein,,,No,
ASD21510000_1,BPE1,Solanum tuberosum,Q43837,6KDY,,NAD,A,Lig,Activator,NICOTINAMIDE-ADENINE-DINUCLEOTIDE,401,Allosteric function,Allosteric position,,,No,
ASD21530000_1,DAO,Oryza sativa subsp. indica,Q01IX6,6KUN,,IAC,A,Lig,Activator,1H-INDOL-3-YLACETIC ACID,402,Allosteric function,Allosteric position,,,Yes,
ASD21540000_1,,Zika virus,A0A024B7W1,6LD2,,KY3,A,Lig,Inhibitor,"(1S,2S,4S,5R)-2,4-dimethoxy-5-thiophen-2-yl-cyclohexane-1-carboxylic acid",903,,,,,,
ASD21560000_1,EIF2AK4,Homo sapiens,Q9P2K8,6N3N,,KA4,A,lig,Inhibitor,"N-{3-[(2-aminopyrimidin-5-yl)ethynyl]-2,4-difluorophenyl}-2,5-dichloro-3-(hydroxymethyl)benzene-1-sulfonamide",1004,Allosteric function,Allosteric position,,,No,6N3N
ASD21560000_1,EIF2AK4,Homo sapiens,Q9P2K8,6N3O,,KA7,A,lig,Inhibitor,"N-{3-[(2-aminopyrimidin-5-yl)ethynyl]-2,4-difluorophenyl}-5-chloro-2-methoxypyridine-3-sulfonamide",2500,Allosteric function,Allosteric position,,,No,6N3O
ASD21570000_1,camC,Pseudomonas putida,P00183,6NBL,,CYN,A,Ion,Activator,CYANIDE ION,502,Allosteric function,Inner Protein,,,No,
ASD21580000_1,PPARGC1A,Homo sapiens,Q9UBK2,6NWK,,DEX,A,Lig,Activator,"(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyethanoyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one",301,Allosteric function,Allosteric position,,,No,6NWK
ASD21580000_1,PPARGC1A,Homo sapiens,Q9UBK2,6NWL,,HCY,A,Lig,Activator,"(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione",301,Allosteric function,Allosteric position,,,No,6NWL
ASD21590000_1,menD,Mycobacterium tuberculosis,P9WK11,6O04,,DNA,A,,Inhibitor,"1,4-dihydroxy-2-naphthoic acid",601,,,,,,
ASD21590000_1,menD,Mycobacterium tuberculosis,P9WK11,6O0G,,DNA,A,Lig,Inhibitor,"1,4-dihydroxy-2-naphthoic acid",601,Allosteric function,Allosteric position,,,No,
ASD21590000_1,menD,Mycobacterium tuberculosis,P9WK11,6O0J,,DNA,A,Lig,Inhibitor,"1,4-dihydroxy-2-naphthoic acid",601,Allosteric function,Allosteric position,,,No,
ASD21590000_1,menD,Mycobacterium tuberculosis,P9WK11,6O0N,,DNA,A,Lig,Inhibitor,"1,4-dihydroxy-2-naphthoic acid",601,Allosteric function,Allosteric position,,,No,
ASD21600000_1,sqv-4,Caenorhabditis elegans,Q19905,6OM8,,UDX,A,Lig,Inhibitor,URIDINE-5'-DIPHOSPHATE-XYLOPYRANOSE,501,Allosteric function,Allosteric position,,,Yes,
ASD21610000_1,RBP2,Homo sapiens,P50120,6ON5,,ZN,A,Lon,Regulator,ZINC ION,201,Allosteric function,Allosteric position,,,No,6ON5
ASD21620000_1,hppA,Thermotoga maritima,Q9S5X0,6QXA,,GQB,A,lig,Inhibitor,"~{N}-[(2-azanyl-3~{H}-1,3-benzothiazol-6-yl)methyl]-1~{H}-indole-2-carboxamide",809,Allosteric function,Allosteric position,,,No,
ASD21630000_1,PA4179,Pseudomonas aeruginosa,Q9HWK2,6QXL,,G6P,A,Lig,Activator,6-O-phosphono-alpha-D-glucopyranose,501,Allosteric function,Allosteric position,,,No,
ASD21640000_1,nanA,Streptococcus pneumoniae,P62575,6QZH,,JLW,A,,Inhibitor,"3-[[4-[[(1~{R})-2,2-dimethyl-1-(5-methylfuran-2-yl)propyl]amino]-1,1-bis(oxidanylidene)-1,2,5-thiadiazol-3-yl]amino]-~{N},~{N},6-trimethyl-2-oxidanyl-benzamide",1502,,,,,,
ASD21650000_1,hisZ,Psychrobacter arcticus,Q4FTX3,6R02,,HIS,A,Lig,Inhibitor,HISTIDINE,401,Allosteric function,Allosteric position,,,No,
ASD21670000_1,,Trypanosoma brucei brucei,P50098,6RFU,,ATP,A,lig,activator,ADENOSINE-5'-TRIPHOSPHATE,601,Allosteric function,Allosteric position,,,Yes,
ASD21680000_1,gyrB,Escherichia coli,P0AES6,6RKS,,JHN,G,lig,Inhibitor,"(3~{R})-3-[[4-(3,4-dihydro-2~{H}-pyrano[2,3-c]pyridin-6-ylmethylamino)piperidin-1-yl]methyl]-1,4,7-triazatricyclo[6.3.1.0^{4,12}]dodeca-6,8(12),9-triene-5,11-dione",101,Inner DNA/RNA,Inner DNA/RNA,,,Yes,
ASD21680000_1,gyrB,Escherichia coli,P0AES6,6RKU,,JHN,G,lig,Inhibitor,"(3~{R})-3-[[4-(3,4-dihydro-2~{H}-pyrano[2,3-c]pyridin-6-ylmethylamino)piperidin-1-yl]methyl]-1,4,7-triazatricyclo[6.3.1.0^{4,12}]dodeca-6,8(12),9-triene-5,12-dione",101,Inner DNA/RNA,Inner DNA/RNA,,,Yes,
ASD21680000_1,gyrB,Escherichia coli,P0AES6,6RKW,,JHN,G,lig,Inhibitor,"(3~{R})-3-[[4-(3,4-dihydro-2~{H}-pyrano[2,3-c]pyridin-6-ylmethylamino)piperidin-1-yl]methyl]-1,4,7-triazatricyclo[6.3.1.0^{4,12}]dodeca-6,8(12),9-triene-5,11-dione",101,Inner DNA/RNA,Inner DNA/RNA,,,Yes,
ASD21690000_1,TTHA1717,Thermus thermophilus,Q5SHL3,6S2T,,G4P,A,Lig,Regulator,"GUANOSINE-5',3'-TETRAPHOSPHATE",401,,,,,,
ASD21690000_1,TTHA1717,Thermus thermophilus,Q5SHL3,6S2U,,GN3,A,Lig,Regulator,"[[[(2~{R},3~{S},4~{R},5~{R})-5-(2-azanyl-6-oxidanylidene-1~{H}-purin-9-yl)-4-oxidanyl-2-[[oxidanyl(phosphonooxy)phosphoryl]oxymethyl]oxolan-3-yl]oxy-oxidanyl-phosphoryl]amino]phosphonic acid",403,,,,,,
ASD21700000_1,ftsZ,Mycobacterium tuberculosis,P9WN94,6S7Z,,KZN,A,lig,Inhibitor,"~{N}-[5-(3,4-dihydro-1~{H}-isoquinolin-2-ylsulfonyl)-2-methoxy-phenyl]-2-(4-oxidanylidene-3~{H}-phthalazin-1-yl)ethanamide",468,Allosteric function,Allosteric position,,,Yes,
ASD21710000_1,lptF,Shigella flexneri,P0AFA1,6S8G,,ANP,A,Lig,Activator,PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER,401,Allosteric function,Allosteric position,,,No,
ASD21720000_1,CYTH3,Homo sapiens,O43739,6U3E,,4IP,A,Lig,Activator,"INOSITOL-(1,3,4,5)-TETRAKISPHOSPHATE",400,Allosteric function,Allosteric position,,,No,6U3E
ASD21720000_1,CYTH3,Homo sapiens,O43739,6U3G,,4IP,A,Lig,Activator,"INOSITOL-(1,3,4,5)-TETRAKISPHOSPHATE",400,Allosteric function,Allosteric position,,,No,6U3G
ASD21730000_1,lpxA,Pseudomonas aeruginosa,A6V1E4,6UEE,,,,Lig,,,,Inner Protein Regulator,Inner Protein,,,No,
ASD21730000_1,lpxA,Pseudomonas aeruginosa,A6V1E4,6UEG,,,,Lig,,,,Inner Protein Regulator,Inner Protein,,,No,
ASD21740000_1,FG01410.1,Gibberella zeae,A0A098D3M4,6UI4,,Q8V,A,lig,Inhibitor,ethyl (2Z)-3-amino-2-cyano-3-phenylprop-2-enoate,802,,,,,,
ASD21750000_1,JKP90_15375,Desulfofustis sp. PB-SRB1,V4JF97,6V4S,,CA,A,Ion,Regulator,CALCIUM ION,701,Inner Protein Regulator,Inner Protein,,,No,
ASD21760000_1,sacA,Neisseria meningitidis serogroup A / serotype 4A,A0A0U1RGY0,6VLC,,UD1,"A, C",Lig,Regulator,URIDINE-DIPHOSPHATE-N-ACETYLGLUCOSAMINE,400,,,,,,
ASD21770000_1,gsk,Escherichia coli,P0AEW6,6VWP,,g4p,A,Lig,Regulator,"GUANOSINE-5',3'-TETRAPHOSPHATE",501,,,,,,
ASD21780000_1,lmo1009,Listeria monocytogenes serovar 1/2a,Q8Y8A3,6XNV,,2BA,A,Lig,Regulator,"(2R,3R,3aS,5R,7aR,9R,10R,10aS,12R,14aR)-2,9-bis(6-amino-9H-purin-9-yl)octahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-3,5,10,12-tetrol 5,12-dioxide",201,,,,,,
ASD21790000_1,ftsZ,Staphylococcus aureus,P0A031,6YD5,,OM8,A,Lig,Inhibitor,"3-[(3-chlorophenyl)methoxy]-2,6-bis(fluoranyl)benzamide",401,,,,,,
ASD21790000_1,ftsZ,Staphylococcus aureus,P0A031,6YD6,,OMW,A,Lig,Inhibitor,"2,6-bis(fluoranyl)-3-[[3-(trifluoromethyl)phenyl]methoxy]benzamide",402,,,,,,
ASD21800000_1,MAP2K7,Homo sapiens,O14733,6YZ4,,1.00E+08,A,Lig,activator,"1-{(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl}prop-2-en-1-one",514,,,,,,6YZ4
ASD21810000_1,NCSTN,Homo sapiens,Q92542,7D8X,,GZR,B,Lig,Regulator,1-[(1S)-1-(4-fluorophenyl)ethyl]-3-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]piperidin-2-one,502,,,,,,7D8X
ASD21820000_1,CTPsyn,Drosophila melanogaster,Q9VUL1,7DPT,,GTP,A,Lig,activator,GUANOSINE-5'-TRIPHOSPHATE,701,,,,,,
ASD21830000_1,dapA,Candidatus Liberibacter solanacearum,A0A0F4VK59,7LVL,,LYS,A,Lig,Inhibitor,LYSINE,401,,,,,,
ASD21840000_1,tyrA,Bacillus anthracis,Q81P63,5UYY,,TYR,A,Lig,Inhibitor,tyrosine,401,,,,,,
ASD21840000_1,tyrA,Bacillus anthracis,Q81P63,6U60,,TYR,A,Lig,Inhibitor,tyrosine,401,,,,,,
ASD21850000_1,lpg2603,Legionella pneumophila subsp. pneumophila,Q5ZSB6,6VVD,,IHP,A,Lig,Activator,INOSITOL HEXAKISPHOSPHATE,401,,,,,,
ASD21850000_1,lpg2603,Legionella pneumophila subsp. pneumophila,Q5ZSB6,6VVE,,IHP,A,Lig,Activator,INOSITOL HEXAKISPHOSPHATE,401,,,,,,
ASD21860000_1,Trpv2,Rattus norvegicus,Q9WUD2,6WKN,,LQ4,A,Lig,Inhibitor,piperlongumine,801,,,,,,
ASD21880000_1,Mapk14,Mus musculus,P47811,6Y4T,,O8W,A,Lig,Inhibitor,5-azanyl-~{N}-[[4-[[(2~{S})-1-[[(2~{S})-butan-2-yl]amino]-4-cyclohexyl-1-oxidanylidene-butan-2-yl]carbamoyl]phenyl]methyl]-1-phenyl-pyrazole-4-carboxamide,401,,,,,,
ASD21880000_1,Mapk14,Mus musculus,P47811,6Y4U,,O98,A,Lig,Inhibitor,5-azanyl-~{N}-[[4-[[(2~{S})-4-cyclohexyl-1-oxidanylidene-1-(pentan-3-ylamino)butan-2-yl]carbamoyl]phenyl]methyl]-1-phenyl-pyrazole-4-carboxamide,401,,,,,,
ASD21880000_1,Mapk14,Mus musculus,P47811,6Y4V,,O8Z,A,Lig,Inhibitor,5-azanyl-~{N}-[[4-[[(2~{S})-4-cyclohexyl-1-(3-methylbutylamino)-1-oxidanylidene-butan-2-yl]carbamoyl]phenyl]methyl]-1-phenyl-pyrazole-4-carboxamide,401,,,,,,
ASD21880000_1,Mapk14,Mus musculus,P47811,6Y4W,,O8T,A,Lig,Inhibitor,5-azanyl-~{N}-[[4-[[(2~{S})-4-cyclohexyl-1-(cyclohexylamino)-1-oxidanylidene-butan-2-yl]carbamoyl]phenyl]methyl]-1-phenyl-pyrazole-4-carboxamide,401,,,,,,
ASD21880000_1,Mapk14,Mus musculus,P47811,6Y4X,,O8Q,A,Lig,Inhibitor,5-azanyl-~{N}-[[4-[[(2~{S})-1-[2-(4-chlorophenyl)ethylamino]-4-cyclohexyl-1-oxidanylidene-butan-2-yl]carbamoyl]phenyl]methyl]-1-phenyl-pyrazole-4-carboxamide,408,,,,,,
ASD21880000_1,Mapk14,Mus musculus,P47811,6Y6V,,OE5,A,Lig,Inhibitor,5-azanyl-~{N}-[[4-[[5-~{tert}-butyl-2-(4-methylphenyl)pyrazol-3-yl]carbamoyl]phenyl]methyl]-1-phenyl-pyrazole-4-carboxamide,401,,,,,,
ASD21880000_1,Mapk14,Mus musculus,P47811,6YJC,,OSZ,A,Lig,Inhibitor,5-azanyl-~{N}-[[4-[[(2~{S})-4-cyclohexyl-1-oxidanylidene-1-piperazin-1-yl-butan-2-yl]carbamoyl]phenyl]methyl]-1-phenyl-pyrazole-4-carboxamide,401,,,,,,
ASD21880000_1,Mapk14,Mus musculus,P47811,6YK7,,OU2,A,Lig,Inhibitor,5-azanyl-~{N}-[[4-[[(2~{S})-4-cyclohexyl-1-(ethylamino)-1-oxidanylidene-butan-2-yl]carbamoyl]phenyl]methyl]-1-phenyl-pyrazole-4-carboxamide,401,,,,,,
ASD21880000_1,Mapk14,Mus musculus,P47811,6ZWP,,OE8,A,Lig,Inhibitor,5-azanyl-~{N}-[[4-[[(2~{S})-4-cyclohexyl-1-[(4-fluorophenyl)amino]-1-oxidanylidene-butan-2-yl]carbamoyl]phenyl]methyl]-1-phenyl-pyrazole-4-carboxamide,401,,,,,,
ASD21880000_1,Mapk14,Mus musculus,P47811,6ZWR,,OEB,A,Lig,Inhibitor,5-azanyl-~{N}-[[4-[[(2~{S})-4-cyclohexyl-1-oxidanylidene-1-(pyridin-4-ylmethylamino)butan-2-yl]carbamoyl]phenyl]methyl]-1-phenyl-pyrazole-4-carboxamide,401,,,,,,
ASD21890000_1,LEPBI_p0053,Leptospira biflexa serovar Patoc,B0SUI1,6ZXM,,C2E,A,Lig,Inhibitor,"9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin-6-one)",301,,,,,,
ASD21900000_1,POLRMT,Homo sapiens,O00411,7A8P,,R4Q,A,Lig,Inhibitor,(3~{R})-1-[(2~{R})-2-[4-(2-chloranyl-4-fluoranyl-phenyl)-2-oxidanylidene-chromen-7-yl]oxypropanoyl]piperidine-3-carboxylic acid,1301,,,,,,7A8P
ASD21920000_1,GDAP1,Homo sapiens,Q8TB36,7AIA,,RF8,A,Lig,Regulator,exadecanedioic acid,513,,,,,,7AIA
ASD21930000_1,GPBAR1,Homo sapiens,Q8TDU6,7CFM,,FWX,R,Lig,Activator,"2-(ethylamino)-6-[3-(4-propan-2-ylphenyl)propanoyl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine-4-carboxamide",401,,,,,,7CFM
ASD21930000_1,GPBAR1,Homo sapiens,Q8TDU6,7CFN,,FX0,R,Lig,Activator,"(2S,4R)-4-[(3R,5S,6R,7R,8R,9S,10S,12S,13R,14S,17R)-6-ethyl-10,13-dimethyl-3,7,12-tris(oxidanyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-pentanoic acid",401,,,,,,7CFN
ASD21940000_1,GMPPB,Homo sapiens,Q9Y5P6,7D72,,GDD,L,Lig,Regulator,GUANOSINE-5'-DIPHOSPHATE-ALPHA-D-MANNOSE,401,,,,,,7D72
ASD21950000_1,SLC26A5,Homo sapiens,P58743,7LGU,,CL,A,Ion,Regulator,CHLORIDE ION,801,,,,,,7LGU
ASD21950000_1,SLC26A5,Homo sapiens,P58743,7LGW,,CL,A,Ion,Regulator,CHLORIDE ION,801,,,,,,7LGW
ASD21950000_1,SLC26A5,Homo sapiens,P58743,7LH2,,CL,A,Ion,Regulator,CHLORIDE ION,802,,,,,,7LH2
ASD21960000_1,ECBD_2681,Escherichia coli,A0A140NBS6,7MEW,,Z5Y,A,Lig,Inhibitor,"(2E)-3-{1-cyclopropyl-7-[(1S)-1-(3,6-dichloro-2-fluorophenyl)ethoxy]naphthalen-2-yl}prop-2-enoic acid",601,,,,,,
ASD21970000_1,,Schistosoma mansoni,A0A3Q0KFL1,7NPX,,FAD,A,Lig,Inhibitor,FLAVIN-ADENINE DINUCLEOTIDE,601,,,,,,
ASD21990000_1,Epas1,Mus musculus,P97481,6E3U,,HNJ,B,Lig,Activator,"3-{[2-(pyrrolidin-1-yl)phenyl]amino}-1H-1lambda~6~,2-benzothiazole-1,1-dione",401,,,,,,
ASD22000000_1,,Sulfolobus islandicus,Q54324,6GVT,,,,DNA,Regulator,5'-D(*CP*TP*GP*TP*GP*CP*TP*CP*A)-3',,,,,,,
ASD22010000_1,csm2,Streptococcus thermophilus,A0A0A7HIX1,6NUD,,,,RNA,Activator,target ssRNA,,,,,,,
ASD22020000_1,,Bothrops moojeni,Q9I834,6PWH,,VRD,A,Lig,,({3-[amino(oxo)acetyl]-1-benzyl-2-ethyl-1H-indol-4-yl}oxy)acetic acid,201,,,,,,
ASD22030000_1,gyrB,Staphylococcus aureus,P0A0K8,6QX1,,JK8,B,Lig,Inhibitor,"(2~{R})-2-[[5-(2-chlorophenyl)-1,2-benzoxazol-3-yl]oxy]-2-phenyl-ethanamine",702,,,,,,
ASD22030000_1,gyrB,Staphylococcus aureus,P0A0K8,6QX2,,JK8,B,Lig,Inhibitor,"(2~{R})-2-[[5-(2-chlorophenyl)-1,2-benzoxazol-3-yl]oxy]-2-phenyl-ethanamine",702,,,,,,
ASD22040000_1,LDHA,Homo sapiens,P00338,6SBU,,L5N,A,Lig,Inhibitor,"4-[[4-[(5-chloranylthiophen-2-yl)carbonylamino]-1,3-bis(oxidanylidene)isoindol-2-yl]methyl]benzoic acid",1001,,,,,,6SBU
ASD22040000_1,LDHA,Homo sapiens,P00338,6SBV,,L5K,A,Lig,Inhibitor,~{N}-[3-[(7-nitrodibenzofuran-2-yl)sulfonylamino]phenyl]-1-oxidanyl-cyclopropane-1-carboxamide,1001,,,,,,6SBV
ASD22050000_1,pfk,Trypanosoma brucei brucei,O15648,6QU3,,JJ5,A,Lig,Inhibitor,"1-[(3,4-dichlorophenyl)methyl]-7~{H}-pyrrolo[3,2-c]pyridin-4-one",1001,,,,,,
ASD22050000_1,pfk,Trypanosoma brucei brucei,O15648,6QU4,,JJ2,A,Lig,Inhibitor,"1-[(3,4-dichlorophenyl)methyl]-5-[2-(dimethylamino)ethyl]pyrrolo[3,2-c]pyridin-4-one",1001,,,,,,
ASD80060000_2,,Vibrio cholerae,,3IRW,ASD06980001,C2E,R,Lig,Regulator,"9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)- 3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro- 2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine- 2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin- 6-one)",1,Protein-DNA/RNA Interaction Regulator,Inner DNA/RNA,19898477,Structural basis of ligand binding by a c-di-GMP riboswitch.,No,Chain R:ALA47
ASD80060000_2,,Vibrio cholerae,,3IWN,ASD06980001,C2E,A,Lig,Regulator,"9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)- 3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro- 2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine- 2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin- 6-one)",501,Protein-DNA/RNA Interaction Regulator,Inner DNA/RNA,19898478,Recognition of the bacterial second messenger cyclic diguanylate by its cognate riboswitch.,No,Chain A:CYS88
ASD80060000_2,,Vibrio cholerae,,3MUM,ASD06980001,C2E,R,Lig,Regulator,"9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)- 3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro- 2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine- 2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin- 6-one)",1,Protein-DNA/RNA Interaction Regulator,Inner DNA/RNA,20690679,Structural and biochemical determinants of ligand binding by the c-di-GMP riboswitch .,No,Chain R:ALA47
ASD80060000_2,,Vibrio cholerae,,3MUR,ASD06980001,C2E,R,Lig,Regulator,"9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)- 3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro- 2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine- 2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin- 6-one)",1,Protein-DNA/RNA Interaction Regulator,Inner DNA/RNA,20690679,Structural and biochemical determinants of ligand binding by the c-di-GMP riboswitch .,No,Chain R:ALA47
ASD80060000_2,,Vibrio cholerae,,3MUT,ASD06980001,C2E,R,Lig,Regulator,"9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)- 3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro- 2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine- 2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin- 6-one)",1,Protein-DNA/RNA Interaction Regulator,Inner DNA/RNA,20690679,Structural and biochemical determinants of ligand binding by the c-di-GMP riboswitch .,No,Chain R:ALA47
ASD80060000_2,,Vibrio cholerae,,3MUV,ASD05550002,2BA,R,Lig,Regulator,"(2R,3R,3aS,5R,7aR,9R,10R,10aS,12R,14aR)-2,9- bis(6-amino-9H-purin-9-yl)octahydro-2H,7H- difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine- 3,5,10,12-tetrol 5,12-dioxide",358,Protein-DNA/RNA Interaction Regulator,Inner DNA/RNA,20690679,Structural and biochemical determinants of ligand binding by the c-di-GMP riboswitch .,No,Chain R:ALA47
ASD80060000_2,,Vibrio cholerae,,3MXH,ASD06980001,C2E,R,Lig,Regulator,"9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)- 3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro- 2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine- 2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin- 6-one)",1,Protein-DNA/RNA Interaction Regulator,Inner DNA/RNA,20690679,Structural and biochemical determinants of ligand binding by the c-di-GMP riboswitch .,No,Chain R:ALA47
ASD80060000_2,,Vibrio cholerae,,3OWI,ASD01260003,GLY,A,Lig,Regulator,2-aminoethanoic acid,89,Inner DNA/RNA Regulator,Inner DNA/RNA,21145485,Structural insights into ligand recognition by a sensing domain of the cooperative glycine riboswitch.,No,Chain A:GLY36
ASD80060000_2,,Vibrio cholerae,,3OWW,ASD01260003,GLY,A,Lig,Regulator,2-aminoethanoic acid,89,Inner DNA/RNA Regulator,Inner DNA/RNA,21145485,Structural insights into ligand recognition by a sensing domain of the cooperative glycine riboswitch.,No,Chain A:GLY36
ASD80060000_2,,Vibrio cholerae,,3OWZ,ASD01260003,GLY,A,Lig,Regulator,2-aminoethanoic acid,89,Inner DNA/RNA Regulator,Inner DNA/RNA,21145485,Structural insights into ligand recognition by a sensing domain of the cooperative glycine riboswitch.,No,Chain A:GLY36
ASD80060000_2,,Vibrio cholerae,,3OXE,ASD01260003,GLY,A,Lig,Regulator,2-aminoethanoic acid,89,Inner DNA/RNA Regulator,Inner DNA/RNA,21145485,Structural insights into ligand recognition by a sensing domain of the cooperative glycine riboswitch.,No,Chain A:GLY36
ASD80060000_2,,Vibrio cholerae,,3OXJ,ASD01260003,GLY,A,Lig,Regulator,2-aminoethanoic acid,89,Inner DNA/RNA Regulator,Inner DNA/RNA,21145485,Structural insights into ligand recognition by a sensing domain of the cooperative glycine riboswitch.,No,Chain A:GLY36
ASD80060000_2,,Vibrio cholerae,,3OXM,ASD01260003,GLY,A,Lig,Regulator,2-aminoethanoic acid,89,Inner DNA/RNA Regulator,Inner DNA/RNA,21145485,Structural insights into ligand recognition by a sensing domain of the cooperative glycine riboswitch.,No,Chain A:GLY36
ASD80060000_2,,Vibrio cholerae,,3Q3Z,ASD06980001,C2E,A,Lig,Regulator,"9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)- 3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro- 2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine- 2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin- 6-one)",2,Protein-DNA/RNA Interaction Regulator,Inner DNA/RNA,21518891,Structural basis of differential ligand recognition by two classes of bis-(3'-5')-cyclic dimeric guanosine monophosphate-binding riboswitches.,No,Chain A:ALA70